<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ğŸ¦ çš„çŸ¥è­˜èŠ±åœ’ ğŸŒ± on</title><link>https://www.physician.tw/</link><description>Recent content in ğŸ¦ çš„çŸ¥è­˜èŠ±åœ’ ğŸŒ± on</description><generator>Hugo -- gohugo.io</generator><language>zh-tw</language><atom:link href="https://www.physician.tw/index.xml" rel="self" type="application/rss+xml"/><item><title>balloon-retrograde transvenous obliteration</title><link>https://www.physician.tw/balloon-retrograde-transvenous-obliteration/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/balloon-retrograde-transvenous-obliteration/</guid><description>balloon-retrograde transvenous obliteration</description></item><item><title>bivalirudin</title><link>https://www.physician.tw/bivalirudin/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bivalirudin/</guid><description>bivalirudin</description></item><item><title>capsule endoscopy</title><link>https://www.physician.tw/capsule-endoscopy/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/capsule-endoscopy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[diagnostic studies of gastrointestinal bleeding]]
capsule endoscopy ğŸš§ A capsule endoscopy is a type of procedure that allows your doctor to see the inside of your gastrointestinal tract.</description></item><item><title>chloroquine</title><link>https://www.physician.tw/chloroquine/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chloroquine/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Transcellular shifts]]
chloroquine Chloroquine is an antimalarial and anti-inflammatory drug used to treat and prevent malariaï¿½</description></item><item><title>hepatopulmonary syndrome</title><link>https://www.physician.tw/hepatopulmonary-syndrome/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatopulmonary-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Definition-cirrhosis]]
hepatopulmonary syndrome ğŸš§ Hepatopulmonary syndrome is a chronic lung condition that occurs when there is an insufficient blood supply to the lungs.</description></item><item><title>lua</title><link>https://www.physician.tw/lua/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lua/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[neovim]]
lua Lua is a lightweight, interpreted, scripting language with a design based on the concept of prototypes</description></item><item><title>medical statistics</title><link>https://www.physician.tw/medical-statistics/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medical-statistics/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[researcher]]
medical statistics #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>multiprocessing</title><link>https://www.physician.tw/multiprocessing/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiprocessing/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[UNIX systems]]
multiprocessing Multiprocessing is a process where two or more processors are working on two or more separate programs at the same time</description></item><item><title>open-source</title><link>https://www.physician.tw/open-source/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/open-source/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[zotero]]
open-source Open-source software (OSS) is software that is licensed under an open-source license. Open-source licenses are licenses that comply with the Open Source Definition â€” in brief, they allow software to be freely used, modified, and shared</description></item><item><title>PUD</title><link>https://www.physician.tw/PUD/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PUD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[peptic ulcer disease]]
PUD ğŸš§ A peptic ulcer is a sore that forms in the lining of your digestive tract.</description></item><item><title>researcher</title><link>https://www.physician.tw/researcher/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/researcher/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[index]]
researcher A researcher is someone who conducts research, which is defined as a process of gathering, processing, and analyzing data in order to answer a question or solve a problem</description></item><item><title>UNIX systems</title><link>https://www.physician.tw/UNIX-systems/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/UNIX-systems/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[vimscripts]]
UNIX systems #ğŸš§ æ–½å·¥ä¸­ UNIX is a [[multiprocessing]], multitasking operating system that was developed in the early 1970s.</description></item><item><title>villous adenoma</title><link>https://www.physician.tw/villous-adenoma/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/villous-adenoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[GI potassium losses]]
villous adenoma A villous adenoma is a type of adenoma that occurs in the lining of the intestine.</description></item><item><title>vim buffer</title><link>https://www.physician.tw/vim-buffer/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-buffer/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[vim]]
vim buffer A buffer is a file that is loaded into memory for editing.</description></item><item><title>vimscripts</title><link>https://www.physician.tw/vimscripts/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vimscripts/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[vim]]
vimscripts #ğŸš§ æ–½å·¥ä¸­ Vim is a highly configurable text editor built to enable efficient text editing.</description></item><item><title>zotero</title><link>https://www.physician.tw/zotero/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zotero/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[zotero plugin]]
zotero Zotero is a free, [[open-source]] reference management tool for tracking and organizing research sources.</description></item><item><title>zotero plugin</title><link>https://www.physician.tw/zotero-plugin/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zotero-plugin/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ç”¨Zoteroä¾†ç®¡ç†Paper]]
[[zotero]] plugin I&amp;rsquo;m not sure what you&amp;rsquo;re asking</description></item><item><title>Î²2-agonists</title><link>https://www.physician.tw/%CE%B22-agonists/</link><pubDate>Sat, 28 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B22-agonists/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Transcellular shifts]]
Î²2-agonists Î²2-agonists is a class of medications that stimulate the Î²2-adrenergic receptors, resulting in bronchodilation and relaxation of smooth muscle in the bronchi and uterus</description></item><item><title>ABC Score</title><link>https://www.physician.tw/ABC-Score/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ABC-Score/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Assess severity as initial management of gastrointestinal bleeding]]
ABC Score #ğŸš§ æ–½å·¥ä¸­ Penetrating mechanism (Yes = 1, No = 0) Systolic BP â‰¤ 90 mmHg in the Emergency Department (Yes = 1, No = 0) HR â‰¥ 120 in the Emergency Department (Yes = 1, No = 0) Positive FAST Ultrasound (Yes = 1, No = 0) Nunez TC, Voskresensky IV, Dossett LA, et al.</description></item><item><title>AIMS65</title><link>https://www.physician.tw/AIMS65/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AIMS65/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Assess severity as initial management of gastrointestinal bleeding]]
AIMS65 Albumin &amp;lt;3 g/dL (30 g/L) INR &amp;gt;1.</description></item><item><title>Assess severity as initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Assess-severity-as-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Assess-severity-as-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Assess severity as initial management of gastrointestinal bleeding VS including orthostatic Î”s, JVP.</description></item><item><title>blood urea nitrogen creatinine (BUN Cr) ratio</title><link>https://www.physician.tw/blood-urea-nitrogen-creatinine-BUN-Cr-ratio/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blood-urea-nitrogen-creatinine-BUN-Cr-ratio/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Lab studies for gastrointestinal bleeding]]
blood urea nitrogen creatinine (BUN Cr) ratio #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Clinical manifestations of gastrointestinal bleeding</title><link>https://www.physician.tw/Clinical-manifestations-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[gastrointestinal bleeding]]
Clinical manifestations of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ Hematemesis = blood in vomitus (UGIB) Coffee-ground emesis = emesis of blood exposed to gastric acid (UGIB) Melena = black, tarry stools from digested blood (usually UGIB, but can be SB or R colon) Hematochezia = bloody or maroon-colored stools (LGIB or rapid UGIB) Hematemesis refers to blood in vomit, which is commonly caused by upper gastrointestinal bleeding (UGIB).</description></item><item><title>Definition of gastrointestinal bleeding</title><link>https://www.physician.tw/Definition-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[gastrointestinal bleeding]]
Definition of gastrointestinal bleeding Intraluminal blood loss anywhere from the oropharynx to the anus Classification: upper = above the ligament of Treitz; lower = below the ligament of Treitz â€œSevereâ€ GIB: defined as having associated shock, orthostatic hypotension, â†“ Hct by 6% (or â†“ Hb by 2 g/dL), or requiring transfusion â‰¥2U PRBCs.</description></item><item><title>diagnostic studies of gastrointestinal bleeding</title><link>https://www.physician.tw/diagnostic-studies-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[gastrointestinal bleeding]]
diagnostic studies of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ è©³è¦‹â¡ï¸ï¼š JACR 2021;18:S139
UGIB: EGD w/in 24 h (NEJM 2020;382:1299).</description></item><item><title>erythromycin 250 mg</title><link>https://www.physician.tw/erythromycin-250-mg/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/erythromycin-250-mg/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[diagnostic studies of gastrointestinal bleeding]]
erythromycin 250 mg #ğŸš§ æ–½å·¥ä¸­ We suggest that patients only undergo NGT lavage if particulate matter, fresh blood, or clots need to be removed from the stomach to facilitate endoscopy.</description></item><item><title>exit 0</title><link>https://www.physician.tw/exit-0/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/exit-0/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Shell Scripting åŸºç¤æŒ‡å—]]
exit 0 In a shell script, exit 0 typically indicates that the script has completed successfully and the shell should exit with a status code of 0.</description></item><item><title>Fitz-Hugh-Curtis syndrome</title><link>https://www.physician.tw/Fitz-Hugh-Curtis-syndrome/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fitz-Hugh-Curtis-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Etiologies-ascites]]
Fitz-Hugh-Curtis syndrome #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>gastroesophageal reflux disease</title><link>https://www.physician.tw/gastroesophageal-reflux-disease/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroesophageal-reflux-disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Treatment gastroesophageal reflux disease ]]
gastroesophageal reflux disease [[pathophysiology gastroesophageal reflux disease]] [[clinical manifestations gastroesophageal reflux disease]] [[diagnosis gastroesophageal reflux disease]] [[treatment gastroesophageal reflux disease]] [[complications gastroesophageal reflux disease]]</description></item><item><title>gastrointestinal bleeding</title><link>https://www.physician.tw/gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastrointestinal-bleeding/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[gastroenterology]]
gastrointestinal bleeding [[sxtodx]]: [[GI bleeding]]
[[Definition of gastrointestinal bleeding]] [[Clinical manifestations of gastrointestinal bleeding]] [[initial management of gastrointestinal bleeding]] [[diagnostic studies of gastrointestinal bleeding]] etiology of [[upper gastrointestinal bleeding]] etiology of [[lower gastrointestinal bleeding]] [[Obscure GIB]]</description></item><item><title>Henoch-SchÃ¶nlein purpura</title><link>https://www.physician.tw/Henoch-Sch%C3%B6nlein-purpura/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Henoch-Sch%C3%B6nlein-purpura/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[IgA nephropathy]]
Henoch-SchÃ¶nlein purpura #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[gastrointestinal bleeding]]
initial management of gastrointestinal bleeding Uptodate: [[rapid overview of emergency management of gastrointestinal bleeding]]</description></item><item><title>Lab studies for gastrointestinal bleeding</title><link>https://www.physician.tw/Lab-studies-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lab-studies-for-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Lab studies for gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ Hct (may be normal in first 24 h of acute GIB before equilibration) 2â€“3% â†’ 500 mL blood loss; low MCV â†’ Fe deficient and chronic blood loss; plt, PT/INR, PTT; BUN/Cr (ratio &amp;gt;36 in UGIB b/c GI resorption of blood Â± prerenal azotemia); LFTs</description></item><item><title>Pathogenesis of ascites and related complications of cirrhosis</title><link>https://www.physician.tw/Pathogenesis-of-ascites-and-related-complications-of-cirrhosis/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-of-ascites-and-related-complications-of-cirrhosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pathophysiology-ascites]]
Pathogenesis of ascites and related complications of cirrhosis #ğŸš§ æ–½å·¥ä¸­ Figure: I. Introduction
Pathogenesis of ascites and related complications of cirrhosis II.</description></item><item><title>Physical exam of gastrointestinal bleeding</title><link>https://www.physician.tw/Physical-exam-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Physical exam of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ When evaluating a patient for abdominal conditions, it is important to assess for localizable tenderness, signs of peritoneal irritation, masses, and localized adenopathy.</description></item><item><title>rapid overview of emergency management of gastrointestinal bleeding</title><link>https://www.physician.tw/rapid-overview-of-emergency-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rapid-overview-of-emergency-management-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
rapid overview of emergency management of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ Major causes Peptic ulcer, esophagogastric varices, arteriovenous malformation, tumor, esophageal (Mallory-Weiss) tear</description></item><item><title>Resuscitation for gastrointestinal bleeding</title><link>https://www.physician.tw/Resuscitation-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Resuscitation-for-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Resuscitation for gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ To support a patient&amp;rsquo;s fluid and electrolyte balance, two large-bore intravenous lines (18-gauge or larger) are inserted.</description></item><item><title>Reverse coagulopathy for gastrointestinal bleeding</title><link>https://www.physician.tw/Reverse-coagulopathy-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reverse-coagulopathy-for-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Reverse coagulopathy for gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ consider FFP to normalize INR (however caution in ESLD where INR does not correlate with bleeding risk); plts &amp;gt;50k, ddAVP if uremic, consider reversal agents if on anticoagulants (qv)</description></item><item><title>Risk factor of initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Risk-factor-of-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factor-of-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Risk factor of initial management of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ When evaluating a patient for gastrointestinal bleeding (GIB), it is important to consider the patient&amp;rsquo;s past history of GIB, the speed at which the current bleed is occurring, specific symptoms related to the bleed (such as hematemesis or melena) other gastrointestinal symptoms (such as abdominal pain, changes in bowel habits, weight loss, or nausea and vomiting) use of medications such as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) or alcohol, use of anticoagulant or antiplatelet medications, a history or risk factors for cirrhosis, radiation therapy, or prior gastrointestinal or aortic surgery.</description></item><item><title>sclerotherapy</title><link>https://www.physician.tw/sclerotherapy/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sclerotherapy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rapid overview of emergency management of gastrointestinal bleeding]]
sclerotherapy #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Shell Scripting åŸºç¤æŒ‡å—</title><link>https://www.physician.tw/Shell-Scripting-%E5%9F%BA%E7%A4%8E%E6%8C%87%E5%8D%97/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shell-Scripting-%E5%9F%BA%E7%A4%8E%E6%8C%87%E5%8D%97/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[command line know how]]
Shell Scripting åŸºç¤æŒ‡å— #ğŸš§ æ–½å·¥ä¸­ ä»€éº¼æ˜¯ Shell Scriptingï¼Ÿ Shell Scripting æ˜¯ä¸€ç¨®åœ¨å‘½ä»¤æç¤ºå­—å…ƒ ([[command line interface]]) ä¸­ä½¿ç”¨çš„ç¨‹å¼èªè¨€ï¼Œç”¨æ–¼è‡ªå‹•åŒ–ç³»çµ±ç®¡ç†å’Œå…¶ä»–ä»»å‹™ã€‚</description></item><item><title>small-vessel vasculitis</title><link>https://www.physician.tw/small-vessel-vasculitis/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-vessel-vasculitis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[IgA nephropathy]]
small-vessel vasculitis #ğŸš§ æ–½å·¥ä¸­ Backlinkï¼š [[Clinical manifestations of Eosinophilic gran with polyangiitis]] [[Glomerular Pathology Associated with Nephritic Syndrome]] [[IgA nephropathy]] [[IgA vasculitis]] [[immune complex IC â€“associated small-vessel vasculitis]] [[vasculitis]]</description></item><item><title>Transfuse for gastrointestinal bleeding</title><link>https://www.physician.tw/Transfuse-for-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfuse-for-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Transfuse for gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ type &amp;amp; cross; use O-neg if emerg; for UGIB (esp.</description></item><item><title>transjugular intrahepatic portosystemic shunt</title><link>https://www.physician.tw/transjugular-intrahepatic-portosystemic-shunt/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transjugular-intrahepatic-portosystemic-shunt/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Portal HTN gastropathy]]
transjugular intrahepatic portosystemic shunt</description></item><item><title>Triage of initial management of gastrointestinal bleeding</title><link>https://www.physician.tw/Triage-of-initial-management-of-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Triage-of-initial-management-of-gastrointestinal-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[initial management of gastrointestinal bleeding]]
Triage of initial management of gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ alert endoscopist.</description></item><item><title>upper gastrointestinal bleeding</title><link>https://www.physician.tw/upper-gastrointestinal-bleeding/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upper-gastrointestinal-bleeding/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[diagnostic studies of gastrointestinal bleeding]]
upper gastrointestinal bleeding #ğŸš§ æ–½å·¥ä¸­ [[peptic ulcer disease]](20â€“60%; duodenal&amp;gt;gastric) [erosive gastropathy] [[esophagitis]] [[esophageal or gastric varices]] [[portal HTN gastropathy]]</description></item><item><title>vascular-enteric fistula</title><link>https://www.physician.tw/vascular-enteric-fistula/</link><pubDate>Fri, 27 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vascular-enteric-fistula/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rapid overview of emergency management of gastrointestinal bleeding]]
vascular-enteric fistula #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>checkifalive</title><link>https://www.physician.tw/checkifalive/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/checkifalive/</guid><description>checkifalive</description></item><item><title>checkifalivedd</title><link>https://www.physician.tw/checkifalivedd/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/checkifalivedd/</guid><description>checkifalivedd</description></item><item><title>Meigsâ€™ syndrome</title><link>https://www.physician.tw/Meigs-syndrome/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Meigs-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[index]]
Meigsâ€™ syndrome #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>protein-losing enteropathy</title><link>https://www.physician.tw/protein-losing-enteropathy/</link><pubDate>Thu, 26 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protein-losing-enteropathy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Etiologies-ascites]]
protein-losing enteropathy #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>abdominal pain</title><link>https://www.physician.tw/abdominal-pain/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominal-pain/</guid><description>abdominal pain [[approach to abdominal pain]]
Backlinkï¼š [[Acetaminophen hepatotoxicity]] [[Acute Diarrhea (3 weeks)]] [[acute diarrhea]] [[Adrenal Insufficiency (AI)]] [[an acid-base abnormality]] [[autoimmune pancreatitis]] [[Calcium]] [[Cholestatic Liver Diseases]] [[Cirrhosis and its Complications]] [[Clinical manifestations of IgA vasculitis]] [[clinical manifestations of peptic ulcer disease]] [[clinical manifestations of primary myelofibrosis (PMF)]] [[Clinical manifestations peptic ulcer disease ]] [[Clinical manifestations-crohnâ€™s disease]] [[Clinical manifestations-diabetic ketoacidosis]] [[Clinical manifestations-hypercalcemia]] [[Complications-aortic aneurysms]] [[Contents]] [[Contributing Authors]] [[Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS)]] [[Diseases of the Vasculature]] [[Functional Bowel Disorders]] [[Gallbladder Stone Diseases]] [[gastroenterology approaches and chief complaints]] [[Genitourinary (GU) Infections]] [[GI bleeding]] [[hyponatremia.</description></item><item><title>approach to abdominal pain</title><link>https://www.physician.tw/approach-to-abdominal-pain/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-abdominal-pain/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[abdominal pain]]
approach to abdominal pain #ğŸš§ æ–½å·¥ä¸­ [[differential diagnoses in abdominal pain organized by time course]]</description></item><item><title>differential diagnoses in abdominal pain organized by time course</title><link>https://www.physician.tw/differential-diagnoses-in-abdominal-pain-organized-by-time-course/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnoses-in-abdominal-pain-organized-by-time-course/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[approach to abdominal pain]]
differential diagnoses in abdominal pain organized by time course #ğŸš§ æ–½å·¥ä¸­ acute first episode AAA Acute mesenteric ischemia Appendicitis Biliary disease Diverticulitis DKA Ectopic pregnancy Gastroenteritis schemic colitis Myocardial infarction Ovarian torsion Nephrolithiasis Pancreatitis Peritonitis (from ruptured PUD, diverticulitis, etc) PID Small or large bowel obstruction Splenic rupture recurrent episode Biliary disease Diverticulitis DKA Nephrolithiasis Pancreatitis PID Small or large bowel obstruction subacute Chronic mesenteric ischemia IBD IBS Hepatitis PUD</description></item><item><title>Etiologies-hemoptysis</title><link>https://www.physician.tw/Etiologies-hemoptysis/</link><pubDate>Wed, 25 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hemoptysis/</guid><description>Etiologies-hemoptysis (Crit Care Med 2000;28:1642)
I-N-C-V
Parenchyma Bronchitis 70% Endobronchial lesions cavitary leion Vascular Artery Pulmonary emolism / aneurysms Capillary DAH AVM Vein CHF PVOD Infection/Inflammation Bronchitis (most common cause of trivial hemoptysis) Bronchiectasis incl CF (common cause of massive hemoptysis) TB or aspergilloma (can be massive); pneumonia or lung abscess Neoplasm Usually primary lung cancer, sometimes metastasis (can be massive) Cardiovasc PE (can be massive), pulmonary artery rupture (2Â° to instrumentation), CHF, mitral stenosis, trauma/foreign body, bronchovascular fistula Other Vasculitis (GPA, anti-GBM, BehÃ§etâ€™s, SLE), AVM, anticoag (withunderlying lung disease), coagulopathy, cocaine, pulm hemosiderosis</description></item><item><title>sxtodx</title><link>https://www.physician.tw/sxtodx/</link><pubDate>Tue, 24 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sxtodx/</guid><description>sxtodx [[I have a patient with a problem. How do I figure out the possible causes]] [[I have a healthy patient.</description></item><item><title>ambulatory</title><link>https://www.physician.tw/ambulatory/</link><pubDate>Mon, 23 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ambulatory/</guid><description>ambulatory Acute Respiratory Tract Infection Dizziness [[low back pain]] [[hypertension]] Hypercholesterolemia Cancer Screening [[vaccination]] [[smoking cessation]] Chronic Pain and Opioids</description></item><item><title>inbox</title><link>https://www.physician.tw/inbox/</link><pubDate>Mon, 23 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inbox/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[index]]
inbox #ğŸš§ æ–½å·¥ä¸­ [[tttttest]]
hellow worl</description></item><item><title>osteoarthritis</title><link>https://www.physician.tw/osteoarthritis/</link><pubDate>Mon, 23 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osteoarthritis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory]]
osteoarthritis #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>a bleeding disorder</title><link>https://www.physician.tw/a-bleeding-disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/a-bleeding-disorder/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
a bleeding disorder #ğŸš§ æ–½å·¥ä¸­ a bleeding disorder Philip Hoffman, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>a rash</title><link>https://www.physician.tw/a-rash/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/a-rash/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
a rash #ğŸš§ æ–½å·¥ä¸­ a rash Sarah Stein, MD
CHIEF COMPLAINT PATIENT
Ms. N is a 23-year-old woman who comes to see you complaining of a rash.</description></item><item><title>ACE Inhibitor-ARB Combination</title><link>https://www.physician.tw/ACE-Inhibitor-ARB-Combination/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACE-Inhibitor-ARB-Combination/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
ACE Inhibitor-ARB Combination #ğŸš§ æ–½å·¥ä¸­ ACE Inhibitor-ARB Combination â€¢Â VA-NEPHRON D. N Eng J Med 2013;369(20):1892â€“1903.</description></item><item><title>Acidâ€“Base Disorders</title><link>https://www.physician.tw/AcidBase-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AcidBase-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acidâ€“Base Disorders #ğŸš§ æ–½å·¥ä¸­ Acidâ€“Base Disorders First, a reminder of the normal values:</description></item><item><title>Acknowledgments</title><link>https://www.physician.tw/Acknowledgments/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acknowledgments/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
Acknowledgments #ğŸš§ æ–½å·¥ä¸­ Acknowledgments We would like to thank our coauthors, who now number twenty one, for their hard work in expanding this text.</description></item><item><title>Acneiform Eruptions</title><link>https://www.physician.tw/Acneiform-Eruptions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acneiform-Eruptions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acneiform Eruptions #ğŸš§ æ–½å·¥ä¸­ Acneiform Eruptions Acne vulgaris â€¢Â Pathophysiology: Inflammation of the hair follicle/sebaceous gland due to increased sebum production (androgen driven), abnormal keratinization, and proliferation of Cutibacterium acnes (formerly P.</description></item><item><title>Acute Coronary Syndrome (ACS) and Post-ACS Care</title><link>https://www.physician.tw/Acute-Coronary-Syndrome-ACS-and-Post-ACS-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Coronary-Syndrome-ACS-and-Post-ACS-Care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Coronary Syndrome (ACS) and Post-ACS Care #ğŸš§ æ–½å·¥ä¸­ Acute Coronary Syndrome (ACS) and Post-ACS Care â€¢Â CAPRICORN.</description></item><item><title>acute diarrhea</title><link>https://www.physician.tw/acute-diarrhea/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-diarrhea/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
acute diarrhea #ğŸš§ æ–½å·¥ä¸­ acute diarrhea Keith W. Hamilton, MD
CHIEF COMPLAINT PATIENT
Mr. C is a 35-year-old man who comes to your outpatient office complaining of 3 days of diarrhea.</description></item><item><title>Acute Diarrhea (3 weeks)</title><link>https://www.physician.tw/Acute-Diarrhea-3-weeks/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Diarrhea-3-weeks/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Diarrhea (3 weeks) #ğŸš§ æ–½å·¥ä¸­ Acute Diarrhea (&amp;lt;3 weeks) Infection
Bloody:
â€¢Â Shigella: Colonic infection.</description></item><item><title>Acute GVHD</title><link>https://www.physician.tw/Acute-GVHD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-GVHD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
Acute GVHD #ğŸš§ æ–½å·¥ä¸­ Acute GVHD (usually within 6 mo of transplant; NEJM 2017;377:2167) Clinical grades Iâ€“IV based on scores for skin (severity of maculopapular rash), liver (bilirubin level) and GI (volume of diarrhea); bx supports diagnosis Prevention: immunosuppression (MTX + cyclosporine, or tacrolimus), T-cell depletion of graft, post-Tx cyclophos.</description></item><item><title>Acute Liver Failure (ALF)</title><link>https://www.physician.tw/Acute-Liver-Failure-ALF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Liver-Failure-ALF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Liver Failure (ALF) #ğŸš§ æ–½å·¥ä¸­ Acute Liver Failure (ALF) â€¢Â Definitions:
-Â Acute liver injury (ALI): AST/ALT &amp;gt;100 IU/L</description></item><item><title>Acute Myeloid Leukemia</title><link>https://www.physician.tw/Acute-Myeloid-Leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Myeloid-Leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Myeloid Leukemia #ğŸš§ æ–½å·¥ä¸­ Acute Myeloid Leukemia â€¢Â Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation.</description></item><item><title>acute promyelocytic leukemia (APL)</title><link>https://www.physician.tw/acute-promyelocytic-leukemia-APL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-promyelocytic-leukemia-APL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
acute promyelocytic leukemia (APL) #ğŸš§ æ–½å·¥ä¸­ acute promyelocytic leukemia (APL)Â  (BloodÂ 2009;113:1875)</description></item><item><title>Acute Red Eye</title><link>https://www.physician.tw/Acute-Red-Eye/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Red-Eye/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Red Eye #ğŸš§ æ–½å·¥ä¸­ Acute Red Eye â€¢Â Physical exam: Fundoscopic exam, pupillary examination, visual acuity, EOM, peripheral vision</description></item><item><title>acute respiratory complaints of cough and congestion</title><link>https://www.physician.tw/acute-respiratory-complaints-of-cough-and-congestion/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-complaints-of-cough-and-congestion/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
acute respiratory complaints of cough and congestion #ğŸš§ æ–½å·¥ä¸­ acute respiratory complaints of cough and congestion Scott D.</description></item><item><title>Acute Respiratory Distress Syndrome (ARDS)</title><link>https://www.physician.tw/Acute-Respiratory-Distress-Syndrome-ARDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Respiratory-Distress-Syndrome-ARDS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Acute Respiratory Distress Syndrome (ARDS) #ğŸš§ æ–½å·¥ä¸­ Acute Respiratory Distress Syndrome (ARDS) â€¢Â Berlin Definition.</description></item><item><title>acuteÂ leukemia</title><link>https://www.physician.tw/acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[leukemia]]
acuteÂ leukemia Definition
â€¢ Clonal proliferation of hematopoietic progenitor with failed differentiation into mature elements â†’ â†‘ blasts in bone marrow and periphery â†’ â†“ RBCs, platelets, and neutrophils</description></item><item><title>acuteÂ lymphoblasticÂ leukemiaÂ (ALL)</title><link>https://www.physician.tw/acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[leukemia]]
acuteÂ lymphoblasticÂ leukemiaÂ (ALL) Lancet2020;395:1146
[[classification of acute lymphoblastic leukemia (ALL)]]
[[treatment of acute lymphoblastic leukemia (ALL)]]</description></item><item><title>acuteÂ myelogenousÂ leukemiaÂ (AML)</title><link>https://www.physician.tw/acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-myelogenous-leukemia-AML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[leukemia]]
acuteÂ myelogenousÂ leukemiaÂ (AML) [[classification of acute myelogenous leukemia (AML)]]
[[ENL 2017 Genetic Risk Classification]]</description></item><item><title>Additional Details about the Platelet Destructive Processes</title><link>https://www.physician.tw/Additional-Details-about-the-Platelet-Destructive-Processes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-Details-about-the-Platelet-Destructive-Processes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Additional Details about the Platelet Destructive Processes #ğŸš§ æ–½å·¥ä¸­ Additional Details about the Platelet Destructive Processes Immune Thrombocytopenic Purpura (ITP)</description></item><item><title>Additional History</title><link>https://www.physician.tw/Additional-History/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-History/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Additional History #ğŸš§ æ–½å·¥ä¸­ Additional History TABLE A1.3 â€¢ PMH, PSH, Meds, Allergies, FHx, SoHx</description></item><item><title>Adrenal Insufficiency (AI)</title><link>https://www.physician.tw/Adrenal-Insufficiency-AI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-Insufficiency-AI/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Adrenal Insufficiency (AI) #ğŸš§ æ–½å·¥ä¸­ Adrenal Insufficiency (AI) â€¢Â Etiologies:
-Â Primary:
â€¢Â Autoimmune: Antibody against adrenal enzymes (most common)</description></item><item><title>Adrenal Masses</title><link>https://www.physician.tw/Adrenal-Masses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-Masses/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Adrenal Masses #ğŸš§ æ–½å·¥ä¸­ Adrenal Masses Incidentally discovered adrenal mass â€¢Â Epidemiology: Common (at least 2% in the general population, more common with increasing age)</description></item><item><title>Advanced Care Planning</title><link>https://www.physician.tw/Advanced-Care-Planning/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Advanced-Care-Planning/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Advanced Care Planning #ğŸš§ æ–½å·¥ä¸­ Advanced Care Planning â€¢Â Advanced Directives and Outcomes of Surrogate Decision Making Before Death.</description></item><item><title>Alcohol-Induced Liver Disease</title><link>https://www.physician.tw/Alcohol-Induced-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcohol-Induced-Liver-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Alcohol-Induced Liver Disease #ğŸš§ æ–½å·¥ä¸­ Alcohol-Induced Liver Disease Alcoholic hepatitis â€¢Â Clinical features: Jaundice, anorexia, fever, tender hepatomegaly</description></item><item><title>Alcoholic Hepatitis</title><link>https://www.physician.tw/Alcoholic-Hepatitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcoholic-Hepatitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Alcoholic Hepatitis #ğŸš§ æ–½å·¥ä¸­ Alcoholic Hepatitis â€¢Â STOPAH. N Engl J Med 2015;372(17):1619â€“1628.</description></item><item><title>Altered Mental Status</title><link>https://www.physician.tw/Altered-Mental-Status/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Altered-Mental-Status/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Altered Mental Status #ğŸš§ æ–½å·¥ä¸­ Altered Mental Status There are many approaches to altered mental status (AMS).</description></item><item><title>Alveolar Hemorrhage</title><link>https://www.physician.tw/Alveolar-Hemorrhage/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alveolar-Hemorrhage/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Alveolar Hemorrhage #ğŸš§ æ–½å·¥ä¸­ Alveolar Hemorrhage â€¢Â Definition: Bleeding into the alveolar space due to disruption of the alveolarâ€“capillary basement membrane</description></item><item><title>an acid-base abnormality</title><link>https://www.physician.tw/an-acid-base-abnormality/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/an-acid-base-abnormality/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
an acid-base abnormality #ğŸš§ æ–½å·¥ä¸­ an acid-base abnormality Scott D. C. Stern, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>An Approach to Diagnosing and Treating Infectious Diseases</title><link>https://www.physician.tw/An-Approach-to-Diagnosing-and-Treating-Infectious-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/An-Approach-to-Diagnosing-and-Treating-Infectious-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
APPROACHES &amp;amp; CHIEF COMPLAINTS #ğŸš§ æ–½å·¥ä¸­ APPROACHES &amp;amp; CHIEF COMPLAINTS TABLE 8.</description></item><item><title>ANA-Associated Connective Tissue Disorders</title><link>https://www.physician.tw/ANA-Associated-Connective-Tissue-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ANA-Associated-Connective-Tissue-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
ANA-Associated Connective Tissue Disorders #ğŸš§ æ–½å·¥ä¸­ ANA-Associated Connective Tissue Disorders â€¢Â Rheumatologic conditions associated with a +ANA:</description></item><item><title>Analgesia, Sedation, Paralytics, and Vasoactive Medications</title><link>https://www.physician.tw/Analgesia-Sedation-Paralytics-and-Vasoactive-Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Analgesia-Sedation-Paralytics-and-Vasoactive-Medications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Analgesia, Sedation, Paralytics, and Vasoactive Medications #ğŸš§ æ–½å·¥ä¸­ Analgesia, Sedation, Paralytics, and Vasoactive Medications This section includes key medications used in the ICU, including their indications, pharmacokinetics, and adverse effects.</description></item><item><title>Anatomy of the Lungs</title><link>https://www.physician.tw/Anatomy-of-the-Lungs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anatomy-of-the-Lungs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anatomy of the Lungs #ğŸš§ æ–½å·¥ä¸­ Anatomy of the Lungs FIGURE 2.1: Anatomy of the lungs.</description></item><item><title>Ann Arbor Staging System with Cotswolds Modifications</title><link>https://www.physician.tw/Ann-Arbor-Staging-System-with-Cotswolds-Modifications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ann-Arbor-Staging-System-with-Cotswolds-Modifications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[overview of lymphoma and CLL]]
Ann Arbor Staging System with Cotswolds Modifications #ğŸš§ æ–½å·¥ä¸­ Ann Arbor Staging System with Cotswolds Modifications Stage Features I Single lymph node (LN) region II â‰¥2 LN regions on the same side of the diaphragm III LN regions on both sides of the diaphragm IV Disseminated involvement of one or more extralymphatic organs Modifiers: A = no symptoms; B = fever, night sweats or weight loss; X = â€bulkyâ€ mediastinal disease or mass &amp;gt;10 cm; E = single contiguous extranodal site; H = hepatic; S = splenic</description></item><item><title>Anterior Mediastinal Mass</title><link>https://www.physician.tw/Anterior-Mediastinal-Mass/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anterior-Mediastinal-Mass/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anterior Mediastinal Mass #ğŸš§ æ–½å·¥ä¸­ Anterior Mediastinal Mass â€¢Â Anterior mediastinal mass: 4Ts: Thymus, Teratoma/germ cell, (Terrible) lymphoma, Thyroid</description></item><item><title>Anterior Pituitary</title><link>https://www.physician.tw/Anterior-Pituitary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anterior-Pituitary/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anterior Pituitary #ğŸš§ æ–½å·¥ä¸­ Anterior Pituitary Hypopituitarism â€¢Â Etiologies:
-Â Impaired synthesis or secretion of one or more hormones; can be primary or secondary (process impairs hypothalamic hormones, with resultant pituitary failure)</description></item><item><title>Anti-Inflammatory Agents</title><link>https://www.physician.tw/Anti-Inflammatory-Agents/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-Inflammatory-Agents/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anti-Inflammatory Agents #ğŸš§ æ–½å·¥ä¸­ Anti-Inflammatory Agents NSAIDS â€¢Â Mechanism: Decreased prostaglandin production and thus reduced prostaglandin-mediated capillary leakage and inflammatory cell recruitment.</description></item><item><title>Anticoagulation</title><link>https://www.physician.tw/Anticoagulation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anticoagulation #ğŸš§ æ–½å·¥ä¸­ Anticoagulation TABLE 7.6 â€¢ Parenteral and Oral Anticoagulants</description></item><item><title>Antifungal Therapies</title><link>https://www.physician.tw/Antifungal-Therapies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antifungal-Therapies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Antifungal Therapies #ğŸš§ æ–½å·¥ä¸­ Antifungal Therapies First-line treatments for invasive fungal infections â€¢Â Anti-fungal agents: See Table 8.</description></item><item><title>Antipsychotic Medications</title><link>https://www.physician.tw/Antipsychotic-Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antipsychotic-Medications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Antipsychotic Medications #ğŸš§ æ–½å·¥ä¸­ Antipsychotic Medications â€¢Â CATIE Study (Phase 1). N Engl J Med 2005;353:1209â€“1223.</description></item><item><title>Antiretroviral Therapy (ART)</title><link>https://www.physician.tw/Antiretroviral-Therapy-ART/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiretroviral-Therapy-ART/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Antiretroviral Therapy (ART) #ğŸš§ æ–½å·¥ä¸­ Antiretroviral Therapy (ART) Antiretroviral therapies are listed here, with select pros (+) and cons (-) indicated.</description></item><item><title>Anxiety Disorders</title><link>https://www.physician.tw/Anxiety-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anxiety-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Anxiety Disorders #ğŸš§ æ–½å·¥ä¸­ Anxiety Disorders â€¢Â Panic disorder: Recurrent unexpected panic attacks, resulting in a fear of future panic attacks and avoidance of potential panic triggers.</description></item><item><title>Aortic Stenosis</title><link>https://www.physician.tw/Aortic-Stenosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aortic-Stenosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Aortic Stenosis #ğŸš§ æ–½å·¥ä¸­ Aortic Stenosis â€¢Â PARTNER A. N Engl J Med 2011;364(23):2187â€“2198; PARTNER B.</description></item><item><title>Approach to Analysis of an Arterial Blood Gas (ABG)</title><link>https://www.physician.tw/Approach-to-Analysis-of-an-Arterial-Blood-Gas-ABG/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Analysis-of-an-Arterial-Blood-Gas-ABG/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Analysis of an Arterial Blood Gas (ABG) #ğŸš§ æ–½å·¥ä¸­ Approach to Analysis of an Arterial Blood Gas (ABG) FIGURE 3.</description></item><item><title>Approach to Bradycardia (HR 60 bpm)</title><link>https://www.physician.tw/Approach-to-Bradycardia-HR-60-bpm/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Bradycardia-HR-60-bpm/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Bradycardia (HR 60 bpm) #ğŸš§ æ–½å·¥ä¸­ Approach to Bradycardia (HR &amp;lt; 60 bpm) â€¢Â UNSTABLE:</description></item><item><title>Approach to Headaches</title><link>https://www.physician.tw/Approach-to-Headaches/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Headaches/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Headaches #ğŸš§ æ–½å·¥ä¸­ Approach to Headaches â€¢Â History:
-Â Is this an old or new headache?</description></item><item><title>Approach to Lactic Acidosis</title><link>https://www.physician.tw/Approach-to-Lactic-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Lactic-Acidosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Lactic Acidosis #ğŸš§ æ–½å·¥ä¸­ Approach to Lactic Acidosis â€¢Â Description: Elevated serum lactate.</description></item><item><title>Approach to Managing a Patient with Cardiac Arrest, aka â€œCode Blueâ€</title><link>https://www.physician.tw/Approach-to-Managing-a-Patient-with-Cardiac-Arrest-aka-Code-Blue/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Managing-a-Patient-with-Cardiac-Arrest-aka-Code-Blue/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Managing a Patient with Cardiac Arrest, aka â€œCode Blueâ€ #ğŸš§ æ–½å·¥ä¸­ Approach to Managing a Patient with Cardiac Arrest, aka â€œCode Blueâ€ â€¢Â Three key principles:</description></item><item><title>Approach to Narrow QRS Complex Tachycardia</title><link>https://www.physician.tw/Approach-to-Narrow-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Narrow-QRS-Complex-Tachycardia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Narrow QRS Complex Tachycardia #ğŸš§ æ–½å·¥ä¸­ Approach to Narrow QRS Complex Tachycardia â€¢Â UNSTABLE: If sinus tachycardia, treat the underlying cause if present (e.</description></item><item><title>Approach to Reading a Hand X-Ray</title><link>https://www.physician.tw/Approach-to-Reading-a-Hand-X-Ray/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Reading-a-Hand-X-Ray/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Reading a Hand X-Ray #ğŸš§ æ–½å·¥ä¸­ Approach to Reading a Hand X-Ray â€¢Â Alignment: Misaligned joints can help suggest specific pathologies.</description></item><item><title>Approach to Shock</title><link>https://www.physician.tw/Approach-to-Shock/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Shock/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Shock #ğŸš§ æ–½å·¥ä¸­ Approach to Shock â€¢Â Important formulas:
-Â MAP = CO x SVR</description></item><item><title>Approach to Vascular Access</title><link>https://www.physician.tw/Approach-to-Vascular-Access/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Vascular-Access/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Approach to Vascular Access #ğŸš§ æ–½å·¥ä¸­ Approach to Vascular Access TABLE 3.1 â€¢ Flow Relationship Defined by the Poiseuille Equation</description></item><item><title>Arthridities</title><link>https://www.physician.tw/Arthridities/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Arthridities/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Arthridities #ğŸš§ æ–½å·¥ä¸­ Arthridities Osteoarthritis (OA) â€¢Â Pathogenesis: Progressive cartilage and meniscal degradation due to complex interplay of pathologic joint loading (due to obesity, joint malalignment, specific types of exercise or occupation, etc.</description></item><item><title>Assessment of Fluid Responsiveness</title><link>https://www.physician.tw/Assessment-of-Fluid-Responsiveness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Assessment-of-Fluid-Responsiveness/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Assessment of Fluid Responsiveness #ğŸš§ æ–½å·¥ä¸­ Assessment of Fluid Responsiveness â€¢Â Hypotension is a common problem in the ICU</description></item><item><title>Autoimmune Bullous Diseases</title><link>https://www.physician.tw/Autoimmune-Bullous-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Bullous-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Autoimmune Bullous Diseases #ğŸš§ æ–½å·¥ä¸­ Autoimmune Bullous Diseases Bullous pemphigoid (BP) â€¢Â Pathophysiology: Chronic autoimmune blistering disease most commonly seen in the elderly due to autoantibodies targeting hemidesmosomes in the basement membrane, resulting in sub-epidermal blistering (â€œbullowâ€).</description></item><item><title>Autoimmune Etiologies of Liver Disease</title><link>https://www.physician.tw/Autoimmune-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Etiologies-of-Liver-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Autoimmune Etiologies of Liver Disease #ğŸš§ æ–½å·¥ä¸­ Autoimmune Etiologies of Liver Disease Autoimmune hepatitis â€¢Â Epidemiology: F:M = 4:1, associated with other autoimmune conditions</description></item><item><title>Axial and Appendicular Skeleton</title><link>https://www.physician.tw/Axial-and-Appendicular-Skeleton/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Axial-and-Appendicular-Skeleton/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Axial and Appendicular Skeleton #ğŸš§ æ–½å·¥ä¸­ Axial and Appendicular Skeleton The skeletal system is divided into the axial skeleton and the appendicular skeleton (Figure 9.</description></item><item><title>Bacterial Infections</title><link>https://www.physician.tw/Bacterial-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bacterial-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bacterial Infections #ğŸš§ æ–½å·¥ä¸­ Bacterial Infections Gram-positive bacteria TABLE 8.2 â€¢ Key Clinically Relevant Gram-Positive Bacteria</description></item><item><title>Barrettâ€™s Esophagus</title><link>https://www.physician.tw/Barretts-Esophagus/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Barretts-Esophagus/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Barrettâ€™s Esophagus #ğŸš§ æ–½å·¥ä¸­ Barrettâ€™s Esophagus â€¢Â Radiofrequency Ablation in Barrettâ€™s Esophagus with Dysplasia.</description></item><item><title>Biases</title><link>https://www.physician.tw/Biases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Biases #ğŸš§ æ–½å·¥ä¸­ Biases Recruitment â€¢Â Selection bias: Bias in selecting the study group.</description></item><item><title>Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs)</title><link>https://www.physician.tw/Biologic-Disease-Modifying-Antirheumatic-Drugs-aka-Biologics-or-Biologic-DMARDs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biologic-Disease-Modifying-Antirheumatic-Drugs-aka-Biologics-or-Biologic-DMARDs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs) #ğŸš§ æ–½å·¥ä¸­ Biologic Disease-Modifying Antirheumatic Drugs (aka â€œBiologicsâ€ or Biologic DMARDs) â€¢Â Definition: DMARDs that work by targeting immune system pathways</description></item><item><title>Bipolar Disorder</title><link>https://www.physician.tw/Bipolar-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bipolar-Disorder/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bipolar Disorder #ğŸš§ æ–½å·¥ä¸­ Bipolar Disorder â€¢Â The STEP-BD Trial. N Engl J Med 2007;356:1711â€“1722.</description></item><item><title>Bleeding as complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/Bleeding-as-complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bleeding-as-complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
Bleeding as complications of hematopoietic stem cell transplantation #ğŸš§ æ–½å·¥ä¸­ Bleeding as complications of hematopoietic stem cell transplantation incidence ~25%, 2/2 â†“â†“ plts; sites: CNS, GI, pulm.</description></item><item><title>Bloodstream Infections</title><link>https://www.physician.tw/Bloodstream-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bloodstream-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bloodstream Infections #ğŸš§ æ–½å·¥ä¸­ Bloodstream Infections â€¢Â Pathophysiology: A bloodstream infection can arise from:</description></item><item><title>BoneJoint Infections</title><link>https://www.physician.tw/BoneJoint-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BoneJoint-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
BoneJoint Infections #ğŸš§ æ–½å·¥ä¸­ Bone/Joint Infections Osteomyelitis â€¢Â Types of osteomyelitis and pathogenesis:</description></item><item><title>Bradycardia</title><link>https://www.physician.tw/Bradycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bradycardia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bradycardia #ğŸš§ æ–½å·¥ä¸­ Bradycardia</description></item><item><title>Bradycardic Rhythms</title><link>https://www.physician.tw/Bradycardic-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bradycardic-Rhythms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bradycardic Rhythms #ğŸš§ æ–½å·¥ä¸­ Bradycardic Rhythms Sinus bradycardia â€¢Â ECG: See Figure 1.14</description></item><item><title>Brain</title><link>https://www.physician.tw/Brain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Brain #ğŸš§ æ–½å·¥ä¸­ Brain Cerebral cortex â€¢Â Functions: Higher processing
â€¢Â Clinical effects of a lesion: Contralateral motor, sensory, visual symptoms</description></item><item><title>Brain abscess</title><link>https://www.physician.tw/Brain-abscess/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brain-abscess/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Brain abscess #ğŸš§ æ–½å·¥ä¸­ Brain abscess â€¢Â Pathophysiology: Complication of otitis media, sinusitis, odontogenic infection, post-surgical infection</description></item><item><title>Bridging Anticoagulation</title><link>https://www.physician.tw/Bridging-Anticoagulation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bridging-Anticoagulation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Bridging Anticoagulation #ğŸš§ æ–½å·¥ä¸­ Bridging Anticoagulation â€¢Â Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures.</description></item><item><title>Calcium</title><link>https://www.physician.tw/Calcium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Calcium #ğŸš§ æ–½å·¥ä¸­ Calcium Calcium regulation (Ca2+ 8.5â€“10.5 mg/dL) â€¢Â Physiology: Most calcium is bound to albumin; free ionized calcium is the physiologic active form under control of PTH</description></item><item><title>Cardiac Anatomy</title><link>https://www.physician.tw/Cardiac-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Anatomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiac Anatomy #ğŸš§ æ–½å·¥ä¸­ Cardiac Anatomy FIGURE 1.1: Cardiac chambers, valves, and major vessels.</description></item><item><title>Cardiac Electrophysiology</title><link>https://www.physician.tw/Cardiac-Electrophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Electrophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiac Electrophysiology #ğŸš§ æ–½å·¥ä¸­ Cardiac Electrophysiology â€¢Â Cardiac electrical conduction system: Sinoatrial (SA) node (1Â° pacemaker) â†’ Atrioventricular (AV) node (stalls conduction; can also act as a backup pacemaker with rate of 40â€“60 bpm) â†’ Bundle of His â†’ Right/left bundle â†’ Purkinje fibers â†’ Ventricle</description></item><item><title>Cardiac Stress Testing</title><link>https://www.physician.tw/Cardiac-Stress-Testing/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Stress-Testing/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiac Stress Testing #ğŸš§ æ–½å·¥ä¸­ Cardiac Stress Testing â€¢Â Indications:
-Â Assessment for a new diagnosis of coronary artery disease (CAD) in patients with chest pain who have been ruled out for acute coronary syndrome (ACS)</description></item><item><title>Cardiac Valve Infection and Inflammation</title><link>https://www.physician.tw/Cardiac-Valve-Infection-and-Inflammation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-Valve-Infection-and-Inflammation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiac Valve Infection and Inflammation #ğŸš§ æ–½å·¥ä¸­ Cardiac Valve Infection and Inflammation Rheumatic fever â€¢Â Etiology: Complication of inflammatory reaction to group A strep spp.</description></item><item><title>Cardiology anatomy and physiology of cardiology</title><link>https://www.physician.tw/Cardiology-anatomy-and-physiology-of-cardiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-anatomy-and-physiology-of-cardiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology anatomy and physiology of cardiology #ğŸš§ æ–½å·¥ä¸­ Cardiology anatomy and physiology of cardiology [[Cardiac Anatomy]]</description></item><item><title>Cardiology approaches and chief complaints</title><link>https://www.physician.tw/Cardiology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-approaches-and-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology approaches and chief complaints #ğŸš§ æ–½å·¥ä¸­ Cardiology approaches and chief complaints [[books/h_note/Chest Pain]]</description></item><item><title>Cardiology diagnostics</title><link>https://www.physician.tw/Cardiology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology diagnostics #ğŸš§ æ–½å·¥ä¸­ Cardiology diagnostics [[books/h_note/Electrocardiography]]
[[Echocardiography]]
[[Cardiac Stress Testing]]</description></item><item><title>Cardiology diseases and pathophysiology</title><link>https://www.physician.tw/Cardiology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ Cardiology diseases and pathophysiology [[Ischemic Heart Disease]]</description></item><item><title>Cardiology key clinical trials and publications</title><link>https://www.physician.tw/Cardiology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ Cardiology key clinical trials and publications [[Cardiovascular Disease Risk Prevention]]</description></item><item><title>Cardiology key medications and interventions</title><link>https://www.physician.tw/Cardiology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Cardiology of Huppert&amp;rsquo;s Notes]]
Cardiology key medications and interventions #ğŸš§ æ–½å·¥ä¸­ Cardiology key medications and interventions TABLE 1.</description></item><item><title>Cardiology of Huppert's Notes</title><link>https://www.physician.tw/Cardiology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiology-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiology of Huppert&amp;rsquo;s Notes [[Cardiology anatomy and physiology of cardiology]]
[[Cardiology diagnostics]]
[[Cardiology approaches and chief complaints]]</description></item><item><title>Cardiovascular Disease Risk Prevention</title><link>https://www.physician.tw/Cardiovascular-Disease-Risk-Prevention/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiovascular-Disease-Risk-Prevention/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cardiovascular Disease Risk Prevention #ğŸš§ æ–½å·¥ä¸­ Cardiovascular Disease Risk Prevention â€¢Â FOURIER. N Engl J Med 2017;376(18):1713-1722.</description></item><item><title>Categories of MPN</title><link>https://www.physician.tw/Categories-of-MPN/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Categories-of-MPN/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[overview of myeloproliferative neoplasms]]
Categories of MPN #ğŸš§ æ–½å·¥ä¸­ Categories of MPN :Â polycythemia veraÂ (PV);Â essential thrombocythemiaÂ (ET);Â primary myelofibrosisÂ (PMF); chronic myelogenous leukemia (CML;Â BCR-ABL1Â âŠ•); atypical CML (aCML); chronic neutrophilic leukemia (CNL); systemic mastocytosis; chronic eosinophilic leukemia; MPN-NOS/unclassifiable</description></item><item><title>Categories of Stem Cell Transplantation</title><link>https://www.physician.tw/categories-of-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/categories-of-stem-cell-transplantation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
Categories of Stem Cell Transplantation #ğŸš§ æ–½å·¥ä¸­ Categories of Stem Cell Transplantation Feature Allogeneic (Allo) Autologous (Auto) Donorâ€“recipient relationship Immunologically distinct Donor is also recipient Graft-vs.</description></item><item><title>Cellulitis and Cellulitis Mimickers</title><link>https://www.physician.tw/Cellulitis-and-Cellulitis-Mimickers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cellulitis-and-Cellulitis-Mimickers/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cellulitis and Cellulitis Mimickers #ğŸš§ æ–½å·¥ä¸­ Cellulitis and Cellulitis Mimickers â€¢Â Effect of dermatology consultation on outcomes for patients with presumed cellulitis.</description></item><item><title>Central Nervous System (CNS)</title><link>https://www.physician.tw/Central-Nervous-System-CNS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-CNS/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System (CNS) #ğŸš§ æ–½å·¥ä¸­ Central Nervous System (CNS)</description></item><item><title>Central Nervous System (CNS) Tumors</title><link>https://www.physician.tw/Central-Nervous-System-CNS-Tumors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-CNS-Tumors/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System (CNS) Tumors #ğŸš§ æ–½å·¥ä¸­ Central Nervous System (CNS) Tumors â€¢Â Epidemiology:</description></item><item><title>Central Nervous System Infections</title><link>https://www.physician.tw/Central-Nervous-System-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Nervous-System-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Central Nervous System Infections #ğŸš§ æ–½å·¥ä¸­ Central Nervous System Infections Meningitis â€¢Â Note: Meningitis and encephalitis are two distinct clinical entities, each with their own list of causative organisms.</description></item><item><title>Central Venous Pressure (CVP) Waveform Jugular Venous Pulse (JVP)</title><link>https://www.physician.tw/Central-Venous-Pressure-CVP-Waveform-Jugular-Venous-Pulse-JVP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-Venous-Pressure-CVP-Waveform-Jugular-Venous-Pulse-JVP/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Central Venous Pressure (CVP) Waveform Jugular Venous Pulse (JVP) #ğŸš§ æ–½å·¥ä¸­ Central Venous Pressure (CVP) Waveform / Jugular Venous Pulse (JVP) â€¢Â a wave: atrial contraction</description></item><item><title>Chemotherapy</title><link>https://www.physician.tw/Chemotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemotherapy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chemotherapy #ğŸš§ æ–½å·¥ä¸­ Chemotherapy â€¢Â Cell cycle non-specific phase: Activity not dependent upon the agent being available during a certain phase of the cell cycle.</description></item><item><title>Chemotherapy, Targeted Therapy, and Immunotherapy</title><link>https://www.physician.tw/Chemotherapy-Targeted-Therapy-and-Immunotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemotherapy-Targeted-Therapy-and-Immunotherapy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chemotherapy, Targeted Therapy, and Immunotherapy #ğŸš§ æ–½å·¥ä¸­ Chemotherapy, Targeted Therapy, and Immunotherapy See Oncology treatment section at the end of this chapter.</description></item><item><title>Chest CT</title><link>https://www.physician.tw/Chest-CT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-CT/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chest CT #ğŸš§ æ–½å·¥ä¸­ Chest CT â€¢Â Types of Chest CT:
-Â Standard: Images may be obtained with or without contrast.</description></item><item><title>Chest Tubes</title><link>https://www.physician.tw/Chest-Tubes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-Tubes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chest Tubes #ğŸš§ æ–½å·¥ä¸­ Chest Tubes â€¢Â Description: Flexible plastic tube placed into the pleural space (or mediastinum) through the chest wall for drainage of air, fluid, or pus</description></item><item><title>Chest x-ray (CXR)</title><link>https://www.physician.tw/Chest-x-ray-CXR/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-x-ray-CXR/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chest x-ray (CXR) #ğŸš§ æ–½å·¥ä¸­ Chest x-ray (CXR) â€¢Â Types of CXR:
-Â PA and lateral CXR: Method: Radiation posterior â†’ anterior; obtained with lateral images.</description></item><item><title>Chief Complaint and History of Present Illness (HPI)</title><link>https://www.physician.tw/Chief-Complaint-and-History-of-Present-Illness-HPI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chief-Complaint-and-History-of-Present-Illness-HPI/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chief Complaint and History of Present Illness (HPI) #ğŸš§ æ–½å·¥ä¸­ Chief Complaint and History of Present Illness (HPI) TABLE A1.</description></item><item><title>Chimeric-Antigen Receptor (CAR)-T cell therapy</title><link>https://www.physician.tw/Chimeric-Antigen-Receptor-CAR-T-cell-therapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chimeric-Antigen-Receptor-CAR-T-cell-therapy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chimeric-Antigen Receptor (CAR)-T cell therapy #ğŸš§ æ–½å·¥ä¸­ Chimeric-Antigen Receptor (CAR)-T cell therapy â€¢Â Mechanism: T cells are collected from the patient and genetically modified with a chimeric antigen receptor (CAR) to direct the T-cells against the tumor cells.</description></item><item><title>Cholecystectomy</title><link>https://www.physician.tw/Cholecystectomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cholecystectomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cholecystectomy #ğŸš§ æ–½å·¥ä¸­ Cholecystectomy â€¢Â ACDC. Ann Surg 2013;258:385â€“393.
-Â Parallel-group, open-label, randomized controlled trial comparing early laparoscopic cholecystectomy (&amp;lt;24 hours) versus initial antibiotics and delayed surgery (7â€“45 days).</description></item><item><title>Cholestatic Liver Diseases</title><link>https://www.physician.tw/Cholestatic-Liver-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cholestatic-Liver-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cholestatic Liver Diseases #ğŸš§ æ–½å·¥ä¸­ Cholestatic Liver Diseases Primary biliary cholangitis (PBC) â€¢Â Etiology: Immune-mediated destruction of intrahepatic bile ducts, most common in females 40â€“50 yr</description></item><item><title>Chronic Cough (8 wk) in Immunocompetent Adults</title><link>https://www.physician.tw/Chronic-Cough-8-wk-in-Immunocompetent-Adults/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Cough-8-wk-in-Immunocompetent-Adults/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chronic Cough (8 wk) in Immunocompetent Adults #ğŸš§ æ–½å·¥ä¸­ Chronic Cough (&amp;gt;8 wk) in Immunocompetent Adults â€¢Â Evaluate for red flags: Evaluate for red flags and consider CXR.</description></item><item><title>Chronic Diarrhea (3 weeks)</title><link>https://www.physician.tw/Chronic-Diarrhea-3-weeks/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Diarrhea-3-weeks/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chronic Diarrhea (3 weeks) #ğŸš§ æ–½å·¥ä¸­ Chronic Diarrhea (&amp;gt;3 weeks) â€¢Â Work-up:
-Â Use history/physical to determine the probable subtype of diarrhea (i.</description></item><item><title>Chronic GVHD</title><link>https://www.physician.tw/Chronic-GVHD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-GVHD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
Chronic GVHD #ğŸš§ æ–½å·¥ä¸­ Chronic GVHD (developing or persisting &amp;gt;3 mo posttransplant; NEJM 2017;377:2565) Clinical: malar rash, sicca syndrome, arthritis, obliterative bronchiolitis, bile duct degeneration, cholestasis, and many others.</description></item><item><title>Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)</title><link>https://www.physician.tw/Chronic-Kidney-Disease-CKD-and-End-Stage-Renal-Disease-ESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Kidney-Disease-CKD-and-End-Stage-Renal-Disease-ESRD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) #ğŸš§ æ–½å·¥ä¸­ Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) â€¢Â Definitions:</description></item><item><title>Chronic Noncancer Pain</title><link>https://www.physician.tw/Chronic-Noncancer-Pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Noncancer-Pain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chronic Noncancer Pain #ğŸš§ æ–½å·¥ä¸­ Chronic Noncancer Pain â€¢Â Clinical:
-Â Assess pain: OPQRST- Onset, Provocation/Palliation, Quality, Region/Radiation, Severity, Timing</description></item><item><title>Chronic Pain Management</title><link>https://www.physician.tw/Chronic-Pain-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-Pain-Management/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Chronic Pain Management #ğŸš§ æ–½å·¥ä¸­ Chronic Pain Management â€¢Â Pain Management With Opioids in 2019-2020.</description></item><item><title>chronicÂ myelogenousÂ leukemiaÂ (CML)</title><link>https://www.physician.tw/chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[leukemia]]
chronicÂ myelogenousÂ leukemiaÂ (CML) Lancet2021;398:1914)
[[definition of chronic myelogenous leukemia (CML)]]
[[epidemiology and risk factors of chronic myelogenous leukemia (CML)]]</description></item><item><title>Cirrhosis and its Complications</title><link>https://www.physician.tw/Cirrhosis-and-its-Complications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cirrhosis-and-its-Complications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cirrhosis and its Complications #ğŸš§ æ–½å·¥ä¸­ Cirrhosis and its Complications Decompensated cirrhosis â€¢Â Decompensated cirrhosis: Defined by any one of: ascites, hepatic encephalopathy, and/or variceal bleed</description></item><item><title>Cirrhosis Management</title><link>https://www.physician.tw/Cirrhosis-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cirrhosis-Management/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cirrhosis Management #ğŸš§ æ–½å·¥ä¸­ Cirrhosis Management â€¢Â Norfloxacin vs. Ceftriaxone in the Prophylaxis of Infections in Patients with Advanced Cirrhosis and Hemorrhage.</description></item><item><title>classification of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/classification-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute lymphoblastic leukemia (ALL)]]
classification of acute lymphoblastic leukemia (ALL) #ğŸš§ æ–½å·¥ä¸­ classification of acute lymphoblastic leukemia (ALL) â€¢ Lymphoblastic neoplasms may present as acute leukemia (ALL) w/ &amp;gt;20% BM blastsÂ or as lymphoblastic lymphoma (LBL, more common in T-cell) w/ mass lesion w/ &amp;lt;20% BM blast</description></item><item><title>classification of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/classification-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classification-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
classification of acute myelogenous leukemia (AML) #ğŸš§ æ–½å·¥ä¸­ classification of acute myelogenous leukemia (AML)Â  (WHO;Â BloodÂ 2016;127:2391)</description></item><item><title>clinical manifestations of acute leukemia</title><link>https://www.physician.tw/clinical-manifestations-of-acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-acute-leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute leukemia]]
clinical manifestations of acute leukemia #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of acute leukemia â€¢ Cytopenias â†’Â fatigueÂ (anemia),Â infectionÂ (neutropenia),Â bleeding(thrombocytopenia)</description></item><item><title>clinical manifestations of multiple myeloma (MM)</title><link>https://www.physician.tw/clinical-manifestations-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-multiple-myeloma-MM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[multiple myeloma (MM)]]
clinical manifestations of multiple myeloma (MM) #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of multiple myeloma (MM) (CRAB criteria and other less common features) â€¢ HyperCalcemia due to â†‘ osteoclast activity â€¢ Renal disease: multiple mechanisms include toxic effect of filtered light chains â†’ renal failure (cast nephropathy) or type II RTA; amyloidosis or light chain deposition disease â†’ nephrotic syndrome; hypercalcemia, urate nephropathy, type I cryoglobulinemia â€¢ Anemia (normocytic) due to bone marrow involvement; rarely, may see AIHA â€¢ Lytic Bone lesions due to â†‘ osteoclast activity â†’ pathologic fx â€¢ Recurrent infxns due to relative hypogammaglob.</description></item><item><title>clinical manifestations of overview of lymphoma and CLL</title><link>https://www.physician.tw/clinical-manifestations-of-overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-overview-of-lymphoma-and-CLL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[overview of lymphoma and CLL]]
clinical manifestations of overview of lymphoma and CLL #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of overview of lymphoma and CLL â€¢ Lymphadenopathy (usually nontender) HL: superficial (usually cervical/supraclavicular) Â± mediastinal LAN; nodal disease with orderly, anatomic spread to adjacent nodes NHL: diffuse; nodal and/or extranodal disease with noncontiguous spread; symptoms reflect involved sites (abdominal fullness, bone pain) â€¢ Constitutional (â€œBâ€) symptoms: fever (&amp;gt;38Â°), drenching sweats, â†“ weight (&amp;gt;10% in 6 mo) HL: periodic, recurrent â€œPel-Ebsteinâ€ fever; 10â€“15% have pruritus; ~35% â€œBâ€ symptoms NHL: â€œBâ€ symptoms vary between subtypes, ~15â€“50%</description></item><item><title>clinical manifestations of polycythemia vera</title><link>https://www.physician.tw/clinical-manifestations-of-polycythemia-vera/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-polycythemia-vera/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[polycythemia vera (PV)]]
clinical manifestations of polycythemia vera #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of polycythemia vera (common between PV and ET)</description></item><item><title>clinical manifestations of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/clinical-manifestations-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-primary-myelofibrosis-PMF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[primary myelofibrosis (PMF)]]
clinical manifestations of primary myelofibrosis (PMF) #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of primary myelofibrosis (PMF) (BJHÂ 2012;158:453)</description></item><item><title>clinical manifestations of smallÂ lymphocyticÂ lymphoma</title><link>https://www.physician.tw/clinical-manifestations-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-small-lymphocytic-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[small lymphocytic lymphoma]]
clinical manifestations of smallÂ lymphocyticÂ lymphoma #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of smallÂ lymphocyticÂ lymphoma â€¢Â Often asxÂ &amp;amp; identified by lymphocytosis on CBC; 10â€“20% p/w â€œB symptomsâ€</description></item><item><title>clinical manifestations of waldenstromâ€™s macroglobulinemia (WM)</title><link>https://www.physician.tw/clinical-manifestations-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[waldenstromâ€™s macroglobulinemia (WM)]]
clinical manifestations of waldenstromâ€™s macroglobulinemia (WM) #ğŸš§ æ–½å·¥ä¸­ clinical manifestations of waldenstromâ€™s macroglobulinemia (WM) â€¢ Fatigue from anemia is most common sx â€¢ Tumor infiltration: BM (cytopenias), hepatomegaly, splenomegaly, lymphadenopathy â€¢ Circulating monoclonal IgM Hyperviscosity syndrome (~15%): Neurologic: blurred vision (â€œsausageâ€ retinal veins), HA, dizziness, Î” MS.</description></item><item><title>clinical trials</title><link>https://www.physician.tw/clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-trials/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
clinical trials #ğŸš§ æ–½å·¥ä¸­ clinical trials [[Types of Clinical Studies &amp;amp; Trials]]
[[Biases]]</description></item><item><title>Clostridium difficile</title><link>https://www.physician.tw/Clostridium-difficile/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clostridium-difficile/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Clostridium difficile #ğŸš§ æ–½å·¥ä¸­ Clostridium difficile â€¢Â [Guideline] Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA).</description></item><item><title>CNS Infections</title><link>https://www.physician.tw/CNS-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CNS-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
CNS Infections #ğŸš§ æ–½å·¥ä¸­ CNS Infections â€¢Â Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015;2015(9):CD004405.</description></item><item><title>CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/CNS-prophylaxis-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CNS-prophylaxis-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[treatment of acute lymphoblastic leukemia (ALL)]]
CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL) #ğŸš§ æ–½å·¥ä¸­ CNS prophylaxis of treatment of acute lymphoblastic leukemia (ALL) intrathecal MTX/cytarabine Â± cranial irradiationÂ _or_systemic MTX</description></item><item><title>Coagulation Disorders</title><link>https://www.physician.tw/Coagulation-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coagulation-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Coagulation Disorders #ğŸš§ æ–½å·¥ä¸­ Coagulation Disorders â€¢Â Definition: Elevated prothrombin time (PT) and/or partial thromboplastin time (PTT) with normal platelet count and bleeding time</description></item><item><title>Cognitive Impairment</title><link>https://www.physician.tw/Cognitive-Impairment/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cognitive-Impairment/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cognitive Impairment #ğŸš§ æ–½å·¥ä¸­ Cognitive Impairment Alzheimerâ€™s disease â€¢Â Epidemiology: Most common form of dementia.</description></item><item><title>Colon</title><link>https://www.physician.tw/Colon/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colon/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Colon #ğŸš§ æ–½å·¥ä¸­ Colon</description></item><item><title>Colon Cancer</title><link>https://www.physician.tw/Colon-Cancer/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colon-Cancer/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Colon Cancer #ğŸš§ æ–½å·¥ä¸­ Colon Cancer â€¢Â Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.</description></item><item><title>command line know how</title><link>https://www.physician.tw/command-line-know-how/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/command-line-know-how/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[command line interface]]
command line know how #ğŸš§ æ–½å·¥ä¸­ [[Shell Scripting åŸºç¤æŒ‡å—]]
[[åœ¨macé—œé–‰micrfosoft update]]</description></item><item><title>Common ICU Indications</title><link>https://www.physician.tw/Common-ICU-Indications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-ICU-Indications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Common ICU Indications #ğŸš§ æ–½å·¥ä¸­ Common ICU Indications â€¢Â Need for mechanical ventilation or noninvasive ventilation</description></item><item><title>Common Skin Cancers</title><link>https://www.physician.tw/Common-Skin-Cancers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Skin-Cancers/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Common Skin Cancers #ğŸš§ æ–½å·¥ä¸­ Common Skin Cancers Benign skin conditions â€¢Â Seborrheic keratosis (SK): Benign pigmented neoplasm; common after age 50 yr; presents as tan-brown â€œstuck onâ€ papules or plaques.</description></item><item><title>Common Skin Infections</title><link>https://www.physician.tw/Common-Skin-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Skin-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Common Skin Infections #ğŸš§ æ–½å·¥ä¸­ Common Skin Infections Bacterial Folliculitis â€¢Â Pathophysiology: Staph aureus &amp;raquo; Klebsiella, Enterobacter, and Pseudomonas (hot tub exposure).</description></item><item><title>common toxicities of Rx of multiple myeloma (MM)</title><link>https://www.physician.tw/common-toxicities-of-Rx-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/common-toxicities-of-Rx-of-multiple-myeloma-MM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[multiple myeloma (MM)]]
common toxicities of Rx of multiple myeloma (MM) #ğŸš§ æ–½å·¥ä¸­ common toxicities of Rx of multiple myeloma (MM) melphalan â†’ myelosuppression; lenalidomide â†’ low plts &amp;amp; thromboembolism; bortezomib â†’ periph.</description></item><item><title>Complications Associated with Mechanical Ventilation</title><link>https://www.physician.tw/Complications-Associated-with-Mechanical-Ventilation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-Associated-with-Mechanical-Ventilation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Complications Associated with Mechanical Ventilation #ğŸš§ æ–½å·¥ä¸­ Complications Associated with Mechanical Ventilation â€¢Â See â€œIntubation and Mechanical Ventilationâ€ under Key Medications and Interventions</description></item><item><title>complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
complications of hematopoietic stem cell transplantation â€¢ Either direct chemoradiotoxicities associated with preparative regimen or consequences of interaction between donor and recipient immune systems</description></item><item><title>Congenital Adrenal Hyperplasia</title><link>https://www.physician.tw/Congenital-Adrenal-Hyperplasia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Adrenal-Hyperplasia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Congenital Adrenal Hyperplasia #ğŸš§ æ–½å·¥ä¸­ Congenital Adrenal Hyperplasia 21-hydroxylase deficiency â€¢Â Pathophysiology: Autosomal recessive genetic disorder.</description></item><item><title>Congenital Heart Disease with Early Cyanosis (R â†’ L shunt)</title><link>https://www.physician.tw/Congenital-Heart-Disease-with-Early-Cyanosis-R-L-shunt/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-Disease-with-Early-Cyanosis-R-L-shunt/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart Disease with Early Cyanosis (R â†’ L shunt) #ğŸš§ æ–½å·¥ä¸­ Congenital Heart Disease with Early Cyanosis (R â†’ L shunt) Tetralogy of Fallot â€¢Â Etiology: Associated with Down syndrome; includes four anatomic components: 1) VSD; 2) Right ventricular hypertrophy; 3) Pulmonary stenosis; 4) Overriding aorta</description></item><item><title>Congenital Heart disease with late Cyanosis (L â†’ R shunt)</title><link>https://www.physician.tw/Congenital-Heart-disease-with-late-Cyanosis-L-R-shunt/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-disease-with-late-Cyanosis-L-R-shunt/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart disease with late Cyanosis (L â†’ R shunt) #ğŸš§ æ–½å·¥ä¸­ Congenital Heart disease with late Cyanosis (L â†’ R shunt) Atrial septal defect (ASD) â€¢Â Etiolgy: Defect in the middle (ostum secundum, most common) or lower (ostum primum, which occurs in Down syndrome) part of atrial septum</description></item><item><title>Congenital Heart Diseases</title><link>https://www.physician.tw/Congenital-Heart-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Congenital-Heart-Diseases/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Congenital Heart Diseases #ğŸš§ æ–½å·¥ä¸­ Congenital Heart Diseases</description></item><item><title>consolidation therapy of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/consolidation-therapy-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consolidation-therapy-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
consolidation therapy of acute myelogenous leukemia (AML) #ğŸš§ æ–½å·¥ä¸­ consolidation therapy of acute myelogenous leukemia (AML) â€¢ If c_omplete remission_Â (CR) = ANC &amp;gt;103, plt &amp;gt;100, no RBC Rx, &amp;lt;5% BM blasts;Â CR â‰  cure</description></item><item><title>Contents</title><link>https://www.physician.tw/Contents/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contents/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
Contents #ğŸš§ æ–½å·¥ä¸­ Contents Contributing Authors
Preface
Acknowledgments
1. Diagnostic Process
Diane Altkorn, MD</description></item><item><title>Contraception</title><link>https://www.physician.tw/Contraception/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contraception/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Contraception #ğŸš§ æ–½å·¥ä¸­ Contraception â€¢Â Approach to contraception counseling: Recommend discussion of contraception with all patients of reproductive age.</description></item><item><title>Contributing Authors</title><link>https://www.physician.tw/Contributing-Authors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contributing-Authors/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
Contributing Authors #ğŸš§ æ–½å·¥ä¸­ Contributing Authors Jason Alexander, MD
Assistant Professor of Medicine
Section of General Internal Medicine</description></item><item><title>COPD</title><link>https://www.physician.tw/COPD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COPD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
COPD #ğŸš§ æ–½å·¥ä¸­ COPD â€¢Â Antibiotic therapy in exacerbations of COPD. Ann Intern Med 1987;106:196â€“204.</description></item><item><title>Coronary Artery Disease (CAD)</title><link>https://www.physician.tw/Coronary-Artery-Disease-CAD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-Artery-Disease-CAD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Coronary Artery Disease (CAD) #ğŸš§ æ–½å·¥ä¸­ Coronary Artery Disease (CAD) â€¢Â FAME-2. N Engl J Med 2012;367(11):991â€“1001.</description></item><item><title>Coronary CT Angiography (CCTA)</title><link>https://www.physician.tw/Coronary-CT-Angiography-CCTA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-CT-Angiography-CCTA/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Coronary CT Angiography (CCTA) #ğŸš§ æ–½å·¥ä¸­ Coronary CT Angiography (CCTA) â€¢Â Indications: Direct anatomic assessment of the coronary anatomy (less sensitive than invasive coronary angiography); CT can increasingly provide physiologic assessment with FFR (fractional flow reserve, a measure of pressure/flow across a coronary lesion); CT-FFR allows clinicians to estimate the hemodynamic significance of coronary lesions noninvasively.</description></item><item><title>critical care common complications of icu admission</title><link>https://www.physician.tw/critical-care-common-complications-of-icu-admission/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-common-complications-of-icu-admission/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care common complications of icu admission #ğŸš§ æ–½å·¥ä¸­ critical care common complications of icu admission [[Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability]]</description></item><item><title>critical care diseases and pathophysiology</title><link>https://www.physician.tw/critical-care-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ critical care diseases and pathophysiology [[SIRS, Sepsis, Severe Sepsis, and Septic Shock]]</description></item><item><title>critical care key clinical trials and publications</title><link>https://www.physician.tw/critical-care-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ critical care key clinical trials and publications [[Shock Management]]</description></item><item><title>critical care key medications and interventions</title><link>https://www.physician.tw/critical-care-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care key medications and interventions #ğŸš§ æ–½å·¥ä¸­ critical care key medications and interventions [[Respiratory Support]]</description></item><item><title>critical care medicine</title><link>https://www.physician.tw/critical-care-medicine/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care-medicine/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Critical Care Medicine of Huppert&amp;rsquo;s Notes]]
critical care medicine #ğŸš§ æ–½å·¥ä¸­ critical care medicine [[Goals of Intensive Care Unit (ICU) Care]]</description></item><item><title>Critical Care Medicine of Huppert's Notes</title><link>https://www.physician.tw/Critical-Care-Medicine-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Care-Medicine-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Critical Care Medicine of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness</title><link>https://www.physician.tw/Critical-Illness-Polyneuropathy-Critical-Illness-Myopathy-and-ICU-Acquired-Weakness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Critical-Illness-Polyneuropathy-Critical-Illness-Myopathy-and-ICU-Acquired-Weakness/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness #ğŸš§ æ–½å·¥ä¸­ Critical Illness Polyneuropathy, Critical Illness Myopathy, and ICU-Acquired Weakness â€¢Â Risk factors: Mechanical ventilation, sepsis, prolonged use of paralytics, multiorgan failure, ARDS</description></item><item><title>Cutaneous Drug Reactions</title><link>https://www.physician.tw/Cutaneous-Drug-Reactions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-Drug-Reactions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Cutaneous Drug Reactions #ğŸš§ æ–½å·¥ä¸­ Cutaneous Drug Reactions Morbilliform drug eruption â€¢Â Pathophysiology: Most common type of cutaneous drug reaction (~75 to 90% of cases); common culprits include antibiotics, antiepileptics, NSAIDs, and calcium channel blockers</description></item><item><title>daily presentations and notes</title><link>https://www.physician.tw/daily-presentations-and-notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/daily-presentations-and-notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Practical Skills for Learners]]
daily presentations and notes #ğŸš§ æ–½å·¥ä¸­ daily presentations and notes [[How to Do Daily Presentations and Notes]]</description></item><item><title>Decubitus Ulcers</title><link>https://www.physician.tw/Decubitus-Ulcers/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Decubitus-Ulcers/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Decubitus Ulcers #ğŸš§ æ–½å·¥ä¸­ Decubitus Ulcers â€¢Â Definition: Injury to skin and underlying tissue from prolonged pressure on the skin</description></item><item><title>definition and epidemiology of multiple myeloma (MM)</title><link>https://www.physician.tw/definition-and-epidemiology-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-and-epidemiology-of-multiple-myeloma-MM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[multiple myeloma (MM)]]
definition and epidemiology of multiple myeloma (MM) #ğŸš§ æ–½å·¥ä¸­ definition and epidemiology of multiple myeloma (MM) (Lancet 2021;397:410) â€¢ Malignant neoplasm of plasma cells producing a monoclonal Ig = â€œM proteinâ€ â€¢ ~27,000 new cases/y; median age at diagnosis 69 y; more common in African Americans</description></item><item><title>definition of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/definition-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
definition of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ definition of chronic myelogenous leukemia (CML) Â (BloodÂ 2009;114:937)</description></item><item><title>definition of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/definition-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-primary-myelofibrosis-PMF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[primary myelofibrosis (PMF)]]
definition of primary myelofibrosis (PMF) #ğŸš§ æ–½å·¥ä¸­ definition of primary myelofibrosis (PMF) â€¢ Clonal myeloproliferation with reactive marrow fibrosis &amp;amp; extramedullary hematopoiesis</description></item><item><title>definition of smallÂ lymphocyticÂ lymphoma</title><link>https://www.physician.tw/definition-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-small-lymphocytic-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[small lymphocytic lymphoma]]
definition of smallÂ lymphocyticÂ lymphoma #ğŸš§ æ–½å·¥ä¸­ definition of smallÂ lymphocyticÂ lymphomaÂ  (NEJMÂ 2005;352:804;Â BloodÂ 2008;111:5446)</description></item><item><title>definition of waldenstromâ€™s macroglobulinemia (WM)</title><link>https://www.physician.tw/definition-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[waldenstromâ€™s macroglobulinemia (WM)]]
definition of waldenstromâ€™s macroglobulinemia (WM) #ğŸš§ æ–½å·¥ä¸­ definition of waldenstromâ€™s macroglobulinemia (WM) (Blood 2009;114:2375; NEJM 2012;367:826) â€¢ B-cell neoplasm (lymphoplasmacytic lymphoma) that secretes monoclonal IgM â€¢ 91% w/ MYD88 (NF-ÎºB pathway) L265P mut.</description></item><item><title>delirium or dementia</title><link>https://www.physician.tw/delirium-or-dementia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delirium-or-dementia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
delirium or dementia #ğŸš§ æ–½å·¥ä¸­ delirium or dementia Payal K. Sanghani, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>Depressed MoodSuicidal Ideation</title><link>https://www.physician.tw/Depressed-MoodSuicidal-Ideation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Depressed-MoodSuicidal-Ideation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Depressed MoodSuicidal Ideation #ğŸš§ æ–½å·¥ä¸­ Depressed Mood/Suicidal Ideation â€¢Â Definitions:
-Â Suicidal ideation (SI)</description></item><item><title>dermatology key medications and interventions</title><link>https://www.physician.tw/dermatology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dermatology-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Dermatology of Huppert&amp;rsquo;s Notes]]
dermatology key medications and interventions #ğŸš§ æ–½å·¥ä¸­ â€¢Â Treatment pearls:
-Â Steroid strength typically: Ointment &amp;gt; Cream &amp;gt; Lotion</description></item><item><title>Dermatology of Huppert's Notes</title><link>https://www.physician.tw/Dermatology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dermatology-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]</description></item><item><title>Determinants of Cardiac Function</title><link>https://www.physician.tw/Determinants-of-Cardiac-Function/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Determinants-of-Cardiac-Function/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Determinants of Cardiac Function #ğŸš§ æ–½å·¥ä¸­ Determinants of Cardiac Function â€¢Â Preload: Myocardial stretch before contraction (i.</description></item><item><title>Diabetes</title><link>https://www.physician.tw/Diabetes-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-key-clinical-trials/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diabetes #ğŸš§ æ–½å·¥ä¸­ Diabetes â€¢Â Diabetes Control and Complication Trial (DCCT). N Engl J Med 1993;329(14):977â€“986.</description></item><item><title>Diabetes Prevention</title><link>https://www.physician.tw/Diabetes-Prevention-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-Prevention-key-clinical-trials/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diabetes Prevention #ğŸš§ æ–½å·¥ä¸­ Diabetes Prevention â€¢Â Diabetes Prevention Program (DPP). N Engl J Med 2002;346(6):393â€“403.</description></item><item><title>Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS)</title><link>https://www.physician.tw/Diabetic-Ketoacidosis-DKA-and-Hyperosmolar-Hyperglycemic-Syndrome-HHS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetic-Ketoacidosis-DKA-and-Hyperosmolar-Hyperglycemic-Syndrome-HHS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS) #ğŸš§ æ–½å·¥ä¸­ Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS) DKA and HHS are medical emergencies that require prompt triaging, evaluation, and treatment, often in the ICU, due to the need for close monitoring, frequent lab draws, and IV insulin therapy.</description></item><item><title>diagnostic and staging evaluation of overview of lymphoma and CLL</title><link>https://www.physician.tw/diagnostic-and-staging-evaluation-of-overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-and-staging-evaluation-of-overview-of-lymphoma-and-CLL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[overview of lymphoma and CLL]]
diagnostic and staging evaluation of overview of lymphoma and CLL #ğŸš§ æ–½å·¥ä¸­ diagnostic and staging evaluation of overview of lymphoma and CLL â€¢ Physical exam: lymph nodes, liver/spleen size, Waldeyerâ€™s ring, testes (~1% of NHL), skin â€¢ Pathology: excisional lymph node bx (not FNA b/c need surrounding architecture) with immunophenotyping and cytogenetics (Reed-Sternberg (RS) cells in HL); BM bx if cytopenias; CLL by peripheral flow in patients w/ peripheral disease; LP if CNS involvement clinically suspected â€¢ Lab tests: CBC, BUN/Cr, LFTs, ESR, LDH, UA, Ca, alb; âœ“ HBV &amp;amp; HCV (and must âœ“ HBsAg &amp;amp; anti-HBc if planning rituximab Rx due to risk of HBV reactivation); HIV â€¢ Imaging: PET-CT to assess disease burden and guide biopsy/therapy, especially in HL, DLBCL.</description></item><item><title>Diagnostic Approach to Joint Pain</title><link>https://www.physician.tw/Diagnostic-Approach-to-Joint-Pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Approach-to-Joint-Pain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diagnostic Approach to Joint Pain #ğŸš§ æ–½å·¥ä¸­ Diagnostic Approach to Joint Pain (1) Consider non-articular mimics of joint pain â€¢Â Articular structures: Synovium, synovial fluid, articular cartilage, intraarticular ligaments, joint capsule, and juxtaarticular bone</description></item><item><title>diagnostic evaluation</title><link>https://www.physician.tw/diagnostic-evaluation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute leukemia]]
diagnostic evaluation #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluationÂ  (BloodÂ 2009;114:937)
â€¢Â Peripheral smear:Â thrombocytopenia,Â blastsÂ (seen in &amp;gt;95%; âŠ• Auer Rods in AML)</description></item><item><title>diagnostic evaluation of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/diagnostic-evaluation-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
diagnostic evaluation of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of chronic myelogenous leukemia (CML) â€¢Â Peripheral smear: leukocytosis, left-shifted withÂ all stages of myeloid maturation;Â thrombocytosis,Â basophilia</description></item><item><title>diagnostic evaluation of essential thrombocythemia (ET)</title><link>https://www.physician.tw/diagnostic-evaluation-of-essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-essential-thrombocythemia-ET/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[essential thrombocythemia (ET)]]
diagnostic evaluation of essential thrombocythemia (ET) #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of essential thrombocythemia (ET) â€¢ Peripheral smear: large hypogranular platelets</description></item><item><title>diagnostic evaluation of polycythemia vera</title><link>https://www.physician.tw/diagnostic-evaluation-of-polycythemia-vera/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-polycythemia-vera/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[polycythemia vera (PV)]]
diagnostic evaluation of polycythemia vera #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of polycythemia vera â€¢ Men: Hb &amp;gt;16.</description></item><item><title>diagnostic evaluation of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/diagnostic-evaluation-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-primary-myelofibrosis-PMF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[primary myelofibrosis (PMF)]]
diagnostic evaluation of primary myelofibrosis (PMF) #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of primary myelofibrosis (PMF)Â  (BloodÂ 2010;115:1703 &amp;amp; 2016;127:2391)</description></item><item><title>diagnostic evaluation of smallÂ lymphocyticÂ lymphoma</title><link>https://www.physician.tw/diagnostic-evaluation-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-small-lymphocytic-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[small lymphocytic lymphoma]]
diagnostic evaluation of smallÂ lymphocyticÂ lymphoma #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of smallÂ lymphocyticÂ lymphoma â€¢Â CBC w/ diff:Â B-cell count</description></item><item><title>diagnostic evaluation of waldenstromâ€™s macroglobulinemia (WM)</title><link>https://www.physician.tw/diagnostic-evaluation-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-evaluation-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[waldenstromâ€™s macroglobulinemia (WM)]]
diagnostic evaluation of waldenstromâ€™s macroglobulinemia (WM) #ğŸš§ æ–½å·¥ä¸­ diagnostic evaluation of waldenstromâ€™s macroglobulinemia (WM) â€¢ SPEP + immunofixation with IgM &amp;gt;3 g/dL; 24-h urine for UPEP (only 20% have âŠ• UPEP) â€¢ Bone marrow biopsy: â†‘ plasmacytoid lymphocytes; Î²2-microglobulin for prognostic eval â€¢ Relative serum viscosity: ratio serum viscosity to H2O (nl 1.</description></item><item><title>Diagnostic Reasoning in Rheumatology</title><link>https://www.physician.tw/Diagnostic-Reasoning-in-Rheumatology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Reasoning-in-Rheumatology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diagnostic Reasoning in Rheumatology #ğŸš§ æ–½å·¥ä¸­ Diagnostic Reasoning in Rheumatology â€¢Â Most rheumatologic diseases are diagnosed â€œclinicallyâ€ â€“ e.</description></item><item><title>DIAGNOSTICS</title><link>https://www.physician.tw/DIAGNOSTICS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DIAGNOSTICS/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
DIAGNOSTICS #ğŸš§ æ–½å·¥ä¸­ DIAGNOSTICS</description></item><item><title>DialysisAccess</title><link>https://www.physician.tw/DialysisAccess/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DialysisAccess/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
DialysisAccess #ğŸš§ æ–½å·¥ä¸­ Dialysis/Access Types of dialysis â€¢Â Hemodialysis (HD):
-Â Blood is pumped along a semipermeable membrane across which electrolytes, water, and toxins are removed by diffusion into another fluid being pumped along the other side of the membrane (dialysate).</description></item><item><title>Diarrhea in a Patient with HIV and a Low CD4 Count</title><link>https://www.physician.tw/Diarrhea-in-a-Patient-with-HIV-and-a-Low-CD4-Count/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diarrhea-in-a-Patient-with-HIV-and-a-Low-CD4-Count/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diarrhea in a Patient with HIV and a Low CD4 Count #ğŸš§ æ–½å·¥ä¸­ Diarrhea in a Patient with HIV and a Low CD4 Count May be due to a common cause, but also consider the following broader differential diagnosis:</description></item><item><title>Diet and Exercise</title><link>https://www.physician.tw/Diet-and-Exercise/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diet-and-Exercise/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diet and Exercise #ğŸš§ æ–½å·¥ä¸­ Diet and Exercise â€¢Â Association of Step Volume and Intensity With All-Cause Mortality in Older Woman.</description></item><item><title>Diffuse alveolar hemorrhage (DAH)</title><link>https://www.physician.tw/Diffuse-alveolar-hemorrhage-DAH/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diffuse-alveolar-hemorrhage-DAH/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
Diffuse alveolar hemorrhage (DAH) #ğŸš§ æ–½å·¥ä¸­ Diffuse alveolar hemorrhage (DAH) Dx: bronchoscopy to exclude infection; â†‘ bloody lavage fluid.</description></item><item><title>Discharge Checklist</title><link>https://www.physician.tw/Discharge-Checklist/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Discharge-Checklist/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Discharge Checklist #ğŸš§ æ–½å·¥ä¸­ Discharge Checklist â€¢Â Approach to discharging a patient: Discharges from the hospital are a transition that creates a risk for breakdown in a patientâ€™s care.</description></item><item><title>disease classification and manifestations of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/disease-classification-and-manifestations-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-classification-and-manifestations-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
disease classification and manifestations of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ disease classification and manifestations of chronic myelogenous leukemia (CML)Â  (WHO;Â NCCNÂ v 2.</description></item><item><title>Diseases involving the Vasculature</title><link>https://www.physician.tw/Diseases-involving-the-Vasculature/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-involving-the-Vasculature/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diseases involving the Vasculature #ğŸš§ æ–½å·¥ä¸­ Diseases involving the Vasculature Pulmonary Embolism (PE) â€¢Â Etiology: Virchowâ€™s triad: 1) Endothelial injury, 2) Venous stasis, 3) Hypercoagulability.</description></item><item><title>Diseases of the Pleura</title><link>https://www.physician.tw/Diseases-of-the-Pleura/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-of-the-Pleura/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diseases of the Pleura #ğŸš§ æ–½å·¥ä¸­ Diseases of the Pleura â€¢Â Pleural Effusion:</description></item><item><title>Diseases of the Vasculature</title><link>https://www.physician.tw/Diseases-of-the-Vasculature/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diseases-of-the-Vasculature/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diseases of the Vasculature #ğŸš§ æ–½å·¥ä¸­ Diseases of the Vasculature Hypertensive emergency â€¢Â Definitions: Elevated SBP with end-organ damage</description></item><item><title>Disorders of the Mucous Membranes</title><link>https://www.physician.tw/Disorders-of-the-Mucous-Membranes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-the-Mucous-Membranes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Disorders of the Mucous Membranes #ğŸš§ æ–½å·¥ä¸­ Disorders of the Mucous Membranes â€¢Â Aphthous ulcers (â€œcanker soresâ€): Painful, shallow oral ulcers with a gray base and a red surrounding halo; if recurrent or severe may suggest underlying disease such as BehÃ§etâ€™s syndrome, Crohnâ€™s disease, or HIV.</description></item><item><title>Dissociative Disorders</title><link>https://www.physician.tw/Dissociative-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dissociative-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Dissociative Disorders #ğŸš§ æ–½å·¥ä¸­ Dissociative Disorders â€¢Â Dissociative amnesia: Episodes of inability to remember salient details about oneâ€™s self.</description></item><item><title>Diverticular Disease</title><link>https://www.physician.tw/Diverticular-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diverticular-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Diverticular Disease #ğŸš§ æ–½å·¥ä¸­ Diverticular Disease Diverticulosis â€¢Â Pathophysiology: Multiple outpouchings of colonic mucosa/submucosa through areas of focal weakness in the setting of increased intraluminal pressure, particularly in the sigmoid colon.</description></item><item><title>DrugToxin-Induced Liver Injury</title><link>https://www.physician.tw/DrugToxin-Induced-Liver-Injury/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DrugToxin-Induced-Liver-Injury/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
DrugToxin-Induced Liver Injury #ğŸš§ æ–½å·¥ä¸­ Drug/Toxin-Induced Liver Injury Acetaminophen â€¢Â Epidemiology: Most common cause of intrinsic drug-induced liver injury.</description></item><item><title>DVTPE</title><link>https://www.physician.tw/DVTPE/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DVTPE/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
DVTPE #ğŸš§ æ–½å·¥ä¸­ DVT/PE â€¢Â Risk factors: ICU patients are considered high risk for VTE given immobility and severe inflammation</description></item><item><title>Dynamics Flow, Resistance, and VQ Matching</title><link>https://www.physician.tw/Dynamics-Flow-Resistance-and-VQ-Matching/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dynamics-Flow-Resistance-and-VQ-Matching/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Dynamics Flow, Resistance, and VQ Matching #ğŸš§ æ–½å·¥ä¸­ Dynamics: Flow, Resistance, and V/Q Matching â€¢Â Flow:</description></item><item><title>Eating Disorders</title><link>https://www.physician.tw/Eating-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eating-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Eating Disorders #ğŸš§ æ–½å·¥ä¸­ Eating Disorders Anorexia nervosa â€¢Â Definition: Intense fear of gaining weight leading to low body weight (&amp;lt;85% ideal, BMI &amp;lt;18.</description></item><item><title>Echocardiography</title><link>https://www.physician.tw/Echocardiography/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Echocardiography/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Echocardiography #ğŸš§ æ–½å·¥ä¸­ Echocardiography Transthoracic echocardiography (TTE) â€¢Â Definition: Most common type of echocardiogram.</description></item><item><title>Eczematous Dermatoses</title><link>https://www.physician.tw/Eczematous-Dermatoses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eczematous-Dermatoses/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Eczematous Dermatoses #ğŸš§ æ–½å·¥ä¸­ Eczematous Dermatoses Dermatitis is red and scaly. The differential is primarily clinical â€“ breakdown the differential by distribution and appearance.</description></item><item><title>Electroencephalogram (EEG)</title><link>https://www.physician.tw/Electroencephalogram-EEG/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electroencephalogram-EEG/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Electroencephalogram (EEG) #ğŸš§ æ–½å·¥ä¸­ Electroencephalogram (EEG) â€¢Â Definition: Test used to evaluate the electrical activity in the brain, particularly for seizure or â€œinterictalâ€ (between seizures) epileptiform discharges</description></item><item><title>Electromyography (EMG) and Nerve Conduction Studies</title><link>https://www.physician.tw/Electromyography-EMG-and-Nerve-Conduction-Studies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electromyography-EMG-and-Nerve-Conduction-Studies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Electromyography (EMG) and Nerve Conduction Studies #ğŸš§ æ–½å·¥ä¸­ Electromyography (EMG) and Nerve Conduction Studies â€¢Â Definitions:</description></item><item><title>Endocarditis</title><link>https://www.physician.tw/Endocarditis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocarditis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Endocarditis #ğŸš§ æ–½å·¥ä¸­ Endocarditis â€¢Â [Guideline] Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American heart association.</description></item><item><title>Endocrine Axes</title><link>https://www.physician.tw/Endocrine-Axes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrine-Axes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Endocrine Axes #ğŸš§ æ–½å·¥ä¸­ Endocrine Axes â€¢Â Organization: There are five parallel endocrine axes in the hypothalamic-anterior pituitary regulatory system (Figure 5.</description></item><item><title>endocrine pancreas</title><link>https://www.physician.tw/endocrine-pancreas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrine-pancreas/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
endocrine pancreas #ğŸš§ æ–½å·¥ä¸­ endocrine pancreas [[books/h_note/Diabetes Mellitus]]
[[books/h_note/Hypoglycemia]]</description></item><item><title>endocrinology anatomy and physiology</title><link>https://www.physician.tw/endocrinology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrinology-anatomy-and-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
endocrinology anatomy and physiology [[Endocrine Axes]]</description></item><item><title>Endocrinology of Huppert's Notes</title><link>https://www.physician.tw/Endocrinology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Endocrinology of Huppert&amp;rsquo;s Notes [[endocrinology anatomy and physiology]]
[[pituitary]]
[[thyroid]]
[[adrenal gland]]
[[reproductive endocrinology]]</description></item><item><title>engraftment syndrome</title><link>https://www.physician.tw/engraftment-syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/engraftment-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
engraftment syndrome #ğŸš§ æ–½å·¥ä¸­ engraftment syndrome: fever, rash, noncardiogenic pulm.</description></item><item><title>ENL 2017 Genetic Risk Classification</title><link>https://www.physician.tw/ENL-2017-Genetic-Risk-Classification/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ENL-2017-Genetic-Risk-Classification/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
ENL 2017 Genetic Risk Classification #ğŸš§ æ–½å·¥ä¸­ ENL 2017 Genetic Risk Classification Â (BloodÂ 2017;129:424)</description></item><item><title>Epidemiology and risk factors</title><link>https://www.physician.tw/Epidemiology-and-risk-factors/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hodgkin lymphoma (HL)]]
Epidemiology and risk factors #ğŸš§ æ–½å·¥ä¸­ Epidemiology and risk factors â€¢ ~9,000 cases/y; bimodal distribution (15â€“35 &amp;amp; &amp;gt;50 y); â†‘ â™‚; role of EBV in subsets of HL, esp.</description></item><item><title>epidemiology and risk factors of acute leukemia</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-acute-leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-acute-leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute leukemia]]
epidemiology and risk factors of acute leukemia #ğŸš§ æ–½å·¥ä¸­ epidemiology and risk factors of acute leukemia â€¢ Acute myelogenous (AML): ~20k cases/y in U.</description></item><item><title>epidemiology and risk factors of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
epidemiology and risk factors of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ epidemiology and risk factors of chronic myelogenous leukemia (CML) â€¢ ~6600 new cases/y in U.</description></item><item><title>epidemiology and risk factors of non-Hodgkin lymphoma (NHL)</title><link>https://www.physician.tw/epidemiology-and-risk-factors-of-non-Hodgkin-lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidemiology-and-risk-factors-of-non-Hodgkin-lymphoma-NHL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[non-Hodgkin lymphoma (NHL)]]
epidemiology and risk factors of non-Hodgkin lymphoma (NHL) #ğŸš§ æ–½å·¥ä¸­ epidemiology and risk factors of non-Hodgkin lymphoma (NHL) â€¢ 79 types of NHL, ~70,000 new cases/y; median age dx 65 y; â™‚ predom; 85% B-cell origin</description></item><item><title>Epilepsy</title><link>https://www.physician.tw/Epilepsy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epilepsy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Epilepsy #ğŸš§ æ–½å·¥ä¸­ Epilepsy â€¢Â Veterans Affairs Status Epilepticus Cooperative Study Group: A comparison of four treatments for generalized convulsive status.</description></item><item><title>Esophagus</title><link>https://www.physician.tw/Esophagus/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Esophagus/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Esophagus #ğŸš§ æ–½å·¥ä¸­ Esophagus Gastroesophageal reflux disease (GERD) â€¢Â Pathophysiology: Decreased lower esophageal sphincter (LES) tone; may also have decreased esophageal motility, gastric outlet obstruction, and/or hiatal hernia</description></item><item><title>essentialÂ thrombocythemiaÂ (ET)</title><link>https://www.physician.tw/essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/essential-thrombocythemia-ET/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myeloproliferative neoplasms]]
essentialÂ thrombocythemiaÂ (ET) definition of essential thrombocythemia (ET)
â€¢ Sustained â†‘ in platelets (&amp;gt;450,000/ÂµL) Â± â†‘ RBC and granulocytes</description></item><item><title>etiologies of erythrocytosis</title><link>https://www.physician.tw/etiologies-of-erythrocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-erythrocytosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[polycythemia vera (PV)]]
etiologies of erythrocytosis #ğŸš§ æ–½å·¥ä¸­ etiologies of erythrocytosisÂ  (absoluteÂ â†‘Â RBC)</description></item><item><title>Etiologies of Liver Disease</title><link>https://www.physician.tw/Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Liver-Disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Etiologies of Liver Disease #ğŸš§ æ–½å·¥ä¸­ Etiologies of Liver Disease</description></item><item><title>etiologies of myelofibrosis</title><link>https://www.physician.tw/etiologies-of-myelofibrosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-myelofibrosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[primary myelofibrosis (PMF)]]
etiologies of myelofibrosis #ğŸš§ æ–½å·¥ä¸­ etiologies of myelofibrosis â€¢ 1Â° myelofibrosis (PMF): myeloproliferative neoplasm</description></item><item><title>etiologies of thrombocytosis</title><link>https://www.physician.tw/etiologies-of-thrombocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-thrombocytosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[essential thrombocythemia (ET)]]
etiologies of thrombocytosis #ğŸš§ æ–½å·¥ä¸­ etiologies of thrombocytosis â€¢ 1Â° = ET or other MPN; myelodysplastic syndromes (5q-syndrome); RARS-T</description></item><item><title>Evaluation of a Peripheral Blood Smear</title><link>https://www.physician.tw/Evaluation-of-a-Peripheral-Blood-Smear/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-a-Peripheral-Blood-Smear/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Evaluation of a Peripheral Blood Smear #ğŸš§ æ–½å·¥ä¸­ Evaluation of a Peripheral Blood Smear Evaluate a peripheral blood smear using a systematic and thorough approach:</description></item><item><title>Extra Heart Sounds</title><link>https://www.physician.tw/Extra-Heart-Sounds/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extra-Heart-Sounds/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Extra Heart Sounds #ğŸš§ æ–½å·¥ä¸­ Extra Heart Sounds â€¢Â S3 (Ventricular gallop): OVERLOAD; early diastolic sound, listen with the stethoscopeâ€™s bell</description></item><item><title>falls and fracture prevention</title><link>https://www.physician.tw/falls-and-fracture-prevention/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/falls-and-fracture-prevention/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[endocrinology]]
falls and fracture prevention #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Females</title><link>https://www.physician.tw/Females/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Females/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Females #ğŸš§ æ–½å·¥ä¸­ Females Menstrual Cycle â€¢Â Follicular phase (day 0â€“13): From the onset of menses to the LH surge.</description></item><item><title>Fever in a Returning Traveler</title><link>https://www.physician.tw/Fever-in-a-Returning-Traveler/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fever-in-a-Returning-Traveler/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Fever in a Returning Traveler #ğŸš§ æ–½å·¥ä¸­ Fever in a Returning Traveler â€¢Â Approach to Fever in the Returning Traveler.</description></item><item><title>Fluids, Electrolytes, and AcidBase Disorders</title><link>https://www.physician.tw/Fluids-Electrolytes-and-AcidBase-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluids-Electrolytes-and-AcidBase-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Fluids, Electrolytes, and AcidBase Disorders #ğŸš§ æ–½å·¥ä¸­ Fluids, Electrolytes, and Acid/Base Disorders For each electrolyte, we will discuss the normal regulation and then discuss what happens when levels of the electrolyte are too low or too high.</description></item><item><title>Functional Bowel Disorders</title><link>https://www.physician.tw/Functional-Bowel-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Functional-Bowel-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Functional Bowel Disorders #ğŸš§ æ–½å·¥ä¸­ Functional Bowel Disorders â€¢Â Cognitive-Behavioral Therapy Versus Education and Desipramine Versus Placebo for Moderate to Severe Functional Bowel Disorders.</description></item><item><title>Gallbladder and Biliary Tract</title><link>https://www.physician.tw/Gallbladder-and-Biliary-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gallbladder-and-Biliary-Tract/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gallbladder and Biliary Tract #ğŸš§ æ–½å·¥ä¸­ Gallbladder and Biliary Tract</description></item><item><title>Gallbladder Stone Diseases</title><link>https://www.physician.tw/Gallbladder-Stone-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gallbladder-Stone-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gallbladder Stone Diseases #ğŸš§ æ–½å·¥ä¸­ Gallbladder Stone Diseases Cholelithiasis â€¢Â Etiology: Stone in the gallbladder</description></item><item><title>Gas exchange</title><link>https://www.physician.tw/Gas-exchange/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gas-exchange/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gas exchange #ğŸš§ æ–½å·¥ä¸­ Gas exchange â€¢Â Oxygen:
-Â Oxygen is transported in two forms: 1) Dissolved in blood; 2) Bound to Hgb (most important/majority)</description></item><item><title>gastroenterology anatomy and physiology</title><link>https://www.physician.tw/gastroenterology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-anatomy-and-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology anatomy and physiology #ğŸš§ æ–½å·¥ä¸­ gastroenterology anatomy and physiology [[Structure and Innervation of the GI Tract]]</description></item><item><title>gastroenterology approaches and chief complaints</title><link>https://www.physician.tw/gastroenterology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-approaches-and-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology approaches and chief complaints #ğŸš§ æ–½å·¥ä¸­ gastroenterology approaches and chief complaints [[books/h_note/Abdominal Pain]]</description></item><item><title>gastroenterology diagnostics</title><link>https://www.physician.tw/gastroenterology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology diagnostics #ğŸš§ æ–½å·¥ä¸­ gastroenterology diagnostics TABLE 4.2 â€¢ Diagnostic Tests in Gastroenterology</description></item><item><title>gastroenterology diseases and pathophysiology</title><link>https://www.physician.tw/gastroenterology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ gastroenterology diseases and pathophysiology [[Esophagus]]</description></item><item><title>gastroenterology key clinical trials and publications</title><link>https://www.physician.tw/gastroenterology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ gastroenterology key clinical trials and publications [[GI Bleed]]</description></item><item><title>gastroenterology key medications and interventions</title><link>https://www.physician.tw/gastroenterology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Gastroenterology of Huppert&amp;rsquo;s Notes]]
gastroenterology key medications and interventions #ğŸš§ æ–½å·¥ä¸­ gastroenterology key medications and interventions [[Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology]]</description></item><item><title>Gastroenterology of Huppert's Notes</title><link>https://www.physician.tw/Gastroenterology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroenterology-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gastroenterology of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­ Gastroenterology of Huppert&amp;rsquo;s Notes</description></item><item><title>General Approach to the Diagnosis and Management of AKI</title><link>https://www.physician.tw/General-Approach-to-the-Diagnosis-and-Management-of-AKI/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Approach-to-the-Diagnosis-and-Management-of-AKI/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
General Approach to the Diagnosis and Management of AKI #ğŸš§ æ–½å·¥ä¸­ General Approach to the Diagnosis and Management of AKI â€¢Â Step 1: Address any urgent management needs (e.</description></item><item><title>General Approaches to Treating Cancer</title><link>https://www.physician.tw/General-Approaches-to-Treating-Cancer/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Approaches-to-Treating-Cancer/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
General Approaches to Treating Cancer #ğŸš§ æ–½å·¥ä¸­ General Approaches to Treating Cancer Surgery, radiation, and medications</description></item><item><title>General Medicine of Huppert's Notes</title><link>https://www.physician.tw/General-Medicine-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-Medicine-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
General Medicine of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­ General Medicine of Huppert&amp;rsquo;s Notes [[INTRODUCTION]]</description></item><item><title>Genitourinary (GU) Infections</title><link>https://www.physician.tw/Genitourinary-GU-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genitourinary-GU-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Genitourinary (GU) Infections #ğŸš§ æ–½å·¥ä¸­ Genitourinary (GU) Infections Asymptomatic bacteriuria â€¢Â Definition: Bacterial growth in a properly collected urine culture specimen from a patient without symptoms of inflammation of the GU system, such as urinary urgency, frequency, dysuria, or flank pain</description></item><item><title>GI Bleed</title><link>https://www.physician.tw/GI-Bleed/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-Bleed/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
GI Bleed #ğŸš§ æ–½å·¥ä¸­ GI Bleed â€¢Â Transfusion Strategies for Acute Upper Gastrointestinal Bleeding.</description></item><item><title>GI bleeding</title><link>https://www.physician.tw/GI-bleeding/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-bleeding/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
GI bleeding #ğŸš§ æ–½å·¥ä¸­ GI bleeding Deepa Rani Nandiwada, MD, MS
CHIEF COMPLAINT PATIENT</description></item><item><title>Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria</title><link>https://www.physician.tw/Glomerular-Pathologies-Commonly-Associated-with-Nephrotic-Range-Proteinuria/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Pathologies-Commonly-Associated-with-Nephrotic-Range-Proteinuria/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria #ğŸš§ æ–½å·¥ä¸­ Glomerular Pathologies Commonly Associated with Nephrotic-Range Proteinuria Minimal change glomerulopathy (MCG, â€œminimal change diseaseâ€) â€¢Â Epidemiology: Most common cause of nephrotic syndrome in children, less common in adults</description></item><item><title>Glomerular Pathology Associated with Nephritic Syndrome</title><link>https://www.physician.tw/Glomerular-Pathology-Associated-with-Nephritic-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Pathology-Associated-with-Nephritic-Syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Glomerular Pathology Associated with Nephritic Syndrome #ğŸš§ æ–½å·¥ä¸­ Glomerular Pathology Associated with Nephritic Syndrome Post-streptococcal glomerulonephritis â€¢Â Epidemiology: More common in children</description></item><item><title>Goals of Intensive Care Unit (ICU) Care</title><link>https://www.physician.tw/Goals-of-Intensive-Care-Unit-ICU-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Goals-of-Intensive-Care-Unit-ICU-Care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Goals of Intensive Care Unit (ICU) Care #ğŸš§ æ–½å·¥ä¸­ Goals of Intensive Care Unit (ICU) Care â€¢Â Stabilize, diagnose, and treat patients with acute life-, limb-, or organ-threatening conditions</description></item><item><title>graft-versus-host disease</title><link>https://www.physician.tw/graft-versus-host-disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/graft-versus-host-disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
graft-versus-host disease #ğŸš§ æ–½å·¥ä¸­ æ€¥æ€§ GVHD å¯è¡¨ç¾ç‚ºæ–‘ä¸˜ç–¹ã€è‚åŠŸèƒ½éšœç¤™å’Œ/æˆ–è…¹ç€‰ï¼Œå› ç‚ºæ”»æ“Šçš„ä¸»è¦ç›®æ¨™æ˜¯çš®è†šã€è‚è‡Ÿå’Œèƒƒè…¸é“ (GI)ã€‚
æ€¥æ€§ GVHD ä»ç„¶æ˜¯ç™¼ç—…ç‡å’Œæ­»äº¡ç‡çš„ä¸»è¦åŸå› ï¼Œå°¤å…¶æ˜¯åœ¨ç„¡é—œçš„åŒç¨®ç•°é«”ç§»æ¤ä¸­ã€‚</description></item><item><title>Gram-Negative Bacteremia</title><link>https://www.physician.tw/Gram-Negative-Bacteremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gram-Negative-Bacteremia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gram-Negative Bacteremia #ğŸš§ æ–½å·¥ä¸­ Gram-Negative Bacteremia â€¢Â Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia : A noninferiority randomized controlled trial.</description></item><item><title>GU Infections</title><link>https://www.physician.tw/GU-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GU-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
GU Infections #ğŸš§ æ–½å·¥ä¸­ GU Infections â€¢Â [Guideline] International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.</description></item><item><title>GYN Malignancies</title><link>https://www.physician.tw/GYN-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GYN-Malignancies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
GYN Malignancies #ğŸš§ æ–½å·¥ä¸­ GYN Malignancies Ovarian cancer
â€¢Â Epidemiology: Median age at diagnosis 63 yr, lifetime risk 1.</description></item><item><title>Gynecologic</title><link>https://www.physician.tw/Gynecologic/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gynecologic/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Gynecologic #ğŸš§ æ–½å·¥ä¸­ Gynecologic</description></item><item><title>Hair and Nail Disorders</title><link>https://www.physician.tw/Hair-and-Nail-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hair-and-Nail-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hair and Nail Disorders #ğŸš§ æ–½å·¥ä¸­ Hair and Nail Disorders â€¢Â Hirsutism: Excess hair growth in androgen-dependent areas (upper lip, lateral cheeks, chin, chest, lower abdomen, groin, and buttocks); most commonly caused by polycystic ovary syndrome (~60% of cases) but can also be due to other forms of androgen excess (e.</description></item><item><title>Head &amp; Neck Malignancies</title><link>https://www.physician.tw/Head-Neck-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Head-Neck-Malignancies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Head &amp;amp; Neck Malignancies #ğŸš§ æ–½å·¥ä¸­ Head &amp;amp; Neck Malignancies Thyroid cancer
â€¢Â Diagnosis: Thyroid ultrasound and biopsy</description></item><item><title>Head and Neck</title><link>https://www.physician.tw/Head-and-Neck/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Head-and-Neck/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Head and Neck #ğŸš§ æ–½å·¥ä¸­ Head and Neck</description></item><item><title>Health Care Maintenance and Disease Screening</title><link>https://www.physician.tw/Health-Care-Maintenance-and-Disease-Screening/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Health-Care-Maintenance-and-Disease-Screening/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Health Care Maintenance and Disease Screening #ğŸš§ æ–½å·¥ä¸­ Health Care Maintenance and Disease Screening These health care maintenance and disease screening guidelines summarize recommendations from the U.</description></item><item><title>Hearing loss</title><link>https://www.physician.tw/Hearing-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hearing-loss/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hearing loss #ğŸš§ æ–½å·¥ä¸­ Hearing loss â€¢Â Physical exam: Otoscopic exam, Weber test (performed by pressing the handle of the tuning fork to the center of the forehead), Rinne test (performed by comparing the sound heard when a tuning fork is placed on the mastoid bone behind the ear to when a tuning fork is held near the ear, in order to compare bone and air conduction)</description></item><item><title>Heart Failure (HF)</title><link>https://www.physician.tw/Heart-Failure-HF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-HF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Heart Failure (HF) #ğŸš§ æ–½å·¥ä¸­ Heart Failure (HF) â€¢Â Etiology:
-Â Left-sided HF: Ischemic vs.</description></item><item><title>Heart Failure with Preserved Ejection Fraction (HFpEF)</title><link>https://www.physician.tw/Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Heart Failure with Preserved Ejection Fraction (HFpEF) #ğŸš§ æ–½å·¥ä¸­ Heart Failure with Preserved Ejection Fraction (HFpEF) â€¢Â TOPCAT.</description></item><item><title>Heart Failure with Reduced Ejection Fraction (HFrEF)</title><link>https://www.physician.tw/Heart-Failure-with-Reduced-Ejection-Fraction-HFrEF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-Failure-with-Reduced-Ejection-Fraction-HFrEF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Heart Failure with Reduced Ejection Fraction (HFrEF) #ğŸš§ æ–½å·¥ä¸­ Heart Failure with Reduced Ejection Fraction (HFrEF) â€¢Â PARADIGM-HF.</description></item><item><title>hematology of Huppert's Notes</title><link>https://www.physician.tw/hematology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
[[books/h_note/Hematopoiesis]]
[[The Coagulation Cascade]]
[[Evaluation of a Peripheral Blood Smear]]
First, some terminology and then weâ€™ll dive into each of these conditions separately below:</description></item><item><title>Hemoglobin Targets in Patients with CKD</title><link>https://www.physician.tw/Hemoglobin-Targets-in-Patients-with-CKD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemoglobin-Targets-in-Patients-with-CKD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hemoglobin Targets in Patients with CKD #ğŸš§ æ–½å·¥ä¸­ Hemoglobin Targets in Patients with CKD â€¢Â TREAT.</description></item><item><title>HIV-associated NHL</title><link>https://www.physician.tw/HIV-associated-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIV-associated-NHL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[non-Hodgkin lymphoma (NHL)]]
HIV-associated NHL #ğŸš§ æ–½å·¥ä¸­ HIV-associated NHLÂ  (BloodÂ 2006;107:13)
â€¢ HIV âŠ• imparts 60â€“100Ã— relative risk</description></item><item><title>HIVAIDS</title><link>https://www.physician.tw/HIVAIDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIVAIDS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
HIVAIDS #ğŸš§ æ–½å·¥ä¸­ HIV/AIDS â€¢Â [Guideline] Panel on Antiretroviral Guidelines for Adults and Adolescents.</description></item><item><title>hodgkin lymphoma (HL)</title><link>https://www.physician.tw/hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hodgkin-lymphoma-HL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[lymphoma and CLL]]
hodgkin lymphoma (HL) (Am J Hematol 2018;93:704; Lancet 2021;398:1518)
[[Epidemiology and risk factors]] [[pathology of hodgkin lymphoma (HL)]]</description></item><item><title>Hormone Therapy</title><link>https://www.physician.tw/Hormone-Therapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hormone-Therapy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hormone Therapy #ğŸš§ æ–½å·¥ä¸­ Hormone Therapy â€¢Â Definition: Medications that suppress endogenous hormones that drive growth of certain tumor types (e.</description></item><item><title>how to call a consult</title><link>https://www.physician.tw/how-to-call-a-consult/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-call-a-consult/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Practical Skills for Learners]]
how to call a consult #ğŸš§ æ–½å·¥ä¸­ how to call a consult â€¢Â Consult question: In general, consults should be structured around a specific question in regard to a patientâ€™s care (e.</description></item><item><title>How to Do Daily Presentations and Notes</title><link>https://www.physician.tw/How-to-Do-Daily-Presentations-and-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-to-Do-Daily-Presentations-and-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
How to Do Daily Presentations and Notes #ğŸš§ æ–½å·¥ä¸­ How to Do Daily Presentations and Notes â€¢Â Format: Typically, daily presentations about each patient are presented in a â€œSOAPâ€ note format.</description></item><item><title>how to pre-round</title><link>https://www.physician.tw/how-to-pre-round/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-pre-round/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Practical Skills for Learners]]
how to pre-round #ğŸš§ æ–½å·¥ä¸­ how to pre-round â€¢Â Purpose of pre-rounding: Pre-rounding refers to the activity of gathering data prior to rounds, typically including 24 hour and overnight events, nursing updates/concerns, the patientâ€™s subjective report, vital signs, physical exam, labs, and other test results.</description></item><item><title>HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;P)</title><link>https://www.physician.tw/HOW-TO-WRITE-A-HISTORY-AND-PHYSICAL-HP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HOW-TO-WRITE-A-HISTORY-AND-PHYSICAL-HP/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Practical Skills for Learners]]
HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;amp;P) #ğŸš§ æ–½å·¥ä¸­ HOW TO WRITE A HISTORY AND PHYSICAL (H&amp;amp;P) Early in training, writing an H&amp;amp;P can sometimes seem overwhelming.</description></item><item><title>Hypercarbic Respiratory Failure</title><link>https://www.physician.tw/Hypercarbic-Respiratory-Failure/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypercarbic-Respiratory-Failure/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hypercarbic Respiratory Failure #ğŸš§ æ–½å·¥ä¸­ Hypercarbic Respiratory Failure â€¢Â Definition: Respiratory failure due to alveolar hypoventilation â†’ ineffective carbon dioxide elimination</description></item><item><title>Hyperkinetic Movement Disorders</title><link>https://www.physician.tw/Hyperkinetic-Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperkinetic-Movement-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hyperkinetic Movement Disorders #ğŸš§ æ–½å·¥ä¸­ Hyperkinetic Movement Disorders Tremor â€¢Â Essential tremor: Postural and action tremor that usually starts in the hands/arms and spreads to the head, voice, and legs; often improves with alcohol intake.</description></item><item><title>Hyperlipidemia</title><link>https://www.physician.tw/Hyperlipidemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperlipidemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hyperlipidemia #ğŸš§ æ–½å·¥ä¸­ Hyperlipidemia â€¢Â Risk factors:
-Â Lifestyle: Diet (high saturated fats), inactivity, advanced age, family history, male gender (M&amp;gt;F)</description></item><item><title>Hypertension Management</title><link>https://www.physician.tw/Hypertension-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypertension-Management/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hypertension Management #ğŸš§ æ–½å·¥ä¸­ Hypertension Management â€¢Â SPRINT. N Eng J Med 2015;373(22):2103â€“2116</description></item><item><title>Hypokinetic Movement Disorders</title><link>https://www.physician.tw/Hypokinetic-Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypokinetic-Movement-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hypokinetic Movement Disorders #ğŸš§ æ–½å·¥ä¸­ Hypokinetic Movement Disorders Parkinsonism â€¢Â Symptoms: Syndrome of bradykinesia (#1), rigidity, tremor, postural instability</description></item><item><title>hyponatremia. I have a patient with hypernatremia</title><link>https://www.physician.tw/hyponatremia.-I-have-a-patient-with-hypernatremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyponatremia.-I-have-a-patient-with-hypernatremia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
hyponatremia. I have a patient with hypernatremia #ğŸš§ æ–½å·¥ä¸­ hyponatremia. I have a patient with hypernatremia Scott D.</description></item><item><title>Hypoxemic Respiratory Failure</title><link>https://www.physician.tw/Hypoxemic-Respiratory-Failure/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoxemic-Respiratory-Failure/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Hypoxemic Respiratory Failure #ğŸš§ æ–½å·¥ä¸­ Hypoxemic Respiratory Failure â€¢Â Definition: PaO2 &amp;lt;60 mmHg, P/F &amp;lt;300, or PaO2 decrease from baseline of 10 mmHg</description></item><item><title>I have a healthy patient without HIV risk factors who asks about HIV screening. How do I diagnose or exclude HIV infection</title><link>https://www.physician.tw/I-have-a-healthy-patient-without-HIV-risk-factors-who-asks-about-HIV-screening.-How-do-I-diagnose-or-exclude-HIV-infection/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-healthy-patient-without-HIV-risk-factors-who-asks-about-HIV-screening.-How-do-I-diagnose-or-exclude-HIV-infection/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have a healthy patient without HIV risk factors who asks about HIV screening. How do I diagnose or exclude HIV infection #ğŸš§ æ–½å·¥ä¸­ I have a healthy patient without HIV risk factors who asks about HIV screening.</description></item><item><title>I have a healthy patient. How do I determine which screening tests to order</title><link>https://www.physician.tw/I-have-a-healthy-patient.-How-do-I-determine-which-screening-tests-to-order/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-healthy-patient.-How-do-I-determine-which-screening-tests-to-order/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have a healthy patient. How do I determine which screening tests to order #ğŸš§ æ–½å·¥ä¸­ I have a healthy patient.</description></item><item><title>I have a patient who is concerned that she has diabetes. How do I confirm the diagnosis and treat patients with diabetes</title><link>https://www.physician.tw/I-have-a-patient-who-is-concerned-that-she-has-diabetes.-How-do-I-confirm-the-diagnosis-and-treat-patients-with-diabetes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-patient-who-is-concerned-that-she-has-diabetes.-How-do-I-confirm-the-diagnosis-and-treat-patients-with-diabetes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have a patient who is concerned that she has diabetes. How do I confirm the diagnosis and treat patients with diabetes #ğŸš§ æ–½å·¥ä¸­ I have a patient who is concerned that she has diabetes.</description></item><item><title>I have a patient with a problem. How do I figure out the possible causes</title><link>https://www.physician.tw/I-have-a-patient-with-a-problem.-How-do-I-figure-out-the-possible-causes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-a-patient-with-a-problem.-How-do-I-figure-out-the-possible-causes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have a patient with a problem. How do I figure out the possible causes #ğŸš§ æ–½å·¥ä¸­ I have a patient with a problem.</description></item><item><title>I have an HIV-positive patient who complains of headache. How do I determine the cause</title><link>https://www.physician.tw/I-have-an-HIV-positive-patient-who-complains-of-headache.-How-do-I-determine-the-cause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-an-HIV-positive-patient-who-complains-of-headache.-How-do-I-determine-the-cause/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have an HIV-positive patient who complains of headache. How do I determine the cause #ğŸš§ æ–½å·¥ä¸­ I have an HIV-positive patient who complains of headache.</description></item><item><title>I have an HIV-positive patient with a cough and fever. How do I determine the cause</title><link>https://www.physician.tw/I-have-an-HIV-positive-patient-with-a-cough-and-fever.-How-do-I-determine-the-cause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-an-HIV-positive-patient-with-a-cough-and-fever.-How-do-I-determine-the-cause/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have an HIV-positive patient with a cough and fever. How do I determine the cause #ğŸš§ æ–½å·¥ä¸­ I have an HIV-positive patient with a cough and fever.</description></item><item><title>I have patients with AIDS-related complaints.</title><link>https://www.physician.tw/I-have-patients-with-AIDS-related-complaints./</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/I-have-patients-with-AIDS-related-complaints./</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
I have patients with AIDS-related complaints. #ğŸš§ æ–½å·¥ä¸­ I have patients with AIDS-related complaints.</description></item><item><title>IBD</title><link>https://www.physician.tw/IBD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IBD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
IBD #ğŸš§ æ–½å·¥ä¸­ IBD â€¢Â SONIC. N Engl J Med 2010;362:1383â€“1395.
-Â Double-blind randomized controlled trial assessing the safety and efficacy of infliximab and azathioprine alone or in combination for patients with Crohnâ€™s disease.</description></item><item><title>idiopathic pneumonia syndrome (IPS)</title><link>https://www.physician.tw/idiopathic-pneumonia-syndrome-IPS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/idiopathic-pneumonia-syndrome-IPS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
idiopathic pneumonia syndrome (IPS) #ğŸš§ æ–½å·¥ä¸­ idiopathic pneumonia syndrome (IPS) 5â€“25% of Pts, &amp;gt;50% mortality (Blood 2003;102:2777) Alveolar injury 2/2 direct toxicity â†’ fever, hypoxia, diffuse infiltrates; occult infxn frequent</description></item><item><title>Imaging</title><link>https://www.physician.tw/Imaging/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Imaging #ğŸš§ æ–½å·¥ä¸­ Imaging Non-contrast head computed tomography (NCHCT) â€¢Â Description: CT scanning is particularly useful for evaluation of bony defects, metallic objects, calcifications, hemorrhage, and hydrocephalus</description></item><item><title>Immunotherapy</title><link>https://www.physician.tw/Immunotherapy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunotherapy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Immunotherapy #ğŸš§ æ–½å·¥ä¸­ Immunotherapy â€¢Â Mechanism: Checkpoint inhibitors enable the patientâ€™s own immune system to better target and destroy malignant cells by blocking the signals that turn the immune system off.</description></item><item><title>Impulse Control Disorders</title><link>https://www.physician.tw/Impulse-Control-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Impulse-Control-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Impulse Control Disorders #ğŸš§ æ–½å·¥ä¸­ Impulse Control Disorders â€¢Â Intermittent explosive disorder: Recurrent aggressive outbursts, out of proportion with stressor, then remorse (unlike antisocial personality).</description></item><item><title>indications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/indications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
indications of hematopoietic stem cell transplantation (BBMT 2015;21:1863; BMT 2015;50:1037) â€¢ Malignant disease: Auto HSCT allows high-dose myeloablative chemo and then rescue what would be otherwise lethal cytopenias with autologous stem cells.</description></item><item><title>induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/induction-chemotherapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/induction-chemotherapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[treatment of acute lymphoblastic leukemia (ALL)]]
induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL) #ğŸš§ æ–½å·¥ä¸­ induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL) Ph âŠ• t(9;22) (seen in ~25% of B-ALL): tyrosine kinase inhibitor + chemo/steroids</description></item><item><title>Infections</title><link>https://www.physician.tw/Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Infections #ğŸš§ æ–½å·¥ä¸­ Infections Central line-associated bloodstream infections (CLABSI)
â€¢Â Pathogens:
-Â Typically skin flora with coagulase-negative staph, S.</description></item><item><title>infectious complications of hematopoietic stem cell transplantation</title><link>https://www.physician.tw/infectious-complications-of-hematopoietic-stem-cell-transplantation/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-complications-of-hematopoietic-stem-cell-transplantation/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[complications of hematopoietic stem cell transplantation]]
infectious complications of hematopoietic stem cell transplantation #ğŸš§ æ–½å·¥ä¸­ infectious complications of hematopoietic stem cell transplantation due to regimen-induced pancytopenia and immunosuppression auto HSCT recipients: no immunosuppression âˆ´ at â†‘ risk only pre-/postengraftment both primary infections and reactivation events occur (eg, CMV, HSV, VZV)</description></item><item><title>infectious diseases and pathophysiology</title><link>https://www.physician.tw/infectious-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ infectious diseases and pathophysiology Because diagnostic and therapeutic decisions in infectious diseases are heavily informed by a patientâ€™s clinical syndrome, they are included with each specific disease.</description></item><item><title>infectious diseases key clinical trials &amp; publications</title><link>https://www.physician.tw/infectious-diseases-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-key-clinical-trials-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases key clinical trials &amp;amp; publications #ğŸš§ æ–½å·¥ä¸­ infectious diseases key clinical trials &amp;amp; publications [[books/h_note/Fever of Unknown Origin]]</description></item><item><title>infectious diseases key medications &amp; interventions</title><link>https://www.physician.tw/infectious-diseases-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-key-medications-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
infectious diseases key medications &amp;amp; interventions #ğŸš§ æ–½å·¥ä¸­ infectious diseases key medications &amp;amp; interventions [[books/h_note/Antibiotics]]</description></item><item><title>Infectious Diseases of Huppert's Notes</title><link>https://www.physician.tw/Infectious-Diseases-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Diseases-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Infectious Diseases of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­ Infectious Diseases of Huppert&amp;rsquo;s Notes [[microbiology]]</description></item><item><title>Infectious Etiologies of Liver Disease</title><link>https://www.physician.tw/Infectious-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infectious-Etiologies-of-Liver-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Infectious Etiologies of Liver Disease #ğŸš§ æ–½å·¥ä¸­ Infectious Etiologies of Liver Disease Hepatitis A virus (HAV), Hepatitis E virus (HAE) â€¢Â HAV: Fecalâ€“oral transmission.</description></item><item><title>Inflammatory and Autoimmune Conditions</title><link>https://www.physician.tw/Inflammatory-and-Autoimmune-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inflammatory-and-Autoimmune-Conditions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Inflammatory and Autoimmune Conditions #ğŸš§ æ–½å·¥ä¸­ Inflammatory and Autoimmune Conditions Pyoderma gangrenosum (PG) â€¢Â Pathophysiology: Neutrophilic dermatosis; often associated with underlying systemic disease (IBD, RA, malignancy)</description></item><item><title>Inflammatory Bowel Disease (IBD)</title><link>https://www.physician.tw/Inflammatory-Bowel-Disease-IBD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inflammatory-Bowel-Disease-IBD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Inflammatory Bowel Disease (IBD) #ğŸš§ æ–½å·¥ä¸­ Inflammatory Bowel Disease (IBD) â€¢Â History:
-Â Even if you suspect IBD, always rule out infection first!</description></item><item><title>Influenza</title><link>https://www.physician.tw/Influenza/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Influenza/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Influenza #ğŸš§ æ–½å·¥ä¸­ Influenza â€¢Â Diagnosis of influenza in intensive care units: Lower respiratory tract samples are better than nose-throat swabs.</description></item><item><title>Inhaler Glossary</title><link>https://www.physician.tw/Inhaler-Glossary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inhaler-Glossary/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Inhaler Glossary #ğŸš§ æ–½å·¥ä¸­ Inhaler Glossary FIGURE 2.15: Respiratory treatments by inhaler class.</description></item><item><title>Inpatient Dermatology</title><link>https://www.physician.tw/Inpatient-Dermatology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inpatient-Dermatology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Inpatient Dermatology #ğŸš§ æ–½å·¥ä¸­ Inpatient Dermatology â€¢Â Prevalence of cutaneous findings in hospitalized medical patients.</description></item><item><title>Insterstitial Lung Disease</title><link>https://www.physician.tw/Insterstitial-Lung-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Insterstitial-Lung-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Insterstitial Lung Disease #ğŸš§ æ–½å·¥ä¸­ Insterstitial Lung Disease â€¢Â A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.</description></item><item><title>Intra-Abdominal Infections</title><link>https://www.physician.tw/Intra-Abdominal-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intra-Abdominal-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Intra-Abdominal Infections #ğŸš§ æ–½å·¥ä¸­ Intra-Abdominal Infections Peritonitis/intra-abdominal abscess â€¢Â Pathogenesis: Disruption of or inflammation in the GI tract may allow normal bowel flora to enter the abdominal cavity and cause frank peritonitis and/or the development of intra-abdominal abscesses</description></item><item><title>Intracranial Hemorrhage</title><link>https://www.physician.tw/Intracranial-Hemorrhage/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intracranial-Hemorrhage/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Intracranial Hemorrhage #ğŸš§ æ–½å·¥ä¸­ Intracranial Hemorrhage Epidural hematoma â€¢Â Etiology: Rupture middle meningeal artery due to head trauma.</description></item><item><title>INTRODUCTION</title><link>https://www.physician.tw/INTRODUCTION/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/INTRODUCTION/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[General Medicine of Huppert&amp;rsquo;s Notes]]
INTRODUCTION #ğŸš§ æ–½å·¥ä¸­ INTRODUCTION This chapter will focus on general outpatient medicine, acknowledging that a whole textbook could be dedicated to this subject alone.</description></item><item><title>Invasive Candidiasis</title><link>https://www.physician.tw/Invasive-Candidiasis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Invasive-Candidiasis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Invasive Candidiasis #ğŸš§ æ–½å·¥ä¸­ Invasive Candidiasis â€¢Â [Guideline] Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.</description></item><item><title>Irregular Atrial Rhythms</title><link>https://www.physician.tw/Irregular-Atrial-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irregular-Atrial-Rhythms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Irregular Atrial Rhythms #ğŸš§ æ–½å·¥ä¸­ Irregular Atrial Rhythms Premature atrial complexes (PACs) â€¢Â Description: Most common cause of irregular pulse and palpitations; benign, increased frequency with age, illness, tobacco/alcohol/caffeine</description></item><item><title>Ischemic Heart Disease</title><link>https://www.physician.tw/Ischemic-Heart-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ischemic-Heart-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Ischemic Heart Disease #ğŸš§ æ–½å·¥ä¸­ Ischemic Heart Disease Stable coronary artery disease (CAD) â€¢Â Types: Asymptomatic CAD or stable angina (angina that occurs reliably with exertion and emotional stress, relived with rest or nitroglycerin; due to fixed atherosclerosis)</description></item><item><title>jaundice or abnormal liver enzymes</title><link>https://www.physician.tw/jaundice-or-abnormal-liver-enzymes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice-or-abnormal-liver-enzymes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
jaundice or abnormal liver enzymes #ğŸš§ æ–½å·¥ä¸­ jaundice or abnormal liver enzymes Jason Alexander, MD</description></item><item><title>joint pain</title><link>https://www.physician.tw/joint-pain/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/joint-pain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
joint pain #ğŸš§ æ–½å·¥ä¸­ joint pain Adam S. Cifu, MD
CHIEF COMPLAINT PATIENT
Mrs. K is a 75-year-old woman who complains of a painful left knee.</description></item><item><title>key clinical trials and publications</title><link>https://www.physician.tw/Endocrinology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrinology-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ key clinical trials and publications [[Thyroid Disease key clinical trials]]</description></item><item><title>Key Terms and Definitions</title><link>https://www.physician.tw/Key-Terms-and-Definitions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Key-Terms-and-Definitions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Key Terms and Definitions #ğŸš§ æ–½å·¥ä¸­ Key Terms and Definitions â€¢Â Dyspnea: Subjective experience of breathing discomfort, must be self-reported</description></item><item><title>Large Vessel Vasculitis</title><link>https://www.physician.tw/Large-Vessel-Vasculitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Large-Vessel-Vasculitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Large Vessel Vasculitis #ğŸš§ æ–½å·¥ä¸­ Large Vessel Vasculitis Temporal arteritis/giant cell arteritis (GCA) â€¢Â Pathogenesis: Not fully elucidated; association with HLA-DRB*04 suggests cell-mediated autoimmunity resulting in granulomatous inflammation of vessel walls.</description></item><item><title>Left Heart CatheterizationCoronary Angiogram</title><link>https://www.physician.tw/Left-Heart-CatheterizationCoronary-Angiogram/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Left-Heart-CatheterizationCoronary-Angiogram/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Left Heart CatheterizationCoronary Angiogram #ğŸš§ æ–½å·¥ä¸­ Left Heart Catheterization/Coronary Angiogram â€¢Â Procedure: A thin catheter is placed in an artery (usually radial, sometimes femoral), advanced to the ascending aorta, and then contrast is injected to visualize the coronary arteries from their origin off of the aorta (diagnostic).</description></item><item><title>leukemia</title><link>https://www.physician.tw/leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematology]]
[[acute leukemia]]
[[acute myelogenous leukemia (AML)]]
[[acute lymphoblastic leukemia (ALL)]]
[[chronic myelogenous leukemia (CML)]]</description></item><item><title>Leukemias</title><link>https://www.physician.tw/Leukemias/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Leukemias/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Leukemias #ğŸš§ æ–½å·¥ä¸­ Leukemias â€¢Â Malignant hematology overview: Within malignant hematology, there are three broad categories of disease: 1) Leukemias, 2) Lymphomas, and 3) Multiple Myeloma</description></item><item><title>Liver</title><link>https://www.physician.tw/Liver/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Liver/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Liver #ğŸš§ æ–½å·¥ä¸­ Liver</description></item><item><title>Lumbar Puncture</title><link>https://www.physician.tw/Lumbar-Puncture/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lumbar-Puncture/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Lumbar Puncture #ğŸš§ æ–½å·¥ä¸­ Lumbar Puncture â€¢Â Common indications: Concern for CNS infection, autoimmune or inflammatory condition, or malignancy; also can be used to diagnose subarachnoid hemorrhage, intracranial pressure abnormalities, or to reduce CSF pressure therapeutically</description></item><item><title>Lymphoma</title><link>https://www.physician.tw/Lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Lymphoma #ğŸš§ æ–½å·¥ä¸­ Lymphoma â€¢Â Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial.</description></item><item><title>lymphoma and CLL</title><link>https://www.physician.tw/lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphoma-and-CLL/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[hematology]]
[[overview of lymphoma and CLL]]
[[hodgkin lymphoma (HL)]]
[[non-Hodgkin lymphoma (NHL)]]
[[smallÂ lymphocyticÂ lymphoma]]Â </description></item><item><title>Lymphomas</title><link>https://www.physician.tw/Lymphomas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphomas/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Lymphomas #ğŸš§ æ–½å·¥ä¸­ Lymphomas â€¢Â Organizational framework for lymphomas: See Table 7.3. Lymphoma may be Hodgkinâ€™s or Non-Hodgkinâ€™s.</description></item><item><title>Magnesium</title><link>https://www.physician.tw/Magnesium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Magnesium/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Magnesium #ğŸš§ æ–½å·¥ä¸­ Magnesium Magnesium homeostasis (Mg2+ 1.8â€“2.5 mg/dL) â€¢Â Distribution:
-Â 99% intracellular, two-third of that in bones</description></item><item><title>Major Depressive Disorder</title><link>https://www.physician.tw/Major-Depressive-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-Depressive-Disorder/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Major Depressive Disorder #ğŸš§ æ–½å·¥ä¸­ Major Depressive Disorder â€¢Â STAR*D Study. Cleve Clin J Med 2008;75(1):57â€“66.</description></item><item><title>Males</title><link>https://www.physician.tw/Males/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Males/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Males #ğŸš§ æ–½å·¥ä¸­ Males Physiology: GnRH pulse elicits pulses of LH/FSH. LH acts on Leydig cells â†’ Testosterone.</description></item><item><title>Malnutrition</title><link>https://www.physician.tw/Malnutrition/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malnutrition/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Malnutrition #ğŸš§ æ–½å·¥ä¸­ Malnutrition â€¢Â Risk factors: Critical illness often associated with increased catabolism and muscle breakdown</description></item><item><title>Management of Complications Associated with Advanced CKDESRD</title><link>https://www.physician.tw/Management-of-Complications-Associated-with-Advanced-CKDESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-Complications-Associated-with-Advanced-CKDESRD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Management of Complications Associated with Advanced CKDESRD #ğŸš§ æ–½å·¥ä¸­ Management of Complications Associated with Advanced CKD/ESRD Blood pressure/volume â€¢Â Pathophysiology of hypertension in CKD: Complex and multifactorial, attributed to reduced nephron mass, increased Na+ retention, extracellular volume expansion, activation of hormones (RAAS) and the sympathetic nervous system, and endothelial dysfunction</description></item><item><title>Mechanisms of Psychiatric Disease</title><link>https://www.physician.tw/Mechanisms-of-Psychiatric-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-of-Psychiatric-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mechanisms of Psychiatric Disease #ğŸš§ æ–½å·¥ä¸­ Mechanisms of Psychiatric Disease â€¢Â Mechanisms of psychiatric disease remain partially understood</description></item><item><title>Medications</title><link>https://www.physician.tw/Medications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Medications #ğŸš§ æ–½å·¥ä¸­ Medications TABLE 4.15 â€¢ Key Medications in Gastroenterology</description></item><item><title>Medium Vessel Vasculitis</title><link>https://www.physician.tw/Medium-Vessel-Vasculitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medium-Vessel-Vasculitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Medium Vessel Vasculitis #ğŸš§ æ–½å·¥ä¸­ Medium Vessel Vasculitis Polyarteritis nodosa (PAN) â€¢Â Epidemiology: Incidence 3â€“4.</description></item><item><title>Melanoma</title><link>https://www.physician.tw/Melanoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Melanoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Melanoma #ğŸš§ æ–½å·¥ä¸­ Melanoma â€¢Â Epidemiology: 5th most common cancer in the United States.</description></item><item><title>Menopause</title><link>https://www.physician.tw/Menopause/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Menopause/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Menopause #ğŸš§ æ–½å·¥ä¸­ Menopause â€¢Â Diagnosis:
-Â Clinical diagnosis made after 12 consecutive months of amenorrhea.</description></item><item><title>Mental Status Exam</title><link>https://www.physician.tw/Mental-Status-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mental-Status-Exam/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mental Status Exam #ğŸš§ æ–½å·¥ä¸­ Mental Status Exam â€¢Â Appearance: Apparent age, weight, clothing, personal hygiene, odor, skin markings, etc.</description></item><item><title>Metabolic Acidosis</title><link>https://www.physician.tw/Metabolic-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Acidosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Metabolic Acidosis #ğŸš§ æ–½å·¥ä¸­ Metabolic Acidosis â†“pH, â†“ HCO3â€“, (Immediate respiratory compensation = Hyperventilation â†“PaCO2)</description></item><item><title>Metabolic Alkalosis</title><link>https://www.physician.tw/Metabolic-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Alkalosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Metabolic Alkalosis #ğŸš§ æ–½å·¥ä¸­ Metabolic Alkalosis â†‘ pH, â†‘ HCO 3â€“ (Immediate respiratory compensation = Hypoventilation: â†‘PaCO2)</description></item><item><title>Metabolic Emergencies</title><link>https://www.physician.tw/Metabolic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Emergencies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Metabolic Emergencies #ğŸš§ æ–½å·¥ä¸­ Metabolic Emergencies Hypercalcemia of malignancy
â€¢Â Pathophysiology: Multiple possible mechanisms</description></item><item><title>Metabolic Etiologies of Liver Disease</title><link>https://www.physician.tw/Metabolic-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Metabolic-Etiologies-of-Liver-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Metabolic Etiologies of Liver Disease #ğŸš§ æ–½å·¥ä¸­ Metabolic Etiologies of Liver Disease Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) â€¢Â Risk factors: Associated with obesity, HLD, DM2</description></item><item><title>microbiology</title><link>https://www.physician.tw/microbiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/microbiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infectious Diseases of Huppert&amp;rsquo;s Notes]]
microbiology #ğŸš§ æ–½å·¥ä¸­ microbiology [[Overview of Clinically Important Pathogens]]
[[Bacterial Infections]]</description></item><item><title>Miscellaneous</title><link>https://www.physician.tw/Miscellaneous/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Miscellaneous/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Miscellaneous #ğŸš§ æ–½å·¥ä¸­ Miscellaneous â€¢Â Milaria (â€œheat rashâ€): Numerous non-follicular papules or pustules; caused by occlusion of the sweat ducts.</description></item><item><title>Mixed Acidosis</title><link>https://www.physician.tw/Mixed-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-Acidosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mixed Acidosis #ğŸš§ æ–½å·¥ä¸­ Mixed Acidosis â†“pH, â†‘PaCO2, â†“HCO3â€“</description></item><item><title>Mixed Alkalosis</title><link>https://www.physician.tw/Mixed-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-Alkalosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mixed Alkalosis #ğŸš§ æ–½å·¥ä¸­ Mixed Alkalosis â†‘pH, â†“PaCO2**,** â†‘HCO3â€“</description></item><item><title>Mixed PlateletCoagulation Disorders</title><link>https://www.physician.tw/Mixed-PlateletCoagulation-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-PlateletCoagulation-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mixed PlateletCoagulation Disorders #ğŸš§ æ–½å·¥ä¸­ Mixed Platelet/Coagulation Disorders Disseminated intravascular coagulation (DIC)
â€¢Â Pathophysiology: Tissue factor release (e.</description></item><item><title>monoclonal gammopathy of uncertain significance (MGUS)</title><link>https://www.physician.tw/monoclonal-gammopathy-of-uncertain-significance-MGUS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/monoclonal-gammopathy-of-uncertain-significance-MGUS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[plasma cell dyscrasias]]
monoclonal gammopathy of uncertain significance (MGUS) #ğŸš§ æ–½å·¥ä¸­ monoclonal gammopathy of uncertain significance (MGUS) (NEJM 2018;378:241) â€¢ âœ“ CBC, Ca, Cr, SPEP, serum free light chains, UPEP w/ immunofixation (to exclude MM) â€¢ Close observation: repeat SPEP in 6 mo, then yearly thereafter if stable â€¢ ~1%/y or ~25% lifetime risk â†’ MM, WM, amyloidosis, or malign.</description></item><item><title>Mood Disorders</title><link>https://www.physician.tw/Mood-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mood-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Mood Disorders #ğŸš§ æ–½å·¥ä¸­ Mood Disorders Major depressive disorder (MDD) â€¢Â Etiology: Multiple synergistic biopsychosocial risk factors at play.</description></item><item><title>Movement Disorders</title><link>https://www.physician.tw/Movement-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Movement-Disorders/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Movement Disorders #ğŸš§ æ–½å·¥ä¸­ Movement Disorders</description></item><item><title>Multiple Myeloma</title><link>https://www.physician.tw/Multiple-Myeloma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Myeloma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Multiple Myeloma #ğŸš§ æ–½å·¥ä¸­ Multiple Myeloma â€¢Â Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma.</description></item><item><title>multiple myeloma (MM)</title><link>https://www.physician.tw/multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiple-myeloma-MM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[plasma cell dyscrasias]]
multiple myeloma (MM) [[definition and epidemiology of multiple myeloma (MM)]]
[[clinical manifestations of multiple myeloma (MM)]]</description></item><item><title>multiple myeloma staging systems</title><link>https://www.physician.tw/multiple-myeloma-staging-systems/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/multiple-myeloma-staging-systems/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[multiple myeloma (MM)]]
multiple myeloma staging systems #ğŸš§ æ–½å·¥ä¸­ multiple myeloma staging systems (OS does not account for cytogenetics) Stage ISS Criteria* Durie-Salmon (DS) Criteria ISS Median OS I Î²2M &amp;lt;3.</description></item><item><title>Multiple Sclerosis</title><link>https://www.physician.tw/Multiple-Sclerosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Sclerosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Multiple Sclerosis #ğŸš§ æ–½å·¥ä¸­ Multiple Sclerosis â€¢Â Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis [Cochrane Review].</description></item><item><title>Musculoskeletal (MSK)</title><link>https://www.physician.tw/Musculoskeletal-MSK/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Musculoskeletal-MSK/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Musculoskeletal (MSK) #ğŸš§ æ–½å·¥ä¸­ Musculoskeletal (MSK)</description></item><item><title>mutations useful as clonal markers and dx tools of myeloproliferative neoplasms</title><link>https://www.physician.tw/mutations-useful-as-clonal-markers-and-dx-tools-of-myeloproliferative-neoplasms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mutations-useful-as-clonal-markers-and-dx-tools-of-myeloproliferative-neoplasms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[overview of myeloproliferative neoplasms]]
mutations useful as clonal markers and dx tools of myeloproliferative neoplasms Gain of fxn mutations inÂ JAK2Â V617F (Janus kinase) frequently present (PV ~95%, ET ~50%, PMF ~50%;Â NEJMÂ 2005;352:1779)</description></item><item><title>myelodysplastic syndromes (MDS) overview</title><link>https://www.physician.tw/myelodysplastic-syndromes-MDS-overview/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelodysplastic-syndromes-MDS-overview/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
myelodysplastic syndromes (MDS) overview #ğŸš§ æ–½å·¥ä¸­ myelodysplastic syndromes (MDS) overview (Lancet 2014;383:2239) â€¢ Acquired clonal stem cell disorder â†’ ineffective hematopoiesis â†’ cytopenias, dysmorphic blood cells and precursors, variable risk of leukemic transformation â€¢ Epidemiology: 20â€“30,000 cases/y; median age ~70 y; male predominance (1.</description></item><item><title>Myeloid neoplasm overview</title><link>https://www.physician.tw/Myeloid-neoplasm-overview/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myeloid-neoplasm-overview/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
Myeloid neoplasm overview (Blood 2016;1272391) #ğŸš§ æ–½å·¥ä¸­ (Blood 2016;127:2391) â€¢ Categories based on clinical features, morphology, immunophenotyping, and genetics</description></item><item><title>Myelopathy and Radiculopathy</title><link>https://www.physician.tw/Myelopathy-and-Radiculopathy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myelopathy-and-Radiculopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Myelopathy and Radiculopathy #ğŸš§ æ–½å·¥ä¸­ Myelopathy and Radiculopathy â€¢Â Description: Neurologic deficit related to the spinal cord</description></item><item><title>Myocardial Diseases</title><link>https://www.physician.tw/Myocardial-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myocardial-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Myocardial Diseases #ğŸš§ æ–½å·¥ä¸­ Myocardial Diseases Myocarditis â€¢Â Etiology: Inflammation of the myocardium due to a viral infection (e.</description></item><item><title>Myocardial Viability Study</title><link>https://www.physician.tw/Myocardial-Viability-Study/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myocardial-Viability-Study/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Myocardial Viability Study #ğŸš§ æ–½å·¥ä¸­ Myocardial Viability Study â€¢Â Indications: Identifies â€œhibernatingâ€ myocardium that could regain function after revascularization</description></item><item><title>Myopathies</title><link>https://www.physician.tw/Myopathies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myopathies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Myopathies #ğŸš§ æ–½å·¥ä¸­ Myopathies â€¢Â Definition: Myopathy refers to any disease that affects the muscle tissue, which can occur due to inherited or acquired causes</description></item><item><title>Narrow QRS Complex Tachycardia</title><link>https://www.physician.tw/Narrow-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Narrow-QRS-Complex-Tachycardia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Narrow QRS Complex Tachycardia #ğŸš§ æ–½å·¥ä¸­ Narrow QRS Complex Tachycardia</description></item><item><title>NauseaVomiting</title><link>https://www.physician.tw/NauseaVomiting/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NauseaVomiting/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
NauseaVomiting #ğŸš§ æ–½å·¥ä¸­ Nausea/Vomiting Differential diagnosis:
â€¢Â Neuropsychiatric:
-Â Intracerebral: Increased intracranial pressure (ICP) due to malignancy, hemorrhage, abscess, hydrocephalus</description></item><item><title>neovim</title><link>https://www.physician.tw/neovim/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neovim/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[èœ¥èœ´èˆ‡VIM]]
neovim #ğŸš§ æ–½å·¥ä¸­ [[lua]]</description></item><item><title>Nephritic Syndrome</title><link>https://www.physician.tw/Nephritic-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephritic-Syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Nephritic Syndrome #ğŸš§ æ–½å·¥ä¸­ Nephritic Syndrome â€¢Â Pathophysiology: Syndrome of symptoms and findings caused by inflammation of glomeruli</description></item><item><title>nephrology anatomy and physiology</title><link>https://www.physician.tw/nephrology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-anatomy-and-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology anatomy and physiology #ğŸš§ æ–½å·¥ä¸­ nephrology anatomy and physiology [[Renal Anatomy]]</description></item><item><title>nephrology approaches and chief complaints</title><link>https://www.physician.tw/nephrology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-approaches-and-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology approaches and chief complaints #ğŸš§ æ–½å·¥ä¸­ nephrology approaches and chief complaints [[books/h_note/Proteinuria]]</description></item><item><title>nephrology diseases and pathophysiology</title><link>https://www.physician.tw/nephrology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ nephrology diseases and pathophysiology [[Renal Dysfunction]]</description></item><item><title>nephrology key clinical trials and publications</title><link>https://www.physician.tw/nephrology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ nephrology key clinical trials and publications [[books/h_note/Acute Kidney Injury]]</description></item><item><title>nephrology key medications and interventions</title><link>https://www.physician.tw/nephrology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nephrology of Huppert&amp;rsquo;s Notes]]
nephrology key medications and interventions #ğŸš§ æ–½å·¥ä¸­ nephrology key medications and interventions TABLE 6.</description></item><item><title>Nephrology of Huppert's Notes</title><link>https://www.physician.tw/Nephrology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nephrology-of-Hupperts-Notes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Nephrology of Huppert&amp;rsquo;s Notes [[nephrology anatomy and physiology]]
[[DIAGNOSTICS]]</description></item><item><title>Neuro-oncology</title><link>https://www.physician.tw/Neuro-oncology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuro-oncology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neuro-oncology #ğŸš§ æ–½å·¥ä¸­ Neuro-oncology Metastatic brain tumors â€¢Â Radiographic findings: Multifocal lesions at the gray-white junction, ring enhancement with contrast</description></item><item><title>Neurocritical Care</title><link>https://www.physician.tw/Neurocritical-Care/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurocritical-Care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neurocritical Care #ğŸš§ æ–½å·¥ä¸­ Neurocritical Care â€¢Â Mild Therapeutic Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest (HACA).</description></item><item><title>Neuroimmunology</title><link>https://www.physician.tw/Neuroimmunology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuroimmunology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neuroimmunology #ğŸš§ æ–½å·¥ä¸­ Neuroimmunology Multiple sclerosis (MS) â€¢Â Diagnostic criteria:
-Â Relapsing-remitting MS: An attack, relapse, or exacerbation of symptoms typical of acute inflammatory demyelinating event with duration of at least 24 hours in the absence of fever or infection and clinical and/or radiographic evidence of dissemination in space and time</description></item><item><title>Neurologic Emergencies</title><link>https://www.physician.tw/Neurologic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurologic-Emergencies/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neurologic Emergencies #ğŸš§ æ–½å·¥ä¸­ Neurologic Emergencies</description></item><item><title>neurology anatomy and physiology</title><link>https://www.physician.tw/neurology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-anatomy-and-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology anatomy and physiology #ğŸš§ æ–½å·¥ä¸­ neurology anatomy and physiology In neurology, we talk about â€œlocalizingâ€ a lesion.</description></item><item><title>neurology approaches &amp; chief complaints</title><link>https://www.physician.tw/neurology-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-approaches-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology approaches &amp;amp; chief complaints #ğŸš§ æ–½å·¥ä¸­ neurology approaches &amp;amp; chief complaints [[Altered Mental Status]]</description></item><item><title>neurology diagnostics</title><link>https://www.physician.tw/neurology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology diagnostics #ğŸš§ æ–½å·¥ä¸­ neurology diagnostics [[The Neurologic Exam]]
[[Imaging]]
[[Lumbar Puncture]]</description></item><item><title>neurology diseases &amp; pathophysiology</title><link>https://www.physician.tw/neurology-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-diseases-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology diseases &amp;amp; pathophysiology #ğŸš§ æ–½å·¥ä¸­ neurology diseases &amp;amp; pathophysiology [[Neurologic Emergencies]]</description></item><item><title>neurology key clinical trials &amp; publications</title><link>https://www.physician.tw/neurology-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-key-clinical-trials-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology key clinical trials &amp;amp; publications #ğŸš§ æ–½å·¥ä¸­ neurology key clinical trials &amp;amp; publications [[books/h_note/Stroke]]</description></item><item><title>neurology key medications &amp; interventions</title><link>https://www.physician.tw/neurology-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology-key-medications-interventions/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Neurology of Huppert&amp;rsquo;s Notes]]
neurology key medications &amp;amp; interventions #ğŸš§ æ–½å·¥ä¸­ neurology key medications &amp;amp; interventions</description></item><item><title>Neurology of Huppert's Notes</title><link>https://www.physician.tw/Neurology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurology-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neurology of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­ Neurology of Huppert&amp;rsquo;s Notes</description></item><item><title>Neuromuscular</title><link>https://www.physician.tw/Neuromuscular/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular #ğŸš§ æ–½å·¥ä¸­ Neuromuscular â€¢Â Intravenous immunoglobulin for Guillain-BarrÃ© syndrome. [Cochrane Review]. Cochrane Database of Systematic Reviews 2014;(9):CD002063.</description></item><item><title>Neuromuscular Disorders</title><link>https://www.physician.tw/Neuromuscular-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular Disorders #ğŸš§ æ–½å·¥ä¸­ Neuromuscular Disorders Motor Neuron Diseases Amyotrophic lateral sclerosis (ALS) â€¢Â Pathophysiology: Degeneration of upper and lower motor neurons leading to a combination of hyperreflexia/spasticity and atrophy/fasciculations</description></item><item><title>Neuromuscular Junction Disorders</title><link>https://www.physician.tw/Neuromuscular-Junction-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-Junction-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neuromuscular Junction Disorders #ğŸš§ æ–½å·¥ä¸­ Neuromuscular Junction Disorders Exam is notable for LMN signs which are usually symmetric; may have proximal muscle weakness; check for bulbar signs/symptoms (â€œDâ€ symptoms â€“ Dysphagia, Diplopia, Dysarthria); may have extraocular movement restriction, ptosis and shortness of breath (especially orthopnea).</description></item><item><title>Neutropenic Fever</title><link>https://www.physician.tw/Neutropenic-Fever/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neutropenic-Fever/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Neutropenic Fever #ğŸš§ æ–½å·¥ä¸­ Neutropenic Fever â€¢Â [Guideline] Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America.</description></item><item><title>Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs)</title><link>https://www.physician.tw/Non-Biologic-Disease-Modifying-Antirheumatic-Drugs-DMARDs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-Biologic-Disease-Modifying-Antirheumatic-Drugs-DMARDs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) #ğŸš§ æ–½å·¥ä¸­ Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) â€¢Â Definition: DMARDs comprise a group of otherwise unrelated medications that are used to treat rheumatoid arthritis and other rheumatic conditions.</description></item><item><title>non-HodgkinÂ lymphomaÂ (NHL)</title><link>https://www.physician.tw/non-Hodgkin-lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/non-Hodgkin-lymphoma-NHL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[lymphoma and CLL]]
non-HodgkinÂ lymphomaÂ (NHL) [[epidemiology and risk factors of non-Hodgkin lymphoma (NHL)]]
[[WHO Classification of Lymphoid Malignancies]]</description></item><item><title>Non-Hodgkinâ€™s Lymphoma (NHL)</title><link>https://www.physician.tw/Non-Hodgkins-Lymphoma-NHL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-Hodgkins-Lymphoma-NHL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Non-Hodgkinâ€™s Lymphoma (NHL) #ğŸš§ æ–½å·¥ä¸­ Non-Hodgkinâ€™s Lymphoma (NHL) â€¢Â Risk factors: HIV, immunosuppression, EBV/HTLV-1 infection, H.</description></item><item><title>obesity</title><link>https://www.physician.tw/obesity/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obesity/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[endocrinology]]
obesity #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Obstructive Lung Diseases</title><link>https://www.physician.tw/Obstructive-Lung-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-Lung-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Obstructive Lung Diseases #ğŸš§ æ–½å·¥ä¸­ Obstructive Lung Diseases â€¢Â Obstructive = â†‘compliance, â†“elastance â†’ problem emptying the lung.</description></item><item><title>Odds Ratio, Risk Ratio, and Related Statistics</title><link>https://www.physician.tw/Odds-Ratio-Risk-Ratio-and-Related-Statistics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Odds-Ratio-Risk-Ratio-and-Related-Statistics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Odds Ratio, Risk Ratio, and Related Statistics #ğŸš§ æ–½å·¥ä¸­ Odds Ratio, Risk Ratio, and Related Statistics FIGURE A2.</description></item><item><title>Ophthalmologic</title><link>https://www.physician.tw/Ophthalmologic/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ophthalmologic/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Ophthalmologic #ğŸš§ æ–½å·¥ä¸­ Ophthalmologic</description></item><item><title>Osteoporosis</title><link>https://www.physician.tw/Osteoporosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Osteoporosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Osteoporosis #ğŸš§ æ–½å·¥ä¸­ Osteoporosis â€¢Â Bone biology:
-Â Osteoblasts promote bone formation and osteoclasts promote bone absorption/breakdown.</description></item><item><title>Other Conditions that Affect the Small Bowel</title><link>https://www.physician.tw/Other-Conditions-that-Affect-the-Small-Bowel/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Conditions-that-Affect-the-Small-Bowel/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Conditions that Affect the Small Bowel #ğŸš§ æ–½å·¥ä¸­ Other Conditions that Affect the Small Bowel Microscopic colitis â€¢Â Epidemiology: Age of diagnosis typically 45â€“65 yr; more common in females than males</description></item><item><title>Other Diseases Affecting Renal Tubular Absorption</title><link>https://www.physician.tw/Other-Diseases-Affecting-Renal-Tubular-Absorption/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-Renal-Tubular-Absorption/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting Renal Tubular Absorption #ğŸš§ æ–½å·¥ä¸­ Other Diseases Affecting Renal Tubular Absorption Renal papillary necrosis â€¢Â Etiology: Poor medullary perfusion resulting in ischemia and necrosis.</description></item><item><title>Other Diseases Affecting the Colon</title><link>https://www.physician.tw/Other-Diseases-Affecting-the-Colon/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-the-Colon/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting the Colon #ğŸš§ æ–½å·¥ä¸­ Other Diseases Affecting the Colon Angiodysplasia of the colon (AV malformations, vascular ectasia) â€¢Â Clinical features: Tortuous dilated veins in the colon can rupture and cause a lower GI bleed.</description></item><item><title>Other Diseases Affecting the Kidney</title><link>https://www.physician.tw/Other-Diseases-Affecting-the-Kidney/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-Affecting-the-Kidney/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Diseases Affecting the Kidney #ğŸš§ æ–½å·¥ä¸­ Other Diseases Affecting the Kidney</description></item><item><title>Other Diseases of the Biliary Tree</title><link>https://www.physician.tw/Other-Diseases-of-the-Biliary-Tree/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Diseases-of-the-Biliary-Tree/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Diseases of the Biliary Tree #ğŸš§ æ–½å·¥ä¸­ Other Diseases of the Biliary Tree â€¢Â Biliary cysts: Cysts in the biliary tree.</description></item><item><title>Other Malignant Hematologic Conditions</title><link>https://www.physician.tw/Other-Malignant-Hematologic-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Malignant-Hematologic-Conditions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Malignant Hematologic Conditions #ğŸš§ æ–½å·¥ä¸­ Other Malignant Hematologic Conditions Hemophagocytic lymphohistiocytosis (HLH)</description></item><item><title>Other Neurologic Emergencies</title><link>https://www.physician.tw/Other-Neurologic-Emergencies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Neurologic-Emergencies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Neurologic Emergencies #ğŸš§ æ–½å·¥ä¸­ Other Neurologic Emergencies Elevated intracranial pressure (ICP) â€¢Â Definition: Elevation of the pressure in the cranium.</description></item><item><title>Other Organ Systems</title><link>https://www.physician.tw/Other-Organ-Systems/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Organ-Systems/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Organ Systems #ğŸš§ æ–½å·¥ä¸­ Other Organ Systems</description></item><item><title>Other Pathologies Affecting the Liver</title><link>https://www.physician.tw/Other-Pathologies-Affecting-the-Liver/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Pathologies-Affecting-the-Liver/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Pathologies Affecting the Liver #ğŸš§ æ–½å·¥ä¸­ Other Pathologies Affecting the Liver Hypoperfusion â€¢Â Shock liver: Hypotension causes hypoperfusion of the liver; labs are notable for an elevated AST/ALT with relatively normal bilirubin/AlkP.</description></item><item><title>Other Rheumatologic Conditions</title><link>https://www.physician.tw/Other-Rheumatologic-Conditions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Rheumatologic-Conditions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Rheumatologic Conditions #ğŸš§ æ–½å·¥ä¸­ Other Rheumatologic Conditions Polymyalgia rheumatica (PMR) â€¢Â Clinical features:</description></item><item><title>Other Statistical Concepts and Formulas</title><link>https://www.physician.tw/Other-Statistical-Concepts-and-Formulas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Statistical-Concepts-and-Formulas/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Statistical Concepts and Formulas #ğŸš§ æ–½å·¥ä¸­ Other Statistical Concepts and Formulas â€¢Â Standard deviation (SD): For normal distribution, 68% of results within one SD, 95% of results within two SDs, 99% of results within three SDs</description></item><item><title>Other Systemic Disorders Associated with Nephrotic-Range Proteinuria</title><link>https://www.physician.tw/Other-Systemic-Disorders-Associated-with-Nephrotic-Range-Proteinuria/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Systemic-Disorders-Associated-with-Nephrotic-Range-Proteinuria/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Other Systemic Disorders Associated with Nephrotic-Range Proteinuria #ğŸš§ æ–½å·¥ä¸­ Other Systemic Disorders Associated with Nephrotic-Range Proteinuria â€¢Â Diabetes:</description></item><item><title>Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology</title><link>https://www.physician.tw/Overlap-of-Diagnostic-and-Therapeutic-Interventions-in-Gastroenterology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overlap-of-Diagnostic-and-Therapeutic-Interventions-in-Gastroenterology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology #ğŸš§ æ–½å·¥ä¸­ Overlap of Diagnostic and Therapeutic Interventions in Gastroenterology Several diagnostic tests commonly used by gastroenterologists also have therapeutic potential; for information about EGD, colonoscopy, ERCP, and other modalities, refer to the Diagnostics section of this chapter.</description></item><item><title>Overview</title><link>https://www.physician.tw/Overview-of-lung-anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-of-lung-anatomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Overview #ğŸš§ æ–½å·¥ä¸­ Overview â€¢Â Mech
anics:
-Â Statics refer to forces acting</description></item><item><title>Overview of Clinically Important Pathogens</title><link>https://www.physician.tw/Overview-of-Clinically-Important-Pathogens/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-of-Clinically-Important-Pathogens/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Overview of Clinically Important Pathogens #ğŸš§ æ–½å·¥ä¸­ Overview of Clinically Important Pathogens TABLE 8.</description></item><item><title>overview of lymphoma and CLL</title><link>https://www.physician.tw/overview-of-lymphoma-and-CLL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-of-lymphoma-and-CLL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[lymphoma and CLL]]
overview of lymphoma and CLL â€¢ Malignant disorder of lymphoid cells that reside predominantly in lymphoid tissues â€¢ Generally characterized as Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL)</description></item><item><title>overview of myeloproliferative neoplasms</title><link>https://www.physician.tw/overview-of-myeloproliferative-neoplasms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-of-myeloproliferative-neoplasms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myeloproliferative neoplasms]]
(NEJMÂ 2017;376:2168)
â€¢ Results from clonal expansion of multipotent hematopoietic stem cell
[[Categories of MPN]]</description></item><item><title>Pancreas</title><link>https://www.physician.tw/Pancreas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pancreas/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pancreas #ğŸš§ æ–½å·¥ä¸­ Pancreas Acute pancreatitis â€¢Â Etiology: Premature activation of pancreatic digestive enzymes causes autodigestion of pancreatic tissue</description></item><item><title>Panic Disorder</title><link>https://www.physician.tw/Panic-Disorder/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Panic-Disorder/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Panic Disorder #ğŸš§ æ–½å·¥ä¸­ Panic Disorder â€¢Â CBT, imipramine, or their combination for panic disorder.</description></item><item><title>Papulosquamous Dermatoses</title><link>https://www.physician.tw/Papulosquamous-Dermatoses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Papulosquamous-Dermatoses/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Papulosquamous Dermatoses #ğŸš§ æ–½å·¥ä¸­ Papulosquamous Dermatoses Psoriasis â€¢Â Pathophysiology: Immune dysregulation (Th1, Th17, excess IFN-gamma) and keratinocyte hyperproliferation</description></item><item><title>Paracentesis</title><link>https://www.physician.tw/Paracentesis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paracentesis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Paracentesis #ğŸš§ æ–½å·¥ä¸­ Paracentesis â€¢Â Indications: 1) All patients with new-onset ascites of uncertain cause, 2) All patients with preexisting ascites in whom SBP is suspected, 3) All patients with cirrhosis and ascites who are being admitted to the hospital</description></item><item><title>Parasitic Infections</title><link>https://www.physician.tw/Parasitic-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Parasitic-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Parasitic Infections #ğŸš§ æ–½å·¥ä¸­ Parasitic Infections Protozoa infections Protozoa are single celled parasites under the parent category of parasites.</description></item><item><title>pathology of hodgkin lymphoma (HL)</title><link>https://www.physician.tw/pathology-of-hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathology-of-hodgkin-lymphoma-HL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hodgkin lymphoma (HL)]]
pathology of hodgkin lymphoma (HL) #ğŸš§ æ–½å·¥ä¸­ pathology of hodgkin lymphoma (HL) â€¢ Affected nodes show RS cells (&amp;lt;1%) in background of non-neoplastic inflammatory cells â€¢ Classic RS cells: bilobed nucleus &amp;amp; prominent nucleoli with surrounding clear space (â€œowlâ€™s eyesâ€).</description></item><item><title>Peripheral Eosinophilia and Hypereosinophilia Syndromes</title><link>https://www.physician.tw/Peripheral-Eosinophilia-and-Hypereosinophilia-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peripheral-Eosinophilia-and-Hypereosinophilia-Syndromes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Peripheral Eosinophilia and Hypereosinophilia Syndromes #ğŸš§ æ–½å·¥ä¸­ Peripheral Eosinophilia and Hypereosinophilia Syndromes â€¢Â Definition</description></item><item><title>Peripheral Nervous System</title><link>https://www.physician.tw/Peripheral-Nervous-System/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peripheral-Nervous-System/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Peripheral Nervous System #ğŸš§ æ–½å·¥ä¸­ Peripheral Nervous System Includes nerves and ganglia outside the brain and spinal cord.</description></item><item><title>Personality Disorders</title><link>https://www.physician.tw/Personality-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Personality-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Personality Disorders #ğŸš§ æ–½å·¥ä¸­ Personality Disorders Definitions:
â€¢Â Personality: Patterns of relating to and perceiving the world and oneself that persist across multiple contexts</description></item><item><title>Phases of the Cardiac Cycle</title><link>https://www.physician.tw/Phases-of-the-Cardiac-Cycle/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phases-of-the-Cardiac-Cycle/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Phases of the Cardiac Cycle #ğŸš§ æ–½å·¥ä¸­ Phases of the Cardiac Cycle â€¢Â Diastole:</description></item><item><title>Phosphate</title><link>https://www.physician.tw/Phosphate/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phosphate/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Phosphate #ğŸš§ æ–½å·¥ä¸­ Phosphate Phosphate regulation (PO4â€“ 3.0â€“4.5 mg/dL) â€¢Â Distribution: Most phosphorus is in the bones (85%), remainder is in the soft tissues (15%)</description></item><item><title>Physical Exam</title><link>https://www.physician.tw/Physical-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Physical Exam #ğŸš§ æ–½å·¥ä¸­ Physical Exam â€¢Â Purpose: The cornerstone of dermatologic diagnosis is the physical exam</description></item><item><title>Physical Exam, Labs, and Other Data</title><link>https://www.physician.tw/Physical-Exam-Labs-and-Other-Data/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam-Labs-and-Other-Data/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Physical Exam, Labs, and Other Data #ğŸš§ æ–½å·¥ä¸­ Physical Exam, Labs, and Other Data TABLE A1.</description></item><item><title>Plasma Cell Disorders</title><link>https://www.physician.tw/Plasma-Cell-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Plasma-Cell-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Plasma Cell Disorders #ğŸš§ æ–½å·¥ä¸­ Plasma Cell Disorders A framework for plasma cell disorders:</description></item><item><title>plasma cell dyscrasias ğŸš§ æ–½å·¥ä¸­</title><link>https://www.physician.tw/plasma-cell-dyscrasias/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/plasma-cell-dyscrasias/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[plasma cell dyscrasiasxxx]]
[[spectrum of nonmalignant to malignant clonal plasma cell disorders]]
[[monoclonal gammopathy of uncertain significance (MGUS)]]</description></item><item><title>polycystic ovary syndrome</title><link>https://www.physician.tw/polycystic-ovary-syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polycystic-ovary-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[endocrinology]]
polycystic ovary syndrome #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Polycythemia</title><link>https://www.physician.tw/Polycythemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polycythemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Polycythemia #ğŸš§ æ–½å·¥ä¸­ Polycythemia â€¢Â Definition: High hemoglobin (Hbg &amp;gt;16.5 g/dL in men, Hbg &amp;gt;16 g/dL in women)</description></item><item><title>polycythemiaÂ veraÂ (PV)</title><link>https://www.physician.tw/polycythemia-vera-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polycythemia-vera-PV/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myeloproliferative neoplasms]]
polycythemiaÂ veraÂ (PV) #ğŸš§ æ–½å·¥ä¸­ polycythemiaÂ veraÂ (PV) definition of myeloproliferative neoplasms
â€¢ â†‘ in RBC mass Â± â†‘ granulocytes and platelets in the absence of physiologic stimulus</description></item><item><title>Post-Intensive Care Syndrome &amp; Other Long-Term Physical and Cognitive Disability</title><link>https://www.physician.tw/Post-Intensive-Care-Syndrome-Other-Long-Term-Physical-and-Cognitive-Disability/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-Intensive-Care-Syndrome-Other-Long-Term-Physical-and-Cognitive-Disability/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability #ğŸš§ æ–½å·¥ä¸­ Post-Intensive Care Syndrome &amp;amp; Other Long-Term Physical and Cognitive Disability â€¢Â Definition: Generally defined as new or worsening cognitive, psychiatric, and/or physical function</description></item><item><title>post-remission therapy of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/post-remission-therapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/post-remission-therapy-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[treatment of acute lymphoblastic leukemia (ALL)]]
post-remission therapy of treatment of acute lymphoblastic leukemia (ALL) #ğŸš§ æ–½å·¥ä¸­ post-remission therapy of treatment of acute lymphoblastic leukemia (ALL) Â (choice depends on risk of recurrence)</description></item><item><title>Posterior Pituitary</title><link>https://www.physician.tw/Posterior-Pituitary/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Posterior-Pituitary/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Posterior Pituitary #ğŸš§ æ–½å·¥ä¸­ Posterior Pituitary â†“Antidiuretic hormone (ADH): Diabetes insipidus (DI) â€¢Â Etiology: ADH channels do not function to reabsorb water, either due to inadequate ADH (central) or lack of response to ADH at the kidneys (nephrogenic)</description></item><item><title>Potassium</title><link>https://www.physician.tw/Potassium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Potassium/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Potassium #ğŸš§ æ–½å·¥ä¸­ Potassium Potassium regulation (K**+** 3.5â€“5.0 mEq/L) â€¢Â Distribution:
-Â 98% intracellular, maintained by Na+/K+ ATPase</description></item><item><title>Practical Skills for Learners</title><link>https://www.physician.tw/Practical-Skills-for-Learners/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Practical-Skills-for-Learners/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Practical Skills for Learners #ğŸš§ æ–½å·¥ä¸­ Practical Skills for Learners how to write a history and physical (h&amp;amp;p) Early in training, writing an H&amp;amp;P can sometimes seem overwhelming.</description></item><item><title>Precision vs. Accuracy</title><link>https://www.physician.tw/Precision-vs.-Accuracy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precision-vs.-Accuracy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Precision vs. Accuracy #ğŸš§ æ–½å·¥ä¸­ Precision vs. Accuracy â€¢Â Precision/reliability: Does a test generate similar results on repeat measurements?</description></item><item><title>Preface</title><link>https://www.physician.tw/Preface/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preface/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
Preface #ğŸš§ æ–½å·¥ä¸­ Preface Our goal in creating Symptom to Diagnosis was to develop an interesting, practical, and informative approach to teaching the diagnostic process in internal medicine.</description></item><item><title>Pregnancy-Related Liver Diseases</title><link>https://www.physician.tw/Pregnancy-Related-Liver-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pregnancy-Related-Liver-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pregnancy-Related Liver Diseases #ğŸš§ æ–½å·¥ä¸­ Pregnancy-Related Liver Diseases Hyperemesis gravidarum: First trimester, severe vomiting, elevated ALT.</description></item><item><title>preparing a patient for discharge</title><link>https://www.physician.tw/preparing-a-patient-for-discharge/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preparing-a-patient-for-discharge/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Practical Skills for Learners]]
preparing a patient for discharge #ğŸš§ æ–½å·¥ä¸­ preparing a patient for discharge [[Discharge Checklist]]</description></item><item><title>Prevalence vs. Incidence</title><link>https://www.physician.tw/Prevalence-vs.-Incidence/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevalence-vs.-Incidence/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Prevalence vs. Incidence #ğŸš§ æ–½å·¥ä¸­ Prevalence vs. Incidence â€¢Â Prevalence: Total cases in a population at a given time/total population (â†“Prevalance can be due to more prevention or more treatment; â†‘Prevalance if those living with the disease have a longer lifespan)</description></item><item><title>Preventative Health</title><link>https://www.physician.tw/Preventative-Health/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preventative-Health/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Preventative Health #ğŸš§ æ–½å·¥ä¸­ Preventative Health â€¢Â ASPREE. N Engl J Med 2018;379(16):1â€“10.</description></item><item><title>Primary Fever Syndromes</title><link>https://www.physician.tw/Primary-Fever-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Fever-Syndromes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Primary Fever Syndromes #ğŸš§ æ–½å·¥ä¸­ Primary Fever Syndromes Fever â€¢Â Definition: A regulated elevation in core body temperature, usually defined as â‰¥38.</description></item><item><title>Primary Headache Disorders</title><link>https://www.physician.tw/Primary-Headache-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Headache-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Primary Headache Disorders #ğŸš§ æ–½å·¥ä¸­ Primary Headache Disorders Migraine headache â€¢Â Symptoms:
-Â POUND: Pulsatile quality, One day duration, Unilateral, Nausea/vomiting, Debilitating</description></item><item><title>primaryÂ myelofibrosisÂ (PMF)</title><link>https://www.physician.tw/primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-myelofibrosis-PMF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myeloproliferative neoplasms]]
primaryÂ myelofibrosisÂ (PMF) [[definition of primary myelofibrosis (PMF)]]
[[etiologies of myelofibrosis]]
[[clinical manifestations of primary myelofibrosis (PMF)]]</description></item><item><title>Principles of Antibiotic Selection and Infection Management</title><link>https://www.physician.tw/Principles-of-Antibiotic-Selection-and-Infection-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-Antibiotic-Selection-and-Infection-Management/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Principles of Antibiotic Selection and Infection Management #ğŸš§ æ–½å·¥ä¸­ Principles of Antibiotic Selection and Infection Management â€¢Â Start antibiotics early: Early antibiotics in sepsis decrease mortality</description></item><item><title>ProceduralSurgical Interventions</title><link>https://www.physician.tw/ProceduralSurgical-Interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ProceduralSurgical-Interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
ProceduralSurgical Interventions #ğŸš§ æ–½å·¥ä¸­ Procedural/Surgical Interventions Many procedures are done by cardiologists or cardiac surgeons.</description></item><item><title>prognosis of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/prognosis-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
prognosis of acute myelogenous leukemia (AML) #ğŸš§ æ–½å·¥ä¸­ prognosis of acute myelogenous leukemia (AML) â€¢ CR achieved in 70â€“80% of Pts &amp;lt;60 y and in 40â€“50% of Pts &amp;gt;60 y</description></item><item><title>prognosis of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/prognosis-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
prognosis of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ prognosis of chronic myelogenous leukemia (CML) Â (NEJMÂ 2017;376:917)</description></item><item><title>prognosis of essential thrombocythemia (ET)</title><link>https://www.physician.tw/prognosis-of-essential-thrombocythemia-ET/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-essential-thrombocythemia-ET/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[essential thrombocythemia (ET)]]
prognosis of essential thrombocythemia (ET) #ğŸš§ æ–½å·¥ä¸­ prognosis of essential thrombocythemia (ET) â€¢ Low-risk Pts have overall survival â‰ˆ control population</description></item><item><title>Prognosis of myelodysplastic syndromes</title><link>https://www.physician.tw/prognosis-of-myelodysplastic-syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-myelodysplastic-syndromes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
Prognosis of myelodysplastic syndromes #ğŸš§ æ–½å·¥ä¸­ Prognosis of myelodysplastic syndromes : mutations inTP53, ASXL1, EZH2, RUNX1, ETV6 (NEJM 2011; 364:2496) â†“ survival</description></item><item><title>prognosis of polycythemia vera (PV)</title><link>https://www.physician.tw/prognosis-of-polycythemia-vera-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prognosis-of-polycythemia-vera-PV/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[polycythemia vera (PV)]]
prognosis of polycythemia vera (PV) #ğŸš§ æ–½å·¥ä¸­ prognosis of polycythemia vera (PV) â€¢ Median survival w/ Rx ~13.</description></item><item><title>prophylaxis supportive medications during HSCT</title><link>https://www.physician.tw/prophylaxis-supportive-medications-during-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prophylaxis-supportive-medications-during-HSCT/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
prophylaxis supportive medications during HSCT #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>psychiatric</title><link>https://www.physician.tw/psychiatric/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[medical]]
psychiatric anatomy &amp;amp; physiology [[Mechanisms of Psychiatric Disease]]
psychiatric diagnostics [[Mental Status Exam]]
psychiatric approaches &amp;amp; chief complaints [[Depressed MoodSuicidal Ideation]]</description></item><item><title>psychiatric anatomy &amp; physiology</title><link>https://www.physician.tw/psychiatric-anatomy-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-anatomy-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric anatomy &amp;amp; physiology #ğŸš§ æ–½å·¥ä¸­ psychiatric anatomy &amp;amp; physiology [[Mechanisms of Psychiatric Disease]]</description></item><item><title>psychiatric approaches &amp; chief complaints</title><link>https://www.physician.tw/psychiatric-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-approaches-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric approaches &amp;amp; chief complaints #ğŸš§ æ–½å·¥ä¸­ psychiatric approaches &amp;amp; chief complaints [[Depressed MoodSuicidal Ideation]]</description></item><item><title>psychiatric diagnostics</title><link>https://www.physician.tw/psychiatric-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric diagnostics #ğŸš§ æ–½å·¥ä¸­ psychiatric diagnostics [[Mental Status Exam]]</description></item><item><title>psychiatric diseases &amp; pathophysiology</title><link>https://www.physician.tw/psychiatric-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-diseases-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric diseases &amp;amp; pathophysiology #ğŸš§ æ–½å·¥ä¸­ psychiatric diseases &amp;amp; pathophysiology [[Psychotic Disorders]]</description></item><item><title>psychiatric key clinical trials &amp; publications</title><link>https://www.physician.tw/psychiatric-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-key-clinical-trials-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric key clinical trials &amp;amp; publications #ğŸš§ æ–½å·¥ä¸­ psychiatric key clinical trials &amp;amp; publications [[Major Depressive Disorder]]</description></item><item><title>psychiatric key medications &amp; interventions</title><link>https://www.physician.tw/psychiatric-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/psychiatric-key-medications-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Psychiatry of Huppert&amp;rsquo;s Notes]]
psychiatric key medications &amp;amp; interventions #ğŸš§ æ–½å·¥ä¸­ psychiatric key medications &amp;amp; interventions TABLE 13.</description></item><item><title>Psychiatry of Huppert's Notes</title><link>https://www.physician.tw/Psychiatry-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychiatry-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Psychiatry of Huppert&amp;rsquo;s Notes</description></item><item><title>Psychosis (e.g., Delusions andor Hallucinations)</title><link>https://www.physician.tw/Psychosis-e.g.-Delusions-andor-Hallucinations/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychosis-e.g.-Delusions-andor-Hallucinations/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Psychosis (e.g., Delusions andor Hallucinations) #ğŸš§ æ–½å·¥ä¸­ Psychosis (e.g., Delusions and/or Hallucinations) â€¢Â Definitions:</description></item><item><title>Psychotic Disorders</title><link>https://www.physician.tw/Psychotic-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Psychotic-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Psychotic Disorders #ğŸš§ æ–½å·¥ä¸­ Psychotic Disorders Schizophrenia â€¢Â Etiology: Likely multiple diseases with similar signs/symptoms (Neuropsychopharmacol 2009;34(9): 2081).</description></item><item><title>Pulmonary Function Testing (PFTs)</title><link>https://www.physician.tw/Pulmonary-Function-Testing-PFTs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Function-Testing-PFTs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Function Testing (PFTs) #ğŸš§ æ–½å·¥ä¸­ Pulmonary Function Testing (PFTs) â€¢Â Approach to interpreting PFTs:</description></item><item><title>Pulmonary Hypertension (PH)</title><link>https://www.physician.tw/Pulmonary-Hypertension-PH/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Hypertension-PH/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Hypertension (PH) #ğŸš§ æ–½å·¥ä¸­ Pulmonary Hypertension (PH) â€¢Â Note: See Cardiology Chapter 1 for additional details</description></item><item><title>Pulmonary Infections</title><link>https://www.physician.tw/Pulmonary-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pulmonary Infections #ğŸš§ æ–½å·¥ä¸­ Pulmonary Infections Community acquired pneumonia (CAP) â€¢Â Definition: An acute pulmonary infection that develops outside of the hospital or within the first 48 hours of admission</description></item><item><title>pulmonology anatomy and physiology</title><link>https://www.physician.tw/pulmonology-anatomy-and-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-anatomy-and-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology anatomy and physiology #ğŸš§ æ–½å·¥ä¸­ pulmonology anatomy and physiology [[Anatomy of the Lungs]]</description></item><item><title>pulmonology approaches and chief complaints</title><link>https://www.physician.tw/pulmonology-approaches-and-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-approaches-and-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology approaches and chief complaints #ğŸš§ æ–½å·¥ä¸­ [[Key Terms and Definitions]]</description></item><item><title>pulmonology diagnostics</title><link>https://www.physician.tw/pulmonology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology diagnostics #ğŸš§ æ–½å·¥ä¸­ pulmonology diagnostics [[Chest x-ray (CXR)]]
[[Chest CT]]</description></item><item><title>pulmonology diseases and pathophysiology</title><link>https://www.physician.tw/pulmonology-diseases-and-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-diseases-and-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology diseases and pathophysiology #ğŸš§ æ–½å·¥ä¸­ pulmonology diseases and pathophysiology [[Alveolar Hemorrhage]]</description></item><item><title>pulmonology key clinical trials and publications</title><link>https://www.physician.tw/pulmonology-key-clinical-trials-and-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-key-clinical-trials-and-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology key clinical trials and publications #ğŸš§ æ–½å·¥ä¸­ pulmonology key clinical trials and publications [[books/h_note/Asthma]]</description></item><item><title>pulmonology key medications and interventions</title><link>https://www.physician.tw/pulmonology-key-medications-and-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology-key-medications-and-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Pulmonology of Huppert&amp;rsquo;s Notes]]
pulmonology key medications and interventions #ğŸš§ æ–½å·¥ä¸­ pulmonology key medications and interventions [[Respiratory Support]]</description></item><item><title>Pulmonology of Huppert's Notes</title><link>https://www.physician.tw/Pulmonology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonology-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Pulmonology of Huppert&amp;rsquo;s Notes #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Qualitative Platelet Disorders</title><link>https://www.physician.tw/Qualitative-Platelet-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Qualitative-Platelet-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Qualitative Platelet Disorders #ğŸš§ æ–½å·¥ä¸­ Qualitative Platelet Disorders â€¢Â Definition: Normal platelet count but abnormal platelet function (i.</description></item><item><title>Quantitative Platelet Disorders</title><link>https://www.physician.tw/Quantitative-Platelet-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Quantitative-Platelet-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Quantitative Platelet Disorders #ğŸš§ æ–½å·¥ä¸­ Quantitative Platelet Disorders Thrombocytopenia
â€¢Â Definition*:* Low number of platelets (&amp;lt;150K/Î¼l)</description></item><item><title>Rash</title><link>https://www.physician.tw/Rash/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rash/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Rash #ğŸš§ æ–½å·¥ä¸­ Rash â€¢Â Approach to the patient with a rash:
-Â General approach: Typically, start with a physical exam before taking an extensive history</description></item><item><title>RBC Disorders</title><link>https://www.physician.tw/RBC-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RBC-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
RBC Disorders #ğŸš§ æ–½å·¥ä¸­ RBC Disorders Anemia
â€¢Â Definition: Low hemoglobin (Hg &amp;lt;13 g/dL in men, Hg &amp;lt;12 g/dL in women)</description></item><item><title>Regular Atrial Rhythms</title><link>https://www.physician.tw/Regular-Atrial-Rhythms/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Regular-Atrial-Rhythms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Regular Atrial Rhythms #ğŸš§ æ–½å·¥ä¸­ Regular Atrial Rhythms Sinus tachycardia (ST) â€¢Â Etiologies: Infection, hypovolemia/hemorrhage, hypoxia, anemia, anxiety, PE, alcohol withdrawal, hyperthyroidism.</description></item><item><title>relapse refractory of treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/relapse-refractory-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/relapse-refractory-of-treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[treatment of acute lymphoblastic leukemia (ALL)]]
relapse refractory of treatment of acute lymphoblastic leukemia (ALL) #ğŸš§ æ–½å·¥ä¸­ relapse refractory of treatment of acute lymphoblastic leukemia (ALL) salvage therapy (below), then allogeneic HSCT if able</description></item><item><title>Renal Anatomy</title><link>https://www.physician.tw/Renal-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Anatomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Anatomy #ğŸš§ æ–½å·¥ä¸­ Renal Anatomy FIGURE 6.1: Anatomy of the urinary tract and kidney.</description></item><item><title>Renal Artery Stenosis</title><link>https://www.physician.tw/Renal-Artery-Stenosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Artery-Stenosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Artery Stenosis #ğŸš§ æ–½å·¥ä¸­ Renal Artery Stenosis â€¢Â CORAL. N Eng J Med 2014;370(1):13â€“22.</description></item><item><title>Renal Cystic Diseases</title><link>https://www.physician.tw/Renal-Cystic-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Cystic-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Cystic Diseases #ğŸš§ æ–½å·¥ä¸­ Renal Cystic Diseases Renal cysts â€¢Â Classification: Categorized as simple or complex based on imaging appearance</description></item><item><title>Renal Dysfunction</title><link>https://www.physician.tw/Renal-Dysfunction/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Dysfunction/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Dysfunction #ğŸš§ æ–½å·¥ä¸­ Renal Dysfunction</description></item><item><title>Renal Formulas</title><link>https://www.physician.tw/Renal-Formulas/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Formulas/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Formulas #ğŸš§ æ–½å·¥ä¸­ Renal Formulas â€¢Â Important renal concepts and formulas: See Table 6.</description></item><item><title>Renal Physiology</title><link>https://www.physician.tw/Renal-Physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Physiology #ğŸš§ æ–½å·¥ä¸­ Renal Physiology FIGURE 6.2: Diagram of the nephron. The nephron is the functional unit of the kidney that uses four mechanisms to process the filtrate: filtration, reabsorption, secretion, and excretion.</description></item><item><title>Renal Tubular Acidosis (RTA)</title><link>https://www.physician.tw/Renal-Tubular-Acidosis-RTA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Tubular-Acidosis-RTA/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Tubular Acidosis (RTA) #ğŸš§ æ–½å·¥ä¸­ Renal Tubular Acidosis (RTA) RTA Type I (Distal) â€¢Â Pathophysiology: Defect in collecting tubuleâ€™s ability to excrete H+ due to congenital causes, multiple myeloma, autoimmunity, amphotericin B toxicity</description></item><item><title>Renal Vascular Diseases</title><link>https://www.physician.tw/Renal-Vascular-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-Vascular-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Renal Vascular Diseases #ğŸš§ æ–½å·¥ä¸­ Renal Vascular Diseases Renal artery stenosis â€¢Â Etiology: Majority of cases are due to atherosclerosis, most others are due to fibromuscular dysplasia (often in young women, 50% bilateral, can be hereditary).</description></item><item><title>reproductive endocrinology</title><link>https://www.physician.tw/reproductive-endocrinology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/reproductive-endocrinology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Endocrinology of Huppert&amp;rsquo;s Notes]]
reproductive endocrinology #ğŸš§ æ–½å·¥ä¸­ reproductive endocrinology FIGURE 5.5: Hypothalamicâ€“pituitaryâ€“gonadal axis. Shown is the hypothalamicâ€“pituitaryâ€“gonadal axis, which regulates the production of the sex hormones estradiol and testosterone.</description></item><item><title>Respiratory Acidosis</title><link>https://www.physician.tw/Respiratory-Acidosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Acidosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Respiratory Acidosis #ğŸš§ æ–½å·¥ä¸­ Respiratory Acidosis â†“pH, â†‘PaCO2**, (Delayed compensation:â†‘HCO3â€“)**
â€¢Â Clinical features: Somnolence, confusion, myoclonus, headache, papilledema</description></item><item><title>Respiratory Alkalosis</title><link>https://www.physician.tw/Respiratory-Alkalosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Alkalosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Respiratory Alkalosis #ğŸš§ æ–½å·¥ä¸­ Respiratory Alkalosis â†‘pH, â†“PaCO2**, (Delayed compensation:** â†“HCO3â€“)
â€¢Â Clinical features: Decreased cerebral blood flow: dizziness, anxiety; tetany (indistinguishable from hypocalcemia), arrhythmias if severe</description></item><item><title>Respiratory Distress</title><link>https://www.physician.tw/Respiratory-Distress/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Distress/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Respiratory Distress #ğŸš§ æ–½å·¥ä¸­ Respiratory Distress â€¢Â Ask for help: Call your team and consider rapid response</description></item><item><title>Respiratory Support</title><link>https://www.physician.tw/Respiratory-Support/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Respiratory-Support/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Respiratory Support #ğŸš§ æ–½å·¥ä¸­ Respiratory Support TABLE 3.6 â€¢ Supplemental oxygen delivery devices</description></item><item><title>Restrictive Lung Diseases</title><link>https://www.physician.tw/Restrictive-Lung-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Restrictive-Lung-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Restrictive Lung Diseases #ğŸš§ æ–½å·¥ä¸­ Restrictive Lung Diseases â€¢Â Restrictive = â†“Compliance, â†‘Elastanceâ†’ Problem getting air in.</description></item><item><title>Rheumatologic Differential Diagnosis for Common Clinical Syndromes</title><link>https://www.physician.tw/Rheumatologic-Differential-Diagnosis-for-Common-Clinical-Syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatologic-Differential-Diagnosis-for-Common-Clinical-Syndromes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Rheumatologic Differential Diagnosis for Common Clinical Syndromes #ğŸš§ æ–½å·¥ä¸­ Rheumatologic Differential Diagnosis for Common Clinical Syndromes TABLE 9.</description></item><item><title>rheumatology anatomy &amp; physiology</title><link>https://www.physician.tw/rheumatology-anatomy-physiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-anatomy-physiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology anatomy &amp;amp; physiology #ğŸš§ æ–½å·¥ä¸­ rheumatology anatomy &amp;amp; physiology [[Axial and Appendicular Skeleton]]</description></item><item><title>rheumatology approaches &amp; chief complaints</title><link>https://www.physician.tw/rheumatology-approaches-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-approaches-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology approaches &amp;amp; chief complaints #ğŸš§ æ–½å·¥ä¸­ rheumatology approaches &amp;amp; chief complaints [[Diagnostic Approach to Joint Pain]]</description></item><item><title>rheumatology diagnostics</title><link>https://www.physician.tw/rheumatology-diagnostics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-diagnostics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology diagnostics #ğŸš§ æ–½å·¥ä¸­ rheumatology diagnostics [[Diagnostic Reasoning in Rheumatology]]
[[Approach to Reading a Hand X-Ray]]</description></item><item><title>rheumatology diseases &amp; pathophysiology</title><link>https://www.physician.tw/rheumatology-diseases-pathophysiology/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-diseases-pathophysiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology diseases &amp;amp; pathophysiology #ğŸš§ æ–½å·¥ä¸­ rheumatology diseases &amp;amp; pathophysiology [[ANA-Associated Connective Tissue Disorders]]</description></item><item><title>rheumatology key clinical trials &amp; publications</title><link>https://www.physician.tw/rheumatology-key-clinical-trials-publications/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-key-clinical-trials-publications/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology key clinical trials &amp;amp; publications #ğŸš§ æ–½å·¥ä¸­ rheumatology key clinical trials &amp;amp; publications [[books/h_note/Rheumatoid Arthritis]]</description></item><item><title>rheumatology key medications &amp; interventions</title><link>https://www.physician.tw/rheumatology-key-medications-interventions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology-key-medications-interventions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Rheumatology of Huppert&amp;rsquo;s Notes]]
rheumatology key medications &amp;amp; interventions #ğŸš§ æ–½å·¥ä¸­ rheumatology key medications &amp;amp; interventions [[Anti-Inflammatory Agents]]</description></item><item><title>Rheumatology of Huppert's Notes</title><link>https://www.physician.tw/Rheumatology-of-Hupperts-Notes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rheumatology-of-Hupperts-Notes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]</description></item><item><title>Rhinitis</title><link>https://www.physician.tw/Rhinitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhinitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Rhinitis #ğŸš§ æ–½å·¥ä¸­ Rhinitis â€¢Â Physical exam: Inspect the nasal cavities and oropharynx</description></item><item><title>Right Heart Catheterization</title><link>https://www.physician.tw/Right-Heart-Catheterization/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Right-Heart-Catheterization/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Right Heart Catheterization #ğŸš§ æ–½å·¥ä¸­ Right Heart Catheterization â€¢Â Procedure: Insertation of a catheter into the right heart and pulmonary arteries usually via the IJ or brachial vein in order to measure the RA, RV, PA, and wedge pressures as well as cardiac output.</description></item><item><title>S. aureus Bacteremia</title><link>https://www.physician.tw/S.-aureus-Bacteremia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/S.-aureus-Bacteremia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
S. aureus Bacteremia #ğŸš§ æ–½å·¥ä¸­ S. aureus Bacteremia â€¢Â Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.</description></item><item><title>Sarcoma</title><link>https://www.physician.tw/Sarcoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sarcoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sarcoma #ğŸš§ æ–½å·¥ä¸­ Sarcoma Soft tissue sarcoma
â€¢Â Epidemiology: Rare, heterogeneous tumor of mesenchymal origin.</description></item><item><title>Secondary Headache Disorders</title><link>https://www.physician.tw/Secondary-Headache-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Headache-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Secondary Headache Disorders #ğŸš§ æ–½å·¥ä¸­ Secondary Headache Disorders Medication overuse headache (â€œrebound headacheâ€) â€¢Â Drugs that cause rebound headaches: Abortive medications taken â‰¥2 times per week, such as acetaminophen-butalbital-caffeine, APAP, NSAIDs, caffeine, ergotamine, opioids, triptans</description></item><item><title>Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value</title><link>https://www.physician.tw/Sensitivity-Specificity-Positive-Predictive-Value-and-Negative-Predictive-Value/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sensitivity-Specificity-Positive-Predictive-Value-and-Negative-Predictive-Value/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value #ğŸš§ æ–½å·¥ä¸­ Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value FIGURE A2.</description></item><item><title>Severe Cutaneous Drug Reactions</title><link>https://www.physician.tw/Severe-Cutaneous-Drug-Reactions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severe-Cutaneous-Drug-Reactions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Severe Cutaneous Drug Reactions #ğŸš§ æ–½å·¥ä¸­ Severe Cutaneous Drug Reactions Can be life threatening due to profound insensible losses and resultant fluid and electrolyte shifts.</description></item><item><title>Sexually Transmitted Diseases</title><link>https://www.physician.tw/Sexually-Transmitted-Diseases/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sexually-Transmitted-Diseases/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sexually Transmitted Diseases #ğŸš§ æ–½å·¥ä¸­ Sexually Transmitted Diseases â€¢Â [Guideline] Sexually transmitted diseases treatment guidelines, 2015.</description></item><item><title>Sexually Transmitted Infections (STIs)</title><link>https://www.physician.tw/Sexually-Transmitted-Infections-STIs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sexually-Transmitted-Infections-STIs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sexually Transmitted Infections (STIs) #ğŸš§ æ–½å·¥ä¸­ Sexually Transmitted Infections (STIs) Chlamydia &amp;amp; gonorrhea â€¢Â Pathogens: Chlamydia trachomatis &amp;amp; Neisseria gonorrhoeae.</description></item><item><title>SGLT2 Inhibitors in Diabetic Kidney Disease</title><link>https://www.physician.tw/SGLT2-Inhibitors-in-Diabetic-Kidney-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2-Inhibitors-in-Diabetic-Kidney-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
SGLT2 Inhibitors in Diabetic Kidney Disease #ğŸš§ æ–½å·¥ä¸­ SGLT2 Inhibitors in Diabetic Kidney Disease â€¢Â CREDENCE.</description></item><item><title>Shock Management</title><link>https://www.physician.tw/Shock-Management/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shock-Management/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Shock Management #ğŸš§ æ–½å·¥ä¸­ Shock Management â€¢Â SMART Trial. New Engl J Med 2018;378(9):829â€“839.</description></item><item><title>Sick Euthyroid Syndrome</title><link>https://www.physician.tw/Sick-Euthyroid-Syndrome/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sick-Euthyroid-Syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sick Euthyroid Syndrome #ğŸš§ æ–½å·¥ä¸­ Sick Euthyroid Syndrome â€¢Â Pathophysiology: Illness causes caloric deprivation and an increased inflammatory state, which may lead to abnormal thyroid function tests</description></item><item><title>Sinusitis</title><link>https://www.physician.tw/Sinusitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinusitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sinusitis #ğŸš§ æ–½å·¥ä¸­ Sinusitis â€¢Â Physical exam: Palpate the sinuses (frontal, ethmoid, maxillary); inspect the oropharynx and nasal cavities; perform a cranial nerve exam</description></item><item><title>SIRS, Sepsis, Severe Sepsis, and Septic Shock</title><link>https://www.physician.tw/SIRS-Sepsis-Severe-Sepsis-and-Septic-Shock/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SIRS-Sepsis-Severe-Sepsis-and-Septic-Shock/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
SIRS, Sepsis, Severe Sepsis, and Septic Shock #ğŸš§ æ–½å·¥ä¸­ SIRS, Sepsis, Severe Sepsis, and Septic Shock â€¢Â Introduction:</description></item><item><title>Skin and Soft Tissue Infections (SSTIs)</title><link>https://www.physician.tw/Skin-and-Soft-Tissue-Infections-SSTIs/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Skin-and-Soft-Tissue-Infections-SSTIs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Skin and Soft Tissue Infections (SSTIs) #ğŸš§ æ–½å·¥ä¸­ Skin and Soft Tissue Infections (SSTIs) Non-purulent and purulent cellulitis â€¢Â Pathophysiology: Cellulitis is an infection of the deeper layers of the dermis.</description></item><item><title>Small Bowel</title><link>https://www.physician.tw/Small-Bowel/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Bowel/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Small Bowel #ğŸš§ æ–½å·¥ä¸­ Small Bowel</description></item><item><title>small lymphocytic lymphoma</title><link>https://www.physician.tw/small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-lymphocytic-lymphoma/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[leukemia]]
small lymphocytic lymphoma #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Small Vessel Vasculitis ANCA-Associated Vasculitides (AAV)</title><link>https://www.physician.tw/Small-Vessel-Vasculitis-ANCA-Associated-Vasculitides-AAV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Vessel-Vasculitis-ANCA-Associated-Vasculitides-AAV/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Small Vessel Vasculitis ANCA-Associated Vasculitides (AAV) #ğŸš§ æ–½å·¥ä¸­ Small Vessel Vasculitis: ANCA-Associated Vasculitides (AAV) Granulomatosis with polyangiitis (GPA, formerly Wegenerâ€™s granulomatosis)</description></item><item><title>Small Vessel Vasculitis Immune-Complex Mediated</title><link>https://www.physician.tw/Small-Vessel-Vasculitis-Immune-Complex-Mediated/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Small-Vessel-Vasculitis-Immune-Complex-Mediated/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Small Vessel Vasculitis Immune-Complex Mediated #ğŸš§ æ–½å·¥ä¸­ Small Vessel Vasculitis: Immune-Complex Mediated Palpable purpura on exam, leukocytoclastic vasculitis on skin biopsy</description></item><item><title>smallÂ lymphocyticÂ lymphoma</title><link>https://www.physician.tw/small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/small-lymphocytic-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[non-Hodgkin lymphoma (NHL)]]
smallÂ lymphocyticÂ lymphoma #ğŸš§ æ–½å·¥ä¸­ (SLL)Â ORÂ CHRONICLYMPHOCYTICÂ LEUKEMIAÂ (CLL)
[[definition of small lymphocytic lymphoma]]</description></item><item><title>smears</title><link>https://www.physician.tw/smears/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/smears/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematology]]
smears #ğŸš§ æ–½å·¥ä¸­ [[Evaluation of a Peripheral Blood Smear]]</description></item><item><title>Sodium</title><link>https://www.physician.tw/Sodium/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sodium/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Sodium #ğŸš§ æ–½å·¥ä¸­ Sodium Sodium homeostasis (Na**+** 135 to 145 mmol/L) â€¢Â Extracellular Na+ concentration reflects water homeostasis: Hyponatremia and hypernatremia are caused by too much/too little water.</description></item><item><title>Somatic Symptom and Related Disorders</title><link>https://www.physician.tw/Somatic-Symptom-and-Related-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Somatic-Symptom-and-Related-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Somatic Symptom and Related Disorders #ğŸš§ æ–½å·¥ä¸­ Somatic Symptom and Related Disorders â€¢Â Somatic symptom disorder: Somatic symptoms with excessive thoughts, anxieties, or behaviors causing significant disruption to social, occupational, and/or other areas of functioning lasting &amp;gt;6 months.</description></item><item><title>spectrum of nonmalignant to malignant clonal plasma cell disorders</title><link>https://www.physician.tw/spectrum-of-nonmalignant-to-malignant-clonal-plasma-cell-disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spectrum-of-nonmalignant-to-malignant-clonal-plasma-cell-disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[plasma cell dyscrasias]]
spectrum of nonmalignant to malignant clonal plasma cell disorders #ğŸš§ æ–½å·¥ä¸­ spectrum of nonmalignant to malignant clonal plasma cell disorders see figure</description></item><item><title>Spondyloarthritis (SpA)</title><link>https://www.physician.tw/Spondyloarthritis-SpA/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spondyloarthritis-SpA/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Spondyloarthritis (SpA) #ğŸš§ æ–½å·¥ä¸­ Spondyloarthritis (SpA) Group of disorders with shared features of inflammatory arthritis with varying degrees of axial skeleton involvement, enthesitis (inflammation of tendon-bone insertion points), overt or subclinical intestinal inflammation, association with uveitis, and association with the HLA-B27 MHC allele.</description></item><item><title>Statics Volumes Capacities, Compliance, and Surface Tension</title><link>https://www.physician.tw/Statics-Volumes-Capacities-Compliance-and-Surface-Tension/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Statics-Volumes-Capacities-Compliance-and-Surface-Tension/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Statics VolumesCapacities, Compliance, and Surface Tension #ğŸš§ æ–½å·¥ä¸­ Statics: Volumes/Capacities, Compliance, and Surface Tension â€¢Â Volumes and Capacities:</description></item><item><title>Statins in ESRD</title><link>https://www.physician.tw/Statins-in-ESRD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Statins-in-ESRD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Statins in ESRD #ğŸš§ æ–½å·¥ä¸­ Statins in ESRD â€¢Â 4D. N Eng J Med 2005;353:238â€“248.</description></item><item><title>statistical concepts and test characteristics</title><link>https://www.physician.tw/statistical-concepts-and-test-characteristics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/statistical-concepts-and-test-characteristics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
statistical concepts and test characteristics #ğŸš§ æ–½å·¥ä¸­ statistical concepts and test characteristics [[Odds Ratio, Risk Ratio, and Related Statistics]]</description></item><item><title>Stem Cell Transplant Basics</title><link>https://www.physician.tw/Stem-Cell-Transplant-Basics/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stem-Cell-Transplant-Basics/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Stem Cell Transplant Basics #ğŸš§ æ–½å·¥ä¸­ Stem Cell Transplant Basics â€¢Â Types of hematopoietic stem cells (HSCs):</description></item><item><title>Stomach</title><link>https://www.physician.tw/Stomach/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stomach/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Stomach #ğŸš§ æ–½å·¥ä¸­ Stomach Peptic ulcer disease (PUD) â€¢Â Pathophysiology: Ulcers that develop in the stomach or duodenum.</description></item><item><title>Stones and Obstructions</title><link>https://www.physician.tw/Stones-and-Obstructions/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stones-and-Obstructions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Stones and Obstructions #ğŸš§ æ–½å·¥ä¸­ Stones and Obstructions Nephrolithiasis (kidney stones) â€¢Â Types:</description></item><item><title>Structure and Function of the Skin</title><link>https://www.physician.tw/Structure-and-Function-of-the-Skin/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structure-and-Function-of-the-Skin/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Structure and Function of the Skin #ğŸš§ æ–½å·¥ä¸­ Structure and Function of the Skin â€¢Â Function of skin: The skin is a large, complex organ with a variety of important functions: Mechanical barrier, temperature regulation, fluid balance, immune response</description></item><item><title>Structure and Innervation of the GI Tract</title><link>https://www.physician.tw/Structure-and-Innervation-of-the-GI-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structure-and-Innervation-of-the-GI-Tract/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Structure and Innervation of the GI Tract #ğŸš§ æ–½å·¥ä¸­ Structure and Innervation of the GI Tract â€¢Â Components: The GI tract includes epithelial cells (specialized for absorption/secretion), muscularis mucosa (changes surface area for absorption/secretion), circular muscle (decreases the diameter of the lumen), and longitudinal muscle (shortens a segment of the GI tract)</description></item><item><title>Substance Use Disorders</title><link>https://www.physician.tw/Substance-Use-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Substance-Use-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Substance Use Disorders #ğŸš§ æ–½å·¥ä¸­ Substance Use Disorders â€¢Â Overview: Named by type of substance involved in problematic use (i.</description></item><item><title>Substance Use Disorders and Treatments</title><link>https://www.physician.tw/Substance-Use-Disorders-and-Treatments/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Substance-Use-Disorders-and-Treatments/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Substance Use Disorders and Treatments #ğŸš§ æ–½å·¥ä¸­ Substance Use Disorders and Treatments â€¢Â Methadone maintenance vs.</description></item><item><title>symptoms &amp; chief complaints</title><link>https://www.physician.tw/symptoms-chief-complaints/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptoms-chief-complaints/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[General Medicine of Huppert&amp;rsquo;s Notes]]
symptoms &amp;amp; chief complaints #ğŸš§ æ–½å·¥ä¸­ symptoms &amp;amp; chief complaints [[Head and Neck]]</description></item><item><title>Synovial Joint Anatomy</title><link>https://www.physician.tw/Synovial-Joint-Anatomy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Synovial-Joint-Anatomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Synovial Joint Anatomy #ğŸš§ æ–½å·¥ä¸­ Synovial Joint Anatomy â€¢Â Joint capsule (â€œarticular capsuleâ€): Envelope surrounding a synovial joint that connects to the periosteum (Figure 9.</description></item><item><title>Systemic Fungal Infections</title><link>https://www.physician.tw/Systemic-Fungal-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Fungal-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Systemic Fungal Infections #ğŸš§ æ–½å·¥ä¸­ Systemic Fungal Infections â€¢Â Pathogens:
-Â See Tables 8.</description></item><item><title>Systemic Lupus Erythematosus (SLE)</title><link>https://www.physician.tw/Systemic-Lupus-Erythematosus-SLE/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Lupus-Erythematosus-SLE/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Systemic Lupus Erythematosus (SLE) #ğŸš§ æ–½å·¥ä¸­ Systemic Lupus Erythematosus (SLE) â€¢Â A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.</description></item><item><title>Systemic Scleroderma</title><link>https://www.physician.tw/Systemic-Scleroderma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-Scleroderma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Systemic Scleroderma #ğŸš§ æ–½å·¥ä¸­ Systemic Scleroderma â€¢Â Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II Study).</description></item><item><title>Tachycardia</title><link>https://www.physician.tw/Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tachycardia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Tachycardia #ğŸš§ æ–½å·¥ä¸­ Tachycardia Tachycardia is defined as having a heart rate &amp;gt;100 bpm.</description></item><item><title>Targeted Therapies</title><link>https://www.physician.tw/Targeted-Therapies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Targeted-Therapies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Targeted Therapies #ğŸš§ æ–½å·¥ä¸­ Targeted Therapies â€¢Â Nomenclature:
-Â Small molecule inhibitors end in â€œ-inibâ€</description></item><item><title>The Assessment and Plan (A&amp;P)</title><link>https://www.physician.tw/The-Assessment-and-Plan-AP/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Assessment-and-Plan-AP/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
The Assessment and Plan (A&amp;amp;P) #ğŸš§ æ–½å·¥ä¸­ The Assessment and Plan (A&amp;amp;P) The assessment and plan (A&amp;amp;P) is the most important part of the H&amp;amp;P (and the oral presentation).</description></item><item><title>The Coagulation Cascade</title><link>https://www.physician.tw/The-Coagulation-Cascade/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Coagulation-Cascade/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
The Coagulation Cascade #ğŸš§ æ–½å·¥ä¸­ The Coagulation Cascade FIGURE 7.2: The coagulation cascade. The intrinsic pathway and extrinsic pathways converge in the common pathway.</description></item><item><title>The Neuroendocrine System of the Gut</title><link>https://www.physician.tw/The-Neuroendocrine-System-of-the-Gut/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Neuroendocrine-System-of-the-Gut/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
The Neuroendocrine System of the Gut #ğŸš§ æ–½å·¥ä¸­ The Neuroendocrine System of the Gut Classification of GI regulatory substances â€¢Â Hormones: Released from endocrine cells in the GI tract into the portal circulation.</description></item><item><title>The Neurologic Exam</title><link>https://www.physician.tw/The-Neurologic-Exam/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Neurologic-Exam/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
The Neurologic Exam #ğŸš§ æ–½å·¥ä¸­ The Neurologic Exam Mental status â€¢Â Orientation: Person, place, time, situation</description></item><item><title>Thrombocytosis</title><link>https://www.physician.tw/Thrombocytosis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombocytosis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Thrombocytosis #ğŸš§ æ–½å·¥ä¸­ Thrombocytosis â€¢Â Definition: High number of platelets (platelets &amp;gt;450K/Î¼l)
â€¢Â Etiologies:</description></item><item><title>Thrombotic Disorders</title><link>https://www.physician.tw/Thrombotic-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombotic-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Thrombotic Disorders #ğŸš§ æ–½å·¥ä¸­ Thrombotic Disorders Inherited hypercoagulable states
â€¢Â Factor V Leiden: Autosomal dominant disorder, but heterozygotes have an increased risk of thrombosis (avoid OCPs).</description></item><item><title>Thyroid Disease</title><link>https://www.physician.tw/Thyroid-Disease-key-clinical-trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-Disease-key-clinical-trials/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Thyroid Disease #ğŸš§ æ–½å·¥ä¸­ Thyroid Disease â€¢Â Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association task force on thyroid hormone replacement.</description></item><item><title>Thyroid Nodule</title><link>https://www.physician.tw/Thyroid-Nodule/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-Nodule/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Thyroid Nodule #ğŸš§ æ–½å·¥ä¸­ Thyroid Nodule â€¢Â Etiologies:
-Â Benign follicular epithelial cell adenomas (common, present in 5â€“10% of adults)</description></item><item><title>Tick-Borne Illnesses</title><link>https://www.physician.tw/Tick-Borne-Illnesses/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tick-Borne-Illnesses/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Tick-Borne Illnesses #ğŸš§ æ–½å·¥ä¸­ Tick-Borne Illnesses Lyme disease â€¢Â Etiology: Borrelia burgdorferi spirochete is spread by the Ixodidae scapularis tick in the Northeastern United States, Northern Midwest.</description></item><item><title>timing of complications following allogeneic HSCT</title><link>https://www.physician.tw/timing-of-complications-following-allogeneic-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timing-of-complications-following-allogeneic-HSCT/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
timing of complications following allogeneic HSCT #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Timing of Dialysis Initiation in CKD</title><link>https://www.physician.tw/Timing-of-Dialysis-Initiation-in-CKD/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Timing-of-Dialysis-Initiation-in-CKD/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Timing of Dialysis Initiation in CKD #ğŸš§ æ–½å·¥ä¸­ Timing of Dialysis Initiation in CKD â€¢Â IDEAL.</description></item><item><title>Tracts of the CNS</title><link>https://www.physician.tw/Tracts-of-the-CNS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tracts-of-the-CNS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Tracts of the CNS #ğŸš§ æ–½å·¥ä¸­ Tracts of the CNS The CNS includes the brain and spinal cord.</description></item><item><title>Transfusion Medicine</title><link>https://www.physician.tw/Transfusion-Medicine/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-Medicine/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Transfusion Medicine #ğŸš§ æ–½å·¥ä¸­ Transfusion Medicine Standard testing
â€¢Â ABO typing: Determine A/B antigens present on RBCs (blood type A, B, AB, or O)</description></item><item><title>Transient Ischemic Attack and Acute Ischemic Stroke</title><link>https://www.physician.tw/Transient-Ischemic-Attack-and-Acute-Ischemic-Stroke/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transient-Ischemic-Attack-and-Acute-Ischemic-Stroke/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Transient Ischemic Attack and Acute Ischemic Stroke #ğŸš§ æ–½å·¥ä¸­ Transient Ischemic Attack and Acute Ischemic Stroke Transient ischemic attack (TIA) â€¢Â Definition: Transient neurologic deficit that lasts &amp;lt;24 hr with a normal brain MRI</description></item><item><title>transient loss of consciousness</title><link>https://www.physician.tw/transient-loss-of-consciousness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transient-loss-of-consciousness/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
transient loss of consciousness #ğŸš§ æ–½å·¥ä¸­ transient loss of consciousness Scott D. C. Stern, MD</description></item><item><title>transplantation procedure (for Allo HSCT)</title><link>https://www.physician.tw/transplantation-procedure-for-Allo-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transplantation-procedure-for-Allo-HSCT/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
transplantation procedure (for Allo HSCT) #ğŸš§ æ–½å·¥ä¸­ transplantation procedure (for Allo HSCT) â€¢ Pre-Tx conditioning regimen goal: immunosuppression to allow donor cell engraftment &amp;amp; anti-tumor efficacy to â†“ relapse risk.</description></item><item><title>treatment and prognosis of multiple myeloma (MM)</title><link>https://www.physician.tw/treatment-and-prognosis-of-multiple-myeloma-MM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-and-prognosis-of-multiple-myeloma-MM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[multiple myeloma (MM)]]
treatment and prognosis of multiple myeloma (MM) #ğŸš§ æ–½å·¥ä¸­ treatment and prognosis of multiple myeloma (MM) (NEJM 2016;375:754 &amp;amp; 1319; 2018;378:518 &amp;amp; 379:1811) â€¢ Decisions dictated by risk stratification and transplant eligibility; generally incurable.</description></item><item><title>Treatment forÂ JAK2Â + PV</title><link>https://www.physician.tw/Treatment-for-JAK2-+-PV/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-for-JAK2-+-PV/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[polycythemia vera (PV)]]
Treatment forÂ JAK2Â + PV #ğŸš§ æ–½å·¥ä¸­ Treatment forÂ JAK2Â + PV â€¢Â PhlebotomyÂ to goal Hct &amp;lt;45%Â (NEJMÂ 2013;368:22), consider &amp;lt;42% in women</description></item><item><title>treatment of acute lymphoblastic leukemia (ALL)</title><link>https://www.physician.tw/treatment-of-acute-lymphoblastic-leukemia-ALL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-acute-lymphoblastic-leukemia-ALL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute lymphoblastic leukemia (ALL)]]
treatment of acute lymphoblastic leukemia (ALL) [[induction chemotherapy of treatment of acute lymphoblastic leukemia (ALL)]]</description></item><item><title>treatment of chronic myelogenous leukemia (CML)</title><link>https://www.physician.tw/treatment-of-chronic-myelogenous-leukemia-CML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-chronic-myelogenous-leukemia-CML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[chronic myelogenous leukemia (CML)]]
treatment of chronic myelogenous leukemia (CML) #ğŸš§ æ–½å·¥ä¸­ treatment of chronic myelogenous leukemia (CML)Â  (LancetÂ 2015;385:1447;Â Hematol Oncol Clin North Am2017;31:577)</description></item><item><title>treatment of hodgkin lymphoma (HL)</title><link>https://www.physician.tw/treatment-of-hodgkin-lymphoma-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-hodgkin-lymphoma-HL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hodgkin lymphoma (HL)]]
treatment of hodgkin lymphoma (HL) #ğŸš§ æ–½å·¥ä¸­ treatment of hodgkin lymphoma (HL) (NCCN Guidelines v5.</description></item><item><title>treatment of myelodysplastic syndromes</title><link>https://www.physician.tw/treatment-of-myelodysplastic-syndromes/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-myelodysplastic-syndromes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
treatment of myelodysplastic syndromes #ğŸš§ æ–½å·¥ä¸­ treatment of myelodysplastic syndromes (Am J Hematol 2012;87:692): intensity based on IPSS-R (qv), age, performance status (PS) Poor PS, any risk â†’ supportive care (transfusions, G-CSF, Epo, TPO-mimetic, abx prn) Very low/low risk (IPSS-R) â†’ ESA if Epo &amp;lt;500; lenalidomide (esp.</description></item><item><title>treatment of non-Hodgkin lymphoma</title><link>https://www.physician.tw/treatment-of-non-Hodgkin-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-non-Hodgkin-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[non-Hodgkin lymphoma (NHL)]]
treatment of non-Hodgkin lymphoma #ğŸš§ æ–½å·¥ä¸­ treatment of non-Hodgkin lymphoma Â (LancetÂ 2017;390:298)</description></item><item><title>treatment of primary myelofibrosis (PMF)</title><link>https://www.physician.tw/treatment-of-primary-myelofibrosis-PMF/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-primary-myelofibrosis-PMF/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[primary myelofibrosis (PMF)]]
treatment of primary myelofibrosis (PMF) #ğŸš§ æ–½å·¥ä¸­ treatment of primary myelofibrosis (PMF)Â  (Am J HematolÂ 2021;96:145)</description></item><item><title>treatment of smallÂ lymphocyticÂ lymphoma</title><link>https://www.physician.tw/treatment-of-small-lymphocytic-lymphoma/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-small-lymphocytic-lymphoma/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[small lymphocytic lymphoma]]
treatment of smallÂ lymphocyticÂ lymphoma #ğŸš§ æ–½å·¥ä¸­ treatment of smallÂ lymphocyticÂ lymphoma Â (NEJMÂ 2020;383:460)</description></item><item><title>treatment of waldenstromâ€™s macroglobulinemia (WM)</title><link>https://www.physician.tw/treatment-of-waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[waldenstromâ€™s macroglobulinemia (WM)]]
treatment of waldenstromâ€™s macroglobulinemia (WM) #ğŸš§ æ–½å·¥ä¸­ treatment of waldenstromâ€™s macroglobulinemia (WM) â€¢ Hyperviscosity: plasmapheresis; limit transfusions if possible (worsen hyperviscosity) â€¢ Sx (eg, prog.</description></item><item><title>Types of Allo HSCT</title><link>https://www.physician.tw/Types-of-Allo-HSCT/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Allo-HSCT/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematopoietic stem cell transplantation]]
Types of Allo HSCT based on donor/recipient matching of major HLA antigens on Chr.</description></item><item><title>Types of Clinical Studies &amp; Trials</title><link>https://www.physician.tw/Types-of-Clinical-Studies-Trials/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Clinical-Studies-Trials/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Types of Clinical Studies &amp;amp; Trials #ğŸš§ æ–½å·¥ä¸­ Types of Clinical Studies &amp;amp; Trials â€¢Â Case control study: Compares a group of patients with a disease (â€œcasesâ€) to a group of patients who do not have the disease (â€œcontrolsâ€).</description></item><item><title>unintentional weight loss</title><link>https://www.physician.tw/unintentional-weight-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/unintentional-weight-loss/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
unintentional weight loss #ğŸš§ æ–½å·¥ä¸­ unintentional weight loss Andrew Olson, MD
CHIEF COMPLAINT PATIENT</description></item><item><title>upfront treatment of acute myelogenous leukemia (AML)</title><link>https://www.physician.tw/upfront-treatment-of-acute-myelogenous-leukemia-AML/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upfront-treatment-of-acute-myelogenous-leukemia-AML/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]
upfront treatment of acute myelogenous leukemia (AML) #ğŸš§ æ–½å·¥ä¸­ upfront treatment of acute myelogenous leukemia (AML) â€¢Â Induction chemoÂ â€œ7+3â€: 7d cont.</description></item><item><title>Urinary Incontinence</title><link>https://www.physician.tw/Urinary-Incontinence/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urinary-Incontinence/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Urinary Incontinence #ğŸš§ æ–½å·¥ä¸­ Urinary Incontinence â€¢Physical exam: Abdominal exam, rectal exam, pelvic exam in females, consider post-void residual</description></item><item><title>Vascular Etiologies of Liver Disease</title><link>https://www.physician.tw/Vascular-Etiologies-of-Liver-Disease/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Etiologies-of-Liver-Disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vascular Etiologies of Liver Disease #ğŸš§ æ–½å·¥ä¸­ Vascular Etiologies of Liver Disease Portal vein thrombosis â€¢Â Etiology: Blood clot in the hepatic portal vein, which can lead to increased pressure in the portal venous system and reduced blood supply to the liver</description></item><item><title>Vasculature of the GI Tract</title><link>https://www.physician.tw/Vasculature-of-the-GI-Tract/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasculature-of-the-GI-Tract/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vasculature of the GI Tract #ğŸš§ æ–½å·¥ä¸­ Vasculature of the GI Tract FIGURE 4.</description></item><item><title>Vasculitis and Vasculopathy</title><link>https://www.physician.tw/Vasculitis-and-Vasculopathy/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasculitis-and-Vasculopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vasculitis and Vasculopathy #ğŸš§ æ–½å·¥ä¸­ Vasculitis and Vasculopathy â€¢Â Leukocytoclastic vasculitis (LCV): Histopathologic term that describes nuclear debris from an inflammatory infiltrate; often used interchangeably with small vessel or cutaneous vasculitis</description></item><item><title>Vertigo</title><link>https://www.physician.tw/Vertigo/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vertigo/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vertigo #ğŸš§ æ–½å·¥ä¸­ Vertigo â€¢Â Physical exam: Perform a cranial nerve exam and a HINTS exam (Head-Impulse, Nystagmus, Test of Skew); perform an otoscopic exam and assess for hearing loss; evaluate the patientâ€™s gait; perform the Dix-Hallpike maneuver</description></item><item><title>vim TODO</title><link>https://www.physician.tw/vim-TODO/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-TODO/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[èœ¥èœ´èˆ‡VIM]]
vim TODO #ğŸš§ æ–½å·¥ä¸­ [[pandoc in vim]]
1
2
1. Enns RA, Hookey L, Armstrong D, et al.</description></item><item><title>Viral Infections</title><link>https://www.physician.tw/Viral-Infections/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Viral-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Viral Infections #ğŸš§ æ–½å·¥ä¸­ Viral Infections DNA viruses TABLE 8.5 â€¢ Key Clinically Relevant DNA Viruses</description></item><item><title>Vision loss</title><link>https://www.physician.tw/Vision-loss/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vision-loss/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vision loss #ğŸš§ æ–½å·¥ä¸­ Vision loss â€¢Â Physical exam: Perform a fundoscopic exam, pupillary exam, test visual acuity, extraocular motions, and peripheral vision.</description></item><item><title>Vulvovaginitis</title><link>https://www.physician.tw/Vulvovaginitis/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vulvovaginitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Vulvovaginitis #ğŸš§ æ–½å·¥ä¸­ Vulvovaginitis â€¢Â Physical exam: Pelvic exam
â€¢Â Differential diagnosis:
-Â Bacterial vaginitis (BV)</description></item><item><title>waldenstromâ€™s macroglobulinemia (WM)</title><link>https://www.physician.tw/waldenstroms-macroglobulinemia-WM/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/waldenstroms-macroglobulinemia-WM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[plasma cell dyscrasias]]
waldenstromâ€™s macroglobulinemia (WM) [[definition of waldenstromâ€™s macroglobulinemia (WM)]]
[[clinical manifestations of waldenstromâ€™s macroglobulinemia (WM)]]</description></item><item><title>WBC Disorders</title><link>https://www.physician.tw/WBC-Disorders/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WBC-Disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
WBC Disorders #ğŸš§ æ–½å·¥ä¸­ WBC Disorders Leukopenia
â€¢Â Definition: Low WBC (&amp;lt;4K/Î¼l). If absolute neutrophil count (ANC) &amp;lt;1000/Î¼l, that is called neutropenia and carries an increased risk of infection.</description></item><item><title>Weakness</title><link>https://www.physician.tw/Weakness/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Weakness/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Weakness #ğŸš§ æ–½å·¥ä¸­ Weakness â€¢Â Step 1: Delineate neurologic versus non-neurologic causes of weakness and take a detailed history</description></item><item><title>wheezing or stridor</title><link>https://www.physician.tw/wheezing-or-stridor/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wheezing-or-stridor/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[sxtodx]]
wheezing or stridor #ğŸš§ æ–½å·¥ä¸­ wheezing or stridor Nadia L. Bennett, MD, MSEd
CHIEF COMPLAINT PATIENT</description></item><item><title>WHO 2016 Classification of Myeloid Neoplasms &amp; Acute Leukemia</title><link>https://www.physician.tw/WHO-2016-Classification-of-Myeloid-Neoplasms-and-Acute-Leukemia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-2016-Classification-of-Myeloid-Neoplasms-and-Acute-Leukemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
WHO 2016 Classification of Myeloid Neoplasms &amp;amp; Acute Leukemia #ğŸš§ æ–½å·¥ä¸­ WHO 2016 Classification of Myeloid Neoplasms &amp;amp; Acute Leukemia Acute myeloid leukemia Clonal myeloid stem cell (SC) disorder w/ â‰¥20% blasts Myelodysplastic syndromes Dysplastic clonal myeloid SC disorder â†’ cytopenias; &amp;lt;20% blasts, risk of leukemic transformation Myeloproliferative neoplasms Nondysplastic multipotent myeloid SC clonal expansion MDS/MPN neoplasms Features of MDS &amp;amp; MPN (eg, CMML, atypical CML) Myeloid/lymphoid malig.</description></item><item><title>WHO 2016 Classification Systems for MDS</title><link>https://www.physician.tw/WHO-2016-Classification-Systems-for-MDS/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-2016-Classification-Systems-for-MDS/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[myelodysplastic syndromes]]
WHO 2016 Classification Systems for MDS #ğŸš§ æ–½å·¥ä¸­ WHO 2016 Classification Systems for MDS (Blood 2016;127:2391) Classification WHO 2008 Features MDS w/ single lineage dysplasia (MDS-SLD) RCUD (RA/RN/RT) 1 dysplastic lineage, 1â€“2 cytopenias, &amp;lt;15% RS*, &amp;lt;5% BM/ &amp;lt;1% PB blasts, no Auer rods MDS w/ multilineage dysplasia (MDS-MLD) RCMD 2â€“3 dysplastic lineages, 1â€“3 cytopenias, &amp;lt;15% RS*, &amp;lt;5% BM/ &amp;lt;1% PB blasts, no Auer rods MDS w/ ring sideroblast (MDS-RS) RARS â‰¥15% RS or â‰¥5% RS if SF3B1 mut.</description></item><item><title>WHO Classification of Lymphoid Malignancies</title><link>https://www.physician.tw/WHO-Classification-of-Lymphoid-Malignancies/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-Classification-of-Lymphoid-Malignancies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[non-Hodgkin lymphoma (NHL)]]
WHO Classification of Lymphoid Malignancies #ğŸš§ æ–½å·¥ä¸­ WHO Classification of Lymphoid Malignancies (BloodÂ 2016;127:2375)</description></item><item><title>WHO Histologic Classification of Classical HL</title><link>https://www.physician.tw/WHO-Histologic-Classification-of-Classical-HL/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHO-Histologic-Classification-of-Classical-HL/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hodgkin lymphoma (HL)]]
WHO Histologic Classification of Classical HL #ğŸš§ æ–½å·¥ä¸­ WHO Histologic Classification of Classical HL Nodular sclerosis 60â€“80% Collagen bands; frequent mediastinal LAN; young adults; female predominance; usually stage I or II at dx Mixed cellularity 15â€“30% Pleomorphic; older age; male predominance; â‰¥50% stage III or IV at presentation; intermediate prognosis Lymphocyte rich 5% Abundant normal-appearing lymphocytes; mediastinal LAN uncommon; male predominance; good prognosis Lymphocyte depleted &amp;lt;1% Diffuse fibrosis and large numbers of RS cells; older, male patients; disseminated at dx; seen in HIV; worst prognosis â€¢ Nonclassical HL (5%): nodular lymphocyte predominant (NLP); involves peripheral LN 80% present in stages Iâ€“II, Rx w/ RT vs.</description></item><item><title>Wide QRS Complex Tachycardia</title><link>https://www.physician.tw/Wide-QRS-Complex-Tachycardia/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wide-QRS-Complex-Tachycardia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Huppert&amp;rsquo;s Notes]]
Wide QRS Complex Tachycardia #ğŸš§ æ–½å·¥ä¸­ Wide QRS Complex Tachycardia Ventricular tachycardia (VT) â€¢Â Etiology: VT can be due to active ischemia, chronic ischemic heart disease (e.</description></item><item><title>åœ¨macé—œé–‰micrfosoft update</title><link>https://www.physician.tw/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</link><pubDate>Sun, 22 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%9C%A8mac%E9%97%9C%E9%96%89micrfosoft-update/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[command line know how]]
åœ¨macé—œé–‰micrfosoft update #ğŸš§ æ–½å·¥ä¸­ launchctl disable gui/$(id -u)/com.microsoft.update.agent</description></item><item><title>pericardiectomy</title><link>https://www.physician.tw/pericardiectomy/</link><pubDate>Sat, 21 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardiectomy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[pericardial disease]]
pericardiectomy #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>hugo</title><link>https://www.physician.tw/hugo/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hugo/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
hugo #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>R programing</title><link>https://www.physician.tw/R-programing/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/R-programing/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ç¨‹å¼èªè¨€]]
R programing #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>shell scripts</title><link>https://www.physician.tw/shell-scripts/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/shell-scripts/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ç¨‹å¼èªè¨€]]
shell scripts #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>ç¨‹å¼èªè¨€</title><link>https://www.physician.tw/%E7%A8%8B%E5%BC%8F%E8%AA%9E%E8%A8%80/</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E7%A8%8B%E5%BC%8F%E8%AA%9E%E8%A8%80/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[index]]
ç¨‹å¼èªè¨€ [[regex]] [[R programing]] [[shell scripts]] [[dcheckifalive]]</description></item><item><title>abdominopelvic emergencies</title><link>https://www.physician.tw/abdominopelvic-emergencies/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominopelvic-emergencies/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[nephrology]]
abdominopelvic emergencies #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>APS Type II</title><link>https://www.physician.tw/APS-Type-II/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/APS-Type-II/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Hashimotoâ€™s thyroiditis]]
APS Type II #ğŸš§ æ–½å·¥ä¸­ Polyglandular Autoimmune Syndrome Type II - StatPearls - NCBI Bookshelf</description></item><item><title>chronic kidney disease</title><link>https://www.physician.tw/chronic-kidney-disease/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-kidney-disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[nephrology]]
chronic kidney disease #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Cochrane 2009:CD001288</title><link>https://www.physician.tw/Cochrane-2009CD001288/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cochrane-2009CD001288/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Corticosteroids of COPDAE]]
Cochrane 2009:CD001288 #ğŸš§ æ–½å·¥ä¸­ Treatment of an exacerbation of COPD with oral or parenteral corticosteroids significantly reduces treatment failure and the need for additional medical treatment and shortens hospital stay.</description></item><item><title>evaluation of back and spinal cord disease</title><link>https://www.physician.tw/evaluation-of-back-and-spinal-cord-disease/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/evaluation-of-back-and-spinal-cord-disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[back pain]]
evaluation of back and spinal cord disease Figure:</description></item><item><title>general physical exam of back pain</title><link>https://www.physician.tw/general-physical-exam-of-back-pain/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-physical-exam-of-back-pain/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[back pain]]
general physical exam of back pain #ğŸš§ æ–½å·¥ä¸­ local tenderness ROM signs of infection or malignancy paraspinal tenderness or spasm in musculoskeletal strain</description></item><item><title>Haldane effect</title><link>https://www.physician.tw/Haldane-effect/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Haldane-effect/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Oxygenation of COPDAE]]
Haldane effect #ğŸš§ æ–½å·¥ä¸­ Haldane effect - å°å°æ•´ç†ç¶²ç«™ Smallcollation
O2+hemoglobin = CO2 release</description></item><item><title>Hashimotoâ€™s thyroiditis</title><link>https://www.physician.tw/Hashimotos-thyroiditis/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hashimotos-thyroiditis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[hypothyroidism]]
Hashimotoâ€™s thyroiditis Autoimmune destruction with diffuse lymphocytic infiltration Associated with other autoimmune disease and may be part of [[APS Type II]] âŠ• antithyroid peroxidase (anti-TPO) and antithyroglobulin (anti-Tg) Abs in &amp;gt;90%</description></item><item><title>hematopoiesis</title><link>https://www.physician.tw/hematopoiesis/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematopoiesis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Transcellular shifts]]
hematopoiesis #ğŸš§ æ–½å·¥ä¸­ Figure:</description></item><item><title>Prednisone</title><link>https://www.physician.tw/Prednisone/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prednisone/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Corticosteroids of COPDAE]]
Prednisone #ğŸš§ æ–½å·¥ä¸­ The main difference between prednisone and prednisolone is that prednisone must be converted by liver enzymes to prednisolone before it can work.</description></item><item><title>Quartz</title><link>https://www.physician.tw/Quartz/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Quartz/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
Quartz #ğŸš§ æ–½å·¥ä¸­ ğŸª´ Quartz 3.</description></item><item><title>signs of radiculopathy</title><link>https://www.physician.tw/signs-of-radiculopathy/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/signs-of-radiculopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[back pain]]
signs of radiculopathy #ğŸš§ æ–½å·¥ä¸­ [[spurling sign]]
[[straight leg raise]]</description></item><item><title>treatment of CRAB</title><link>https://www.physician.tw/treatment-of-CRAB/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-CRAB/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[CRAB]]
treatment of CRAB #ğŸš§ æ–½å·¥ä¸­ Ampicillin-sulbactam 9gIV q8h over 4 hours OR 27 gIV q24h as a continuous infusion</description></item><item><title>ä»€éº¼æ˜¯æ•¸ä½èŠ±åœ’</title><link>https://www.physician.tw/%E4%BB%80%E9%BA%BC%E6%98%AF%E6%95%B8%E4%BD%8D%E8%8A%B1%E5%9C%92/</link><pubDate>Thu, 19 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E4%BB%80%E9%BA%BC%E6%98%AF%E6%95%B8%E4%BD%8D%E8%8A%B1%E5%9C%92/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
ä»€éº¼æ˜¯æ•¸ä½èŠ±åœ’ æˆ‘å€‘ç”Ÿæ´»åœ¨ä¸€å€‹è³‡è¨Šæ™‚ä»£ã€‚æˆ‘å€‘ç”¢ç”Ÿçš„æ•¸æ“šé‡é é è¶…éæˆ‘å€‘æ¶ˆè€—çš„æ•¸æ“šé‡ï¼Œä»¥è‡³æ–¼å®ƒé é è¶…å‡ºäº†æˆ‘å€‘æœ‰æ„ç¾©åœ°åˆ©ç”¨å®ƒçš„èƒ½åŠ›ã€‚
é€™ä¸æ˜¯å› ç‚ºæˆ‘ä¸å–œæ­¡ç§©åºï¼Œè€Œæ˜¯å› ç‚ºæˆ‘èªç‚ºä¸€é»æ··äº‚å’Œç†µå°æ–°æƒ³æ³•æœ‰å¥½è™•ã€‚å®ƒå€‘æœ‰åŠ©æ–¼é€£æ¥å…©å€‹ä½ é€šå¸¸ä¸æœƒç›¸äº’é—œè¯çš„ç¨ç«‹æƒ³æ³•ï¼Œä¸¦æ›´é »ç¹åœ°æƒ³åƒâ€œå‡è¨­â€ã€‚
ä»€éº¼æ˜¯æ•¸ä½åœ’è—ï¼Ÿ çŸ¥è­˜èŠ±åœ’ä¸æ˜¯æª”æ¡ˆæ«ƒï¼Œä¹Ÿä¸æ˜¯å®Œå…¨çš„ç´¢å¼•ã€‚äº‹å¯¦ä¸Šï¼Œæ•¸å­—èŠ±åœ’èˆ‡å…¶èªªæ˜¯ä¸€å¡Šæ•´æ½”çš„è¾²åœ°ï¼Œä¸å¦‚èªªæ˜¯ä¸€åœ˜ç³¾çºçš„ç”Ÿé•·è’é‡ã€‚å®ƒæ˜¯ä¸€å€‹ç›¸äº’è¯ç¹«çš„æƒ³æ³•å’Œæ€æƒ³çš„ç¶²è·¯ï¼Œç”±å®ƒå€‘å¦‚ä½•ç›¸äº’é—œè¯è€Œèšé›†åœ¨ä¸€èµ·ã€‚
é€™ä¸æ˜¯å› ç‚ºæˆ‘ä¸å–œæ­¡ç§©åºï¼Œè€Œæ˜¯å› ç‚ºæˆ‘èªç‚ºä¸€é»æ··äº‚å’Œç†µå°æ–°æƒ³æ³•æœ‰å¥½è™•ã€‚å®ƒå€‘æœ‰åŠ©æ–¼é€£æ¥å…©å€‹ä½ é€šå¸¸ä¸æœƒç›¸äº’é—œè¯çš„ç¨ç«‹æƒ³æ³•ï¼Œä¸¦æ›´é »ç¹åœ°æƒ³åƒâ€œå‡è¨­â€ã€‚
æˆ‘å°æ•¸ä½èŠ±åœ’çš„ç›®æ¨™ä¸åƒ…åƒ…æ˜¯ä½œç‚ºä¸€å€‹çµ„ç¹”ç³»çµ±å’Œè³‡è¨Šå­˜å„²ï¼Œèªç‚ºå®ƒå°æ­¤æ•ˆæœå¾ˆå¥½ã€‚æˆ‘å¸Œæœ›æˆ‘çš„æ•¸ä½èŠ±åœ’æˆç‚ºå‰µæ„é€£æ¥çš„æ–°æ–¹å¼çš„éŠæ¨‚å ´ã€‚å› æ­¤ï¼Œç¾æœ‰çš„æ­£å¼çµ„ç¹”ç³»çµ±ï¼ˆå¦‚Zettelkastenï¼‰æˆ–Conceptçš„åˆ†å±¤è³‡æ–™å¤¾çµæ§‹å°æˆ‘ä¾†èªªæ•ˆæœä¸ä½³ã€‚æœ‰å¤ªå¤šçš„å‰æœŸæ‘©æ“¦ï¼Œç•¶æˆ‘è€ƒæ…®å¦‚ä½•å°‡æˆ‘çš„æƒ³æ³•çµ„ç¹”æˆé¡åˆ¥æ™‚ï¼Œæˆ‘å·²ç¶“å¤±å»äº†å®ƒã€‚
è¨±å¤šäººè©¦åœ–é€šéè¨˜ç­†è¨˜ä¾†çµ„ç¹”è‡ªå·±çš„ç”Ÿæ´»ã€‚æœ‰ä¸€ç¨®ç¶“å…¸çš„â€œè‡ªä¸Šè€Œä¸‹â€èˆ‡â€œè‡ªä¸‹è€Œä¸Šâ€çš„è¨­è¨ˆå¼µåŠ›æŠ•å°„åˆ°äººå€‘å¦‚ä½•åšç­†è¨˜ä¸Šã€‚æœ‰äº›äººç›¸ä¿¡ä»–å€‘é æ¸¬æœªä¾†çš„èƒ½åŠ›ï¼Œä»–å€‘æƒ³è¦è‡ªä¸Šè€Œä¸‹ï¼Œä»–å€‘æƒ³åœ¨èŠ±åœ’è£¡é‹ªå¹³é“è·¯ã€‚å…¶ä»–äººï¼ˆé€šå¸¸æ˜¯é‚£äº›å˜—è©¦éä½†å¤±æ•—çš„äººï¼‰ä¸ç›¸ä¿¡è‡ªå·±é æ¸¬æœªä¾†çš„èƒ½åŠ›ï¼Œä»–å€‘æƒ³è®“å¥¶ç‰›èƒ½å¤ å®‰å…¨åœ°æ¼«éŠï¼Œç„¶å¾Œé‹ªå¹³é“è·¯ã€‚æ…¾æœ›è·¯å¾‘åœ¨å®ƒå€‘å½¢æˆä¹‹å¾Œã€‚
é€™å°±æ˜¯æª”æ¡ˆæ«ƒçš„å•é¡Œï¼šå®ƒå´é‡æ–¼è¨ªå•æ•ˆç‡å’Œäº’æ“ä½œæ€§è€Œä¸æ˜¯ç”Ÿæˆæ€§å’Œå‰µé€ åŠ›ã€‚æ€ç¶­ä¸æ˜¯ç·šæ€§çš„ï¼Œä¹Ÿä¸æ˜¯ç·šæ€§çš„å±¤æ¬¡.äº‹å¯¦ä¸Šï¼Œæ²’æœ‰å¤šå°‘äº‹æƒ…æ˜¯ç·šæ€§çš„æˆ–åˆ†å±¤çš„ã€‚é‚£éº¼ï¼Œç‚ºä»€éº¼å¤§å¤šæ•¸å·¥å…·å’Œæ€ç¶­ç­–ç•¥éƒ½ç‚ºæˆ‘çš„æ€ç¶­éç¨‹å‡è¨­ä¸€å€‹å¾ˆå¥½çš„æ™‚é–“é †åºæˆ–å±¤æ¬¡çµæ§‹ï¼Ÿå°æˆ‘ä¾†èªªï¼Œç†æƒ³çš„æ€è€ƒå·¥å…·æ˜¯æ“æŠ±æˆ‘é ­è…¦çš„æ··äº‚ï¼Œä¸¦æœ‰æ©Ÿåœ°èª¬æ˜æ´å¯ŸåŠ›å¾æ··äº‚ä¸­å‡ºç¾ï¼Œè€Œä¸æ˜¯å¼·è¿«äººç‚ºçš„ç§©åºã€‚
æˆ‘å¦‚ä½•åœ’è— æ•¸å­—èŠ±åœ’çš„é‡é»ä¸æ˜¯æˆç‚ºæ˜ç¢ºçš„çœŸç†ä¾†æºï¼Œè€Œæ˜¯éš¨è‘—æ‚¨è‡ªå·±çš„çŸ¥è­˜çš„å¢é•·å’Œè®ŠåŒ–è€Œä¸æ–·ç™¼å±•çš„ä¾†æºã€‚
æˆ‘çš„éƒ¨è½æ ¼è®“æˆ‘å®³æ€•ç™¼æ–‡ã€‚æˆ‘å®³æ€•æŠŠäº‹æƒ…å…¬ä¹‹æ–¼çœ¾ï¼Œå› ç‚ºæˆ‘æ“”å¿ƒäººå€‘åœ¨ç¾åœ¨å’Œå°‡ä¾†éƒ½èƒ½ä»¥ä¸åŒçš„æ–¹å¼çœ‹å¾…å®ƒã€‚å¦‚æœæˆ‘ç™¼ä½ˆäº†äººå€‘èªç‚ºæ„šè ¢çš„æ±è¥¿æ€éº¼è¾¦ï¼Ÿæˆ–è€…æ›´ç³Ÿç³•çš„æ˜¯ï¼Œå°‡ä¾†æœ‰äººæœƒçœ‹åˆ°æˆ‘ç›®å‰çš„å·¥ä½œï¼Œä¸¦å› ç‚ºæˆ‘çš„æƒ³æ³•æ˜¯å¤šéº¼å¹¼ç¨šè€Œç§ä¸èµ·æˆ‘ã€‚æˆ‘å®³æ€•æ•¸ä½æŒä¹…æ€§.
ä½†è€å¯¦èªªï¼Œæˆ‘å¯«å¾—è¶Šå¤šï¼Œåªæ˜¯æŠŠæ±è¥¿æ”¾åœ¨é‚£è£¡ï¼Œé€™ç¨®æ€è·¯å°±è¶Šæ²’æœ‰æ„ç¾©ã€‚
ç¸½çš„ä¾†èªªï¼Œæˆ‘ä»ç„¶ç‚ºè‡ªå·±å¯«ä½œã€‚å¯«ä½œï¼Œå°æˆ‘ä¾†èªªï¼Œæ˜¯ä¸€ç¨®å½¢å¼çŸ¥è­˜è’¸é¤¾ï¼Œå®ƒæœ‰åŠ©æ–¼æ¾„æ¸…æˆ‘çš„æƒ³æ³•ä¸¦æ¿ƒç¸®æˆ‘çš„çŸ¥è­˜ï¼Œä»¥ä¾¿æˆ‘å¯ä»¥è¼•é¬†åœ°å‘ä»–äººè¡¨é”ã€‚å¦‚æœåšå¾—å¥½ï¼Œæˆ‘æœ‰ä¸€å€‹å¯åˆ†äº«çš„è¡¨é”æˆ‘çš„æƒ³æ³•ï¼Œæˆ‘å¯ä»¥æŠŠå®ƒç™¼é€åˆ°ä¸–ç•Œä¸Šï¼Œäººå€‘å¯ä»¥å›æ‡‰ã€‚å³ä½¿æ˜¯æˆ‘æœ€åŠç”Ÿä¸ç†Ÿçš„æƒ³æ³•ï¼Œé€™ä¹Ÿæœ‰åŠ©æ–¼æˆ‘å‰µå»ºä¸€å€‹åé¥‹é€±æœŸä¾†åŠ å¼·å’Œå……åˆ†å……å¯¦é€™å€‹æƒ³æ³•ã€‚</description></item><item><title>abdominal swelling</title><link>https://www.physician.tw/abdominal-swelling/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abdominal-swelling/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Gastrointestinal Function]]
abdominal swelling [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>acute kidney injury</title><link>https://www.physician.tw/acute-kidney-injury/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-kidney-injury/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
acute kidney injury #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>acute respiratory tract infection</title><link>https://www.physician.tw/acute-respiratory-tract-infection/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-tract-infection/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
acute respiratory tract infection #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>acute septic arthritis</title><link>https://www.physician.tw/acute-septic-arthritis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-septic-arthritis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
acute septic arthritis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>aids hiv infection</title><link>https://www.physician.tw/aids-hiv-infection/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aids-hiv-infection/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
aids hiv infection [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>allergic rhinitis conjunctivitis sinusitis</title><link>https://www.physician.tw/allergic-rhinitis-conjunctivitis-sinusitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergic-rhinitis-conjunctivitis-sinusitis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
allergic rhinitis conjunctivitis sinusitis #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>allergy and immunology</title><link>https://www.physician.tw/allergy-and-immunology/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergy-and-immunology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[resident360]]
allergy and immunology #ğŸš§ æ–½å·¥ä¸­ The following topics are addressed in this rotation guide: [[allergic rhinitis conjunctivitis sinusitis]]</description></item><item><title>ambulatory care</title><link>https://www.physician.tw/ambulatory-care/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ambulatory-care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[resident360]]
ambulatory care #ğŸš§ æ–½å·¥ä¸­ The following topics are addressed in this rotation guide: [[acute respiratory tract infection]]</description></item><item><title>aphasia, memory loss, and other cognitive disorders</title><link>https://www.physician.tw/aphasia-memory-loss-and-other-cognitive-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aphasia-memory-loss-and-other-cognitive-disorders/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
aphasia, memory loss, and other cognitive disorders [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>approach to the patient with a heart murmur</title><link>https://www.physician.tw/approach-to-the-patient-with-a-heart-murmur/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-the-patient-with-a-heart-murmur/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Circulatory and Respiratory Functions]]
approach to the patient with a heart murmur [!</description></item><item><title>asphyxiation</title><link>https://www.physician.tw/asphyxiation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asphyxiation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Treatment-hemoptysis]]
asphyxiation #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>atopic dermatitis</title><link>https://www.physician.tw/atopic-dermatitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atopic-dermatitis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[allergy and immunology]]
atopic dermatitis #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>autoimmune myocarditis</title><link>https://www.physician.tw/autoimmune-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-myocarditis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[MYOCARDITIS]]
autoimmune myocarditis Idiopathic [[giant cell myocarditis]] (GCM): avg age 42, fulminant, AVB/VT (Circ HF 2013;6:15) Eosinophilic (variable peripheral eos): hypersensitivity (mild HF but at risk for SCD) or acute necrotizing eosinophilic myocarditis (ANEM; STE, effusion, severe HF) Collagen vasc.</description></item><item><title>azotemia</title><link>https://www.physician.tw/azotemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/azotemia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Renal and Urinary Tract Function]]
azotemia [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>bladder pain syndrome</title><link>https://www.physician.tw/bladder-pain-syndrome/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bladder-pain-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Renal and Urinary Tract Function]]
bladder pain syndrome [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>bleeding disorders</title><link>https://www.physician.tw/bleeding-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bleeding-disorders/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
bleeding disorders #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>cancer screening</title><link>https://www.physician.tw/cancer-screening/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-screening/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
cancer screening #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Chagas</title><link>https://www.physician.tw/Chagas/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chagas/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[infectious myocarditis]]
Chagas [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>chronic pain and opioids</title><link>https://www.physician.tw/chronic-pain-and-opioids/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-pain-and-opioids/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
chronic pain and opioids #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>coma</title><link>https://www.physician.tw/coma/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coma/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
coma [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>contraindications to enteral nutrition</title><link>https://www.physician.tw/contraindications-to-enteral-nutrition/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/contraindications-to-enteral-nutrition/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
contraindications to enteral nutrition #ğŸš§ æ–½å·¥ä¸­ severe hemodynamic instability</description></item><item><title>critical care</title><link>https://www.physician.tw/critical-care/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[resident360]]
critical care #ğŸš§ æ–½å·¥ä¸­ Resident 360 [[sepsis and shock]] [[respiratory failure]] [[mechanical ventilation]] [[acute respiratory distress syndrome]] [[Resuscitation Fluids and Transfusion]] [[acid-base disturbances]] [[sedation]] and [[delirium]] [[Nutrition in the ICU]] [[Hyperglycemic Emergencies]] (Endocrinology) [[disseminated intravascular coagulation]] (Hematology) [[neurologic outcomes after cardiac arrest]] (Neurology) [[cardiac arrest]] [[syncope]] [[overdose and toxidromes]] (Emergency Medicine) MOUNT SINAI EXPERT GUIDES Critical Care part 1: [[basic techniques and procedures]]</description></item><item><title>crystal-induced arthritis</title><link>https://www.physician.tw/crystal-induced-arthritis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crystal-induced-arthritis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
crystal-induced arthritis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>definition of restrictive and infiltrative cardiomyopathy</title><link>https://www.physician.tw/definition-of-restrictive-and-infiltrative-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-of-restrictive-and-infiltrative-cardiomyopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[restrictive and infiltrative cardiomyopathy]]
definition of restrictive and infiltrative cardiomyopathy Restrictive CMP: â†“ ventricular filling with â†“ compliance in nonhypertrophied, nondilated ventricles; nl/â†“ diastolic volumes, nl or near-nl EF; must r/o pericardial disease</description></item><item><title>delirium</title><link>https://www.physician.tw/delirium/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delirium/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[critical care]]
delirium #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>dementia</title><link>https://www.physician.tw/dementia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dementia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
dementia [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>diagnostic studies and workup of dilated cardiomyopathy</title><link>https://www.physician.tw/diagnostic-studies-and-workup-of-dilated-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-and-workup-of-dilated-cardiomyopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[dilated cardiomyopathy]]
diagnostic studies and workup of dilated cardiomyopathy (JACC 2016;67:2996)
ECG of dilated cardiomyopathy may see PRWP, Q waves, or BBB; low-voltage; AF (20%); may be normal</description></item><item><title>diarrhea and constipation</title><link>https://www.physician.tw/diarrhea-and-constipation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diarrhea-and-constipation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Gastrointestinal Function]]
diarrhea and constipation [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>disorders of hearing</title><link>https://www.physician.tw/disorders-of-hearing/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-hearing/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of hearing [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>disorders of smell and taste</title><link>https://www.physician.tw/disorders-of-smell-and-taste/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-smell-and-taste/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of smell and taste [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>disorders of the eye</title><link>https://www.physician.tw/disorders-of-the-eye/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-eye/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
disorders of the eye [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>dizziness</title><link>https://www.physician.tw/dizziness/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dizziness/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
dizziness #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>dizziness and vertigo</title><link>https://www.physician.tw/dizziness-and-vertigo/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dizziness-and-vertigo/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
dizziness and vertigo [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>drug allergy</title><link>https://www.physician.tw/drug-allergy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drug-allergy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
drug allergy #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>dysuria</title><link>https://www.physician.tw/dysuria/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysuria/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
dysuria #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>earache</title><link>https://www.physician.tw/earache/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/earache/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
earache [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>edema</title><link>https://www.physician.tw/edema/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/edema/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Circulatory and Respiratory Functions]]
edema [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>eosinophilia and mast-cell disorders</title><link>https://www.physician.tw/eosinophilia-and-mast-cell-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/eosinophilia-and-mast-cell-disorders/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[allergy and immunology]]
eosinophilia and mast-cell disorders #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>etiologies of dilated cardiomyopathy</title><link>https://www.physician.tw/etiologies-of-dilated-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/etiologies-of-dilated-cardiomyopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[dilated cardiomyopathy]]
etiologies of dilated cardiomyopathy (JACC 2021;77:2551; can also be prior myocarditis, vide infra)</description></item><item><title>fever</title><link>https://www.physician.tw/fever/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Body Temperature]]
fever [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>fibromyalgia</title><link>https://www.physician.tw/fibromyalgia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fibromyalgia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
fibromyalgia [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>fluid and electrolyte disturbances</title><link>https://www.physician.tw/fluid-and-electrolyte-disturbances/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fluid-and-electrolyte-disturbances/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Renal and Urinary Tract Function]]
fluid and electrolyte disturbances [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>food allergy</title><link>https://www.physician.tw/food-allergy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/food-allergy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
food allergy #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>gait disorders, imbalance, and falls</title><link>https://www.physician.tw/gait-disorders-imbalance-and-falls/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gait-disorders-imbalance-and-falls/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
gait disorders, imbalance, and falls [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>giant cell myocarditis</title><link>https://www.physician.tw/giant-cell-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/giant-cell-myocarditis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[MYOCARDITIS]]
giant cell myocarditis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>glycemic management in the ICU setting</title><link>https://www.physician.tw/glycemic-management-in-the-ICU-setting/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glycemic-management-in-the-ICU-setting/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
glycemic management in the ICU setting #ğŸš§ æ–½å·¥ä¸­ [[Management of hyperglycemia in inPts]]</description></item><item><title>hypercholesterolemia</title><link>https://www.physician.tw/hypercholesterolemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercholesterolemia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
hypercholesterolemia #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>hypomagnesemia</title><link>https://www.physician.tw/hypomagnesemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypomagnesemia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[refeeding syndrome]]
hypomagnesemia #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>hypophosphatemia</title><link>https://www.physician.tw/hypophosphatemia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypophosphatemia/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[refeeding syndrome]]
hypophosphatemia #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>immune-mediated thrombocytopenia</title><link>https://www.physician.tw/immune-mediated-thrombocytopenia/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-mediated-thrombocytopenia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Etiologies-of thrombocytopenia]]
immune-mediated thrombocytopenia #ğŸš§ æ–½å·¥ä¸­ [[Primary immune thrombocytopenic purpura (ITP) ]]
2Â°: infxn (HIV, HCV, HSV), collagen vascular dis.</description></item><item><title>immunodeficiency</title><link>https://www.physician.tw/immunodeficiency/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immunodeficiency/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[allergy and immunology]]
immunodeficiency #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>infectious myocarditis</title><link>https://www.physician.tw/infectious-myocarditis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-myocarditis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[MYOCARDITIS]]
infectious myocarditis (Lancet 2012;379:738; JACC 2012;59:779)
Viruses (parvoB19, Coxsackie, adeno, HIV, SARS-CoV-2/vaccine, etc.) Bacterial, fungal, rickettsial, TB, Lyme (mild myocarditis, often with AVB) [[Chagas]]: apical aneurysm Â± thrombus, RBBB, megaesophagus/colon (Lancet 2018;391:82)</description></item><item><title>interstitial cystitis</title><link>https://www.physician.tw/interstitial-cystitis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interstitial-cystitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Renal and Urinary Tract Function]]
interstitial cystitis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>jaundice</title><link>https://www.physician.tw/jaundice/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Gastrointestinal Function]]
jaundice [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>jaundice and abnormal liver enzymes</title><link>https://www.physician.tw/jaundice-and-abnormal-liver-enzymes/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jaundice-and-abnormal-liver-enzymes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
jaundice and abnormal liver enzymes #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>Kimmelstiel-Wilson</title><link>https://www.physician.tw/Kimmelstiel-Wilson/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kimmelstiel-Wilson/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Systemic diseases with secondary glomerular involvement]]
Kimmelstiel-Wilson [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>leukotrienes</title><link>https://www.physician.tw/leukotrienes/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leukotrienes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Clinical manifestations]]
leukotrienes #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>medical</title><link>https://www.physician.tw/medical/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medical/</guid><description>æ­¡è¿ä¾†åˆ°ğŸ¦çš„Medical Wiki [[cardiology]] ğŸ«€ [[pulmonology]] ğŸ« [[gastroenterology]] ğŸ’© [[nephrology]] ğŸš½ [[hematology]] ğŸ©¸ [[oncology]] ğŸ› [[infectious disease]] ğŸ¦  [[endocrinology]] ğŸ¼ [[rheumatology]] ğŸ¤¡ å…§ç§‘çš„å…¶ä»–çŸ¥è­˜ ğŸ¤” [[clinical reasoning]] ğŸ’¡ [[Practical Skills for Learners]] [[critical care]] ğŸ˜­ [[neurology]] ğŸ§  [[ambulatory]] ğŸš¶ [[ACLS]] ğŸ˜µ [[emergency medicine]] [[POCUS]] [[geriatrics]] [[pain and palliative care]] [[resident360]] å…¶ä»–æ¬¡å°ˆç§‘ [[dermatology]] [[ophthalmic]] [[woman health]] [[obs gyn issues]] [[radiology]] [[mental health]] [[surgical issues]] [[psychiatric]] EBM [[clinical trials]] [[statistical concepts and test characteristics]] Draft paper note: [[journals/index.</description></item><item><title>myelofibrosis</title><link>https://www.physician.tw/myelofibrosis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelofibrosis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Etiologies-of thrombocytopenia]]
myelofibrosis #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>nausea, vomiting, and indigestion</title><link>https://www.physician.tw/nausea-vomiting-and-indigestion/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nausea-vomiting-and-indigestion/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Gastrointestinal Function]]
nausea, vomiting, and indigestion [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>neurologic causes of weakness and paralysis</title><link>https://www.physician.tw/neurologic-causes-of-weakness-and-paralysis/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-causes-of-weakness-and-paralysis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
neurologic causes of weakness and paralysis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>NICE-SUGAR trial</title><link>https://www.physician.tw/NICE-SUGAR-trial/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NICE-SUGAR-trial/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[glycemic management in the ICU setting]]
NICE-SUGAR trial March 26, 2009 N Engl J Med 2009; 360:1283-1297 DOI: 10.</description></item><item><title>numbness, tingling, and sensory loss</title><link>https://www.physician.tw/numbness-tingling-and-sensory-loss/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/numbness-tingling-and-sensory-loss/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
numbness, tingling, and sensory loss [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Nutrition in the ICU</title><link>https://www.physician.tw/Nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nutrition-in-the-ICU/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[critical care]]
Nutrition in the ICU #ğŸš§ æ–½å·¥ä¸­ Patients in the intensive care unit (ICU) are at increased risk of malnutrition, and few can feed themselves.</description></item><item><title>obstructive sleep apnea</title><link>https://www.physician.tw/obstructive-sleep-apnea/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obstructive-sleep-apnea/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[etiologies of dilated cardiomyopathy]]
obstructive sleep apnea [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>oral manifestations of disease</title><link>https://www.physician.tw/oral-manifestations-of-disease/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oral-manifestations-of-disease/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
oral manifestations of disease [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>other supraventricular rhythms</title><link>https://www.physician.tw/other-supraventricular-rhythms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-supraventricular-rhythms/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
other supraventricular rhythms [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>palpitations</title><link>https://www.physician.tw/palpitations/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/palpitations/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Circulatory and Respiratory Functions]]
palpitations [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>PLASMIC score to discriminate TTP from other TMAs</title><link>https://www.physician.tw/PLASMIC-score-to-discriminate-TTP-from-other-TMAs/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PLASMIC-score-to-discriminate-TTP-from-other-TMAs/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[thrombotic thrombocytopenic purpura]]
PLASMIC score to discriminate TTP from other TMAs #ğŸš§ æ–½å·¥ä¸­ Predicts ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura (TTP) with high discrimination.</description></item><item><title>rate of nutrition in the ICU</title><link>https://www.physician.tw/rate-of-nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rate-of-nutrition-in-the-ICU/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
rate of nutrition in the ICU The recommendation in critically ill patients is to initiate feeding at 20%âˆ’30% of metabolic need during the first week in the ICU.</description></item><item><title>refeeding syndrome</title><link>https://www.physician.tw/refeeding-syndrome/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/refeeding-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
refeeding syndrome #ğŸš§ æ–½å·¥ä¸­ When starting artificial nutrition, it is important to monitor for refeeding syndrome</description></item><item><title>resident360</title><link>https://www.physician.tw/resident360/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/resident360/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[medical]]
resident360 [[allergy and immunology]] [[ambulatory care]] [[emergency medicine]] [[gastroenterology]] [[geriatrics]] [[hematology]] [[infectious disease]] [[mental health]] [[nephrology]] [[neurology]] [[oncology]] [[palliative care]] [[pulmonology]] [[rheumatology]] [[womenâ€™s health]]</description></item><item><title>restrictive and infiltrative cardiomyopathy</title><link>https://www.physician.tw/restrictive-and-infiltrative-cardiomyopathy/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/restrictive-and-infiltrative-cardiomyopathy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[cardiomyopathies]]
restrictive and infiltrative cardiomyopathy [[definition of restrictive and infiltrative cardiomyopathy]] (JACC 2018;71:1130 &amp;amp; 1149) Etiologies (JACC 2018;71:1130 &amp;amp; 1149) [[amyloidosis]]: age at presentation ~60 y; â™‚:â™€ = 3:2 AL (eg, MM, etc.</description></item><item><title>sedation</title><link>https://www.physician.tw/sedation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sedation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[critical care]]
sedation #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>sinus symptoms</title><link>https://www.physician.tw/sinus-symptoms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sinus-symptoms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
sinus symptoms [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>sleep disorders</title><link>https://www.physician.tw/sleep-disorders/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sleep-disorders/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Nervous System Dysfunction]]
sleep disorders [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>smoking cessation</title><link>https://www.physician.tw/smoking-cessation/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/smoking-cessation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
smoking cessation #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>sore throat</title><link>https://www.physician.tw/sore-throat/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sore-throat/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
sore throat [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>stress ulcers of nutrition in the ICU</title><link>https://www.physician.tw/stress-ulcers-of-nutrition-in-the-ICU/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stress-ulcers-of-nutrition-in-the-ICU/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
stress ulcers of nutrition in the ICU #ğŸš§ æ–½å·¥ä¸­ Patients in the ICU are at increased risk for stress ulcers.</description></item><item><title>Takotsubo</title><link>https://www.physician.tw/Takotsubo/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Takotsubo/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[etiologies of dilated cardiomyopathy]]
Takotsubo [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
Backlinkï¼š [[Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture ]] [[EKG pocket brain]] [[etiologies of dilated cardiomyopathy]] [[Etiologies of Prolonged-QT-interval]] [[PocketBrain]] [[ST-elevation]] [[T-wave-inversion]] [[Troponin]]</description></item><item><title>timing of nutrition</title><link>https://www.physician.tw/timing-of-nutrition/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timing-of-nutrition/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Nutrition in the ICU]]
timing of nutrition #ğŸš§ æ–½å·¥ä¸­ Timing of nutritional support is an important factor in ICU patients.</description></item><item><title>upper respiratory symptoms</title><link>https://www.physician.tw/upper-respiratory-symptoms/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/upper-respiratory-symptoms/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Disorders of Eyes, Ears, Nose, and Throat]]
upper respiratory symptoms [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>urticaria and angioedema</title><link>https://www.physician.tw/urticaria-and-angioedema/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urticaria-and-angioedema/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[allergy and immunology]]
urticaria and angioedema #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>vaccination</title><link>https://www.physician.tw/vaccination/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vaccination/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory care]]
vaccination #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>vitamin deficiencies</title><link>https://www.physician.tw/vitamin-deficiencies/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vitamin-deficiencies/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[refeeding syndrome]]
vitamin deficiencies #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>weight loss</title><link>https://www.physician.tw/weight-loss/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/weight-loss/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Alterations in Gastrointestinal Function]]
weight loss [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Why is this NOT Wandering Pacer</title><link>https://www.physician.tw/Why-is-this-NOT-Wandering-Pacer/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Why-is-this-NOT-Wandering-Pacer/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
Why is this NOT Wandering Pacer [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>womenâ€™s health</title><link>https://www.physician.tw/womens-health/</link><pubDate>Wed, 18 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/womens-health/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[resident360]]
womenâ€™s health #ğŸš§ æ–½å·¥ä¸­</description></item><item><title>assessment of hospitalized cancer patients</title><link>https://www.physician.tw/assessment-of-hospitalized-cancer-patients/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/assessment-of-hospitalized-cancer-patients/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[inpatient oncology]]
assessment of hospitalized cancer patients [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>ATS Reading List</title><link>https://www.physician.tw/ATS-Reading-List/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ATS-Reading-List/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[pulmonary reading list]]
ATS Reading List [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
ARDS Asthma Bronchiectasis (Non-Cystic Fibrosis) Cardiology Critical Care Chest Imaging COPD Cough COVID-19 Cystic Fibrosis Drug-Induced Lung Disease ECMO Endocrine Critical Care Gastroenterology Critical Care Hematology Critical Care ICU Administration Immunocompromised Host Infection Control Interstitial Lung Disease Lung Cancer/Solitary Pulmonary Nodule Lung Transplantation Mycobacterial Diseases Nephrology Critical Care Neurology Critical Care Nutrition in Critical Illness Obstetrics and Critical Care Occupational and Environmental Medicine Palliative/End of Life Care in the ICU Pleural Disease Pneumonia Procedures Pulmonary Embolism Pulmonary Function Testing Pulmonary Hypertension Pulmonary Rehabilitation Sedation / AnalgesiaÂ / Delirium Sepsis / Septic Shock Sleep Medicine Smoking Cessation Ultrasound in the ICU Ventilation and Weaning 2018 Update:Caraganis AJ, Kempainen RR, University of Minnesota2019 Update:Caraganis AJ, Kempainen RR, University of Minnesota2020 Update:Wong JL, Kempainen RR, University of Minnesota2021 Update:Lambert CS, Kempainen RR, University of Minnesota2022 Update:Schwegman A, Kempainen RR, University of Minnesota [[inbox]]</description></item><item><title>autoinflammatory syndromes</title><link>https://www.physician.tw/autoinflammatory-syndromes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoinflammatory-syndromes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
autoinflammatory syndromes [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults</title><link>https://www.physician.tw/Balanced-Multielectrolyte-Solution-versus-Saline-in-Critically-Ill-Adults/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Balanced-Multielectrolyte-Solution-versus-Saline-in-Critically-Ill-Adults/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Fluids-sepsis and shock]]
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults March 3, 2022 N Engl J Med 2022; 386:815-826 DOI: 10.</description></item><item><title>Bartonella</title><link>https://www.physician.tw/Bartonella/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bartonella/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[diagnosis of culture-negative endocarditis]]
Bartonella B. henselae, B. quintana
cats (B. henselae), homelessness (B. quintana), body lice (B.</description></item><item><title>basal cell skin cancer</title><link>https://www.physician.tw/basal-cell-skin-cancer/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basal-cell-skin-cancer/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[NCCN guideline]]
basal cell skin cancer [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Bazett formula</title><link>https://www.physician.tw/Bazett-formula/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bazett-formula/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Prolonged-QT-interval]]
Bazett formula Which QT Correction Formulae to Use for QT Monitoring? | Journal of the American Heart Association Fridericia and Framingham correction formulae showed the best rate correction and significantly improved prediction of 30â€day and 1â€year mortality.</description></item><item><title>bedside percutaneous dilational tracheostomy</title><link>https://www.physician.tw/bedside-percutaneous-dilational-tracheostomy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bedside-percutaneous-dilational-tracheostomy/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[basic techniques and procedures]]
bedside percutaneous dilational tracheostomy [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Berlin definition</title><link>https://www.physician.tw/Berlin-definition/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Berlin-definition/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Berlin definition (JAMA 2012;307:2526)
Acute onset within 1 week of clinical insult or worsening respiratory status Bilateral infiltrates without alternative explanation (eg, effusion, atelectasis, nodules) Edema not fully explained by fluid overload or congestive heart failure Hypoxemia: PaO2/FiO2 determined with 5 cm H2O of PEEP PaO2/FiO2 200â€“300 = mild ARDS (may be on NPPV), 100â€“200 = mod, &amp;lt;100 = severe</description></item><item><title>bladder cancer</title><link>https://www.physician.tw/bladder-cancer/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bladder-cancer/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[NCCN guideline]]
bladder cancer [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Blood Products and Indications</title><link>https://www.physician.tw/Blood-Products-and-Indications/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Products-and-Indications/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[transfusion therapy]]
Blood Products and Indications (Lancet 2013;381:1845)
[[Packed red blood cells]] (PRBCs) [[Platelets-transfusion]] (plts) (Annals Int Med 2015;162:205) [[Fresh frozen plasma]] (FFP) [[Cryoprecipitate]] [[Irradiated blood products]] [[CMV-negative]] [[Leuko-reduced blood products]] [[IV immune globulin]] (IVIg) [[Therapeutic apheresis]] [[Massive transfusion]]</description></item><item><title>blood products and transfusions</title><link>https://www.physician.tw/blood-products-and-transfusions/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blood-products-and-transfusions/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[hematology and oncology in critical care]]
blood products and transfusions [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>bronchodilator</title><link>https://www.physician.tw/bronchodilator/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchodilator/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Diagnostic studies]]
bronchodilator [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>bronchoscopy</title><link>https://www.physician.tw/bronchoscopy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchoscopy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[basic techniques and procedures]]
bronchoscopy [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Brucella</title><link>https://www.physician.tw/Brucella/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Brucella/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[diagnosis of culture-negative endocarditis]]
Brucella Consumption of unpasteurized dairy products, exposure to tissue or fluids from infected animals (cattle, goats, sheep, or dogs)</description></item><item><title>calcium pyrophosphate dihydrate - cppd - deposition disease</title><link>https://www.physician.tw/calcium-pyrophosphate-dihydrate-cppd-deposition-disease/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-pyrophosphate-dihydrate-cppd-deposition-disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[crystal deposition arthritides]]
calcium pyrophosphate dihydrate - cppd - deposition disease</description></item><item><title>cancer epidemiology</title><link>https://www.physician.tw/cancer-epidemiology/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-epidemiology/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[general oncology]]
cancer epidemiology [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
remark-cli - npm</description></item><item><title>cancer of unknown primary</title><link>https://www.physician.tw/cancer-of-unknown-primary/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-of-unknown-primary/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[oncology]]
cancer of unknown primary [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>cancer prevention and screening</title><link>https://www.physician.tw/cancer-prevention-and-screening/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-prevention-and-screening/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[general oncology]]
cancer prevention and screening [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>cardiac arrest</title><link>https://www.physician.tw/cardiac-arrest/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-arrest/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
cardiac arrest [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>cardiology reading list</title><link>https://www.physician.tw/cardiology-reading-list/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiology-reading-list/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[cardiology]]
cardiology reading list #ğŸ¦´ [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>command line interface</title><link>https://www.physician.tw/command-line-interface/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/command-line-interface/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[index]]
command line interface [[vim]] [[command line know how]]</description></item><item><title>comparison of gout and pseudogout</title><link>https://www.physician.tw/comparison-of-gout-and-pseudogout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/comparison-of-gout-and-pseudogout/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[crystal deposition arthritides]]
comparison of [[gout]] and [[pseudogout]] [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>complications of endocarditis</title><link>https://www.physician.tw/complications-of-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-endocarditis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Treatment-bacterial endocarditis]]
complications of endocarditis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
CHF, conduction block, osteomyelitis, new embolic phenomenon) which can occur even on abx</description></item><item><title>connective tissue diseases</title><link>https://www.physician.tw/connective-tissue-diseases/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/connective-tissue-diseases/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
connective tissue diseases [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>CRAB</title><link>https://www.physician.tw/CRAB/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRAB/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections]]
CRAB [[treatment of CRAB]] ğŸ’Š</description></item><item><title>CVP</title><link>https://www.physician.tw/CVP/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CVP/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[The 6 Ps-acute respiratory distress syndrome]]
CVP [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>cystitis</title><link>https://www.physician.tw/cystitis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cystitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Clinical manifestations-urinary tract infections]]
cystitis dysuria, urgency, frequency, hematuria suprapubic pain; fever absent. R/o vaginitis if symptoms of cystitis &amp;amp; urethritis.</description></item><item><title>depression</title><link>https://www.physician.tw/depression/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/depression/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[fatigue]]
depression [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>diagnosis of culture-negative endocarditis</title><link>https://www.physician.tw/diagnosis-of-culture-negative-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnosis-of-culture-negative-endocarditis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[bacterial endocarditis]]
diagnosis of culture-negative endocarditis [[Bartonella]] [[Brucella]]</description></item><item><title>Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency</title><link>https://www.physician.tw/Diagnostic-Approach-in-a-Patient-with-Possible-Primary-Ovarian-Insufficiency/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-Approach-in-a-Patient-with-Possible-Primary-Ovarian-Insufficiency/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[primary ovarian insufficiency]]
Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency Figure:</description></item><item><title>dm</title><link>https://www.physician.tw/dm/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dm/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[diabetes mellitus]]
dm</description></item><item><title>dyssynchrony</title><link>https://www.physician.tw/dyssynchrony/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dyssynchrony/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[The 6 Ps-acute respiratory distress syndrome]]
dyssynchrony [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>estradiol</title><link>https://www.physician.tw/estradiol/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/estradiol/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[primary ovarian insufficiency]]
estradiol [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Etiologies acute respiratory distress syndrome</title><link>https://www.physician.tw/Etiologies-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-acute-respiratory-distress-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Etiologies acute respiratory distress syndrome Direct Injury Pneumonia (~40%) Aspiration (~15%) Near drowning Inhalation injury Lung contusion Indirect Injury Sepsis (~25%) Shock [[disseminated intravascular coagulation]] [[pancreatitis]] Trauma/multiple fractures [[transfusion-related acute lung injury]]</description></item><item><title>external beam radiation therapy</title><link>https://www.physician.tw/external-beam-radiation-therapy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/external-beam-radiation-therapy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[radiation oncology]]
external beam radiation therapy [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>fatigue</title><link>https://www.physician.tw/fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fatigue/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[symptom to diagnosis]]
fatigue [[flowchart of approach to fatigue]]
A. Psychiatric [[depression]] Anxiety [[somatization disorder]] Substance abuse B.</description></item><item><title>flowchart of approach to fatigue</title><link>https://www.physician.tw/flowchart-of-approach-to-fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/flowchart-of-approach-to-fatigue/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[fatigue]]
flowchart of approach to fatigue Figure: history tier 1 recent life stressor? new medications or substance use?</description></item><item><title>follicle-stimulating hormone</title><link>https://www.physician.tw/follicle-stimulating-hormone/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/follicle-stimulating-hormone/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[primary ovarian insufficiency]]
follicle-stimulating hormone [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Glycemic Control in intensive care unit</title><link>https://www.physician.tw/Glycemic-Control-in-intensive-care-unit/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glycemic-Control-in-intensive-care-unit/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[basic techniques and procedures]]
Glycemic Control in intensive care unit [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>gout</title><link>https://www.physician.tw/gout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gout/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[crystal deposition arthritides]]
gout [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>hematology and oncology in critical care</title><link>https://www.physician.tw/hematology-and-oncology-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology-and-oncology-in-critical-care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
hematology and oncology in critical care 54 blood products and transfusions [[transfusion therapy]] 55 anticoagulationâ€related bleeding 56 coagulopathy and thrombocytopenia 57 venous thromboembolism and pulmonary embolism 58 oncologic emergencies</description></item><item><title>hemodynamic monitoring</title><link>https://www.physician.tw/hemodynamic-monitoring/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemodynamic-monitoring/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[cardiovascular critical care]]
hemodynamic monitoring</description></item><item><title>hormone-replacement therapy</title><link>https://www.physician.tw/hormone-replacement-therapy/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hormone-replacement-therapy/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[primary ovarian insufficiency]]
hormone-replacement therapy [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>how not to overlook Aflutter</title><link>https://www.physician.tw/how-not-to-overlook-Aflutter/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-not-to-overlook-Aflutter/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
how not to overlook Aflutter [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>how to define sinus rhythm</title><link>https://www.physician.tw/how-to-define-sinus-rhythm/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-to-define-sinus-rhythm/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
how to define sinus rhythm [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections</title><link>https://www.physician.tw/IDSA-Guidance-on-the-Treatment-of-Antimicrobial-Resistant-Gram-Negative-Infections/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IDSA-Guidance-on-the-Treatment-of-Antimicrobial-Resistant-Gram-Negative-Infections/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[pathogen]]
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections [[CRAB]]
IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.</description></item><item><title>IgG4-related disease</title><link>https://www.physician.tw/IgG4-related-disease/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgG4-related-disease/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
IgG4-related disease [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>immune phenomena</title><link>https://www.physician.tw/immune-phenomena/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-phenomena/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Modified Duke Criteria]]
immune phenomena glomerulonephritis [[Osler nodes]] Roth spots rheumatoid factor</description></item><item><title>indications-mechanical ventilation</title><link>https://www.physician.tw/indications-mechanical-ventilation/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-mechanical-ventilation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[mechanical ventilation]]
indications-mechanical ventilation [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>infectious arthritis and bursitis</title><link>https://www.physician.tw/infectious-arthritis-and-bursitis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-arthritis-and-bursitis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
infectious arthritis and bursitis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>infectious diseases in critical care</title><link>https://www.physician.tw/infectious-diseases-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-diseases-in-critical-care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
infectious diseases in critical care 42 The Febrile Patient, 44 Infections Acquired in the Intensive Care Unit 45 Antimicrobial Therapy 48 Acquired Immune Deficiency Syndrome 55 Anticoagulationâ€Related Bleeding</description></item><item><title>infective endocarditis</title><link>https://www.physician.tw/infective-endocarditis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infective-endocarditis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[bacteremia and endocarditis]]
infective endocarditis [[bacterial endocarditis]] [[native valve endocarditis]]</description></item><item><title>long QT syndrome</title><link>https://www.physician.tw/long-QT-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/long-QT-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Etiologies of Prolonged-QT-interval]]
long QT syndrome Those at risk for LQTS include: Children who are deaf at birth Children and young adults who have unexplained sudden death or syncope in family members Blood relatives of family members with LQTS Those with LQTS taking medications that can further prolong the QT intervals.</description></item><item><title>Mechanisms of VILI Ventilator Strategies</title><link>https://www.physician.tw/Mechanisms-of-VILI-Ventilator-Strategies/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-of-VILI-Ventilator-Strategies/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Mechanisms of VILI Ventilator Strategies Barotrauma/volutrauma: alveolar dist â†’ mech damage VT â‰¤6 mL/kg, Pplat â‰¤30 cm H2O, tolerate â†‘ PaCO2 (but keep pH &amp;gt;7.</description></item><item><title>medications of fatigue</title><link>https://www.physician.tw/medications-of-fatigue/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/medications-of-fatigue/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[fatigue]]
medications of fatigue</description></item><item><title>Minor clinical criteria</title><link>https://www.physician.tw/Minor-clinical-criteria/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Minor-clinical-criteria/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Modified Duke Criteria]]
Minor clinical criteria Presence of predisposing cardiac condition or intravenous drug use Temperature â‰¥38.</description></item><item><title>neurologic outcomes after cardiac arrest</title><link>https://www.physician.tw/neurologic-outcomes-after-cardiac-arrest/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-outcomes-after-cardiac-arrest/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
neurologic outcomes after cardiac arrest [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>obs gyn issues</title><link>https://www.physician.tw/obs-gyn-issues/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/obs-gyn-issues/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[medical]]
obs gyn issues [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
[[primary ovarian insufficiency]]</description></item><item><title>OGTT</title><link>https://www.physician.tw/OGTT/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OGTT/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Definition-diabetes mellitus]]
OGTT å£æœè‘¡è„ç³–è€é‡è©¦é©—(Oral Glucose Tolerance Testï¼ŒOGTT)å°ç³–å°¿ç—…è¨ºæ–·å…·æœ‰å¾ˆå¤§çš„åƒ¹å€¼ã€‚ D.Mæ‚£è€…ï¼Œè€ç³–åŠŸèƒ½ä½ä¸‹ï¼Œå£æœè‘¡è„ç³–å³°å€¼è¶…é200mg/dLï¼Œä¸”é«˜å³°å»¶é²</description></item><item><title>ophthalmic</title><link>https://www.physician.tw/ophthalmic/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ophthalmic/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[medical]]
ophthalmic [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Osler nodes</title><link>https://www.physician.tw/Osler-nodes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Osler-nodes/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[immune phenomena]]
Osler nodes Osler&amp;rsquo;s nodes result from the deposition of immune complexes. The resulting inflammatory response leads to swelling, redness, and pain that characterize these lesions.</description></item><item><title>overdose and toxidromes</title><link>https://www.physician.tw/overdose-and-toxidromes/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overdose-and-toxidromes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
overdose and toxidromes [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Pathology acute respiratory distress syndrome</title><link>https://www.physician.tw/Pathology-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathology-acute-respiratory-distress-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Pathology acute respiratory distress syndrome diffuse alveolar damage (DAD) seen in 40% of autopsies (AJRCCM 2013;187:761) If no clear inciting event and ILD considered as alt dx, consider bx (Chest 2015;148:1073)</description></item><item><title>Pathophysiology of acute respiratory distress syndrome</title><link>https://www.physician.tw/Pathophysiology-of-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-acute-respiratory-distress-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Pathophysiology of acute respiratory distress syndrome (Lancet 2016;388:2416)
â†‘ intrapulmonary shunt â†’ hypoxemia (âˆ´ Rx w/ PEEP to prevent derecruitment) â†‘ increased dead space fraction (see Appendix), predicts â†‘ mort (NEJM 2002;346:1281) â†“ compliance: VT/(Pplat â€“ PEEP) &amp;lt;50 mL/cm H2O</description></item><item><title>PEEP titration methods</title><link>https://www.physician.tw/PEEP-titration-methods/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PEEP-titration-methods/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[The 6 Ps-acute respiratory distress syndrome]]
PEEP titration methods [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>PEEP titration methods of acute respiratory distress syndrome</title><link>https://www.physician.tw/PEEP-titration-methods-of-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PEEP-titration-methods-of-acute-respiratory-distress-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
PEEP titration methods of acute respiratory distress syndrome [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>polysomnogram</title><link>https://www.physician.tw/polysomnogram/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polysomnogram/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[flowchart of approach to fatigue]]
polysomnogram [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>primary ovarian insufficiency</title><link>https://www.physician.tw/primary-ovarian-insufficiency/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/primary-ovarian-insufficiency/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[obs gyn issues]]
primary ovarian insufficiency [[Diagnostic Approach in a Patient with Possible Primary Ovarian Insufficiency]].</description></item><item><title>pseudogout</title><link>https://www.physician.tw/pseudogout/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pseudogout/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[crystal deposition arthritides]]
pseudogout [!info]
[[calcium pyrophosphate dihydrate - cppd - deposition disease]]</description></item><item><title>pulmonary reading list</title><link>https://www.physician.tw/pulmonary-reading-list/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-reading-list/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[pulmonology]]
pulmonary reading list [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
[[ATS Reading List]]</description></item><item><title>Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin</title><link>https://www.physician.tw/Reduction-in-the-Incidence-of-Type-2-Diabetes-with-Lifestyle-Intervention-or-Metformin/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reduction-in-the-Incidence-of-Type-2-Diabetes-with-Lifestyle-Intervention-or-Metformin/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Definition-diabetes mellitus]]
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin [!</description></item><item><title>regex</title><link>https://www.physician.tw/regex/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/regex/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[command line interface]]
regex Regex for lazy developers - DEV Community ğŸ‘©ğŸ’»ğŸ‘¨ğŸ’»</description></item><item><title>remark</title><link>https://www.physician.tw/remark/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/remark/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[macçš„ä¸€äº›å¥½ç”¨è»Ÿé«”]]
remark [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
remark-cli - npm</description></item><item><title>renal disorders in critical care</title><link>https://www.physician.tw/renal-disorders-in-critical-care/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-disorders-in-critical-care/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[ICU]]
renal disorders in critical care 49 Fluid Resuscitation 50 Acute Kidney Injury 51 Dialysis 52 Electrolyte Disorders 53 Acidâ€“Base Disorders</description></item><item><title>S saprophyticus</title><link>https://www.physician.tw/S-saprophyticus/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/S-saprophyticus/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Microbiology-urinary tract infections]]
S saprophyticus æ®ºå©†é£›è¸¢å’³æ­»
Staphylo - bunch of grapes Staphylococcus - grape-like coccus Saprophyticus - è…ç”Ÿçš„ å…¼æ€§å­æ°§èŒï¼ˆfacultative anaerobeï¼‰</description></item><item><title>seronegative spondyloarthritis</title><link>https://www.physician.tw/seronegative-spondyloarthritis/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/seronegative-spondyloarthritis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
seronegative spondyloarthritis [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>somatization disorder</title><link>https://www.physician.tw/somatization-disorder/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/somatization-disorder/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[fatigue]]
somatization disorder [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>systemic lupus erythematosus</title><link>https://www.physician.tw/systemic-lupus-erythematosus/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systemic-lupus-erythematosus/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[rheumatology]]
systemic lupus erythematosus [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>The 6 Ps-acute respiratory distress syndrome</title><link>https://www.physician.tw/The-6-Ps-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-6-Ps-acute-respiratory-distress-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
The 6 Ps-acute respiratory distress syndrome [[PEEP titration methods]] (see below) Proning: if PaO2/FiO2 &amp;lt;150, prone positioning â‰¥16 h â†“ mort ~50% (NEJM 2013;368:2159) Paralysis: no benefit routinely (NEJM 2019;380:1997); consider if [[ventilator dyssynchrony]] Peeing (fluid balance): target [[CVP]] 4â€“6 cm H2O (if nonoliguric &amp;amp; normotensive) â†’ â†‘ vent/ICU-free days, but no Î” mortality (NEJM 2006;354:2564); PA catheter unproven (NEJM 2006;354:2213); consider BNP &amp;gt;200 to trigger diuresis (UOP goal 4.</description></item><item><title>The Composition of Saline, Lactated Ringerâ€™s Solution, and Plasma-Lyte 148</title><link>https://www.physician.tw/The-Composition-of-Saline-Lactated-Ringers-Solution-and-Plasma-Lyte-148/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Composition-of-Saline-Lactated-Ringers-Solution-and-Plasma-Lyte-148/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Fluids-sepsis and shock]]
The Composition of Saline, Lactated Ringerâ€™s Solution, and Plasma-Lyte 148 Saline Na: 154 Cl: 154 Lactated Ringerâ€™s Solution Na: 130 K: 4 Ca: 1.</description></item><item><title>tip</title><link>https://www.physician.tw/tip/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tip/</guid><description>tip remark-renumber-references - npm Remark Definition &amp;amp; Meaning - Merriam-Webster</description></item><item><title>Treatment acute respiratory distress syndrome</title><link>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[acute respiratory distress syndrome]]
Treatment acute respiratory distress syndrome (Lancet 2021;398:622)
Goal is to maintain gas exchange, sustain life, &amp;amp; avoid [[ventilator-induced lung injury]] (VILI) In Pts on O2 for COVID-19 PNA, dexamethasone â†“ 28-day mortality (NEJM 2021;384:693)</description></item><item><title>tricks</title><link>https://www.physician.tw/tricks/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tricks/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Raycast]]
tricks [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§
remark-cli - npm</description></item><item><title>vagal maneuvers to confirm AFlutter</title><link>https://www.physician.tw/vagal-maneuvers-to-confirm-AFlutter/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vagal-maneuvers-to-confirm-AFlutter/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
vagal maneuvers to confirm AFlutter [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>vascular phenomena</title><link>https://www.physician.tw/vascular-phenomena/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vascular-phenomena/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Modified Duke Criteria]]
vascular phenomena septic arterial or pulmonary emboli mycotic aneurysms Janeway lesions septic pulmonary emboli intracranial hemorrhage conjunctival hemorrhages</description></item><item><title>ventilator dyssynchrony</title><link>https://www.physician.tw/ventilator-dyssynchrony/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ventilator-dyssynchrony/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[The 6 Ps-acute respiratory distress syndrome]]
ventilator dyssynchrony [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>ventilator-induced lung injury</title><link>https://www.physician.tw/ventilator-induced-lung-injury/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ventilator-induced-lung-injury/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Treatment acute respiratory distress syndrome]]
ventilator-induced lung injury [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>very fast Afib â€” Think WPW</title><link>https://www.physician.tw/very-fast-Afib-Think-WPW/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/very-fast-Afib-Think-WPW/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
very fast Afib â€” Think WPW [!info]
ğŸ‘· å·¥äº‹ä¸­ ğŸŒ± æ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>vim</title><link>https://www.physician.tw/vim/</link><pubDate>Tue, 17 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[command line interface]]
vim Getting Started With Vim - A Practical Guide - DEV Community ğŸ‘©ğŸ’»ğŸ‘¨ğŸ’»</description></item><item><title>Coxiella burnetii</title><link>https://www.physician.tw/Coxiella-burnetii/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coxiella-burnetii/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Major clinical criteria]]
Coxiella burnetii Qç†±æ˜¯è²æ°è€ƒå…‹æ–¯èŒï¼ˆCoxiella burnetiiï¼‰ æ‰€å¼•èµ·ä¹‹äººç•œå…±é€šå‚³æŸ“ç—…ï¼ˆzoonosisï¼‰ï¼Œ å¯åˆ†ç‚ºæ€¥æ€§Qç†±åŠæ…¢æ€§Qç†±ã€‚ å‹•ç‰©æ„ŸæŸ“Qç†±é€šå¸¸æ²’æœ‰ç—‡ç‹€ï¼Œ ä½†å¯èƒ½æœƒé€ æˆæ‡·å­•çš„å‹•ç‰©æµç”¢ã€ æ­»ç”¢æˆ–ä¸å­•ï¼› é€™äº›å‹•ç‰©çš„èƒç›¤çµ„ç¹”ã€ç¾Šæ°´ã€æ­»èƒåŠå­å®®æ’å‡ºç‰©ç­‰å«æœ‰å¤§é‡çš„ç—…åŸé«”ï¼Œè‹¥æœªå¦¥å–„è™•ç†ä¸”éš¨æ„æ©åŸ‹ï¼Œ å³å¯èƒ½æ±¡æŸ“ç’°å¢ƒè€Œæˆç‚ºäººé¡æ„ŸæŸ“Qç†±çš„é‡è¦æ„ŸæŸ“æºã€‚ ç¸é†«ã€æ¯›çš®æ¥­è€…ã€è¾²å ´å“¡å·¥ã€å± å®°å ´å“¡å·¥ã€ç•œç‰§æ¥­è€…åŠç›¸é—œç ”ç©¶äººå“¡ç­‰ï¼Œå°¤å…¶æ˜¯ç¶“å¸¸æ¥è§¸ç‰²ç•œï¼ˆå±±ç¾Šã€ç¶¿ç¾Šã€ç‰›éš»ç­‰ï¼‰çš„å·¥ä½œè€…ï¼Œ ç‚ºQç†±çš„é«˜å±éšªç¾¤ã€‚</description></item><item><title>Crystalloid</title><link>https://www.physician.tw/Crystalloid/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Crystalloid/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Fluids-sepsis and shock]]
Crystalloid å…¶å¯¦æ˜¯Lactate Ringerå’Œäººé«”å…§é›¢å­çµ„æˆæ¯”è¼ƒç›¸è¿‘çš„ï¼Œå› æ­¤åš´æ ¼ä¾†èªª0.9% Salineä¸èƒ½ç¨±ç‚ºã€Œ Normal Saline ã€ã€‚</description></item><item><title>Cutibacterium</title><link>https://www.physician.tw/Cutibacterium/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutibacterium/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Risk factors for bloodstream infections]]
Cutibacterium [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>definitions of bacteremia</title><link>https://www.physician.tw/definitions-of-bacteremia/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definitions-of-bacteremia/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[bacteremia]]
definitions of bacteremia 1Â° bacteremia: bloodstream infection due to direct inoculation of the blood Central line associated bloodstream infection (CLABSI): bacteremia in which the same organism is growing from peripheral and catheter cultures (CID 2009;49:1) 2Â° bacteremia: infection of another site (eg, UTI, PNA, colitis, etc.</description></item><item><title>disseminated intravascular coagulation</title><link>https://www.physician.tw/disseminated-intravascular-coagulation/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disseminated-intravascular-coagulation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Microangiopathic hemolytic anemia]]
disseminated intravascular coagulation [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>HELLP</title><link>https://www.physician.tw/HELLP/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HELLP/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Microangiopathic hemolytic anemia]]
HELLP [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Major clinical criteria</title><link>https://www.physician.tw/Major-clinical-criteria/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-clinical-criteria/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Modified Duke Criteria]]
Major clinical criteria Positive blood culture Typical microorganisms Staphylococcus aureus,</description></item><item><title>native valve endocarditis</title><link>https://www.physician.tw/native-valve-endocarditis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/native-valve-endocarditis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[bacterial endocarditis]]
native valve endocarditis The [[modified Duke criteria]], which are based on findings on physical examination, echocardiography, microbiologic studies, and computed tomographic and magnetic resonance imaging of target organs, are sensitive and specific for the clinical diagnosis of infective endocarditis.</description></item><item><title>propofol infusion syndrome</title><link>https://www.physician.tw/propofol-infusion-syndrome/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/propofol-infusion-syndrome/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Sedation-and-Analgesia]]
propofol infusion syndrome PRISå¸¸è¦‹çš„è‡¨åºŠç‰¹å¾µå¯èƒ½åŒ…å«äº† ä»£è¬æ€§é…¸ä¸­æ¯’ã€æ©«ç´‹è‚Œæº¶è§£ã€å¿ƒå¾‹ä¸æ•´ã€å¿ƒè‚ŒåŠè…çš„è¡°ç«­ã€è‚è…«å¤§ã€é«˜è¡€é‰€åŠè„‚è¡€ã€‚æ©«ç´‹è‚Œæº¶è§£çš„ç—‡ç‹€åŒ…æ‹¬äº†è‚Œè‚‰ç„¡åŠ›ã€è‚Œçƒè›‹ç™½å°¿åŠè…è¡°ç«­ã€‚
PRISçš„å®šç¾©ç‚º (1)çªç„¶æœ‰é¡¯è‘—çš„å¿ƒæéç·©ä¸”å°æ²»ç™‚åæ‡‰ä¸ä½³ï¼Œä¸¦æ¼¸æ¼¸é€²å±•ç‚ºå¿ƒè·³åœæ­¢ã€‚(2)è„‚è¡€ç—‡ã€‚(3)ç”±æ–¼è„‚è‚ªæµ¸æ½¤æ‰€é€ æˆçš„è‚è…«å¤§ã€‚(4)åš´é‡çš„ä»£è¬æ€§é…¸ä¸­æ¯’ã€‚(5)èˆ‡è‚Œè‚‰ç›¸é—œçš„æ©«ç´‹è‚Œæº¶è§£æˆ–è‚Œçƒè›‹ç™½å°¿ã€‚è€ŒPRISçš„è¨ºæ–·å‰‡æ˜¯åœ¨å¿ƒæéç·©çš„å­˜åœ¨ä¸‹è‡³å°‘æœ‰ä»¥ä¸‹å…¶ä¸­ä¸€é …ç—‡ç‹€ï¼šè„‚è¡€ç—‡ã€è‚è…«å¤§ã€ä»£è¬æ€§é…¸ä¸­æ¯’ã€æˆ–æ©«ç´‹è‚Œæº¶è§£ç—‡</description></item><item><title>prostatitis</title><link>https://www.physician.tw/prostatitis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prostatitis/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Infection as Etiologies of Classic FUO]]
prostatitis Chronic: similar to cystitis + symptoms of obstruction (hesitancy, weak stream)</description></item><item><title>schistocytes</title><link>https://www.physician.tw/schistocytes/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/schistocytes/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Microangiopathic hemolytic anemia]]
schistocytes [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Streptococcus gallolyticus</title><link>https://www.physician.tw/Streptococcus-gallolyticus/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Streptococcus-gallolyticus/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Major clinical criteria]]
Streptococcus gallolyticus [!info]
Streptococcus gallolyticus (Sg), previously known as Streptococcus bovis</description></item><item><title>thrombotic thrombocytopenic purpura</title><link>https://www.physician.tw/thrombotic-thrombocytopenic-purpura/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thrombotic-thrombocytopenic-purpura/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[Microangiopathic hemolytic anemia]]
thrombotic thrombocytopenic purpura Pathophys: â†“â†“ ADAMTS13 protease activity (hereditary [Upshaw Schulman Syn.] or autoAb) â†’ vWF multimers persist on endothelial surface â†’ plt adhesion/aggregation â†’ thrombosis</description></item><item><title>vertebral osteomyelitis</title><link>https://www.physician.tw/vertebral-osteomyelitis/</link><pubDate>Mon, 16 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vertebral-osteomyelitis/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[Risk factors for bloodstream infections]]
vertebral [[osteomyelitis]] [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>EKG pocket brain</title><link>https://www.physician.tw/EKG-pocket-brain/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/EKG-pocket-brain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[electrocardiography]]
EKG pocket brain [!info]
original: [[PocketBrain]]
00.6 â€“ ECG Crib Sheet
00.7 â€“ The 6 Essential Lists</description></item><item><title>Systematic Approach to 12-Lead ECG Interpretation</title><link>https://www.physician.tw/Systematic-Approach-to-12-Lead-ECG-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systematic-Approach-to-12-Lead-ECG-Interpretation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
Systematic Approach to 12-Lead ECG Interpretation [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>The 2 Steps to Systematic Interpretation</title><link>https://www.physician.tw/The-2-Steps-to-Systematic-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-2-Steps-to-Systematic-Interpretation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
The 2 Steps to Systematic Interpretation [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>WHY 2 Separate Steps for Interpretation</title><link>https://www.physician.tw/WHY-2-Separate-Steps-for-Interpretation/</link><pubDate>Sun, 15 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WHY-2-Separate-Steps-for-Interpretation/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[EKG pocket brain]]
WHY 2 Separate Steps for Interpretation [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>Raycast</title><link>https://www.physician.tw/Raycast/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Raycast/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[macçš„ä¸€äº›å¥½ç”¨è»Ÿé«”]]
Raycast [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§
[[tip]] [[tricks]]</description></item><item><title>Ventilator-associated pneumonia</title><link>https://www.physician.tw/Ventilator-associated-pneumonia/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ventilator-associated-pneumonia/</guid><description>&lt;blockquote>
&lt;p>[!info]&lt;/p>
&lt;p>ğŸŒ± ä¾†è‡ª: [[Definitions-and-clinical-manifestations]]&lt;/p>
&lt;/blockquote>
&lt;h1 id="ventilator-associated-pneumonia">Ventilator-associated pneumonia&lt;/h1>
&lt;blockquote>
&lt;p>[!info]&lt;/p>
&lt;p>&lt;strong>ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§&lt;/strong>&lt;/p>
&lt;/blockquote></description></item><item><title>ç”¨Zoteroä¾†ç®¡ç†Paper</title><link>https://www.physician.tw/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</link><pubDate>Sat, 14 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E7%94%A8Zotero%E4%BE%86%E7%AE%A1%E7%90%86Paper/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[index]]
ç”¨Zoteroä¾†ç®¡ç†Paper [!info]
ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§
[[wow]]
[[zotero plugin]]</description></item><item><title>Aldosterone</title><link>https://www.physician.tw/Aldosterone/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aldosterone/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[overview-sodium and water homeostasis]]
Aldosterone ç•™éˆ‰æ’é‰€
[[aldosterone synthetic pathway]]
primary hormone that regulates total body sodium (and âˆ´ volume)</description></item><item><title>aldosterone synthetic pathway</title><link>https://www.physician.tw/aldosterone-synthetic-pathway/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aldosterone-synthetic-pathway/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Aldosterone]]
aldosterone synthetic pathway Figure: adrenocorticotropic hormone (ACTH) , angiotensin II (Ang II) , and K + regulate steroidogenic acute regulatory protein (StAR) , which stimulates cholesterol uptake by mitochondria and thus substrate availability for synthesis of all of the steroid hormones.</description></item><item><title>Antidiuretic hormone</title><link>https://www.physician.tw/Antidiuretic-hormone/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antidiuretic-hormone/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[overview-sodium and water homeostasis]]
Antidiuretic hormone primary hormone that regulates sodium concentration stimuli: hyperosmolality (290â€“295 mOsm), â†“â†“ effective arterial volume, angiotensin II action: insertion of [[aquaporin-2 channels]] in [[principal cells]] â†’ passive water reabsorption urine osmolality is an indirect functional assay of the ADH-renal axis Uosm range 50 mOsm/L (no ADH) to 1200 mOsm/L (maximal ADH) The normal range for urine specific gravity is 1.</description></item><item><title>Calcium homeostasis in normal humans</title><link>https://www.physician.tw/Calcium-homeostasis-in-normal-humans/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium-homeostasis-in-normal-humans/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[calcium disorders]]
Calcium homeostasis in normal humans Figure:</description></item><item><title>Low Back Pain</title><link>https://www.physician.tw/Low-Back-Pain/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Low-Back-Pain/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[ambulatory]]
Low Back Pain ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>macçš„ä¸€äº›å¥½ç”¨è»Ÿé«”</title><link>https://www.physician.tw/mac%E7%9A%84%E4%B8%80%E4%BA%9B%E5%A5%BD%E7%94%A8%E8%BB%9F%E9%AB%94/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mac%E7%9A%84%E4%B8%80%E4%BA%9B%E5%A5%BD%E7%94%A8%E8%BB%9F%E9%AB%94/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[index]]
macçš„ä¸€äº›å¥½ç”¨è»Ÿé«” ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§
[[Raycast]] [[remark]]</description></item><item><title>Obsidian</title><link>https://www.physician.tw/Obsidian/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obsidian/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
Obsidian ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§</description></item><item><title>principal cells</title><link>https://www.physician.tw/principal-cells/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/principal-cells/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Antidiuretic hormone]]
principal cells Backlinkï¼š [[Aldosterone]] [[Antidiuretic hormone]]</description></item><item><title>Vimwikiè¨­å®š</title><link>https://www.physician.tw/Vimwiki%E8%A8%AD%E5%AE%9A/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vimwiki%E8%A8%AD%E5%AE%9A/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
Vimwiki Vimwikiæ˜¯ä¸€å€‹éå¸¸å¼·å¤§çš„ç­†è¨˜ç®¡ç†è»Ÿé«”ï¼Œæ˜¯åŸºæ–¼Vimç·¨è¼¯å™¨é–‹ç™¼çš„ä¸€å€‹å¤–æ›ã€‚å®ƒå¯ä»¥è®“ä½ ç”¨ç°¡å–®çš„æ–‡å­—æ ¼å¼å‰µå»ºã€çµ„ç¹”å’Œç®¡ç†ä½ çš„ç­†è¨˜ã€‚
Vimwikiæ”¯æ´å¤šç¨®æª”æ¡ˆæ ¼å¼ï¼ŒåŒ…æ‹¬Markdown, Mediawiki, Org-mode, LaTeXç­‰ã€‚å®ƒé‚„æ”¯æ´è¶…éˆæ¥ï¼Œå¯ä»¥åœ¨ä¸åŒçš„ç­†è¨˜ä¹‹é–“å»ºç«‹è¯ç¹«ï¼Œä½¿å¾—ç­†è¨˜ä¹‹é–“çš„è³‡è¨Šå…±äº«æ›´åŠ æ–¹ä¾¿ã€‚
ç¸½ä¹‹ï¼ŒVimwikiæ˜¯ä¸€å€‹åŠŸèƒ½å¼·å¤§ï¼Œæ˜“ç”¨çš„ç­†è¨˜ç®¡ç†å·¥å…·ï¼Œå¯ä»¥å¹«åŠ©ä½ æ›´å¥½çš„ç®¡ç†å’Œçµ„ç¹”ä½ çš„ç­†è¨˜ï¼Œä¸¦ä¸”å¯ä»¥æé«˜ä½ çš„å·¥ä½œæ•ˆç‡ã€‚
markdown çš„æ“ä½œ [[ç¨‹å¼èªè¨€]]</description></item><item><title>å¡ç‰‡ç›’ç­†è¨˜æ³•</title><link>https://www.physician.tw/%E5%8D%A1%E7%89%87%E7%9B%92%E7%AD%86%E8%A8%98%E6%B3%95/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%8D%A1%E7%89%87%E7%9B%92%E7%AD%86%E8%A8%98%E6%B3%95/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
å¡ç‰‡ç›’ç­†è¨˜æ³• ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§
a card #ğŸ“š content
^1673622483031
[[test123]]</description></item><item><title>å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’</title><link>https://www.physician.tw/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%A6%82%E4%BD%95%E6%89%93%E9%80%A0%E4%B8%80%E5%BA%A7%E7%9F%A5%E8%AD%98%E8%8A%B1%E5%9C%92/</guid><description> [!info]
ğŸŒ± ä¾†è‡ª: [[index]]
å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’ [[ä»€éº¼æ˜¯æ•¸ä½èŠ±åœ’]] [[å¡ç‰‡ç›’ç­†è¨˜æ³•]] [[Obsidian]] [[èœ¥èœ´èˆ‡VIM]] [[Vimwikiè¨­å®š]] [[hugo]] [[Quartz]]</description></item><item><title>èœ¥èœ´èˆ‡VIM</title><link>https://www.physician.tw/%E8%9C%A5%E8%9C%B4%E8%88%87VIM/</link><pubDate>Fri, 13 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E8%9C%A5%E8%9C%B4%E8%88%87VIM/</guid><description>[!info]
ğŸŒ± ä¾†è‡ª: [[å¦‚ä½•æ‰“é€ ä¸€åº§çŸ¥è­˜èŠ±åœ’]]
èœ¥èœ´èˆ‡VIM ğŸ‘· å·¥äº‹ä¸­ï¼Œæ•¬è«‹æœŸå¾… ğŸš§
[[neovim]] [[vim TODO]]</description></item><item><title>24-hour urinary free cortisol</title><link>https://www.physician.tw/24-hour-urinary-free-cortisol/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/24-hour-urinary-free-cortisol/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[3 options for screening for hypercortisolism]]
24-hour urinary free cortisol Normal range is 4 to 40 mcg/24 hours or 11 to 110 nmol/day.</description></item><item><title>3 options for screening for hypercortisolism</title><link>https://www.physician.tw/3-options-for-screening-for-hypercortisolism/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/3-options-for-screening-for-hypercortisolism/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Approach to suspected Cushingâ€™s syndrome]]
3 options for screening for hypercortisolism [[24-hour urinary free cortisol]] (UFC) [[dexamethasone suppression test]]; [[11 pm Salivary Cortisol]]</description></item><item><title>48-hr LD-dexamethasone suppression test</title><link>https://www.physician.tw/48-hr-LD-dexamethasone-suppression-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/48-hr-LD-dexamethasone-suppression-test/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Approach to suspected Cushingâ€™s syndrome]]
48-hr LD-dexamethasone suppression test 48-h LD DST + CRH = 0.</description></item><item><title>adrenal incidentaloma</title><link>https://www.physician.tw/adrenal-incidentaloma/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-incidentaloma/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Primary Hyperaldosteronism]]
adrenal incidentaloma All patients with an adrenal mass that is discovered during diagnostic testing for another condition (an â€œincidentalomaâ€) should undergo biochemical testing to detect pheochromocytoma and excess cortisol secretion, and those who also have high blood pressure should undergo biochemical testing to detect primary hyperaldosteronism.</description></item><item><title>Approach to suspected Cushingâ€™s syndrome</title><link>https://www.physician.tw/Approach-to-suspected-Cushings-syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-Cushings-syndrome/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Diagnosis-Cushingâ€™s Syndrome]]
Approach to suspected Cushingâ€™s syndrome</description></item><item><title>BIPSS</title><link>https://www.physician.tw/BIPSS/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BIPSS/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Diagnosis-Cushingâ€™s Syndrome]]
BIPSS bilat. Inferior petrosal é¡³éª¨å²©éƒ¨ sinus vein sampling; âœ“ petrosal:peripheral ACTH ratio (âŠ• â‰¥2 basal, â‰¥3 after CRH)</description></item><item><title>catheter-directed pharmacomech</title><link>https://www.physician.tw/catheter-directed-pharmacomech/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/catheter-directed-pharmacomech/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Mechanical intervention-venous thromboembolism]]
catheter-directed pharmacomech low-dose lytic infused (eg, tPA 1 mg/h for 12â€“24 hr per catheter) + U/S or mech fragmentation of clot.</description></item><item><title>CRH stimulations test</title><link>https://www.physician.tw/CRH-stimulations-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRH-stimulations-test/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Approach to suspected Cushingâ€™s syndrome]]
CRH stimulations test CRH stim test = 1 Âµg/kg IV; âœ“ cortisol and ACTH (âŠ• if &amp;gt; 35% â†‘ in ACTH or &amp;gt;20% â†‘ in cortisol above baseline)</description></item><item><title>Cushingâ€™s disease</title><link>https://www.physician.tw/Cushings-disease/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cushings-disease/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Approach to suspected Cushingâ€™s syndrome]]
Cushingâ€™s disease Cushingâ€™s syndrome 2Â° to pituitary ACTH hypersecretion
[[Cushingâ€™s Syndrome]]</description></item><item><title>dexamethasone suppression test</title><link>https://www.physician.tw/dexamethasone-suppression-test/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dexamethasone-suppression-test/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Diagnosis-Cushingâ€™s Syndrome]]
dexamethasone suppression test give 1 mg at 11 p.m.; âœ“ 8 a.m. serum cortisol (suppression if &amp;lt;1.</description></item><item><title>Diagnosis Cushingâ€™s Syndrome</title><link>https://www.physician.tw/Diagnosis-Cushings-Syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-Cushings-Syndrome/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Cushingâ€™s Syndrome]]
Diagnosis Cushingâ€™s Syndrome Typically performed in outPt setting Very difficult as inPt b/c hypercortisolism from acute illness and hosp.</description></item><item><title>Fondaparinux</title><link>https://www.physician.tw/Fondaparinux/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fondaparinux/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Initial anticoagulation options for-venous thromboembolism]]
Fondaparinux Fondaparinuxçš„å»ºè­°åŠ‘é‡ç‚ºæ¯æ—¥ä¸€æ¬¡2.5æ¯«å…‹ã€‚ç¬¬ä¸€åŠ‘Fondaparinuxæ‡‰ä»¥éœè„ˆæ³¨. å°„çš„æ–¹å¼çµ¦è—¥ï¼Œå¾ŒçºŒçš„åŠ‘é‡å‰‡æ‡‰ä»¥çš®ä¸‹æ³¨å°„çš„æ–¹å¼çµ¦è—¥</description></item><item><title>Nonaldosterone mineralocorticoid excess</title><link>https://www.physician.tw/Nonaldosterone-mineralocorticoid-excess/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonaldosterone-mineralocorticoid-excess/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Etiologies-hyperaldosteronism]]
Nonaldosterone mineralocorticoid excess 11Î²-HSD defic. (â†’ lack of inactivation of cortisol, which binds to mineralocorticoid recept.</description></item><item><title>pheochromocytoma</title><link>https://www.physician.tw/pheochromocytoma/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pheochromocytoma/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Etiologies of hypercortisolism]]
pheochromocytoma</description></item><item><title>postthrombotic syndrome</title><link>https://www.physician.tw/postthrombotic-syndrome/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/postthrombotic-syndrome/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Complications &amp;amp; prognosis-venous thromboembolism]]
postthrombotic syndrome PTS symptoms include leg pain sensations of leg heaviness, pulling, or fatigue limb swelling Symptoms can be present in various combinations, may be persistent or intermittent, and are usually aggravated by standing or walking and tend to improve with rest and leg elevation.</description></item><item><title>Rationale of BIPSS</title><link>https://www.physician.tw/Rationale-of-BIPSS/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rationale-of-BIPSS/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[BIPSS]]
Rationale of BIPSS In the setting of hypercortisolemia, the procedure is performed to differentiate a pituitary from an ectopic source of ACTH.</description></item><item><title>somatostatin scan</title><link>https://www.physician.tw/somatostatin-scan/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/somatostatin-scan/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Approach to suspected Cushingâ€™s syndrome]]
somatostatin scan An octreotide scan is a type of SPECT scintigraphy used to find carcinoid, pancreatic neuroendocrine tumors, and to localize sarcoidosis.</description></item><item><title>surgical embolectomy</title><link>https://www.physician.tw/surgical-embolectomy/</link><pubDate>Thu, 12 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-embolectomy/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Mechanical intervention-venous thromboembolism]]
surgical embolectomy if large, proximal PE + hemodynamic compromise + contraindic. to lysis; consider in experienced ctr if large prox.</description></item><item><title>54321-PUMA-å˜”æ€•</title><link>https://www.physician.tw/54321-PUMA-%E5%98%94%E6%80%95/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/54321-PUMA-%E5%98%94%E6%80%95/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Diagnosis of migraine]]
54321-PUMA-å˜”æ€• ä¸€èˆ¬å°åé ­ç—›æœ‰ã€Œ54321ã€é€™å€‹è¨ºæ–·æ¨™æº– 5æ˜¯æ‚£è€…åœ¨å°±è¨ºä¹‹å‰æœ‰5æ¬¡ä»¥ä¸Šçš„é ­ç—›æƒ…å½¢ï¼› 4èˆ‡3åˆ†åˆ¥æ˜¯é ­ç—›æ™‚é–“é”4å°æ™‚æˆ–åˆ°3å¤©ä¹‹é–“ï¼› 2 in 4 æ˜¯åœ¨
unilateral location é ­éƒ¨å–®å´ç™¼ä½œ pulsating quality åšå‹•æ€§ç—‡ç‹€èˆ‡é‹å‹• moderate or severe pain intensity ä¸­ã€é‡åº¦é ­ç—›ï¼ˆç–¼ç—›æŒ‡æ•¸7è‡³10åˆ†ï¼‰ aggravation by or causing avoidance of routine physical activity æ´»å‹•æ™‚ç—‡ç‹€æœƒåŠ åŠ‡ 1 in 2 å‰‡æ˜¯æœ‰å™å¿ƒã€å˜”åæˆ–ç•å…‰ã€æ€•åµé€™2é …æ“‡1ï¼Œ å¦‚æœ‰é€™5ç¨®æƒ…å½¢ï¼Œå³å¯èªå®šæ˜¯åé ­ç—›ç—…ç—‡ã€‚</description></item><item><title>central role of tissue factor in tumor progression and thrombosis</title><link>https://www.physician.tw/central-role-of-tissue-factor-in-tumor-progression-and-thrombosis/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/central-role-of-tissue-factor-in-tumor-progression-and-thrombosis/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Venous Thromboembolism and Cancer]]
central role of tissue factor in tumor progression and thrombosis</description></item><item><title>Cockcroft-Gault formula</title><link>https://www.physician.tw/Cockcroft-Gault-formula/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cockcroft-Gault-formula/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[Hestia Criteria for Outpatient Pulmonary Embolism Treatment]]
Cockcroft-Gault formula</description></item><item><title>critical actions of Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/critical-actions-of-Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/critical-actions-of-Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Pulmonary Embolism Severity Index PESI]]
critical actions of Pulmonary Embolism Severity Index PESI The PESI is only meant for risk stratification of pulmonary embolism after the diagnosis has been made.</description></item><item><title>d-dimer</title><link>https://www.physician.tw/d-dimer/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/d-dimer/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Diagnostic studiesâ€”DVT]]
d-dimer by-product of the blood clotting and break-down process that can be measured via analysis of a blood sample.</description></item><item><title>deep vein thrombosis</title><link>https://www.physician.tw/deep-vein-thrombosis/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/deep-vein-thrombosis/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[venous thromboembolism]]
deep vein thrombosis [[Clinical manifestationsâ€”DVT]] [[Simplified Wells Pretest Probability Scoring of DVT]] [[Diagnostic studiesâ€”DVT]]</description></item><item><title>Diagnostic studiesâ€”DVT</title><link>https://www.physician.tw/Diagnostic-studiesDVT/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studiesDVT/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[deep vein thrombosis]]
Diagnostic studiesâ€”DVT [[d-dimer]]: (DVT excluded at D-dimer levels &amp;lt;0.5 Âµg/mL = 500 Âµg/L).</description></item><item><title>fluoroquinolones</title><link>https://www.physician.tw/fluoroquinolones/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fluoroquinolones/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[preferred antibiotics for uncomplicated cystitis caused by ESBL-E]]
fluoroquinolones have been associated with an increased risk for prolonged QTc intervals, tendinitis and tendon rupture, aortic dissections, seizures, peripheral neuropathy, and Clostridioides difficile infections, compared to other antibiotics</description></item><item><title>Hestia Criteria for Outpatient Pulmonary Embolism Treatment</title><link>https://www.physician.tw/Hestia-Criteria-for-Outpatient-Pulmonary-Embolism-Treatment/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hestia-Criteria-for-Outpatient-Pulmonary-Embolism-Treatment/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk factors-venous thromboembolism]]
Hestia Criteria for Outpatient Pulmonary Embolism Treatment Hemodynamically unstable sBP &amp;lt;100 mmHg and HR &amp;gt;100, needing ICU care, or by clinician judgment</description></item><item><title>Homanâ€™s sign</title><link>https://www.physician.tw/Homans-sign/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Homans-sign/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Clinical manifestationsâ€”DVT]]
Homanâ€™s sign Homanâ€™s sign test also called dorsiflexon sign test is a physical examination procedure that is used to test for Deep Vein Thrombosis (DVT).</description></item><item><title>IDSA Guidance</title><link>https://www.physician.tw/IDSA-Guidance/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IDSA-Guidance/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Treatment of UTIs]]
IDSA Guidance [[treatment of antimicrobial-resistant gram-negative infections]]</description></item><item><title>Interpretation of Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/Interpretation-of-Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Interpretation-of-Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Pulmonary Embolism Severity Index PESI]]
Interpretation of Pulmonary Embolism Severity Index PESI 0-65 I 0.0-1.6%</description></item><item><title>preferred antibiotics for uncomplicated cystitis caused by ESBL-E</title><link>https://www.physician.tw/preferred-antibiotics-for-uncomplicated-cystitis-caused-by-ESBL-E/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preferred-antibiotics-for-uncomplicated-cystitis-caused-by-ESBL-E/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[treatment of antimicrobial-resistant gram-negative infections]]
preferred antibiotics for uncomplicated cystitis caused by ESBL-E Nitrofurantoin and trimethoprim-sulfamethoxazole have been shown to be safe and effective options for uncomplicated cystitis, including uncomplicated ESBL-E cystitis.</description></item><item><title>PRES</title><link>https://www.physician.tw/PRES/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PRES/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[warning signs of headache]]
PRES Posterior reversible encephalopathy syndrome (PRES)
characterized by headache, visual disturbances seizures altered mental states.</description></item><item><title>pulmonary embolism</title><link>https://www.physician.tw/pulmonary-embolism/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-embolism/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[venous thromboembolism]]
pulmonary embolism [[Clinical manifestationsâ€”PE]] [[Modified Wells Pretest Probability Scoring for PE ]] [[Diagnostic studies of PE]] [[Approach to suspected PE]] [[Workup for idiopathic VTE]] [[Risk stratification for Pts with PE]]</description></item><item><title>Pulmonary Embolism Severity Index PESI</title><link>https://www.physician.tw/Pulmonary-Embolism-Severity-Index-PESI/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Embolism-Severity-Index-PESI/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk factors-venous thromboembolism]]
Pulmonary Embolism Severity Index PESI Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria.</description></item><item><title>Red Flags-SNOOP for headache</title><link>https://www.physician.tw/Red-Flags-SNOOP-for-headache/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Red-Flags-SNOOP-for-headache/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[warning signs of headache]]
Red Flags-SNOOP for headache Systemic Sx (fever, weight loss) Secondary risk factors (HIV, cancer) Neurologic Sx (confusion, impaired alertness or consciousness) Onset (sudden, abrupt, or split-second) Older (&amp;gt;50 yr) Pattern change Progressive Precipitated by Valsalva Postural aggravation Papilledema Dodick DW.</description></item><item><title>risk classification of pulmonary embolism</title><link>https://www.physician.tw/risk-classification-of-pulmonary-embolism/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/risk-classification-of-pulmonary-embolism/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk stratification for Pts with PE]]
risk classification of pulmonary embolism High risk (â€œmassiveâ€): * hemodyn unstable w/ arrest, * obstructive shock * persistent HoTN Intermediate risk (â€œsubmassiveâ€): * sPESI â‰¥1 * â€œIntermediate-highâ€ if both RV dysfunction &amp;amp; elevated Tn * â€œIntermediate-lowâ€ if either or neither RV dysfunction or elevated Tn Low risk: * clinically stable, * sPESI = 0, * normal RV function, * normal Tn [[simplified PE severity index]]</description></item><item><title>simplified PE severity index</title><link>https://www.physician.tw/simplified-PE-severity-index/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/simplified-PE-severity-index/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk stratification for Pts with PE]]
simplified PE severity index age &amp;gt;80 y</description></item><item><title>tamoxifen</title><link>https://www.physician.tw/tamoxifen/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tamoxifen/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Virchowâ€™s triad]]
tamoxifen å»ºè­°åƒè€ƒåŠ‘é‡ æ¯æ—¥20ï½40mgã€‚
å¸¸è¦‹å‰¯ä½œç”¨ æœˆç¶“é€±æœŸä¸è¦å‰‡ã€æ½®ç´…ã€é™°é“åˆ†æ³Œç‰©ã€‚
å°‘è¦‹ä½†åš´é‡ä¹‹å‰¯ä½œç”¨ æ·±å±¤éœè„ˆæ “å¡ã€ å²è’‚èŠ¬å¼·ç”Ÿç—‡å€™ç¾¤ã€ ç™½å…§éšœã€ å­å®®å…§è†œç™Œã€ é–“è³ªæ€§è‚ºç‚ã€ è‚ºæ “å¡ã€‚
è‡´åç­‰ç´š ä½ã€‚</description></item><item><title>treatment of antimicrobial-resistant gram-negative infections</title><link>https://www.physician.tw/treatment-of-antimicrobial-resistant-gram-negative-infections/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-antimicrobial-resistant-gram-negative-infections/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[IDSA Guidance]]
treatment of antimicrobial-resistant gram-negative infections [[preferred antibiotics for uncomplicated cystitis caused by ESBL-E]]</description></item><item><title>Venous Thromboembolism and Cancer</title><link>https://www.physician.tw/Venous-Thromboembolism-and-Cancer/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Venous-Thromboembolism-and-Cancer/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk factors-venous thromboembolism]]
Venous Thromboembolism and Cancer Venous Thromboembolism and Cancer | Circulation
Pathophysiological changes that favor thrombosis in patients with cancer include platelet activation direct factor X activation, decreased hepatic anticoagulant synthesis reduced hepatic clearance of coagulation factors and autoimmune phenomena such as the development of antiphospholipid antibodies Most patients with active cancer have evidence of chronic systemic coagulation activation, such as elevated plasma d-dimer levels</description></item><item><title>Virchowâ€™s triad</title><link>https://www.physician.tw/Virchows-triad/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Virchows-triad/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Risk factors-venous thromboembolism]]
Virchowâ€™s triad s.i.t: statis, injury, thrombophilia
Stasis: bed rest, inactivity CHF CVA w/in 3 mo air travel &amp;gt;6 h.</description></item><item><title>warning signs of headache</title><link>https://www.physician.tw/warning-signs-of-headache/</link><pubDate>Wed, 11 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/warning-signs-of-headache/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Clinical evaluation of Secondary causes of headaches]]
warning signs of headache (should prompt neuroimaging)
Explosive onset (vasc) â€œworst HA of lifeâ€ (SAH, RCVS) meningismus (SAH, infxn) Positional: lying &amp;gt;standing (â†‘ ICP) N/V (â†‘ ICP; migraines) coughing/bearing down (â†‘ ICP) Visual sx: diplopia, blurring, â†“ acuity (GCA, glaucoma, â†‘ ICP) eye pain glaucoma, trigeminal autonomic cephalalgia optic neuritis Abnl exam (struct.</description></item><item><title>epithelial sodium channel - ENaC</title><link>https://www.physician.tw/epithelial-sodium-channel-ENaC/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epithelial-sodium-channel-ENaC/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Liddleâ€™s syndrome]]
epithelial sodium channel - ENaC open in response to signals that sodium levels in the blood are too low, which allows sodium to flow into cells.</description></item><item><title>licorice</title><link>https://www.physician.tw/licorice/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/licorice/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Etiologies-of-Metabolic-Alkalosis]]
licorice (glycyrrhizic acid inhibits 11Î²-HSD)
çš®è³ªé†‡ï¼Œä¸€ç¨®ç³–çš®è³ªæ¿€ç´ ï¼Œèˆ‡ç³–çš®è³ªæ¿€ç´ å—é«”çµåˆã€‚ ç„¶è€Œï¼Œç”±æ–¼å…¶èˆ‡é†›å›ºé…®çš„åˆ†å­ç›¸ä¼¼æ€§ï¼Œ å®ƒä¹Ÿåœ¨è¼ƒé«˜æ¿ƒåº¦ä¸‹èˆ‡é¹½çš®è³ªæ¿€ç´ å—é«”çµåˆã€‚ é†›å›ºé…®å’Œçš®è³ªé†‡å°é¹½çš®è³ªæ¿€ç´ å—é«”æœ‰ç›¸ä¼¼çš„è¦ªå’ŒåŠ›ï¼› ç„¶è€Œï¼Œå¾ªç’°ä¸­çš„çš®è³ªé†‡é é å¤šæ–¼é†›å›ºé…®ã€‚
ç‚ºäº†é˜²æ­¢çš®è³ªé†‡å°é¹½çš®è³ªæ¿€ç´ å—é«”çš„éåº¦åˆºæ¿€ 11Î²-HSDå°‡å…·æœ‰ç”Ÿç‰©æ´»æ€§çš„çš®è³ªé†‡è½‰åŒ–ç‚ºä¸å†èˆ‡é¹½çš®è³ªæ¿€ç´ å—é«”çµåˆçš„éæ´»æ€§çš®è³ªé†‡ 11Î²-HSDèˆ‡è…ä¸Šè…ºçš®è³ªæ¿€ç´ å—é«”å…±å®šä½ã€‚ ç”˜è‰å«æœ‰ç”˜è‰é…¸å’Œç”˜è‰æ¬¡é…¸ï¼Œèƒ½æŠ‘åˆ¶11Î²-HSDï¼Œå°è‡´é¹½çš®è³ªæ¿€ç´ éå¤šç—‡å€™ç¾¤ã€‚ çš®è³ªé†‡æ°´å¹³éš¨ä¹‹å‡é«˜</description></item><item><title>Liddleâ€™s syndrome</title><link>https://www.physician.tw/Liddles-syndrome/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Liddles-syndrome/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[Etiologies-hyperaldosteronism]]
Liddleâ€™s syndrome Liddle syndrome is an inherited form of high blood pressure (hypertension).
caused by mutations in the SCNN1B or SCNN1G gene.</description></item><item><title>opportunistic infections</title><link>https://www.physician.tw/opportunistic-infections/</link><pubDate>Tue, 10 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/opportunistic-infections/</guid><description>[!info] ğŸŒ± ä¾†è‡ª: [[infectious disease]]
opportunistic infections test</description></item><item><title>acid-base abnormalities</title><link>https://www.physician.tw/acid-base-abnormalities/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acid-base-abnormalities/</guid><description>acid-base abnormalities</description></item><item><title>adult-onset Stillâ€™s disease</title><link>https://www.physician.tw/adult-onset-Stills-disease-/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adult-onset-Stills-disease-/</guid><description>from: [[rheumatology]]
adult-onset Stillâ€™s disease</description></item><item><title>approach to rheumatic disease</title><link>https://www.physician.tw/approach-to-rheumatic-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-rheumatic-disease/</guid><description>from: [[rheumatology]]
approach to rheumatic disease</description></item><item><title>brother</title><link>https://www.physician.tw/brother/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/brother/</guid><description>from: [[orphan]]
brother [[cousin]]</description></item><item><title>BufNewFile</title><link>https://www.physician.tw/BufNewFile/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BufNewFile/</guid><description>BufNewFile</description></item><item><title>Clinical features-peripheral artery disease</title><link>https://www.physician.tw/Clinical-features-peripheral-artery-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-features-peripheral-artery-disease/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[peripheral artery disease]]
Clinical features-peripheral artery disease</description></item><item><title>Conservative therapy of nerve root compression</title><link>https://www.physician.tw/Conservative-therapy-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Conservative-therapy-of-nerve-root-compression/</guid><description>from: [[Evaluation and treatment of nerve root compression]]
Conservative therapy of nerve root compression avoid bending/lifting; soft collar (cervical radiculopathy); NSAIDs; muscle relaxants; lidocaine patch/ointment; Rx neuropathic pain (see â€œPeripheral Neuropathiesâ€); physical/occup therapy.</description></item><item><title>crystal deposition arthritides</title><link>https://www.physician.tw/crystal-deposition-arthritides/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crystal-deposition-arthritides/</guid><description>from: [[rheumatology]]
crystal deposition arthritides [[comparison of gout and pseudogout]]
[[gout]]
[[calcium pyrophosphate dihydrate - cppd - deposition disease]] [[pseudogout]]</description></item><item><title>Diagnosis-peripheral artery disease</title><link>https://www.physician.tw/Diagnosis-peripheral-artery-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-peripheral-artery-disease/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[peripheral artery disease]]
Diagnosis-peripheral artery disease</description></item><item><title>differential diagnosis of back pain</title><link>https://www.physician.tw/differential-diagnosis-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnosis-of-back-pain/</guid><description>from: [[back pain]]
differential diagnosis of back pain [[Musculoskeletal ddx of back pain]]
Spinal cord (myelopathy) nerve root (radiculopathy):</description></item><item><title>Duty note of hypokalemia</title><link>https://www.physician.tw/Duty-note-of-hypokalemia/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duty-note-of-hypokalemia/</guid><description>from: [[/Users/htlin/Documents/Medical/hypokalemia]]
Duty note of hypokalemia</description></item><item><title>Etiologies of spinal cord compression</title><link>https://www.physician.tw/Etiologies-of-spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-spinal-cord-compression/</guid><description>from: [[spinal cord compression]]
Etiologies of spinal cord compression tumor (vertebral mets intradural meningioma/[[neurofibroma]]) epidural abscess/ hematoma, vascular malformation (dural AV fistula) degen.</description></item><item><title>Evaluation and treatment of nerve root compression</title><link>https://www.physician.tw/Evaluation-and-treatment-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-and-treatment-of-nerve-root-compression/</guid><description>from: [[nerve root compression]]
Evaluation and treatment of nerve root compression (NEJM 2016;374:1763)
MRI if sx not improved after 6 wk of conservative tx; if nondiagnostic, consider EMG/NCS</description></item><item><title>Evaluation and treatment of spinal cord compression</title><link>https://www.physician.tw/Evaluation-and-treatment-of-spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-and-treatment-of-spinal-cord-compression/</guid><description>from: [[spinal cord compression]]
Evaluation and treatment of spinal cord compression Empiric spine immobilization (collar, board) for all trauma patients</description></item><item><title>History taking of back and spinal cord disease</title><link>https://www.physician.tw/History-taking-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-taking-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
History taking of back and spinal cord disease location, timing (acute/subacute/chronic) worse w/ Valsalva radiation trauma wt loss cancer fever immunocompromised IVDU neurologic symptom saddle anesthesia Lhermitte phenomenon bowel/bladder/sexual sx (retention, incontinence)</description></item><item><title>inpatient diabetes management</title><link>https://www.physician.tw/inpatient-diabetes-management/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inpatient-diabetes-management/</guid><description> [!info] ğŸŒ± ä¾†è‡ª: [[endocrinology]]
inpatient diabetes management</description></item><item><title>Laboratory of back and spinal cord disease</title><link>https://www.physician.tw/Laboratory-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
Laboratory of back and spinal cord disease (depending on suspicion): CBC w/ diff, ESR/CRP, Ca, PO4, CSF, BCx</description></item><item><title>mother</title><link>https://www.physician.tw/mother/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mother/</guid><description>mother [[father]]</description></item><item><title>Musculoskeletal ddx of back pain</title><link>https://www.physician.tw/Musculoskeletal-ddx-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Musculoskeletal-ddx-of-back-pain/</guid><description>from: [[differential diagnosis of back pain]]
Musculoskeletal ddx of back pain involving spine (vertebra, facet joints), paraspinal muscles &amp;amp; ligaments sacroiliac joint, or hip joint Spondylolisthesis vertebral fx OA inflam.</description></item><item><title>nerve root compression</title><link>https://www.physician.tw/nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nerve-root-compression/</guid><description>nerve root compression (NEJM 2015;372:1240 &amp;amp; Continuum 2021;27:163)
Radicular pain aggravated by activity (esp. bending, straining, coughing), relieved by lying</description></item><item><title>Neuro exam of back and spinal cord disease</title><link>https://www.physician.tw/Neuro-exam-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuro-exam-of-back-and-spinal-cord-disease/</guid><description>from: [[back and spinal cord disease]]
Neuro exam of back and spinal cord disease full motor (incl. sphincter tone); gait; sensory (temp/pain, position, vibration; â†‘ perineal; ?</description></item><item><title>neurofibroma</title><link>https://www.physician.tw/neurofibroma/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurofibroma/</guid><description>from: [[Etiologies of spinal cord compression]]
neurofibroma</description></item><item><title>neurogenic claudication</title><link>https://www.physician.tw/neurogenic-claudication/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurogenic-claudication/</guid><description>from: [[nerve root compression]]
neurogenic claudication Lumbar spinal stenosis (with nerve root compression)
Radicular back/buttock pain
Radiating down legs
Worse with Walking &amp;amp; standing; Hyperextension/lying prone</description></item><item><title>Pathophysiology of nerve root compression</title><link>https://www.physician.tw/Pathophysiology-of-nerve-root-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-nerve-root-compression/</guid><description>from: [[nerve root compression]]
Pathophysiology of nerve root compression &amp;lt;65 y: 90% from disc herniation. â‰¥65 y also w/ more degenerative contributors: ligamentous hypertrophy, osteophyte formation, facet arthropathy, neural foraminal narrowing</description></item><item><title>Patrick FABER test</title><link>https://www.physician.tw/Patrick-FABER-test/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patrick-FABER-test/</guid><description>from: [[back and spinal cord disease]]
Patrick FABER test (SI joint synd): severe pain on hip ext rotation; 70% Se, 100% Sp</description></item><item><title>Red flags of back and spinal cord disease</title><link>https://www.physician.tw/Red-flags-of-back-and-spinal-cord-disease/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Red-flags-of-back-and-spinal-cord-disease/</guid><description>from: [[back pain]]
Red flags of back and spinal cord disease acute change (pain, weakness), upper motor neuron signs (hyperreflexia, upgoing toes) cauda equina conus medullaris syndromes (saddle anesthesia bowel/bladder or sexual dysfunction reduced rectal tone loss of sacral reflexes) dyspnea when flat (C3â€“C5) pain at rest or at night</description></item><item><title>referred pain from visceral disease of back pain</title><link>https://www.physician.tw/referred-pain-from-visceral-disease-of-back-pain/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/referred-pain-from-visceral-disease-of-back-pain/</guid><description>from: [[differential diagnosis of back pain]]
referred pain from visceral disease of back pain GI: PUD cholelithiasis pancreatitis pancreatic cancer GU: pyelonephritis nephrolithiasis uterine or ovarian cancer salpingitis Vascular: aortic dissection leaking aortic aneurysm</description></item><item><title>rheumatoid arthritis</title><link>https://www.physician.tw/rheumatoid-arthritis/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatoid-arthritis/</guid><description>from: [[rheumatology]]
rheumatoid arthritis</description></item><item><title>sciatica</title><link>https://www.physician.tw/sciatica/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sciatica/</guid><description>from: [[nerve root compression]]
sciatica = radicular pain radiating from buttocks down lateral aspect of leg, often to knee or lateral calf Â± numbness and paresthesias radiating to lateral foot.</description></item><item><title>screening and health maintenance</title><link>https://www.physician.tw/screening-and-health-maintenance/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/screening-and-health-maintenance/</guid><description>from: [[symptom to diagnosis]]
screening and health maintenance</description></item><item><title>spinal cord compression</title><link>https://www.physician.tw/spinal-cord-compression/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spinal-cord-compression/</guid><description>from: [[neurology]]
spinal cord compression (Continuum 2021;27:163)
[[Etiologies of spinal cord compression]]
Acute: flaccid paraparesis and absent reflexes (â€œspinal shockâ€)</description></item><item><title>spondyloarthritis</title><link>https://www.physician.tw/spondyloarthritis/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spondyloarthritis/</guid><description>from: [[rheumatology]]
spondyloarthritis</description></item><item><title>spurling sign</title><link>https://www.physician.tw/spurling-sign/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/spurling-sign/</guid><description>from: [[back and spinal cord disease]]
spurling sign (cervical radiculopathy):
radicular pain with: downward force to extended &amp;amp; ipsilaterally rotated head 30% Se, 93% Sp</description></item><item><title>straight leg raise</title><link>https://www.physician.tw/straight-leg-raise/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/straight-leg-raise/</guid><description>from: [[back and spinal cord disease]]
straight leg raise (sciatica or lumbosacral radiculopathy): radicular pain at 30â€“70Â°
ipsilateral: 92% Se, 28% Sp</description></item><item><title>Vascular Claudication</title><link>https://www.physician.tw/Vascular-Claudication/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Claudication/</guid><description>from: [[nerve root compression]]
Vascular Claudication Peripheral artery disease
(with limb ischemia)
Cramping leg pain
Mostly in calves; radiating up legs</description></item><item><title>vim append</title><link>https://www.physician.tw/vim-append/</link><pubDate>Mon, 09 Jan 2023 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vim-append/</guid><description>from: [[Vimwiki]]
vim append</description></item><item><title/><link>https://www.physician.tw/blog/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/blog/</guid><description>2022-08-08-zotero.md 2022-08-13-bitly.md 2022-08-13-vim-search-and-replace.md 2022-08-01-command-line-tool.md 2022-08-13-obsidian.md 2022-08-18-obsidian-to-anki-connect.md 2022-08-22-pyenv.md 2022-08-22-zotero.md 2022-08-28-md-bib-make.md 2022-08-29-anki-obsidian.md 2022-08-31-r-bookdown.md 2022-09-01-jama-temp.md 2022-09-13-pandoc-md-to-pptx.md</description></item><item><title/><link>https://www.physician.tw/Blood-Tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Tests/</guid><description>Blood Tests erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels usually elevated1 other blood test findings reported with giant cell arteritis include anemia (hemoglobin &amp;lt; 12 g/dL) in about one-half of patients thrombocytosis in about one-half of patients leukocytosis in about one-quarter of patients Reference - [16148728Medicine (Baltimore) 2005 Sep;84(5):277][160] vascular endothelial growth factor (VEGF) may be elevated and play a role in pathogenesis, but clinical significance has not been established5 individual blood tests appear to have low-to-moderate performance for diagnosis of giant cell arteritis</description></item><item><title/><link>https://www.physician.tw/change/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/change/</guid><description/></item><item><title/><link>https://www.physician.tw/chest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest/</guid><description/></item><item><title/><link>https://www.physician.tw/coronary/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary/</guid><description/></item><item><title/><link>https://www.physician.tw/duty/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/duty/</guid><description>title1 titles title2</description></item><item><title/><link>https://www.physician.tw/orphan/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/orphan/</guid><description>[[mother]] [[sister]] [[brother]]</description></item><item><title/><link>https://www.physician.tw/pandoc-in-vim/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pandoc-in-vim/</guid><description>pandoc in vim #ğŸš§ æ–½å·¥ä¸­ pandoc --citeproc --bibliography=&amp;quot;$HOME/Zotero/zotero_main.bib&amp;quot; -s -t gfm --csl=&amp;quot;$HOME/Zotero/styles/american-medical-association.csl&amp;quot; &amp;quot;%&amp;quot; -o &amp;quot;%&amp;quot;
Shell script for converting a batch of *.</description></item><item><title/><link>https://www.physician.tw/PocketBrain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PocketBrain/</guid><description>Section 00.1 - Table of CONTENTS -
00.1 â€“ Table of CONTENTS
00.2 â€“** **Front Matter: TITLE Page
00.3 â€“ Acknowledgements/Copyright</description></item><item><title/><link>https://www.physician.tw/stable/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stable/</guid><description/></item><item><title/><link>https://www.physician.tw/Testing-Overview/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Testing-Overview/</guid><description>Testing Overview urgently refer patients with suspected giant cell arteritis to specialist3 diagnosis can be confirmed by either [temporal artery biopsy][123] [imaging][124] for temporal or other cranial arteries, [ultrasound][125] or [magnetic resonance imaging][126] (MRI) for aorta/extracranial arteries, [computed tomography][127] (CT), [positron emission tomography computed tomography][128] (PET-CT), MRI or ultrasound do not delay glucocorticoid therapy in patients with typical symptoms, increased inflammatory markers, and acute visual disturbance; diagnosis can still be confirmed after initiation of glucocorticoid therapy3 [blood tests][130] may show elevation in erythrocyte sedimentation rate or C-reactive protein</description></item><item><title/><link>https://www.physician.tw/%E6%9C%AA%E5%91%BD%E5%90%8D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E6%9C%AA%E5%91%BD%E5%90%8D/</guid><description/></item><item><title>1</title><link>https://www.physician.tw/PART-1-The-Profession-of-Medicine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PART-1-The-Profession-of-Medicine/</guid><description>The Profession of Medicine PA RT 1 The Practice of Medicine The Editors
1 ENDURING VALUES OF THE MEDICAL PROFESSION No greater opportunity, responsibility, or obligation can fall to the lot of a human being than to become a physician.</description></item><item><title>2018 ACC AHA Cholesterol Guidelines</title><link>https://www.physician.tw/2018-ACC-AHA-Cholesterol-Guidelines/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/2018-ACC-AHA-Cholesterol-Guidelines/</guid><description>2018 ACC AHA Cholesterol Guidelines Population Recommendation
Very high-risk ASCVD* High-intensity statin; add EZE then PCSK9i if LDL-C â‰¥70
Clinical ASCVD High-intensity statin (?</description></item><item><title>5-y survival of lung cancer</title><link>https://www.physician.tw/5-y-survival-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/5-y-survival-of-lung-cancer/</guid><description>5-y survival of lung cancer ~70â€“90% for stage I, 50â€“60% stage II, 15â€“35% stage III, 0â€“10% stage IV (J Thorac Oncol 2016;11:39); survival improving with newer therapies (NEJM 2020;383:640).</description></item><item><title>5H5T</title><link>https://www.physician.tw/5H5T/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/5H5T/</guid><description>5H5T 5H Hypovolemia: volume Hypoxia: oxygenate H+ ions (acidosis): NaHCO3 Hypo/hyper K: KCI/Ca et al. Hypothermia: warm
5T [[POCUS]] Tension PTX: needle decomp.</description></item><item><title>ABG-vs-VBG</title><link>https://www.physician.tw/ABG-vs-VBG/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ABG-vs-VBG/</guid><description>ABG-vs-VBG concordant for pH (~0.04), HCO3 (~2 mEq) but not PCO2 (~8Â±17 mmHg) VBG can be used to screen for hypercarbia w/ PCO2 cutoff â‰¥45 mmHg (100% Se), but may not accurately assess degree of hypercarbia (Am J Emerg Med 2012;30:896)</description></item><item><title>Ablation-atrial fibrillation</title><link>https://www.physician.tw/Ablation-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ablation-atrial-fibrillation/</guid><description>Ablation-atrial fibrillation (Heart Rhythm 2017;14:e445; JACC 2020;75:1689)
Controlling triggers in pulm veins effective when little atrial fibrosis; as AF persists, substrate more complex Pulm vein isolation (radiofreq or cryo; NEJM 2016;374:2235): ~70% success; superior to AAD (JAMA 2014;311:692; NEJM 2021;384:305 &amp;amp; 316) &amp;amp; â†‘ QoL (JAMA 2019;321:1059) If NYHA IIâ€“IV + EF &amp;lt;35%, ablation â†“ D/HF hosp vs.</description></item><item><title>abnormal liver tests</title><link>https://www.physician.tw/abnormal-liver-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/abnormal-liver-tests/</guid><description>abnormal liver tests [[Tests of hepatocellular injury or cholestasis]] [[Tests of hepatic function]] [[Patterns of LFTs]] [[Acute mild-to-moderate elevation in ALT AST ]] [[Chronic mild-to-moderate elevation in ALT AST ]] [[Acute severe elevation in ALT AST]] [[Approach to abnormal liver tests with cholestatic pattern]] [[Approach to abnormal liver tests with infiltrative pattern]] [[Medication causes of abnormal LFTs]]</description></item><item><title>about line</title><link>https://www.physician.tw/about-line/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/about-line/</guid><description>about line</description></item><item><title>ACC AHA Classification for Office-Based BP</title><link>https://www.physician.tw/ACC-AHA-Classification-for-Office-Based-BP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACC-AHA-Classification-for-Office-Based-BP/</guid><description>ACC AHA Classification for Office-Based BP (HTN 2018;71:e13) Category Systolic (mmHg) Diastolic (mmHg) Normal &amp;lt;120 &amp;lt;80 Elevated 120â€“129 &amp;lt;80 Stage 1 hypertension 130â€“139 80â€“89 Stage 2 hypertension â‰¥140 â‰¥90</description></item><item><title>accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/accessory-pathways-wolff-parkinson-white/</guid><description>accessory pathways (wolff-parkinson-white) [[Definitions-accessory pathways (wolff-parkinson-white)]] [[Classic tachycardias of WPW accessory pathways]] [[Treatment-accessory pathways (wolff-parkinson-white)]]</description></item><item><title>Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acetaminophen-hepatotoxicity/</guid><description>Acetaminophen hepatotoxicity (Clin J Transl Hepatol 2016;4:131; BMJ 2016;353:i2579)
[[Pathophysiology-Acetaminophen hepatotoxicity]]
CYP2E1 induced by fasting, alcohol, certain anticonvulsants and anti-TB drugs, resulting in injury with even low doses (2â€“6 g) of acetaminophen</description></item><item><title>Acetaminophen-toxicology</title><link>https://www.physician.tw/Acetaminophen-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acetaminophen-toxicology/</guid><description>Acetaminophen-toxicology Vomiting, â†‘ AG &amp;amp; nl OG metabolic acidosis, hepatitis &amp;amp; hepatic failure, renal failure
N-acetylcysteine (NAC) infusion
Hemodialysis if massive O/D</description></item><item><title>acid-base disturbances</title><link>https://www.physician.tw/acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acid-base-disturbances/</guid><description>acid-base disturbances [[Definitions-acid-base disturbances]] [[Consequences-of-Severe-Acid-Base-Disturbances]] [[Workup-acid-base disturbances]] [[metabolic-acidosis]] [[metabolic-alkalosis]] [[respiratory-acidosis]] [[respiratory-alkalosis]]</description></item><item><title>Acinetobacter sp</title><link>https://www.physician.tw/Acinetobacter-sp/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acinetobacter-sp/</guid><description>Acinetobacter sp aerobic non-fermentative coccobacilary gram negative bacilli
cause soft tissue, wounds and bone, urinary tract infections, meningitis ;eye infection resistance is a problem 50% multidrug resistant extended spectrum beta-lactamase Tigecycine is not recommended sub-theraputic serum concentrations in bacteremia increased risk of all cause mortality [[IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections]]</description></item><item><title>ACLS</title><link>https://www.physician.tw/ACLS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS/</guid><description>ACLS [[CPRäººåŠ›é…ç½®]] [[ICU]]
[[electrocardiography]] [[arrhythmias]] [[Pulseless Arrest]] [[ACLS Tachycardia Algorithm]] [[ACLS Bradycardia Algorithm]]</description></item><item><title>ACLS Bradycardia Algorithm</title><link>https://www.physician.tw/ACLS-Bradycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS-Bradycardia-Algorithm/</guid><description>ACLS Bradycardia Algorithm å°è—ä¸Šä¸åˆ°4å€‹å«æ…¢(&amp;lt;60pbm)ï¼Œå…«å€‹å«å¿«(100bpm+) bradycardia w/ Pulse (HR &amp;lt;50 &amp;amp; inadequate for clinical condition) Airway, IV Access, O2, monitor BP &amp;amp; rhythm, 12-lead ECG if Type ll 2Â° AVB or 3Â° AVB proceed to pacing ASAP äºŒåº¦2ä»¥ä¸Šä¸ç”¨Adenosine atropine 1 mg IV q3-5min, max 3 mg æ‰“ä¸‰æ¬¡ å¿ƒå¾‹åˆ¤è®€ è¦å‰‡:ä¸€æˆ–ä¸‰</description></item><item><title>ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ACLS-Tachycardia-Algorithm/</guid><description>ACLS Tachycardia Algorithm [[electrocardiography]]
unstable = hypotension, change of MS, s/s shock, chest pain, heart failure</description></item><item><title>Acromegaly</title><link>https://www.physician.tw/Acromegaly/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acromegaly/</guid><description>Acromegaly (â†‘ GH; 10% of adenomas; Nat Rev Dis Primer 2019;5:1)
Physiology: stimulates secretion of insulin-like growth factor 1 (IGF-1) Clinical manifestations: â†‘ soft tissue, arthralgias, jaw enlargement, headache, carpal tunnel syndrome, macroglossia, hoarseness, sleep apnea, amenorrhea, impotence, diabetes mellitus, acanthosis/skin tags, â†‘ sweating, HTN/CMP, colonic polyps Diagnostic studies: low utility in checking random GH levels because of pulsatile secretion â†‘ IGF-1 (somatomedin C); Â± â†‘ PRL; OGTT â†’ GH not suppressed to &amp;lt;1 (&amp;lt;0.</description></item><item><title>Acute Anti Ischemic and Analgesic Treatment</title><link>https://www.physician.tw/Acute-Anti-Ischemic-and-Analgesic-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Anti-Ischemic-and-Analgesic-Treatment/</guid><description>Acute Anti Ischemic and Analgesic Treatment Nitrates (SL or IV) 0.3â€“0.4 mg SL q5min Ã— 3, then consider IV if still sx Use for relief of sx, Rx for HTN or HF.</description></item><item><title>acute aortic syndromes</title><link>https://www.physician.tw/acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-aortic-syndromes/</guid><description>acute aortic syndromes [[Definitions-acute aortic syndromes]] [[Classification-acute aortic syndromes]] [[Risk factors-acute aortic syndromes]] [[Clinical Manifestations and Physical Exam-acute aortic syndromes]] [[Initial evaluation diagnostic studies-acute aortic syndromes]] [[Treatment-acute aortic syndromes]] [[Complications-acute aortic syndromes]]</description></item><item><title>acute bacterial meningitis</title><link>https://www.physician.tw/acute-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-bacterial-meningitis/</guid><description>acute bacterial meningitis Definition Inflammation of tissue around the brain/spinal cord Usually arising from nasopharynx (hematogenous spread), bacteremia, or direct inoculation (surgery, contiguous infection, trauma, foreign body [eg, CSF shunt]) [[Microbiology in Bacterial Meningitis]] Clinical manifestations (Lancet 2016;339:16) Headache (84%), fever (74%), stiff neck (74%), photosensitivity, GCS &amp;lt;14 (71%), nausea (62%), seizure (23%); 95% have 2 of 4: HA, fever, stiff neck, Î”MS Presentation may be atypical (eg, lethargy w/o fever) in elderly and immunosupp.</description></item><item><title>Acute bacterial skin and skin structure infections</title><link>https://www.physician.tw/Acute-bacterial-skin-and-skin-structure-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-bacterial-skin-and-skin-structure-infections/</guid><description>Acute bacterial skin and skin structure infections Primary Regimens Elevate the involved leg Inpatient parenteral therapy: Penicillin G 1 to 2 million units IV q6h If history of pencillin skin rash and nothing to suggest IgE-mediated allergic reaction: Cefazolin 1 gm IV q8h or Ceftriaxone 2 gm IV once daily If history/evidence of past IgE-mediated allergic reaction (anaphylaxis), then may be forced to use: Vancomycin 15-20 mg/kg IV q8-12h to achieve preferred target AUC24 400-600 Î¼g/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 Î¼g/mL Linezolid 600 mg IV/po bid Treat IV until afebrile; then outpatient Penicillin V-K 500 mg po qid ac and hs for a total of 10 days of therapy.</description></item><item><title>acute coronary syndromes</title><link>https://www.physician.tw/acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-coronary-syndromes/</guid><description>acute coronary syndromes [[NSTE-ACS]] (Circ 2014;130:e344; EHJ 2021;42:1289) [[STEMI]] (Circ 2013;127:529; EHJ 2018;39:119) [[CHECKLIST AND LONG TERM POST ACS MANAGEMENT]]</description></item><item><title>Acute hemolytic</title><link>https://www.physician.tw/Acute-hemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-hemolytic/</guid><description>Acute hemolytic : fever, HoTN, flank pain, AKI w/in 24 h. Due to ABO incompatibility â†’ preformed Abs vs. donor RBCs.</description></item><item><title>Acute Infectious Etiologies</title><link>https://www.physician.tw/Acute-Infectious-Etiologies-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Infectious-Etiologies-/</guid><description>Acute Infectious Etiologies [[NONINFLAMMATORY-Acute Infectious Etiologies]] [[INFLAMMATORY-Acute Infectious Etiologies]]</description></item><item><title>Acute interstitial nephritis</title><link>https://www.physician.tw/Acute-interstitial-nephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-interstitial-nephritis/</guid><description>Acute interstitial nephritis etiology Allergic: Î²-lactams, sulfa drugs, NSAIDs, PPIs Infection: pyelo, viral, legionella, TB, leptospirosis Infiltrative: sarcoid, lymphoma, leukemia Autoimmune: SjÃ¶grenâ€™s, TINU, IgG4, SLE, ICIs treatment (CJASN 2017;12:2046 &amp;amp; JASN 2020;31:435)</description></item><item><title>acute kidney injury AKI</title><link>https://www.physician.tw/acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-kidney-injury-AKI/</guid><description>acute kidney injury (AKI) [[Definition-acute kidney injury (AKI)]] [[Workup-acute kidney injury (AKI)]] [[Etiologies and Diagnosis of Acute Kidney Injury ]] [[General treatment-acute kidney injury (AKI)]] [[Managing complications-acute kidney injury (AKI)]]</description></item><item><title>Acute Kidney Injury in Patients with Liver Disease | American Society of Nephrology</title><link>https://www.physician.tw/Acute-Kidney-Injury-in-Patients-with-Liver-Disease-American-Society-of-Nephrology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Kidney-Injury-in-Patients-with-Liver-Disease-American-Society-of-Nephrology/</guid><description/></item><item><title>acute liver failure</title><link>https://www.physician.tw/acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-liver-failure/</guid><description>acute liver failure [[Definition-acute liver failure]] [[Etiology-acute liver failure]] [[Clinical manifestations-acute liver failure]] [[Workup-acute liver failure]] [[Management-acute liver failure]] [[Prognosis-acute liver failure]]</description></item><item><title>acute mesenteric ischemia</title><link>https://www.physician.tw/acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-mesenteric-ischemia/</guid><description>acute mesenteric ischemia [[Definition and causes-acute mesenteric ischemia]]
[[Clinical manifestations-acute mesenteric ischemia]]
[[Diagnostic studies-acute mesenteric ischemia]]</description></item><item><title>Acute mild-to-moderate elevation in ALT AST</title><link>https://www.physician.tw/Acute-mild-to-moderate-elevation-in-ALT-AST-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-mild-to-moderate-elevation-in-ALT-AST-/</guid><description>Acute mild-to-moderate elevation in ALT AST (&amp;lt;15Ã— ULN)
Assess risk of EtOH/drug/toxin: H&amp;amp;P; in EtOH AST:ALT ratio &amp;gt;2:1</description></item><item><title>acute pancreatitis</title><link>https://www.physician.tw/acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-pancreatitis/</guid><description>acute pancreatitis [[Pathogenesis-acute pancreatitis]] [[Etiologies-acute pancreatitis]] [[Clinical manifestations-acute pancreatitis]] [[Diagnostic studies-acute pancreatitis]] [[Severity-acute pancreatitis]] [[Prognosis-acute pancreatitis]] [[Treatment-acute pancreatitis]] [[Complications-acute pancreatitis]]</description></item><item><title>acute respiratory distress syndrome</title><link>https://www.physician.tw/acute-respiratory-distress-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/acute-respiratory-distress-syndrome/</guid><description>acute respiratory distress syndrome [[Berlin definition]] [[Pathophysiology of acute respiratory distress syndrome]] [[Pathology acute respiratory distress syndrome]] [[Etiologies acute respiratory distress syndrome]] [[Treatment acute respiratory distress syndrome]] [[Mechanisms of VILI Ventilator Strategies]] [[The 6 Ps-acute respiratory distress syndrome]] [[PEEP titration methods]] [[Prognosis of acute respiratory distress syndrome]]</description></item><item><title>Acute severe elevation in ALT AST</title><link>https://www.physician.tw/Acute-severe-elevation-in-ALT-AST/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-severe-elevation-in-ALT-AST/</guid><description>Acute severe elevation in ALT AST (&amp;gt;1000)
Massive elevations (&amp;gt;5000) usually due to ischemic injury or drug-induced hepatitis</description></item><item><title>Acute Treatment of Hypercalcemia</title><link>https://www.physician.tw/Acute-Treatment-of-Hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-Treatment-of-Hypercalcemia/</guid><description>Acute Treatment of Hypercalcemia Normal saline (4â€“6 L/d) h during Rx Natriuresis â†’ â†‘ renal Ca excretion æ’éˆ‰ â†’ â†‘ è…éˆ£æ’æ³„</description></item><item><title>Acute treatment of Migraine</title><link>https://www.physician.tw/Acute-treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-treatment-of-Migraine/</guid><description>Acute treatment of Migraine First-line medication NSAIDs (acetylsalicylic acid, ibuprofen or diclofenac potassium) Second-line medication Triptans When triptans provide insufficient pain relief, combine with fast-acting NSAIDs Third-line medication Ditans Gepants Adjunct medications for nausea and/or vomiting Prokinetic antiemetics (domperidone or metoclopramide)</description></item><item><title>Acute treatment-nephrolithiasis</title><link>https://www.physician.tw/Acute-treatment-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-treatment-nephrolithiasis/</guid><description>Acute treatment-nephrolithiasis (JAMA 2020;323:1961)
Analgesia (narcotics Â± NSAIDs; combination superior, Ann Emerg Med 2006;48:173), ensure adequate fluid repletion, antibiotics if UTI</description></item><item><title>Acute tubular necrosis ATN</title><link>https://www.physician.tw/Acute-tubular-necrosis-ATN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Acute-tubular-necrosis-ATN/</guid><description>Acute tubular necrosis (ATN) Allergic: Î²-lactams, sulfa drugs, NSAIDs, PPIs
Infection: pyelo, viral, legionella, TB, leptospirosis</description></item><item><title>Additional Diabetes Treatment Options</title><link>https://www.physician.tw/Additional-Diabetes-Treatment-Options/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-Diabetes-Treatment-Options/</guid><description>Additional Diabetes Treatment Options DPP-4 inhibitors (~0.5â€“1%) Block degrad. GLP-1 &amp;amp; GIP â†’ â†‘ insulin. â†‘ risk of HF w/ saxagliptin (NEJM 2013;369:1317), not w/ others.</description></item><item><title>Additional pleural fluid studies</title><link>https://www.physician.tw/Additional-pleural-fluid-studies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Additional-pleural-fluid-studies/</guid><description>Additional pleural fluid studies (NEJM 2002;346:1971)
NT-proBNP â‰¥1500 pg/mL has 91% Se &amp;amp; 93% Sp for CHF (Am J Med 2004;116:417)</description></item><item><title>Adeno or Other in Stage IV NSCLC Treatment</title><link>https://www.physician.tw/Adeno-or-Other-in-Stage-IV-NSCLC-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adeno-or-Other-in-Stage-IV-NSCLC-Treatment/</guid><description>Adeno or Other in Stage IV NSCLC Treatment Genetics % Treatment [[EGFR]] ~15 1st line: osimertinib if L858R, ex19del (NEJM 2018;378:113) [[EGFR ex20 insertion]] 2â€“3 Subsequent Rx w/ amivantamab (JCO 2021;39:3391) or mobocertinib (JAMA Onc 2021;7:e214761) after platinum chemo ALK ~4 1st line: alectinib pref.</description></item><item><title>Adrenal crisis in adrenal insufficiency</title><link>https://www.physician.tw/Adrenal-crisis-in-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-crisis-in-adrenal-insufficiency/</guid><description>Adrenal crisis in adrenal insufficiency (NEJM 2019;381;852)
Precipitants: preexisting adrenal insufficiency + serious infection or GI illness, bilateral adrenal hemorrhage or infarction, pituitary infarction Presentation: shock + anorexia, N/V, abd pain, weakness, fatigue, confusion, coma, fever Lab findings: hyponatremia, hyperkalemia (1Â°) Rx: hydrocortisone 100 mg IV followed by 50 mg IV q6 + IVF; do not delay for dx tests</description></item><item><title>adrenal disorders</title><link>https://www.physician.tw/adrenal-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-disorders/</guid><description>adrenal disorders [[Cushingâ€™s Syndrome]] (Hypercortisolism) [[hyperaldosteronism]] [[adrenal insufficiency]] FIGURE 5.4: Hypothalamicâ€“pituitaryâ€“adrenal axis and adrenal hormone production. A) Shown is the hypothalamicâ€“pituitaryâ€“adrenal axis, which regulates the production of adrenal hormones.</description></item><item><title>adrenal incidentalomas</title><link>https://www.physician.tw/adrenal-incidentalomas/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-incidentalomas/</guid><description>adrenal incidentalomas Epidemiology
4% of Pts undergoing abdominal CT scan have incidentally discovered adrenal mass; prevalence â†‘ with age Differential diagnosis Nonfunctioning mass: adenoma, cysts, abscesses, granuloma, hemorrhage, lipoma, myelolipoma, primary or metastatic malignancy Functioning mass: pheochromocytoma, adenoma (cortisol, aldosterone, sex hormones), other endocrine tumor, carcinoma Hormonal workup (EJE 2016;175:G1; NEJM 2021;384:1542) Rule out subclinical Cushingâ€™s syndrome in all Pts using 1 mg overnight DST (Sp 91%).</description></item><item><title>adrenal insufficiency</title><link>https://www.physician.tw/adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/adrenal-insufficiency/</guid><description>adrenal insufficiency [[Etiologies-adrenal insufficiency]] [[Clinical manifestations-adrenal insufficiency]] [[Diagnostic studies-adrenal insufficiency]] [[Treatment-adrenal insufficiency]] [[Adrenal insufficiency and critical illness]] [[Adrenal crisis in adrenal insufficiency]] [[pheochromocytoma and paraganglioma]] [[adrenal incidentalomas]]</description></item><item><title>Adrenal insufficiency and critical illness</title><link>https://www.physician.tw/Adrenal-insufficiency-and-critical-illness/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Adrenal-insufficiency-and-critical-illness/</guid><description>Adrenal insufficiency and critical illness (NEJM 2003;348:727; JAMA 2009;301:2362)
Low cortisol binding proteins; âˆ´ dx of adrenal insufficiency problematic (NEJM 2013;368:1477) Adrenal insufficiency rare in most cases of shock unless adrenal infarction or bleed, Waterhouse-Friderichson, CNS or pituitary bleed Reasonable to collect cortisol level in HoTN Pt w/ suspicion for adrenal insufficiency Can consider above dx criteria, but decision for Rx should also be based on clinical assessment due to risk of false âŠ– and âŠ• results in context of altered physiology If concerned, initiate corticosteroids early: use hydrocortisone 100 mg IV followed by 50 mg IV q6h Controversial data for empiric steroids in all critically ill Pts [[sepsis and shock]]</description></item><item><title>aflatoxin</title><link>https://www.physician.tw/aflatoxin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aflatoxin/</guid><description>é»ƒéº´æ¯’ç´ ï¼ˆAflatoxinï¼‰æ˜¯ç”±è¨±å¤šéº´èŒå±¬ï¼ˆAspergillusï¼‰é»´èŒæ‰€ç”¢ç”Ÿçš„é»´èŒæ¯’ç´ ï¼ˆmycotoxinï¼‰çµ±ç¨±ï¼Œå…¶ä¸­æœ€æœ‰åçš„æ˜¯é»ƒéº´èŒï¼ˆ[[Aspergillus flavus]]ï¼‰</description></item><item><title>AIP acute IP Hamman-Rich syndrome</title><link>https://www.physician.tw/AIP-acute-IP-Hamman-Rich-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AIP-acute-IP-Hamman-Rich-syndrome/</guid><description>AIP acute IP (Hamman-Rich syndrome) Diffuse ground-glass opacities, consolidations w/ lobular sparing. Path/imaging similar to DAD (diffuse, bilateral, central&amp;gt;periph ground glass or consolidative opacities).</description></item><item><title>Airway-Management</title><link>https://www.physician.tw/Airway-Management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Airway-Management/</guid><description>Airway-Management âœ¨Functional anatomy of the upper airwayé‡é»: åœ¨èˆŒæ ¹ä¸‹æ–¹ï¼Œæœƒå­å°‡å£å’½èˆ‡å–‰å’½æˆ–ä¸‹åš¥åˆ†é–‹ã€‚ æœƒå­é€šéåœ¨ååš¥éç¨‹ä¸­è¦†è“‹å–‰éƒ¨ï¼ˆè²é–€ï¼‰çš„é–‹å£ä¾†é˜²æ­¢èª¤å¸ã€‚ å–‰æ˜¯ç”±ä¹å€‹è»Ÿéª¨ä»¥åŠéŸŒå¸¶å’Œè‚Œè‚‰çµ„æˆçš„è»Ÿéª¨éª¨æ¶ã€‚ ç”²ç‹€è»Ÿéª¨çš„éƒ¨åˆ†åŠŸèƒ½æ˜¯ä¿è­·è²å¸¶ã€‚ [[predictors of difficult mask ventilation]] [[equipment of airway-management]] [[positioning-airway-management]] [[preoxygenation]] [[bag and mask ventilation]] [[premedication of airway-management]] [[laryngoscopy and confirmation of placement]]</description></item><item><title>Albuterol of COPDAE</title><link>https://www.physician.tw/Albuterol-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Albuterol-of-COPDAE/</guid><description>Albuterol of COPDAE MDI 4â€“8 puffs q1â€“2h or Nebulizer 2.5â€“5 mg q1â€“2h Benefit if component of reversible bronchoconstriction</description></item><item><title>alcohol withdrawal</title><link>https://www.physician.tw/alcohol-withdrawal/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/alcohol-withdrawal/</guid><description/></item><item><title>Alcohol-associated hepatitis</title><link>https://www.physician.tw/Alcohol-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alcohol-associated-hepatitis/</guid><description>Alcohol-associated hepatitis Sx: progressive jaundice, tender hepatomegaly, fever, ascites, GIB, encephalopathy Symptoms: gradual yellowing of the skin, painful enlargement of the liver, fever, accumulation of fluid in the abdomen, gastrointestinal bleeding, brain dysfunction.</description></item><item><title>Aldosterone-antagonists</title><link>https://www.physician.tw/Aldosterone-antagonists/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aldosterone-antagonists/</guid><description>Aldosterone-antagonists Add after RASi and bB if adeq. renal fxn and w/o hyperkalemia
25â€“30% â†“ mort. in NYHA IIâ€“IV &amp;amp; EF â‰¤35% (NEJM 2011;364:11)</description></item><item><title>Allergic Transfusion reactions</title><link>https://www.physician.tw/Allergic-Transfusion-reactions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Allergic-Transfusion-reactions/</guid><description>Allergic Transfusion reactions urticaria; rarely, anaphylaxis due to rxn to txfused proteins, especially in IgA-deficient Pts w/ anti-IgA Abs (use washed products).</description></item><item><title>allergy immunology</title><link>https://www.physician.tw/allergy-immunology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/allergy-immunology/</guid><description>allergy immunology Allergic Rhinitis/Conjunctivitis/Sinusitis Anaphylaxis Drug Allergy Food Allergy Urticaria and Angioedema Eosinophilia and Mast-Cell Disorders Immunodeficiency</description></item><item><title>Alterations in Body Temperature</title><link>https://www.physician.tw/Alterations-in-Body-Temperature/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Body-Temperature/</guid><description>Alterations in Body Temperature Chapter 18: [[fever]] Chapter 19: [[fever and rash]] Chapter 20: [[fever of unknown origin]]</description></item><item><title>Alterations in Circulatory and Respiratory Functions</title><link>https://www.physician.tw/Alterations-in-Circulatory-and-Respiratory-Functions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Circulatory-and-Respiratory-Functions/</guid><description>Alterations in Circulatory and Respiratory Functions Chapter 37: [[dyspnea]] Chapter 38: [[cough]] Chapter 39: [[hemoptysis]] Chapter 40: [[Hypoxia and Cyanosis]] Chapter 41: [[edema] Chapter 42: [[approach to the patient with a heart murmur]] Chapter 43: [[palpitations]]</description></item><item><title>Alterations in Renal and Urinary Tract Function</title><link>https://www.physician.tw/Alterations-in-Renal-and-Urinary-Tract-Function/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-Renal-and-Urinary-Tract-Function/</guid><description>Alterations in Renal and Urinary Tract Function Chapter 51: [[interstitial cystitis]] and [[bladder pain syndrome]] Chapter 52: [[azotemia]] and Urinary Abnormalities Chapter 53: [[fluid and electrolyte disturbances]] Chapter 54: [[hypercalcemia]] and [[hypocalcemia]] Chapter 55: Acidosis and Alkalosis</description></item><item><title>Alterations in the Skin</title><link>https://www.physician.tw/Alterations-in-the-Skin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Alterations-in-the-Skin/</guid><description>Alterations in the Skin Chapter 56: Approach to the Patient with a Skin Disorder Chapter 57: Eczema, Psoriasis, Cutaneous Infections, Acne, and Other Common Skin Disorders Chapter 58: Skin Manifestations of Internal Disease Chapter 59: Immunologically Mediated Skin Diseases Chapter 60: Cutaneous Drug Reactions Chapter 61: Photosensitivity and Other Reactions to Sunlight</description></item><item><title>Amiodarone</title><link>https://www.physician.tw/Amiodarone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Amiodarone/</guid><description>Amiodarone 150 mg/3 mL loading infusionï¼š150 mg in 100 mL over 10 minï¼› followed by 900 mg in 500 mL over 6 hr MAX initial infusion rate 30 mg/minã€‚ 5-7 mg/kg /V over 30-60 mg/min, 10-g load</description></item><item><title>amiodarone and thyroid disease</title><link>https://www.physician.tw/amiodarone-and-thyroid-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/amiodarone-and-thyroid-disease/</guid><description>amiodarone and thyroid disease Overview (JCEM 2021;106:226) 6 mg iodine per 200-mg tablet; risk of thyroid dysfunction lower with lower doses âœ“ TSH prior to therapy, at 4-mo intervals on amio, and for 1 y after if amio d/câ€™d Hypothyroidism (occurs in ~10%; more common in iodine-replete areas) Pathophysiology (1) Wolff-Chaikoff effect: iodine load â†“ Iâ€“ uptake, organification and release of T4 &amp;amp; T3 (2) inhibits T4 â†’ T3 conversion (3) ?</description></item><item><title>amyloidosis</title><link>https://www.physician.tw/amyloidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/amyloidosis/</guid><description>amyloidosis [[Systemic diseases with secondary glomerular involvement]]</description></item><item><title>anaphylaxis</title><link>https://www.physician.tw/anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anaphylaxis/</guid><description>anaphylaxis [[Definition and pathophysiology-anaphylaxis]] [[Diagnosis-anaphylaxis]] [[Treatment-anaphylaxis]] [[Disposition-anaphylaxis]] [[Angioedema]]</description></item><item><title>Anaplastic thyroid cancer</title><link>https://www.physician.tw/Anaplastic-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anaplastic-thyroid-cancer/</guid><description>Anaplastic thyroid cancer â™€:â™‚ 1.5â€“2:1; poorly differentiated, extremely aggressive, mortality 90% at 5 y P/w rapidly growing fixed &amp;amp; hard neck mass, regional or distant spread in 90% at dx Rx options include surgery, radiation, trach, chemo, investigational clinical trials</description></item><item><title>ANCA positive Vasculitis</title><link>https://www.physician.tw/ANCA-positive-Vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ANCA-positive-Vasculitis/</guid><description>ANCA positive Vasculitis Differential diagnosis of ANCA (Nat Rev Dis Primers 2020;6:71) #â­
anti-PR3: GPA, EGPA, microscopic polyangiitis (rarely), levamisole (contam.</description></item><item><title>anemia</title><link>https://www.physician.tw/anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anemia/</guid><description>anemia â†“ in RBC mass: Hct &amp;lt;41% or Hb &amp;lt;13.5 g/dL (men); Hct &amp;lt;36% or Hb &amp;lt;12 g/dL (women)</description></item><item><title>Anemia in chronic kidney disease</title><link>https://www.physician.tw/Anemia-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemia-in-chronic-kidney-disease/</guid><description>Anemia in chronic kidney disease goal Hb 10â€“11.5 g/dL, worse outcomes if target higher (NEJM 2009;361:2019)
epoetin (start 80â€“120 U/kg SC, divided 3Ã—/wk) or darbepoetin (0.</description></item><item><title>Anemia of chronic inflammation</title><link>https://www.physician.tw/Anemia-of-chronic-inflammation-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemia-of-chronic-inflammation-/</guid><description>Anemia of chronic inflammation (ACI; NEJM 2012;366:4)
â†“ RBC production due to impaired iron utilization and functional iron deficiency from â†‘ hepcidin; cytokines (IL-6, TNF-Î±) cause â†“ Epo responsiveness/production</description></item><item><title>Anemias of other chronic disorders</title><link>https://www.physician.tw/Anemias-of-other-chronic-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anemias-of-other-chronic-disorders/</guid><description>Anemias of other chronic disorders Anemia of CKD: â†“ Epo; treat w/ Epo &amp;amp; iron (see â€œChronic Kidney Diseaseâ€)</description></item><item><title>Angioedema</title><link>https://www.physician.tw/Angioedema/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Angioedema/</guid><description>Angioedema (J Allergy Clin Immunol 2013;131:1491)
Localized swelling of skin/mucosa; involves face, lips, tongue, uvula, larynx, and bowels</description></item><item><title>anion gap</title><link>https://www.physician.tw/anion-gap/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/anion-gap/</guid><description>anion gap (AG) = Na+ â€“ (Clâ€“ + HCO3â€“) = unmeasured anions â€“ unmeasured cations If â†‘ glc, use measured not corrected Na Expected AG is [albumin] Ã— 2.</description></item><item><title>Annotations</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM/</guid><description>Annotations Mdnotes File Name: [[Nonspecific Low Back Pain]] Annotations (8/12/2022, 12:37:26 AM)
â€œNonspecific Low Back Pain * Nonspecific low back pain is diagnosed on the basis of the exclusion of specific causes, usually by means of history taking and physical examination.</description></item><item><title>Anorectal disorders</title><link>https://www.physician.tw/Anorectal-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anorectal-disorders/</guid><description>Anorectal disorders Internal, external hemorrhoids; anal fissures, rectal ulcers, rectal varices (Rx by â†“ portal venous pressure in cirrhosis), XRT</description></item><item><title>Anti Depressant KFSYSCC</title><link>https://www.physician.tw/Anti-Depressant-KFSYSCC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-Depressant-KFSYSCC/</guid><description>1.2.3
Category Medication Selective Serotonin Reuptake Inhibitors Escitalopram, Sertraline Serotonin Norepinephrine Reuptake Inhibitors Duloxetine, Venlafaxine Tricyclic Amitriptyline, Amitriptyline 5-HT Triazolopyridine Trazodone Other 5-HT Receptor Modulators Vortioxetine Tetracyclic Mirtazapine, Aminoketone Bupropion [ How does this thing work?</description></item><item><title>Anti-GBM Disease</title><link>https://www.physician.tw/Anti-GBM-Disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-GBM-Disease/</guid><description>Anti-GBM Disease (linear staining) &amp;lt;15% of total (CJASN 2017;12:1162)
Goodpastureâ€™s Glomerulonephritis: æœ‰ Pulm Hemorrhage: æœ‰ Anti-GBM disease: æœ‰ Anti-GBM Glomerulonephritis: æœ‰ Pulm Hemorrhage: - Anti-GBM disease: æœ‰</description></item><item><title>Anti-IL5</title><link>https://www.physician.tw/Anti-IL5/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anti-IL5/</guid><description>Anti-IL5 (eg, mepolizumab, benralizumab): mixed data on â†“ exacerb in Pts with eos (NEJM 2017;377:1613 æˆ‘å€‘ç™¼ç¾è¡€æ¶²ä¸­å«æœ‰å¤§é‡å—œé…¸æ€§ç™½è¡€çƒçš„é‡åº¦æ°£å–˜æ‚£è€…ï¼Œå¯ä»¥å¾æœç”¨ mepolizumabã€ reslizumab æˆ– benralizumab ä¾†æ¸›å°‘æ°£å–˜ç™¼ä½œã€‚åœ¨ç”Ÿæ´»å“è³ªå’Œå‘¼å¸æ¸¬è©¦æ–¹é¢å‡æœ‰å°å¹…çš„æ”¹å–„ï¼Œä½†æ”¹å–„å¹…åº¦å¯èƒ½å¤ªå°ä»¥è‡³æ–¼ç„¡æ³•è¢«æ‚£è€…å¯Ÿè¦ºã€‚æˆ‘å€‘åŒæ„åœ‹éš›æŒ‡å¼•ç¨±é€™äº›è—¥ç‰©å¯ä»¥æ–°å¢åˆ°é‡åº¦æ°£å–˜æ‚£è€…çš„æ¨™æº–æ²»ç™‚ä¸­ä¹‹èªªæ³•ã€‚éœ€è¦é€²ä¸€æ­¥çš„ç ”ç©¶ä¾†é—¡æ˜ä¸€äº›æ–¹é¢ï¼Œä¾‹å¦‚å¦‚ä½•è©•åƒ¹æ²»ç™‚åæ‡‰ä»¥åŠçµ¦äºˆæ²»ç™‚å¤šé•·æ™‚é–“ã€‚&amp;amp; 2019;381:1023)</description></item><item><title>Antiarrhythmic Drugs AAD for AF</title><link>https://www.physician.tw/Antiarrhythmic-Drugs-AAD-for-AF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiarrhythmic-Drugs-AAD-for-AF/</guid><description>Antiarrhythmic Drugs (AAD) for AF III IC IA Underlying disease &amp;amp; maintenance AAD of choice: None or minimal (incl HTN wlo LVH): class IC (â€œpill in pocket&amp;quot;).</description></item><item><title>antibiotics</title><link>https://www.physician.tw/antibiotics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/antibiotics/</guid><description>antibiotics</description></item><item><title>Antibiotics of COPDAE</title><link>https://www.physician.tw/Antibiotics-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antibiotics-of-COPDAE/</guid><description>Antibiotics of COPDAE Amox, TMP-SMX, doxy, azithro, antipneumococcal FQ all reasonable (no single abx proven superior). Consider local flora and avoid repeat courses of same abx.</description></item><item><title>Antibiotics-sepsis and shock</title><link>https://www.physician.tw/Antibiotics-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antibiotics-sepsis-and-shock/</guid><description>Antibiotics-sepsis and shock Start empiric IV abx as soon as possible after recognition of severe sepsis or septic shock; every hr delay in abx admin a/w 7.</description></item><item><title>Anticoagulant in chronic kidney disease</title><link>https://www.physician.tw/Anticoagulant-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulant-in-chronic-kidney-disease/</guid><description>Anticoagulant in chronic kidney disease : ESRD at â†‘ bleed risk; if using DOAC, consider apixiban &amp;gt;rivaroxaban &amp;gt;dabigatran due to protein binding/renal clearance (JASN 2017;28:2241)</description></item><item><title>Anticoagulant Therapy</title><link>https://www.physician.tw/Anticoagulant-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulant-Therapy/</guid><description>Anticoagulant Therapy For NSTEMI UFH: 60 U/kg IVB (max 4000 U) then 12 U/kg/h (max 1000 U/h initially) Ã— 48 h or until end of PCI 24% â†“ D/MI (JAMA 1996;276:811)</description></item><item><title>Anticoagulation antiplatelet therapy-prosthetic-heart-valves</title><link>https://www.physician.tw/Anticoagulation-antiplatelet-therapy-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation-antiplatelet-therapy-prosthetic-heart-valves/</guid><description>Anticoagulation antiplatelet therapy-prosthetic-heart-valves (Circ 2021;143:e72)
Mechanical: warfarin (not DOAC), INR 3 or 2.5 if low-risk mech AVR (none of following: prior thromboembolism, AF, EF &amp;lt;30â€“35%, hypercoagulable).</description></item><item><title>Anticoagulation-Treatment of Chronic HF with Reduced EF</title><link>https://www.physician.tw/Anticoagulation-Treatment-of-Chronic-HF-with-Reduced-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Anticoagulation-Treatment-of-Chronic-HF-with-Reduced-EF/</guid><description>Anticoagulation-Treatment of Chronic HF with Reduced EF [[antiplatelet Therapy of STEMI]] If AF, VTE, LV thrombus, Â± if large akinetic LV segments.</description></item><item><title>antimetabolites</title><link>https://www.physician.tw/antimetabolites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/antimetabolites/</guid><description>antimetabolites [[Methotrexate]]</description></item><item><title>Antiphospholipid antibodies</title><link>https://www.physician.tw/Antiphospholipid-antibodies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiphospholipid-antibodies/</guid><description>Antiphospholipid antibodies [[Antiphospholipid syndrome (APS)]]
âœ“ if: SLE, age &amp;lt;40 y &amp;amp; arterial thromb, recurrent venous thromb, spontaneous abortion</description></item><item><title>Antiphospholipid syndrome APS</title><link>https://www.physician.tw/Antiphospholipid-syndrome-APS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiphospholipid-syndrome-APS/</guid><description>Antiphospholipid syndrome (APS) [[Definition-Antiphospholipid syndrome]] (APS) Features: DVT/PE/CVA, recurrent fetal loss, â†“ plts, hemolytic anemia, livedo reticularis
â€œCatastrophic APSâ€: â‰¥3 organ systems in &amp;lt;1 wk w/ âŠ• APLA &amp;amp; tissue microthrombi; 44% mortality (Arth Rheum 2006;54:2568); Rx w/ plasmapheresis, rituximab</description></item><item><title>Antiplatelet Therapy</title><link>https://www.physician.tw/Antiplatelet-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiplatelet-Therapy/</guid><description>Antiplatelet Therapy [[Aspirin]] P2Y12 (ADP receptor) inhibitor (choose one of the following in addition to ASA). Timing (on presentation or at angiography) remains controversial.</description></item><item><title>Antiplatelet Therapy of STEMI</title><link>https://www.physician.tw/Antiplatelet-Therapy-of-STEMI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiplatelet-Therapy-of-STEMI/</guid><description>Antiplatelet Therapy of STEMI Aspirin 162â€“325 mg Ã— 1 (crushed/chewed) then 81 mg qd 23% â†“ in death (Lancet 1988;ii:349) Should not be stopped if CABG required</description></item><item><title>Antiretrovirals ARVs</title><link>https://www.physician.tw/Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antiretrovirals-ARVs/</guid><description>Antiretrovirals (ARVs) [[nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals (ARVs)]] [[non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals (ARVs)]] [[protease inhibitors - PI-Antiretrovirals (ARVs)]] [[entry inhibitors-EI-Antiretrovirals (ARVs)]] [[integrase strand transfer inhibitor-INSTI-Antiretrovirals (ARVs)]]</description></item><item><title>Antituberculous Medications</title><link>https://www.physician.tw/Antituberculous-Medications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antituberculous-Medications/</guid><description>Antituberculous Medications [[Antituberculous Treatment Regimens]]
*Risk of hepatitis â†‘ w/ pre-existing liver disease. Consult ID, consider holding/replacing PZA or INH.</description></item><item><title>Antituberculous Treatment Regimens</title><link>https://www.physician.tw/Antituberculous-Treatment-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Antituberculous-Treatment-Regimens/</guid><description>Antituberculous Treatment Regimens [[Antituberculous Medications]]
Pulmonary TB â‰¥4% INH-resist. in community (incl. most of U.S.) INH + RIF + PZA + EMB until suscept.</description></item><item><title>aortic aneurysms</title><link>https://www.physician.tw/aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-aneurysms/</guid><description>aortic aneurysms [[Definitions-aortic aneurysms]] [[Epidemiology-aortic aneurysms]] [[Pathophysiology risk factors -aortic aneurysms]] [[Screening-aortic aneurysms]] [[Diagnostic studies-aortic aneurysms]] [[Treatment-aortic aneurysms]]
Surgery-aortic aneurysms (EHJ 2014;25:2873)</description></item><item><title>aortic-regurgitation</title><link>https://www.physician.tw/aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-regurgitation/</guid><description>aortic-regurgitation [[Etiology-aortic-regurgitation]] (Circ 2006;114:422) [[Clinical-manifestations-aortic-regurgitation]] [[Physical-exam-aortic-regurgitation]] [[Classic-Eponymous-Signs-in-Chronic-AR]] (South Med J 1981;74:459) [[Diagnostic-studies-aortic-regurgitation]] [[Treatment-aortic-regurgitation]] (Lancet 2016;387:1312; Circ 2021;143:e72)</description></item><item><title>aortic-stenosis</title><link>https://www.physician.tw/aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aortic-stenosis/</guid><description>aortic-stenosis [[Etiology-aortic-stenosis]] [[Clinical-manifestations-aortic-stenosis]] [[Physical-exam-aortic-stenosis]] [[Diagnostic-studies-aortic-stenosis]] [[valve-replacement]] (Circ 2021;143:e72) [[TAVI]] (transcatheter AoV implantation) (JAMA 2021;325:2480; Circ 2021;143:e72)</description></item><item><title>Aplastic anemia</title><link>https://www.physician.tw/Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aplastic-anemia/</guid><description>Aplastic anemia (stem cell failure) (NEJM 2015;373:35)
Epidemiology: 2â€“5 cases/106/y; biphasic (major peak in adolescents, 2nd peak in elderly)</description></item><item><title>Appearance of cerebrospinal fluid</title><link>https://www.physician.tw/Appearance-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Appearance-of-cerebrospinal-fluid/</guid><description>Appearance of cerebrospinal fluid Clear and colorlessï¼šæ­£å¸¸CSF Turbidï¼šå¯èƒ½ä»£è¡¨ WBC &amp;gt; 200 æˆ– RBC &amp;gt; 400 Bloodyï¼šRBC &amp;gt; 6000 Xanthochromiaï¼šCSF ä¸­çš„ RBC åˆ†è§£ â†’ å½¢æˆ oxyhemoglobin ä½¿ CSF è®Šç²‰ç´…è‰² â†’ è¢«è½‰æˆ bilirubin ä½¿ CSF è®Šæˆé»ƒè‰²ã€‚ï¼ˆé™¤äº† SAH ä¹‹å¤–ï¼Œåœ¨ CSF total protein &amp;gt; 150mg/dL æˆ– serum bilirubin &amp;gt; 10â€“15 mg/dL æ™‚ä¹Ÿå¯èƒ½ç™¼ç”Ÿï¼‰</description></item><item><title>approach to abnormal hemostasis</title><link>https://www.physician.tw/approach-to-abnormal-hemostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/approach-to-abnormal-hemostasis/</guid><description>approach to abnormal hemostasis (NEJM 2014;370:847)</description></item><item><title>Approach to abnormal liver tests with cholestatic pattern</title><link>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-cholestatic-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-cholestatic-pattern/</guid><description>Approach to abnormal liver tests with cholestatic pattern</description></item><item><title>Approach to abnormal liver tests with infiltrative pattern</title><link>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-infiltrative-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-abnormal-liver-tests-with-infiltrative-pattern/</guid><description>Approach to abnormal liver tests with infiltrative pattern</description></item><item><title>Approach to acute AF</title><link>https://www.physician.tw/Approach-to-acute-AF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-acute-AF/</guid><description>Approach to acute AF (Adapted from Circ 2014;130:e199)</description></item><item><title>Approach to anemia and common causes</title><link>https://www.physician.tw/Approach-to-anemia-and-common-causes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-anemia-and-common-causes/</guid><description>Approach to anemia and common causes</description></item><item><title>Approach to Diuresis</title><link>https://www.physician.tw/Approach-to-Diuresis-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-Diuresis-/</guid><description>Approach to Diuresis Loop diuretic PO: âœ“ response at 1â€“3 h, redose at 2Ã— prior dose if needed</description></item><item><title>Approach to glomerulonephritis based on immunofluorescence pattern</title><link>https://www.physician.tw/Approach-to-glomerulonephritis-based-on-immunofluorescence-pattern/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-glomerulonephritis-based-on-immunofluorescence-pattern/</guid><description>Approach to glomerulonephritis based on immunofluorescence pattern çœ‹åœ–èªªæ•…äº‹</description></item><item><title>Approach to hypernatremia</title><link>https://www.physician.tw/Approach-to-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-hypernatremia/</guid><description>Approach to hypernatremia</description></item><item><title>Approach to hypokalemia</title><link>https://www.physician.tw/Approach-to-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-hypokalemia/</guid><description>Approach to hypokalemia</description></item><item><title>Approach to metabolic acidosis</title><link>https://www.physician.tw/Approach-to-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-metabolic-acidosis/</guid><description>Approach to metabolic acidosis</description></item><item><title>Approach to microcytic anemias</title><link>https://www.physician.tw/Approach-to-microcytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-microcytic-anemias/</guid><description>Approach to microcytic anemias</description></item><item><title>Approach to newly diagnosed HIV positive Pt</title><link>https://www.physician.tw/Approach-to-newly-diagnosed-HIV-positive-Pt/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-newly-diagnosed-HIV-positive-Pt/</guid><description>Approach to newly diagnosed HIV positive Pt (CID 2020;73:e3572)
Counsel re: excellent prognosis w/adherence to treatment, treatment options, &amp;amp; disclosure Lab evaluation: CD4 count, HIV VL &amp;amp; genotype, CBC w/ diff.</description></item><item><title>Approach to oxygenation, hypoxemia, and hypoxemic respiratory failure</title><link>https://www.physician.tw/Approach-to-oxygenation-hypoxemia-and-hypoxemic-respiratory-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-oxygenation-hypoxemia-and-hypoxemic-respiratory-failure/</guid><description>Approach to oxygenation, hypoxemia, and hypoxemic respiratory failure Common misconceptions and mistakes Hypoxemia is a significant cause of dyspnea A cutaneous O 2 sat â‰¥ 92% predicts adequate oxygenation and is the appropriate target for O 2 orders 100% O 2 suppresses respiratory drive in CO 2 retainers O 2 supplementation for patients with COPD is given to improve exercise tolerance Confusing failure of oxygen delivery to tissues, hypoxia (the job of the circulatory system) with hypoxemia, and failure to maintain an adequate Pa o 2 (the job of the respiratory system) å¸¸è¦‹çš„èª¤è§£å’ŒéŒ¯èª¤ ä½æ°§è¡€ç—‡æ˜¯å°è‡´å‘¼å¸å›°é›£çš„é‡è¦åŸå›  çš®è†š O 2 sat â‰¥ 92% é ç¤ºæ°§åˆå……è¶³ï¼Œæ˜¯ O 2 ç´šçš„åˆé©ç›®æ¨™ 100% O 2 æŠ‘åˆ¶ CO 2 ä¿æŒå™¨ä¸­çš„å‘¼å¸é©…å‹• ç‚º COPD æ‚£è€…è£œå…… O 2 ä»¥æé«˜é‹å‹•è€é‡ å°‡ç„¡æ³•å‘çµ„ç¹”è¼¸é€æ°§æ°£ã€ç¼ºæ°§ï¼ˆå¾ªç’°ç³»çµ±çš„å·¥ä½œï¼‰èˆ‡ä½æ°§è¡€ç—‡ä»¥åŠç„¡æ³•ç¶­æŒè¶³å¤ çš„ Pa o 2ï¼ˆå‘¼å¸ç³»çµ±çš„å·¥ä½œï¼‰ç›¸æ··æ·† [[oxygenation]]</description></item><item><title>Approach to polyuria</title><link>https://www.physician.tw/Approach-to-polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-polyuria/</guid><description>Approach to polyuria</description></item><item><title>Approach to previously established HIV positive Pt</title><link>https://www.physician.tw/Approach-to-previously-established-HIV-positive-Pt/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-previously-established-HIV-positive-Pt/</guid><description>Approach to previously established HIV positive Pt H&amp;amp;P (mucocutaneous, neurocognitive, OIs, malignancies, STDs); meds and adherence Review ARVs (past and current); if hospitalized typically continue ARVs, if any must be held, stop all to â†“ risk of resistance Regimen failure: cannot achieve undetectable VL after months on ARVs, viral rebound (VL &amp;gt;200 copies/mL Ã—2 after prior suppression), â†“ CD4 count or clinical worsening</description></item><item><title>Approach to suspected DVT</title><link>https://www.physician.tw/Approach-to-suspected-DVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-DVT/</guid><description>Approach to suspected DVT</description></item><item><title>Approach to suspected PE</title><link>https://www.physician.tw/Approach-to-suspected-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-suspected-PE/</guid><description>Approach to suspected PE</description></item><item><title>Approach to syncope-syncope</title><link>https://www.physician.tw/Approach-to-syncope-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-syncope-syncope/</guid><description>Approach to syncope-syncope (Adapted from JACC 2017;70:e39)</description></item><item><title>Approach to thrombocytopenia</title><link>https://www.physician.tw/Approach-to-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-thrombocytopenia/</guid><description>Approach to thrombocytopenia Backlinkï¼š [[platelet disorders]]</description></item><item><title>Approach to treatment-of-hyponatremia</title><link>https://www.physician.tw/Approach-to-treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-treatment-of-hyponatremia/</guid><description>Approach to treatment-of-hyponatremia depends on volume status, acuity of hyponatremia, and if symptomatic
Acute sx: initial rapid correction of [Na]serum (2 mEq/L/h for the first 2â€“3 h) until sx resolve</description></item><item><title>Approach to TSH levels</title><link>https://www.physician.tw/Approach-to-TSH-levels/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-to-TSH-levels/</guid><description>Approach to TSH levels</description></item><item><title>Approach-electrocardiography</title><link>https://www.physician.tw/Approach-electrocardiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Approach-electrocardiography/</guid><description>Approach-electrocardiography ä¸€å€‹é€Ÿåº¦ã€å…©å€‹ç¯€å¥ã€ä¸‰å€‹é–“éš”ã€å››å€‹è…”å®¤ã€äº”å€‹æ¢—å¡
Rate tachy or brady rhythm ? P waves regularity P &amp;amp; QRS relationship ==&amp;gt; Afib or atrioventricular block Intervals PR, QRS, QT Axis LAD or RAD chamber abnormal LAA, RAA, LVH, RVH QRST changes ?</description></item><item><title>arrhythmias</title><link>https://www.physician.tw/arrhythmias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/arrhythmias/</guid><description>arrhythmias [[bradycardias av block and av dissociation]] [[supraventricular tachycardias (SVTS)]] [[accessory pathways (wolff-parkinson-white)]] [[wide-complex tachycardias (WCTS)]]</description></item><item><title>Arrhythmias post MI</title><link>https://www.physician.tw/Arrhythmias-post-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Arrhythmias-post-MI/</guid><description>Arrhythmias post MI Arrhythmias post-MI (treat all per ACLS protocols if unstable or symptomatic)
AF (10â€“16% incidence): Î²B or amio, Â± digoxin (particularly if HF), heparin</description></item><item><title>ascites</title><link>https://www.physician.tw/ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ascites/</guid><description>ascites Due to portal HTN (defined as hepatic venous pressure gradient [HVPG] &amp;gt;5 mmHg)
Develops in 60% w/in 10 y; often first decompensating event</description></item><item><title>Ascites fluid total protein AFTP</title><link>https://www.physician.tw/Ascites-fluid-total-protein-AFTP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ascites-fluid-total-protein-AFTP/</guid><description>Ascites fluid total protein (AFTP) useful when SAAG â‰¥1.1 to distinguish cirrhosis (AFTP &amp;lt;2.5 g/dL) from cardiac ascites (AFTP â‰¥2.5 g/dL).</description></item><item><title>aseptic meningitis</title><link>https://www.physician.tw/aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aseptic-meningitis/</guid><description>aseptic meningitis Definition Clinical/lab evidence of meningeal inflammation with negative bacterial cx (CSF &amp;amp; blood)
[[Etiologies-aseptic meningitis]]</description></item><item><title>Aspergillosis</title><link>https://www.physician.tw/Aspergillosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspergillosis/</guid><description>Aspergillosis (Lancet 2021;397:499)
ABPA: airway hypersensitivity secondary to aspergillus colonization Chronic pulmonary aspergillosis: includes aspergilloma (fungus ball), pulm. nodules, chronic cavitary and chronic fibrotic pulmonary aspergillosis that can present with subacute cough, dyspnea, hemoptysis; aspergilloma/nodules can be asymptomatic Invasive aspergillosis: seen in immunosupp.</description></item><item><title>Aspergillus flavus</title><link>https://www.physician.tw/Aspergillus-flavus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspergillus-flavus/</guid><description>Monday 22å¹´7æœˆ18æ—¥ 02:59:03
Write about Aspergillus flavus here!</description></item><item><title>Aspirin</title><link>https://www.physician.tw/Aspirin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Aspirin/</guid><description>Aspirin 162â€“325 mg Ã— 1, then 81 mg qd (nonâ€“enteric-coated, chewable) 50â€“70% â†“ D/MI (NEJM 1988;319:1105) Low dose (~81 mg) pref long term (NEJM 2010;363:930) If allergy, use clopi and/or desensitize to ASA</description></item><item><title>asthma</title><link>https://www.physician.tw/asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asthma/</guid><description>asthma [[Definition and epidemiology]] [[Clinical manifestations]] [[Physical examination]] [[Diagnostic studies]] [[differential diagnosis]] [[differential diagnosis]] [[Asthma plus syndromes]] CHRONIC MANAGEMENT [[Reliever medications-asthma]] [[Controller medications]] [[Immunotherapies-asthma]] [[Principles of treatment-asthma]] [[Asthma Stepwise Therapy]] EXACERBATION [[Evaluation-asthma-EXACERBATION]] [[Severity of Asthma Exacerbation]] [[Initial treatment details of asthma]] [[Disposition of patients after initial treatment of asthma exacerbation]] [[ICU-level care-asthma-EXACERBATION]]</description></item><item><title>Asthma plus syndromes</title><link>https://www.physician.tw/Asthma-plus-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Asthma-plus-syndromes/</guid><description>Asthma plus syndromes Atopy = asthma + allergic rhinitis + atopic dermatitis
Aspirin-exacerbated respiratory disease (Samterâ€™s syndrome) = asthma + ASA sensitivity + nasal polyps (J Allergy Clin Immunol 2015;135:676)</description></item><item><title>Asthma Stepwise Therapy</title><link>https://www.physician.tw/Asthma-Stepwise-Therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Asthma-Stepwise-Therapy/</guid><description>Asthma Stepwise Therapy</description></item><item><title>asymptomatic glomerular hematuria</title><link>https://www.physician.tw/asymptomatic-glomerular-hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/asymptomatic-glomerular-hematuria/</guid><description>asymptomatic glomerular hematuria Definition and etiologies Hematuria Â± proteinuria of glomerular origin w/o renal insufficiency or systemic disease (nonglomerular more common; see â€œHematuriaâ€) Ddx: any cause of GN (esp.</description></item><item><title>At client</title><link>https://www.physician.tw/setup/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/setup/</guid><description>[æ•™å­¸][NAS] Synology NAS SSH å…å¯†ç¢¼ç™»å…¥ | Gary&amp;rsquo;s &amp;hellip;Lasamia (garynil.tw)
At client ssh-keygen at home Copy id rsa.pub file to NAS home dir via</description></item><item><title>atezolizumab</title><link>https://www.physician.tw/atezolizumab/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atezolizumab/</guid><description>ä½œç”¨æ©Ÿè½‰ Atezolizumabæ˜¯å±¬æ–¼[[PD-L1]]çš„å…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘ã€‚Tæ·‹å·´ç´°èƒ (Tç´°èƒ)èˆ‡ç™Œç´°èƒä¸Šæœ‰è¨±å¤šå…ç–«æª¢æŸ¥é»ï¼Œæœ‰äº›æ˜¯ä¿ƒé€²å®ƒå€‘æ´»åŒ–å°±åƒè¸©æ²¹é–€ï¼Œæœ‰äº›åè€Œæ˜¯æŠ‘åˆ¶å®ƒå€‘å°±åƒè¸©ç…è»Šã€‚
å…¶ä¸­PD-L1æ˜¯å±¬æ–¼æŠ‘åˆ¶æ€§å…ç–«æª¢æŸ¥é»ï¼Œè€ŒPD-L1å…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘å‰‡æ˜¯æŠ‘åˆ¶PD-L1ï¼Œä¹Ÿå°±æ˜¯æ‹¿æ‰ç…è»Šï¼Œé‡æ–°å–šé†’Tç´°èƒç™¼æ®å…¶æŠ—ç™Œä½œç”¨ã€‚
é©æ‡‰ç—‡ è‚ç´°èƒç™Œã€éå°ç´°èƒè‚ºç™Œã€å°ç´°èƒè‚ºç™Œã€æ³Œå°¿é“ä¸Šçš®ç™Œã€ä¸‰é™°æ€§ä¹³ç™Œã€é»‘è‰²ç´ ç´°èƒç˜¤ã€‚
ç”¨æ³•ç”¨é‡ æ¯äºŒè‡³ä¸‰é€±ä¸€æ¬¡ï¼Œæ¯æ¬¡çµ¦äºˆ840-1200mgã€‚
å‰¯ä½œç”¨
å¸¸è¦‹ é«˜è¡€å£“(17-30%)ã€è„«é«®(32-56%)ã€ä¾¿ç§˜(12-36%)ã€é£Ÿæ…¾é™ä½(15-30%)ã€è…¹ç€‰(11-33%)ã€å™å¿ƒ(12-50%)ã€é—œç¯€ç—›(12-26%)ã€è™›å¼±(12-51%)ã€ç¥ç¶“ç—…è®Š(33-56%)ã€å’³å—½(27%)ã€å‘¼å¸å›°é›£(32%)ã€ç–²å€¦(47-61%)
åš´é‡ å¿ƒè‚Œç‚(1%)ã€è…ä¸Šè…ºåŠŸèƒ½ä¸å…¨(0.4-0.8%)ã€ç³–å°¿ç—…(0.1ï¼…)ã€è…¦ä¸‹å‚é«”ç™¼ç‚(0.4%)ã€ç”²ç‹€è…ºåŠŸèƒ½äº¢é€²(1.6ï¼…-19ï¼…)ã€ç”²ç‹€è…ºåŠŸèƒ½ä½ä¸‹(4.6-22ï¼…)ã€è…¹éƒ¨ç–¼ç—›(10-17%)ã€å¤§è…¸ç‚(2%)ã€è‚ç‚(14-53%)ã€æ€¥æ€§è…æå‚·(2.2ï¼…)ã€è¡€å°¿(14ï¼…)ã€æ³Œå°¿é“æ„ŸæŸ“(22ï¼…)ã€è‚ºéƒ¨ç™¼ç‚(5.5ï¼…)ã€ç™¼ç‡’(14-49ï¼…)ã€è¼¸æ³¨åæ‡‰(1.6-11ï¼…)</description></item><item><title>atrial fibrillation</title><link>https://www.physician.tw/atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/atrial-fibrillation/</guid><description>atrial fibrillation [[Classification-atrial fibrillation]] [[Epidemiology and etiologies-atrial fibrillation]] Evaluation-atrial fibrillation H&amp;amp;P, ECG, CXR, TTE (LA size, thrombus, valves, LV fxn, pericardium), K, Mg, Cr, TFTs In acute AF &amp;lt;48Âº, ~70% spont.</description></item><item><title>Atrial flutter</title><link>https://www.physician.tw/Atrial-flutter/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atrial-flutter/</guid><description>Atrial flutter peice of note</description></item><item><title>Atrial-Abnormality</title><link>https://www.physician.tw/Atrial-Abnormality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atrial-Abnormality/</guid><description>Atrial-Abnormality ECG P-wave criteria
Left Atrial Abnormality (LAA) Right Atrial Abnormality (RAA)</description></item><item><title>ATTRACTION-3</title><link>https://www.physician.tw/ATTRACTION-3/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ATTRACTION-3/</guid><description>ATTRACTION-3 Summary Background Chemotherapy for patients with advanced oesophageal squamous cell carcinoma offers poor long-term survival prospects. We report the final analysis from our study of the immune checkpoint PD-1 inhibitor nivolumab versus chemotherapy in patients with previously treated advanced oesophageal squamous cell carcinoma.</description></item><item><title>Atypical ANCA patterns</title><link>https://www.physician.tw/Atypical-ANCA-patterns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Atypical-ANCA-patterns/</guid><description>Atypical ANCA patterns drug-induced vasculitis, nonvasculitic rheumatic diseases, ulcerative colitis, primary sclerosing cholangitis, endocarditis, cystic fibrosis</description></item><item><title>aura</title><link>https://www.physician.tw/aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/aura/</guid><description>aura Aura is defined as transient focal neurological symptoms that usually precede, but sometimes accompany, the headache phase of a migraine attack.</description></item><item><title>Autoimmune hemolytic anemia</title><link>https://www.physician.tw/Autoimmune-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-hemolytic-anemia/</guid><description>Autoimmune hemolytic anemia Acquired, antibody-mediated RBC destruction
Warm AIHA: IgG Abs opsonize RBCs at body temp â†’ removal by spleen</description></item><item><title>autoimmune hepatitis AIH</title><link>https://www.physician.tw/autoimmune-hepatitis-AIH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-hepatitis-AIH/</guid><description>autoimmune hepatitis (AIH) [[Classification-autoimmune hepatitis (AIH)]] [[Diagnosis and treatment-autoimmune hepatitis (AIH) ]]</description></item><item><title>autoimmune pancreatitis</title><link>https://www.physician.tw/autoimmune-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/autoimmune-pancreatitis/</guid><description>autoimmune pancreatitis Pathogenesis (Am J Gastro 2018;113:1301) Type 1: lymphoplasmacytic sclerosing panc. w/ dense fibrosis; â†‘ IgG4; high relapse Type 2: idiopathic duct-centric pancreatitis; minimal â†‘ IgG4; a/w IBD; fewer relapses Clinical manifestations Abdominal pain, can p/w obstructive jaundice and panc mass mimicking panc Ca Can be primary, or in a/w IgG4 cholangiopathy, salivary gland disease (eg, SjÃ¶grenâ€™s), mediastinal or RP fibrosis, interstitial nephritis, autoimmune thyroiditis, UC/PSC, RA Diagnosis Labs: cholestatic LFTs (â†‘ AÏ• &amp;gt;AST/ALT), â†‘ Î³-globulins and IgG4, âŠ• ANA, RF HISORt criteria: Histology, Imaging (â€œsausage pancreas,â€ bile duct stricture), Serology, other Organ involvement, Response to therapy Treatment Glucocorticoids 1st-line; immunomod.</description></item><item><title>Autoimmune Polyglandular Syndromes</title><link>https://www.physician.tw/Autoimmune-Polyglandular-Syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Autoimmune-Polyglandular-Syndromes/</guid><description>Autoimmune Polyglandular Syndromes (NEJM 2018;378:1132) Type Features
I (APECED) Child onset, mucocutaneous candidiasis, hypoparathyroidism, adrenal insufficiency, AIRE mutation
II Adult onset, adrenal insufficiency, autoimmune thyroid disease, diabetes mellitus type 1; polygenic</description></item><item><title>AV Block</title><link>https://www.physician.tw/AV-Block/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AV-Block/</guid><description>AV Block (Circ 2019;140:e382) Type Features
1Â° Prolonged PR (&amp;gt;200 ms), all atrial impulses conducted (1:1).
2Â° Mobitz I (Wenckebach) Progressive â†‘ PR until impulse not conducted (â†’ â€grouped beatingâ€).</description></item><item><title>AV dissociation</title><link>https://www.physician.tw/AV-dissociation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/AV-dissociation/</guid><description>AV dissociation Default: slowing of SA node allows subsidiary pacemaker (eg, AV junction) to take over Usurpation: acceleration of subsidiary pacemaker (eg, AV junctional tach, VT) 3Â° AV block: atrial pacemaker unable to capture ventricles, subsidiary pacemaker emerges; distinguish from isorhythmic dissociation (A â‰ˆ V rate, some P waves nonconducting)</description></item><item><title>Axis-deviation</title><link>https://www.physician.tw/Axis-deviation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Axis-deviation/</guid><description>Axis-deviation Left axis deviation (LAD) Definition: axis beyond â€“30Â° (S &amp;gt;R in lead II)
Etiologies: LVH, LBBB, inferior MI, WPW</description></item><item><title>back pain</title><link>https://www.physician.tw/back-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/back-pain/</guid><description>Back pain [[differential diagnosis of back pain]] Lancet 2017;389:736 &amp;amp; Continuum 2021;27:12
initial [[evaluation of back and spinal cord disease]] [[differential diagnosis of back pain]]</description></item><item><title>Background of vasculitis</title><link>https://www.physician.tw/Background-of-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Background-of-vasculitis/</guid><description>Background of vasculitis [Vasculitis Pathophysiology Overview - YouTube]( https://www.youtube.com/watch?v=D9h6-LPySPI&amp;ab channel=ArmandoHasudungan) [Vasculitis | Clinical Presentation - YouTube]( https://www.youtube.com/watch?v=VfdeBT7e-dc&amp;ab channel=Medscape) Classified by size of predominant vessel affected (Arthritis Rheum 2013;65:1); overlap of vessel size affected is common çœ‹ä¸€ä¸‹é€™å¼µåœ–ï¼š æœ‰å¾ˆå¤šéƒ¨åˆ†æœƒé‡ç–Šï¼šæ³¨æ„æ˜¯æ‰€æœ‰ç¨®çš„éƒ½æœƒå½±éŸ¿åˆ°å¤§ä¸­å°ï¼Œæ‰€ä»¥ä¸èƒ½æ’é™¤ Clinical manifestations based on size of vessels involved; specific symptom constitutional sx (low-grade fever, fatigue, weight loss, myalgias, anorexia) common to all from inflammatory response Vasculitis is typically divided into 2 main categories: primary (idiopathic) secondary, caused by an underlying condition, such as an autoimmune process, infection, a neoplastic process, or certain medications Vasculitis can occur in any vessel type in any organ system of the body.</description></item><item><title>bacteremia</title><link>https://www.physician.tw/bacteremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacteremia/</guid><description>bacteremia [[definitions of bacteremia]] Diagnosis â‰¥2 sets BCx prior to abx (set = aerobic + aneaerobic cx) at separate puncture sites If proven bacteremia, daily surveillance cxs until 48 hrs of âŠ– cxs.</description></item><item><title>bacteremia and endocarditis</title><link>https://www.physician.tw/bacteremia-and-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacteremia-and-endocarditis/</guid><description>bacteremia and endocarditis [[bacteremia]] [[bacterial endocarditis]] [[infective endocarditis]]</description></item><item><title>bacterial endocarditis</title><link>https://www.physician.tw/bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bacterial-endocarditis/</guid><description>bacterial endocarditis Definition Infection of endothelium of heart (including but not limited to the valves) including both prosthetic valve endocarditis (PVE) and [[native valve endocarditis]] (NVE) [[Risk Factors-bacterial endocarditis]] Fungal: â†‘ risk w/ DM, indwelling lines, immunosupp.</description></item><item><title>Bacterial peritonitis</title><link>https://www.physician.tw/Bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bacterial-peritonitis/</guid><description>Bacterial peritonitis (Gut 2012;61:297; Hepatology 2021;74:1014)
âŠ• Ascites Culture Ascites PMNâ‰¥250/ÂµL [[Spontaneous bacterial peritonitis (SBP)]] [[secondary bacterial peritonitis]] Ascites PMN&amp;lt;250/ÂµL [[Nonneutrocytic bacterascites (NNBA)]] âŠ– Ascites Culture Ascites PMNâ‰¥250/ÂµL [[Culture-negative neutrocytic ascites (CNNA)]] [[Peritoneal dialysis-associated-Bacterial peritonitis]]</description></item><item><title>bag and mask ventilation</title><link>https://www.physician.tw/bag-and-mask-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bag-and-mask-ventilation/</guid><description>bag and mask ventilation âœ¨é‡é»: åˆ°ç›®å‰ç‚ºæ­¢ï¼Œä½¿ç”¨è¢‹å­å’Œç½©ç‚ºæ‚£è€…é€šæ°£çš„èƒ½åŠ›æ˜¯ä»»ä½•æ°£é“æä¾›è€…æŒæ¡çš„æœ€é‡è¦çš„æŠ€èƒ½ã€‚ å¦‚æœå¯ä»¥é€²è¡Œé¢ç½©é€šæ°£ï¼Œå‰‡ç„¡æ³•é€²è¡Œæ°£ç®¡æ’ç®¡ä¸¦ä¸è‡´å‘½ï¼Œé€™ä½¿å…¶æˆç‚º ASA å›°é›£æ°£é“ç®—æ³•çš„é‡è¦çµ„æˆéƒ¨åˆ†ã€‚ é¢ç½©é€šæ°£çš„ç›¸å°ç¦å¿Œç—‡æ˜¯é£½è…¹/åæµé¢¨éšªã€åš´é‡çš„é¢éƒ¨å‰µå‚·å’Œä¸ç©©å®šçš„é ¸æ¤éª¨æŠ˜ã€‚ é€²è¡Œé¢ç½©é€šæ°£æ™‚ï¼Œæä¾›è€…å·¦æ‰‹æ‹¿è‘—é¢ç½©ï¼Œå°‡é¢ç½©æ”¾åœ¨æ‚£è€…çš„é¼»å­å’Œå˜´å·´ä¸Šï¼Œç¬¬ä¸‰ã€ç¬¬å››å’Œç¬¬äº”æ ¹æ‰‹æŒ‡æ¡ä½ä¸‹é œéª¨ï¼Œå°‡é¢éƒ¨æŠ¬å…¥é¢ç½©ï¼Œ åŒæ™‚æ‹‡æŒ‡å’Œé£ŸæŒ‡åœ¨é è¿‘é›»è·¯é€£æ¥çš„é¢ç½©çš„é ˜å£å‘¨åœå½¢æˆä¸€å€‹â€œCâ€å½¢ã€‚ ç•¶è¢‹å­è¢«æ“ å£“æ™‚ï¼Œæ‡‰è©²æ³¨æ„åˆ°èƒ¸ç½©ä¸Šå‡å’Œå†·å‡ï¼Œä¸¦ä¸”æ‡‰è©²è½åˆ°æ²’æœ‰ç©ºæ°£é€¸å‡ºï¼Œé€™è¡¨æ˜ç”±æ–¼å¯†å°ä¸è¶³è€Œå°è‡´æ´©æ¼ã€‚ æ‡‰æ³¨æ„ä¸è¦å£“è¿«ä¸‹é œä¸‹çµ„ç¹”ï¼Œå› ç‚ºé€™æœƒä½¿æ°£é“å¡Œé™·ä¸¦ä½¿é€šæ°£æ›´åŠ å›°é›£ã€‚ å¦‚æœé¢ç½©é€šæ°£å›°é›£ï¼Œå¯ä»¥æ¡ç”¨é›™æ‰‹æŠ€è¡“ï¼Œå…¶ä¸­ä¸€åæä¾›è€…é›™æ‰‹æ¡ä½é¢ç½©ï¼Œæ‹‡æŒ‡æ”¾åœ¨é¢ç½©é ‚éƒ¨ï¼Œå…¶é¤˜æ‰‹æŒ‡æ”¾åœ¨ä¸‹é œéª¨ä¸Šï¼Œå°‡é¢éƒ¨æŠ¬å…¥é¢ç½©ï¼ŒåŒæ™‚åŠ©æ‰‹æ“ å£“è¢‹å­. å£è…”å’Œé¼»è…”æ°£é“ä¹Ÿå¾ˆæœ‰ç”¨ï¼Œå› ç‚ºå®ƒå€‘å°‡èˆŒé ­å’Œæœƒå­æ‹‰é›¢å’½å¾Œå£ï¼Œå¾è€Œå…è¨±æ›´å¤šçš„æ°£æµã€‚</description></item><item><title>Barrettâ€™s esophagitis</title><link>https://www.physician.tw/Barretts-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Barretts-esophagitis/</guid><description>Barrettâ€™s esophagitis (BE): metaplastic columnar mucosa above GE jxn replaces squam epithel. Screen if chronic (&amp;gt;5 y) and/or frequent GERD (â‰¥1/wk) in â™‚ w/ â‰¥2 risk factor for Barrettâ€™s/esophageal adeno: &amp;gt;50 y, white, hiatal hernia, central adiposity, smoking, FHx of Barrettâ€™s/esophageal adeno.</description></item><item><title>basic techniques and procedures</title><link>https://www.physician.tw/basic-techniques-and-procedures/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basic-techniques-and-procedures/</guid><description>basic techniques and procedures [[Airway-Management]] [[Sedation-and-Analgesia]] [[Vascular-Access]] [[POCUS]] [[bedside percutaneous dilational tracheostomy]] [[Nutritional Support and Total Parenteral Nutrition]] [[Glycemic Control in intensive care unit]] [[Hyperglycemic Emergencies]] [[Prevention of Complications in intensive care unit]] [[pain and palliative care]] [[bronchoscopy]]</description></item><item><title>basophilia</title><link>https://www.physician.tw/basophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/basophilia/</guid><description>basophilia Neoplasm MPN, CML, AML, Hodgkin lymph.
Infection TB, smallpox, parasites
Alteration in BM or reticuloendothelial compartment Hemolytic anemia, splenectomy</description></item><item><title>begins</title><link>https://www.physician.tw/begins/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/begins/</guid><description>begins [[zettle]]
Backlinkï¼š [[Clinical manifestations-cholelithiasis]] [[Clinical-manifestations-aortic-regurgitation]] [[Clinical-manifestations-mitral-regurgitation]]</description></item><item><title>BehÃ§etâ€™s syndrome</title><link>https://www.physician.tw/Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Beh%C3%A7ets-syndrome/</guid><description>BehÃ§etâ€™s syndrome (Nat Rev Dis Primers 2021;7:67)
Systemic vasculitis affecting all vessel sizes, venous and arterial, a/w painful oral and/or genital ulcers Epi: usually young adults (25â€“35 y); â™‚ = â™€, â†‘ severity in â™‚; a/w HLA-B51; â†‘ prev on old Silk Road (Turkey, Middle East, Asia) w/ 5 vs.</description></item><item><title>Bellâ€™s palsy</title><link>https://www.physician.tw/Bells-palsy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bells-palsy/</guid><description>Bellâ€™s palsy Definition &amp;amp; clinical manifestations
Acute idiopathic unilat. facial nerve palsy (CN VII), often presumed HSV reactivation P/w unilateral facial muscle weakness, hyperacusis, â†“ taste, lacrimation, &amp;amp; salivation Risk factors: pregnancy (preeclampsia), obesity, HTN, diabetes, preceding URI Diagnosis (Otol Head Neck Surg 2013;149:656)</description></item><item><title>Benzodiazepines-toxicology</title><link>https://www.physician.tw/Benzodiazepines-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Benzodiazepines-toxicology/</guid><description>Benzodiazepines-toxicology â†“ mentation, ataxia, â†“ RR
Flumazenil not rec (can precipitate withdrawal/seizures)</description></item><item><title>Beta blockers-toxicology</title><link>https://www.physician.tw/Beta-blockers-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Beta-blockers-toxicology/</guid><description>Beta blockers-toxicology Bradycardia, AV block, hypotension, HF, hypoglycemia
Glucagon, vasopressors, pacing</description></item><item><title>bevacizumab</title><link>https://www.physician.tw/bevacizumab/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bevacizumab/</guid><description>bevacizumab AvastinÂ®ï¼›ç™Œæ€åœÂ®æ³¨å°„åŠ‘ã€‚
è½‰ç§»æ€§å¤§è…¸ç›´è…¸ç™Œ(mCRC) AvastinÂ®(bevacizumab) èˆ‡å«æœ‰5-fluorouracilç‚ºåŸºç¤çš„åŒ–å­¸ç™‚æ³•åˆä½µä½¿ç”¨ï¼Œå¯ä»¥ä½œç‚ºè½‰ç§»æ€§å¤§è…¸æˆ–ç›´è…¸ç™Œç—…äººçš„ç¬¬ä¸€ç·šæ²»ç™‚ã€‚
AvastinÂ®èˆ‡å«æœ‰5-fluorouracil/leucovorin/oxaliplatinçš„åŒ–å­¸ç™‚æ³•åˆä½µä½¿ç”¨ï¼Œå¯ä»¥ä½œç‚ºå…ˆå‰æ¥å—éä»¥fluoropyrimidineç‚ºåŸºç¤çš„åŒ–å­¸ç™‚æ³•ç„¡æ•ˆä¸”æœªæ›¾æ¥å—éAvastinÂ®æ²»ç™‚çš„è½‰ç§»æ€§å¤§è…¸æˆ–ç›´è…¸ç™Œç—…äººçš„æ²»ç™‚ã€‚
Avastin (bevacizumab)èˆ‡å«æœ‰fluoropyrimidine-irinotecan-æˆ–fluoropyrimidine-oxaliplatin-ç‚ºåŸºç¤çš„åŒ–å­¸ç™‚æ³•åˆä½µä½¿ç”¨ï¼Œå¯ä»¥åšç‚ºç¬¬ä¸€ç·šå·²æ¥å—éä»¥Avastin ä½µç”¨åŒ–ç™‚å¾Œæƒ¡åŒ–ä¹‹è½‰ç§»æ€§å¤§è…¸æˆ–ç›´è…¸ç™Œç—…äººçš„ç¬¬äºŒç·šæ²»ç™‚ã€‚
èªªæ˜: Avastin (bevacizumab) ä¸é©ç”¨æ–¼é«˜é¢¨éšªçš„äºŒæœŸä»¥åŠä¸‰æœŸå¤§è…¸ç™Œè¼”åŠ©æ€§ç™‚æ³• (high risk stage II and III adjuvant colon cancer; aCC)</description></item><item><title>biliary tract disease</title><link>https://www.physician.tw/biliary-tract-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/biliary-tract-disease/</guid><description>biliary tract disease [[cholelithiasis]] [[cholecystitis]] [[choledocholithiasis]] [[cholangitis]]</description></item><item><title>Biologics</title><link>https://www.physician.tw/Biologics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Biologics/</guid><description>Biologics (eg, TNF inhibitors, anti-B- cell Rx; âœ“ for TB before starting) Bacteria: sepsis, septic arthritis, TB, NTM, Listeria, Legionella Fungi: Pneumocystis, Histo, Coccidio, Aspergillus, endemic fungi Viruses: JC virus (PML), EBV, HSV, VZV, HBV Parasites: Strongyloides reactivation</description></item><item><title>Bioprosthetic</title><link>https://www.physician.tw/Bioprosthetic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bioprosthetic/</guid><description>Bioprosthetic Bovine pericardial or porcine heterograft (eg, Carpentier-Edwards), homograft Less durable, but min. thrombogenic; consider if &amp;gt;~65 y, lifespan &amp;lt;20 y, or Ã˜ anticoag If 50â€“69 y, 2Ã— reop but Â½ bleeding or stroke vs.</description></item><item><title>Blastomycosis</title><link>https://www.physician.tw/Blastomycosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blastomycosis/</guid><description>Blastomycosis (CID 2008;46:1801)
Epidemiology endemic to the eastern Â½ of U.S. Clinical manifestations Acute: PNA w/o hilar LAN that can progress to ARDS Chronic: cough + â€œBâ€ sx, fibronodular infiltrates, masses Â± cavitary lesions (Ddx TB, histo) Disseminated (seen in immunosupp.</description></item><item><title>Bleeding Treatment for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Bleeding-Treatment-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bleeding-Treatment-for-idiopathic-thrombocytopenic-purpura/</guid><description>Bleeding Treatment for idiopathic thrombocytopenic purpura Aminocaproic acid Inhibits plasmin activation
Methylprednisolone 1 g/d IV Ã— 3 d See above</description></item><item><title>Blood Products and Indications</title><link>https://www.physician.tw/Blood-Products-and-Indications-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Blood-Products-and-Indications-/</guid><description/></item><item><title>BP control in chronic kidney disease</title><link>https://www.physician.tw/BP-control-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/BP-control-in-chronic-kidney-disease/</guid><description>BP control in chronic kidney disease goal ideally &amp;lt;120/80, a/w â†“ mortality. ACEI or ARB, not both. For outPts, âœ“ Cr &amp;amp; K in 1â€“2 wk, d/c if Cr â†‘ 30% or K &amp;gt;5.</description></item><item><title>bradycardias av block and av dissociation</title><link>https://www.physician.tw/bradycardias-av-block-and-av-dissociation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bradycardias-av-block-and-av-dissociation/</guid><description>bradycardias av block and av dissociation [[Sinus bradycardia]] [[Tachycardia-bradycardia (â€œtachy-bradyâ€) syndrome]] [[AV Block]] [[AV dissociation]] [[Temporary pacing wires]]</description></item><item><title>breast cancer</title><link>https://www.physician.tw/breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/breast-cancer/</guid><description>breast cancer [[index]]
[[Epidemiology of breast cancer]] [[Clinical manifestations of breast cancer]] [[Screening of breast cancer]] [[Diagnostic evaluation of breast cancer]] [[Staging of breast cancer]] [[general approach to treatment of breast cancer]] (JAMA 2019;321:288 &amp;amp; 1716) [[surgery and radiation for local control of breast cancer]] [[systemic therapy of breast cancer]]</description></item><item><title>Broad categories-interstitial lung disease</title><link>https://www.physician.tw/Broad-categories-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Broad-categories-interstitial-lung-disease/</guid><description>Broad categories-interstitial lung disease (1) Sarcoid; (2) Exposures (eg, drugs, XRT, organic &amp;amp; inorganic dusts, vaping);
(3) Collagen vasc dis (eg, scleroderma, ANCA, myositis, RA); (4) Idiopathic PNAs (qv)</description></item><item><title>bronchiectasis</title><link>https://www.physician.tw/bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/bronchiectasis/</guid><description>bronchiectasis [[Definition and epidemiology-bronchiectasis]] [[Initial workup-bronchiectasis]] [[Treatment-bronchiectasis]] [[Non-tuberculous mycobacterium-bronchiectasis]]</description></item><item><title>Bronchodilators</title><link>https://www.physician.tw/Bronchodilators/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bronchodilators/</guid><description>Bronchodilators (1st-line): long-acting muscarinic antag (LAMA), Î²2-agonists (LABA) LAMA (eg, tiotropium): â†“ exacerb, slows â†“ FEV1, â†“ admit, â†“ resp failure; better than [[ipratropium]] or LABA (NEJM 2008;359:1543; 2011;364:1093; 2017;377:923)</description></item><item><title>Budd-Chiari syndrome</title><link>https://www.physician.tw/Budd-Chiari-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Budd-Chiari-syndrome/</guid><description>Budd-Chiari syndrome (World J Hepatol 2016;8:691)
Hepatic outflow obstruction 2/2 occlusion of hepatic vein(s) or IVC â†’ sinusoidal congestion and portal HTN.</description></item><item><title>Bundle-Branch-Blocks</title><link>https://www.physician.tw/Bundle-Branch-Blocks/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Bundle-Branch-Blocks/</guid><description>Bundle-Branch-Blocks Normal Initial depol. left to right across septum (r in V1 &amp;amp; q in V6; nb, absent in LBBB) followed by LV &amp;amp; RV free wall, with LV dominating (nb, RV depol.</description></item><item><title>buy mac</title><link>https://www.physician.tw/buy-mac/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/buy-mac/</guid><description>M1 256GB 16GB with AirPods 2 NT$33,200
M2 512GB 8G with AirPods 2 NT$43,900
M2 512GB 16GB with AirPod 2 NT$49,300</description></item><item><title>C5-9 deficiency</title><link>https://www.physician.tw/C5-9-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/C5-9-deficiency/</guid><description>C5-9 deficiency Terminal complement pathway deficiency is a genetic condition affecting the complement membrane attack complex (MAC)
Suspect terminal complement pathway deficiency with patients who have more than one episode of Neisseria infection.</description></item><item><title>Calciphylaxis</title><link>https://www.physician.tw/Calciphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calciphylaxis/</guid><description>Calciphylaxis calcific uremic arteriopathy, NEJM 2018;378:1704)
Pathophys: calcification of media in dermal small- to med-sized blood vessels &amp;amp; SC fat â†’ ischemia and skin necrosis w/ painful lesions (NEJM 2007;356:1049)</description></item><item><title>Calcitriol</title><link>https://www.physician.tw/Calcitriol/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcitriol/</guid><description>Calcitriol [Calcitriol (1, 25-OH Vitamin D3) | KFSYSCC Formulary]( https://www.unboundmedicine.com/ucentral/view/KFSYSCC%20Formulary/2236448/all/Calcitriol 1 25 OH Vitamin D3 ?q=D3)
Hypocalcemia: Dialysis patients: Adults: initially, 0.</description></item><item><title>Calcium channel blockers-toxicology</title><link>https://www.physician.tw/Calcium-channel-blockers-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Calcium-channel-blockers-toxicology/</guid><description>Calcium channel blockers-toxicology Bradycardia, AV block, hypotension, HF, hyperglycemia
IVF, vasopressors, Ca infusion, hyperinsulinemic euglycemia,
? intralipid emulsion, pacing</description></item><item><title>calcium disorders</title><link>https://www.physician.tw/calcium-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/calcium-disorders/</guid><description>calcium disorders [[Calcium homeostasis in normal humans]]
[[Laboratory Findings in Calcium Disorders]] [[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]].</description></item><item><title>Cameronâ€™s lesions</title><link>https://www.physician.tw/Camerons-lesions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Camerons-lesions/</guid><description>Cameronâ€™s lesions Linear erosions in hiatal hernia due to mech trauma of diaphragm</description></item><item><title>cancer biology</title><link>https://www.physician.tw/cancer-biology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-biology/</guid><description>cancer biology Cancer Hallmarks and Stem Cells Mechanisms of Oncogenesis Growth Factor Signaling Cell Cycle Control Apoptosis and TP53 DNA Repair and Angiogenesis</description></item><item><title>cancer complications</title><link>https://www.physician.tw/cancer-complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-complications/</guid><description>cancer complications Tumor Lysis Syndrome (TLS) Neutropenic Fever Superior Vena Cava (SVC) Syndrome Symptom Management Metastatic Spinal Cord Compression &amp;amp; Brain Metastases [[leptomeningeal disease]] Venous Thromboembolism (VTE) in Malignancy Malignant Bowel Obstruction (MBO) Treatment Toxicities</description></item><item><title>cancer pharmacology</title><link>https://www.physician.tw/cancer-pharmacology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-pharmacology/</guid><description>cancer pharmacology [[antimetabolites]]</description></item><item><title>Cancer screening of inflammatory bowel disease</title><link>https://www.physician.tw/Cancer-screening-of-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cancer-screening-of-inflammatory-bowel-disease/</guid><description>Cancer screening of inflammatory bowel disease (NEJM 2015;372:1441)
Colon cancer: risk in UC ~2% at 10 y, ~8% at 20 y, ~18% at 30 y.</description></item><item><title>cancer survivorship</title><link>https://www.physician.tw/cancer-survivorship/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cancer-survivorship/</guid><description>cancer survivorship</description></item><item><title>Candida species</title><link>https://www.physician.tw/Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Candida-species/</guid><description>Candida species Microbiology: normal GI flora; C. albicans &amp;amp; nonalbicans spp. Epidemiology: neutropenia, immunosupp., broad-spectrum abx, intravascular catheters (esp. if TPN), IVDU, abd surgery, DM, renal failure, age &amp;gt;65 [[Clinical manifestations-Candida species]] [[Treatment-Candida species]] (CID 2016;62:409) ***(())</description></item><item><title>Cangrelor</title><link>https://www.physician.tw/Cangrelor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cangrelor/</guid><description>Cangrelor Only IV P2Y12 inhibitor Rapid onset/offset; tÂ½ 3â€“5 min 22% â†“ CV events (mostly peri-PCI MI and stent thrombosis) vs.</description></item><item><title>CAPT-resistant GNB</title><link>https://www.physician.tw/CAPT-resistant-GNB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CAPT-resistant-GNB/</guid><description>CAPT-resistant GNB Gram-negative bacteria (GNB) co-resistant to carbapanems, aminoglycosides, polymyxins and tigecycline (CAPT-resistant) Treatment options for K. pneumoniae, P.</description></item><item><title>CAR-T-Toxicity</title><link>https://www.physician.tw/CAR-T-Toxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CAR-T-Toxicity/</guid><description>CAR-T-Toxicity Toxicities Cytokine release syndrome (CRS): fever, HoTN, shock secondary to overwhelming cytokine release from proliferating T cells Immune effector cell-associated neurotoxicitiy synd.</description></item><item><title>Carbon monoxide-toxicology</title><link>https://www.physician.tw/Carbon-monoxide-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Carbon-monoxide-toxicology/</guid><description>Carbon monoxide-toxicology HA, dizziness, nausea, Î”MS
carboxyHb level, CO-oximetry
100% normobaric oxygen, hyperbaric O2 in severe cases</description></item><item><title>Cardiac conditions-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Cardiac-conditions-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-conditions-Endocarditis-Prophylaxis/</guid><description>Cardiac conditions-Endocarditis Prophylaxis Prosthetic valve; previous endocarditis; congenital heart disease (CHD) including unrepaired or incompletely repaired cyanotic CHD (palliative shunts or conduits), 1st 6 mo after completely repaired CHD using prosthetic material; cardiac transplant recipients w/ valvulopathy.</description></item><item><title>Cardiac output PA catheter and tailored therapy</title><link>https://www.physician.tw/Cardiac-output-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-output-PA-catheter-and-tailored-therapy/</guid><description>Cardiac output PA catheter and tailored therapy Thermodilution: saline injected in RA or intermittent heating of prox thermal filament in some PA lines (â€œcontinuous COâ€).</description></item><item><title>Cardiac resynch therapy (CRT) Biventricular BiV pacing</title><link>https://www.physician.tw/Cardiac-resynch-therapy-CRT-Biventricular-BiV-pacing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-resynch-therapy-CRT-Biventricular-BiV-pacing/</guid><description>Cardiac resynch therapy (CRT) Biventricular (BiV) pacing (JACC 2013;61:e6)
3-lead pacemaker (RA, RV, coronary sinus to LV); R &amp;gt;S in V1 suggests approp LV capture Synch LV fxn (â†‘ CO/EF, â†“ adv remodeling); â†“ HF sx &amp;amp; hosp, â†‘ survival (NEJM 2010;363:2385) Indications: LVEF â‰¤35% + NYHA IIâ€“IV despite med Rx + SR + LBBB â‰¥150 ms (also reasonable if LBBB â‰¥120 ms, any non-LBBB â‰¥150 ms, or &amp;gt;40% V-pacing); mort.</description></item><item><title>cardiac rhythm management devices</title><link>https://www.physician.tw/cardiac-rhythm-management-devices/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-rhythm-management-devices/</guid><description>cardiac rhythm management devices [[Pacemaker Code]] [[Common Pacing Modes]] [[Indications for Permanent Pacing]] [[Pacemaker Complications]] [[Cardiac resynch therapy (CRT) Biventricular (BiV) pacing]] [[Implantable cardiac defibrillator (ICD)]] [[Device infection]]</description></item><item><title>cardiac risk assessment for noncardiac surgery</title><link>https://www.physician.tw/cardiac-risk-assessment-for-noncardiac-surgery/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiac-risk-assessment-for-noncardiac-surgery/</guid><description>cardiac risk assessment for noncardiac surgery [[Preoperative evaluation]] [[Approach to preop CV eval for non-CV surgery]] [[Noninvasive Testing Result-cardiac risk assessment for noncardiac surgery]]</description></item><item><title>Cardiac-resynch-therapy</title><link>https://www.physician.tw/Cardiac-resynch-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiac-resynch-therapy/</guid><description>Cardiac-resynch-therapy Consider if EF â‰¤35%, LBBB (QRS â‰¥130 ms) and symptomatic HF
36% â†“ mort. &amp;amp; â†‘ EF in NYHA IIIâ€“IV (CARE-HF, NEJM 2005;352:1539)</description></item><item><title>Cardiogenic shock</title><link>https://www.physician.tw/Cardiogenic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiogenic-shock/</guid><description>Cardiogenic shock Myocardial infarction
Myocarditis
Arrhythmia
Valvular
Severe aortic valve insufficiency
Severe mitral valve insufficiency</description></item><item><title>cardiology</title><link>https://www.physician.tw/cardiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiology/</guid><description>cardiology å¿ƒè·³ä¸é½Šï¼Œè¡€ç®¡ç‹¹çª„ï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚ ç¶“çµ¡ç›¸é€šï¼Œé«”å…§é‹è¡Œï¼Œ ç—…è‹—æ»‹é•·ï¼Œè‹¦é›£å¤šã€‚
[[electrocardiography]] [[chest pain]] [[noninvasive evaluation of CAD]] [[coronary angiography PCI]] [[stable ischemic heart disease]] [[acute coronary syndromes]] [[PA catheter and tailored therapy]] [[heart failure]] [[cardiomyopathies]] [[valvular heart disease]] [[pericardial disease]] [[hypertension]] [[aortic aneurysms]] [[acute aortic syndromes]] [[arrhythmias]] [[atrial fibrillation]] [[syncope]] [[cardiac rhythm management devices]] [[cardiac risk assessment for noncardiac surgery]] [[peripheral artery disease]] Additional topics Coronary Artery Disease (CAD) and Acute Coronary Syndrome (ACS) Congestive Heart Failure (CHF) Arrhythmias Valvular Disease Pericardial Disease and Myocarditis Other topics related to cardiology are covered in the following rotation guides: Hypertension, Hypercholesterolemia (Ambulatory Care)</description></item><item><title>cardiomyopathies</title><link>https://www.physician.tw/cardiomyopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiomyopathies/</guid><description>cardiomyopathies Diseases with mechanical and/or electrical dysfunction of the myocardium
[[dilated cardiomyopathy]] (DCM) [[myocarditis]] [[hypertrophic cardiomyopathy]] (HCM) [[restrictive and infiltrative cardiomyopathy]]</description></item><item><title>Cardiorenal syndrome</title><link>https://www.physician.tw/Cardiorenal-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiorenal-syndrome/</guid><description>Cardiorenal syndrome (CJASN 2017;12:1624)
Multifactorial pathophys including: â†“ CO, â†‘ renal venous congestion, â†‘ RAAS Bidirectionality: acute CHF â†’ AKI, and oliguric AKI can worsen CHF (JACC 2008;52:1527) Rx IV loop diuretics (bypass gut edema; dosing below) no diff.</description></item><item><title>cardiovascular critical care</title><link>https://www.physician.tw/cardiovascular-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardiovascular-critical-care/</guid><description>cardiovascular critical care [[hemodynamic monitoring]] [[vasoactive drugs]] [[mechanical circulatory support]] [[cardiac arrhythmias]] [[Shock-Syndromes]] [[Cardiac-Arrest]]</description></item><item><title>Cardiovascular-complications of HIV AIDS</title><link>https://www.physician.tw/Cardiovascular-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardiovascular-complications-of-HIV-AIDS/</guid><description>Cardiovascular-complications of HIV AIDS Higher rates of CAD, stroke, VTE, dilated CMP; pulm. HTN; pericarditis/effusion</description></item><item><title>Cardioversion</title><link>https://www.physician.tw/Cardioversion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cardioversion/</guid><description>Cardioversion Consider if: 1st AF, sx, tachycardia-mediated CMP, or difficult to rate control If AF &amp;gt;48 h 2â€“5% risk stroke w/ cardioversion (pharmacologic or electric) âˆ´ either TEE to r/o thrombus or ensure therapeutic anticoagulation â‰¥3 wk prior If needs to cardiovert urgently, often anticoagulate acutely (eg, IV UFH) For AF &amp;lt;36 hrs, no Î” in % in SR at 4 wks w/ early cardioversion vs.</description></item><item><title>cardioversion of ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/cardioversion-of-ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cardioversion-of-ACLS-Tachycardia-Algorithm/</guid><description>cardioversion of ACLS Tachycardia Algorithm Ancillary equipment O2 sat monitor suction, IV line intubation equipment Premedicate call anesthesia service midazolam 1-5 mg fentanyl 100-300 mcg Synch cardioversion 100J é›™å‘ è¶ŠåŠ è¶Šå¤§ å°éº» 50-200 J biphasic 100-200 J monophasic</description></item><item><title>Cat bite</title><link>https://www.physician.tw/Cat-bite/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cat-bite/</guid><description>Cat bite *Cat scratch disease caused by Bartonella acquired via cat scratch or bite. Results in lymphadenitis.
Pasturella spp Rapid onset erythema, swelling, lymphangitis, fever Amox/clav</description></item><item><title>Categories-diabetes mellitus</title><link>https://www.physician.tw/Categories-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Categories-diabetes-mellitus/</guid><description>Categories-diabetes mellitus Type 1 (Lancet 2018;391:2449): islet cell destruction; absolute insulin deficiency; ketosis in absence of insulin; prevalence 0.4%; usual onset in childhood but can occur throughout adulthood; â†‘ risk if âŠ• FHx; HLA associations; anti-GAD, anti-islet cell &amp;amp; anti-insulin autoAb Type 2 (Lancet 2017;389:2239): insulin resistance + relative insulin â†“; prevalence 6%; onset generally later in life; no HLA assoc.</description></item><item><title>Causes of Hemolytic Anemia by Mechanism</title><link>https://www.physician.tw/Causes-of-Hemolytic-Anemia-by-Mechanism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-Hemolytic-Anemia-by-Mechanism/</guid><description>Causes of Hemolytic Anemia by Mechanism (Lancet 2000;355:1169 &amp;amp; 1260)
Intrinsic Enzyme deficiency G6PD deficiency Hemoglobinopathies Sickle cell anemia, thalassemia Membrane abnormalities Hereditary spherocytosis PNH, spur cell anemia in liver Extrinsic-Acquired Immune-mediated Autoimmune; drug-induced, tx rxn Traumatic MAHA; prostheses (valves, TIPS) Direct infections, toxins Malaria, babesiosis; snake &amp;amp; spider venoms; Wilsonâ€™s; hypotonic infusions Entrapment Hypersplenism</description></item><item><title>Causes of low Mg</title><link>https://www.physician.tw/Causes-of-low-Mg/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-low-Mg/</guid><description>Causes of low Mg hypomagnesemia
GI loss (diarrhea, bypass, pancreatitis, malnutrition, PPI)
renal loss (diuretics, nephrotoxic drugs, EtOH, â†‘ Ca, 1Â° wasting syndromes, volume expansion)</description></item><item><title>Causes of Shock Classified by Mechanism and Hemodynamics</title><link>https://www.physician.tw/Causes-of-Shock-Classified-by-Mechanism-and-Hemodynamics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Causes-of-Shock-Classified-by-Mechanism-and-Hemodynamics/</guid><description>Causes of Shock Classified by Mechanism and Hemodynamics åˆ†é¡ [[Distributive shock]] [[Hypovolemic shock]] [[Obstructive shock]] [[Cardiogenic shock]]
Shown is an algorithm for the initial assessment of a patient in shock (Panel A), relative frequencies of the main types of shock (Panel B), and schematic representations of the four main types of shock (Panel C).</description></item><item><title>Celiac disease</title><link>https://www.physician.tw/Celiac-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Celiac-disease/</guid><description>Celiac disease (JAMA 2017;318:647; Lancet 2018;391:70; Gastro 2019;156:4)
Immune rxn in genetically predisposed Pts (~1% pop) to gliadin, a component of gluten (wheat protein) â†’ small bowel inflammatory infiltrate â†’ impaired absorption</description></item><item><title>Cell count of ascites</title><link>https://www.physician.tw/Cell-count-of-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cell-count-of-ascites/</guid><description>Cell count of ascites normal limit of PMNs in ascitic fluid up to 250 PMNs/mm3. Bloody tap (typically from traumatic para) can skew cell count; subtract 1 PMN for every 250 RBCs to correct PMN count.</description></item><item><title>Cell count of cerebrospinal fluid</title><link>https://www.physician.tw/Cell-count-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cell-count-of-cerebrospinal-fluid/</guid><description>Cell count of cerebrospinal fluid RBC æ­£å¸¸ CSF RBC &amp;lt; 5 è‹¥ä¸Šå‡å¯èƒ½åŸå› æœ‰ traumatic tappingã€SAH ç­‰</description></item><item><title>Cellulitis Treatment</title><link>https://www.physician.tw/Cellulitis-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cellulitis-Treatment/</guid><description>Cellulitis Treatment (NEJM 2014;370:2238; CID 2014;59:e10; JAMA 2016;316:325 &amp;amp; 2017;317:2088) | Purulent | Usual Micro | Severity | Treatment |</description></item><item><title>Central adrenal insufficiency</title><link>https://www.physician.tw/Central-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-adrenal-insufficiency/</guid><description>Central adrenal insufficiency Sx similar to 1Â° adrenal insufficiency (see â€œAdrenal Disordersâ€) except: no salt cravings or hyperkalemia (b/c aldo preserved) no hyperpigmentation (b/c ACTH/MSH is not â†‘)</description></item><item><title>Central diabetes insipidus</title><link>https://www.physician.tw/Central-diabetes-insipidus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-diabetes-insipidus/</guid><description>Central diabetes insipidus â†“ ADH
Typically from mass lesion extrinsic to sella; pituitary tumor does not typically present w/ DI Clinical manifestations: severe polyuria, thirst, nl to mild hyperNa (severe if â†“ access to H2O) Diagnostic studies: see â€œSodium and Water Homeostasisâ€ [[overview-sodium and water homeostasis]] [[polyuria]]</description></item><item><title>Central hypogonadism</title><link>https://www.physician.tw/Central-hypogonadism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-hypogonadism/</guid><description>Central hypogonadism Clinical manifestations: â†“ libido, impotence, oligomenorrhea or amenorrhea, infertility, â†“ muscle mass, osteoporosis Physical exam: â†“ testicular size; loss of axillary, pubic and body hair Dx with: â†“ a.</description></item><item><title>Central hypothyroidism</title><link>https://www.physician.tw/Central-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-hypothyroidism/</guid><description>Central hypothyroidism â†“ TSH
Sx of central hypothyroidism similar to 1Â° (see â€œThyroid Disordersâ€) except absence of goiter Dx with free T4 in addition to TSH, as TSH may be low or inappropriately normal</description></item><item><title>Central vein stenosis</title><link>https://www.physician.tw/Central-vein-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Central-vein-stenosis/</guid><description>Central vein stenosis assoc. with longer HD duration, tunneled catheters. HeRO grafts bypass subclavian stenosis with flow into central vein (J Vasc Access 2016;17:138).</description></item><item><title>Cerebral edema-Management-acute liver failure</title><link>https://www.physician.tw/Cerebral-edema-Management-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cerebral-edema-Management-acute-liver-failure/</guid><description>Cerebral edema-Management-acute liver failure consider ICP monitoring if grade 3/4 enceph; if â†‘ ICP â†’ mannitol 0.5â€“1.0 mg/kg; if arterial NH3 &amp;gt;150, grade 3/4 enceph, AKI or on vasopressors â†’ prophylactic 3% saline with goal Na 145â€“155 mEq/L; barbiturates &amp;amp; hypothermia if refractory â†‘ ICP</description></item><item><title>cerebrospinal fluid lab results</title><link>https://www.physician.tw/cerebrospinal-fluid-lab-results/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cerebrospinal-fluid-lab-results/</guid><description>cerebrospinal fluid lab results æ­£å¸¸ï¼šæ¸…ã€ä½å£“&amp;lt;18ã€å°‘çƒ&amp;lt;5ã€å«ç³–50+ã€ä½è›‹ç™½&amp;lt;40
[[Appearance of cerebrospinal fluid]] [[open pressure]] æ­£å¸¸ 9â€“18 cmH2O [[Cell count of cerebrospinal fluid]] æ­£å¸¸ CSF RBC &amp;lt; 5 [[WBC of cerebrospinal fluid]] æ­£å¸¸ CSF WBC &amp;lt; 5 [[Protein of cerebrospinal fluid]] æ­£å¸¸ 15â€“40 mg/dL [[Glucose of cerebrospinal fluid]] æ­£å¸¸ç´„ 50â€“75 mg/dLï¼Œç´„æ˜¯ serum çš„ 0.</description></item><item><title>CHA2DS2-VASc</title><link>https://www.physician.tw/CHA2DS2-VASc/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CHA2DS2-VASc/</guid><description>CHA2DS2-VASc CHF (1 point); HTN (1); Age â‰¥75 y (2); DM (1), Stroke/TIA (2); Vascular disease (eg, MI, PAD, Ao plaque) (1); Age 65â€“74 (1); â™€ Sex category (1) Annual risk of stroke (Lancet 2012;379:648): at low end, ~1% per point: 0 â†’ ~0%, 1 â†’ 1.</description></item><item><title>change in mental status</title><link>https://www.physician.tw/change-in-mental-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/change-in-mental-status/</guid><description>change in mental status [[Consciousness Arousal]] [[Etiologies of Decreased Responsiveness]] [[Initial evaluation of change in mental status]] see [[Stepwise Evaluation of a Patient with Delirium]] [[The Confusion Assessment Method]]</description></item><item><title>Characteristics of Pleural Fluid</title><link>https://www.physician.tw/Characteristics-of-Pleural-Fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Characteristics-of-Pleural-Fluid/</guid><description>Characteristics of Pleural Fluid</description></item><item><title>CHECKLIST AND LONG TERM POST ACS MANAGEMENT</title><link>https://www.physician.tw/CHECKLIST-AND-LONG-TERM-POST-ACS-MANAGEMENT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CHECKLIST-AND-LONG-TERM-POST-ACS-MANAGEMENT/</guid><description>CHECKLIST AND LONG TERM POST ACS MANAGEMENT Risk stratification Stress test if anatomy undefined; consider stress if signif residual CAD post-PCI of culprit Assess LVEF prior to d/c; EF â†‘ ~6% in STEMI over 6 mo (JACC 2007;50:149) Antiplatelet therapy Aspirin: 81 mg daily (no clear benefit to higher doses) P2Y12 inhibitor: ticagrelor or prasugrel preferred over clopi.</description></item><item><title>Chemical Causes of Cellular Hypoxia</title><link>https://www.physician.tw/Chemical-Causes-of-Cellular-Hypoxia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chemical-Causes-of-Cellular-Hypoxia/</guid><description>Chemical Causes of Cellular Hypoxia CO binds to Hb more avidly than does O2. Pulse oximeter (Ox) misreads COHb as HbO2 â†’ falsely nl sat.</description></item><item><title>chemo side effects</title><link>https://www.physician.tw/chemo-side-effects/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chemo-side-effects/</guid><description>chemo side effects</description></item><item><title>Chest Discomfort</title><link>https://www.physician.tw/Chest-Discomfort/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chest-Discomfort/</guid><description>Chest Discomfort [[chest pain]]</description></item><item><title>chest pain</title><link>https://www.physician.tw/chest-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest-pain/</guid><description>[[Typical Characteristics and Diagnostic Studies of Chest Pain]]
Initial diagnostic studies [[Focused history of chest pain]]
Targeted exam: VS (incl.</description></item><item><title>chest radiograph</title><link>https://www.physician.tw/chest-radiograph/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chest-radiograph/</guid><description>chest radiograph Tips: Are There Many Lung Lesion Can I ?
Consolidation: æ°´ã€è¡€ã€è†¿ SILHOUETTE SIGN heart, aorta, or diaphragm bronchopneumonia: Multifocal consolidation DIFFUSE CONSOLIDATION: crazy paving pulmonary edema ARDS pulmonary hemorrhage Pneumocystis Cryptogenic organizing pneumonia predominant peribronchial and peripheral distribution FOCAL AND MULTIFOCAL CONSOLIDATION EXTENSIVE CONFLUENT AND DIFFUSE CONSOLIDATION ACUTE CAUSES OF PARENCHYMAL CONSOLIDATION CHRONIC CAUSES OF PARENCHYMAL CONSOLIDATION Atelectasis Obstructive atelectasis Distal to obstruction of a bronchus</description></item><item><title>cholangitis</title><link>https://www.physician.tw/cholangitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholangitis/</guid><description>cholangitis Definition &amp;amp; etiologies (World J Gasrointest Pathophysiol 2018:9:1)
Bile duct obstruction causes stasis â†’ infection proximal to the obstruction Etiologies: BD stone (~85%); malignant (biliary, pancreatic) or benign stricture; infection w/ fluke (Clonorchis sinensis, Opisthorchis viverrini); recurrent pyrogenic cholangitis Clinical manifestations Charcotâ€™s triad: RUQ pain, jaundice, fever/chills; present in ~70% of Pts Reynoldsâ€™ pentad: Charcotâ€™s triad + shock and Î” MS; present in ~15% of Pts Diagnostic studies RUQ U/S: often demonstrates dilation of bile ducts Labs: â†‘ WBC (with left shift), bilirubin, AÏ†, amylase; may see âŠ• BCx ERCP; percutaneous transhepatic cholangiogram if ERCP unsuccessful [[Treatment-cholangitis]]</description></item><item><title>cholecystitis</title><link>https://www.physician.tw/cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholecystitis/</guid><description>cholecystitis [[Pathogenesis-cholecystitis]] [[Clinical manifestations-cholecystitis]] [[Diagnostic studies-cholecystitis]] [[Treatment-cholecystitis]] [[Complications-cholecystitis]]</description></item><item><title>choledocholithiasis</title><link>https://www.physician.tw/choledocholithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/choledocholithiasis/</guid><description>choledocholithiasis Definition Gallstone lodged in common bile duct (CBD) Epidemiology Occurs in 15% of Pts w/ gallbladder stones; can form de novo in CBD due to biliary stasis Clinical manifestations RUQ/epigastric pain 2Â° obstrxn of bile flow â†’ â†‘ CBD pressure, jaundice, pruritus, nausea Rarely asymptomatic [[Diagnostic studies-choledocholithiasis]] Treatment ERCP &amp;amp; papillotomy w/ stone extraction (Â± lithotripsy) CCY w/in 6 wk unless contraindication (&amp;gt;15% Pts develop indication for CCY if unRxâ€™d) Complications Cholangitis, cholecystitis, pancreatitis, stricture</description></item><item><title>cholelithiasis</title><link>https://www.physician.tw/cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cholelithiasis/</guid><description>cholelithiasis [[Epidemiology pathogenesis-cholelithiasis]] [[Types of gallstones-cholelithiasis]] [[Clinical manifestations-cholelithiasis]] [[Diagnostic studies-cholelithiasis]] [[Treatment-cholelithiasis]] [[Complications-cholelithiasis]]</description></item><item><title>chronic kidney disease CKD</title><link>https://www.physician.tw/chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-kidney-disease-CKD/</guid><description>chronic kidney disease (CKD) [[Definition and etiologies-chronic kidney disease (CKD)]] [[Stages of CKD]] [[Signs and Symptoms of Uremia -chronic kidney disease (CKD)]] [[Complications-treatment-chronic kidney disease (CKD)]]</description></item><item><title>chronic mesenteric ischemia</title><link>https://www.physician.tw/chronic-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-mesenteric-ischemia/</guid><description>chronic mesenteric ischemia Pathophysiology: â†“ blood flow to gut typically because of mesenteric atherosclerosis Sx: â€œintestinal anginaâ€ = postprandial abd pain, early satiety, &amp;amp; â†“ wt due to fear of eating.</description></item><item><title>Chronic migraine</title><link>https://www.physician.tw/Chronic-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-migraine/</guid><description>Chronic migraine Chronic migraine is defined as â‰¥15 headache days per month for &amp;gt;3 months and fulfilment of ICHD-3 criteria for migraine on â‰¥8 days per month.</description></item><item><title>Chronic mild-to-moderate elevation in ALT AST</title><link>https://www.physician.tw/Chronic-mild-to-moderate-elevation-in-ALT-AST-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-mild-to-moderate-elevation-in-ALT-AST-/</guid><description>Chronic mild-to-moderate elevation in ALT AST (&amp;lt;15Ã— ULN)
Viral hepatitis: âœ“ HBsAg, anti-HBs, anti-HBc, anti-HCV, IgM anti-HAV
NAFLD: consider BMI, âœ“ lipid panel, HbA1c, liver U/S or elastography</description></item><item><title>chronic obstructive pulmonary disease</title><link>https://www.physician.tw/chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-obstructive-pulmonary-disease/</guid><description>CHRONIC OBSTRUCTIVE PULMONARY DISEASE [[Definition and epidemiology-chronic obstructive pulmonary disease]] [[Emphysema vs. Chronic Bronchitis]] [[Pathogenesis-chronic obstructive pulmonary disease]] [[Clinical manifestations-chronic obstructive pulmonary disease]] [[Diagnostic studies-chronic obstructive pulmonary disease]] [[Chronic treatment-chronic obstructive pulmonary disease]] [[Staging and prognosis-chronic obstructive pulmonary disease]] EXACERBATION [[COPD Exacerbation Treatment]]</description></item><item><title>Chronic or refractory for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Chronic-or-refractory-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-or-refractory-for-idiopathic-thrombocytopenic-purpura/</guid><description>Chronic or refractory for idiopathic thrombocytopenic purpura Romiplostim or eltrombopag Allows splenectomy to be deferred
Fostamatinib: 75â€“150 mg BID Spleen tyrosine kinase (SYK) inhibitor</description></item><item><title>chronic pancreatitis</title><link>https://www.physician.tw/chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/chronic-pancreatitis/</guid><description>chronic pancreatitis [[Pathogenesis etiology-chronic pancreatitis]] [[Clinical manifestations-chronic pancreatitis]] [[Diagnostic studies-chronic pancreatitis ]] [[Treatment-chronic pancreatitis]]</description></item><item><title>Chronic treatment-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Chronic-treatment-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-treatment-chronic-obstructive-pulmonary-disease/</guid><description>Chronic treatment-chronic obstructive pulmonary disease COPD Staging and Recommended Therapies by GOLD Criteria
ä¸€å¹´å…©æ¬¡ä»¥ä¸‹ç®—A,B A Short-acting inh dilator prn B LAMA ä¸€å¹´å…©æ¬¡ä»¥ä¸Šç®—C,D C LAMA D LAMA + LABA Â± ICS è€ƒæ…®åœ¨æ”¯æ°£ç®¡æ“´å¼µåŠ‘ä¸­æ·»åŠ PDE-4æŠ‘åˆ¶ Treatment [[Bronchodilators]] [[Corticosteroids for chronic obstructive pulmonary disease]] Triple Therapy (LAMA+LABA+ICS) â†“ exac, â†“ hosp, â†‘ PNA (NEJM 2020;383:35) [[Roflumilast]] [[Anti-IL5]] daily azithro â†“ exacerbations, but not routine (JAMA 2014;311:2225) [[Oxygen for chronic obstructive pulmonary disease]] Night NPPV if recent exacerb &amp;amp; PaCO2 &amp;gt;&amp;ldquo;53&amp;rdquo; â†“ risk of readmit or death (JAMA 2017;317:2177) [[Prevention of chronic obstructive pulmonary disease]] Rehabilitation: â†“ dyspnea and fatigue, â†‘ exercise tolerance, â†‘ QoL (NEJM 2009;360:1329) Surgery &amp;amp; bronchoscopic interventions Lung volume reduction surgery: â†‘ exercise capacity, â†“ mortality if FEV1 &amp;gt;20%, upper lobe, low exercise capacity (NEJM 2003;348:2059) Bronchoscopic lung reduction with endobronchial valves or coils: â†‘ lung fxn but significant complications (PTX, PNA) (NEJM 2015;373:2325; Lancet 2015;386:1066; JAMA 2016;315:175) Lung transplant: â†‘ QoL and â†“ sx (Lancet 1998;351:24), ?</description></item><item><title>Chronic treatment-nephrolithiasis</title><link>https://www.physician.tw/Chronic-treatment-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chronic-treatment-nephrolithiasis/</guid><description>Chronic treatment-nephrolithiasis (CJASN 2016;11:1305 &amp;amp; 2017;12:1699)
Increase fluid intake (&amp;gt;2 L/d) for goal UOP 2 L/d (J Nephrol 2016;29:211)</description></item><item><title>Chvostek sign</title><link>https://www.physician.tw/Chvostek-sign/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Chvostek-sign/</guid><description>Chvostek sign èˆ‡ä½éˆ£è¡€ç—‡ç›¸é—œçš„è‡¨åºŠç™¼ç¾
æŒ‡çš„æ˜¯é¢éƒ¨è‚Œè‚‰çš„æŠ½æ ç•¶è¼•è¼•æ•²æ“Šä¸€å€‹äººçš„ è‡‰é °ï¼Œåœ¨è€³å‰ã€‚
å¼•èµ·é¢éƒ¨ç¥ç¶“çš„éå…¸å‹åæ‡‰ï¼Œ (CN VII) æ”¯é…é¢éƒ¨çš„è¨±å¤šè‚Œè‚‰ã€‚
é€šéè¼•è¼•æ‹æ‰“å€‹äººçš„è‡‰é ° è€³å‰ 2 å˜ç±³ï¼ˆç´„ 0.75 è‹±å¯¸ï¼‰ï¼Œ åœ¨ç¬¬ 7 é¡±è…¦ (CN VII) çš„é¢ç¥ç¶“è·¯ç·šä¸Šã€‚</description></item><item><title>cirrhosis</title><link>https://www.physician.tw/cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cirrhosis/</guid><description>cirrhosis [[Definition-cirrhosis]] [[Etiologies-cirrhosis]] [[Clinical manifestations-cirrhosis]] [[Physical exam-cirrhosis]] [[Laboratory studies-cirrhosis]] [[Workup-cirrhosis]] [[Prognosis-cirrhosis]] [[ascites]] [[Spontaneous bacterial peritonitis]] [[Gastroesophageal varices and UGIB-cirrhosis]] [[Hepatic encephalopathy (HE)]] [[Hepatorenal syndrome (HRS)]] [[hepatocellular carcinoma]] [[Hepatopulmonary syndrome (HPS)]] [[Other Complication-cirrhosis]] [[Liver transplantation]] Other Etiologies [[Hemochromatosis &amp;amp; iron overload syndromes]] [[Wilson disease]] [[Î±1-antitrypsin deficiency (Î±1-AT)]] [[Primary biliary cholangitis (PBC)]] [[Primary sclerosing cholangitis (PSC)]]</description></item><item><title>classes of hemorrhagic shock</title><link>https://www.physician.tw/classes-of-hemorrhagic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/classes-of-hemorrhagic-shock/</guid><description>classes of hemorrhagic shock 15 30 40</description></item><item><title>Classic tachycardias of WPW accessory pathways</title><link>https://www.physician.tw/Classic-tachycardias-of-WPW-accessory-pathways/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classic-tachycardias-of-WPW-accessory-pathways/</guid><description>Classic tachycardias of WPW accessory pathways Orthodromic AVRT: narrow-complex SVT (typically), conducting â†“ AVN &amp;amp; â†‘ accessory pathway; requires retrograde conduction and âˆ´ can occur w/ concealed bypass tracts Antidromic AVRT (rare): wide-complex SVT, conducting â†“ accessory pathway &amp;amp; â†‘ AVN; requires antegrade conduction and âˆ´ should see pre-excitation pattern during SR AF w/ rapid conduction down accessory pathway; âˆ´ wide-complex irregular SVT; requires antegrade conduction; âˆ´ should see pre-excitation in SR.</description></item><item><title>Classic-Eponymous-Signs-in-Chronic-AR</title><link>https://www.physician.tw/Classic-Eponymous-Signs-in-Chronic-AR/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classic-Eponymous-Signs-in-Chronic-AR/</guid><description>Classic-Eponymous-Signs-in-Chronic-AR Sign Description Corriganâ€™s pulse â€œwater hammerâ€ pulse (ie, rapid rise/fall or distention/collapse) Hillâ€™s sign (popliteal SBP â€“ brachial SBP) &amp;gt;60 mmHg Duroziezâ€™s sign to-and-fro murmur heard over femoral artery w/ light compression Pistol shot sounds pistol shot sound heard over femoral artery Traubeâ€™s sound double sound heard over femoral artery when compressed distally de Mussetâ€™s sign head-bobbing with each heartbeat (low Se) MÃ¼llerâ€™s sign systolic pulsations of the uvula Quinckeâ€™s pulses subungual capillary pulsations (low Sp)</description></item><item><title>Classification criteria of BehÃ§etâ€™s syndrome</title><link>https://www.physician.tw/Classification-criteria-of-Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-criteria-of-Beh%C3%A7ets-syndrome/</guid><description>Classification criteria of BehÃ§etâ€™s syndrome (#1 + â‰¥2 others is 91% Se &amp;amp; 96% Sp; Lancet 1990;335:1078)
Recurrent oral aphthous ulceration (â‰¥3Ã— in 1 y, usually 1st manifestation) Recurrent genital ulceration (labia in females, scrotum in males) Eye lesions: uveitis, scleritis, retinal vasculitis, optic neuritis; may threaten vision Skin lesions: pustules, papules, folliculitis, erythema nodosum (scarring) âŠ• pathergy test (prick forearm w/ sterile needle â†’ pustule) (not sensitive in Caucasians)</description></item><item><title>Classification of Pain</title><link>https://www.physician.tw/Classification-of-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-of-Pain/</guid><description>Classification of Pain âœ¨é‡é»: æ¨æ–·çš„ç—…ç†ç”Ÿç†å­¸ï¼ˆå‚·å®³æ€§èˆ‡éå‚·å®³æ€§ï¼‰ æ™‚é–“é€²ç¨‹ï¼ˆæ€¥æ€§èˆ‡äºæ€¥æ€§èˆ‡æ…¢æ€§ï¼‰ ä½ç½®ï¼ˆå±€éƒ¨ç–¼ç—›å€åŸŸèˆ‡å»£ç¾©ï¼‰ ç—…å› ï¼ˆä¾‹å¦‚ï¼Œç™Œç—‡ã€é—œç¯€ç‚ã€ç¥ç¶“æå‚·æˆ–é€™äº›çš„çµ„åˆï¼‰ neurophysiologic classification of pain ç¥ç¶“ç”Ÿç†å­¸åˆ†é¡åŸºæ–¼æ¨æ–·çš„ç–¼ç—›æ©Ÿåˆ¶ã€‚ åŸºæœ¬ä¸Šæœ‰å…©ç¨®é¡å‹ï¼šï¼ˆ1ï¼‰å‚·å®³æ€§ï¼Œé€™æ˜¯ç”±æ–¼ç–¼ç—›æ•æ„Ÿçµæ§‹çš„æå‚·ï¼Œå’Œï¼ˆ2ï¼‰éå‚·å®³æ€§ï¼Œå®ƒæ˜¯ç¥ç¶“æ€§å’Œå¿ƒç†æ€§çš„ã€‚ å‚·å®³æ€§ç–¼ç—›å¯ç´°åˆ†ç‚ºè»€é«”æ€§ç–¼ç—›å’Œå…§è‡Ÿæ€§ç–¼ç—›ï¼ˆå–æ±ºæ–¼æ¿€æ´»äº†å“ªçµ„å‚·å®³æ„Ÿå—å™¨ï¼‰ã€‚ ç¥ç¶“æ€§ç–¼ç—›å¯ç´°åˆ†ç‚ºå¤–å‘¨æ€§ç–¼ç—›å’Œä¸­æ¨æ€§ç–¼ç—›ï¼ˆå–æ±ºæ–¼è¢«èªç‚ºè² è²¬ç¶­æŒç–¼ç—›çš„ç¥ç¶“ç³»çµ±ä¸­çš„æå‚·éƒ¨ä½ï¼‰ã€‚ å„˜ç®¡é€™å€‹è¡“èªå·²ç¶“ä½¿ç”¨äº†å¾ˆå¤šå¹´ï¼Œä½†å¿ƒå› æ€§ç–¼ç—›æ˜¯ä¸€å€‹éå¸¸æ¨¡ç³Šçš„è¡“èªï¼Œæ‡‰è©²åªç”¨æ–¼é‚£äº›æœ€çµ‚æ’é™¤äº†æ‰€æœ‰éå¿ƒå› æ€§åŸå› çš„æƒ…æ³â€”â€”ä¹Ÿå°±æ˜¯èªªï¼Œä¸€å€‹äººå¾ˆå°‘ç¶“æ­·å¿ƒå› æ€§ç–¼ç—›ç¨è‡ªçš„ã€‚ æˆ‘å€‘ç¶“å¸¸çœ‹åˆ°è¢«ä½ä¼°çš„æ…¢æ€§ç–¼ç—›æ‚£è€…è¢«è¨ºæ–·ç‚ºå¿ƒå› æ€§ç–¼ç—›ï¼Œè€Œäº‹å¯¦ä¸Šï¼Œä»–å€‘çš„ç–¼ç—›æœ‰ä¸€å€‹æ˜ç¢ºçš„ç—…å› ï¼Œä½†ç”±æ–¼è¨ºæ–·è©•ä¼°ä¸ç†æƒ³è€Œè¢«å¿½è¦–ã€‚</description></item><item><title>Classification-acute aortic syndromes</title><link>https://www.physician.tw/Classification-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-acute-aortic-syndromes/</guid><description>Classification-acute aortic syndromes (proximal more common than distal; JACC 2019;74:1494 &amp;amp; 2020;76:1703)
Proximal: involves ascending Ao, regardless of origin (= Stanford A, DeBakey I &amp;amp; II) Distal: involves descending Ao only, distal to L subclavian art.</description></item><item><title>Classification-atrial fibrillation</title><link>https://www.physician.tw/Classification-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-atrial-fibrillation/</guid><description>Classification-atrial fibrillation (Circ 2014;130:e199)
Paroxysmal (terminates spontaneously or within 7 d) vs. persistent (&amp;gt;7 d) vs. long-standing persistent (&amp;gt;1 y) vs.</description></item><item><title>Classification-autoimmune hepatitis AIH</title><link>https://www.physician.tw/Classification-autoimmune-hepatitis-AIH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Classification-autoimmune-hepatitis-AIH/</guid><description>Classification-autoimmune hepatitis (AIH) (J Hep 2015;62:S100, World J Gastro 2015;21:60)
Type 1: anti-smooth muscle Ab (ASMA), ANA; anti-soluble liver antigen (anti-SLA), a/w more severe disease and relapsing disease (found in 10â€“30% Pts), IgG often â†‘</description></item><item><title>clinical case of epidural abscess</title><link>https://www.physician.tw/clinical-case-of-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-case-of-epidural-abscess/</guid><description>clinical case of epidural abscess A 50-year-old woman with end-stage kidney disease from hypertensive nephrosclerosis presents for her regularly scheduled hemodialysis session.</description></item><item><title>clinical characteristics of bleeding disorders</title><link>https://www.physician.tw/clinical-characteristics-of-bleeding-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-characteristics-of-bleeding-disorders/</guid><description>clinical characteristics of bleeding disorders Platelet/Vascular Defect Skin, mucous membranes Petechiae, ecchymoses Bleeding After minor cuts: yes Bleeding After surgery: immediate, mild Coagulation Defect Deep in soft tissues (muscles, joints) Hemarthroses, hematomas Bleeding After minor cuts: unusual Bleedgin After surgery: delayed, severe</description></item><item><title>Clinical evaluation of Secondary causes of headaches</title><link>https://www.physician.tw/Clinical-evaluation-of-Secondary-causes-of-headaches/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-evaluation-of-Secondary-causes-of-headaches/</guid><description>Clinical evaluation of Secondary causes of headaches (Neurology 2019;92:134 &amp;amp; JAMA 2021;325:1874)
Hx: onset (sudden vs. gradual), quality, evolution (progressive), severity, location, duration, triggers, alleviating factors, positional, hormonal (menstruation), preceding trauma, assoc.</description></item><item><title>Clinical features-cystic fibrosis</title><link>https://www.physician.tw/Clinical-features-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-features-cystic-fibrosis/</guid><description>Clinical features-cystic fibrosis Recurrent PNA, sinus infections
Distal intestinal obstruction syndrome (DIOS), pancreatic insufficiency (steatorrhea, malabsorption, failure to thrive, weight loss), CF-related diabetes, infertility</description></item><item><title>Clinical manifestation-bacterial endocarditis</title><link>https://www.physician.tw/Clinical-manifestation-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestation-bacterial-endocarditis/</guid><description>Clinical manifestation-bacterial endocarditis (Lancet 2016;387:882)
Persistent bacteremia â†’ fever (80â€“90%), rigors, night sweats, anorexia, myalgias Valvular or perivalvular infection â†’ HF, conduction abnormalities (eg, AVB) Septic emboli: stroke, embolic MI, renal/splenic/pulmonary infarcts, septic arthritis, osteo Immune complex phenomena: arthritis, glomerulonephritis Subacute endocarditis can present with subacute progressive â€œBâ€ sx (fatigue, wt loss)</description></item><item><title>Clinical manifestations</title><link>https://www.physician.tw/Clinical-manifestations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations/</guid><description>Clinical manifestations Classic triad = wheezing, cough, dyspnea; others include chest tightness, sputum; symptoms typically chronic with episodic exacerbation</description></item><item><title>Clinical manifestations dx studies-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Clinical-manifestations-dx-studies-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-dx-studies-hyperosmolar-hyperglycemic-state/</guid><description>Clinical manifestations dx studies-hyperosmolar hyperglycemic state (Diabetes Care 2014;37:3124)
Volume depletion and Î” MS â†‘ serum glc (usually &amp;gt;600 mg/dL) and â†‘ meas.</description></item><item><title>Clinical Manifestations and Physical Exam-acute aortic syndromes</title><link>https://www.physician.tw/Clinical-Manifestations-and-Physical-Exam-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Manifestations-and-Physical-Exam-acute-aortic-syndromes/</guid><description>Clinical Manifestations and Physical Exam-acute aortic syndromes (JAMA 2000;283:897) Feature
Proximal Distal â€œAorticâ€ pain (abrupt, severe, tearing or ripping quality, maximal at onset [vs.</description></item><item><title>Clinical manifestations complications-herpes zoster</title><link>https://www.physician.tw/Clinical-manifestations-complications-herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-complications-herpes-zoster/</guid><description>Clinical manifestations complications-herpes zoster Uncomplicated: pain in a dermatomal distribution â†’ dermatomal eruption of erythematous papules â†’ vesicles â†’ crusted plaques in varying stages of evolution Disseminated: vesicles across multiple dermatomes, visceral organ involvement (pneumonia, hepatitis, CNS) seen in immunosupp.</description></item><item><title>Clinical manifestations gastroesophageal reflux disease</title><link>https://www.physician.tw/Clinical-manifestations-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-gastroesophageal-reflux-disease/</guid><description>Clinical manifestations gastroesophageal reflux disease Esophageal: heartburn, atypical chest pain, regurgitation, sour taste, dysphagia Extraesophageal: dry cough, asthma (often poorly controlled), laryngitis, dental erosions Patients with GERD often present with heartburn, regurgitation, mild dysphagia, and noncardiac chest pain.</description></item><item><title>Clinical manifestations of acute coronary syndromes</title><link>https://www.physician.tw/Clinical-manifestations-of-acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-acute-coronary-syndromes/</guid><description>Clinical manifestations of acute coronary syndromes Cardiac chest pain (â€œanginaâ€): retrosternal pressure/pain/tightness Â± radiation to neck, jaw, arms. Precipitated by exertion (physical or emotional), â†“ w/ rest or NTG.</description></item><item><title>Clinical manifestations of breast cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-breast-cancer/</guid><description>Clinical manifestations of breast cancer Breast mass (hard, irregular, fixed, nontender), nipple discharge (higher risk if unilateral, limited to 1 duct, bloody, associated with mass) Special types: Paget disease â†’ unilateral nipple eczema + nipple discharge; inflammatory breast cancer â†’ skin erythema and edema (peau dâ€™orange) Metastases: lymph nodes, bone, liver, lung, brain ç›¸é—œé€£çµï¼š [[breast cancer]]</description></item><item><title>Clinical manifestations of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Cryoglobulinemic-vasculitis/</guid><description>Clinical manifestations of Cryoglobulinemic vasculitis Type I hyperviscosity (cold worsens sx) â†’ HA, visual Î”, livedo, digital ischemia
Type II/III vasculitis (not affected by cold) â†’ fever, derm (54â€“80%; purpura, livedo reticularis, ulcers), arthralgia (44â€“70%; symmetric migratory, small/med joints), glomerulonephritis (50%; MPGN), neurologic (17â€“60%; peripheral neuropathy (polyneuropathy &amp;gt;mononeuritis multiplex), â†“ Hgb, â†“ plt, â†‘ B-cell lymphoma risk, GI (5%; pain, HSM, â†‘ LFTs).</description></item><item><title>Clinical manifestations of Eosinophilic gran with polyangiitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Eosinophilic-gran-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Eosinophilic-gran-with-polyangiitis/</guid><description>Clinical manifestations of Eosinophilic gran with polyangiitis (Rheumatol 2020;59:iii84)
Initial sx: asthma sinusitis allergic rhinitis (new asthma in adult raises suspicion) Eosinophilic infiltrative disease: transient pulm infiltrates, gastroenteritis esophagitis Systemic small-vessel vasculitis: neuropathy (mononeuritis multiplex), renal (glomerulonephritis), skin (palpable purpura, petechial, nodules) Cardiac: coronary arteritis, myocarditis, CHF valvular insufficiency (Medicine 2009;88:236)</description></item><item><title>Clinical manifestations of Giant cell arteritis</title><link>https://www.physician.tw/Clinical-manifestations-of-Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Giant-cell-arteritis/</guid><description>Clinical manifestations of Giant cell arteritis (NEJM 2014;371:50): constitutional sx: fevers, fatigue, wt loss
Temporal artery (TA) â†’ headache, tender TAs and scalp, absent TA pulse</description></item><item><title>Clinical manifestations of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Clinical-manifestations-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Granulomatosis-with-polyangiitis/</guid><description>Clinical manifestations of Granulomatosis with polyangiitis Upper respiratory tract: perforation of nasal septum, chronic sinusitis, otitis media, mastoiditis. Lower respiratory tract: hemoptysis, cough, dyspnea.</description></item><item><title>Clinical manifestations of IgA vasculitis</title><link>https://www.physician.tw/Clinical-manifestations-of-IgA-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-IgA-vasculitis/</guid><description>Clinical manifestations of IgA vasculitis é—œç¯€ã€è‚šå­ã€è…ã€çš®
Palpable purpura on extensor surfaces (lower extremity first) &amp;amp; buttocks Polyarthralgias (nondeforming) esp. involving hips, knees, &amp;amp; ankles Colicky abdominal pain Â± GIB or intussusception Nephritis ranging from microscopic hematuria &amp;amp; proteinuria to ESRD</description></item><item><title>Clinical manifestations of lung cancer</title><link>https://www.physician.tw/Clinical-manifestations-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-lung-cancer/</guid><description>Clinical manifestations of lung cancer ~10% asymptomatic at dx, detected incidentally (only 16% w/ localized dis. at presentation) Endobronchial growth of 1Â° tumor: cough, hemoptysis, dyspnea, pain, wheezing, post-obstructive pneumonia; more common with squamous or small cell (central location) Regional spread: can cause dysphagia (esophageal compression), stridor (tracheal obstruction), hoarseness (recurrent laryngeal nerve palsy).</description></item><item><title>clinical manifestations of peptic ulcer disease</title><link>https://www.physician.tw/clinical-manifestations-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-of-peptic-ulcer-disease/</guid><description>clinical manifestations of peptic ulcer disease Epigastric gnawing abdominal pain: relieved with food (DU) or worsened by food (GU) Complic.</description></item><item><title>Clinical manifestations of Polyarteritis nodosa</title><link>https://www.physician.tw/Clinical-manifestations-of-Polyarteritis-nodosa/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-of-Polyarteritis-nodosa/</guid><description>Clinical manifestations of Polyarteritis nodosa (Arth Rheum 2010;62:616):
const. sx (80%): wt loss, fever, fatigue Neuro (79%): mononeuritis multiplex, peripheral neuropathies, stroke Musculoskeletal (64%): extremity pain, myalgias, arthralgias, arthritis Renal (51%): HTN, hematuria, proteinuria, renal failure; glomerulonephritis unusual GI (38%): abd pain, GIB/infarction, cholecystitis; GU (25%): ovarian or testicular pain Skin (50%): livedo reticularis, purpura, nodules, ulcers, Raynaudâ€™s Ophthalmic (9%): retinal vasculitis, retinal exudates, conjunctivitis, uveitis Cardiac (22%): coronary arteritis, cardiomyopathy, pericarditis Pulmonary: rare; if lung involvement, suspect other vasculitis</description></item><item><title>Clinical Manifestations of Sarcoidosis</title><link>https://www.physician.tw/Clinical-Manifestations-of-Sarcoidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-Manifestations-of-Sarcoidosis/</guid><description>Clinical Manifestations of Sarcoidosis Pulmonary
Hilar LAN; fibrosis; pulm hypertension. Stages: I = bilat hilar
LAN; II = LAN + ILD; III = ILD only; IV = diffuse fibrosis.</description></item><item><title>Clinical manifestations peptic ulcer disease</title><link>https://www.physician.tw/Clinical-manifestations-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-peptic-ulcer-disease-/</guid><description>Clinical manifestations peptic ulcer disease Epigastric gnawing abdominal pain: relieved with food (DU) or worsened by food (GU)</description></item><item><title>Clinical manifestations-acute liver failure</title><link>https://www.physician.tw/Clinical-manifestations-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-liver-failure/</guid><description>Clinical manifestations-acute liver failure Initial presentation: N/V, malaise, RUQ pain, jaundice, encephalopathy, multiorgan failure
Neurologic: encephalopathy: grade 1 = attn deficit, disordered sleep; grade 2 = asterixis, confusion; grade 3 = somnolence, rigidity; grade 4 = coma; â†‘ ICP w/ bradycardia &amp;amp; HTN</description></item><item><title>Clinical manifestations-acute mesenteric ischemia</title><link>https://www.physician.tw/Clinical-manifestations-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-mesenteric-ischemia/</guid><description>Clinical manifestations-acute mesenteric ischemia Arterial occlusion: sudden intense abd pain out of proportion to tenderness on exam
Venous occlusion: often more insidious in onset, intermittent pain with peaks and valleys</description></item><item><title>Clinical manifestations-acute pancreatitis</title><link>https://www.physician.tw/Clinical-manifestations-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-acute-pancreatitis/</guid><description>Clinical manifestations-acute pancreatitis Epigastric abdominal or LUQ pain (90%), only Â½ w/ bandlike pain radiating to back
10% pain-free (due to analgesic/steroid use, immunosuppressed, Î”MS, ICU); âˆ´ âœ“ lipase in unexplained shock, periumbilical or flank (Cullen or Grey Turner signs) bruising</description></item><item><title>Clinical manifestations-adrenal insufficiency</title><link>https://www.physician.tw/Clinical-manifestations-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-adrenal-insufficiency/</guid><description>Clinical manifestations-adrenal insufficiency (Lancet 2021;397:613)
Primary or secondary: weakness and fatigability (95%), weight loss (70%), orthostatic hypotension (60%), nausea (50%), vomiting (50%), hyponatremia (75%) Primary only (extra s/s due to lack of aldosterone and â†‘ ACTH): marked orthostatic hypotension (because volume depleted), salt craving, hyperpigmentation (seen in creases, mucous membranes, pressure areas, nipples), hyperkalemia Secondary only: Â± other manifestations of [[hypopituitary syndromes]]</description></item><item><title>clinical manifestations-anemia</title><link>https://www.physician.tw/clinical-manifestations-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-manifestations-anemia/</guid><description>clinical manifestations-anemia Symptoms: â†“ O2 delivery â†’ fatigue, exertional dyspnea, angina (if CAD)
Signs: pallor (mucous membranes, palmar creases), tachycardia, orthostatic hypotension</description></item><item><title>Clinical manifestations-Candida species</title><link>https://www.physician.tw/Clinical-manifestations-Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Candida-species/</guid><description>Clinical manifestations-Candida species Mucocutaneous cutaneous (eg, red, macerated lesions in intertriginous zones); oral thrush (exudative, erythematous or atrophic; if unexplained, r/o HIV); esophageal (odynophagia; Â± oral thrush); vulvovaginal, balanitis</description></item><item><title>Clinical manifestations-cholecystitis</title><link>https://www.physician.tw/Clinical-manifestations-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cholecystitis/</guid><description>Clinical manifestations-cholecystitis History: RUQ/epigastric pain Â± radiation to R shoulder/back, nausea, vomiting, fever
Physical exam: RUQ tenderness, Murphyâ€™s sign = â†‘ RUQ pain and inspiratory arrest with deep breath during palpation of R subcostal region, Â± palpable gallbladder</description></item><item><title>Clinical manifestations-cholelithiasis</title><link>https://www.physician.tw/Clinical-manifestations-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cholelithiasis/</guid><description>Clinical manifestations-cholelithiasis Asx in ~80%. Biliary pain develops in 1â€“4%/y. Once sx, rate of complications ~1â€“3%/y.
Biliary pain = episodic RUQ or epigastric pain; begins abruptly, continuous, resolves slowly and lasts 30 minâ€“3 h; Â± radiation to scapula; precip by fatty foods; nausea</description></item><item><title>Clinical manifestations-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Clinical-manifestations-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-chronic-obstructive-pulmonary-disease/</guid><description>Clinical manifestations-chronic obstructive pulmonary disease Chronic cough, sputum production, dyspnea; later stages â†’ freq exacerb, AM headache, wt loss</description></item><item><title>Clinical manifestations-chronic pancreatitis</title><link>https://www.physician.tw/Clinical-manifestations-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-chronic-pancreatitis/</guid><description>Clinical manifestations-chronic pancreatitis Epigastric pain, N/V; over time can be painless; signs of exocrine insuff (steatorrhea, wt loss) or endocrine insuff (DM: polydipsia, polyuria); 13Ã— â†‘ risk of pancreatic cancer</description></item><item><title>Clinical manifestations-cirrhosis</title><link>https://www.physician.tw/Clinical-manifestations-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-cirrhosis/</guid><description>Clinical manifestations-cirrhosis Nonspecific sx (anorexia, fatigue) or jaundice, encephalopathy, ascites, variceal bleeding</description></item><item><title>Clinical manifestations-clostridioides difficile infection</title><link>https://www.physician.tw/Clinical-manifestations-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-clostridioides-difficile-infection/</guid><description>Clinical manifestations-clostridioides difficile infection Asx colonization: &amp;lt;3% healthy adults; ~20% in hospitalized patients on antibiotics
Acute watery diarrhea (&amp;gt;3 stool/d), occ bloody Â± mucus, lower abd pain, fever, â†‘â†‘â†‘ WBC</description></item><item><title>Clinical manifestations-crohnâ€™s disease</title><link>https://www.physician.tw/Clinical-manifestations-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-crohns-disease/</guid><description>Clinical manifestations-crohnâ€™s disease Abdominal pain,
loose/frequent stools (up to 50% âŠ• FOBT),
malaise,
wt loss</description></item><item><title>Clinical manifestations-Cushingâ€™s Syndrome</title><link>https://www.physician.tw/Clinical-manifestations-Cushings-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Cushings-Syndrome/</guid><description>Clinical manifestations-Cushingâ€™s Syndrome Nonspecific: glucose intolerance or DM, HTN, obesity, oligo- or amenorrhea, osteoporosis More specific: central obesity w/ extremity wasting, dorsocervical fat pads, spont.</description></item><item><title>Clinical manifestations-diabetic ketoacidosis</title><link>https://www.physician.tw/Clinical-manifestations-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-diabetic-ketoacidosis/</guid><description>Clinical manifestations-diabetic ketoacidosis (Diabetes Care 2009;32:1335 &amp;amp; 2016;39:S99)
Polyuria, polydipsia, &amp;amp; dehydration â†’ â†‘ HR, HoTN, dry mucous membranes, â†“ skin turgor N/V, abdominal pain (either due to intra-abdominal process or DKA), ileus Kussmaulâ€™s respirations (deep) to compensate for metabolic acidosis with odor of acetone Î” MS â†’ somnolence, stupor, coma; mortality ~1% even at tertiary care centers</description></item><item><title>Clinical manifestations-hyperaldosteronism</title><link>https://www.physician.tw/Clinical-manifestations-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hyperaldosteronism/</guid><description>Clinical manifestations-hyperaldosteronism Mild-to-moderate HTN: 16-22% of all HTN, 11% of refractory cases (Annals 2020;173:10) Headache, muscle weakness, polyuria, polydipsia; no peripheral edema because of â€œescapeâ€ from Na retention; malignant HTN is rare Classically hypokalemia (but often normal), metabolic alkalosis, mild hypernatremia</description></item><item><title>Clinical manifestations-hypercalcemia</title><link>https://www.physician.tw/Clinical-manifestations-hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypercalcemia/</guid><description>Clinical manifestations-hypercalcemia (â€œbones, stones, abdominal groans, and psychic moansâ€)
[[Primary hyperparathyroidism]]
Hypercalcemic crisis (usually when Ca &amp;gt;13â€“15): polyuria, dehydration, Î”MS</description></item><item><title>Clinical manifestations-hyperkalemia</title><link>https://www.physician.tw/Clinical-manifestations-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hyperkalemia/</guid><description>Clinical manifestations-hyperkalemia Weakness, nausea, paresthesias, palpitations; Renal: â†“ NH4+ secretion â†’ acidosis
ECG: ST depression, peaked T waves, â†“ QT, â†‘ PR interval, â†‘ QRS width, loss of P wave, sine wave pattern, PEA/VF (ECG: low sens.</description></item><item><title>Clinical manifestations-hypocalcemia</title><link>https://www.physician.tw/Clinical-manifestations-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypocalcemia/</guid><description>Clinical manifestations-hypocalcemia Neuromuscular irritability: perioral paresthesias, cramps, âŠ• Trousseauâ€™s (inflation of BP cuff â‰¥3 min â†’ carpal spasm), âŠ• Chvostekâ€™s (tapping facial nerve â†’ contraction of facial muscles), laryngospasm; irritability, depression, psychosis, seizures, â†‘ QT</description></item><item><title>Clinical manifestations-hypokalemia</title><link>https://www.physician.tw/Clinical-manifestations-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-hypokalemia/</guid><description>Clinical manifestations-hypokalemia Nausea, vomiting, ileus, weakness, muscle cramps, rhabdomyolysis, â†“ insulin secretion
Renal: ammoniagenesis, phosphaturia, hypocitraturia, NaCl &amp;amp; HCO3 retention, polyuria</description></item><item><title>Clinical manifestations-mitral-stenosis</title><link>https://www.physician.tw/Clinical-manifestations-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-mitral-stenosis/</guid><description>Clinical manifestations-mitral-stenosis Dyspnea and pulmonary edema (if due to RHD, sx usually begin in 30s) precipitants: exercise, fever, anemia, volume overload (incl.</description></item><item><title>Clinical manifestations-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Clinical-manifestations-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-necrotizing-soft-tissue-infections/</guid><description>Clinical manifestations-necrotizing soft-tissue infections Erythema, edema, warmth + systemic illness Â± crepitus, bullae, necrosis Rapid progression of clinical signs Pain out of proportion to apparent cellulitis; skin hyperesthetic and later anesthetic</description></item><item><title>Clinical manifestations-nephrolithiasis</title><link>https://www.physician.tw/Clinical-manifestations-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-nephrolithiasis/</guid><description>Clinical manifestations-nephrolithiasis Hematuria (absence does not exclude diagnosis), flank pain, N/V, dysuria, frequency
Ureteral obstruction (stones &amp;gt;5 mm unlikely to pass spont.</description></item><item><title>Clinical manifestations-osteomyelitis</title><link>https://www.physician.tw/Clinical-manifestations-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-osteomyelitis/</guid><description>Clinical manifestations-osteomyelitis Surrounding soft-tissue compromise Â± fistula to superficial skin Â± Fever, malaise, and night sweats (more common in hematogenous than contiguous) Vertebral osteomyelitis (esp.</description></item><item><title>Clinical manifestations-pericardial tamponade</title><link>https://www.physician.tw/Clinical-manifestations-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pericardial-tamponade/</guid><description>Clinical manifestations-pericardial tamponade Cardiogenic shock (hypotension, fatigue) without pulmonary edema Dyspnea (seen in ~85%) may be due to â†‘ respiratory drive to augment venous return ç—‡ç‹€ï¼šèƒ¸ç—›ã€æšˆå¥å‰å…†æˆ–æšˆå¥ã€å‘¼å¸å›°é›£æˆ–å‘¼å¸æ€¥ä¿ƒã€ç«¯åå‘¼å¸ é«”æ ¼æª¢æŸ¥ï¼šä½è¡€å£“ã€å¿ƒå‹•éé€Ÿã€JVP å‡é«˜ã€ç„¡è‚ºçˆ†è£‚éŸ³ã€å¿ƒéŸ³æ¸›å¼±ã€å¿ƒåŒ…æ‘©æ“¦éŸ³ï¼ˆç½•è¦‹ï¼‰ã€å¤–å‘¨æ°´è…« çŸ›ç›¾è„ˆï¼ˆå¸æ°£æ™‚æ”¶ç¸®å£“é™ä½&amp;gt;10 mmHgï¼‰ ECGï¼šä¸æ•æ„Ÿæˆ–ç‰¹ç•°ï¼šå¿ƒå‹•éé€Ÿã€ä½é›»å£“ï¼ˆè‚¢é«”å°è¯æœ€å¤§ QRS æŒ¯å¹… &amp;lt;0.</description></item><item><title>Clinical manifestations-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Clinical-manifestations-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pericarditis-and-pericardial-effusion/</guid><description>Clinical manifestations-pericarditis and pericardial effusion NEJM 2014;371:2410; JACC 2020;75:76)
Pericarditis: retrosternal CP, pleuritic, positional (often â†“ by sitting forward), â†’ trapezius; may be absent in TB, neoplastic, XRT, or uremic; Â± fever; Â± s/s of systemic etiologies</description></item><item><title>Clinical manifestations-pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/Clinical-manifestations-pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-pheochromocytoma-and-paraganglioma/</guid><description>Clinical manifestations-pheochromocytoma and paraganglioma (NEJM 2019;381:552)
Neuroendocrine neoplasm leads to inappropriate and paroxysmal release of adrenergic agents including epinephrine, norepinephrine, and rarely dopamine Classic triad: episodic headaches, palpitations and profuse sweating; only 50% have paroxysmal hypertension and most Pts do not have three classic sx Paroxysms can be triggered by meds (eg, Î²-blockers), abdominal manipulation Up to 40% of pheos/paragangliomas thought to have underlying genetic etiology; genetic testing frequently recommended Associated with MEN2A/2B, von Hippel Lindau, NF1, familial paraganglioma (mutations in succinate dehydrogenase gene B, C and D), MAX or TMEM127 mutations</description></item><item><title>Clinical manifestations-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Clinical-manifestations-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Portal-vein-thrombosis-PVT/</guid><description>Clinical manifestations-Portal vein thrombosis (PVT) acute: abd pain, fever, variceal bleed or asx w/ incidental finding on U/S or CT. If mesenteric vein involved may p/w intestinal infarct.</description></item><item><title>Clinical manifestations-Screening for latent TB</title><link>https://www.physician.tw/Clinical-manifestations-Screening-for-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-Screening-for-latent-TB/</guid><description>Clinical manifestations-Screening for latent TB (Lancet 2016;387:1211)
Constitutional symptoms are common in all manifestations, but may be absent Primary TB pneumonia: middle or lower lobe consolidation, Â± effusion, Â± cavitation TB pleurisy: pulmonary effusion Â± pericardial and peritoneal effusions secondary to granuloma breakdown and local inflammation; can occur in primary or reactivation Reactivation TB pulmonary disease: upper lobe infiltrate Â± volume loss Â± cavitation Milliary TB: diffuse millet seed-sized lesions, more common in immunosupp.</description></item><item><title>Clinical manifestations-ulcerative colitis</title><link>https://www.physician.tw/Clinical-manifestations-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-ulcerative-colitis/</guid><description>Clinical manifestations-ulcerative colitis Grossly bloody diarrhea, lower abdominal cramps, tenesmus, small, frequent BM
Extracolonic (&amp;gt;25%): erythema nodosum, pyoderma gangrenosum, aphthous ulcers, uveitis, episcleritis, thromboembolic events (esp.</description></item><item><title>Clinical manifestations-urinary tract infections</title><link>https://www.physician.tw/Clinical-manifestations-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-urinary-tract-infections/</guid><description>Clinical manifestations-urinary tract infections [[cystitis]] Urethritis: dysuria, urethral discharge (see â€œSTIâ€) [[prostatitis]] pyelonephritis: fever, chills, flank or back pain, nausea, vomiting, diarrhea Renal abscess: pyelonephritis sx + persistent fever on appropriate antibiotics</description></item><item><title>Clinical manifestationsâ€”DVT</title><link>https://www.physician.tw/Clinical-manifestationsDVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestationsDVT/</guid><description>Clinical manifestationsâ€”DVT Calf pain
swelling (&amp;gt;3 cm c/w unaffected side)
venous distention
erythema, warmth, tenderness, palpable cord,</description></item><item><title>Clinical manifestationsâ€”PE</title><link>https://www.physician.tw/Clinical-manifestationsPE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestationsPE/</guid><description>Clinical manifestationsâ€”PE Dyspnea (~50%),
pleuritic chest pain (~40%),
cough (~23%),
hemoptysis (~8%)</description></item><item><title>clinical reasoning</title><link>https://www.physician.tw/clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-reasoning/</guid><description>clinical reasoning [[positive and negative predictive values of tests]] [[symptom to diagnosis]] [[Physical Exam Secret]] cardinal manifestations [[Pain]] [[Alterations in Body Temperature]] [[Nervous System Dysfunction]] [[Disorders of Eyes, Ears, Nose, and Throat]] [[Alterations in Circulatory and Respiratory Functions]] [[Alterations in Gastrointestinal Function]] [[Alterations in Renal and Urinary Tract Function]] [[Alterations in the Skin]] [[Hematologic Alterations]]</description></item><item><title>clinical research methods</title><link>https://www.physician.tw/clinical-research-methods/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clinical-research-methods/</guid><description>clinical research methods Phase I Clinical Trials Phase Iï¼Œäººé«”è—¥ç†ç ”ç©¶ Phase II and III Clinical Trials Phase IIï¼Œæ²»ç™‚æ¢ç´¢ Phase IIIï¼Œæ²»ç™‚ç¢ºèª é•·åºšç´€å¿µé†«é™¢è‡¨åºŠè©¦é©—ä¸­å¿ƒ Biomarker Development Biostatistics Regulatory Aspects of Clinical Trials</description></item><item><title>Clinical-manifestations-aortic-regurgitation</title><link>https://www.physician.tw/Clinical-manifestations-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-aortic-regurgitation/</guid><description>Clinical-manifestations-aortic-regurgitation Acute: sudden â†“ forward SV and â†‘ LVEDP (noncompliant ventricle) â†’ pulmonary edema Â± hypotension and cardiogenic shock Chronic: clinically silent while LV dilates (to â†‘ compliance to keep LVEDP low) more than it hypertrophies â†’ chronic volume overload â†’ LV decompensation â†’ CHF Natural hx: variable progression (unlike AS, can be fast or slow); once decompensation begins, prognosis poor w/o AVR (mortality ~10%/y)</description></item><item><title>Clinical-manifestations-aortic-stenosis</title><link>https://www.physician.tw/Clinical-manifestations-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-aortic-stenosis/</guid><description>Clinical-manifestations-aortic-stenosis (usually indicates AVA &amp;lt;1 cm2 or concomitant CAD
Angina: â†‘ O2 demand (hypertrophy) + â†“ O2 supply (â†“ cor perfusion pressure) Â± CAD Syncope (exertional): peripheral vasodil.</description></item><item><title>Clinical-manifestations-mitral-regurgitation</title><link>https://www.physician.tw/Clinical-manifestations-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clinical-manifestations-mitral-regurgitation/</guid><description>Clinical-manifestations-mitral-regurgitation Acute: sudden â†“ forward SV and â†‘ LVEDP (noncompliant ventricle) â†’ pulmonary edema Â± hypotension and cardiogenic shock Chronic: clinically silent while LV dilates (to â†‘ compliance to keep LVEDP low) more than it hypertrophies â†’ chronic volume overload â†’ LV decompensation â†’ CHF Natural hx: variable progression (unlike AS, can be fast or slow); once decompensation begins, prognosis poor w/o AVR (mortality ~10%/y)</description></item><item><title>Clopidogrel</title><link>https://www.physician.tw/Clopidogrel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Clopidogrel/</guid><description>Clopidogrel 300â€“600 mg Ã— 1 â†’ 75 mg qd ~6 h to steady state Wait 5 d prior to surgery ASA+clopi â†’ 20% â†“ CVD/MI/stroke vs.</description></item><item><title>clostridioides difficile infection</title><link>https://www.physician.tw/clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/clostridioides-difficile-infection/</guid><description>clostridioides difficile infection [[Pathogenesis epidemiology-clostridioides difficile infection]] [[Clinical manifestations-clostridioides difficile infection]] [[Diagnosis-clostridioides difficile infection]] [[Initial treatment-clostridioides difficile infection ]] [[Recurrent infection-clostridioides difficile infection]]</description></item><item><title>Cluster headache</title><link>https://www.physician.tw/Cluster-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cluster-headache/</guid><description>Cluster headache and other trigeminal autonomic cephalalgias (TACs) (Continuum 2018;24:1137) Characterized by unilateral headache a/w ipsilateral autonomic sx (rhinorrhea, red/tearing eye, miosis, ptosis, lid edema, sweating), subtypes differentiated by timing.</description></item><item><title>CMV-negative</title><link>https://www.physician.tw/CMV-negative/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CMV-negative/</guid><description>CMV-negative From CMV-negative donors. For CMV-seronegative pregnant women, transplant candidates/recipients, SCID, AIDS Pts.</description></item><item><title>coagulation cascade and sites of action for anticoagulants</title><link>https://www.physician.tw/coagulation-cascade-and-sites-of-action-for-anticoagulants/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coagulation-cascade-and-sites-of-action-for-anticoagulants/</guid><description>coagulation cascade and sites of action for anticoagulants See â€œCoagulopathiesâ€ for reversal agents for anticoagulants. APC, activated protein C; AT, antithrombin; PrC, protein C; PrS, protein S; TF, tissue factor; TFPI, tissue factor pathway inhib.</description></item><item><title>Coagulation factor inhibitors</title><link>https://www.physician.tw/Coagulation-factor-inhibitors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coagulation-factor-inhibitors/</guid><description>Coagulation factor inhibitors (anti-factor antibodies; anti-factor VIII most common)
Etiologies: hemophilia; postpartum; lymphoproliferative &amp;amp; autoimmune disorders; cancers
Diagnosis: â†‘ PTT (does not normalize w/ mixing study); Bethesda assay quantitates titer</description></item><item><title>coagulopathies</title><link>https://www.physician.tw/coagulopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coagulopathies/</guid><description>coagulopathies [[Screening Test Abnormalities in Inherited and Acquired Coagulopathies]] [[Further coagulation tests]] [[Hemophilias]] [[Coagulation factor inhibitors]] [[Disseminated intravascular coagulation (DIC)]] [[Vitamin K deficiency]] [[Properties and Antidotes for Anticoagulants Fibrinolytics]] [[The Coagulation Cascade]]</description></item><item><title>Coccidioidomycosis</title><link>https://www.physician.tw/Coccidioidomycosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coccidioidomycosis/</guid><description>Coccidioidomycosis Epidemiology: endemic to SW U.S., Central and South America Clinical manifestations Acute: subclinical PNA, arthralgias, rash (erythema nodosum) Chronic lung disease (seen in immunosupp): dyspnea, chest pain, hemoptysis, â€œBâ€ sx Disseminated (immunosupp, pregnant): meningitis, osteo, monoarthritis, cutaneous Treatment: no Rx for mild PNA in immunosupp.</description></item><item><title>Colitis</title><link>https://www.physician.tw/Colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Colitis/</guid><description>Colitis Infectious (see â€œAcute Diarrheaâ€), IBD, ischemic colitis, XRT
[[diarrhea]] [[inflammatory bowel disease]]</description></item><item><title>Collagen vascular diseases</title><link>https://www.physician.tw/Collagen-vascular-diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Collagen-vascular-diseases/</guid><description>Collagen vascular diseases (Chest 2013;143:814)
Rheumatologic disease Scleroderma: ILD in ~50%; PHT seen in ~10% of Pts with limited disease</description></item><item><title>colonoscopy for LGIB</title><link>https://www.physician.tw/colonoscopy-for-LGIB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/colonoscopy-for-LGIB/</guid><description>colonoscopy for LGIB colonoscopy (identifies cause in &amp;gt;70%); early colo (w/in 24 h) unlikely to improve outcome vs. late (24-96 h) (Gastro 2020;158:168).</description></item><item><title>colorectal cancer</title><link>https://www.physician.tw/colorectal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/colorectal-cancer/</guid><description>colorectal cancer colon cancer [[index]]
[[Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer]]</description></item><item><title>Common biases in clinical reasoning</title><link>https://www.physician.tw/Common-biases-in-clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-biases-in-clinical-reasoning/</guid><description>Common biases in clinical reasoning Availability ä¸‹äº†è‡ªå·±ç†Ÿçš„çš„è¨ºæ–· Considering easily remembered diagnoses more likely irrespective of prevalence
Base rate neglect æ‰¾äº†æ–‘é¦¬ Pursuing &amp;ldquo;zebrasâ€</description></item><item><title>Common Diagnostic Tests in Thyroid Disorders</title><link>https://www.physician.tw/Common-Diagnostic-Tests-in-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Diagnostic-Tests-in-Thyroid-Disorders/</guid><description>Common Diagnostic Tests in Thyroid Disorders Thyroid-stimulating hormone (TSH) Most sensitive test to detect 1Â° hypo- and hyperthyroidism. Used as primary screening test for thyroid disease.</description></item><item><title>Common Etiologies of SVT</title><link>https://www.physician.tw/Common-Etiologies-of-SVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Etiologies-of-SVT/</guid><description>Common Etiologies of SVT Atrial Sinus tachycardia (ST) Caused by pain, fever, hypovolemia, hypoxia, PE, anemia, anxiety, withdrawal, Î²-agonists, etc.</description></item><item><title>Common Pacing Modes</title><link>https://www.physician.tw/Common-Pacing-Modes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Common-Pacing-Modes/</guid><description>Common Pacing Modes VVI Ventricular pacing on demand w/ single lead in RV. Sensed ventricular beat inhibits V pacing. Used in chronic AF with symptomatic bradycardia.</description></item><item><title>Commonly drug-induced Acute interstitial nephritis</title><link>https://www.physician.tw/Commonly-drug-induced-Acute-interstitial-nephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Commonly-drug-induced-Acute-interstitial-nephritis/</guid><description>Commonly drug-induced Acute interstitial nephritis Î²-lactams, sulfa drugs, NSAIDs, PPIs, quinolones, allopurinol</description></item><item><title>Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Comparison-of-bronchodilator-responsiveness-in-asthma-and-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Comparison-of-bronchodilator-responsiveness-in-asthma-and-chronic-obstructive-pulmonary-disease/</guid><description>Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease å°‡æ”¯æ°£ç®¡æ“´å¼µåŠ‘åæ‡‰è¦–ç‚ºé™½æ€§çš„å…¶ä»–æ¨™æº–æ˜¯æ”¯æ°£ç®¡æ“´å¼µåŠ‘å¾Œ FEV1 ç™¾åˆ†æ¯”å¢åŠ å¤§æ–¼åŸºç·šçš„ 15%ï¼Œæ”¯æ°£ç®¡æ“´å¼µåŠ‘å¾Œ FEV1 å¢åŠ å¤§æ–¼é æ¸¬å€¼çš„ 10% (10) æˆ– FEV1 çµ•å°å¢åŠ  400 ml (6)ã€‚</description></item><item><title>Compensation-for-Acid-Base-Disorders</title><link>https://www.physician.tw/Compensation-for-Acid-Base-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Compensation-for-Acid-Base-Disorders/</guid><description>Compensation-for-Acid-Base-Disorders (NEJM 2014;371:1434) Respiratory: hyper/hypoventilation alters PaCO2 to counteract 1Â° metabolic process Renal: excretion/retention of H+/HCO3â€“ to counteract 1Â° respiratory process Respiratory compensation occurs in mins-hrs; renal compensation takes days</description></item><item><title>Complicated vs uncomplicated parapneumonic</title><link>https://www.physician.tw/Complicated-vs-uncomplicated-parapneumonic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complicated-vs-uncomplicated-parapneumonic/</guid><description>Complicated vs uncomplicated parapneumonic complicated âŠ• Gram stain or culture or pH &amp;lt;7.2 or glucose &amp;lt;60
complicated parapneumonic effusions usually require tube thoracostomy for resolution</description></item><item><title>Complications Gastro 2020;158:760</title><link>https://www.physician.tw/Complications-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-gastroesophageal-reflux-disease/</guid><description>Complications (Gastro 2020;158:760) Reflux esophagitis (erosions/ulcers above GE jxn), strictures (caused by chronic inflamm) [[Barrettâ€™s esophagitis]].</description></item><item><title>Complications &amp; prognosis-venous thromboembolism</title><link>https://www.physician.tw/Complications-prognosis-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-prognosis-venous-thromboembolism/</guid><description>Complications &amp;amp; prognosis-venous thromboembolism [[postthrombotic syndrome]] (23â€“60%) pain, edema, venous ulcers
Recurrent VTE:
1%/y (after 1st VTE) to 5%/y (after recurrent VTE) Chronic thromboembolic PHT after acute PE ~2â€“3%, consider thromboendarterectomy</description></item><item><title>Complications gastroesophageal reflux disease</title><link>https://www.physician.tw/Complications-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-gastroesophageal-reflux-disease-/</guid><description>Complications gastroesophageal reflux disease (Gastro 2020;158:760)
Reflux esophagitis (erosions/ulcers above GE jxn), strictures (caused by chronic inflamm)
Barrettâ€™s esoph.</description></item><item><title>complications of bacterial meningitis</title><link>https://www.physician.tw/complications-of-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-bacterial-meningitis/</guid><description>complications of bacterial meningitis The neurologic complications of bacterial meningitis include: Impaired mental status
Increased intracranial pressure and cerebral edema</description></item><item><title>complications of HIV AIDS</title><link>https://www.physician.tw/complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/complications-of-HIV-AIDS/</guid><description>complications of HIV AIDS Any S. pneumo, TB, VZV, HPV complications, Kaposiâ€™s sarcoma, lymphoma, â†‘ CVD risk, â†“ bone density.</description></item><item><title>Complications of HTN</title><link>https://www.physician.tw/Complications-of-HTN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-of-HTN/</guid><description>Complications of HTN è…¦å¿ƒç®¡çœ¼è…
Neurologic: TIA/CVA, ruptured aneurysms, vascular dementia
Retinopathy stage I = arteriolar(å°å‹•è„ˆ) narrowing stage II = copper-wiring, AV nicking stage III = hemorrhages and exudates stage IV = papilledema Cardiac: CAD, LVH, HF, AF</description></item><item><title>Complications PA catheter and tailored therapy</title><link>https://www.physician.tw/Complications-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-PA-catheter-and-tailored-therapy/</guid><description>Complications PA catheter and tailored therapy Central venous access: pneumo/hemothorax (~1%), arterial puncture (if inadvertent cannulation w/ dilation â†’ surgical/endovasc eval), air embolism, thoracic duct injury</description></item><item><title>Complications-acute aortic syndromes</title><link>https://www.physician.tw/Complications-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-acute-aortic-syndromes/</guid><description>Complications-acute aortic syndromes (occur in ~20%; Circ 2010;121:e266; Lancet 2015;385:800)
Freq assess (sx, BP, UOP), pulses, labs (Cr, Hb, lactic acid), imaging (~7 d or sooner if âˆ†s) Uncontrolled BP or persistent pain may indicate complication/extension Progression: propagation of dissection, â†‘ aneurysm size, â†‘ false lumen size Rupture: pericardial sac â†’ tamponade (avoid pericardiocentesis unless PEA); blood in pleural space, mediast.</description></item><item><title>Complications-acute pancreatitis</title><link>https://www.physician.tw/Complications-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-acute-pancreatitis/</guid><description>Complications-acute pancreatitis Systemic: ARDS, abdominal compartment syndrome, AKI, GIB (pseudoaneurysm), DIC
Metabolic: hypocalcemia, hyperglycemia, hypertriglyceridemia
Fluid collections:</description></item><item><title>Complications-aortic aneurysms</title><link>https://www.physician.tw/Complications-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-aortic-aneurysms/</guid><description>Complications-aortic aneurysms (Circ 2010;121:e266; Nat Rev Cardiol 2011;8:92)
Pain: gnawing chest, back, or abdominal pain; new or worse pain may signal rupture Rupture: risk â†‘ w/ diameter, â™€, current smoking, HTN TAA: ~2.</description></item><item><title>Complications-cholecystitis</title><link>https://www.physician.tw/Complications-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-cholecystitis/</guid><description>Complications-cholecystitis Gangrenous cholecystitis: necrosis w/ risk of empyema and perforation
Emphysematous cholecystitis: infection by gas-forming organisms (air in GB wall)</description></item><item><title>Complications-cholelithiasis</title><link>https://www.physician.tw/Complications-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-cholelithiasis/</guid><description>Complications-cholelithiasis Cholecystitis: 20% of Pts with symptomatic biliary pain progress to cholecystitis w/in 2 y
Choledocholithiasis â†’ cholangitis or gallstone pancreatitis</description></item><item><title>Complications-crohnâ€™s disease</title><link>https://www.physician.tw/Complications-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-crohns-disease/</guid><description>Complications-crohnâ€™s disease Perianal disease: fissures, fistulas, skin tags, perirectal abscesses (in 24% of Pts; perianal disease precedes intestinal symptoms)</description></item><item><title>Complications-diabetes mellitus</title><link>https://www.physician.tw/Complications-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-diabetes-mellitus/</guid><description>Complications-diabetes mellitus (NEJM 2004;350:48; 2016;374:1455; CJASN 2017;12:1366)
Retinopathy nonproliferative: â€œdot &amp;amp; blotâ€ and retinal hemorrhages, cotton-wool/protein exudates proliferative: neovascularization, vitreous hemorrhage, retinal detachment, blindness treatment: photocoagulation, surgery, intravitreal bevacizumab injections</description></item><item><title>Complications-prosthetic-heart-valves</title><link>https://www.physician.tw/Complications-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-prosthetic-heart-valves/</guid><description>Complications-prosthetic-heart-valves Structural failure (r/o endocarditis); mechanical valves: rare except for Bjork-Shiley; bioprosth: up to 30% rate w/in 10â€“15 y, mitral &amp;gt;aortic; consider TAVR (JACC 2017; 69:2253) Paravalvular leak (r/o endocarditis); small central jet of regurg is normal in mech.</description></item><item><title>Complications-treatment-chronic kidney disease CKD</title><link>https://www.physician.tw/Complications-treatment-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-treatment-chronic-kidney-disease-CKD/</guid><description>Complications-treatment-chronic kidney disease (CKD) (JAMA 2019;322:1294; KI 2021;99:S1)
General: renal referral when GFR &amp;lt;30 or proteinuria, access planning (avoid subclavian lines, preserve an arm by avoiding phlebotomy, BP measurements, IVs)</description></item><item><title>Complications-ulcerative colitis</title><link>https://www.physician.tw/Complications-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Complications-ulcerative-colitis/</guid><description>Complications-ulcerative colitis Toxic megacolon (5%): colon dilatation (â‰¥6 cm on KUB), colonic atony, systemic toxicity, &amp;amp; â†‘ risk of perf.</description></item><item><title>computed tomogram in central nervous system infection</title><link>https://www.physician.tw/computed-tomogram-in-central-nervous-system-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/computed-tomogram-in-central-nervous-system-infection/</guid><description>computed tomogram in central nervous system infection ä»€éº¼æƒ…æ³ä¸‹è¦å…ˆåšCTå†åšLumbar Punctureï¼š #ğŸ“š The most appropriate sequence in managing a patient with suspected bacterial meningitis and a new-onset, 10-second seizure is to obtain blood cultures, then initiate dexamethasone and empiric antimicrobial therapy, and then obtain a CT scan of the head (before performing a lumbar puncture)</description></item><item><title>config</title><link>https://www.physician.tw/config/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/config/</guid><description>echo -e &amp;ldquo;site name:MyDocs\ntheme:\n\tname:material&amp;rdquo; &amp;raquo; /volume1/docker/mkdocs/mkdocs.yml
docker run &amp;ndash;rm -i -v /volume1/docker/mkdocs:/docs squidfunk/mkdocs-material new . docker run -d &amp;ndash;name=mkdocs -p 9898:8000 -v /volume1/docker/mkdocs:/docs &amp;ndash;restart always squidfunk/mkdocs-material</description></item><item><title>Confusion and Delirium</title><link>https://www.physician.tw/Confusion-and-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Confusion-and-Delirium/</guid><description>Confusion and Delirium [[terms used to describe patients with delirium]]
altered attention &amp;amp; awareness,
develops over hrs to days,</description></item><item><title>Connective tissue disease as Etiologies of Classic FUO</title><link>https://www.physician.tw/Connective-tissue-disease-as-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Connective-tissue-disease-as-Etiologies-of-Classic-FUO/</guid><description>Connective tissue disease as Etiologies of Classic FUO [[Giant cell arteritis]] [[Polymyalgia rheumatica]] headache, scalp pain, jaw claudication, visual disturbances, myalgias, arthralgias, â†‘ ESR</description></item><item><title>Consciousness Arousal</title><link>https://www.physician.tw/Consciousness-Arousal/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consciousness-Arousal/</guid><description>Consciousness Arousal Arousal: spectrum from awake/alert â†’ drowsy â†’ stupor â†’ coma Terms vague &amp;amp; subjective, so most useful to describe response to increasing stimulation (eg, voice â†’ noxious).</description></item><item><title>Consequences-of-Severe-Acid-Base-Disturbances</title><link>https://www.physician.tw/Consequences-of-Severe-Acid-Base-Disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consequences-of-Severe-Acid-Base-Disturbances/</guid><description>Consequences-of-Severe-Acid-Base-Disturbances (NEJM 1998;338:26 &amp;amp; 107)
Cardiovascular Acidemia (pH &amp;lt;7.20) â†“ contractility, arteriolar vasodilation â†“ MAP &amp;amp; CO; â†“ response to catecholamines â†‘ risk of arrhythmias Alkalemia (pH &amp;gt;7.</description></item><item><title>Consider Advanced Airway</title><link>https://www.physician.tw/Consider-Advanced-Airway/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Consider-Advanced-Airway/</guid><description>Consider Advanced Airway Endotracheal intubation or supraglottic advanced aiway Clinical assessment: bilat. chest expansion &amp;amp; breath sounds Device to âœ” tube placement Continuous waveform capnography (~100% Se ï¼† Sp) Colorimetric exhaled CO, detection (~clinical assess.</description></item><item><title>consider the potential harms</title><link>https://www.physician.tw/consider-the-potential-harms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/consider-the-potential-harms/</guid><description>consider the potential harms Consider the potential harms of both a missed diagnosis and the treatment. A. It is very harmful to miss certain diagnoses, such as MI or pulmonary embolism, while it is not so harmful to miss others, such as mild carpal tunnel syndrome.</description></item><item><title>Constipation</title><link>https://www.physician.tw/Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Constipation/</guid><description>Constipation (Annals 2015;162:ITC1, Nat Rev Dis Primers 2017;3:17095; JAMA 2019;322:2239)
[[Definition of Constipation]] [[Etiologies of Constipation]] Dx: H&amp;amp;P w/ DRE.</description></item><item><title>constrictive pericarditis</title><link>https://www.physician.tw/constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/constrictive-pericarditis/</guid><description>constrictive pericarditis [[Etiology-constrictive pericarditis]] [[Pathophysiology-constrictive pericarditis]]
Clinical manifestations (NEJM 2011;364:1350)
Right-sided &amp;gt;left-sided heart failure (systemic congestion &amp;gt;pulmonary congestion) [[Physical exam-constrictive pericarditis]] [[Diagnostic studies-constrictive pericarditis]] [[Constrictive Pericarditis vs.</description></item><item><title>Contact</title><link>https://www.physician.tw/Contact/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contact/</guid><description>Site officiel: http://www.notational.net/fr/
DÃ©velopment: http://github.com/scrod/nv/tree/
Contact: Zachary Schneirov scrod@notational.net
Traduction: David Bosman david.bosman@gmail.com</description></item><item><title>Context sensitive half time</title><link>https://www.physician.tw/Context-sensitive-half-time/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Context-sensitive-half-time/</guid><description>Context sensitive half time Context sensitive half time | Deranged Physiology</description></item><item><title>Continuous veno-venous hemofiltration CVVH</title><link>https://www.physician.tw/Continuous-veno-venous-hemofiltration-CVVH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Continuous-veno-venous-hemofiltration-CVVH/</guid><description>Continuous veno-venous hemofiltration (CVVH) Hemofiltration rather than dialysis. Blood under pressure passes down one side highly permeable membrane filtering H2O and solutes via TMP gradient (convective clearance); filtrate discarded.</description></item><item><title>Contraindications to Fibrinolysis</title><link>https://www.physician.tw/Contraindications-to-Fibrinolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contraindications-to-Fibrinolysis/</guid><description>Contraindications to Fibrinolysis Absolute Contraindications *Any prior ICH *Intracranial neoplasm, aneurysm, AVM *Ischemic stroke or closed head trauma w/in 3 mo; head/spinal surg.</description></item><item><title>Contrast-induced acute kidney injury</title><link>https://www.physician.tw/Contrast-induced-acute-kidney-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Contrast-induced-acute-kidney-injury/</guid><description>Contrast-induced acute kidney injury Definition increase in the creatinine of 0.5mg/dL or a 25% increase from basline w/i 3 days after the contrast media and abscense of alternative cause (CIAKI) (NEJM 2019;380:2146) natural history 24-48h increase after exposure and peak at 3-5 days resolves in 7 to 10 days if prolonged duration: look for other cause, e.</description></item><item><title>Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor</title><link>https://www.physician.tw/Control-of-Mineral-Homeostasis-by-Parathyroid-Hormone-and-the-Calcium-Sensing-Receptor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Control-of-Mineral-Homeostasis-by-Parathyroid-Hormone-and-the-Calcium-Sensing-Receptor/</guid><description>Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor é‡è¦åè©ï¼š éˆ£æ•æ„Ÿå—é«”ï¼šcalcium-sensing receptor (CaSR), é‡é» è¡€éˆ£é™ä½æœƒå¼•ç™¼: ä¸»è¦é€šéç”²ç‹€æ—è…ºæ¿€ç´  (PTH) å’Œé›¢å­éˆ£ (Ca2+) å° PTH å—é«”å’Œéˆ£æ•æ„Ÿå—é«” (CaSR) çš„ä½œç”¨ä»‹å°ï¼Œé€™å…©è€…éƒ½æ˜¯ 7-è·¨è†œGè›‹ç™½å¶è¯å—é«”( 7-transmembrane, G-proteinâ€“coupled receptors.</description></item><item><title>Controller medications</title><link>https://www.physician.tw/Controller-medications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Controller-medications/</guid><description>Controller medications (JAMA 2020;324:2301)
ICS Rx of choice. Superior to LAMA if sputum w/ â‰¥2% eos (NEJM 2019;380:2009). PO steroids may be needed for severely uncontrolled asthma; avoid if possible b/c of systemic side effects.</description></item><item><title>COP cryptogenic organizing PNA</title><link>https://www.physician.tw/COP-cryptogenic-organizing-PNA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COP-cryptogenic-organizing-PNA/</guid><description>COP cryptogenic organizing PNA Patchy, migratory consolidations; subpleural &amp;amp; peribronchial. Excessive proliferation of granulation tissue in small airways and alveolar ducts.</description></item><item><title>COPD Exacerbation Treatment</title><link>https://www.physician.tw/COPD-Exacerbation-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COPD-Exacerbation-Treatment/</guid><description>COPD Exacerbation Treatment [[Ipratropium of COPDAE]] [[Albuterol of COPDAE]] [[Corticosteroids of COPDAE]] [[Antibiotics of COPDAE]] [[Oxygenation of COPDAE]] [[Noninvasive positive-pressure ventilation of COPDAE]] [[Endotracheal intubation of COPDAE]] [[Other measures of COPDAE]] [[Post-exacerb care of COPDAE]]</description></item><item><title>Coronary angiography</title><link>https://www.physician.tw/Coronary-angiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-angiography/</guid><description>Coronary angiography Immediate/urgent coronary angiography (w/in 2 h) if refractory/recurrent angina or hemodynamic or electrical instability
Routine angiography (aka â€œinvasive strategyâ€) = coronary angiography for all</description></item><item><title>coronary angiography PCI</title><link>https://www.physician.tw/coronary-angiography-PCI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronary-angiography-PCI/</guid><description>coronary angiography PCI è¡€ä¹‹å¾ªç’°ï¼Œå‘½ä¹‹æ‰€åœ¨ï¼Œ ä¿å…¶å¥åº·ï¼Œæ°¸çºŒç”Ÿæ©Ÿã€‚
Precath checklist Peripheral arterial exam (radial, femoral, DP, PT pulses; bruits); palmar arch eval (eg, w/ pulse oximetry &amp;amp; plethysmography) not routinely done.</description></item><item><title>Coronary artery bypass grafting CABG -related MI</title><link>https://www.physician.tw/Coronary-artery-bypass-grafting-CABG-related-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-artery-bypass-grafting-CABG-related-MI/</guid><description>Coronary artery bypass grafting (CABG)-related MI is arbitrarily defined as elevation of cTn values &amp;gt;10 times the 99th percentile URL in patients with normal baseline cTn values.</description></item><item><title>Coronary-angiography-for-SIHD</title><link>https://www.physician.tw/Coronary-angiography-for-SIHD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Coronary-angiography-for-SIHD/</guid><description>Coronary-angiography-for-SIHD High-risk noninvasive testing results suggestive of left main or multivessel CAD Angina that is refractory to optimal medical therapy Uncertain dx after noninvasive testing, occupational need (eg, pilot) Unexplained heart failure or â†“ EF</description></item><item><title>coronavirus covid-19</title><link>https://www.physician.tw/coronavirus-covid-19/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/coronavirus-covid-19/</guid><description>coronavirus (covid-19) Microbiology &amp;amp; epidemiology
Person-to-person transmission via respiratory particles; asx &amp;amp; pre-sx transmission can occur Incubation period: up to 14 days, median time of 4â€“5 days from exposure to sx onset Presentation Ranges from asx to severe illness.</description></item><item><title>Correction of overanticoagulation</title><link>https://www.physician.tw/Correction-of-overanticoagulation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Correction-of-overanticoagulation/</guid><description>Correction of overanticoagulation (Circ 2021;143:e72)
Risk from major bleeding must be weighed against risk of valve thrombosis Not bleeding: if INR 5â€“10, withhold warfarin Bleeding: PCC (or FFP); reversal agent for DOACs; Â± low-dose (1 mg) vit K IV if on VKA</description></item><item><title>Corticosteroids for chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Corticosteroids-for-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Corticosteroids-for-chronic-obstructive-pulmonary-disease/</guid><description>Corticosteroids for chronic obstructive pulmonary disease (inhaled, ICS): ~11% â†“ in exacerbations &amp;amp; slows â†“ FEV1; no Î” in mortality (Lancet 2016;387:1817).</description></item><item><title>Corticosteroids of COPDAE</title><link>https://www.physician.tw/Corticosteroids-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Corticosteroids-of-COPDAE/</guid><description>Corticosteroids of COPDAE [[Prednisone]] 40 mg/d Ã— 5d (JAMA 2013;309:2223); some Pts will benefit from higher dose/longer course if severe Methylprednisolone 125 mg IV q6h Ã— 72 h for more severe exacerbations</description></item><item><title>COVID-19 associated AKI</title><link>https://www.physician.tw/COVID-19-associated-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/COVID-19-associated-AKI/</guid><description>COVID-19 associated AKI</description></item><item><title>CPRäººåŠ›é…ç½®</title><link>https://www.physician.tw/CPR%E4%BA%BA%E5%8A%9B%E9%85%8D%E7%BD%AE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CPR%E4%BA%BA%E5%8A%9B%E9%85%8D%E7%BD%AE/</guid><description>CPRäººåŠ›é…ç½® ä¸‰äººçµ„ï¼š
æ›ä¸‹ä¾†çš„äººè¦è² è²¬check pulse çµ¦è—¥çš„äººè¦è² è²¬é›»(å¦‚æœå¯ä»¥çš„è©±) Endoå‰è¦å®Œæˆå£“èƒ¸é›»æ“Šçµ¦è—¥å…©åˆ†é˜</description></item><item><title>CPS-22C3</title><link>https://www.physician.tw/CPS-22C3/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CPS-22C3/</guid><description>CPS-22C3 PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs</description></item><item><title>CRC screening</title><link>https://www.physician.tw/CRC-screening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CRC-screening/</guid><description>CRC screening (JAMA 2021;325:1978)
Colonoscopy gold standard. Other options: FOBT/FIT yearly, flex sig q5y or flex sig q10y + FIT every year, fecal DNA testing (eg, Cologuard) q3y or CT colonography q5y Start screening in average risk Pts at age 45 (typically q10y unless abnl found) If âŠ• FHx, start age 40, or 10 y before age of dx in youngest family member, repeat q5y</description></item><item><title>Criteria-Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Criteria-Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Criteria-Hepatorenal-syndrome-HRS/</guid><description>Criteria-Hepatorenal syndrome (HRS) (1) cirrhosis w/ ascites; (2) acute kidney injury (serum Cr â†‘ â‰¥0.3 mg/dL w/in 48 h or â‰¥50% â†‘ in serum Cr from baseline; Gut 2015;64:531) (3) Ã˜ improvement in Cr after d/c diuretic &amp;amp; volume expansion (1 g/kg/d of albumin Ã— 2 d); (4) Ã˜ shock (prerenal azotemia/ATN); (5) Ã˜ nephrotoxic meds; (6) Ã˜ intrinsic kidney disease</description></item><item><title>crohnâ€™s disease</title><link>https://www.physician.tw/crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/crohns-disease/</guid><description>crohnâ€™s disease (Lancet 2017;389:1741)
[[Clinical manifestations-crohnâ€™s disease]] [[Diagnosis-crohnâ€™s disease]] [[Complications-crohnâ€™s disease]] Prognosis Variable at 1 y: ~50% in remission, ~20% flare, ~20% low activity, ~10% chronic active At 20 y, majority will have required some surgery; overall life expectancy is slightly â†“</description></item><item><title>Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryoglobulinemic-vasculitis/</guid><description>Cryoglobulinemic vasculitis (Lancet 2012;379:348; Nat Rev Dis Primers 2018;4:11)
Cryoglobulins: proteins that precipitate from serum or plasma on exposure to cold and redissolve on rewarming, characterized by their composition; a/w chronic immune stimulation and/or lymphoproliferation Distinguish from cryofibrinogenemia = proteins (eg, fibrin, fibrinogen) that precipitate only from plasma; found in autoimmune dis, malignancies, infxns; unclear clinical significance [[Types of Cryoglobulinemia]] (J Autoimmun 2019;105:102313) Epidemiology: ~1/100,000, but prevalence varies with HCV rates; â™€ &amp;gt;â™‚ Etiologies (idiopathic in ~10%) Hematologic diseases: multiple myeloma, MGUS, WaldenstrÃ¶mâ€™s, chronic lymphocytic leukemia in type I; B-cell lymphomas or solid-organ malignancies in type II Infxns (types II &amp;amp; III): viral (HCV [&amp;gt;80% RNA âŠ•], HBV, HIV, HAV, EBV, CMV), bacterial (endocarditis, strep, etc.</description></item><item><title>Cryoprecipitate</title><link>https://www.physician.tw/Cryoprecipitate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryoprecipitate/</guid><description>Cryoprecipitate Enriched for fibrinogen, vWF, VIII, and XIII. 1st line for fibrinogen &amp;lt;100 mg/dL. For bleeding in vWD factor XIII deficiency, use if other products not available.</description></item><item><title>Cryptococcus</title><link>https://www.physician.tw/Cryptococcus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryptococcus/</guid><description>Cryptococcus Epidemiology: immunosupp. most susceptible (espec. AIDS, transplant recipients, and cirrhosis); can occur in healthy hosts (esp C. gattii) Clinical manifestations CNS (meningoencephalitis): subacute HA, fever, meningismus, CN abnl, Â± stupor Other sites: pulm.</description></item><item><title>Cryptococcus neoformans</title><link>https://www.physician.tw/Cryptococcus-neoformans/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cryptococcus-neoformans/</guid><description>Cryptococcus neoformans A common infectious cause of subacute and chronic meningoencephalitis associated with raised intracranial pressure in immunocompromised patients is Cryptococcus neoformans.</description></item><item><title>CSF leak</title><link>https://www.physician.tw/CSF-leak/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CSF-leak/</guid><description>CSF leak headache clear fluid leaking from the nose or ear. Some CSF leaks may heal with conservative treatments such as bed rest.</description></item><item><title>culture negative-bacterial endocarditis</title><link>https://www.physician.tw/culture-negative-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/culture-negative-bacterial-endocarditis/</guid><description>culture negative-bacterial endocarditis abiotrophic strep [[HACEK]] (Haemophilus para-influenzae &amp;amp; aphrophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella), T. whipplei [[Bartonella]], [[Coxiella burnetii]] Chlamydia Legionella [[Brucella]] (JAMA 2007;297:1354; Annals 2007;147:829; J Clin Microbiol 2012;50:216)</description></item><item><title>Culture-negative neutrocytic ascites CNNA</title><link>https://www.physician.tw/Culture-negative-neutrocytic-ascites-CNNA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Culture-negative-neutrocytic-ascites-CNNA/</guid><description>Culture-negative neutrocytic ascites (CNNA) cell counts suggest infxn but cx âŠ–. No recent abx, w/o other explanation for counts. Often do have [[Spontaneous bacterial peritonitis]] and should be treated with empiric regimen.</description></item><item><title>Cushingâ€™s Syndrome</title><link>https://www.physician.tw/Cushings-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cushings-Syndrome/</guid><description>Cushingâ€™s Syndrome Cushingâ€™s syndrome = cortisol excess Cushingâ€™s disease = Cushingâ€™s syndrome 2Â° to pituitary ACTH hypersecretion [[Etiologies of hypercortisolism]] [[Clinical manifestations-Cushingâ€™s Syndrome]] [[Diagnosis Cushingâ€™s Syndrome]] [[Treatment of Cushingâ€™s syndrome]]</description></item><item><title>Cutaneous arteritis</title><link>https://www.physician.tw/Cutaneous-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-arteritis/</guid><description>Cutaneous arteritis Sometimes called &amp;ldquo;benign cutaneous [[Polyarteritis nodosa]]&amp;rdquo; cPAN can nevertheless result in significant morbidity due to painful skin nodules, digital infarcts, ulcerations, and other complications</description></item><item><title>cutaneous leukocytoclastic angiitis</title><link>https://www.physician.tw/cutaneous-leukocytoclastic-angiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cutaneous-leukocytoclastic-angiitis/</guid><description>cutaneous leukocytoclastic angiitis Occurs 7â€“10 days after certain medications (penicillins, cephalosporins, sulfonamides, phenytoin, allopurinol) or infections (eg, HCV, HIV). Palpable purpura, no visceral involvement.</description></item><item><title>Cutaneous-complications of HIV AIDS</title><link>https://www.physician.tw/Cutaneous-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cutaneous-complications-of-HIV-AIDS/</guid><description>Cutaneous-complications of HIV AIDS Eosinophilic folliculitis; warts (HPV); HSV &amp;amp; VZV; MRSA SSTI; scabies; candidiasis; eczema; prurigo nodularis; psoriasis; drug eruption; subungual onychomycosis Molluscum contagiosum (poxvirus): 2â€“5 mm pearly papules w/ central umbilication Kaposiâ€™s sarcoma (KSHV or HHV8): red-purple nonblanching nodular lesions Bacillary angiomatosis (disseminated Bartonella): friable violaceous vascular papules</description></item><item><title>CXR of Diagnostic studies-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/CXR-of-Diagnostic-studies-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/CXR-of-Diagnostic-studies-chronic-obstructive-pulmonary-disease/</guid><description>CXR of Diagnostic studies-chronic obstructive pulmonary disease (see Radiology inserts):
hyperinflation, flat diaphragms, Â± interstitial markings &amp;amp; bullae</description></item><item><title>Cyanide-toxicology</title><link>https://www.physician.tw/Cyanide-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cyanide-toxicology/</guid><description>Cyanide-toxicology Coma, seizure, metabolic acidosis, hypotension
IV Na nitrite and Na thiosulfate
IV hydroxocobalamin
Call local Poison Control for assistance with management.</description></item><item><title>Cyclic vomiting syndrome</title><link>https://www.physician.tw/Cyclic-vomiting-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cyclic-vomiting-syndrome/</guid><description>Cyclic vomiting syndrome acute recurrent vomiting; a/w marijuana use, personal or FHx of migraine. Acute Rx: antiemetics, IVF, sumatriptan (1st line, followed by aprepitant x 3 d), BDZs; prevention: TCAs/AEDs; avoid marijuana.</description></item><item><title>cynosis</title><link>https://www.physician.tw/cynosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cynosis/</guid><description>cynosis central cyanosis can be detected reliably when the SaO2 has fallen to 85%; in others, particularly in dark-skinned persons, it may not be detected until it has declined to 75%</description></item><item><title>cystic fibrosis</title><link>https://www.physician.tw/cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/cystic-fibrosis/</guid><description>cystic fibrosis [[Definition and pathophysiology-cystic fibrosis]] [[Clinical features-cystic fibrosis]] [[Treatment-cystic fibrosis]]</description></item><item><title>Cytomegalovirus</title><link>https://www.physician.tw/Cytomegalovirus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Cytomegalovirus/</guid><description>Cytomegalovirus Retinitis, esophagitis, colitis, hepatitis, neuropathies, encephalitis. CMV VL may be âŠ–. Consider tissue biopsy. Rx: ganciclovir, valganciclovir, foscarnet, or cidofovir.</description></item><item><title>Dako 28-8</title><link>https://www.physician.tw/Dako-28-8/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dako-28-8/</guid><description>Dako 28-8 S</description></item><item><title>ddMVAC</title><link>https://www.physician.tw/ddMVAC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ddMVAC/</guid><description>Dose-dense MVAC chemotherapy for urothelial carcinoma Keyword: ddMVAC [Dose-dense MVAC chemotherapy for urothelial carcinoma - UpToDate]( https://www.uptodate.com/contents/image?imageKey=ONC%2F111814&amp;topicKey=ONC%2F3000&amp;source=see link)
durg: methotrexate vinblastine doxorubicin cisplatin Pretreatment considerations: å: é«˜ vesicant/irritant properties Infection prophylaxis: é«˜ G-CSF: 240mcg/m2 SC daily on d4-d10 Monitor Parameters: CBC/Electrolytes/Neurologic/3rd space fluid collection/LVEF</description></item><item><title>Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture</title><link>https://www.physician.tw/Ddx-causes-of-myocardial-ischemia-infarction-other-than-atherosclerotic-plaque-rupture-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ddx-causes-of-myocardial-ischemia-infarction-other-than-atherosclerotic-plaque-rupture-/</guid><description>Ddx causes of myocardial ischemia infarction other than atherosclerotic plaque rupture Ischemia w/o plaque rupture (â€œtype 2â€ MI): â†‘ demand (eg, â†‘ HR), â†“ supply (eg, HoTN).</description></item><item><title>Ddx-of-dominant-R-wave-in-V1-or-V2</title><link>https://www.physician.tw/Ddx-of-dominant-R-wave-in-V1-or-V2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ddx-of-dominant-R-wave-in-V1-or-V2/</guid><description>Ddx-of-dominant-R-wave-in-V1-or-V2 Ventricular abnl: RVH (RAD, RAA, deep S waves in I, V5, V6); HCM; Duchenneâ€™s
Posterior MI: anterior R wave = posterior Q wave; often with IMI</description></item><item><title>deafferentation pain</title><link>https://www.physician.tw/deafferentation-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/deafferentation-pain/</guid><description>deafferentation pain å‚³å…¥ç¥ç¶“ç—›æ˜¯ç¥ç¶“æ€§ç–¼ç—›çš„ä¸€å€‹åˆ†æ”¯ï¼Œå®ƒå¯èƒ½ä½¿å¹¾ä¹ä»»ä½•é¡å‹çš„è»€é«”æ„Ÿè¦ºç³»çµ±æå‚·åœ¨å…¶éç¨‹ä¸­çš„ä»»ä½•æ™‚å€™éƒ½è¤‡é›œåŒ–ã€‚ ä¾‹å­åŒ…æ‹¬ç”±å¤–å‘¨ï¼ˆå¹»è‚¢ï¼‰æˆ–ä¸­æ¨ï¼ˆä¸˜è…¦ç–¼ç—›ï¼‰ç—…è®Šå¼•èµ·çš„æ˜ç¢ºçš„ç¶œåˆå¾µã€‚ åœ¨æ‰€æœ‰é€™äº›æƒ…æ³ä¸‹ï¼Œç–¼ç—›é€šå¸¸ç™¼ç”Ÿåœ¨è‡¨åºŠæ„Ÿè¦ºå–ªå¤±çš„å€åŸŸã€‚ å°æ–¼å¹»è‚¢ç—›ï¼Œç–¼ç—›å¯¦éš›ä¸Šæ˜¯åœ¨ä¸å†å­˜åœ¨çš„å€åŸŸæ„Ÿè¦ºåˆ°çš„ã€‚ ä¸˜è…¦ç–¼ç—›æ‚£è€…ï¼Œä¹Ÿç¨±ç‚º Dejerine-Roussy ç¶œåˆå¾µï¼Œå ±å‘Šè‡¨åºŠæ„Ÿè¦ºå–ªå¤±å€åŸŸçš„å…¨éƒ¨æˆ–éƒ¨åˆ†ç–¼ç—›ã€‚</description></item><item><title>Decreased GFR-hyperkalemia</title><link>https://www.physician.tw/Decreased-GFR-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Decreased-GFR-hyperkalemia/</guid><description>Decreased GFR-hyperkalemia Any cause of oliguric or anuric AKI or any cause of end-stage renal disease</description></item><item><title>Definition and causes-acute mesenteric ischemia</title><link>https://www.physician.tw/Definition-and-causes-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-causes-acute-mesenteric-ischemia/</guid><description>Definition and causes-acute mesenteric ischemia Reduced or absent blood flow to small intestine, typically caused by arterial (ie, SMA or its branches) occlusion or transient hypoperfusion or less often by venous occlusion</description></item><item><title>Definition and clinical manifestations of Migraine</title><link>https://www.physician.tw/Definition-and-clinical-manifestations-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-clinical-manifestations-of-Migraine/</guid><description>Definition and clinical manifestations of Migraine (Lancet 2018;391:1315 &amp;amp; Continuum 2021;27:586) [[POUNDing Mnemonic]]
Epidemiology: affects 15% of women and 6% of men; onset usually by 30 y</description></item><item><title>Definition and epidemiology</title><link>https://www.physician.tw/Definition-and-epidemiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology/</guid><description>Definition and epidemiology (Lancet 2018;391:783)
Chronic inflam disorder w/ airway hyperresponsiveness + variable airflow obstruction
Affects 5â€“10% population; ~85% of cases by age 40 y</description></item><item><title>Definition and epidemiology-bronchiectasis</title><link>https://www.physician.tw/Definition-and-epidemiology-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology-bronchiectasis/</guid><description>Definition and epidemiology-bronchiectasis (NEJM 2002;346:1383)
Obstructive airways disease of bronchi and bronchioles, chronic transmural inflammation w/ airway dilatation and thickening, collapsibility, mucus plugging w/ impaired clearance</description></item><item><title>Definition and epidemiology-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Definition-and-epidemiology-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-epidemiology-chronic-obstructive-pulmonary-disease/</guid><description>Definition and epidemiology-chronic obstructive pulmonary disease Progressive airflow limitation caused by airway and parenchymal inflammation</description></item><item><title>definition and etiologies of peptic ulcer disease</title><link>https://www.physician.tw/definition-and-etiologies-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/definition-and-etiologies-of-peptic-ulcer-disease/</guid><description>definition and etiologies of peptic ulcer disease (BMJ 2019;367:5495)
Ulcers (break in mucosal lining &amp;gt;5 mm) &amp;amp; erosions (&amp;lt;5 mm) in stomach and duodenum Principal risk factors: H.</description></item><item><title>Definition and etiologies-chronic kidney disease CKD</title><link>https://www.physician.tw/Definition-and-etiologies-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-etiologies-chronic-kidney-disease-CKD/</guid><description>Definition and etiologies-chronic kidney disease (CKD) (Lancet 2021;10302:786)
GFR &amp;lt;60 for â‰¥3 mo and/or kidney damage (albuminuria, structural abnormality)</description></item><item><title>Definition and pathophysiology-anaphylaxis</title><link>https://www.physician.tw/Definition-and-pathophysiology-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-anaphylaxis/</guid><description>Definition and pathophysiology-anaphylaxis (Ann Emerg Med 2006;47:373)
Severe, rapid onset (mins to hrs), potentially life-threatening systemic allergic response</description></item><item><title>Definition and pathophysiology-cystic fibrosis</title><link>https://www.physician.tw/Definition-and-pathophysiology-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-cystic-fibrosis/</guid><description>Definition and pathophysiology-cystic fibrosis (NEJM 2015;372:351)
Autosomal recessive genetic disorder due to mutations in chloride channel (CFTR gene)</description></item><item><title>Definition and pathophysiology-hemoptysis</title><link>https://www.physician.tw/Definition-and-pathophysiology-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-and-pathophysiology-hemoptysis/</guid><description>Definition and pathophysiology-hemoptysis Expectoration of blood or blood-streaked sputum Massive hemoptysis: &amp;gt;100 mL/h or &amp;gt;500 mL in 24 h; massive hemoptysis usually from tortuous or invaded bronchial arteries [[Etiologies-hemoptysis]]</description></item><item><title>Definition Clinical Manifestations-HIV AIDS</title><link>https://www.physician.tw/Definition-Clinical-Manifestations-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-Clinical-Manifestations-HIV-AIDS/</guid><description>Definition Clinical Manifestations-HIV AIDS Acute HIV: rash, lymphadenopathy, fever, oral ulcers, pharyngitis, myalgias, diarrhea Presents ~2â€“6 wk after exposure; not all HIV infections result in symptoms of acute HIV AIDS: HIV + CD4 &amp;lt;200/mm3 or AIDS-defining opportunistic infection (OI) or malignancy</description></item><item><title>Definition etiologies peptic ulcer disease</title><link>https://www.physician.tw/Definition-etiologies-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-etiologies-peptic-ulcer-disease-/</guid><description>Definition etiologies peptic ulcer disease Ulcers (break in mucosal lining &amp;gt;5 mm) &amp;amp; erosions (&amp;lt;5 mm) in stomach and duodenum</description></item><item><title>Definition of Constipation</title><link>https://www.physician.tw/Definition-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-Constipation/</guid><description>Definition of Constipation Defined as dissatisfaction w/ defecation or (per Rome IV): â‰¥2 of following during last 3â€“6 mos â‰¥25% of the time: straining, lumpy/hard stools, incomplete evacuation, sensation of anorectal obstruction, manual maneuvers to facilitate defecation, stool frequency &amp;lt;3/wk</description></item><item><title>Definition of fever and neutropenia</title><link>https://www.physician.tw/Definition-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-of-fever-and-neutropenia/</guid><description>Definition of fever and neutropenia Fever: single oral temp â‰¥38.3Â°C (101Â°F) or â‰¥38Â°C (100.4Â°F) for â‰¥1 h Neutropenia: ANC &amp;lt;500 cells/ÂµL or &amp;lt;1000 cells/ÂµL with predicted nadir &amp;lt;500 cells/ÂµL</description></item><item><title>Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Definition-precipitants-pathophysiology-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-precipitants-pathophysiology-hyperosmolar-hyperglycemic-state/</guid><description>Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state (Med Clin North Am 2017;101:587)
Extreme hyperglycemia (w/o ketoacidosis) + hyperosm. + Î” MS in T2D (typically elderly) Precip same as for DKA, but also include dehydration and renal failure Hyperglycemia â†’ osmotic diuresis â†’ vol depletion â†’ prerenal azotemia â†’ â†‘ glc, etc.</description></item><item><title>Definition-acute kidney injury AKI</title><link>https://www.physician.tw/Definition-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-acute-kidney-injury-AKI/</guid><description>Definition-acute kidney injury (AKI) #ğŸŒ² #ğŸ“š
(KDIGO 2012;2:1)
Stages in ICU correspond to â†‘ hospital mortality and LOS (Crit Care Med 2009;37:2552) Diagnostic criteria Increase in serum creatinine of â‰¥0.</description></item><item><title>Definition-acute liver failure</title><link>https://www.physician.tw/Definition-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-acute-liver-failure/</guid><description>Definition-acute liver failure Acute liver injury + coagulopathy + encephalopathy w/o preexisting liver dis. (&amp;lt;26 wks)
Fulminant if encephalopathy &amp;lt;8 wks from jaundice onset, subfulminant if 8â€“26 wks</description></item><item><title>Definition-Antiphospholipid syndrome</title><link>https://www.physician.tw/Definition-Antiphospholipid-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-Antiphospholipid-syndrome/</guid><description>Definition-Antiphospholipid syndrome dx requires â‰¥1 clinical &amp;amp; â‰¥1 laboratory criteria
Clinical: thrombosis (any) or complication of pregnancy (â‰¥3 spont. abortions before 10 wk or â‰¥1 fetal loss after 10 wk or premature birth before 34 wk)</description></item><item><title>Definition-cirrhosis</title><link>https://www.physician.tw/Definition-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-cirrhosis/</guid><description>Definition-cirrhosis (Dig Dis 2016;34:374; NEJM 2016;375:767; J Hep 2016;64:717)
Definition fibrosis &amp;amp; regenerative nodules causing distortion of hepatic architecture</description></item><item><title>Definition-diabetes mellitus</title><link>https://www.physician.tw/Definition-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-diabetes-mellitus/</guid><description>Definition-diabetes mellitus (Diabetes Care 2022;45:S256)
HbA1c â‰¥6.5 fasting glc â‰¥126 mg/dL glc 2 h after [[OGTT]] â‰¥200 mg/dL Ã— 2 (for any test) or single random glc â‰¥200 mg/dL w/ classic sx of hyperglycemia; all tests equally reasonable (nb, may be âŠ• on one test but not another); OGTT preferred during preg Blood glc higher than normal, but not frank DM (â€œprediabetics,â€ ~40% U.</description></item><item><title>Definition-glomerulonephritis</title><link>https://www.physician.tw/Definition-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-glomerulonephritis/</guid><description>Definition-glomerulonephritis Lancet 2016;387:2036; JASN 2016;27:1278)
â†‘ glomerular inflammation â†’ endothelial &amp;amp; podocyte injury
Histology: proliferative (â†‘ cells), sclerosing (scar), necrotizing (areas cell death).</description></item><item><title>Definition-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Definition-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-necrotizing-soft-tissue-infections/</guid><description>Definition-necrotizing soft-tissue infections Fulminant tissue destruction, systemic toxicity &amp;amp; high mortality. Surgical emergency. May include cellulitis, fasciitis, myositis, myonecrosis (gas gangrene).</description></item><item><title>Definition-nephrotic syndrome</title><link>https://www.physician.tw/Definition-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-nephrotic-syndrome/</guid><description>Definition-nephrotic syndrome ( JASN 2014;25:2393)
Podocyte injury (effacement) â†’ loss of proteins (albumin, ATIII, Ig)
Clinically: proteinuria &amp;gt;3.</description></item><item><title>Definition-syncope</title><link>https://www.physician.tw/Definition-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definition-syncope/</guid><description>Definition-syncope Symptom of sudden transient loss of consciousness due to global cerebral hypoperfusion If CPR or cardioversion required, then SCD and not syncope (different prognosis) Presyncope = prodrome of light-headedness without LOC</description></item><item><title>Definitions heart failure</title><link>https://www.physician.tw/Definitions-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-heart-failure/</guid><description>Definitions heart failure å„ç¨®å®šç¾©
Failure of heart to pump blood forward at rate sufficient to meet metabolic demands of peripheral tissues, or ability to do so only at abnormally high cardiac filling pressures Low output (â†“ cardiac output) vs.</description></item><item><title>Definitions-accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/Definitions-accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-accessory-pathways-wolff-parkinson-white/</guid><description>Definitions-accessory pathways (wolff-parkinson-white) Accessory pathway (bypass tract) of conducting myocardium connecting atria &amp;amp; ventricles, allowing impulses to bypass normal AVN delay Pre-excitation (WPW) pattern: â†“ PR interval, â†‘ QRS width w/ Î´ wave (slurred onset, can be subtle).</description></item><item><title>Definitions-acid-base disturbances</title><link>https://www.physician.tw/Definitions-acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-acid-base-disturbances/</guid><description>Definitions-acid-base disturbances Acidemia â†’ pH &amp;lt;7.36, alkalemia â†’ pH &amp;gt;7.44; pH = 6.10 + log([HCO3]/[0.03xPCO2]) Acidosis â†’ process that â†‘ [H+] or â†“ pH by â†“ HCO3 or â†‘ PaCO2 Alkalosis â†’ process that â†“ [H+] or â†‘ pH by â†‘ HCO3 or â†“ PaCO2 Primary disorders: metabolic acidosis or alkalosis, respiratory acidosis or alkalosis [[Compensation-for-Acid-Base-Disorders]] The physiological approach uses the carbonic acidâ€“bicarbonate buffer system.</description></item><item><title>Definitions-acute aortic syndromes</title><link>https://www.physician.tw/Definitions-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-acute-aortic-syndromes/</guid><description>Definitions-acute aortic syndromes (Circ 2010;121:e266; Eur Heart J 2012;33:26)
Aortic dissection: intimal tear â†’ blood extravasates into Ao media (creates false lumen) Intramural hematoma (IMH): vasa vasorum rupture â†’ medial hemorrhage that does not communicate with aortic lumen; 6% of aortic syndromes; clinically managed as AoD Penetrating ulcer: atherosclerotic plaque penetrates elastic lamina â†’ medial hemorrhage</description></item><item><title>Definitions-and-clinical-manifestations</title><link>https://www.physician.tw/Definitions-and-clinical-manifestations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-and-clinical-manifestations/</guid><description>Definitions-and-clinical-manifestations Pneumonia: s/s (fever, cough, purulent sputum, dyspnea) + new infiltrate on chest imaging Community-acquired pneumonia (CAP): pneumonia acquired outside of hospital setting [[Hospital-acquired pneumonia]] (HAP): pneumonia acquired â‰¥48 hrs after hospitalization [[Ventilator-associated pneumonia]] (VAP): pneumonia acquired â‰¥48 hrs after intubation Lung empyema: accumulation of pus in pleural space Lung abscess: parenchymal necrosis with confined cavitation Aspiration pneumonitis: acute lung injury after inhalation of gastric contents without infection, though bacterial infection can occur within 24â€“72 hrs of injury</description></item><item><title>Definitions-aortic aneurysms</title><link>https://www.physician.tw/Definitions-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-aortic-aneurysms/</guid><description>Definitions-aortic aneurysms True (â‰¥50% dilation of all 3 layers; &amp;lt;50% = ectasia) vs. false (rupture w/in adventitia) Location: root (annuloaortic ectasia), thoracic aortic aneurysm (TAA), thoracoabdominal aortic aneurysm (TAAA), abdominal aortic aneurysm (AAA) Type: fusiform (circumferential dilation) vs.</description></item><item><title>Definitions-sepsis and shock</title><link>https://www.physician.tw/Definitions-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-sepsis-and-shock/</guid><description>Definitions-sepsis and shock Sepsis Life-threatening organ dysfxn (SOFA â‰¥2) due to infection Quick SOFA (qSOFA): â‰¥2 of the following: RR â‰¥22, æœ‰å¤ å–˜ Î”MS, æœ‰å¤ æ˜ SBP â‰¤100 mmHg æœ‰å¤ ä½ [[Shock]] Septic shock Sepsis-induced circulatory and cellular/metabolic abnormalities severe enough to â†‘ mortality; hypotension requiring pressors for MAP â‰¥65 and lactate &amp;gt;2 despite adequate fluid resuscitation æœ‰sepsisè€Œä¸”éœ€è¦ç”¨åˆ°å‡å£“åŠ‘ Sequential Organ Failure Assessment (SOFA): â†‘ points for worsening organ dysfxn:</description></item><item><title>Definitions-skin and soft tissue infections</title><link>https://www.physician.tw/Definitions-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-skin-and-soft-tissue-infections/</guid><description>Definitions-skin and soft tissue infections Cellulitis: infection of dermis and subcutaneous tissue characterized by erythema, warmth, tenderness, and swelling; often occurs as a result of skin breaches (JAMA 2016;315:3) èœ‚çª©ç¹”ç‚ï¼šä»¥ç´…æ–‘ã€ç™¼ç†±ã€å£“ç—›å’Œè…«è„¹ç‚ºç‰¹å¾µçš„çœŸçš®å’Œçš®ä¸‹çµ„ç¹”æ„ŸæŸ“ï¼›ç¶“å¸¸å› çš®è†šç ´è£‚è€Œç™¼ç”Ÿ (JAMA 2016;315:3) Skin abscess: subcutaneous collection of pus Staph toxic shock syndrome: rapid onset fever, rash, hypotension, and multiorgan injury.</description></item><item><title>Definitions-tuberculosis</title><link>https://www.physician.tw/Definitions-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-tuberculosis/</guid><description>Definitions-tuberculosis Primary: new Mycobacterium tuberculosis (TB) in a naÃ¯ve host; symptomatic or asymptomatic; 90% of infected normal hosts will never develop clinically evident disease Latent: well-controlled infection without clinical or radiographic evidence of active disease; can persist for years to decades Reactivated: activation of latent; more likely in the setting of immunosuppression.</description></item><item><title>Definitions-urinary tract infections</title><link>https://www.physician.tw/Definitions-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-urinary-tract-infections/</guid><description>Definitions-urinary tract infections Asymptomatic bacteriuria: presence of bacteria in urine without signs or sx of infection
Uncomplicated: confined to bladder. No upper tract or systemic infection signs.</description></item><item><title>Definitions-venous thromboembolism</title><link>https://www.physician.tw/Definitions-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Definitions-venous-thromboembolism/</guid><description>Definitions-venous thromboembolism Superficial thrombophlebitis: * pain, tenderness, erythema along superficial vein [[deep vein thrombosis]] Proximal = thrombosis of iliac, femoral, or popliteal veins (nb, â€œsuperficialâ€ femoral vein part of deep venous system).</description></item><item><title>Delayed hemolytic</title><link>https://www.physician.tw/Delayed-hemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Delayed-hemolytic/</guid><description>Delayed hemolytic : generally less severe than acute hemolytic; 5â€“7 d after transfusion, but can be severe â†’ hyperhemolysis. Due to undetected allo-Abs vs.</description></item><item><title>delta-delta</title><link>https://www.physician.tw/delta-delta/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/delta-delta/</guid><description>delta-delta (Î”/Î” = Î”AG/Î”HCO3) to assess if there is an additional metabolic acid-base disturbance; Î”AG = (calculated AG â€“ expected AG), Î”HCO3 = (24 â€“ HCO3) Î”/Î” = 1â€“2 â†’ pure AG metabolic acidosis Î”/Î” &amp;lt;1 â†’ AG metabolic acidosis and simultaneous non-AG acidosis Î”/Î” &amp;gt;2 â†’ AG metabolic acidosis and simultaneous metabolic alkalosis For pure lactic acidosis Î”/Î” 1.</description></item><item><title>dermatology</title><link>https://www.physician.tw/dermatology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dermatology/</guid><description>[[index]]
Keratinocyte Carcinomas (Squamous- and Basal-Cell Carcinomas) Melanoma Acne and Rosacea Psoriasis Atopic Dermatitis &amp;amp; Contact Dermatitis Stasis Dermatitis Cutaneous Herpes Infections Molluscum Contagiosum Warts ddate ddd Other relevant topics in Dermatology are covered in the following rotation guides:</description></item><item><title>Device infection</title><link>https://www.physician.tw/Device-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Device-infection/</guid><description>Device infection (Heart Rhythm 2017;14:e503, NEJM 2019;380:1895)
Presents as pocket infection (warmth, erythema, tenderness) and/or sepsis w/ bacteremia ~2% over 5 y; if S.</description></item><item><title>diabetes mellitus</title><link>https://www.physician.tw/diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetes-mellitus/</guid><description>diabetes mellitus [[Definition-diabetes mellitus]] (Diabetes Care 2022;45:S256) [[Categories-diabetes mellitus]]
alias: [[dm]]
Clinical manifestations Polyuria, polydipsia, polyphagia with unexplained weight loss; may be asymptomatic Topic [[Diabetes Treatment Approach for ASCVD, HF, or CKD]] [[Additional Diabetes Treatment Options]] [[Insulin Preparations]] (Diabetes Care 2019;42:S90) [[Complications-diabetes mellitus]] [[Outpatient screening and treatment goals-diabetes mellitus]] [[Management of hyperglycemia in inPts]] [[diabetic ketoacidosis]] (DKA) [[hyperosmolar hyperglycemic state]] [[hypoglycemia]] [[SGLT2i]]</description></item><item><title>Diabetes Treatment Approach for ASCVD, HF, or CKD</title><link>https://www.physician.tw/Diabetes-Treatment-Approach-for-ASCVD-HF-or-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetes-Treatment-Approach-for-ASCVD-HF-or-CKD/</guid><description>Diabetes Treatment Approach for ASCVD, HF, or CKD Med (â†“ HbA1C) Comments
GLP-1 receptor agonists (~1â€“2%) â†‘ glc-depend. insulin secretion. Delay gastric emptying.</description></item><item><title>Diabetic Foot Infection</title><link>https://www.physician.tw/Diabetic-Foot-Infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diabetic-Foot-Infection/</guid><description>Diabetic Foot Infection ä¾†è‡ª: [[infectious disease]]</description></item><item><title>diabetic foot infections</title><link>https://www.physician.tw/diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetic-foot-infections/</guid><description>diabetic foot infections [[Microbiology and severity-diabetic foot infections]] Initial evaluation-diabetic foot infections Cleanse, debride, probe, and obtain deep anaerobic + aerobic cultures Assess for PVD: sensation, pulses, ABIs Diagnosis Deep tissue wound cx at time of debridement (ideally prior to antibiotics).</description></item><item><title>diabetic ketoacidosis</title><link>https://www.physician.tw/diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diabetic-ketoacidosis/</guid><description>diabetic ketoacidosis [[Precipitants-diabetic ketoacidosis]] (the Iâ€™s) [[Pathophysiology-diabetic ketoacidosis]] [[Clinical manifestations-diabetic ketoacidosis]] [[Diagnostic studies-diabetic ketoacidosis]] [[Treatment of DKA]]</description></item><item><title>Diagnosis and treatment-autoimmune hepatitis AIH</title><link>https://www.physician.tw/Diagnosis-and-treatment-autoimmune-hepatitis-AIH-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-and-treatment-autoimmune-hepatitis-AIH-/</guid><description>Diagnosis and treatment-autoimmune hepatitis (AIH) (J Hepatol 2015;63:1543, Clin Liver Dis 2015;19:57)
70% female; bimodal presentation in the second and fifth decades of life</description></item><item><title>Diagnosis gastroesophageal reflux</title><link>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease/</guid><description>Diagnosis gastroesophageal reflux (Annals 2015;163:ITC1; Nat Rev Gastro Hepatol 2016;13:501)
Clinical diagnosis based on sx and response to empiric trial of PPI (â€œPPI testâ€) EGD if: Ã˜ response to PPI or alarm features: dysphagia, vomiting, â†“ wt, anemia, age &amp;gt;60 If dx uncertain &amp;amp; EGD nl â†’ esoph manometry w/ 24-h pH monitoring Â± impedance to dx: â€œNonerosive reflux diseaseâ€: no erosion, ulceration or Barrettâ€™s; Â½ abnl pH.</description></item><item><title>Diagnosis gastroesophageal reflux disease</title><link>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-gastroesophageal-reflux-disease-/</guid><description>Diagnosis gastroesophageal reflux disease (Annals 2015;163:ITC1; Nat Rev Gastro Hepatol 2016;13:501)
Clinical diagnosis based on sx and response to empiric trial of PPI (â€œPPI testâ€)</description></item><item><title>diagnosis of Giant cell arteritis</title><link>https://www.physician.tw/diagnosis-of-Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnosis-of-Giant-cell-arteritis/</guid><description>diagnosis of Giant cell arteritis â†‘ ESR (Se 84%, Sp 30%), â†‘ CRP (Se 86%, Sp 30%), anemia.</description></item><item><title>Diagnosis of heparin-induced thrombocytopenia</title><link>https://www.physician.tw/Diagnosis-of-heparin-induced-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-heparin-induced-thrombocytopenia/</guid><description>Diagnosis of heparin-induced thrombocytopenia [[Evaluation of Suspected HIT]] (â€œ4Tâ€™sâ€) Clinical: plt &amp;lt;100k or â†“ 50% from baseline; or venous (DVT/PE) or arterial (limb ischemia, CVA, MI) thrombosis (4:1 ratio); skin necrosis; ?</description></item><item><title>Diagnosis of migraine</title><link>https://www.physician.tw/Diagnosis-of-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-migraine/</guid><description>Diagnosis of migraine Record medical history Apply diagnostic criteria Consider differential diagnoses Examine patient to exclude other causes Use neuroimaging only when a secondary headache disorder is suspected [[54321-PUMA-å˜”æ€•]]</description></item><item><title>Diagnosis of SVT Type</title><link>https://www.physician.tw/Diagnosis-of-SVT-Type/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-SVT-Type/</guid><description>Diagnosis of SVT Type (NEJM 2012;367:1438)
Onset Abrupt on/off argues against sinus tachycardia
Rate Not dx b/c most can range from 140â€“250 bpm, but: ST usually &amp;lt;150; AFL often conducts 2:1 â†’ vent.</description></item><item><title>Diagnosis of Thrombotic microangiopathies</title><link>https://www.physician.tw/Diagnosis-of-Thrombotic-microangiopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-of-Thrombotic-microangiopathies/</guid><description>Diagnosis of Thrombotic microangiopathies unexplained thrombocytopenia (typically &amp;lt;20k) + MAHA â†’ sufficient for dx âŠ• schistocytes (&amp;gt;2â€“3/hpf), âŠ– Coombs, normal PT/PTT &amp;amp; fibrinogen â†‘â†‘ LDH (tissue ischemia + hemolysis), â†‘ indirect bili.</description></item><item><title>Diagnosis-anaphylaxis</title><link>https://www.physician.tw/Diagnosis-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-anaphylaxis/</guid><description>Diagnosis-anaphylaxis any of the three following criteria
Acute illness with skin Â± mucosal involvement (rash, flushing, hives), AND at least one of: Respiratory compromise (wheeze, stridor, dyspnea, hypoxemia)</description></item><item><title>Diagnosis-aseptic meningitis</title><link>https://www.physician.tw/Diagnosis-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-aseptic-meningitis/</guid><description>Diagnosis-aseptic meningitis Obtain LP for CSF analysis: lymphocytic pleocytosis common in viral etiologies (see Typical CSF Findings in Meningitis table above) Consider CSF cytology and MRI brain/spine to evaluate for malignancy Consider serum autoimmune and serum viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric treatment</description></item><item><title>Diagnosis-bacterial endocarditis</title><link>https://www.physician.tw/Diagnosis-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-bacterial-endocarditis/</guid><description>Diagnosis-bacterial endocarditis (CID 2010;51:131; EHJ 2015;36:3075; Circ 2015;132:1435)
Blood cultures (before abx): 3 sets (aerobic &amp;amp; anaerobic bottles) from different sites, ideally spaced â‰¥1 h apart.</description></item><item><title>Diagnosis-clostridioides difficile infection</title><link>https://www.physician.tw/Diagnosis-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-clostridioides-difficile-infection/</guid><description>Diagnosis-clostridioides difficile infection (Ann Intern Med 2018;169:49)
Only test if symptomatic (diarrhea, s/s of colitis); test liquid stool (unless concern for ileus)</description></item><item><title>Diagnosis-crohnâ€™s disease</title><link>https://www.physician.tw/Diagnosis-crohns-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-crohns-disease/</guid><description>Diagnosis-crohnâ€™s disease Ileocolonoscopy + bx along w/ small bowel assessment (eg, MR-enterography)
Small bowel/ileitis (~25%), ileocolonic (~50%), colonic (~25%); isolated upper tract rare</description></item><item><title>Diagnosis-Glucose-6-phosphate dehydrogenase</title><link>https://www.physician.tw/Diagnosis-Glucose-6-phosphate-dehydrogenase/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-Glucose-6-phosphate-dehydrogenase/</guid><description>Diagnosis-Glucose-6-phosphate dehydrogenase smear may show RBC Heinz bodies (oxidized Hb) that result in bite cells once removed by spleen; â†“ G6PD levels (may be normal after acute hemolysis because older RBCs have already lysed and young RBCs may still have near-normal levels)</description></item><item><title>Diagnosis-hyperaldosteronism</title><link>https://www.physician.tw/Diagnosis-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-hyperaldosteronism/</guid><description>Diagnosis-hyperaldosteronism (JCEM 2016;101:1889; Endo Metab Clin 2019;48:681; J Clin Endo Met 2021;106:2423)
5â€“10% of Pts w/ HTN; âˆ´ screen if HTN + hypoK, adrenal mass, refractory/early onset HTN Screening: â†“â†“ renin, aldo &amp;gt;15â€“20 ng/dL, plasma aldo:renin ratio (&amp;gt;20 if 1Â°); obtain 8 a.</description></item><item><title>Diagnosis-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Diagnosis-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-necrotizing-soft-tissue-infections/</guid><description>Diagnosis-necrotizing soft-tissue infections Clinical dx is sufficient to initiate urgent surgical exploration Aspiration of necrotic center; BCx; Gram stain; lactate, AST, &amp;amp; CK for deep tissue necrosis Imaging: noncontrast CT, but do not delay Rx/surgery (Arch Surg 2010;145:452) Microbiologic dx from Gram stain and culture of surgical specimens LRINEC score: ä¸»è¦æ˜¯Labçš„åƒè€ƒ If high suspicion for necrotizing fasciitis through clinical history and physical exam, do not calculate a LRINEC score and go straight to operative debridement.</description></item><item><title>Diagnosis-osteomyelitis</title><link>https://www.physician.tw/Diagnosis-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-osteomyelitis/</guid><description>Diagnosis-osteomyelitis (JAMA 2008;299:806)
Crucial to obtain cx data of causative organism to avoid long-term empiric abx Bone biopsy or tissue cx obtained surgically or via percutaneous biopsy (send aerobic, anaerobic, mycobacterial, and fungal cultures + pathology) unless âŠ• blood cx.</description></item><item><title>Diagnosis-sexually transmitted infections</title><link>https://www.physician.tw/Diagnosis-sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-sexually-transmitted-infections/</guid><description>Diagnosis-sexually transmitted infections (MMWR 2021;70:1; JAMA 2022;327:161)
Syphilis: 1st step is treponemal test: IgG to T. pallidum. âŠ• for life.</description></item><item><title>Diagnosis-skin and soft tissue infections</title><link>https://www.physician.tw/Diagnosis-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-skin-and-soft-tissue-infections/</guid><description>Diagnosis-skin and soft tissue infections [[Differential Diagnosis of Cellulitis]] Clinical diagnosis based on physical examination Cultures from intact skin are not helpful and should not be performed (CID 2014;59:e10) BCx are typically low yield (~5â€“10%) Ultrasound can be used to identify deep abscesses and facilitate drainage.</description></item><item><title>Diagnosis-ulcerative colitis</title><link>https://www.physician.tw/Diagnosis-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnosis-ulcerative-colitis/</guid><description>Diagnosis-ulcerative colitis Colonoscopy: involves rectum (95%) &amp;amp; extends prox., circumfer., &amp;amp; contig. w/in colon
Location: proctitis (30â€“60%), L-sided (15â€“45%) and extensive (pancolitis; 15â€“35%)</description></item><item><title>Diagnostic and staging evaluation of lung cancer</title><link>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-and-staging-evaluation-of-lung-cancer/</guid><description>Diagnostic and staging evaluation of lung cancer [[Staging of lung cancer]]
[[5-y survival of lung cancer]]
Imaging: CT w/ contrast of chest &amp;amp; abd/pelvis to assess for mets (adrenal, liver, bones).</description></item><item><title>Diagnostic approach-fever syndromes</title><link>https://www.physician.tw/Diagnostic-approach-fever-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-approach-fever-syndromes/</guid><description>Diagnostic approach-fever syndromes Thorough history including ROS, PMH/PSH, immunizations, including from childhood Fever curve (holding antipyretics); look at trend/pattern. Less likely to mount fever if: ESRD/ESLD, extremes of age, protein calorie malnutrition, immunosupp.</description></item><item><title>Diagnostic clues that favor VT</title><link>https://www.physician.tw/Diagnostic-clues-that-favor-VT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-clues-that-favor-VT/</guid><description>Diagnostic clues that favor VT (assume until proven o/w)
Prior MI, CHF, or LV dysfunction best predictors that WCT is VT (Am J Med 1998;84:53) Hemodynamics and rate do not reliably distinguish VT from SVT MMVT is regular, but initially it may be slightly irregular, mimicking AF w/ aberrancy; grossly irregularly irregular rhythm suggests AF w/ aberrancy or pre-excitation ECG features that favor VT (Circ 2016;133:e506) AV dissociation (independent P waves, capture or fusion beats) proves VT Very wide QRS (&amp;gt;140 ms in RBBB-type or &amp;gt;160 in LBBB-type); extreme axis deviation QRS morphology atypical for BBB (longest precordial RS &amp;gt;100 ms and R wider than S) RBBB-type: absence of tall Râ€² (or presence of monophasic R) in V1, r/S ratio &amp;lt;1 in V6 LBBB-type: onset to nadir &amp;gt;60 ms in V1, q wave in V6 Initial R wave in aVR; concordance (QRS in all precordial leads w/ same pattern/direction)</description></item><item><title>Diagnostic evaluation of breast cancer</title><link>https://www.physician.tw/Diagnostic-evaluation-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-breast-cancer/</guid><description>Diagnostic evaluation of breast cancer Palpable breast mass: age &amp;lt;30 y â†’ observe for resolution over 1â€“2 menstrual cycles; age &amp;lt;30 y, unchanging mass â†’ U/S â†’ aspiration if mass not simple cyst; age &amp;gt;30 y or solid mass on U/S or bloody aspirate or recurrence after aspiration â†’ mammo (detect other lesions) and either fine-needle asp.</description></item><item><title>Diagnostic evaluation of fever and neutropenia</title><link>https://www.physician.tw/Diagnostic-evaluation-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-fever-and-neutropenia/</guid><description>Diagnostic evaluation of fever and neutropenia Exam: skin, oropharynx, lung, perirectal area, surgical &amp;amp; catheter sites; avoid rectal exam Studies: U/A, blood (periph &amp;amp; through each indwelling catheter port), urine, &amp;amp; sputum cx; for localizing s/s â†’ âœ“ stool (C.</description></item><item><title>Diagnostic evaluation of hypercoagulable states</title><link>https://www.physician.tw/Diagnostic-evaluation-of-hypercoagulable-states/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-hypercoagulable-states/</guid><description>Diagnostic evaluation of hypercoagulable states (not routinely required for initial VTE; NEJM 2017;377:1177)
APC resistance screen; prothrombin PCR test; functional assays for proteins C and S, ATIII; homocysteine level; factor VIII levels; anticardiolipin and lupus anticoagulant Ab.</description></item><item><title>Diagnostic evaluation of thrombocytopenia</title><link>https://www.physician.tw/Diagnostic-evaluation-of-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-of-thrombocytopenia/</guid><description>Diagnostic evaluation of thrombocytopenia H&amp;amp;P: meds, infxns, underlying conditions, splenomegaly, lymph nodes, bleeding hx
CBC with differential: isolated thrombocytopenia vs.</description></item><item><title>Diagnostic evaluation-anemia</title><link>https://www.physician.tw/Diagnostic-evaluation-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-anemia/</guid><description>Diagnostic evaluation-anemia History: bleeding, systemic illness, drugs, exposures, alcohol, diet (including pica), FHx
CBC w/ diff.; RBC params incl.</description></item><item><title>Diagnostic evaluation-hemolytic anemias</title><link>https://www.physician.tw/Diagnostic-evaluation-hemolytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-hemolytic-anemias/</guid><description>Diagnostic evaluation-hemolytic anemias â†‘ retic count (RI &amp;gt;2%), â†‘ LDH, â†“ hapto (83% Se, 96% Sp), â†‘ indirect bili, âœ“ vit C &amp;amp; Cu</description></item><item><title>Diagnostic evaluation-hypopituitary syndromes</title><link>https://www.physician.tw/Diagnostic-evaluation-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-evaluation-hypopituitary-syndromes/</guid><description>Diagnostic evaluation-hypopituitary syndromes Hormonal studies Chronic: â†“ target gland hormone + â†“ or (inappropriately) normal trophic pituitary hormone Acute: will develop defic.</description></item><item><title>diagnostic process</title><link>https://www.physician.tw/diagnostic-process/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-process/</guid><description>diagnostic process [[Common biases in clinical reasoning]]. [[model for clinical reasoning]] [[determine the pretest probability]] [[consider the potential harms]] [[the threshold model]]: likelihood ratio nomogram</description></item><item><title>Diagnostic studies</title><link>https://www.physician.tw/Diagnostic-studies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies/</guid><description>Diagnostic studies (JAMA 2017;318:279)
Spirometry: â†“ FEV1, â†“ FEV1/FVC, coved flow-volume loop; lung volumes: Â± â†‘ RV &amp;amp; TLC âŠ• [[bronchodilator]] response (â†‘ FEV1 â‰¥12% &amp;amp; â‰¥200 mL) strongly suggestive of asthma</description></item><item><title>Diagnostic studies acute coronary syndromes</title><link>https://www.physician.tw/Diagnostic-studies-acute-coronary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-coronary-syndromes/</guid><description>Diagnostic studies acute coronary syndromes ECG: ST â†“/â†‘, TWI, new LBBB, hyperacute Tw; Qw/PRWP may suggest prior MI &amp;amp; âˆ´ CAD âœ“ ECG w/in 10 min of presentation, with any âˆ† in sx &amp;amp; at 6â€“12 h; compare w/ baseline</description></item><item><title>Diagnostic studies of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Diagnostic-studies-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-hypertrophic-cardiomyopathy/</guid><description>Diagnostic studies of hypertrophic cardiomyopathy (EHJ 2014;35:2733)
ECG: LVH, anterolateral TWI and inferior pseudo-Qw, Â± apical giant TWI (apical variant)</description></item><item><title>Diagnostic studies of PE</title><link>https://www.physician.tw/Diagnostic-studies-of-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-PE/</guid><description>Diagnostic studies of PE (EHJ 2014;35:3033)
CXR (limited Se &amp;amp; Sp): 12% nl, atelectasis, effusion, â†‘ hemidiaphragm, Hampton hump (wedge-shaped density abutting pleura); Westermark sign (avascularity distal to PE)</description></item><item><title>diagnostic studies of peptic ulcer disease</title><link>https://www.physician.tw/diagnostic-studies-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diagnostic-studies-of-peptic-ulcer-disease/</guid><description>diagnostic studies of peptic ulcer disease Testing for H. pylori: stool Ag, urea breath testing (UBT) or EGD + rapid urease test (RUT) False âŠ– Ag, UBT, RUT if on abx, bismuth, PPI; âˆ´ stop prior to testing if possible Serology: â†“ utility, useful only to exclude infection in lower prevalence areas EGD (definitive dx): if fail empiric Rx or alarm features (see â€œGERDâ€); bx GU to r/o malig &amp;amp; H.</description></item><item><title>Diagnostic studies of solitary pulmonary nodule</title><link>https://www.physician.tw/Diagnostic-studies-of-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-solitary-pulmonary-nodule/</guid><description>Diagnostic studies of solitary pulmonary nodule PET: detects metab. activity of tumors, 97% Se &amp;amp; 78% Sp for malig (esp if &amp;gt;8 mm).</description></item><item><title>Diagnostic studies of thoracentesis</title><link>https://www.physician.tw/Diagnostic-studies-of-thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-of-thoracentesis/</guid><description>Diagnostic studies of thoracentesis âœ“ total protein, LDH, glucose, cell count with differential, Gram stain &amp;amp; culture, pH; (arterial blood gas)</description></item><item><title>Diagnostic studies peptic ulcer disease</title><link>https://www.physician.tw/Diagnostic-studies-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-peptic-ulcer-disease-/</guid><description>Diagnostic studies peptic ulcer disease Testing for H. pylori: stool Ag, urea breath testing (UBT) or EGD + rapid urease test (RUT) False âŠ– Ag, UBT, RUT if on abx, bismuth, PPI; âˆ´ stop prior to testing if possible Serology: â†“ utility, useful only to exclude infection in lower prevalence areas</description></item><item><title>Diagnostic studies-acute mesenteric ischemia</title><link>https://www.physician.tw/Diagnostic-studies-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-mesenteric-ischemia/</guid><description>Diagnostic studies-acute mesenteric ischemia Dx relies on high level of suspicion; rapid dx essential to avoid infarction (occurs w/in hrs)</description></item><item><title>Diagnostic studies-acute pancreatitis</title><link>https://www.physician.tw/Diagnostic-studies-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-acute-pancreatitis/</guid><description>Diagnostic studies-acute pancreatitis (Am J Gastro 2013;108:1400)
Dx requires 2 of 3: characteristic abd pain; lipase or amylase &amp;gt;3Ã— ULN; âŠ• imaging</description></item><item><title>Diagnostic studies-adrenal insufficiency</title><link>https://www.physician.tw/Diagnostic-studies-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-adrenal-insufficiency/</guid><description>Diagnostic studies-adrenal insufficiency (JCEM 2016;101:364)
Early a.m. serum cortisol: &amp;lt;3 Âµg/dL virtually diagnostic â‰¥18 Âµg/dL generally consistent with intact adrenal function, lower cutoff w/ modern specific assays (see Appendix) Standard (250 Âµg) cosyntropin stimulation test (testing ability of ACTH â†’ â†‘ cortisol) normal = 60-min (or 30-min) post-ACTH cortisol â‰¥18 Âµg/dL abnormal in primary b/c adrenal gland diseased and unable to give adequate output abnormal in chronic secondary b/c adrenals atrophied and unable to respond (very rarely, may be normal in acute pituitary injury b/c adrenals still able to respond â†’ use early a.</description></item><item><title>Diagnostic studies-aortic aneurysms</title><link>https://www.physician.tw/Diagnostic-studies-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-aneurysms/</guid><description>Diagnostic studies-aortic aneurysms (JACC 2020;76:201)
Contrast CT: quick, noninvasive, high Se &amp;amp; Sp for all aortic aneurysms TTE/TEE: TTE most useful for root and proximal Ao; TEE can visualize other sites of TAA MRI: favored over CT for AoRoot imaging; useful in AAA but time consuming; noncontrast â€œblack bloodâ€ MR to assess aortic wall Abdominal U/S: screening/surveillance test of choice for infrarenal AAA</description></item><item><title>Diagnostic studies-cholecystitis</title><link>https://www.physician.tw/Diagnostic-studies-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-cholecystitis/</guid><description>Diagnostic studies-cholecystitis RUQ U/S: high Se &amp;amp; Sp for stones, but need specific signs of cholecystitis: GB wall thickening &amp;gt;4 mm, pericholecystic fluid and a sonographic Murphyâ€™s sign</description></item><item><title>Diagnostic studies-choledocholithiasis</title><link>https://www.physician.tw/Diagnostic-studies-choledocholithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-choledocholithiasis/</guid><description>Diagnostic studies-choledocholithiasis (J Hepatol 2016;65:146; Gastrointest Endosc 2019;89:1075)
Labs: â†‘ bilirubin, AÏ•; transient spike in ALT or amylase suggests passage of stone RUQ U/S: BD stones seen ~50â€“80% of cases; usually inferred from dilated CBD (&amp;gt;6 mm) ERCP preferred modality when likelihood high (eg, visualized stone, cholangitis, bili &amp;gt;4, or dilated CBD on U/S + bili 1.</description></item><item><title>Diagnostic studies-cholelithiasis</title><link>https://www.physician.tw/Diagnostic-studies-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-cholelithiasis/</guid><description>Diagnostic studies-cholelithiasis Labs normal in most
RUQ U/S: Se &amp;amp; Sp &amp;gt;95% for stones &amp;gt;5 mm; should be performed after â‰¥8 h fast for distended, bile-filled gallbladder.</description></item><item><title>Diagnostic studies-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Diagnostic-studies-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-chronic-obstructive-pulmonary-disease/</guid><description>Diagnostic studies-chronic obstructive pulmonary disease [[CXR of Diagnostic studies-chronic obstructive pulmonary disease]]
PFTs: obstruction: â†“â†“ FEV1, â†“ FVC, FEV1/FVC &amp;lt;0.</description></item><item><title>Diagnostic studies-chronic pancreatitis</title><link>https://www.physician.tw/Diagnostic-studies-chronic-pancreatitis-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-chronic-pancreatitis-/</guid><description>Diagnostic studies-chronic pancreatitis (Pancreas 2014;43:1143; Am J Gastro 2020;115:322)
Labs: amylase/lipase â†‘ early, may be nl later. âŠ• fecal fat, â†“ stool elastase &amp;amp; A1AT.</description></item><item><title>Diagnostic studies-constrictive pericarditis</title><link>https://www.physician.tw/Diagnostic-studies-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-constrictive-pericarditis/</guid><description>Diagnostic studies-constrictive pericarditis ECG: nonspecific, AF common (up to 33%) in advanced cases CXR: calcification (MTb most common), espec in lateral view (although not specific) Echocardiogram: Â± thickened pericardium, â€œseptal bounceâ€ = abrupt displacement of septum during rapid filling in early diastole Cardiac catheterization: atria w/ Ms or Ws (prominent x and y descents) ventricles: dip-and-plateau or square-root sign (rapid â†“ pressure at onset of diastole, rapid â†‘ to early plateau) discordance between LV &amp;amp; RV pressure peaks during respiratory cycle (Circ 1996;93:2007) CT or MRI: thickened pericardium (&amp;gt;4 mm; Se ~80%) w/ tethering (Circ 2011;123:e418)</description></item><item><title>Diagnostic studies-diabetic ketoacidosis</title><link>https://www.physician.tw/Diagnostic-studies-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-diabetic-ketoacidosis/</guid><description>Diagnostic studies-diabetic ketoacidosis â†‘ Anion gap metabolic acidosis (pH &amp;lt;7.3 &amp;amp; HCO3 &amp;lt;18): can later develop nonanion gap acidosis due to urinary loss of ketones (HCO3 equiv.</description></item><item><title>Diagnostic studies-encephalitis</title><link>https://www.physician.tw/Diagnostic-studies-encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-encephalitis/</guid><description>Diagnostic studies-encephalitis (CID 2013;57:1114)
CSF analysis: lymphocytic pleocytosis; PCR for HSV (95% Se &amp;amp; Sp), VZV; consider other PCR based on risk factors (CMV/EBV, HIV, JC, adeno/enterovirus, WNV) Consider testing for autoimmune etiologies and serologic viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric HSV/VZV Rx MRI (CT if unavailable); HSV temporal lobe; W.</description></item><item><title>Diagnostic studies-hypercalcemia</title><link>https://www.physician.tw/Diagnostic-studies-hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-hypercalcemia/</guid><description>Diagnostic studies-hypercalcemia [[hyperparathyroidism]] Hyperparathyroidism (HPT) and malignancy account for 90% of cases of â†‘ Ca; HPT more likely if asx or chronic; malignancy (usually overt) more likely if acute or sx ç”²ç‹€æ—è…ºåŠŸèƒ½äº¢é€²ï¼ˆHPTï¼‰å’Œæƒ¡æ€§è…«ç˜¤ä½”â†‘Caç—…ä¾‹çš„90%ï¼› å¦‚æœ asx æˆ–æ…¢æ€§ï¼ŒHPT æ›´æœ‰å¯èƒ½ï¼›å¦‚æœæ€¥æ€§æˆ– sxï¼Œå‰‡æ›´æœ‰å¯èƒ½ç™¼ç”Ÿæƒ¡æ€§è…«ç˜¤ï¼ˆé€šå¸¸æ˜¯æ˜é¡¯çš„ï¼‰ [[Parathyroid MIBI Scan]] Ca, alb, ICa, PTH (may be inapprop.</description></item><item><title>Diagnostic studies-interstitial lung disease</title><link>https://www.physician.tw/Diagnostic-studies-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-interstitial-lung-disease/</guid><description>Diagnostic studies-interstitial lung disease see Appendix &amp;amp; Radiology inserts)
CXR and high-resolution chest CT Upper lobe predom: hypersensitivty, coal, silica, smoking-related, sarcoidosis, Langerhanâ€™s</description></item><item><title>Diagnostic studies-mitral-stenosis</title><link>https://www.physician.tw/Diagnostic-studies-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-mitral-stenosis/</guid><description>Diagnostic studies-mitral-stenosis ECG: LAE (â€œP mitraleâ€), Â± AF, Â± RVH CXR: dilated LA (flat L heart border, R double density, displaced L mainstem bronchus) Echo: estimate pressure gradient (âˆ‡), RVSP, valve area, valve echo score (0â€“16, based on leaflet mobility &amp;amp; thick, subvalvular thick.</description></item><item><title>Diagnostic studies-pericardial tamponade</title><link>https://www.physician.tw/Diagnostic-studies-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pericardial-tamponade/</guid><description>Diagnostic studies-pericardial tamponade ECG: â†‘ HR, â†“ voltage (seen in 42%), electrical alternans (20%), Â± signs of pericarditis</description></item><item><title>Diagnostic studies-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Diagnostic-studies-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pericarditis-and-pericardial-effusion/</guid><description>Diagnostic studies-pericarditis and pericardial effusion Need â‰¥2 of the following: chest pain (as noted above), friction rub, ECG findings, effusion [[typical electrocardiogram in a patient with acute pericarditis]] CXR: if lg effusion (&amp;gt;250 mL) â†’ â†‘ cardiac silhouette w/ â€œwater-bottleâ€ heart &amp;amp; epicardial halo Echocardiogram: presence, size, &amp;amp; location of effusion; presence of tamponade physiology; pericarditis itself w/o spec.</description></item><item><title>Diagnostic studies-pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/Diagnostic-studies-pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pheochromocytoma-and-paraganglioma/</guid><description>Diagnostic studies-pheochromocytoma and paraganglioma (JCEM 2014;99:1915)
24Â° urinary fractionated metanephrines: 98% Se, 98% Sp. Screening test of choice if low-risk (b/c false âŠ• with severe illness, renal failure, OSA, labetalol due to assay interference, acetaminophen, TCAs, medications containing sympathomimetics).</description></item><item><title>Diagnostic studies-pleural effusion</title><link>https://www.physician.tw/Diagnostic-studies-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pleural-effusion/</guid><description>Diagnostic studies-pleural effusion [[Thoracentesis]] [[Transudate vs exudate]] [[Complicated vs uncomplicated parapneumonic]] (Chest 1995;108:299) [[Additional pleural fluid studies]]</description></item><item><title>Diagnostic studies-pneumonia</title><link>https://www.physician.tw/Diagnostic-studies-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-pneumonia/</guid><description>Diagnostic studies-pneumonia (AJRCC 2019;200:e45)
Sputum Gram stain/Cx: reliable if high quality (ie, sputum not saliva; &amp;lt;10 squam cells/lpf). If bacterial PNA should be purulent (&amp;gt;25 PMN/lpf).</description></item><item><title>Diagnostic studies-urinary tract infections</title><link>https://www.physician.tw/Diagnostic-studies-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-urinary-tract-infections/</guid><description>Diagnostic studies-urinary tract infections (NEJM 2016;374:562)
Urinalysis: pyuria + bacteriuria Â± hematuria Â± nitrites
Urine Cx (clean-catch midstream or straight-cath) Obtain cx only if symptoms (although in ill Pts, can include âˆ†MS, autonomic instability) âŠ• if: â‰¥105 CFU/mL, though &amp;lt;105 but â‰¥102/mL may still indicate UTI in some scenarios Pyuria &amp;amp; âŠ– UCx=sterile pyuria.</description></item><item><title>Diagnostic workup-hemoptysis</title><link>https://www.physician.tw/Diagnostic-workup-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-workup-hemoptysis/</guid><description>Diagnostic workup-hemoptysis Localize bleeding site
(r/o GI or ENT source by H&amp;amp;P Â± endo);
determine whether</description></item><item><title>Diagnostic-studies-aortic-regurgitation</title><link>https://www.physician.tw/Diagnostic-studies-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-regurgitation/</guid><description>Diagnostic-studies-aortic-regurgitation ECG: can see LVH, LAD, abnl repol; CXR: cardiomegaly Â± ascending Ao dilatation Echo: severity of AR (severe = regurg jet width â‰¥65% LVOT, regurg fraction â‰¥50%, effective regurg orifice â‰¥0.</description></item><item><title>Diagnostic-studies-aortic-stenosis</title><link>https://www.physician.tw/Diagnostic-studies-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-aortic-stenosis/</guid><description>Diagnostic-studies-aortic-stenosis ECG: may see LVH, LAE, LBBB, AF (in late disease) CXR: cardiomegaly, AoV calcification, poststenotic dilation of ascending Ao, pulmonary congestion Echo: valve morph.</description></item><item><title>Diagnostic-studies-mitral-regurgitation</title><link>https://www.physician.tw/Diagnostic-studies-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-mitral-regurgitation/</guid><description>Diagnostic-studies-mitral-regurgitation Diagnostic studies
ECG: can see LVH, LAD, abnl repol; CXR: cardiomegaly Â± ascending Ao dilatation Echo: severity of AR (severe = regurg jet width â‰¥65% LVOT, regurg fraction â‰¥50%, effective regurg orifice â‰¥0.</description></item><item><title>Diagnostic-studies-workup-pulmonary hypertension</title><link>https://www.physician.tw/Diagnostic-studies-workup-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostic-studies-workup-pulmonary-hypertension/</guid><description>Diagnostic-studies-workup-pulmonary hypertension High-res chest CT: dilat. &amp;amp; pruning of pulm arteries, â†‘ RA &amp;amp; RV; r/o parenchymal lung dis. ECG: RAD, RBBB, RAE (â€œP pulmonaleâ€), RVH (Se 55%, Sp 70%) PFTs: disproportionate â†“ DLCO, mild restrictive pattern; r/o obstructive &amp;amp; restrictive lung dis.</description></item><item><title>Diagnostics for active TB</title><link>https://www.physician.tw/Diagnostics-for-active-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diagnostics-for-active-TB/</guid><description>Diagnostics for active TB (CID 2017;64:11)
Pulmonary TB: common CXR findings discussed above; induced sputum AFB smear &amp;amp; culture (3 samples at least 8 h apart) Â± NAAT/ PCR (GeneXpert); consider bronchoscopy + BAL Â± transbronchial biopsy.</description></item><item><title>diarrhea</title><link>https://www.physician.tw/diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diarrhea/</guid><description>diarrhea acute diarrhea [[Acute Infectious Etiologies ]] [[Evaluation acute diarrhea]] [[Treatment acute diarrhea]] [[clostridioides difficile infection]] chronic diarrhea (&amp;gt;4 wk) [[General evaluation or chronic diarrhea]] [[Osmotic diarrhea]] [[Secretory diarrhea]] [[Functional IBS]] [[Malabsorption]] [[Maldigestion]] [[Inflammatory diarrhea]] [[Workup of chronic diarrhea]]</description></item><item><title>differential diagnosis</title><link>https://www.physician.tw/differential-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/differential-diagnosis/</guid><description>differential diagnosis (â€œall that wheezes is not asthmaâ€¦â€)
Hyperventilation &amp;amp; panic attacks
Upper airway obstruction or inh foreign body; laryngeal/vocal cord dysfxn (eg, 2Â° to GERD)</description></item><item><title>Differential Diagnosis of Cellulitis</title><link>https://www.physician.tw/Differential-Diagnosis-of-Cellulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Cellulitis/</guid><description>Differential Diagnosis of Cellulitis Stasis dermatitis Bilateral leg involvement; circumferential erythema and swelling; usually no fevers é›™è…¿ï¼›å‘¨åœç´…æ–‘å’Œè…«è„¹;é€šå¸¸ä¸ç™¼ç‡’ Contact dermatitis Unusual patterns of distribution; pruritus; no fevers Inflammatory arthritis Erythema overlies a joint; pain with range of motion</description></item><item><title>Differential Diagnosis of Delirium</title><link>https://www.physician.tw/Differential-Diagnosis-of-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Delirium/</guid><description>Differential Diagnosis of Delirium Toxins Prescription medications: especially those with anticholinergic properties, narcotics, and benzodiazepines Drugs of abuse: alcohol intoxication and alcohol withdrawal, opiates, ecstasy, LSD, GHB, PCP, ketamine, cocaine, â€œbath salts,â€ marijuana and its synthetic forms Poisons: inhalants, carbon monoxide, ethylene glycol, pesticides Metabolic Conditions Electrolyte disturbances: hypoglycemia, hyperglycemia, hyponatremia, hypernatremia, hypercalcemia, hypocalcemia, hypomagnesemia Hypothermia and hyperthermia Pulmonary failure: hypoxemia and hypercarbia Liver failure/hepatic encephalopathy Renal failure/uremia Cardiac failure Vitamin deficiencies: B12, thiamine, folate, niacin Dehydration and malnutrition Anemia Infections Systemic infections: urinary tract infections, pneumonia, skin and soft tissue infections, sepsis CNS infections: meningitis, encephalitis, brain abscess Endocrine Conditions Hyperthyroidism, hypothyroidism Hyperparathyroidism Adrenal insufficiency Cerebrovascular Disorders Global hypoperfusion states Hypertensive encephalopathy Focal ischemic strokes and hemorrhages (rare): especially nondominant parietal and thalamic lesions Autoimmune Disorders CNS vasculitis Cerebral lupus Neurologic paraneoplastic and autoimmune encephalitis Seizure-Related Disorders Nonconvulsive status epilepticus Intermittent seizures with prolonged postictal states Neoplastic Disorders Diffuse metastases to the brain Gliomatosis cerebri Carcinomatous meningitis CNS lymphoma Hospitalization Terminal end-of-life delirium</description></item><item><title>Differential Diagnosis of Dyspnea</title><link>https://www.physician.tw/Differential-Diagnosis-of-Dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Differential-Diagnosis-of-Dyspnea/</guid><description>Differential Diagnosis of Dyspnea Lung Airways Alveoli (can fill with water, pus, or blood) Interstitium Pleural Heart Endocardium Conduction system Myocardium: HF Coronary arteries Pericardium Chest wall neuromuscular disease Blood Metabolic disorders</description></item><item><title>Digoxin</title><link>https://www.physician.tw/Digoxin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Digoxin/</guid><description>Digoxin 23% â†“ HF hosp., no âˆ† mort (NEJM 1997;336:525); ? â†‘ mort w/ â†‘ levels (NEJM 2002;347:1403); optimal 0.5â€“0.8 ng/mL (JAMA 2003;289:871)</description></item><item><title>Digoxin-toxicology</title><link>https://www.physician.tw/Digoxin-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Digoxin-toxicology/</guid><description>Digoxin-toxicology N/V, bradycardia, AV block, delirium, xanthopsia
âœ“ serum dig level (but may be inaccurate if &amp;lt;6 h since last dose), renal function</description></item><item><title>dilated cardiomyopathy</title><link>https://www.physician.tw/dilated-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dilated-cardiomyopathy/</guid><description>dilated cardiomyopathy Definition and epidemiology (JACC 2016;67:2996; Lancet 2017;390:400) LV or biventricular dilatation and global â†“ contractility Â± â†“ wall thickness in the absence of ischemia/infarct, valvular disease or HTN.</description></item><item><title>DILATED-CARDIOMYOPATHY</title><link>https://www.physician.tw/DILATED-CARDIOMYOPATHY/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DILATED-CARDIOMYOPATHY/</guid><description>DILATED-CARDIOMYOPATHY</description></item><item><title>diltiazem</title><link>https://www.physician.tw/diltiazem/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diltiazem/</guid><description>diltiazem Wt/4
15-20 mg IV over 2 min, 20-25 mg 15 later prn, 5-15 mg/h 1 ibutilide 1 mg over 10 min, repeat * 1 if needed</description></item><item><title>DIP desquamative IP</title><link>https://www.physician.tw/DIP-desquamative-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/DIP-desquamative-IP/</guid><description>DIP desquamative IP Diffuse ground-glass opacities, reticular lines; lower zones. Peripheral macrophage in alveoli.
30â€“50 yo smokers
Sx wksâ€“mos
Death rare</description></item><item><title>Direct Oral Anticoagulants DOACs for NVAF</title><link>https://www.physician.tw/Direct-Oral-Anticoagulants-DOACs-for-NVAF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Direct-Oral-Anticoagulants-DOACs-for-NVAF/</guid><description>Direct Oral Anticoagulants (DOACs) for NVAF Apixaban (FXa inhib) 5 mg bid (2.5 mg bid if â‰¥ 2 of: â‰¥80 y, â‰¤60 kg, Cr â‰¥1.</description></item><item><title>Disease state specific regimens-diuresis</title><link>https://www.physician.tw/Disease-state-specific-regimens-diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disease-state-specific-regimens-diuresis/</guid><description>Disease state specific regimens-diuresis Renal insufficiency: loop diuretic (â†‘ dose to achieve effective delivery to ThAL) Â± thiazide</description></item><item><title>disease-specific management of kidney disease</title><link>https://www.physician.tw/disease-specific-management-of-kidney-disease-2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-specific-management-of-kidney-disease-2/</guid><description>disease-specific management of kidney disease [[Acute interstitial nephritis]] [[Cardiorenal syndrome]] [[Contrast-induced acute kidney injury]] [[Hepatorenal syndrome (HRS)]] [[Pulmonary-Renal Syndromes]] [[Obstructive diseases-disease-specific management of kidney disease ]] [[Polycystic kidney disease]] [[Rhabdomyolysis]] [[Scleroderma renal crisis]] [[COVID-19 associated AKI]] [[Thrombotic microangiopathies]]</description></item><item><title>disease-specific management of kidney disease</title><link>https://www.physician.tw/disease-specific-management-of-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disease-specific-management-of-kidney-disease/</guid><description>disease-specific management of kidney disease</description></item><item><title>disorder of test</title><link>https://www.physician.tw/disorder-of-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorder-of-test/</guid><description>disorder of test ä¾†è‡ª: [[disorders of hemostasis]]</description></item><item><title>Disorders of EGJ Outflow</title><link>https://www.physician.tw/Disorders-of-EGJ-Outflow/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-EGJ-Outflow/</guid><description>Disorders of EGJ Outflow Isolated EGJ outflow obstruction or achalasia. Achalasia: simult. â†“ amp contractions &amp;amp; â†“ LES relaxation; barium swallow w/ dilated esophagus &amp;amp; distal â€œbirdâ€™s beakâ€ narrowing; mostly idiopathic, although can be a/w Chagas; Rx: pneumatic dilation as effective as Heller myotomy (local expertise dependent) (Gut 2016;65:732); peroral endoscopic myotomy; CCB/nitrates/PDEi; botox if Ã˜ surg cand.</description></item><item><title>Disorders of Eyes, Ears, Nose, and Throat</title><link>https://www.physician.tw/Disorders-of-Eyes-Ears-Nose-and-Throat/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-Eyes-Ears-Nose-and-Throat/</guid><description>Disorders of Eyes, Ears, Nose, and Throat Chapter 32: [[disorders of the eye]] Chapter 33: [[disorders of smell and taste]] Chapter 34: [[disorders of hearing]] Chapter 35: [[upper respiratory symptoms]], Including [[earache]], [[sinus symptoms]], and [[sore throat]] Chapter 36: [[oral manifestations of disease]]</description></item><item><title>disorders of hemostasis</title><link>https://www.physician.tw/disorders-of-hemostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-hemostasis/</guid><description>disorders of hemostasis [[clinical characteristics of bleeding disorders]] [[approach to abnormal hemostasis]] [[coagulation cascade and sites of action for anticoagulants]] [[purpura]]</description></item><item><title>disorders of leukocytes</title><link>https://www.physician.tw/disorders-of-leukocytes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-leukocytes/</guid><description>disorders of leukocytes [[neutrophilia]] [[neutropenia]] [[monocytosis]] [[eosinophilia]] [[basophilia]] [[lymphocytosis]] [[lymphadenopathy]]</description></item><item><title>Disorders of Peristalsis</title><link>https://www.physician.tw/Disorders-of-Peristalsis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disorders-of-Peristalsis/</guid><description>Disorders of Peristalsis Absent contractility (failed peristalsis); distal esophageal spasm (uncord. peristalsis w/ simult. contractions); hypercontractile esoph (high amp contract.</description></item><item><title>disorders of the colon</title><link>https://www.physician.tw/disorders-of-the-colon/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/disorders-of-the-colon/</guid><description>disorders of the colon [[diverticulosis]] [[diverticulitis]] [[polyps]]</description></item><item><title>Disposition of patients after initial treatment of asthma exacerbation</title><link>https://www.physician.tw/Disposition-of-patients-after-initial-treatment-of-asthma-exacerbation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disposition-of-patients-after-initial-treatment-of-asthma-exacerbation/</guid><description>Disposition of patients after initial treatment of asthma exacerbation</description></item><item><title>Disposition-anaphylaxis</title><link>https://www.physician.tw/Disposition-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disposition-anaphylaxis/</guid><description>Disposition-anaphylaxis Mild rxn limited to urticaria or mild bronchospasm can be observed for â‰¥6 h; admit all others</description></item><item><title>Disseminated intravascular coagulation DIC</title><link>https://www.physician.tw/Disseminated-intravascular-coagulation-DIC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disseminated-intravascular-coagulation-DIC/</guid><description>Disseminated intravascular coagulation (DIC) (NEJM 2014;370:847)
Etiologies: trauma, shock, infection, malignancy (esp. APL), obstetric complications
[[pathogenesis of disseminated intravascular coagulation (DIC)]]:</description></item><item><title>Disseminated Mycobacterium avium complex DMAC</title><link>https://www.physician.tw/Disseminated-Mycobacterium-avium-complex-DMAC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Disseminated-Mycobacterium-avium-complex-DMAC/</guid><description>Disseminated Mycobacterium avium complex (DMAC) Fever, night sweats, wt loss, abd pain, diarrhea, pancytopenia. Can cause localized lymphadenitis. Rx: clarithro/azithro + ethambutol Â± rifampin/rifabutin.</description></item><item><title>Distinguihing Characteristics of Vascuiti Subtypes</title><link>https://www.physician.tw/Distinguihing-Characteristics-of-Vascuiti-Subtypes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Distinguihing-Characteristics-of-Vascuiti-Subtypes/</guid><description>Distinguihing Characteristics of Vascuiti Subtypes</description></item><item><title>Distributive shock</title><link>https://www.physician.tw/Distributive-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Distributive-shock/</guid><description>Distributive shock Septic shock
Pancreatitis
Severe burns
Anaphylactic shock
Neurogenic shock
Endocrine shock
Adrenal crisis</description></item><item><title>diuresis</title><link>https://www.physician.tw/diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diuresis/</guid><description>diuresis [[General considerations-diuresis]] [[Loop diuretics]] [[Thiazide diuretics ]] [[K-sparing diuretics]] [[Approach to Diuresis ]](if inadequate diuresis, go to next step) [[Disease state specific regimens-diuresis]]</description></item><item><title>Diverticular bleed</title><link>https://www.physician.tw/Diverticular-bleed/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Diverticular-bleed/</guid><description>Diverticular bleed Pathophysiology: Intimal thickening and medial thinning of vasa recta as they course over dome of diverticulum â†’ weakening of vascular wall â†’ arterial rupture.</description></item><item><title>diverticulitis</title><link>https://www.physician.tw/diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diverticulitis/</guid><description>diverticulitis [[Pathophysiology of diverticulitis]] Diagnostic studies Abdominal CT (I+O+): diverticula, bowel wall thickening, pericolic fat Â± abscess, fistula Colonoscopy contraindic.</description></item><item><title>diverticulosis</title><link>https://www.physician.tw/diverticulosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/diverticulosis/</guid><description>diverticulosis Definition &amp;amp; pathophysiology (Aliment Pharm Ther 2015;42:664)
Acquired herniations of colonic mucosa &amp;amp; submucosa in areas where vasa recta penetrate Abnormal motility and â†‘ intraluminal pressure cause protrusion of colonic wall Epidemiology Risk factors: â†“ fiber, chronic constipation, obesity, smoking, physical inactivity, EtOH, NSAIDs, â†‘ age (10% if &amp;lt;40 y; 50â€“66% if &amp;gt;80 y); â†‘ red meat consumption Left side (90%, mostly sigmoid) &amp;gt;R side of colon (except in Asia where 75â€“85% R-sided) Clinical manifestations Usually asx; 5â€“15% develop diverticular hemorrhage (see â€œGIBâ€) and 10â€“25% diverticulitis Limited data for â†‘ fiber diet or avoiding nuts/seeds (Thera Adv Gastro 2016;9:213)</description></item><item><title>Dofetilide</title><link>https://www.physician.tw/Dofetilide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dofetilide/</guid><description>Dofetilide 500 mcg PO bid 500 mcg bid increase QT, increase risk of TdP; renal adj %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Dog bite</title><link>https://www.physician.tw/Dog-bite/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dog-bite/</guid><description>Dog bite Pasturella &amp;amp; Capnocytophaga spp Can cause severe sepsis w/ DIC &amp;amp; gangrene in asplenic/cirrhotics and other immunosupp. Amox/clav If Capno.</description></item><item><title>dotfile</title><link>https://www.physician.tw/dotfile/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dotfile/</guid><description>Dotfiles (MacOS custom configuration specifications) â€“ Index
@epperla2021doublerefractory</description></item><item><title>Dronedarone</title><link>https://www.physician.tw/Dronedarone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dronedarone/</guid><description>Dronedarone n/a 400 mg bid decrease side effects &amp;amp; effic. vs. [[Amiodarone]]
%
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Drug fever</title><link>https://www.physician.tw/Drug-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-fever/</guid><description>Drug fever Anticonvulsants Minocycline [[Other antimicrobial agents of Drug fever]] Allopurinol Heparin Immune checkpoint inhibitors</description></item><item><title>Drug Therapy of Pulseless Arrest</title><link>https://www.physician.tw/Drug-Therapy-of-Pulseless-Arrest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-Therapy-of-Pulseless-Arrest/</guid><description>Drug Therapy of Pulseless Arrest Establish IV/O access (do not interrupt CPR) Epinephrine 1 mg IV q3-5min (or 2 mg via ETT) Amiodarone 300 mg IVB; 2&amp;quot; dose 150 mg å¦‚æœæ˜¯VFå†è€ƒæ…®ï¼Œä¸€èˆ¬çš„PEAå°±ä¸éœ€è¦ Lidocaine 1-1.</description></item><item><title>Drug Treatment-lipid disorders</title><link>https://www.physician.tw/Drug-Treatment-lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-Treatment-lipid-disorders/</guid><description>Drug Treatment-lipid disorders Drug â†“ LDL â†“ TG Side Effects/Comments
Statins 30â€“60% 10â€“25% â†‘ ALT in 0.5â€“3%; âœ“ before starting and then prn Myalgias &amp;lt;10%, rhabdo &amp;lt;0.</description></item><item><title>Drug-induced hemolytic anemia</title><link>https://www.physician.tw/Drug-induced-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-induced-hemolytic-anemia/</guid><description>Drug-induced hemolytic anemia Acquired, Ab-drug mediated destruction vs. direct drug effect. Abx: ceph., sulfa drugs, rifampin, ribavirin. CV: methyldopa, procainamide, quinidine, thiazides.</description></item><item><title>Drug-induced TMA</title><link>https://www.physician.tw/Drug-induced-TMA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drug-induced-TMA/</guid><description>Drug-induced TMA (clinically similar to TTP; Blood 2017;129:2857) [[thrombotic thrombocytopenic purpura]] Immune-mediated (Ab reacts w/ plts &amp;amp; endothelial cells): eg, quinine, gemcitabine?</description></item><item><title>Drugs and toxins that cause acute liver failure</title><link>https://www.physician.tw/Drugs-and-toxins-that-cause-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Drugs-and-toxins-that-cause-acute-liver-failure/</guid><description>Drugs and toxins that cause acute liver failure (nearly 80% of cases in U.S.; Gastro 2015;148:1353, Clin Liver Dis 2017;21:151)</description></item><item><title>drugs routinely used for intrathecal application</title><link>https://www.physician.tw/drugs-routinely-used-for-intrathecal-application/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/drugs-routinely-used-for-intrathecal-application/</guid><description>drugs routinely used for intrathecal application [[Methotrexate]] MTX, AraC a.k.a Cytarabin (including the depot form of liposome-encapsulated AraC) and thiotepa.</description></item><item><title>Duration of full-intensity anticoagulation-venous thromboembolism</title><link>https://www.physician.tw/Duration-of-full-intensity-anticoagulation-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duration-of-full-intensity-anticoagulation-venous-thromboembolism/</guid><description>Duration of full-intensity anticoagulation-venous thromboembolism Superficial venous thrombosis: 4 wk
1st prox DVT or PE 2Â° reversible/time-limited risk factor or distal DVT:</description></item><item><title>Duration of therapy of fever and neutropenia</title><link>https://www.physician.tw/Duration-of-therapy-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Duration-of-therapy-of-fever-and-neutropenia/</guid><description>Duration of therapy of fever and neutropenia Known source: complete standard course (eg, 14 d for bacteremia) Unknown source: continue antibiotics until afebrile and ANC &amp;gt;500 cells/ÂµL Less clear when to d/c abx when Pt is afebrile but prolonged neutropenia</description></item><item><title>Dx of Hemochromatosis</title><link>https://www.physician.tw/Dx-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-of-Hemochromatosis/</guid><description>Dx of Hemochromatosis iron sat &amp;gt;45% (iron/TIBC Ã— 100%); â†‘ ferritin (acute phase reactant, so poor Sp; often nl in young Pts).</description></item><item><title>Dx studies of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Dx-studies-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-studies-of-Cryoglobulinemic-vasculitis/</guid><description>Dx studies of Cryoglobulinemic vasculitis âœ“ Cryoglobulins (keep blood warmed to 37Â°C en route to lab to avoid false âŠ–, loss of RF and â†“â†“ C3, C4).</description></item><item><title>Dx studies of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Dx-studies-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-studies-of-Granulomatosis-with-polyangiitis/</guid><description>Dx studies of Granulomatosis with polyangiitis 90% âŠ• ANCA (80% PR3, 20% MPO), less Se in limited upper-airway disease
CXR or CT â†’ nodules, infiltrates, cavities; sinus CT â†’ sinusitis Â± bone erosions â†‘ BUN &amp;amp; Cr, proteinuria, hematuria; sediment w/ RBC casts, dysmorphic RBCs Biopsy â†’ necrotizing granulomatous inflammation of arterioles, capillaries, veins.</description></item><item><title>Dx-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Dx-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-Portal-vein-thrombosis-PVT/</guid><description>Dx-Portal vein thrombosis (PVT) LFTs usually nl; begin w/ U/S w/ Doppler, confirm w/ MRA or CT (I+), angio; consider hypercoag w/u.</description></item><item><title>Dx-Wilson disease</title><link>https://www.physician.tw/Dx-Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dx-Wilson-disease/</guid><description>Dx-Wilson disease â†‘ 24-h urine Cu, â†“ serum ceruloplasmin (Se 90%), liver bx w/ hepatic Cu content, genetic testing for ATP7B gene helpful if unclear dx.</description></item><item><title>Dyslipidemias</title><link>https://www.physician.tw/Dyslipidemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dyslipidemias/</guid><description>Dyslipidemias 1Â° (inherited causes): familial hyperchol. (1:250): defective LDL receptor; â†‘â†‘ chol; â†‘ CAD; familial hyperTG: â†‘ TG &amp;amp; pancreatitis; familial combined hyperlipid.</description></item><item><title>dysmotility and nutrition</title><link>https://www.physician.tw/dysmotility-and-nutrition/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysmotility-and-nutrition/</guid><description>dysmotility and nutrition [[Functional GI disease]] [[Gastroparesis]] [[Paralytic ileus of the colon &amp;amp; small bowel]] [[Constipation]] [[Nutritional Support and Total Parenteral Nutrition]]</description></item><item><title>dysnatremias</title><link>https://www.physician.tw/dysnatremias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dysnatremias/</guid><description>dysnatremias [[overview-sodium and water homeostasis]]</description></item><item><title>Dysphagia</title><link>https://www.physician.tw/Dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Dysphagia/</guid><description>Dysphagia Oropharyngeal: inability to propel food from mouth through UES into esophagus Esophageal: difficulty swallowing &amp;amp; passing food from esophagus into stomach [[Structural dysphagia]] [[Neuromuscular dysphagia]]</description></item><item><title>dyspnea</title><link>https://www.physician.tw/dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/dyspnea/</guid><description>dyspnea [[Evaluation-dyspnea]] [[alterations in circulatory and respiratory functions]] (Harrison&amp;rsquo;s) [[symptom to diagnosis of dyspnea]] Airway obstruction (â†‘ resistance to airflow) Asthma, COPD, bronchiectasis, cystic fibrosis, tumor, foreign body, vocal cord dysfunction, anaphylaxis</description></item><item><title>Early Goal-Directed Therapy EGDT</title><link>https://www.physician.tw/Early-Goal-Directed-Therapy-EGDT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Early-Goal-Directed-Therapy-EGDT/</guid><description>Early Goal-Directed Therapy (EGDT) Historically: IVF &amp;amp; pressors for MAP â‰¥65 mmHg, CVP 8â€“12 mmHg, UOP â‰¥0.5 mL/kg/h; inotropes &amp;amp; PRBCs for ScvO2 â‰¥70% in 6 h (NEJM 2001;345:1368)</description></item><item><title>Early intravenous administration of glucocorticoids in central nervous system infection</title><link>https://www.physician.tw/Early-intravenous-administration-of-glucocorticoids-in-central-nervous-system-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Early-intravenous-administration-of-glucocorticoids-in-central-nervous-system-infection/</guid><description>Early intravenous administration of glucocorticoids in central nervous system infection Developed regions å°æ‰€æœ‰ç–‘ä¼¼ç´°èŒæ€§è…¦è†œç‚ä¸”å¾®ç”Ÿç‰©æœªçŸ¥çš„æˆå¹´äººä½¿ç”¨Dexamethasone åªæœ‰ç•¶ CSF é©è˜­æŸ“è‰²å’Œ/æˆ– CSF æˆ–è¡€åŸ¹é¤Šé¡¯ç¤ºè‚ºç‚éˆçƒèŒæ™‚ï¼Œæ‰æ‡‰ç¹¼çºŒä½¿ç”¨ Dexamethasone ç‚º 0.</description></item><item><title>Eaton-Lambert</title><link>https://www.physician.tw/Eaton-Lambert/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eaton-Lambert/</guid><description>Eaton-Lambert Lambert-Eaton myasthenic syndrome
anti-P/Q-type voltage-gated Ca2+ channel Abs ç¥ç¶“éƒ¨ - è—ä¼¯ - ä¼Šé “è‚Œç„¡åŠ›ç—‡ (Lambert-Eaton myasthenic syndrome, LEMS)</description></item><item><title>ECG-in-young-athletes</title><link>https://www.physician.tw/ECG-in-young-athletes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ECG-in-young-athletes/</guid><description>ECG-in-young-athletes Normal patterns may include LVH, RVH, early repolarization Evaluate if: arrhythmia, HR &amp;lt;30, â†‘ QT, Îµ/Î´ waves, LBBB, Brugada pattern, QRS &amp;gt;140 ms, PR &amp;gt;400 ms, Mobitz II, 3Ëš AVB, ST depression, TWI</description></item><item><title>Echocardiogram for Constrictive vs Restrictive Pericarditis</title><link>https://www.physician.tw/Echocardiogram-for-Constrictive-vs-Restrictive-Pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Echocardiogram-for-Constrictive-vs-Restrictive-Pericarditis/</guid><description>Echocardiogram for Constrictive vs Restrictive Pericarditis Constrictive Respirophasic variation (25â€“40%): inspir. â†’ â†‘ flow across TV and â†“ flow across MV eâ€² (tissue velocity) nl/â†‘ (&amp;gt;12 cm/sec) Expir.</description></item><item><title>Education and patient centricity</title><link>https://www.physician.tw/Education-and-patient-centricity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Education-and-patient-centricity/</guid><description>Education and patient centricity Provide appropriate reassurance Agree on realistic objectives Identify predisposing and/or trigger factors Follow strategy to individualize therapy according to symptoms and needs</description></item><item><title>Effect of 1 L infusion in 70-kg male</title><link>https://www.physician.tw/Effect-of-1-L-infusion-in-70-kg-male/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Effect-of-1-L-infusion-in-70-kg-male/</guid><description>Effect of 1 L infusion in 70-kg male w/ [Na]serum 110 mEq/L &amp;amp; Uosm 616 mOsm/kg
0.9% NaCl 154 mEq/L No UOP +1.</description></item><item><title>Effect of IV fluids-treatment-of-hyponatremia</title><link>https://www.physician.tw/Effect-of-IV-fluids-treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Effect-of-IV-fluids-treatment-of-hyponatremia/</guid><description>Effect of IV fluids-treatment-of-hyponatremia complex as depends not only on [Na]infusate but also UOP and Uosm
If minimal UOP and none of infused Na excreted åˆ†å­: (current [Na] serum Ã—TBW) + [Na]infusate åˆ†æ¯ï¼šTBW + 1 If euvolemic (eg, in SIADH) &amp;amp; all infused Na excreted åˆ†å­: (current [Na] serum x TBW) + [Na]infusate - [Na]infusate åˆ†æ¯: TBW+1 - (Infusate osm/U osm) In SIADH â€œfixedâ€ high Uosm.</description></item><item><title>Efficacy concerns PA catheter and tailored therapy</title><link>https://www.physician.tw/Efficacy-concerns-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Efficacy-concerns-PA-catheter-and-tailored-therapy/</guid><description>Efficacy concerns PA catheter and tailored therapy Efficacy concerns (NEJM 2006;354:2213; JAMA 2005;294:1664)
No benefit to routine PAC use in high-risk surgery (JACC 2014;62:e77), sepsis, ARDS</description></item><item><title>EGFR ex20 insertion</title><link>https://www.physician.tw/EGFR-ex20-insertion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/EGFR-ex20-insertion/</guid><description>EGFR ex20 insertion EGFR ç¬¬20è™Ÿå¤–é¡¯å­(exon 20ï¼‰æ’å…¥çªè®Šæ˜¯éå°ç´°èƒè‚ºç™Œ(NSCLC) ä¸­çš„ç‰¹äºç¾¤ ç´„ä½”æ‰€æœ‰ EGFR çªè®Š 9%ï¼Œé€™é¡å‹æ‚£è€…å°æ–¼ç¾æœ‰çš„ä¸‰ä»£ EGFR å—é«”é…ªèƒºé…¸æ¿€é…¶æŠ‘è£½åŠ‘ï¼ˆTKIï¼‰æ²»ç™‚ä¸¦ä¸æ•æ„Ÿ èˆ‡å¸¸è¦‹çš„ EGFR exon 19 ç¼ºå¤±æˆ– L858R çªè®Šçš„æ‚£è€…ç›¸æ¯”ï¼Œé å¾Œæ›´å·® å­˜æ´»æœŸä¸­ä½æ•¸ä¸åˆ° 17 å€‹æœˆï¼Œ5 å¹´ç”Ÿå­˜ç‡åƒ…ç‚º 6% å› æ­¤ï¼Œç›®å‰è‡¨åºŠä¸Šçš„æ¨™æº–æ²»ç™‚æ–¹æ¡ˆæ˜¯æ˜¯å¸¸è¦åŒ–ç™‚ï¼Œå°šç„¡ FDA æ ¸å‡†çš„æ¨™é¶ç™‚æ³•ã€‚ Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer</description></item><item><title>electrocardiography</title><link>https://www.physician.tw/electrocardiography/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/electrocardiography/</guid><description>approach to EKG [[Approach-electrocardiography]] (a systematic approach is vital) [[Axis-deviation]] [[Bundle-Branch-Blocks]] (Circ 2009;119:e235) [[Prolonged-QT-interval]] (NEJM 2008;358:169; www.torsades.org) [[Atrial-Abnormality]] [[Left-ventricular-hypertrophy]] (LVH) (Circ 2009;119:e251) [[Right-ventricular-hypertrophy]] (RVH) (Circ 2009;119:e251; JACC 2014;63:672) [[Ddx-of-dominant-R-wave-in-V1-or-V2]] [[Poor-R-wave-progression]] (PRWP) (Am Heart J 2004;148:80) [[Pathologic-Q-waves]] [[ST-elevation]] (STE) (NEJM 2003;349:2128; Circ 2009;119:e241 &amp;amp; e262) [[ST-depression]] (STD) [[T-wave-inversion]] (TWI; generally â‰¥1 mm; deep if â‰¥5 mm) (Circ 2009;119:e241) [[Low-voltage]] [[Electrolyte-abnormalities]] [[ECG-in-young-athletes]] (JACC 2017;69:805) [[è²¼ç‰‡]] [!</description></item><item><title>Electrolyte-abnormalities</title><link>https://www.physician.tw/Electrolyte-abnormalities/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Electrolyte-abnormalities/</guid><description>Electrolyte-abnormalities â†‘ K: tented Tw, â†“ QT, â†‘ PR, AVB, wide QRS, STE; â†“ K: flattened Tw, U waves, â†‘ QT</description></item><item><title>emergency medicine</title><link>https://www.physician.tw/emergency-medicine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/emergency-medicine/</guid><description>emergency medicine [[thereis]] a note t[[est zettel]]</description></item><item><title>empiric replacement fluids can be used for fluid losses</title><link>https://www.physician.tw/empiric-replacement-fluids-can-be-used-for-fluid-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/empiric-replacement-fluids-can-be-used-for-fluid-losses/</guid><description>empiric replacement fluids can be used for fluid losses Sample Osmolarity calculations - GlobalRPH
Sweat: 5% dextrose (D5) {1/4} normal saline solution with 5 KCl/L Gastric, colon: D 5 {1/2} normal saline solution with 30 KCl/L Bile, pancreas, small bowel: lactated Ringerâ€™s solution Third space (interstitial loss): lactated Ringerâ€™s solution é—œæ–¼ [[TaitaNo5]]</description></item><item><title>Empiric Treatment of Bacterial Meningitis</title><link>https://www.physician.tw/Empiric-Treatment-of-Bacterial-Meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Empiric-Treatment-of-Bacterial-Meningitis/</guid><description>Empiric Treatment of Bacterial Meningitis (Lancet 2012;380:1693)
Adults &amp;lt;50 y: Ceftriaxone + vancomycin (trough 15â€“20), consider acyclovir IV Adults &amp;gt;50 y: Ceftriaxone + vancomycin + ampicillin, consider acyclovir IV Immunosuppressed: [Cefepime or meropenem] + vanc Â± amp (not nec.</description></item><item><title>Empiric treatment-aseptic meningitis</title><link>https://www.physician.tw/Empiric-treatment-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Empiric-treatment-aseptic-meningitis/</guid><description>Empiric treatment-aseptic meningitis Suspected bacterial meningitis: see empiric treatment of bacterial meningitis above Suspected viral meningitis: if concern for HSV meningoencephalitis â†’ IV acyclovir Unclear etiology: consider initiation of empiric bacterial meningitis treatment while observing and awaiting CSF studies</description></item><item><title>encephalitis</title><link>https://www.physician.tw/encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/encephalitis/</guid><description>encephalitis Definition Inflammation of brain parenchyma characterized by impaired cerebral function (AMS, neurologic deficits) often due to primary viral infection or post-viral inflammation [[Etiologies-encephalitis]] Clinical manifestations Fever + Î”MS (subtle to severe), seizure, focal neuro deficit, HA in meningoencephalitis [[Diagnostic studies-encephalitis]] Treatment HSV/VZV: IV acyclovir 10 mg/kg IV q8h; consider empiric treatment given frequency</description></item><item><title>Endocarditis Prophylaxis</title><link>https://www.physician.tw/Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocarditis-Prophylaxis/</guid><description>Endocarditis Prophylaxis [[Cardiac conditions-Endocarditis Prophylaxis]] [[Procedures-Endocarditis Prophylaxis]] [[Regimens-Endocarditis Prophylaxis]]</description></item><item><title>Endocrine metabolic</title><link>https://www.physician.tw/Endocrine-metabolic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endocrine-metabolic/</guid><description>Endocrine metabolic Hypogonadism; adrenal insufficiency (CMV, MAC, TB, HIV, or med-related); sarcopenia; osteopenia/porosis/fragility fractures (at all CD4 counts) Lipodystrophy: central obesity, peripheral lipoatrophy, dyslipidemia, hyperglycemia</description></item><item><title>endocrine-Secondary Causes of Hypertension</title><link>https://www.physician.tw/endocrine-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrine-Secondary-Causes-of-Hypertension/</guid><description>endocrine-Secondary Causes of Hypertension Hyperaldo or Cushingâ€™s (1â€“5%) Hypokalemia Metabolic alkalosis See â€œAdrenal Disordersâ€ [[adrenal disorders]]
Pheochromocytoma (&amp;lt;1%) Paroxysmal HTN, H/A, palp.</description></item><item><title>endocrinology</title><link>https://www.physician.tw/endocrinology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/endocrinology/</guid><description>endocrinology [[pituitary disorders]] [[thyroid disorders]] [[adrenal disorders]] [[calcium disorders]] [[diabetes mellitus]] [[lipid disorders]] [[phosphate disorders]] Resident 360 topics Diabetes</description></item><item><title>Endotracheal intubation of COPDAE</title><link>https://www.physician.tw/Endotracheal-intubation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endotracheal-intubation-of-COPDAE/</guid><description>Endotracheal intubation of COPDAE Consider if PaO2 &amp;lt;55â€“60, â†‘â€™ing PaCO2, â†“â€™ing pH, â†‘ RR, respiratory fatigue, Î” MS or hemodynamic instability</description></item><item><title>Endovascular repair EVAR-aortic aneurysms</title><link>https://www.physician.tw/Endovascular-repair-EVAR-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Endovascular-repair-EVAR-aortic-aneurysms/</guid><description>Endovascular repair EVAR-aortic aneurysms (Circ 2015;131:1291; NEJM 2019;380:2126)
Requires favorable aortic anatomy TEVAR (thoracic EVAR) for descending TAA â‰¥5.5 cm may â†“ periop morbidity and possibly mortality (Circ 2010;121:2780; JACC 2010;55:986; J Thorac CV Surg 2010;140:1001 &amp;amp; 2012;144:604) AAA: guidelines support open repair or EVAR for infrarenal AAA in good surg candidates â†“ short-term mort.</description></item><item><title>Entecavir or tenofovir</title><link>https://www.physician.tw/Entecavir-or-tenofovir/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Entecavir-or-tenofovir/</guid><description>Entecavir or tenofovir nucleo(s/t)ide analogs, well tolerated, low resistance; at 5 y, HBeAg seroconversion is 30â€“40% &amp;amp; loss of HBsAg is 5â€“10% (Lancet Gastro Hep 2016;1:185).</description></item><item><title>entry inhibitors-EI-Antiretrovirals ARVs</title><link>https://www.physician.tw/entry-inhibitors-EI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/entry-inhibitors-EI-Antiretrovirals-ARVs/</guid><description>entry inhibitors-EI-Antiretrovirals (ARVs) maraviroc (MVC; Selzentry) Dizziness, hepatotoxicity; âœ“ CCR5 tropism assay</description></item><item><title>eosinophilia</title><link>https://www.physician.tw/eosinophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/eosinophilia/</guid><description>eosinophilia (&amp;gt;500/ÂµL)
Infection Usually parasitic (helminths)
Allergic Drugs; asthma, hay fever, eczema; ABPA
Collagen vasc dis. RA, EGPA (Churg-Strauss), eosinophilic fasciitis, PAN</description></item><item><title>Eosinophilic esophagitis</title><link>https://www.physician.tw/Eosinophilic-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eosinophilic-esophagitis/</guid><description>Eosinophilic esophagitis (JAMA 2021;326:1310):
often young/middle-aged â™‚. Dx: &amp;gt;15 eos/hpf on bx, esoph dysfxn (ie, dysphagia, food impaction). Rx: 1st line is PPI (Â½ respond); alternative (or if fail PPI) is 3Ds: 1st elimination Diet (Ã˜ milk, soy, eggs, wheat, nuts, fish); if no Î”, Drugs (swallow inh steroids); if ongoing sx &amp;amp; stricturing, Dilation (Gastro 2020;158:1776).</description></item><item><title>Eosinophilic gran with polyangiitis</title><link>https://www.physician.tw/Eosinophilic-gran-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Eosinophilic-gran-with-polyangiitis/</guid><description>Eosinophilic gran with polyangiitis Eosinophilic granulomatosis with polyangiitis
EGPA,
formerly Churg-Strauss
Similar to GPA w/ more frequent cardiac involvement,</description></item><item><title>Epidemiology pathogenesis-cholelithiasis</title><link>https://www.physician.tw/Epidemiology-pathogenesis-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-pathogenesis-cholelithiasis/</guid><description>Epidemiology pathogenesis-cholelithiasis (J Hepatol 2016;65:146; Gastro 2016;151:351)
Affects ~10% of Western populations, 15â€“25% of people develop sx over 10â€“15 y</description></item><item><title>Epidemiology and etiologies-atrial fibrillation</title><link>https://www.physician.tw/Epidemiology-and-etiologies-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-etiologies-atrial-fibrillation/</guid><description>Epidemiology and etiologies-atrial fibrillation (Circ A&amp;amp;E 2018;11:e006350)
1â€“2% of pop. has AF (10% of those age â‰¥80); M &amp;gt;F; lifetime risk ~25%; mean age 75 y Acute (up to 50% w/o identifiable cause) Cardiac: HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis, valve dis.</description></item><item><title>Epidemiology and risk factors-lung cancer</title><link>https://www.physician.tw/Epidemiology-and-risk-factors-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-and-risk-factors-lung-cancer/</guid><description>Epidemiology and risk factors-lung cancer Most common cause of cancer-related death for both men and women in the U.S. Two main types: non-small cell (NSCLC, ~85% of cases); small cell (SCLC, ~15%) å…©ç¨®ä¸»è¦é¡å‹ï¼šéå°ç´°èƒï¼ˆNSCLCï¼Œç´„85ï¼…çš„ç—…ä¾‹ï¼‰ï¼›å°å–®å…ƒï¼ˆSCLCï¼Œã€œ15ï¼…ï¼‰ NSCLC comprised of adeno (40%), squamous cell (SCC, 20%), &amp;amp; large cell (5%) carcinomas, as well as other / not classified (20%) NSCLCç”±Adenoï¼ˆ40ï¼…ï¼‰ï¼Œé±—ç‹€ç´°èƒï¼ˆSCCï¼Œ20ï¼…ï¼‰å’Œå¤§ç´°èƒï¼ˆ5ï¼…ï¼‰ç™Œçµ„æˆï¼Œä»¥åŠå…¶ä»– /æœªåˆ†é¡ï¼ˆ20ï¼…ï¼‰ Cigarette smoking: 85% of lung cancers occur in smokers; risk âˆ total pack-yrs, â†“ risk after quitting/reducing but not to baseline (Int J Cancer 2012;131:1210).</description></item><item><title>Epidemiology of breast cancer</title><link>https://www.physician.tw/Epidemiology-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-of-breast-cancer/</guid><description>Epidemiology of breast cancer Epidemiology In U.S., most common cancer in women; 2nd leading cause of cancer death in women</description></item><item><title>Epidemiology-aortic aneurysms</title><link>https://www.physician.tw/Epidemiology-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-aortic-aneurysms/</guid><description>Epidemiology-aortic aneurysms (Circ 2010;121:e266, 2011;124:2020; Nat Rev Cardiol 2011;8:92)
TAA: ~10/100,000 Pt-yrs; â™‚:â™€ 2:1; ~60% root/ascending; 40% descending AAA: ~4â€“8% prev in those &amp;gt;60 y; 5Ã— more common in â™‚; mostly infrarenal</description></item><item><title>Epidemiology-HIV AIDS</title><link>https://www.physician.tw/Epidemiology-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-HIV-AIDS/</guid><description>Epidemiology-HIV AIDS ~1.2 million Americans living w/ HIV (13% unaware); ~37 million worldwide High risk groups: MSM, transgender women, IVDU, sex worker, partners of high-risk Pts Transmission: sexual (risk 0.</description></item><item><title>Epidemiology-tuberculosis</title><link>https://www.physician.tw/Epidemiology-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Epidemiology-tuberculosis/</guid><description>Epidemiology-tuberculosis (NEJM 2016;375:1081)
Transmission via aerosols; untreated active dx requires airborne isolation in healthcare facilities and community isolation measures; must involve local public health authorities Acquisition: residents/travel in TB-endemic area, IVDU, resident/worker in correctional facility or homeless shelter, close contact w/ active TB Reactivation: risk is 5% in first 2 yr, 5â€“10% overall; â†‘ if HIV âŠ•, immunosupp.</description></item><item><title>epidural abscess</title><link>https://www.physician.tw/epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/epidural-abscess/</guid><description>epidural abscess [[clinical case of epidural abscess]] [[Etiology-epidural abscess]] Clinical manifestations-epidural abscess èƒŒç—›ï¼ˆç´„å››åˆ†ä¹‹ä¸‰çš„æ‚£è€…ï¼‰
ç™¼ç‡’ï¼ˆå¹¾ä¹ä¸€åŠçš„æ‚£è€…ï¼‰
ç¥ç¶“åŠŸèƒ½ç¼ºæï¼ˆç´„ä¸‰åˆ†ä¹‹ä¸€çš„æ‚£è€…ï¼‰</description></item><item><title>equipment of airway-management</title><link>https://www.physician.tw/equipment-of-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/equipment-of-airway-management/</guid><description>equipment of airway-management âœ¨é‡é»: é©ç•¶çš„æº–å‚™å°æ–¼æ‰€æœ‰æ°£é“ç®¡ç†æƒ…æ³éƒ½æ˜¯å¿…ä¸å¯å°‘çš„ã€‚ åŸºæœ¬è¨­å‚™åŒ…æ‹¬æ°§æ°£æºï¼ˆç‰†å£æˆ–ç½ï¼‰ã€æŠ½å¸è£ç½®ã€æ°£å›Šé¢ç½©é€šæ°£è¿´è·¯ã€ç›´æ¥å’Œ/æˆ–è¦–é »å–‰é¡ã€å¤šç¨®å°ºå¯¸çš„æ°£ç®¡æ’ç®¡ã€è²é–€ä¸Šæ°£é“è£ç½®ã€è¡€å£“/å¿ƒé›»åœ–/è„ˆæè¡€æ°§å„€å’Œ CO 2 æª¢æ¸¬è£ç½®ã€‚ è²é–€ä¸Šæ°£é“è£ç½®åŒ…æ‹¬æ’å…¥æ‚£è€…å£è…”ä¸¦ä½æ–¼è²é–€ä¸Šæ–¹çš„å–‰ç½©æ°£é“ (LMA)ã€‚ ç”±æ–¼é€™äº›è£ç½®ä¸èƒ½é˜²æ­¢èƒƒå…§å®¹ç‰©å¸å…¥ï¼Œå› æ­¤åœ¨ ICU ä¸­ï¼Œå®ƒå€‘é€šå¸¸åƒ…é™æ–¼é¢ç½©é€šæ°£å’Œæ°£ç®¡æ’ç®¡å›°é›£æƒ…æ³ä¸‹çš„æ•‘æ´è£ç½®ã€‚ é›–ç„¶æœ‰å¤šç¨®é¡å‹çš„ç›´æ¥å–‰é¡å¯ä¾›é¸æ“‡ï¼Œä½†æœ€å¸¸è¦‹çš„å…©ç¨®æ˜¯ Macintosh åˆ€ç‰‡ (MAC) å…©è€…éƒ½æœ‰å¤šç¨®å°ºå¯¸ï¼Œä½†é€šå¸¸ MAC 3 è¿‘å¹´ä¾†ï¼Œè¦–é »å–‰é¡æ˜¯é–“æ¥å–‰é¡æª¢æŸ¥çš„ä¸€ç¨®å½¢å¼ï¼Œå·²åœ¨å¤§å¤šæ•¸æ©Ÿæ§‹ä¸­å¾ˆå®¹æ˜“ç²å¾—ã€‚ è¦–é »å–‰é¡åœ¨åˆ€ç‰‡çš„å½¢ç‹€ã€æ’å…¥å£è…”æ™‚çš„æ­£ç¢ºä½ç½®ã€è¦–é »æºçš„ä½ç½®ä»¥åŠå¯é‡è¤‡ä½¿ç”¨/ä¸€æ¬¡æ€§éƒ¨ä»¶æ–¹é¢å„ä¸ç›¸åŒã€‚ GlidescopeÂ® æœ‰è‡ªå·±çš„ï¼ˆéä¸€æ¬¡æ€§ï¼‰ç®¡å¿ƒé‡ï¼Œä¼´éš¨è‘—ç¨ç‰¹çš„åˆ€ç‰‡å½¢ç‹€ã€‚ è¦–é »å–‰é¡çš„ä¸€å€‹æ½›åœ¨å•é¡Œæ˜¯ï¼Œé›–ç„¶å®ƒå¯ä»¥æä¾›è²é–€é–‹å£çš„æ¸…æ™°è¦–åœ–ï¼Œä½†ä»å¯èƒ½é›£ä»¥å°‡æ°£ç®¡æ’ç®¡æ“ç¸±åˆ°æ­£ç¢ºä½ç½®ã€‚ âœ¨é‡é»: æ°£ç®¡å°ç®¡ (ETT) ä¹Ÿæœ‰å„ç¨®ææ–™å’Œå°ºå¯¸å¯ä¾›é¸æ“‡ã€‚ ICU ä¸­æœ€å¸¸ç”¨çš„æ˜¯ç”±èšæ°¯ä¹™çƒ¯è£½æˆçš„ ETTï¼Œå¸¶æœ‰æ–œé¢å°–ç«¯ä»¥æ›´å¥½åœ°è§€å¯Ÿæ’å…¥ï¼Œå´å­”ï¼ˆå¢¨è²çœ¼ï¼‰ä»¥é˜²æ­¢åœ¨ç²˜æ¶²æ “çš„æƒ…æ³ä¸‹å®Œå…¨é–‰å¡ï¼Œä»¥åŠå……æ°£è¢–å¸¶ã€‚ ETT çš„å°ºå¯¸æ ¹æ“šä»¥æ¯«ç±³ç‚ºå–®ä½çš„ å…§å¾‘ ç¢ºå®šï¼Œé€šå¸¸é©åˆæˆäººçš„å°ºå¯¸ã€‚ 7.</description></item><item><title>ER PR</title><link>https://www.physician.tw/ER-PR/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ER-PR/</guid><description>ER PR Endo (NEJM 2019;380: 1226) Tamoxifen: adjuvant Rx for low-risk pre-meno; â†“ recurrence &amp;amp; â†“ mortality; 10 y superior to 5 y (Lancet 2011;378:771 &amp;amp; 2013;381:805) Aromatase inhib (AI; anastrozole, letrozole, exemestane): adjuvant Rx for post-meno; â†‘ OS vs.</description></item><item><title>Erosive gastropathy</title><link>https://www.physician.tw/Erosive-gastropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erosive-gastropathy/</guid><description>Erosive gastropathy (4â€“30%)
Precipitants: ASA/NSAID, EtOH, cocaine, gut ischemia, XRT
Stress-related mucosal injury in ICU Pts. Risk factors include severe coagulopathy, mech vent &amp;gt;48 h, high-dose glucocorticoids</description></item><item><title>Erythema multiforme</title><link>https://www.physician.tw/Erythema-multiforme/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erythema-multiforme/</guid><description>Erythema multiforme symmetric â€œtargetâ€ lesions often of palms, soles, &amp;amp; mucous memb Infxn etiol: HSV, Mycoplasma, syphilis, VZV, EBV, CMV, adenovirus, etc.</description></item><item><title>Erythema nodosum</title><link>https://www.physician.tw/Erythema-nodosum/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Erythema-nodosum/</guid><description>Erythema nodosum tender erythematous or violaceous nodules usually symmetric on LE Infxn etiol: Strep, TB, EBV, Bartonella, HBV, psittacosis, fungal, L.</description></item><item><title>esophageal and gastric disorders</title><link>https://www.physician.tw/esophageal-and-gastric-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esophageal-and-gastric-disorders/</guid><description>esophageal and gastric disorders dysphagia [[structural dysphagia]] [[neuromuscular dysphagia]] [[gastroesophageal reflux disease]] [[peptic ulcer disease]] [[definition and etiologies of peptic ulcer disease]] [[clinical manifestations of peptic ulcer disease]] [[diagnostic studies of peptic ulcer disease]] [[treatment of peptic ulcer disease]] [[GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug]]</description></item><item><title>esophageal and gastric disorders</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease.md/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease.md/</guid><description>esophageal and gastric disorders [[Dysphagia]] [[Etiologies of and approach to dysphagia]] [[Structural dysphagia]] [[Neuromuscular dysphagia]]
GASTROESOPHAGEAL REFLUX DISEASE (GERD) [[Pathophysiology-gastroesophageal reflux disease]] [[Clinical manifestations gastroesophageal reflux disease]] [[Diagnosis gastroesophageal reflux disease]] [[Treatment gastroesophageal reflux disease]] [[Complications gastroesophageal reflux disease ]]</description></item><item><title>esophageal cancer</title><link>https://www.physician.tw/esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/esophageal-cancer/</guid><description>esophageal cancer OVERALL BOTTOM LINE The incidence of esophageal cancer has increased in certain populations (e.g. adenocarcinoma in patients with undertreated reflux esophagitis) without much improvement in survival over the past three decades.</description></item><item><title>Esophageal or gastric varices</title><link>https://www.physician.tw/Esophageal-or-gastric-varices/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Esophageal-or-gastric-varices/</guid><description>Esophageal or gastric varices (4â€“20%)
(Clin Gastro Hepatol 2015;13:2109; J Gastro Hepatol 2016;31:1519; Hep 2017;65:310)
See â€œ[[cirrhosis]]â€
2Â° to portal HTN.</description></item><item><title>Esophagitis</title><link>https://www.physician.tw/Esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Esophagitis/</guid><description>Esophagitis (15%)
Rx offending cause + high-dose PPI; repeat EGD to r/o [[Barrettâ€™s esophagitis]]</description></item><item><title>est zettel</title><link>https://www.physician.tw/est-zettel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/est-zettel/</guid><description>est zettel ä¾†è‡ª: [[emergency medicine]]</description></item><item><title>Ethylene glycol-toxicology</title><link>https://www.physician.tw/Ethylene-glycol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ethylene-glycol-toxicology/</guid><description>Ethylene glycol-toxicology CNS depression, â†‘ AG &amp;amp; OG metabolic acidosis
Ethanol or fomepizole, NaHCO3
Consider hemodialysis</description></item><item><title>Etiologies and Diagnosis of Acute Kidney Injury</title><link>https://www.physician.tw/Etiologies-and-Diagnosis-of-Acute-Kidney-Injury-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-and-Diagnosis-of-Acute-Kidney-Injury-/</guid><description>Etiologies and Diagnosis of Acute Kidney Injury [[Prerenal acute kidney injury etiology]] [[Intrinsic acute kidney injury etiology]] [[Post-renal acute kidney injury etiology]] [[Urine Dipstick]]</description></item><item><title>Etiologies of Acute Pericarditis</title><link>https://www.physician.tw/Etiologies-of-Acute-Pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Acute-Pericarditis/</guid><description>Etiologies of Acute Pericarditis âœ¨ å­¸ç¿’é‡é» ğŸ¦ æ€¥æ€§å¿ƒåŒ…ç‚ï¼ˆç—…æ¯’æ€§ã€ç´°èŒæ€§ã€çµæ ¸æ€§æˆ–ç‰¹ç™¼æ€§èµ·æºï¼‰ã€‚ è‡ªèº«å…ç–«æ€§ç–¾ç—…ã€‚ å¿ƒè‚Œæ¢—å¡æˆ–å¿ƒè‡Ÿæ‰‹è¡“å¾Œã€‚ å°–éŠ³æˆ–éˆæ€§èƒ¸éƒ¨å‰µå‚·ï¼ŒåŒ…æ‹¬å¿ƒè‡Ÿè¨ºæ–·æˆ–ä»‹å…¥æ‰‹è¡“ã€‚ æƒ¡æ€§è…«ç˜¤ï¼Œç‰¹åˆ¥æ˜¯éå¿ƒè‡ŸåŸç™¼æ€§è…«ç˜¤çš„è½‰ç§»æ“´æ•£ã€‚ ç¸±éš”è¼»å°„ã€‚ è…åŠŸèƒ½è¡°ç«­ä¼´å°¿æ¯’ç—‡ã€‚ ç²˜æ¶²æ€§æ°´è…«ã€‚ ä¸»å‹•è„ˆå¤¾å±¤å»¶ä¼¸åˆ°å¿ƒåŒ…ã€‚ è—¥ç‰© Idiopathic (~90%) Most presumed to be undiagnosed viral etiologies å¤§å¤šæ•¸è¢«èªç‚ºæ˜¯æœªç¢ºè¨ºçš„ç—…æ¯’ç—…å› </description></item><item><title>Etiologies of and approach to dysphagia</title><link>https://www.physician.tw/Etiologies-of-and-approach-to-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-and-approach-to-dysphagia/</guid><description>Etiologies of and approach to dysphagia</description></item><item><title>Etiologies of Classic FUO</title><link>https://www.physician.tw/Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Classic-FUO/</guid><description>Etiologies of Classic FUO [[Infection as Etiologies of Classic FUO]] ~30%
[[Connective tissue disease as Etiologies of Classic FUO]] ~30%</description></item><item><title>Etiologies of Constipation</title><link>https://www.physician.tw/Etiologies-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Constipation/</guid><description>Etiologies of Constipation Primary etiologies: slow transit vs. pelvic floor dyssynergia Secondary etiologies (4 Ms; JAMA 2016:315:185) Mech obstruction: malignancy, compression, rectocele, strictures</description></item><item><title>Etiologies of Decreased Responsiveness</title><link>https://www.physician.tw/Etiologies-of-Decreased-Responsiveness/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Decreased-Responsiveness/</guid><description>Etiologies of Decreased Responsiveness see: [[Differential Diagnosis of Delirium]]
1Â° Neurologic (usually with focal signs) Vasc: ischemic stroke/TIA, ICH, VST, PRES, vasculitis, pituitary apoplexy Seizure: postictal, status, nonconvulsive Infxn: meningitis, encephalitis, abscess Trauma: TBI, concussion, diffuse axonal injury â†‘ intracranial pressure: mass, edema, hydrocephalus, herniation Autoimmune/paraneoplastic enceph.</description></item><item><title>Etiologies of Hematuria</title><link>https://www.physician.tw/Etiologies-of-Hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hematuria/</guid><description>Etiologies of Hematuria Extrarenal (far more common) Nephrolithiasis Neoplasm: transitional cell, prostate Infxn: cystitis, urethritis, prostatitis Foley trauma BPH [[Schistosoma haematobium]] Intrarenal Nephrolithiasis or crystalluria Neoplasm Trauma/exercise Vascular: renal infarcts, renal v.</description></item><item><title>Etiologies of High elevated PaCO2</title><link>https://www.physician.tw/Etiologies-of-High-elevated-PaCO2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-High-elevated-PaCO2/</guid><description>Etiologies of High elevated PaCO2 Hypercapnia - P.CO2 = k x VCO2 / (respiratory rate * tidal volume * (1-Vd/tidal volume))</description></item><item><title>Etiologies of Hypercalcemia</title><link>https://www.physician.tw/Etiologies-of-Hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hypercalcemia/</guid><description>Etiologies of Hypercalcemia [[hyperparathyroidism]] (HPT) (NEJM 2018;379:1050; Lancet 2018;391:168) 1Â°: adenoma (85%), hyperplasia (15â€“20%; spont. vs. MEN1/2A), carcinoma (&amp;lt;1%), meds (Lithium â†’ â†‘ PTH) 3Â°: after long-standing 2Â° hyperparathyroidism (as in renal failure) â†’ autonomous nodule develops, requires surgery [[Secondary hyperPTH]] Familial hypocalciuric hypercalcemia (FHH) Inact.</description></item><item><title>Etiologies of hypercortisolism</title><link>https://www.physician.tw/Etiologies-of-hypercortisolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-hypercortisolism/</guid><description>Etiologies of hypercortisolism Most commonly iatrogenic caused by exogenous glucocorticoids (though underreported) [[Cushingâ€™s disease]] (60â€“70% of non-iatrogenic CS): ACTH-secreting pituitary adenoma (usually microadenoma) or hyperplasia Adrenal tumor (10â€“15%): adenoma or (rarely) carcinoma Ectopic ACTH (10â€“15%): SCLC, carcinoid, islet cell tumors, medullary thyroid carcinoma, [[pheochromocytoma]]</description></item><item><title>Etiologies of Hypocalcemia</title><link>https://www.physician.tw/Etiologies-of-Hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Hypocalcemia/</guid><description>Etiologies of Hypocalcemia [[Laboratory Findings in Calcium Disorders]]
[[Hypoparathyroidism]] [[Pseudo-hypoparathyroidism]] Vit D defic. or resist (NEJM 2011;364:248; JCEM 2012;97:1153)
â­ å­¸ç¿’é‡é» â­ å¤§å¤šæ•¸è¡€æ¸… 25-ç¾¥åŸºç¶­ç”Ÿç´  D (25[OH]D) ç‚º 12 è‡³ 20 ng/mLï¼ˆ30 è‡³ 50 nmol/Lï¼‰çš„å¥åº·æˆäººä¸éœ€è¦ä»»ä½•é¡å¤–è©•ä¼°ã€‚ è¡€æ¸… 25(OH)D æ°´å¹³ &amp;lt;12 ng/mL çš„æ‚£è€…æœ‰ç™¼ç”Ÿéª¨è»ŸåŒ–ç—‡çš„é¢¨éšªã€‚ åœ¨æ­¤é¡æ‚£è€…ä¸­ï¼Œæˆ‘å€‘æ¸¬é‡è¡€æ¸…éˆ£ã€ç£·ã€é¹¼æ€§ç£·é…¸é…¶ã€ç”²ç‹€æ—è…ºæ¿€ç´  (PTH)ã€é›»è§£è³ªã€è¡€å°¿ç´ æ°® (BUN)ã€è‚Œé…å’Œçµ„ç¹”è½‰è°·æ°¨é…°èƒºé…¶æŠ—é«”ï¼ˆä»¥è©•ä¼°ä¹³ç³œç€‰ï¼‰ã€‚ åœ¨æŸäº›æƒ…æ³ä¸‹éœ€è¦ X å…‰ç‰‡ï¼Œä¾‹å¦‚å­˜åœ¨éª¨ç—›ã€‚ [[Synthesis and Metabolism of Vitamin D]].</description></item><item><title>Etiologies of Non-AG Metabolic Acidosis</title><link>https://www.physician.tw/Etiologies-of-Non-AG-Metabolic-Acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Non-AG-Metabolic-Acidosis/</guid><description>Etiologies of Non-AG Metabolic Acidosis GI losses of HCO3 Diarrhea, intestinal or pancreatic fistulas or drainage
RTAs [[Renal tubular acidoses]]</description></item><item><title>Etiologies of Prolonged-QT-interval</title><link>https://www.physician.tw/Etiologies-of-Prolonged-QT-interval/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Prolonged-QT-interval/</guid><description>Etiologies of Prolonged-QT-interval Antiarrhythmics class Ia (procainamide, disopyramide), class III (amio, sotalol, dofet)
Psych drugs antipsychotics (phenothiazines, haloperidol, atypicals), Li, ?</description></item><item><title>Etiologies of Proteinuria</title><link>https://www.physician.tw/Etiologies-of-Proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Proteinuria/</guid><description>Etiologies of Proteinuria [[Glomerular proteinuria]] [[Tubulointerstitial proteinuria]] [[Overflow proteinuria]] [[Isolated proteinuria]]</description></item><item><title>Etiologies-acute pancreatitis</title><link>https://www.physician.tw/Etiologies-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-acute-pancreatitis/</guid><description>Etiologies-acute pancreatitis (JAMA 2021;325:382)
Gallstones (40%): â™€ &amp;gt;â™‚; usually due to small stones (&amp;lt;5 mm) or microlithiasis/sludge
Alcohol (30%): â™‚ &amp;gt;â™€; 4â€“5 drinks/day over â‰¥5 yrs; usually chronic w/ acute flares</description></item><item><title>Etiologies-adrenal insufficiency</title><link>https://www.physician.tw/Etiologies-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-adrenal-insufficiency/</guid><description>Etiologies-adrenal insufficiency Primary = adrenocortical disease = Addisonâ€™s disease autoimmune: isolated or in assoc w/ APS (see table on page 7-2) infection: TB, CMV, histoplasmosis, paracoccidioidomycosis vascular: hemorrhage (usually in setting of sepsis), adrenal vein thrombosis, HIT, trauma metastatic disease: (90% of adrenals must be destroyed to cause insufficiency) deposition diseases: hemochromatosis, amyloidosis, sarcoidosis drugs: azole antifungals, etomidate (even after single dose), rifampin, anticonvulsants Secondary = pituitary failure of ACTH secretion (but adrenal aldosterone intact b/c RAA axis) any cause of primary or secondary hypopituitarism (see â€œPituitary Disordersâ€) glucocorticoid therapy (can occur after â‰¤2 wk of â€œsuppressive dosesâ€; dose effect variable; even &amp;lt;10 mg of prednisone daily chronically can be suppressive) megestrol (a progestin with some glucocorticoid activity)</description></item><item><title>Etiologies-Aplastic anemia</title><link>https://www.physician.tw/Etiologies-Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-Aplastic-anemia/</guid><description>Etiologies-Aplastic anemia idiopathic (Â½ â€“ â…” of cases)
Stem cell destruction: radiation, chemotherapy, chemicals (eg, benzene)</description></item><item><title>Etiologies-ascites</title><link>https://www.physician.tw/Etiologies-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-ascites/</guid><description>Etiologies-ascites Portal HTN Related (SAAG â‰¥1.1) Presinusoidal obstruction portal or splenic vein thrombosis, schisto- somiasis, sarcoidosis
Sinusoidal obstruction: cirrhosis, acute hepatitis (including EtOH), malignancy (HCC or mets)</description></item><item><title>Etiologies-aseptic meningitis</title><link>https://www.physician.tw/Etiologies-aseptic-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-aseptic-meningitis/</guid><description>Etiologies-aseptic meningitis (Neurology 2006;66:75)
Viral: enteroviruses are most common cause (summer/fall; rash, GI, URI sx), HIV, HSV, VZV, mumps (parotitis), lymphocytic choriomeningitis virus (rodent exposure), encephalitis viruses, adenovirus, polio, CMV, EBV, WNV Focal bacterial infection: brain/epidural/subdural abscess, CNS septic thrombophlebitis Partially treated bacterial meningitis Other infectious: TB, fungal (cryptococcus, coccidiodes), Lyme, syphilis, leptospirosis Neoplasm: intracranial tumors (or cysts), lymphomatous or carcinomatous meningitis Drug-induced meningitis: NSAIDs, IVIG, antibiotics (TMP-SMX, PCN), anti-epileptics Systemic autoimmune illness: SLE, sarcoidosis, BehÃ§etâ€™s, SjÃ¶grenâ€™s syndrome, RA Mollaretâ€™s: recurrent lymphocytic meningitis, spontaneously resolving (often HSV-2)</description></item><item><title>Etiologies-cirrhosis</title><link>https://www.physician.tw/Etiologies-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-cirrhosis/</guid><description>Etiologies-cirrhosis Alcohol, toxins (eg, arsenic)
Nonalcoholic fatty liver disease (NAFLD) is the cause of most â€œcryptogenic cirrhosisâ€</description></item><item><title>Etiologies-encephalitis</title><link>https://www.physician.tw/Etiologies-encephalitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-encephalitis/</guid><description>Etiologies-encephalitis (specific etiology found in &amp;lt;20% of cases; Neurology 2006;66:75; CID 2008;47:303)
HSV-1 all ages/seasons. If sxs recur after Rx, consider viral relapse vs.</description></item><item><title>Etiologies-hyperaldosteronism</title><link>https://www.physician.tw/Etiologies-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hyperaldosteronism/</guid><description>Etiologies-hyperaldosteronism [[Primary Hyperaldosteronism]] [[Secondary Hyperaldosteronism]] [[Nonaldosterone mineralocorticoid excess]] mimics hyperaldosteronism</description></item><item><title>Etiologies-hypertension</title><link>https://www.physician.tw/Etiologies-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypertension/</guid><description>Etiologies-hypertension Essential (95%): onset 25â€“55 y; âŠ• FHx. Unclear mechanism but ? additive microvasc renal injury over time w/ contribution of hyperactive sympathetics (NEJM 2002;346:913).</description></item><item><title>Etiologies-hyperthyroidism</title><link>https://www.physician.tw/Etiologies-hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hyperthyroidism/</guid><description>Etiologies-hyperthyroidism Gravesâ€™ disease (60â€“80% of thyrotoxicosis) Thyroiditis: thyrotoxic phase of subacute (granulomatous) or painless (lymphocytic) Toxic adenomas (single or multinodular goiter) Extremely rare: TSH-secreting pituitary tumor or pituitary resistant to thyroid hormone (â†‘ TSH, â†‘ free T4) Misc: amiodarone, iodine-induced, thyrotoxicosis factitia, struma ovarii (3% of ovarian dermoid tumors and teratomas), tumors (eg, choriocarcinoma) secreting hCG (weak bioactivity against TSH-R), large deposits of metastatic follicular thyroid cancer</description></item><item><title>Etiologies-hypoglycemia</title><link>https://www.physician.tw/Etiologies-hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypoglycemia/</guid><description>Etiologies-hypoglycemia Pts w/ diabetes: excess insulin, oral hypoglycemics, missed meals, renal failure (â†“ insulin &amp;amp; SU clearance); Î²-blockers can mask adrenergic symptoms of hypoglycemia Pt without diabetes: low fasting glucose w/o sx can be normal â†‘ insulin: exogenous insulin, sulfonylureas, insulinoma, anti-insulin antibodies â†“ glucose production: hypopituitarism, adrenal insufficiency, glucagon deficiency, hepatic failure, renal failure, CHF, alcoholism, sepsis, severe malnutrition Postprandial, esp.</description></item><item><title>Etiologies-hypopituitary syndromes</title><link>https://www.physician.tw/Etiologies-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-hypopituitary-syndromes/</guid><description>Etiologies-hypopituitary syndromes Primary: surgery radiation (develops after avg 4â€“5 y), tumors (primary or metastatic), infection infiltration (sarcoid, hemochromatosis) autoimmune ischemia (including Sheehanâ€™s syndrome caused by pituitary infarction intrapartum), carotid aneurysms cavernous sinus thrombosis trauma medications (eg, ipilimumab) apoplexy empty sella genetic Secondary: (hypothalamic dysfunction or stalk interruption): tumors (including craniopharyngioma) infection infiltration radiation surgery trauma</description></item><item><title>Etiologies-of thrombocytopenia</title><link>https://www.physician.tw/Etiologies-of-thrombocytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-thrombocytopenia/</guid><description>Etiologies-of thrombocytopenia â†“ production Hypocellular bone marrow: [[aplastic anemia]] (qv), rarely MDS, drugs (eg, thiazides, antibiotics, chemotherapy), alcohol, cirrhosis, viral infection</description></item><item><title>Etiologies-of-AG-Metabolic-Acidosis</title><link>https://www.physician.tw/Etiologies-of-AG-Metabolic-Acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-AG-Metabolic-Acidosis/</guid><description>Etiologies-of-AG-Metabolic-Acidosis â€œGOLD MARKâ€ = Glycols, Oxoproline, Lactic, D-Lactic, Methanol, ASA, Renal, Ketoacidosis
[[diabetic ketoacidosis]] Diabetes mellitus, alcoholism, starvation (NEJM 2015;372:546)</description></item><item><title>Etiologies-of-Metabolic-Alkalosis</title><link>https://www.physician.tw/Etiologies-of-Metabolic-Alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-of-Metabolic-Alkalosis/</guid><description>Etiologies-of-Metabolic-Alkalosis Saline responsive UCl &amp;lt;25
GI loss of H+: emesis, NGT suction, villous adenoma, chloridorrhea Renal loss: loop/thiazide, â†“ Cl intake, milk-alkali, Pendred syndrome Posthypercapnia(bilevel positive airway pressure for chronic obstructive pulmonary disease AE), sweat losses in cystic fibrosis Saline resistant UCl &amp;gt;40</description></item><item><title>Etiologies-pancytopenia</title><link>https://www.physician.tw/Etiologies-pancytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-pancytopenia/</guid><description>Etiologies-pancytopenia Hypocellular bone marrow (nl cellularity ~100 â€“ age): aplastic anemia, hypoplastic MDS
Cellular bone marrow: MDS, aleukemic leukemia, PNH, severe megaloblastic anemia</description></item><item><title>Etiologies-pulmonary hypertension</title><link>https://www.physician.tw/Etiologies-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-pulmonary-hypertension/</guid><description>Etiologies-pulmonary hypertension Primary pulmonary arterial HTN (PAH) (group 1) Precapillary PHT PCWP â‰¤15 mmHg â†‘ transpulm grad â†‘ PVR
Idiopathic (IPAH): yearly incidence 1â€“2 per million; mean age of onset 36 y (â™‚ older than â™€); â™‚: â™€ = ~2:1, usually mild â†‘ in PAP Familial (FPAH) Associated conditions (APAH) Connective tissue dis.</description></item><item><title>Etiologies-solitary pulmonary nodule</title><link>https://www.physician.tw/Etiologies-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-solitary-pulmonary-nodule/</guid><description>Etiologies-solitary pulmonary nodule Benign (70%) Granuloma (80%): TB, histo, coccidio Hamartoma (10%) Bronchogenic cyst, AVM, pulm infarct Echinococcosis, ascariasis, aspergilloma GPA, rheumatoid nodule, sarcoidosis Lipoma, fibroma, amyloidoma</description></item><item><title>Etiologies-syncope</title><link>https://www.physician.tw/Etiologies-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-syncope/</guid><description>Etiologies-syncope Vasovagal (a.k.a. neurocardiogenic, ~25%): â†‘ sympathetic tone â†’ vigorous contraction of LV â†’ LV mechanoreceptors trigger â†‘ vagal tone (hyperactive Bezold-Jarisch reflex) â†’ â†“ HR (cardioinhib.</description></item><item><title>Etiologies-wide-complex tachycardias WCTS</title><link>https://www.physician.tw/Etiologies-wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiologies-wide-complex-tachycardias-WCTS/</guid><description>Etiologies-wide-complex tachycardias (WCTS) (Lancet 2012;380:1520)
Ventricular tachycardia (VT): accounts for 80% of WCT in unselected population SVT conducted with aberrancy: either fixed BBB, rate-dependent BBB (usually RBBB), conduction via an accessory pathway or atrially triggered ventricular pacing</description></item><item><title>Etiology-acute liver failure</title><link>https://www.physician.tw/Etiology-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-acute-liver-failure/</guid><description>Etiology-acute liver failure (J Hepatol 2015;62:S112)
[[Drugs and toxins that cause acute liver failure]]
Viral: HAV, HBV, HCV (rare), HDV + HBV, HEV (esp.</description></item><item><title>Etiology-aortic-regurgitation</title><link>https://www.physician.tw/Etiology-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-aortic-regurgitation/</guid><description>Etiology-aortic-regurgitation Valve disease (43%): rheumatic (usually mixed AS/AR + MV disease); bicuspid AoV (natural hx: â…“â†’ normal, â…“â†’ AS, â…™â†’ AR, â…™â†’ endocarditis â†’ AR); infective endocarditis; valvulitis (RA, SLE, certain anorectics &amp;amp; serotonergics, XRT) Root disease (57%): HTN, aortic aneurysm/dissection, annuloaortic ectasia (ie, Marfan), aortic inflammation (GCA, Takayasuâ€™s, ankylosing spond.</description></item><item><title>Etiology-aortic-stenosis</title><link>https://www.physician.tw/Etiology-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-aortic-stenosis/</guid><description>Etiology-aortic-stenosis Calcific: predominant cause in Pts &amp;gt;70 y; risk factors: HTN, â†‘ LDL-C, â†‘ Lp(a), ESRD Congenital (ie, bicuspid AoV w/ premature calcification): cause in 50% of Pts &amp;lt;70 y Rheumatic heart disease (AS usually accompanied by AR and MV disease) AS mimickers: subvalvular (HCMP, subaortic membrane) or supravalvular stenosis</description></item><item><title>Etiology-constrictive pericarditis</title><link>https://www.physician.tw/Etiology-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-constrictive-pericarditis/</guid><description>Etiology-constrictive pericarditis (Circ 2011;124:1270)
Any cause of pericarditis (~1â€“2% incidence overall after acute pericarditis) Highest risk w/ TB, bacterial, neoplastic, XRT, connective tissue, postcardiac surgery Viral/idiopathic, b/c most common cause of pericarditis, also account for signif proportion</description></item><item><title>Etiology-epidural abscess</title><link>https://www.physician.tw/Etiology-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-epidural-abscess/</guid><description>Etiology-epidural abscess Hematogenous spread (â…”): skin infection, soft tissue (dental abscess), or endocarditis Direct extension (â…“): vertebral osteo, sacral ulcer, spinal anesthesia or surgery, LP Risk factors: IVDU diabetes, renal failure, alcoholism, immunosuppression S.</description></item><item><title>Etiology-mitral-regurgitation</title><link>https://www.physician.tw/Etiology-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-mitral-regurgitation/</guid><description>Etiology-mitral-regurgitation Valve disease (43%): rheumatic (usually mixed AS/AR + MV disease); bicuspid AoV (natural hx: â…“â†’ normal, â…“â†’ AS, â…™â†’ AR, â…™â†’ endocarditis â†’ AR); infective endocarditis; valvulitis (RA, SLE, certain anorectics &amp;amp; serotonergics, XRT) Root disease (57%): HTN, aortic aneurysm/dissection, annuloaortic ectasia (ie, Marfan), aortic inflammation (GCA, Takayasuâ€™s, ankylosing spond.</description></item><item><title>Etiology-mitral-stenosis</title><link>https://www.physician.tw/Etiology-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-mitral-stenosis/</guid><description>Etiology-mitral-stenosis Rheumatic heart disease (RHD): fusion of commissures â†’ â€œfish-mouthâ€ valve from autoimmune rxn to Î² strep infxn; seen largely in developing world (Circ 2020;142:e337) Mitral annular calcification: encroachment upon leaflets â†’ fxnal MS; espec in ESRD Postsurgical repair or post-TEER w/ reduced mitral valve area (MVA) Congenital, infectious endocarditis w/ large lesion, myxoma near MV, thrombus Valvulitis (eg, SLE, amyloid, carcinoid) or infiltration (eg, mucopolysaccharidoses)</description></item><item><title>Etiology-osteomyelitis</title><link>https://www.physician.tw/Etiology-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-osteomyelitis/</guid><description>Etiology-osteomyelitis (Lancet 2004;364:369)
Hematogenous: S. aureus; mycobacterial infection of vertebral body = Pottâ€™s disease Contiguous focus (may be acute or chronic) Open fracture, orthopedic surgery, etc.</description></item><item><title>Etiology-pericardial tamponade</title><link>https://www.physician.tw/Etiology-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Etiology-pericardial-tamponade/</guid><description>Etiology-pericardial tamponade Any cause of pericarditis but espec malignancy, infectious, uremia, ascending AoD, myocardial rupture, periprocedural complication, trauma, post-cardiotomy Rapidly accumulating effusions most likely to cause tamponade b/c no time for pericardium to stretch (eg, to â†‘ compliance) and accommodate â†‘ intrapericardial fluid volume</description></item><item><title>Euvolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Euvolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Euvolemic-hypotonic-hyponatremia/</guid><description>Euvolemic-hypotonic-hyponatremia (ie, â†‘ TBW relative to total body Na)
[[SIADH]]
Endocrinopathies: â†‘ ADH activity seen in glucocorticoid deficiency (co-secretion of ADH &amp;amp; CRH) and severe hypothyroidism/myxedema coma (â†“ CO/SVR â†’ ADH release &amp;amp; â†“ GFR)</description></item><item><title>Evaluation acute diarrhea</title><link>https://www.physician.tw/Evaluation-acute-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-acute-diarrhea/</guid><description>Evaluation acute diarrhea (NEJM 2014;370:1532; Digestion 2017;95:293; PLOS One 2017;12:11)
Ddx: hyperthyroid, adrenal insufficiency, meds (abx, antacids, immune checkpt inhibitors), appendicitis, diverticulitis, radiation, 1st presentation of bowel disorder (eg, IBD, celiac)</description></item><item><title>Evaluation for the potential causes of heart failure</title><link>https://www.physician.tw/Evaluation-for-the-potential-causes-of-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-for-the-potential-causes-of-heart-failure/</guid><description>Evaluation for the potential causes of heart failure ECG: evidence for CAD, LVH, LAE, heart block or low voltage (?</description></item><item><title>Evaluation for the presence of heart failure</title><link>https://www.physician.tw/Evaluation-for-the-presence-of-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-for-the-presence-of-heart-failure/</guid><description>Evaluation for the presence of heart failure CXR (see Radiology insert): pulm edema, pleural effusions Â± cardiomegaly, cephalization, Kerley B-lines; lung U/S better than CXR (PPV &amp;amp; NPV 92% vs.</description></item><item><title>Evaluation in patients without diabetes- but have hypoglycemia</title><link>https://www.physician.tw/Evaluation-in-patients-without-diabetes-but-have-hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-in-patients-without-diabetes-but-have-hypoglycemia/</guid><description>Evaluation in patients without diabetes- but have hypoglycemia (JCEM 2009;94:709)
If clinically ill: take measures to avoid recurrent hypoglycemia; âœ“ BUN, Cr, LFTs, TFTs, prealbumin; IGF-I/IGF-II ratio when appropriate If otherwise healthy: 72-h fast w/ monitored blood glc; stop for neuroglycopenic sx At time of hypoglycemia: insulin, C peptide (â†‘ w/ insulinoma and sulfonylureas, â†“ w/ exogenous insulin), Î²-OH-butyrate, sulfonylurea levels At end of fast, give 1 mg glucagon IV and measure response of plasma glc before feeding</description></item><item><title>Evaluation of Suspected HIT</title><link>https://www.physician.tw/Evaluation-of-Suspected-HIT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-Suspected-HIT/</guid><description>Evaluation of Suspected HIT [[Diagnosis of heparin-induced thrombocytopenia]]
(4Tâ€™s)
Thrombocytopenia â†“ &amp;gt;50% and nadir â‰¥20k</description></item><item><title>Evaluation of vasculitis</title><link>https://www.physician.tw/Evaluation-of-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-of-vasculitis/</guid><description>Evaluation of vasculitis complete blood count (CBC) (with differential) inflammatory markers (erythrocyte sedimentation rate [ESR] and C-reactive protein [CRP]) blood urea nitrogen (BUN)/creatinine levels chest x-ray liver function panel urinalysis antineutrophil cytoplasmic antibody (ANCA) electrolytes [[Principles of Imaging in Vasculitides]]</description></item><item><title>Evaluation-ascites</title><link>https://www.physician.tw/Evaluation-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-ascites/</guid><description>Evaluation-ascites (World J Hepatol 2013;5:251; JAMA 2016;316:340)
Figure: Physical exam: flank dullness (&amp;gt;1500 mL needed), shifting dullness (Se ~83%)</description></item><item><title>Evaluation-asthma-EXACERBATION</title><link>https://www.physician.tw/Evaluation-asthma-EXACERBATION/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-asthma-EXACERBATION/</guid><description>Evaluation-asthma-EXACERBATION History: baseline PEF, steroid requirement, ED visits, hospital admissions, prior intubation Current exacerbation: duration, severity, potential precipitants, meds used</description></item><item><title>Evaluation-dyspnea</title><link>https://www.physician.tw/Evaluation-dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evaluation-dyspnea/</guid><description>Evaluation-dyspnea [[books/sxtodx/dyspnea]]
History: quality of sensation, tempo, positional dependence, exac./allev. factors, exertion
é™¤äº†åŠ‡çƒˆé‹å‹•å¤–ï¼Œä¸æœƒå› å‘¼å¸å›°é›£è€Œç…©æƒ±ã€‚ åœ¨å¹³å¦çš„åœ°é¢ä¸Šè¡Œèµ°æˆ–åœ¨å°å±±å¡ä¸Šè¡Œèµ°æ™‚å‘¼å¸çŸ­ä¿ƒã€‚ ç”±æ–¼å‘¼å¸å›°é›£ï¼Œåœ¨å¹³åœ°ä¸Šèµ°å¾—æ¯”åŒé½¡äººæ…¢ï¼Œæˆ–åœ¨å¹³åœ°ä¸Šä»¥è‡ªå·±çš„æ­¥èª¿è¡Œèµ°æ™‚ä¸å¾—ä¸åœä¸‹ä¾†ä¼‘æ¯ã€‚ æ­¥è¡Œ 100 m æˆ–å¹³åœ°æ­¥è¡Œå¹¾åˆ†é˜å¾Œåœæ­¢ä¼‘æ¯ã€‚ æ°£å–˜ååé›¢é–‹å®¶ï¼Œæˆ–æ—¥å¸¸ç”Ÿæ´»æ´»å‹•æ°£å–˜åç±² ï¼ˆä¾‹å¦‚ï¼Œç©¿è¡£/è„«è¡£ï¼‰ Cardiopulmonary exam, SaO2, CXR, ECG, ABG, U/S Predictors of CHF: h/o CHF, PND, S3, CXR w/ venous congestion, AF (JAMA 2005;294:1944) Dyspnea w/ nl CXR: CAD, asthma, PE, PHT, early ILD, anemia, acidosis, NM disease Based on results of initial evaluation: PFT, chest CT, TTE, cardiopulmonary testing BNP &amp;amp; NT-proBNP â†‘ in CHF (also â†‘ in AF, RV strain from PE, COPD flare, PHT, ARDS) &amp;lt;100 pg/mL to r/o CHF (90% Se), 400 to r/i (NEJM 2002;347:161) NT-proBNP</description></item><item><title>Evolution of Necrotizing Fasciitis or Myonecrosis</title><link>https://www.physician.tw/Evolution-of-Necrotizing-Fasciitis-or-Myonecrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Evolution-of-Necrotizing-Fasciitis-or-Myonecrosis/</guid><description>Evolution of Necrotizing Fasciitis or Myonecrosis</description></item><item><title>Excruciatingly Useful Shortcuts</title><link>https://www.physician.tw/Excruciatingly-Useful-Shortcuts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Excruciatingly-Useful-Shortcuts/</guid><description>In the order of most to least useful:
âŒ˜ L Place insertion point in search/title area Escape Clear current search Return Begin editing note, creating it if necessary Tab Move insertion point between text areas âŒ˜ K Select previous note in list âŒ˜ J Select next note in list âŒ˜ D De-select current note, restoring the search text âŒ˜ â‡§ V Paste clipboard as a new note âŒ˜ R Rename the selected note âŒ˜ âŒ« Delete the selected note(s) âŒ˜ â‡§ T Tag the selected note âŒ˜ G Find next occurrence of search text âŒ˜ â‡§ G Find previous occurrence of search text âŒ˜ â†© Open any URL under the insertion point âŒ˜ â† Move to title-editing when at start of the note-body âŒ˜ â†’ Move to the note-body when at the end of a title âŒ˜ â‡§ D Bookmark the selected note âŒ˜ P Print the selected note(s) âŒ˜ E Export the selected note(s) to other formats</description></item><item><title>excursion</title><link>https://www.physician.tw/excursion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/excursion/</guid><description>excursion Wandering from the usual course. The extent of movement of a part such as the extremities or eyes. In diabetes, an increase in blood glucose levels above normal or typical values, esp.</description></item><item><title>Exercise-tolerance-test</title><link>https://www.physician.tw/Exercise-tolerance-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exercise-tolerance-test/</guid><description>Exercise-tolerance-test Generally preferred if Pt can meaningfully exercise; ECG âˆ†s w/ Se ~65%, Sp ~80%
Typically via treadmill w/ Bruce protocol (modified Bruce or submax if decond.</description></item><item><title>Exposure-interstitial lung disease</title><link>https://www.physician.tw/Exposure-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exposure-interstitial-lung-disease/</guid><description>Exposure-interstitial lung disease Drugs/Iatrogenic Amiodarone: interstitial pneumonitis â†” org. PNA â†” ARDS; Rx: d/c amio; steroids
Other drugs: nitrofurantoin, sulfonamides, inh, hydralazine</description></item><item><title>Extended DOAC strategies-venous thromboembolism</title><link>https://www.physician.tw/Extended-DOAC-strategies-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extended-DOAC-strategies-venous-thromboembolism/</guid><description>Extended DOAC strategies-venous thromboembolism After â‰¥6 mo of anticoag, following regimens compared w/ no extended Rx (or ASA): Full-dose DOAC: * 80â€“90% â†“ recurrent VTE, 2â€“5Ã— bleeding, * but no signif excess in major bleeding * (NEJM 2010;363:2499; 2013;368:699 &amp;amp; 709) Â½ dose apixa or riva: * â‰¥75% â†“ recur.</description></item><item><title>Extrapulmonary TB</title><link>https://www.physician.tw/Extrapulmonary-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extrapulmonary-TB/</guid><description>Extrapulmonary TB Pleural/pericardial effusions or ascites: fluid sampling for AFB cx/smear, NAAT/ PCR, cell counts. Adenosine deaminase (ADA) can be â†‘, best validated in ascites.</description></item><item><title>Extrarenal H2O loss Uosm >700â€“800</title><link>https://www.physician.tw/Extrarenal-H2O-loss-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Extrarenal-H2O-loss-Uosm-700800/</guid><description>Extrarenal H2O loss (Uosm &amp;gt;700â€“800) GI H2O loss: vomiting, NGT drainage, osmotic diarrhea, fistula, lactulose, malabsorption
Insensible loss: fever, exercise, ventilation, burns</description></item><item><title>Exudates</title><link>https://www.physician.tw/Exudates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Exudates/</guid><description>Exudates Lung parenchymal infection (25%) Bacterial (parapneumonic): can evolve along spectrum of exudative (but sterile) â†’ fibropurulent (infected fluid) â†’ organization (fibrosis &amp;amp; formation of rigid pleural peel).</description></item><item><title>Factitious disorder</title><link>https://www.physician.tw/Factitious-disorder/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Factitious-disorder/</guid><description>Factitious disorder æ‰€ä»¥è£ç—…ç—‡å€™ç¾¤è¨ºæ–·çš„ä¸‰å€‹æ¢ä»¶ï¼š
1.æ•…æ„è¡¨ç¾å‡ºä¸€äº›èº«é«”æˆ–å¿ƒç†çš„ç—‡ç‹€
2.å¾ˆå–®ç´”çš„åªæ˜¯è¦ä¼´æ¼”ç—…äººçš„è§’è‰²
3.ä¸èƒ½æœ‰å…¶ä»–çš„é™„å¸¶åƒ¹å€¼æˆ–æ”¶ç²
é‚„æœ‰ä¸€ç¨®è£ç—…æ˜¯å®£ç¨±ä»–æ‰€ç…§é¡§çš„äººç”Ÿç—…ï¼Œè€Œé€™å€‹ç—…äººå¿…é ˆè¦ä»°è³´é€™å€‹å®£ç¨±è€…çš„ç…§é¡§ï¼ˆå¦‚ï¼šæ¯è¦ªèˆ‡å°å­©çš„é—œä¿‚ï¼‰ï¼›å¼•èµ·è£ç—…çš„åŸå› ç›®å‰çš„è§£é‡‹æ˜¯èªªï¼Œåœ¨ç”Ÿé•·éç¨‹ä¸­ä¸€ç›´å—åˆ°å¿½ç•¥æˆ–æ”¾æ£„ï¼Œæ‰€ä»¥å¸Œæœ›è®Šæˆä¸€å€‹ç—…äººï¼Œå¾æ–°ç²å¾—é‡è¦–ã€åƒ¹å€¼åŠå–å¾—ç›¸äº’ä¾è³´çš„æ„Ÿè¦ºã€‚å¦ä¸€ç¨®æ˜¯è—‰ç”±è£ç—…é¨™éé†«ç”Ÿï¼Œå¯ä»¥å¾—åˆ°ä¸€ç¨®å¿«æ„Ÿï¼›å¦‚æœæ˜¯å®£ç¨±è¢«ç…§é¡§çš„äººç”Ÿç—…ï¼Œé‚£é€™è¢«ç…§é¡§è€…æ˜¯è¢«åˆ©ç”¨æˆç‚ºå·¥å…·ä¾†ç²å–ä¸Šåˆ—æ‰€èªªçš„ä¸€äº›çµæœã€‚æœ‰æ™‚åª½åª½å¾å©šå§»ä¸­ç„¡æ³•å¾—åˆ°æƒ³è¦å¾—åˆ°çš„æ»¿è¶³ï¼Œè—‰è‘—å°æœ‹å‹çš„ç”Ÿç—…æœ‰æ©Ÿæœƒç…§é¡§ä»–ï¼Œä¾†æ»¿è¶³è‡ªå·±çš„ä¸æ»¿è¶³ã€‚
è£ç—…çš„äººç—‡ç‹€ç‰¹è³ªæœ‰ï¼šç¶“å¸¸ä¸åœçš„å»çœ‹é†«ç”Ÿã€å°ä¸€äº›é†«å­¸ç—…ååŠæ²»ç™‚æ–¹å¼éƒ½ç­è‹¥æŒ‡æŒï¼Œç”šè‡³å¯ä»¥ä½¿ç”¨ä¸€äº›é†«å­¸åè©ã€ç—‡ç‹€è¡¨ç¾åˆéå¸¸æˆ²åŠ‡åŒ–ï¼Œå¦‚æœé†«ç”Ÿè¦å«ä»–åšæŸäº›æª¢æŸ¥ï¼Œå³ä½¿æœ‰ä¸€äº›å±éšªæ€§ï¼Œéƒ½æœƒæ¯«ä¸è€ƒæ…®ç­”æ‡‰ï¼Œç”šè‡³æ¨‚æ–¼æ¥å—ï¼Œæœ‰æ™‚é€£é–‹åˆ€ä¹Ÿä¸€æ¨£ã€‚å¦‚æœå¯ä»¥å·å·è§€å¯Ÿï¼Œå°±æœƒç™¼ç¾ä¸ç®¡æ˜¯è‡ªå·±çš„ç—‡ç‹€æˆ–æ˜¯ç…§é¡§ä»–äººçš„è£ç—…ï¼Œéƒ½æœƒå¿…é ˆåœ¨æœ‰äººçš„æ™‚å€™æ‰æœƒç™¼ç”Ÿï¼Œå› ç‚ºç‚ºäº†è£ç—…ï¼Œæœ‰æ™‚æœƒé™„å¸¶å…¶ä»–çš„äº‹éœ€è¦éš±çï¼Œä½†å¾€å¾€éƒ½æ˜¯ç”±é€™äº›é–‹å§‹è¢«äººæ³¨æ„çš„ï¼ˆä¾‹å¦‚ï¼šè¬Šç¨±è‡ªå·±æ˜¯æŸå…¬å¸çš„ä¸»ç®¡ï¼Œç‚ºäº†ç”Ÿç—…è€Œä¸Ÿäº†å·¥ä½œï¼Œä½†å¾æ²’çœ‹éä»–çš„åŒäº‹ä¾†çœ‹ä»–ã€‚)
ã€æ²»ç™‚ã€‘
1.ä¸»è¦æ˜¯ä»¥å¿ƒç†æ²»ç™‚ç‚ºä¸»ï¼Œä¹Ÿç­è§£ç—…äººçš„èƒŒæ™¯ä»¥åŠç”Ÿæ´»ä¸Šçš„éœ€è¦ï¼Œèˆ‡ç—…äººç«‹è‰¯å¥½çš„é—œä¿‚ 2.æŸäº›æŠ—æ†‚é¬±çš„è—¥ç‰©ä¹Ÿå¯ä»¥å¹«ä¸Šä¸€äº›å¿™
3.å°æ–¼ä»–è£ç—…çš„äº‹å¯¦è¦ç”¨å’Œç·©çš„æ…‹åº¦å»æ…¢æ…¢ç ´è§£ï¼Œæ‰ä¸æœƒæœ‰åæ•ˆæœ
4.é€šå¸¸ç—…äººéƒ½é‚„å …æŒè‡ªå·±ä¸æ˜¯è£ç—…ï¼Œé›–ç„¶é€±é­çš„äººéƒ½ä¸å¤ªç›¸ä¿¡å³ä½¿äº‹å¯¦å·²ç¶“å¾ˆæ˜é¡¯</description></item><item><title>factitious fever</title><link>https://www.physician.tw/factitious-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/factitious-fever/</guid><description>factitious fever âœ¨é‡é»: ä¸€ç¨®è‡ªæˆ‘èª˜ç™¼çš„äººå·¥ç™¼ç†±ï¼ˆä¾†è‡ªæ‹‰ä¸èªfactitiusï¼Œç”±è—è¡“è£½é€ ï¼‰ã€‚ é€™å¯èƒ½ä»¥å¤šç¨®æ–¹å¼ç™¼ç”Ÿï¼Œæœ€å¸¸è¦‹çš„æ˜¯åœ¨æº«åº¦æª¢æŸ¥ä¹‹å‰æ”å…¥ï¼ˆå’Œå˜´å·´å«ä½ï¼‰ç†±æ¶²é«”ã€‚ äººç‚ºçš„ç™¼ç‡’é€šå¸¸ï¼ˆä½†ä¸ç¸½æ˜¯ï¼‰å¯ä»¥é€šéæ¸¬é‡ç›´è…¸æº«åº¦ï¼ˆç”šè‡³å¯ä»¥ä½œç‚ºæ‡²ç½°æ€§å¨æ‡¾ï¼‰æˆ–æ’å°¿æ™‚çš„å°¿æº«ä¾†æŠµæ¶ˆã€‚ å¦‚æœé€™æ¨£åšï¼Œè«‹è¨˜ä½å°¿æº«ç•¥ä½æ–¼å£è…”æº«åº¦ã€‚</description></item><item><title>Familial Mediterranean fever</title><link>https://www.physician.tw/Familial-Mediterranean-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Familial-Mediterranean-fever/</guid><description>Familial Mediterranean fever (peritonitis, episodic fever, pleuritis; â†‘ WBC &amp;amp; ESR during attacks);</description></item><item><title>Family history of migraine</title><link>https://www.physician.tw/Family-history-of-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Family-history-of-migraine/</guid><description>Family history of migraine Migraine has a strong genetic component and its prevalence is higher among people with directly affected first-degree relatives than among the general population18,19.</description></item><item><title>Fanconiâ€™s syndrome</title><link>https://www.physician.tw/Fanconis-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fanconis-syndrome/</guid><description>Fanconiâ€™s syndrome Proximal convoluted tubule å¤šå°¿ã€å¤šé£²åŠè„«æ°´ã€‚</description></item><item><title>Febrile nonhemolytic</title><link>https://www.physician.tw/Febrile-nonhemolytic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Febrile-nonhemolytic/</guid><description>Febrile nonhemolytic : fever, rigors 0â€“6 h post transfusion. Due to Abs vs. donor WBCs and cytokines in blood product. Rx: acetaminophen Â± meperidine; r/o infection, hemolysis.</description></item><item><title>fever and neutropenia</title><link>https://www.physician.tw/fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-and-neutropenia/</guid><description>fever and neutropenia [[fever in oncology - duty note]]
[[Definition of fever and neutropenia]] [[Pathophysiology and microbiology of fever and neutropenia]] [[Prevention of fever and neutropenia]] (only if intermediate or high-risk) [[Role of hematopoietic growth factors]] [[Diagnostic evaluation of fever and neutropenia]] [[Risk stratification of fever and neutropenia]] (factors that predict lower risk) [[Initial antibiotic therapy of fever and neutropenia]] [[Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia]] [[Duration of therapy of fever and neutropenia]]</description></item><item><title>fever and rash</title><link>https://www.physician.tw/fever-and-rash/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-and-rash/</guid><description>fever and rash Approach to diagnostic workup
Meningococcemia, endocarditis, RMSF, sepsis, &amp;amp; toxic shock need urgent dx &amp;amp; Rx Workup: CBC w/diff, BMP, LFTs, LDH, CK, U/A, HIV Ag/Ab Â± PCR, BCx off abx) To narrow Ddx: characterize time course of rash, progression, &amp;amp; morphology [[Erythema multiforme]] [[Erythema nodosum]] [[Variable and Possible Etiology-fever and rash]] Treatment</description></item><item><title>fever in a returned traveler</title><link>https://www.physician.tw/fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-in-a-returned-traveler/</guid><description>fever in a returned traveler See CDC.gov/travel for up to date information on regional risks and recommendations [[Region or Exposure Common Etiologies -fever in a returned traveler]]</description></item><item><title>fever in oncology - duty note</title><link>https://www.physician.tw/fever-in-oncology-duty-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-in-oncology-duty-note/</guid><description>fever in oncology - duty note ECOG 0â€“1, age &amp;lt;60 y, solid tumor, no sx, no major comorbidities, no h/o fungal infection, [[MASCC Risk Index]] â‰¥21 (Support Care Cancer 2013;21:1487)</description></item><item><title>fever of unknown origin</title><link>https://www.physician.tw/fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-of-unknown-origin/</guid><description>fever of unknown origin Definition &amp;amp; etiologies (NEJM 2022;386:463) Fever (as per above def) on &amp;gt;1 occasion during â‰¥3 wk &amp;amp; no dx despite 1 wk of evaluation More likely to be unusual manifestation of common disease than an uncommon disease In Pts with HIV: &amp;gt;75% causes are infectious, but rarely due to HIV itself Frequent reassessment needed to identify focal signs and progression of disease [[Etiologies of Classic FUO]] [[Workup-fever of unknown origin]] (Archives 2009;169:2018; AJM 2015;128:1138) [[Treatment-fever of unknown origin]]</description></item><item><title>fever syndromes</title><link>https://www.physician.tw/fever-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fever-syndromes/</guid><description>fever syndromes Temperature â‰¥100.4Â°F or â‰¥38Â°C [[What are the most commonly encountered fever patterns]] [[physical findings may help identify the cause of a fever]]</description></item><item><title>Fever workup in patient with HIV AIDS</title><link>https://www.physician.tw/Fever-workup-in-patient-with-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fever-workup-in-patient-with-HIV-AIDS/</guid><description>Fever workup in patient with HIV AIDS Etiologies (Infect Dis Clin North Am 2007;21:1013) infxn (82â€“90%): MAC, TB, CMV, early PCP, Histo, Crypto, Coccidio, Toxo, endocarditis noninfectious: lymphoma, drug reaction.</description></item><item><title>Fibrinolysis vs Hospital Transfer for Primary PCI</title><link>https://www.physician.tw/Fibrinolysis-vs-Hospital-Transfer-for-Primary-PCI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fibrinolysis-vs-Hospital-Transfer-for-Primary-PCI/</guid><description>1.Time required for transport to skilled PCI lab: door-to-balloon &amp;lt;120 min &amp;amp; [door-to-balloon]â€“[door-to-needle] &amp;lt;1 h favors transfer for PCI
2.Risk from STEMI: high-risk Pts (eg, shock) fare better with mechanical reperfusion</description></item><item><title>Fibromuscular dysplasia</title><link>https://www.physician.tw/Fibromuscular-dysplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fibromuscular-dysplasia/</guid><description>Fibromuscular dysplasia çº–ç¶­è‚Œç™¼è‚²ä¸è‰¯ï¼ˆFMDï¼‰æ˜¯è…å‹•è„ˆç‹¹çª„çš„é‡è¦åŸå› ï¼Œå°¤å…¶æ˜¯åœ¨å¹´è¼•å¥³æ€§ä¸­ã€‚ æ“šå ±å°ï¼ŒFMDå’ŒAlpha 1-æŠ—æŠ—è›‹ç™½é…¶ï¼ˆAlpha 1-ATï¼‰ç¼ºä¹ç—‡ä¹‹é–“å­˜åœ¨ç½•è¦‹çš„é—œè¯ã€‚</description></item><item><title>First-line or upfront therapy for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/First-line-or-upfront-therapy-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/First-line-or-upfront-therapy-for-idiopathic-thrombocytopenic-purpura/</guid><description>First-line or upfront therapy for idiopathic thrombocytopenic purpura Steroids: prednisone 0.5â€“2 mg/kg/d PO tapered ~4 wk, or dexamethasone 40 mg PO Ã— 4 d</description></item><item><title>Flecainide</title><link>https://www.physician.tw/Flecainide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Flecainide/</guid><description>Flecainide 300 mg PO x1 100-150 mg bid PreRx w/ AVN blocker. avoid if: structural/ischemic heart dis.
%
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Fluid Resuscitation</title><link>https://www.physician.tw/Fluid-Resuscitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluid-Resuscitation/</guid><description>Fluid Resuscitation [[sensible and insensible fluid losses]] [[classes of hemorrhagic shock]] [[empiric replacement fluids can be used for fluid losses]]</description></item><item><title>Fluids-sepsis and shock</title><link>https://www.physician.tw/Fluids-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fluids-sepsis-and-shock/</guid><description>Fluids-sepsis and shock [[The Composition of Saline, Lactated Ringerâ€™s Solution, and Plasma-Lyte 148]]
Aggressive IV fluid resuscitation (30 mL/kg) admin in boluses w/in 3 h of presentation [[Crystalloid]] as good as colloid for resuscitation (JAMA 2013;310:1809; NEJM 2014;370:1412) No consistently seen benefit of balanced crystalloid (LR, Plasma-Lyte) vs.</description></item><item><title>Focal segmental glomerulosclerosis</title><link>https://www.physician.tw/Focal-segmental-glomerulosclerosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Focal-segmental-glomerulosclerosis/</guid><description>Focal segmental glomerulosclerosis (40%; CJASN 2017;12:502).
Primary: permeability factor.
Secondary adaptive (hyperfiltration, sickle cell, obesity, anabolic steroids, OSA, â†‘ protein, vesico-ureteral reflux); meds/toxins (IFN, bisphosphonates, NSAIDs, heroin), viral (COVID-19, HIV) or genetic (ApoL1 mutation in AA; JASN 2015;26:1443).</description></item><item><title>Focused history of chest pain</title><link>https://www.physician.tw/Focused-history-of-chest-pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Focused-history-of-chest-pain/</guid><description>Focused history of chest pain quality, severity, location, radiation; provoking/palliating factors; intensity at onset; duration, freq, &amp;amp; pattern; setting; assoc sx; cardiac hx &amp;amp; risk factors</description></item><item><title>Folate deficiency</title><link>https://www.physician.tw/Folate-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Folate-deficiency/</guid><description>Folate deficiency Folate present in leafy green vegetables and fruit; total body stores sufficient for 2â€“3 mo
Etiologies: malnutrition (alcoholics, anorectics, elderly), â†“ absorption (sprue), impaired metabolism (methotrexate, pyrimethamine, trimethoprim; NEJM 2015;373:1649), â†‘ requirement (chronic hemolytic anemia, pregnancy, malignancy, dialysis)</description></item><item><title>Follicular thyroid cancer</title><link>https://www.physician.tw/Follicular-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follicular-thyroid-cancer/</guid><description>Follicular thyroid cancer Peak incidence 40 to 60 y, â™€:â™‚ 3:1; RFs: childhood radiation; FHx; familial syndrome Mortality 10â€“20% at 20 y; mets frequently distal due to hematogenous spread Hurthle cell carcinoma: pathologic dx; variant a/w poorer prognosis and â†‘ recurrence rate</description></item><item><title>Follow-up, treatment response and failure of Migraine</title><link>https://www.physician.tw/Follow-up-treatment-response-and-failure-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follow-up-treatment-response-and-failure-of-Migraine/</guid><description>Follow-up, treatment response and failure of Migraine Use headache calendars Assess effectiveness and adverse events When outcomes are suboptimal, review diagnosis, treatment strategy, dosing and adherence When treatment fails, re-evaluate before changing Referral to specialist care should be reserved for patients whose condition is diagnostically challenging, difficult to treat or complicated by comorbidities</description></item><item><title>Follow-up-aortic aneurysms</title><link>https://www.physician.tw/Follow-up-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Follow-up-aortic-aneurysms/</guid><description>Follow-up-aortic aneurysms (Circ 2010;121:e266; Nat Rev Cardiol 2011;8:92; JAMA 2013;309:806)
Expansion rate ~0.1 cm/y for TAA, ~0.3â€“0.4 cm/y for AAA TAA: 6 mo after dx to ensure stable, and if stable, then annually (Circ 2005;111:816) AAA: &amp;lt;4 cm q2â€“3y; 4â€“5.</description></item><item><title>Fourth Universal Definition of Myocardial Infarction 2018</title><link>https://www.physician.tw/Fourth-Universal-Definition-of-Myocardial-Infarction-2018/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fourth-Universal-Definition-of-Myocardial-Infarction-2018/</guid><description>Fourth Universal Definition of Myocardial Infarction (2018) myocardial cell death due to prolonged ischemia Increases in cTnI values have not been reported to occur following injury to noncardiac tissues.</description></item><item><title>Fresh frozen plasma</title><link>https://www.physician.tw/Fresh-frozen-plasma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fresh-frozen-plasma/</guid><description>Fresh frozen plasma Contains all coagulation factors. For bleeding due to defic. of multiple coag factors (eg, DIC, TTP/HUS, liver disease, dilution).</description></item><item><title>Fresh H2O soft tissue infections</title><link>https://www.physician.tw/Fresh-H2O-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fresh-H2O-soft-tissue-infections/</guid><description>Fresh H2O soft tissue infections Aeromonas Myonecrosis/rhabdo can occur. FQ, TMP-SMX, or CTX</description></item><item><title>fromNonspecific Low Back Pain-metadata</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM-1/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-Annotations-8122022-123726-AM-1/</guid><description>fromNonspecific Low Back Pain-metadata</description></item><item><title>Functional GI disease</title><link>https://www.physician.tw/Functional-GI-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Functional-GI-disease/</guid><description>Functional GI disease (~30 types per Rome IV criteria; Gastro 2016;150:1257)
Recurrent GI sx caused by disorders of gut-brain interaction rather than structural cause</description></item><item><title>Functional IBS</title><link>https://www.physician.tw/Functional-IBS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Functional-IBS/</guid><description>Functional IBS (normal osmotic gap, â†“ diarrhea with fasting): see [[dysmotility and nutrition]]</description></item><item><title>Fungal diagnostics</title><link>https://www.physician.tw/Fungal-diagnostics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Fungal-diagnostics/</guid><description>Fungal diagnostics Antigen detection 1,3-Î²-D glucan (Se 75%, Sp 85%): å¯ä»¥åœ¨å“ªäº›fungusçœ‹å¾—åˆ°ï¼Ÿ Candida, Aspergillus, Histo, Coccidio, PCP, for invasive infxn in immunocomp host.</description></item><item><title>fungal infections</title><link>https://www.physician.tw/fungal-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/fungal-infections/</guid><description>fungal infections [[Fungal diagnostics]] [[Candida species]] [[Aspergillosis]] (Lancet 2021;397:499) [[Zygomycetes]] (eg, Mucor, Rhizopus) ENDEMIC FUNGI [[Cryptococcus]] (CID 2010;50:291) [[Histoplasmosis]] [[Coccidioidomycosis]] (CID 2016;63:112) [[Blastomycosis]]</description></item><item><title>Further coagulation tests</title><link>https://www.physician.tw/Further-coagulation-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Further-coagulation-tests/</guid><description>Further coagulation tests (JAMA 2016;316:2146)
Mixing study: useful if â†‘ PT or PTT; mix Ptâ€™s plasma 1:1 w/ normal plasma and retest PT/PTT normalizes â†’ factor deficiency; PT/PTT remains elevated â†’ factor inhibitor</description></item><item><title>Gardening</title><link>https://www.physician.tw/Gardening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gardening/</guid><description>Gardening Sporothrix Ulcerating nodules, lymphatic spread Itraconazole</description></item><item><title>gastroenterology</title><link>https://www.physician.tw/gastroenterology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/gastroenterology/</guid><description>èƒƒç—›è…¹ç—›ï¼Œæ¶ˆåŒ–ä¸è‰¯ï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚ é£Ÿç‰©ä¸æ¶ˆï¼Œèƒƒé…¸å€’æµï¼Œ è…¸èƒƒå…§ç—…ï¼Œè‹¦é›£å¤šã€‚
gastroenterology [[esophageal and gastric disorders]]
[[gastrointestinal bleeding]]
[[diarrhea]]</description></item><item><title>Gastroesophageal varices and UGIB-cirrhosis</title><link>https://www.physician.tw/Gastroesophageal-varices-and-UGIB-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroesophageal-varices-and-UGIB-cirrhosis/</guid><description>Gastroesophageal varices and UGIB-cirrhosis See: [[gastrointestinal bleeding]]
Presence of varices correlates w/ severity of liver dis (40% of Child A Pts â†’ 85% Child C)</description></item><item><title>Gastroparesis</title><link>https://www.physician.tw/Gastroparesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Gastroparesis/</guid><description>Gastroparesis (Nat Rev Dis Primers 2018;4:41)
Delayed gastric emptying w/o mechanical obstruction, typically p/w nausea (&amp;gt;90%), vomiting (&amp;gt;80%), early satiety (60%), postprandial fullness/pain</description></item><item><title>general approach to treatment of breast cancer</title><link>https://www.physician.tw/general-approach-to-treatment-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-approach-to-treatment-of-breast-cancer/</guid><description>general approach to treatment of breast cancer (JAMA 2019;321:288 &amp;amp; 1716)
DCIS Mastectomy or lumpectomy Â± RT Â± chemoprevention (Lancet 2016;387:849 &amp;amp; 866)</description></item><item><title>General considerations-diuresis</title><link>https://www.physician.tw/General-considerations-diuresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-considerations-diuresis/</guid><description>General considerations-diuresis â†‘ Na &amp;amp; H2O excretion for treatment of HTN or edema in CHF, renal failure, and cirrhosis</description></item><item><title>General evaluation or chronic diarrhea</title><link>https://www.physician.tw/General-evaluation-or-chronic-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-evaluation-or-chronic-diarrhea/</guid><description>General evaluation or chronic diarrhea (JAMA 2016;315:2712; Gastro 2019;157:3)
Clinically can be classified as watery, fatty, inflammatory
Additional hx: timing (freq, relation to meals; nocturnal diarrhea a/w organic causes like IBD rather than IBS), abd pain, wt loss, prior surg, chemo/XRT, diet (incl caffeine or poorly absorbed carbs/sugars), infectious sxs, immunocompromise, travel, laxative use, stress</description></item><item><title>general oncology</title><link>https://www.physician.tw/general-oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/general-oncology/</guid><description>general oncology [[cancer epidemiology]] [[cancer prevention and screening]]</description></item><item><title>General treatment-acute kidney injury AKI</title><link>https://www.physician.tw/General-treatment-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-treatment-acute-kidney-injury-AKI/</guid><description>General treatment-acute kidney injury (AKI) (CJASN 2008;3:962)
Prerenal: isotonic IVF â‰ˆ alb (NEJM 2004;350:22). No clear benefit of balanced crystalloids (eg, LR) over normal saline (NEJM 2018;378:829 &amp;amp; 2022;386:815).</description></item><item><title>General-renal replacement and dialysis</title><link>https://www.physician.tw/General-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/General-renal-replacement-and-dialysis/</guid><description>General-renal replacement and dialysis Acute indications: see â€œAKIâ€; choices CVVH vs. HD
Chronic indications: timing of RRT initiation should factor in Pt QoL, uremic sx, risk of development of urgent/acute indications; modalities PD vs.</description></item><item><title>Genetics of Diagnostic and staging evaluation of lung cancer</title><link>https://www.physician.tw/Genetics-of-Diagnostic-and-staging-evaluation-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genetics-of-Diagnostic-and-staging-evaluation-of-lung-cancer/</guid><description>Genetics of Diagnostic and staging evaluation of lung cancer (usually just in adv/metastatic disease):
EGFR (include in stage IIA-IIIB), ALK, ROS1, MET, KRAS, RET, BRAF, NTRK fusion for all non-squamous disease (incidence lower in SCC but still consider testing); PD-L1 expression</description></item><item><title>Genital Discharge</title><link>https://www.physician.tw/Genital-Discharge/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genital-Discharge/</guid><description>Genital Discharge Gonorrhea (N. gonorrhoeae) &amp;amp; Chlamydia (C. trachomatis) â™€: Mucopurulent cervicitis, dysuria, PID; can be asx â™‚: Urethritis, infxn of epididymis/prostate All: pharyngitis</description></item><item><title>Genital Lesions</title><link>https://www.physician.tw/Genital-Lesions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Genital-Lesions/</guid><description>Genital Lesions Painless Syphilis (T. pallidum) 1Â°: chancre = firm, indurated, clean base 2Â°: fever, LAN, rash palms/soles, uveitis, condylomata lata 3Â°: aortitis/aneurysm, gumma, CN palsies (7/8), tabes dorsalis, aseptic meningitis Latent = asx; early latent &amp;lt;1yr; late &amp;gt;1yr/unknown</description></item><item><title>genitourinary malignancies</title><link>https://www.physician.tw/genitourinary-malignancies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/genitourinary-malignancies/</guid><description>genitourinary malignancies [[prostate cancer]] [[renal-cell-carcinoma]] [[urothelial carcinoma]]</description></item><item><title>geriatrics</title><link>https://www.physician.tw/geriatrics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/geriatrics/</guid><description>geriatrics The topics covered are organized as follows:
falls frailty dementia delirium medication management geriatric assessment
other important topics related to geriatrics are covered in the following rotation guides: palliative care delivering bad news (patient communication) ICU delirium (Critical Care) depression, Anxiety (Mental Health) symptom management in oncology</description></item><item><title>GI potassium losses</title><link>https://www.physician.tw/GI-potassium-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-potassium-losses/</guid><description>GI potassium losses GI losses plus metabolic acidosis: diarrhea, laxative abuse, [[villous adenoma]]
Vomiting &amp;amp; NGT drainage usually manifest as renal losses due to 2Â° hyperaldo &amp;amp; met.</description></item><item><title>GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-and-nonsteroidal-anti-inflam-drug/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-and-nonsteroidal-anti-inflam-drug/</guid><description>GI prophylaxis if taking ASA and nonsteroidal anti-inflam drug (Am J Gastro 2009;104:728)
PPI if h/o PUD/UGIB and either (a) on P2Y12 inhib or anticoag, or (b) â‰¥2 of the following: &amp;gt;60 y, steroids or dyspepsia.</description></item><item><title>GI prophylaxis if taking ASA NSAID peptic ulcer disease</title><link>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/GI-prophylaxis-if-taking-ASA-NSAID-peptic-ulcer-disease-/</guid><description>GI prophylaxis if taking ASA NSAID peptic ulcer disease (Am J Gastro 2009;104:728)
PPI if h/o PUD/UGIB and either (a) on P2Y12 inhib or anticoag, or (b) â‰¥2 of the following: &amp;gt;60 y, steroids or dyspepsia.</description></item><item><title>Giant cell arteritis</title><link>https://www.physician.tw/Giant-cell-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Giant-cell-arteritis/</guid><description>Giant cell arteritis Females &amp;gt; 50 years old. é˜¿å«²
Unilateral headache, possible temporal artery tenderness, jaw claudication.</description></item><item><title>Glasgow-Blatchford</title><link>https://www.physician.tw/Glasgow-Blatchford/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glasgow-Blatchford/</guid><description>Glasgow-Blatchford Glasgow-Blatchford scores range from 0 to 23, with higher scores indicating higher risk. Positive predictive values were calculated in a study by Laursen et al.</description></item><item><title>glomerular disease</title><link>https://www.physician.tw/glomerular-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glomerular-disease/</guid><description>glomerular disease [[glomerulonephritis]] (GN) [[asymptomatic glomerular hematuria]] [[nephrotic syndrome]]</description></item><item><title>Glomerular Diseases</title><link>https://www.physician.tw/Glomerular-Diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-Diseases/</guid><description>Glomerular Diseases Backlinkï¼š [[nephrology]] [[nephrotic syndrome]] [[Primary glomerular diseases (grouped by pathology)]]</description></item><item><title>Glomerular proteinuria</title><link>https://www.physician.tw/Glomerular-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glomerular-proteinuria/</guid><description>Glomerular proteinuria (can be &amp;gt;3.5 g/d) Disruption of filtration barrier â†’ lose albumin
Etiologies
Glomerulonephritis Nephrotic syndrome</description></item><item><title>glomerulonephritis</title><link>https://www.physician.tw/glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glomerulonephritis/</guid><description>glomerulonephritis [[Definition-glomerulonephritis]] [[ANCA positive Vasculitis]] [[Anti-GBM Disease]] [[Immune Complex (IC) Disease (granular staining) ]] [[Oncology-related glomerulopathy]] [[Workup-glomerulonephritis]] [[Approach to glomerulonephritis based on immunofluorescence pattern]] [[Treatment-glomerulonephritis]]</description></item><item><title>Glucose of cerebrospinal fluid</title><link>https://www.physician.tw/Glucose-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glucose-of-cerebrospinal-fluid/</guid><description>Glucose of cerebrospinal fluid æ­£å¸¸ç´„ 50â€“75 mg/dLï¼Œç´„æ˜¯ serum çš„ 0.5â€“0.8 ä¸Šå‡ï¼šé€šå¸¸æ˜¯å› ç‚ºé«˜è¡€ç³– ä¸‹é™ï¼šé€šå¸¸æ˜¯ bacteriaã€TBã€fungusã€æŸäº›è…«ç˜¤ â†“â†“ (&amp;lt;20)ï¼šé€šå¸¸æ˜¯ bacteria â†“ï¼šTBã€fungusã€æŸäº›è…«ç˜¤ Viral meningitisã€encephalitis çš„ glucose å¸¸å¸¸æ˜¯æ­£å¸¸çš„</description></item><item><title>glucose water osmolarity</title><link>https://www.physician.tw/glucose-water-osmolarity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/glucose-water-osmolarity/</guid><description>glucose water osmolarity g/180 * 1000
é€Ÿç®—ï¼š% * 50 = osm/L
e.g. D5W = 5*50 = 250 osm/L</description></item><item><title>Glucose-6-phosphate dehydrogenase</title><link>https://www.physician.tw/Glucose-6-phosphate-dehydrogenase/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Glucose-6-phosphate-dehydrogenase/</guid><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency (Lancet 2008;371:64)
X-linked defect of metabolism (G6PD mutations) w/ â†‘ susceptibility to oxidative damage</description></item><item><title>Grading-of-Mitral-Stenosis</title><link>https://www.physician.tw/Grading-of-Mitral-Stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Grading-of-Mitral-Stenosis/</guid><description>Grading-of-Mitral-Stenosis Grading of Mitral Stenosis Stage Mean V (mmHg) Pressure Â½ Time MVA (cm-) PA sys (mmHg) Normal 0 n/a 4-6 ï¼œ25 Mild-mod &amp;lt;5 100-149 1.</description></item><item><title>Granulocytopenia or neutropenia</title><link>https://www.physician.tw/Granulocytopenia-or-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Granulocytopenia-or-neutropenia/</guid><description>Granulocytopenia or neutropenia (includes DM, ESRD â†’ functional impairment) Bacteria: Gram positive: coag âŠ– staph, S. aureus, viridans strep, S. pneumo, other strep; Corynebacterium spp.</description></item><item><title>Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Granulomatosis-with-polyangiitis/</guid><description>Granulomatosis with polyangiitis GPA, formerly Wegenerâ€™s granulomatosis
Predominant type; can see either type (NEJM 2012;367:214);
Necrotizing granulomatous systemic vasculitis frequently affecting upper respiratory tract (nose, sinuses) in addition to kidneys, lower resp tract (lungs), and other organs</description></item><item><title>Gravesâ€™ disease</title><link>https://www.physician.tw/Graves-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Graves-disease/</guid><description>Gravesâ€™ disease â™€:â™‚ ratio is 5â€“10:1, most Pts between 40 and 60 y at dx âŠ• thyroid antibodies: TSI or TBII (âŠ• in 80%), anti-TPO, antithyroglobulin; ANA Clinical manifestations in addition to those of hyperthyroidism (see above): Goiter: diffuse, nontender, w/ thyroid bruit Ophthalmopathy (NEJM 2010;362:726): seen in 50%; up to 90% if formally tested.</description></item><item><title>Growth hormone deficiency</title><link>https://www.physician.tw/Growth-hormone-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Growth-hormone-deficiency/</guid><description>Growth hormone deficiency â†“ GH
â†‘ chronic risk for osteoporosis, fatigue, decreased lean body mass Dx with failure to â†‘ GH w/ appropriate stimulus (eg, insulin tolerance test, glucagon stimulation, and macimorelin stimulation) GH replacement in adults controversial (Annals 2003;35:419; NEJM 2019;380:2551)</description></item><item><title>HACEK</title><link>https://www.physician.tw/HACEK/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HACEK/</guid><description>HACEK fastidious gram-negative bacilli æŒ‘å‰”çš„ä¸€ç¾¤å—œè¡€å‡èšå¿ƒçš„æ„›å•ƒç‹
Haemophilus species å—œè¡€ Aggregat-ibacter å‡èšæ¡¿ Cardio-bacterium å¿ƒæ¡¿èŒ Eiken-ella æ„›å•ƒ King-ella ç‹ 10% of [[culture negative-bacterial endocarditis]]</description></item><item><title>head injury</title><link>https://www.physician.tw/head-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/head-injury/</guid><description>head injury é«˜é¢¨éšªæ¨™æº–ï¼ˆæ ¹æ“šéœ€è¦ç¥ç¶“å¤–ç§‘å¹²é çš„çµ‚é»å¾—å‡ºï¼‰ï¼š ä»¥ä¸‹ä»»ä½•ä¸€é …ç‚ºé™½æ€§ï¼Œè¡Œ CT æƒæï¼š
æ„è­˜ã€æ·¤é’(çœ¼****)ã€éª¨æŠ˜ã€è€ã€å
2å°æ™‚å…§GCS &amp;lt;15
ç–‘ä¼¼é–‹æ”¾æ€§æˆ–å‡¹é™·æ€§é¡±éª¨éª¨æŠ˜
é¡±åº•éª¨æŠ˜çš„ä»»ä½•è·¡è±¡ï¼ˆé¼“å®¤è¡€ã€æµ£ç†Šçœ¼ã€æˆ°é¬¥å¾µâ€”â€”ä¹³çªç˜€æ–‘ã€è…¦è„Šæ¶² [CSF] è€³æ¼æˆ–é¼»æ¼ã€é¡±ç¥ç¶“ç•°å¸¸ï¼‰(hemotympanum, raccoon eyes, Battle signâ€”mastoid ecchymosis, cerebrospinal fluid [CSF] otorrhea or rhinorrhea, cranial nerve abnormality)</description></item><item><title>headache</title><link>https://www.physician.tw/headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/headache/</guid><description>headache [[Primary headache syndromes]] [[Secondary causes of headaches]] [[Migraine]] [[Clinical evaluation of Secondary causes of headaches]] [[headaches from symptom to diagnosis]] Backlinkï¼š [[Acromegaly]] [[acute bacterial meningitis]] [[ambulatory]] [[Clinical manifestations of Giant cell arteritis]] [[Clinical manifestations-chronic obstructive pulmonary disease]] [[Clinical manifestations-hyperaldosteronism]] [[Clinical manifestations-pheochromocytoma and paraganglioma]] [[CSF leak]] [[Etiologies of Classic FUO]] [[Fever workup in patient with HIV AIDS]] [[hypoglycemia]] [[hypopituitary syndromes]] [[hypothyroidism]] [[neurology]] [[Pain]] [[Pituitary apoplexy]] [[Pituitary tumors]] [[Select clinical manifestations-fever in a returned traveler]] Approaching patients with headache and refractory headache</description></item><item><title>headaches from symptom to diagnosis</title><link>https://www.physician.tw/headaches-from-symptom-to-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/headaches-from-symptom-to-diagnosis/</guid><description>headaches from symptom to diagnosis is the headache new or old ? [[old headache]] [[new headache]]</description></item><item><title>heart failure</title><link>https://www.physician.tw/heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/heart-failure/</guid><description>heart failure [[Definitions heart failure]] (Braunwaldâ€™s Heart Disease, 12th ed., 2022) [[History heart failure]] [[New York Heart Association class]] [[Physical exam heart failure]] [[Evaluation for the presence of heart failure]] [[Evaluation for the potential causes of heart failure]] [[precipitants of acute heart failure]] [[Treatment of acute advanced heart failure]] [[Recommended Chronic Therapy by HF Stage]] [[Treatment of Chronic HF with Reduced EF]] [[Heart failure with preserved EF]]</description></item><item><title>Heart failure with preserved EF</title><link>https://www.physician.tw/Heart-failure-with-preserved-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heart-failure-with-preserved-EF/</guid><description>Heart failure with preserved EF (JACC 2022;epub)
Epidemiology: ~Â½ of Pts w/ HF have normal (EF â‰¥50%); risk factors for HFpEF incl â†‘ age, â™€, DM, AF.</description></item><item><title>hectic fever</title><link>https://www.physician.tw/hectic-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hectic-fever/</guid><description>hectic fever âœ¨é‡é»: ä¾†è‡ªå¸Œè‡˜èª hektikosï¼ˆç¿’æ…£æ€§ï¼‰ï¼Œé€™æ˜¯ä¸€ç¨®é–“æ­‡æ€§ç™¼ç‡’ï¼Œå…¶ç‰¹é»æ˜¯æ³¢å‹•å¹…åº¦å¾ˆå¤§ï¼Œé€šå¸¸é«˜æ–¼ 2.5Â°F (1.4Â°C)ã€‚ å®ƒæœ‰ä¸€å€‹å…¸å‹çš„æ¯æ—¥ä¸‹åˆé«˜å³°ï¼Œé€šå¸¸ä¼´æœ‰é¢éƒ¨æ½®ç´…ï¼Œå‚³çµ±ä¸Šèˆ‡æ´»å‹•æ€§è‚ºçµæ ¸æœ‰é—œã€‚</description></item><item><title>Hematologic Alterations</title><link>https://www.physician.tw/Hematologic-Alterations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematologic-Alterations/</guid><description>Hematologic Alterations Chapter 62: Interpreting Peripheral Blood Smears Chapter 63: Anemia and Polycythemia Chapter 64: Disorders of Granulocytes and Monocytes Chapter 65: Bleeding and Thrombosis Chapter 66: Enlargement of Lymph Nodes and Spleen</description></item><item><title>Hematologic oncologic-complications of HIV AIDS</title><link>https://www.physician.tw/Hematologic-oncologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hematologic-oncologic-complications-of-HIV-AIDS/</guid><description>Hematologic oncologic-complications of HIV AIDS (NEJM 2018;378:1029)
Cytopenia: ACD, BM infiltration by tumor/infxn (eg, MAC/TB), drug toxicity, hemolysis, ITP Non-Hodgkin lymphoma: â†‘ frequency with any CD4 count, but incidence â†‘ with â†“ CD4 Hodgkin lymphoma (any CD4; impact of ART unclear) CNS lymphoma: CD4 count &amp;lt;50, EBV-associated Kaposiâ€™s sarcoma (HHV-8): at any CD4 count, incidence â†‘ b/c CD4 â†“, usu.</description></item><item><title>hematology</title><link>https://www.physician.tw/hematology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematology/</guid><description>hematology å‡è¡€ç•°å¸¸ï¼Œè¡€ç™Œç–«æƒ…ï¼Œ æ·‹å·´ç™Œç—›ï¼Œè²§è¡€ç—…è®Šã€‚ è¡€æ¶²ä¸æ¿Ÿï¼Œé«”å…§ç¼ºä¹ï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚
[[oncology]]
[[anemia]]
[[disorders of hemostasis]]
[[platelet disorders]]</description></item><item><title>hematopoietic stem cell transplantation</title><link>https://www.physician.tw/hematopoietic-stem-cell-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematopoietic-stem-cell-transplantation/</guid><description>hematopoietic stem cell transplantation [[graft-versus-host disease]]
Transplantation of donor pluripotent cells that can reconstitute all recipient blood lineages
[[categories of stem cell transplantation]]</description></item><item><title>hematuria</title><link>https://www.physician.tw/hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hematuria/</guid><description>hematuria [[Etiologies of Hematuria]] [[Workup-of-hematuria]]
Backlinkï¼š [[asymptomatic glomerular hematuria]] [[Clinical manifestations of Granulomatosis with polyangiitis]] [[Clinical manifestations of IgA vasculitis]] [[Clinical manifestations of Polyarteritis nodosa]] [[Clinical manifestations-nephrolithiasis]] [[Clinical manifestations-urinary tract infections]] [[Definition-glomerulonephritis]] [[Diagnostic studies-urinary tract infections]] [[Dx studies of Granulomatosis with polyangiitis]] [[Etiologies of Hematuria]] [[glomerular disease]] [[hypertensive crises]] [[IgA nephropathy]] [[Neoplasm Etiologies of Classic FUO]] [[urinalysis]] [[Urine Dipstick]] [[Workup-acute kidney injury (AKI)]] [[Workup-of-hematuria]]</description></item><item><title>Hemochromatosis &amp; iron overload syndromes</title><link>https://www.physician.tw/Hemochromatosis-iron-overload-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemochromatosis-iron-overload-syndromes/</guid><description>Hemochromatosis &amp;amp; iron overload syndromes (Am J Gastro 2019;114:1202)
Recessive disorder of iron sensing or transport leading to tissue iron deposition</description></item><item><title>Hemodialysis HD</title><link>https://www.physician.tw/Hemodialysis-HD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemodialysis-HD/</guid><description>Hemodialysis (HD) Solute removal across semipermeable membrane, countercurrent blood &amp;amp; dialysate flow
Volume removal: Na/H2O ultrafiltered via transmembrane pressure (TMP) gradient Solutes: Cr, urea, K diffuse from blood â†’ dialysate, HCO3 from dialysate â†’ blood Solute removal inversely proportional to size âˆ´ effective removal of K, urea, Cr, not PO4 6Ã— vs.</description></item><item><title>Hemodynamic-Monitoring</title><link>https://www.physician.tw/Hemodynamic-Monitoring/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemodynamic-Monitoring/</guid><description>Hemodynamic-Monitoring</description></item><item><title>hemolytic anemias</title><link>https://www.physician.tw/hemolytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemolytic-anemias/</guid><description>hemolytic anemias [[Causes of Hemolytic Anemia by Mechanism]] [[Diagnostic evaluation-hemolytic anemias]] [[Glucose-6-phosphate dehydrogenase]] [[Sickle cell anemia ]] [[Hereditary spherocytosis (HS) ]] [[Paroxysmal nocturnal hemoglobinuria]] [[Autoimmune hemolytic anemia]] [[Drug-induced hemolytic anemia]] [[Microangiopathic hemolytic anemia]] [[Hypersplenism]]</description></item><item><title>Hemolytic-uremic syndrome</title><link>https://www.physician.tw/Hemolytic-uremic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemolytic-uremic-syndrome/</guid><description>Hemolytic-uremic syndrome Pathophys: (1) Shiga toxin damages renal endothelial cells â†’ intrarenal thrombi; or (2) complement dysregulation (hereditary or acquired), so-called â€œatypical HUSâ€</description></item><item><title>Hemophilias</title><link>https://www.physician.tw/Hemophilias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemophilias/</guid><description>Hemophilias (Lancet 2016;388:187)
X-linked recessive factor VIII (hemophilia A) or factor IX (hemophilia B) deficiency
Classification: mild (5â€“25% normal factor activity), moderate (1â€“5%), or severe (&amp;lt;1%)</description></item><item><title>hemoptysis</title><link>https://www.physician.tw/hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hemoptysis/</guid><description>hemoptysis [[Definition and pathophysiology-hemoptysis]] [[Diagnostic workup-hemoptysis]] [[Treatment-hemoptysis]]</description></item><item><title>Hemothroax</title><link>https://www.physician.tw/Hemothroax/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hemothroax/</guid><description>Hemothroax Hemothorax is an accumulation of blood within the pleural space. Hematocrit of the pleural fluid is greater than 50% of the hematocrit of the patientâ€™s peripheral blood in hemothorax.</description></item><item><title>Heparin-Induced Thrombocytopenias</title><link>https://www.physician.tw/Heparin-Induced-Thrombocytopenias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Heparin-Induced-Thrombocytopenias/</guid><description>Heparin-Induced Thrombocytopenias (Chest 2012;141:e495S; NEJM 2015;373:252)
Type I Heparin-Induced Thrombocytopenias(not clin. signif) Direct effect of heparin (non-immune) Incidence 10â€“20% After 1â€“4 d of heparin therapy Platelet nadir: &amp;gt;100,000/ÂµL Sequelae: None Can continue heparin and observe Type II Heparin-Induced Thrombocytopenias (clinically significant HIT) Immune (Ab)-mediated IgG against plt factor 4â€”heparin complex 1â€“3% with UFH, 0â€“0.</description></item><item><title>Hepatic encephalopathy HE</title><link>https://www.physician.tw/Hepatic-encephalopathy-HE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatic-encephalopathy-HE/</guid><description>Hepatic encephalopathy (HE) (NEJM 2016;375:1660; Hepatology 2014; 60:715)
Pathogenesis: failure of liver to detoxify NH3 + other substances (eg, ADMA; J Hepatol 2013;58:38) that cause cerebral edema, â†“ O2 consumption, â†‘ ROS â†’ brain dysfxn</description></item><item><title>Hepatic hydrothorax</title><link>https://www.physician.tw/Hepatic-hydrothorax/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatic-hydrothorax/</guid><description>Hepatic hydrothorax 2Â° diaphragmatic defect; often unilateral, R &amp;gt;L, Â± ascites
Treatment: avoid chest tube (â†‘ complications); Rx same as ascites (TIPS if refractory).</description></item><item><title>hepatic vascular disease</title><link>https://www.physician.tw/hepatic-vascular-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatic-vascular-disease/</guid><description>hepatic vascular disease [[Normal hepatic vasculature]] [[Portal vein thrombosis (PVT) ]] [[Splenic vein thrombosis]] [[Budd-Chiari syndrome]] [[Sinusoidal obstruction syndrome (SOS)]]</description></item><item><title>hepatitis</title><link>https://www.physician.tw/hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis/</guid><description>hepatitis VIRAL [[Hepatitis A]] [[Hepatitis B]] [[Hepatitis C]] [[Hepatitis D]] [[Hepatitis E]] Other viruses (human pegivirus, CMV, EBV, HSV, VZV) [[autoimmune hepatitis (AIH)]] [[Alcohol-associated hepatitis]] [[Acetaminophen hepatotoxicity]] [[Ischemic hepatitis]] [[Nonalcoholic fatty liver disease (NAFLD)]]</description></item><item><title>Hepatitis A</title><link>https://www.physician.tw/Hepatitis-A/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-A/</guid><description>Hepatitis A (ssRNA; 30â€“45% of acute viral hepatitis in U.S; MMWR 2018;67:1208)
Transmission &amp;amp; RFs: fecalâ€“oral route; contam. food, water, shellfish; daycare ctr; intl travel Incubation: 2â€“6 wk; no chronic carrier state; once antibody forms â†’ lifelong immunity Sx: â†“ appetite, malaise, fever, N/V, RUQ pain, jaundice; rarely ALF (â†‘ w/ chronic HCV) Diagnosis: acute hepatitis = âŠ• IgM anti-HAV; past exposure = âŠ• IgG anti-HAV (âŠ–IgM) Rx for acute HAV: supportive care; refer to liver txplnt center if acute liver failure Vaccinate if: MSM, IVDU, chronic liver disease, international travel; Havrix (2 doses)</description></item><item><title>Hepatitis B</title><link>https://www.physician.tw/Hepatitis-B/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-B/</guid><description>Hepatitis B Transmission: blood (IVDU, transfusion), sexual, perinatal (vertical) Incubation: 6 wkâ€“6 mo (mean 12â€“14 wk) Acute infxn: 70% subclinical, 30% jaundice, &amp;lt;1% acute liver failure (up to 60% mortality) Chronic infxn: HBsAg âŠ• &amp;gt;6 mo in &amp;lt;5% of adult-acquired (â†‘ if immunosupp), &amp;gt;90% of perinatal; ~40% chronic HBV â†’ cirrhosis (â†‘ risk w/ HCV, HDV, or HIV coinfxn, EtOH) HCC: â†‘ risk if cirrhosis, âŠ• FHx HCC, African &amp;gt;20 y old, Asian â™‚ &amp;gt;40 y old or â™€ &amp;gt;50 y old, or &amp;gt;40 y old w/ â†‘ ALT Â± HBV DNA &amp;gt;2000.</description></item><item><title>hepatitis B virus Rx duration</title><link>https://www.physician.tw/hepatitis-B-virus-Rx-duration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-B-virus-Rx-duration/</guid><description>hepatitis B virus Rx duration (1) HBeAg âŠ• immune active w/o cirrhosis: if seroconversion (HBeAg âŠ–, anti- HBe âŠ•), can stop after 1 y if ALT nl &amp;amp; HBV DNA suppressed or until HBsAg clears; (2) HBeAg âŠ– immune reactivation: indefinite; (3) cirrhosis: indefinite</description></item><item><title>Hepatitis C</title><link>https://www.physician.tw/Hepatitis-C/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-C/</guid><description>Hepatitis C (ssRNA; ~10% of acute viral hepatitis in U.S.; Lancet 2015;385:1124)
[[Recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens]]</description></item><item><title>hepatitis C virus acute infxn</title><link>https://www.physician.tw/hepatitis-C-virus-acute-infxn/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-acute-infxn/</guid><description>hepatitis C virus acute infxn 80% subclinical; 10â€“20% sx hepatitis w/ jaundice; acute liver failure rare; prob of spont clearance a/w IL28B &amp;amp; HLA class II genotypes (Annals 2013;158:235)</description></item><item><title>hepatitis C virus extrahepatic syndromes</title><link>https://www.physician.tw/hepatitis-C-virus-extrahepatic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-extrahepatic-syndromes/</guid><description>hepatitis C virus extrahepatic syndromes mixed cryoglobulinemia, porphyria cutanea tarda, lichen planus, leukocytoclastic vasculitis, thyroiditis, MPGN, IPF, NHL and monoclonal gammopathies</description></item><item><title>hepatitis C virus Monitoring on Rx</title><link>https://www.physician.tw/hepatitis-C-virus-Monitoring-on-Rx/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Monitoring-on-Rx/</guid><description>hepatitis C virus Monitoring on Rx CBC, INR, LFTs, GFR, HCV VL prior to starting Rx. PIs contraindicated if decomp. liver dx (ascites, encephalopathy) or CPS â‰¥7.</description></item><item><title>hepatitis C virus recommended First-Line Oral Direct-Acting Antiviral DAA Regimens</title><link>https://www.physician.tw/hepatitis-C-virus-recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</guid><description>hepatitis C virus recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens Sofosbuvir &amp;amp; velpatasvir Genotypes 1â€“6, 12 weeks Rx
Glecaprevir &amp;amp; pibrentasvir Gentotypes 1â€“6; 8 weeks Rx</description></item><item><title>hepatitis C virus Serologic, virologic, &amp; genetic tests</title><link>https://www.physician.tw/hepatitis-C-virus-Serologic-virologic-genetic-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Serologic-virologic-genetic-tests/</guid><description>hepatitis C virus Serologic, virologic, &amp;amp; genetic tests (screen all adults [âœ“ anti-HCV] JAMA 2020;323:970) anti-HCV (ELISA): âŠ• in 6 wk, does not = recovery or immunity; can be âŠ– after recovery</description></item><item><title>hepatitis C virus Treatment indications</title><link>https://www.physician.tw/hepatitis-C-virus-Treatment-indications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatitis-C-virus-Treatment-indications/</guid><description>hepatitis C virus Treatment indications ( www.hcvguidelines.org) (Lancet 2019;393:1453; Hepatology 2020;71:686)
Acute: if no spont. clearance at 12â€“16 wk, can Rx w/ same regimens for chronic HCV Chronic: â†“ HCC &amp;amp; mortality.</description></item><item><title>Hepatitis D</title><link>https://www.physician.tw/Hepatitis-D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-D/</guid><description>Hepatitis D (RNA; Gastro 2019:156;461)
Transmission: blood or sexual; endemic in Africa &amp;amp; E. Europe. Generally requires host to already have HBV infxn in order to cause co-infection or superinfection; in rare cases (immunosupp s/p liver transplant) can replicate autonomously.</description></item><item><title>Hepatitis E</title><link>https://www.physician.tw/Hepatitis-E/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatitis-E/</guid><description>Hepatitis E (ssRNA; World J Gastro 2016;22:7030; Gastro Clin N Am 2017;46:393)
Most common cause of acute viral hepatitis in endemic areas</description></item><item><title>hepatocellular carcinoma</title><link>https://www.physician.tw/hepatocellular-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hepatocellular-carcinoma/</guid><description>hepatocellular carcinoma Risk factors (globally, 3rd leading cause of cancer death, espec. in Africa &amp;amp; Asia) Cirrhosis: present in 70â€“90% HCC cases Infectious: HCV &amp;amp; HBV (~75%), HBV/HDV coinfection; HBV can cause HCC w/o cirrhosis Toxic: EtOH (â…“ cases in U.</description></item><item><title>Hepatopulmonary syndrome HPS</title><link>https://www.physician.tw/Hepatopulmonary-syndrome-HPS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatopulmonary-syndrome-HPS/</guid><description>Hepatopulmonary syndrome (HPS) (Dig Dis Sci 2015;60:1914, Hepatology 2021;74:1014) Abnl gas exchange (A-a gradient â‰¥15 or PaO2 &amp;lt;80) caused by intrapulmonary vascular dilatations leading to intrapulmonary shunting (improves with O2) S/S: platypnea-orthodeoxia (dyspnea &amp;amp; hypoxia w/ sitting up), clubbing, spider angiomas Dx w/ contrast echo showing â€œlateâ€ A-V shunting (contrast in LA 3â€“6 cycles after RA) Rx: O2; potential embolization if large vessel on CT, TIPS, liver tx only definitive Rx</description></item><item><title>Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hepatorenal-syndrome-HRS/</guid><description>Hepatorenal syndrome (HRS) Reference Hepatology 2021;74:1014 Gastro 2016;150:1525 AJKD 2013;62:1198 Pathophysiology: splanchnic vasodilation and renal vasoconstriction w/ â†“ renal blood flow</description></item><item><title>HER2</title><link>https://www.physician.tw/HER2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HER2/</guid><description>HER2 (Lancet 2017;389: 2415)
HER2- targeted
Trastuzumab (anti-HER2): 1st-line Rx combined w/ chemo Trastuzumab emtansine (mAb linked to chemo): â†“ risk of recurrence/death if residual disease post neoadj.</description></item><item><title>Hereditary spherocytosis HS</title><link>https://www.physician.tw/Hereditary-spherocytosis-HS-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hereditary-spherocytosis-HS-/</guid><description>Hereditary spherocytosis (HS) (Lancet 2008;372:1411)
Defect in cytoskeleton of RBC membrane (ankyrin, Î±- and Î²-spectrin, band 3, &amp;amp; pallidin)</description></item><item><title>herpes simplex virus infection</title><link>https://www.physician.tw/herpes-simplex-virus-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/herpes-simplex-virus-infection/</guid><description>herpes simplex virus infection é€šå¸¸å¼•èµ·æ€¥æ€§è…¦ç‚ï¼Œä¼´æœ‰å¿«é€Ÿç™¼ç†±ã€é ­ç—›ã€ç™²ç™‡ç™¼ä½œã€ å±€ç¶æ€§ç¥ç¶“ç³»çµ±é«”å¾µå’Œæ„è­˜æ”¹è®Šã€‚ ç¥ç¶“å½±åƒå­¸é€šå¸¸é¡¯ç¤ºé¡³è‘‰è®ŠåŒ–ã€‚ è…¦è„Šæ¶²åˆ†æé¡¯ç¤ºä»¥æ·‹å·´ç´°èƒç‚ºä¸»ï¼Œå¸¸ä¼´æœ‰ç´…ç´°èƒï¼Œè‘¡è„ç³–æ°´å¹³æ­£å¸¸ ä¼´æœ‰æ€§æ ¼æ”¹è®Šå’ŒMRIé¡³è‘‰å¢å¼·çš„è…¦ç‚ï¼šå–®ç´”çš°ç–¹ç—…æ¯’è…¦ç‚çš„ç‰¹å¾µã€‚ é›™å´é¡³è‘‰äº®èµ·ä¾†é«˜åº¦æç¤º HSV è…¦ç‚ã€‚</description></item><item><title>herpes zoster</title><link>https://www.physician.tw/herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/herpes-zoster/</guid><description>herpes zoster Definition &amp;amp; etiology Painful vesicular rash in a peripheral nerve distribution due to reactivation of VZV Spread by contact with active lesion (prior to crusting) in uncomplicated zoster or via airborne transmission in disseminated zoster [[Clinical manifestations complications-herpes zoster]] Diagnosis Clinical diagnosis if uncomplicated.</description></item><item><title>High-risk features-syncope</title><link>https://www.physician.tw/High-risk-features-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/High-risk-features-syncope/</guid><description>High-risk features-syncope (admit w/ tele; JACC 2017;70:620; EHJ 2018;39:1883)
Age &amp;gt;60 y, h/o CAD, HF/CMP, valvular or congenital heart dis.</description></item><item><title>Histoplasmosis</title><link>https://www.physician.tw/Histoplasmosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Histoplasmosis/</guid><description>Histoplasmosis (CID 2007;45:807)
Epidemiology: endemic to central &amp;amp; SE U.S., but sporadic cases throughout U.S. Clinical manifestations Acute: PNA Â± hilar LAN, often subacute, but high inoculum can cause acute severe PNA Chronic lung disease: cough + B sx Â± cavitary lesions (Ddx TB, blasto) Disseminated (seen in immunosupp.</description></item><item><title>History and physical exam-interstitial lung disease</title><link>https://www.physician.tw/History-and-physical-exam-interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-and-physical-exam-interstitial-lung-disease/</guid><description>History and physical exam-interstitial lung disease Occupational, exposures (eg, birds), tobacco, meds, XRT, FHx, precipitating event
Tempo (acute â†’ infxn, CHF, hypersens pneumonitis, eos PNA, AIP, COP, drug-induced)</description></item><item><title>History heart failure</title><link>https://www.physician.tw/History-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/History-heart-failure/</guid><description>History heart failure Low output: fatigue, weakness, exercise intolerance, âˆ† MS, anorexia Congestive: left-sided â†’ dyspnea, orthopnea, paroxysmal nocturnal dyspnea right-sided â†’ peripheral edema, RUQ discomfort, bloating, satiety</description></item><item><title>HIV AIDS</title><link>https://www.physician.tw/HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/HIV-AIDS/</guid><description>HIV AIDS [[Definition Clinical Manifestations-HIV AIDS]] [[Epidemiology-HIV AIDS]] [[Prophylaxis-HIV AIDS]] [[Screening and Diagnosis-HIV AIDS]] [[Approach to newly diagnosed HIV positive Pt]] [[Antiretrovirals (ARVs)]] [[Approach to previously established HIV positive Pt]] [[OI Prophylaxis-HIV AIDS]] [[complications of HIV AIDS]]</description></item><item><title>Home</title><link>https://www.physician.tw/Home/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Home/</guid><description/></item><item><title>Hornerâ€™s syndrome</title><link>https://www.physician.tw/Horners-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Horners-syndrome/</guid><description>Hornerâ€™s syndrome æ˜¯ä¸€ç¨®å½±éŸ¿èº«é«”ä¸€å´çš„é¢éƒ¨å’Œçœ¼ç›çš„ç–¾ç—…ã€‚ é€™æ˜¯ç”±æ–¼å¾å¤§è…¦åˆ°é ­éƒ¨å’Œé ¸éƒ¨çš„ç¥ç¶“é€šè·¯çš„ç ´å£å¼•èµ·çš„ã€‚
é€šå¸¸ï¼Œéœç´ç¶œåˆå¾µçš„é«”å¾µå’Œç—‡ç‹€åŒ…æ‹¬
TL;DR ç³å­”å¤§å°çš„é™ä½ï¼Œ çœ¼ç¼ä¸‹å‚ è‡‰éƒ¨å—å½±éŸ¿å´çš„å‡ºæ±—æ¸›å°‘ã€‚ Common Sings A persistently small pupil (miosis) A notable difference in pupil size between the two eyes (anisocoria) Little or delayed opening (dilation) of the affected pupil in dim light Drooping of the upper eyelid (ptosis) Slight elevation of the lower lid, sometimes called upside-down ptosis Sunken appearance of the affected eye Little or no sweating (anhidrosis) on the affected side of the face anhidrosis::no sweating</description></item><item><title>How does this thing work?</title><link>https://www.physician.tw/How-does-this-thing-work/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/How-does-this-thing-work/</guid><description>Always begin typing in the
When you select one of the found notes (e.g., using the up/down keys) NV displays its body in the lower text area (what you&amp;rsquo;re reading now).</description></item><item><title>how the human body breathes</title><link>https://www.physician.tw/how-the-human-body-breathes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/how-the-human-body-breathes/</guid><description>how the human body breathes âœ¨é‡é»: è¦äº†è§£æ©Ÿæ¢°é€šæ°£ï¼Œæ‚¨é¦–å…ˆå¿…é ˆå°äººé«”çš„å‘¼å¸æ–¹å¼æœ‰ä¸€å€‹åŸºæœ¬çš„äº†è§£ã€‚ æ°§æ°£æ˜¯äººé«”çš„é£Ÿç‰©ã€‚ æ¯å€‹ç´°èƒéƒ½éœ€è¦å®ƒä¾†ç”¢ç”Ÿèƒ½é‡ä¸¦åŸ·è¡Œå…¶å„ç¨®åŠŸèƒ½ã€‚ å¦ä¸€æ–¹é¢ï¼ŒäºŒæ°§åŒ–ç¢³ (CO2) æ˜¯æ¯å€‹ç´°èƒä½œç‚ºå…¶åŠŸèƒ½çš„å‰¯ç”¢å“ç”¢ç”Ÿçš„äººé«”åƒåœ¾ã€‚ çœ¾æ‰€å‘¨çŸ¥ï¼Œè‚ºæ˜¯å¾ç©ºæ°£ä¸­å¸æ”¶æ°§æ°£ä¸¦å°‡å…¶å¸¶å…¥é«”å…§çš„å™¨å®˜ï¼ŒåŒæ™‚ä¹Ÿæ’å‡ºï¼ˆå‘¼å‡ºï¼‰äºŒæ°§åŒ–ç¢³ã€‚ ä½†æ˜¯è§¸ç™¼é€™ç¨®æƒ…æ³ç™¼ç”Ÿçš„æ©Ÿåˆ¶æ˜¯ä»€éº¼ï¼Œé€™ç¨®äº¤æ›ç©¶ç«Ÿæ˜¯å¦‚ä½•ç™¼ç”Ÿçš„ï¼Ÿ åœ¨æœ¬ç« çµæŸæ™‚ï¼Œæ‚¨å°‡èƒ½å¤ ï¼š è§£é‡‹å¸æ°£å’Œå‘¼æ°£çš„èº«é«”æ©Ÿåˆ¶ã€‚ è­˜åˆ¥åƒèˆ‡å‘¼å¸çš„èº«é«”é—œéµéƒ¨ä½ã€‚ å®šç¾© FRC å’Œå…§åœ¨ PEEP ä»¥åŠå°è‚ºæ³¡çš„é‡è¦æ€§ã€‚ äº†è§£å‘¼å¸éç¨‹ä¸­è‚ºéƒ¨ç™¼ç”Ÿçš„åŸºæœ¬å£“åŠ›è®ŠåŒ–ã€‚ âœ¨é‡é»: æ•¸ä»¥ç™¾è¬è¨ˆçš„â€œå°æ°£çƒâ€ä»ç„¶èƒ½å¤ å¸å…¥èˆ‡ç›¸åŒå¤§å°çš„å–®å€‹æ°£çƒç›¸åŒçš„ç¸½ç©ºæ°£é‡ï¼Œä½†æ˜¯é€šéå°‡ç©ºæ°£é‡åˆ†æˆè‚ºæ³¡è€Œä¸æ˜¯ä¸€å€‹å¤§æ°£çƒï¼Œè‚ºçš„ç¸½è¡¨é¢ç©å¢åŠ æˆå€å¢é•·ã€‚ ç‚ºä»€éº¼é€™å¾ˆé‡è¦ï¼Ÿå—¯ï¼Œæ¯å€‹å–®ç¨çš„è‚ºæ³¡éƒ½è¢«ç¨±ç‚ºâ€œæ¯›ç´°è¡€ç®¡â€çš„è¡€ç®¡åŒ…åœã€‚è‚ºæ³¡å’Œæ¯›ç´°è¡€ç®¡ç›¸é‡çš„åœ°æ–¹æ˜¯å¯¦éš›ç™¼ç”Ÿæ°£é«”äº¤æ›çš„åœ°æ–¹ã€‚ å¯ä»¥ç™¼ç”Ÿé€™ç¨®äº¤æ›çš„è¡¨é¢ç©çš„å¤§å¹…å¢åŠ å…è¨±æ°£é«”äº¤æ›æ›´æ´»èºçš„å€åŸŸï¼Œä¸¦ä¸”é€™ç¨®äº¤æ›å¯ä»¥ä»¥æ›´æœ‰æ•ˆå’Œæ›´å¿«çš„é€Ÿåº¦ç™¼ç”Ÿã€‚ æ°§æ°£å¾è‚ºæ³¡æ“´æ•£åˆ°è¡€æ¶²ä¸­ï¼ŒäºŒæ°§åŒ–ç¢³å¾è¡€æ¶²ä¸­æ“´æ•£åˆ°è‚ºæ³¡ï¼Œç„¶å¾Œå¾è‚ºä¸­å‘¼å‡ºã€‚</description></item><item><title>Humoral immune dysfunction</title><link>https://www.physician.tw/Humoral-immune-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Humoral-immune-dysfunction/</guid><description>Humoral immune dysfunction (eg, CVID, myeloma) and asplenia Encapsulated bacteria: S. pneumo, H. flu, N. meningitidis (vaccinate against these 3, ideally prior to splenectomy) Other bacteria: E.</description></item><item><title>hyaline casts</title><link>https://www.physician.tw/hyaline-casts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyaline-casts/</guid><description>hyaline casts Casts are clusters of urinary sediment elements (red blood cells, white blood cells, fat bodies, etc.) wrapped in a protein matrix.</description></item><item><title>Hydralazine---nitrates</title><link>https://www.physician.tw/Hydralazine---nitrates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hydralazine---nitrates/</guid><description>Hydralazine&amp;mdash;nitrates Consider if cannot tolerate ACEI/ARB or in black Pts w/ class III/IV
25% â†“ mort. (NEJM 1986;314:1547); infer. to ACEI (NEJM 1991;325:303)</description></item><item><title>hyperactive delirium</title><link>https://www.physician.tw/hyperactive-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperactive-delirium/</guid><description>hyperactive delirium The cognitive syndrome associated with severe alcohol withdrawal (i.e., â€œdelirium tremensâ€) remains the classic example of the hyperactive subtype, prominent hallucinations, agitation, and hyperarousal, accompanied by life-threatening autonomic instability.</description></item><item><title>hyperaldosteronism</title><link>https://www.physician.tw/hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperaldosteronism/</guid><description>hyperaldosteronism [[Etiologies-hyperaldosteronism]] [[Clinical manifestations-hyperaldosteronism]] [[Diagnosis-hyperaldosteronism]] [[Treatment-hyperaldosteronism]] Backlinkï¼š [[adrenal disorders]] [[adrenal incidentalomas]] [[Clinical manifestations-hyperaldosteronism]] [[Diagnosis-hyperaldosteronism]] [[Disease state specific regimens-diuresis]] [[Etiologies-hyperaldosteronism]] [[Etiologies-of-Metabolic-Alkalosis]] [[Liddleâ€™s syndrome]] [[metabolic-alkalosis]] [[Pathophysiology-metabolic-alkalosis]] [[Primary Hyperaldosteronism]] [[Renal potassium losses]] [[Secondary Hyperaldosteronism]] [[Treatment-hyperaldosteronism]]</description></item><item><title>hypercalcemia</title><link>https://www.physician.tw/hypercalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercalcemia/</guid><description>hypercalcemia [[Etiologies of Hypercalcemia]] [[Clinical manifestations-hypercalcemia]] (â€œbones, stones, abdominal groans, and psychic moansâ€) [[Diagnostic studies-hypercalcemia]] [[Acute Treatment of Hypercalcemia]] (BMJ 2015;350:h2723) [[Treatment of asymptomatic 1Â° HPT]] (JCEM 2014;99:3561; JAMA 2020;323:1186)</description></item><item><title>hypercoagulable states</title><link>https://www.physician.tw/hypercoagulable-states/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypercoagulable-states/</guid><description>hypercoagulable states Suspect in Pts with venous or arterial thrombosis at young age or unusual locations, recurrent thromboses or pregnancy loss, or âŠ• FHx</description></item><item><title>hyperkalemia</title><link>https://www.physician.tw/hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperkalemia/</guid><description>hyperkalemia [[Transcellular shifts-hyperkalemia]] [[Decreased GFR-hyperkalemia]] [[Normal GFR but with â†“ renal K excretion-hyperkalemia]] [[Clinical manifestations-hyperkalemia]] [[Workup-hyperkalemia]] [[Treatment of Hyperkalemia-hyperkalemia]]</description></item><item><title>hypernatremia</title><link>https://www.physician.tw/hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypernatremia/</guid><description>hypernatremia [[Pathophysiology-hypernatremia]] [[Workup-hypernatremia]] [[Approach to hypernatremia]] [[Extrarenal H2O loss (Uosm &amp;gt;700â€“800)]] [[Renal H2O loss (Uosm &amp;lt;700â€“800)]] [[Other (Uosm &amp;gt;700â€“800)]] [[Treatment-hypernatremia]]</description></item><item><title>hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperosmolar-hyperglycemic-state/</guid><description>hyperosmolar hyperglycemic state [[Definition, precipitants, pathophysiology-hyperosmolar hyperglycemic state]] [[Clinical manifestations dx studies-hyperosmolar hyperglycemic state]] [[Treatment-hyperosmolar hyperglycemic state]]</description></item><item><title>hyperparathyroidism</title><link>https://www.physician.tw/hyperparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperparathyroidism/</guid><description>hyperparathyroidism ç”²ç‹€æ—è…ºåŠŸèƒ½äº¢é€²ç—‡æ˜¯ç”²ç‹€æ—è…ºï¼ˆåœ¨é ¸éƒ¨ï¼Œé è¿‘ç”²ç‹€è…ºï¼‰ç”¢ç”Ÿéå¤šçš„ç”²ç‹€æ—è…ºæ¿€ç´ ã€‚ æœ‰ 4 å€‹å°è…ºé«”ç”¢ç”Ÿé€™ç¨®æ¿€ç´ ï¼Œå¯å¹«åŠ©æ‚¨çš„èº«é«”æ§åˆ¶æ‰€éœ€çš„éˆ£æ°´å¹³ã€‚</description></item><item><title>hyperpituitary syndromes</title><link>https://www.physician.tw/hyperpituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperpituitary-syndromes/</guid><description>hyperpituitary syndromes [[Pituitary tumors]] (NEJM 2020;382:937) [[Hyperprolactinemia]] [[Acromegaly]] [[Cushingâ€™s Syndrome]] (â†‘ ACTH): 5% of adenomas; see â€œAdrenal Disordersâ€ (Hypercortisolism) Central hyperthyroidism (â†‘ TSH, â†‘ Î±-subunit): extremely rare; see [[hyperthyroidism]] â†‘ FSH &amp;amp; LH: often non-fxn, may present as hypopituitarism b/c compression effects [[Multiple Endocrine Neoplasia]] (MEN) Syndromes [[Autoimmune Polyglandular Syndromes]] (APS)</description></item><item><title>Hyperprolactinemia</title><link>https://www.physician.tw/Hyperprolactinemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hyperprolactinemia/</guid><description>Hyperprolactinemia * Etiology Prolactinoma (50% of pituitary adenomas) Stalk compression due to nonprolactinoma â†’ â†“ inhibitory dopamine â†’ â†‘ PRL (mild)</description></item><item><title>Hypersplenism</title><link>https://www.physician.tw/Hypersplenism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypersplenism/</guid><description>Hypersplenism Stasis/trapping in spleen â†’ MÏ• attack/remodel RBCs â†’ spherocytosis â†’ hemolysis
Causes of Splenomegaly RES hyperplasia Hemolytic anemia, sickle cell disease, thalassemia major Immune hyperplasia Infxn [HIV, EBV, CMV, TB, malaria, kala azar (â€œblack water feverâ€ from visceral leishmaniasis), Mycobacterium avium complex], autoimmune disorders (SLE, RA w/ Feltyâ€™s syndrome), sarcoidosis, serum sickness Congestion Cirrhosis, CHF, portal/splenic vein thrombosis, schistosomiasis Infiltration (nonmalignant) Lysosomal storage disorders (Gaucherâ€™s, Niemann-Pick), glycogen storage diseases histiocytosis X, splenic cysts Neoplasm causes of massive splenomegaly.</description></item><item><title>hypertension</title><link>https://www.physician.tw/hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertension/</guid><description>[[index]]
[[ACC AHA Classification for Office-Based BP]] Epidemiology (Circ 2021;143:e254; Lancet 2021;398:957)
Prevalence 47% in U.S. adults, higher in African-Americans; M = F Of those with HTN, ~40% unaware of dx; of those dx w/ HTN, only Â½ achieve target BP [[Etiologies-hypertension]] [[Standard workup-hypertension]] [[Complications of HTN]] [[Treatment-hypertension]] [[Resistant HTN]] [[hypertensive crises]]</description></item><item><title>hypertensive crises</title><link>https://www.physician.tw/hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertensive-crises/</guid><description>hypertensive crises Hypertensive emergency: â†‘ BP (usually SBP &amp;gt;180 or DBP &amp;gt;120) â†’ target-organ damage Neurologic damage: encephalopathy, hemorrhagic or ischemic stroke, papilledema Cardiac damage: ACS, HF/pulmonary edema, aortic dissection Renal damage: proteinuria, hematuria, acute renal failure; scleroderma renal crisis Microangiopathic hemolytic anemia; preeclampsia-eclampsia Hypertensive urgency: SBP &amp;gt;180 or DBP &amp;gt;120 (?</description></item><item><title>hyperthyroidism</title><link>https://www.physician.tw/hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyperthyroidism/</guid><description>hyperthyroidism [[Etiologies-hyperthyroidism]] Clinical manifestations Restlessness, sweating, tremor, moist warm skin, fine hair, tachycardia, AF, weight loss, â†‘ frequency of stools, menstrual irregularities, hyperreflexia, osteoporosis, stare and lid lag (due to sympathetic overactivity) Apathetic thyrotoxicosis: seen in elderly who can present with lethargy as only sx Laboratory testing â†‘ free T4 and total T3; â†“ TSH (except in TSH-secreting tumors) RAIU scan is very useful study to differentiate causes (see table on page 7-3); cannot do if recent IV contrast or amio load b/c iodine blocks uptake, so âœ“ autoantibodies instead Rarely need to âœ“ for autoantibodies except in pregnancy (to assess risk of fetal Gravesâ€™) May see hypercalciuria Â± hypercalcemia, â†‘ AÏ•, anemia [[Gravesâ€™ disease]] [[Thyroiditis]] [[Treatment-hyperthyroidism]] (Thyroid 2016;26:1343; JCEM 2020;105:3704) Subclinical hyperthyroidism (NEJM 2018;378:2411) Mild â†“ TSH and normal free T4 with only subtle or no sx ~15% â†’ overt hyperthyroidism in 2 y; â†‘ risk of AF, CHD, fracture (JAMA 2015;313:2055) Rx controversial: consider if TSH &amp;lt;0.</description></item><item><title>hypertrophic cardiomyopathy</title><link>https://www.physician.tw/hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertrophic-cardiomyopathy/</guid><description>hypertrophic cardiomyopathy Definition, epidemiology, pathology (Circ Res 2017;121:749) LV (usually â‰¥15 mm) and/or RV hypertrophy disproportionate to hemodynamic load</description></item><item><title>hypertrophic pulm osteoarthropathy</title><link>https://www.physician.tw/hypertrophic-pulm-osteoarthropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypertrophic-pulm-osteoarthropathy/</guid><description>hypertrophic pulm osteoarthropathy HPOAæ˜¯ä¸€çµ„å¯èƒ½å½±éŸ¿å™¨å®˜ï¼Œè‚ºï¼Œéª¨éª¼å’Œé—œç¯€çš„ç—‡ç‹€ã€‚é€™æ˜¯ä¸€ç¨®ç½•è¦‹çš„ç¶œåˆç—‡ï¼Œå› æ­¤æ²’æœ‰å¤ªå¤šä¿¡æ¯ã€‚å®ƒä¹Ÿè¢«ç¨±ç‚ºBamberger-Marie
æ‚£æœ‰è‚ºéƒ¨ç‹€æ³çš„äººå¯ä»¥ç²å¾—HPOAã€‚åœ¨ç™Œç—‡ä¸­ï¼Œåœ¨éå°ç´°èƒè‚ºç™Œæ‚£è€…ä¸­æœ€å¸¸è¦‹ã€‚å®ƒé‚„å½±éŸ¿èƒ¸è†œé–“çš®ç˜¤æ‚£è€…ã€‚
HPOAçš„ç—‡ç‹€ HPOAé€šå¸¸æœƒå¼•èµ·æ‰‹è…•å’Œè…³è¸çš„éª¨éª¼å’Œé—œç¯€çš„ç‚ç—‡ã€‚æœ‰æ™‚ï¼Œé€™æœƒé¡¯ç¤ºåœ¨éª¨æƒææˆ–Xå°„ç·šä¸Šã€‚è…³è¸å’Œæ‰‹è…•æœƒè…«è„¹å’Œç™¼ç‚ï¼Œå¾è€Œå¼•èµ·å¾ˆå¤šç—›è‹¦å’Œé‹å‹•çš„å›°é›£ã€‚
HPOAæœ€å¸¸è¦‹çš„ç—‡ç‹€ä¹‹ä¸€æ˜¯ä¸€ç¨®ç¨±ç‚ºClubbing fingerã€‚é€™æ„å‘³è‘—æ‰‹æŒ‡å’Œè…³è¶¾åœ¨æœ«ç«¯å¯¬é—Š ã€‚æŒ‡ç”²æ›²ç·šï¼Œè®Šç¨ ä¸¦é¡¯å¾—å‹ºç‹€ã€‚
æ‰‹æŒ‡çš„æ£æ£’æ˜¯è‚ºå’Œå¿ƒé«’ç—…çš„å¸¸è¦‹ç—‡ç‹€ã€‚æ²’æœ‰äººç¢ºåˆ‡çŸ¥é“ç‚ºä»€éº¼æœƒclubbing ä½†é€™å¯èƒ½æ˜¯å› ç‚ºè¡€æ¶²ä¸­æ²’æœ‰è¶³å¤ çš„æ°§æ°£ã€‚
REF: Hypertrophic osteoarthropathy (HPOA) | Lung cancer | Cancer Research UK</description></item><item><title>Hypervolemic hypotonic hyponatremia</title><link>https://www.physician.tw/Hypervolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypervolemic-hypotonic-hyponatremia/</guid><description>Hypervolemic hypotonic hyponatremia (ie, â†‘ total body Na, â†‘ â†‘ TBW)
â†“ EAV â†’ â†‘ RAAS â†’ â†‘ aldosterone &amp;amp; â†‘ adrenergic tone â†’ â†‘â†‘ ADH (Am J Med 2013;126:S1)</description></item><item><title>hypoactive delirium</title><link>https://www.physician.tw/hypoactive-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypoactive-delirium/</guid><description>hypoactive delirium In striking contrast is the hypoactive subtype, exemplified by benzodiazepine intoxication, in which patients are withdrawn and quiet, with prominent apathy and psychomotor slowing.</description></item><item><title>hypocalcemia</title><link>https://www.physician.tw/hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypocalcemia/</guid><description>hypocalcemia [[Etiologies of Hypocalcemia]] [[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]]. [[Clinical manifestations-hypocalcemia]] Diagnostic studies Ca, alb, ICa, PTH, 25-(OH)D, 1,25-(OH) 2D (if renal failure or rickets), Cr, Mg, PO4, AÏ•, UCa e.</description></item><item><title>hypoglycemia</title><link>https://www.physician.tw/hypoglycemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypoglycemia/</guid><description>hypoglycemia Clinical manifestations (glucose &amp;lt;~55 mg/dL)
CNS: headache, visual Î”s, Î” MS, weakness, seizure, LOC (neuroglycopenic sx) Autonomic: diaphoresis, palpitations, tremor (adrenergic sx) [[Etiologies-hypoglycemia]] [[Evaluation in patients without diabetes- but have hypoglycemia]] Treatment Glucose tablets, paste, &amp;amp; fruit juice are first-line Rx for Pts who can take POs 25â€“50 g of D 50 IV; if no access, glucagon 0.</description></item><item><title>hypokalemia</title><link>https://www.physician.tw/hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypokalemia/</guid><description>hypokalemia [[Transcellular shifts]] (UK:Cr &amp;lt;13 mEq/g) [[GI potassium losses]] (UK:Cr &amp;lt;13 mEq/g) [[Renal potassium losses]] (UK:Cr &amp;gt;13 mEq/g) [[Clinical manifestations-hypokalemia]] [[Workup-hypokalemia]] (JAMA 2021;12:1216) [[Approach to hypokalemia]] [[Treatment-hypokalemia]] [[Duty note of hypokalemia]]</description></item><item><title>hyponatremia</title><link>https://www.physician.tw/hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hyponatremia/</guid><description>hyponatremia [[Pathophysiology-hyponatremia]] [[workup-hyponatremia]] [[Hypovolemic-hypotonic-hyponatremia]] [[Euvolemic-hypotonic-hyponatremia]] [[Hypervolemic hypotonic hyponatremia]] [[Treatment-of-hyponatremia]] [[JAMA review of hyponatremia]]</description></item><item><title>Hypoparathyroidism</title><link>https://www.physician.tw/Hypoparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoparathyroidism/</guid><description>Hypoparathyroidism (NEJM 2019;380:1738; JCEM 2020;105:1722)
[[Control of Mineral Homeostasis by Parathyroid Hormone and the Calcium-Sensing Receptor]]. Iatrogenic (s/p thyroidectomy, rarely after parathyroidectomy); sporadic; familial (APS1, activating Ca-sensing receptor mutations; see page 7-2); Wilsonâ€™s, hemochromatosis; hypoMg (â†“ secretion and effect); activating Ca-sensing receptor autoAb</description></item><item><title>Hypophosphatemia - Approach to the Patient</title><link>https://www.physician.tw/Hypophosphatemia-Approach-to-the-Patient/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypophosphatemia-Approach-to-the-Patient/</guid><description>Hypophosphatemia - Approach to the Patient Hypophosphatemia is commonly defined as a serum phosphate concentration that is &amp;lt; 2.5 mg/dL (0.</description></item><item><title>hypopituitary syndromes</title><link>https://www.physician.tw/hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypopituitary-syndromes/</guid><description>hypopituitary syndromes (Lancet 2016;388:2403; JCEM 2016;11:3888)
[[Etiologies-hypopituitary syndromes]] Clinical manifestations * Hormonal deficiencies: * ACTH, TSH, FSH and LH, GH, prolactin, and ADH * Panhypopituitarism: * deficiencies in multiple hormonal axes * Mass effect: * headache, visual field Î”s, cranial nerve palsies [[Central adrenal insufficiency]]: â†“ ACTH [[Central hypothyroidism]] Hypoprolactinemia: â†“ prolactin Inability to lactate [[Growth hormone deficiency]] [[Central hypogonadism]]: â†“ FSH &amp;amp; LH [[Central diabetes insipidus]] [[Pituitary apoplexy]] [[Diagnostic evaluation-hypopituitary syndromes]] [[Treatment-hypopituitary syndromes]]</description></item><item><title>hypotension</title><link>https://www.physician.tw/hypotension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypotension/</guid><description>hypotension è©•ä¼°ä¸€å€‹ä½è¡€å£“çš„ç—…äºº
Distributive Septicï¼šç´°èŒã€è‡è‡ã€ç—…æ¯’ã€å¯„ç”ŸèŸ² Non-septic: ç™¼ç‚ã€ç¥ç¶“ã€éæ•ã€å…§åˆ†æ³Œ Inflammatory , Neurogenic , Anaphylactic Other: Andrenal, Arteriovenous shunts Cardiogenic ç‰†Cardiomyopathic MI, dilated cardiomyopathy, Myocarditis, Drug-induced (eg, beta blockers) é›»è·¯Arrhythmogenic Tachyarrhythmia â€“ Atrial, ventricular Brady - atrioventricular block, Mobiz type 2 æ°´è·¯Mechanical valvular, [[myxoma]] Hypovolemic Hemorrhagic trauma, GI, æ‰‹è¡“, å¥³æ€§ç”Ÿæ®– Non-hemorrhagic ä¸Šåä¸‹ç€‰ã€ä¸­æš‘ã€renal loss(salt wasting)ã€3rd space loss Obstructive Pulmonary vascular pulmonary embolism, pulmonary hypertension Mechanical Mixed/unknown</description></item><item><title>hypothyroidism</title><link>https://www.physician.tw/hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/hypothyroidism/</guid><description>hypothyroidism Etiologies Primary (&amp;gt;90% of cases of hypothyroidism; â†“ free T4, â†‘ TSH) Goitrous: [[Hashimotoâ€™s thyroiditis]] (after hyperthyroid phase of thyroiditis), iodine deficiency, lithium, amiodarone Nongoitrous: surgical destruction, s/p radioactive iodine or XRT, amiodarone Secondary (central): â†“ free T4; TSH low, inappropriately nl, or slightly high (although functionally inactive due to abnormal glycosylation); due to hypothalamic or pituitary failure Hashimotoâ€™s thyroiditis Clinical manifestations (Annals 2020;173:ITC1) Early: weakness, fatigue, arthralgias, myalgias, headache, depression, cold intolerance, weight gain, constipation, menorrhagia, dry skin, coarse brittle hair, brittle nails, carpal tunnel syndrome, delayed DTRs (â€œhung upâ€ reflexes), diastolic HTN, hyperlipidemia Late: slow speech; hoarseness; loss of outer third of eyebrows; myxedema (nonpitting skin thickening due to â†‘ glycosaminoglycans); periorbital puffiness; bradycardia; pleural, pericardial, &amp;amp; peritoneal effusions; atherosclerosis Myxedema crisis: vide infra Diagnostic studies (Lancet 2017;390:1550) â†“ free T4; â†‘ TSH in 1Âº hypothyroidism; âŠ• antithyroid Ab (TPO) in Hashimotoâ€™s thyroiditis May see hyponatremia, hypoglycemia, anemia, â†‘ LDL, â†“ HDL and â†‘ CK Screening recommended for pregnant women [[Treatment of overt hypothyroidism]] (Endocrine 2019;66:18) [[Subclinical hypothyroidism]] (NEJM 2017;376:2556; JAMA 2019;322:153) [[Myxedema coma]] (ie, profound hypothyroidism; Thyroid 2014;24:1670) Backlinkï¼š [[amiodarone and thyroid disease]] [[Central hypothyroidism]] [[Common Diagnostic Tests in Thyroid Disorders]] [[Differential Diagnosis of Delirium]] [[Dyslipidemias]] [[Etiologies of Acute Pericarditis]] [[Etiologies of Classic FUO]] [[Etiologies of Prolonged-QT-interval]] [[Euvolemic-hypotonic-hyponatremia]] [[Heart failure with preserved EF]] [[Hyperprolactinemia]] [[hypopituitary syndromes]] [[Myxedema coma]] [[nonthyroidal illness (sick euthyroid syndrome) ]] [[# The Profession of Medicine PA RT 1 ]] [[Physical Exam Secret]] [[respiratory-acidosis]] [[Subclinical hypothyroidism]] [[Thyroiditis]] [[thyroid disorders]] [[Treatment of overt hypothyroidism]] [[Treatment-hypopituitary syndromes]] [[Washington Manual Thyroid Disorders]] [[workup-hyponatremia]]</description></item><item><title>Hypovolemic shock</title><link>https://www.physician.tw/Hypovolemic-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypovolemic-shock/</guid><description>Hypovolemic shock Hemorrhagic Trauma
GI bleeding
Ruptured ectopic pregnancy
GI losses Burns Polyuria
Diabetic ketoacidosis
Diabetes insipidus</description></item><item><title>Hypovolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Hypovolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypovolemic-hypotonic-hyponatremia/</guid><description>Hypovolemic-hypotonic-hyponatremia (ie, â†“â†“ total body Na, â†“ TBW)
[[Renal losses of Hypovolemic-hypotonic-hyponatremia]] Extrarenal losses (UNa &amp;lt;10 mEq/L, UCl &amp;lt;10 mEq/L if alkalemia, FENa &amp;lt;1%): hemorrhage, GI loss (diarrhea or vomiting), third-spacing (pancreatitis), â†“ PO intake, insensible losses</description></item><item><title>Hypoxia and Cyanosis</title><link>https://www.physician.tw/Hypoxia-and-Cyanosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Hypoxia-and-Cyanosis/</guid><description>Hypoxia and Cyanosis Respiratory Anemic Carbon Monoxide Circulatory Specific Organ hypoxia Increeased o2 requirments [[cynosis]]
Backlinkï¼š [[Alterations in Circulatory and Respiratory Functions]]</description></item><item><title>Ibutilide</title><link>https://www.physician.tw/Ibutilide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ibutilide/</guid><description>Ibutilide 1 mg IV over 10â€™ may repeat x 1 n/a Contraindic. if J K or 1 QT (3-8% risk of TdP) give wl IV Mg %</description></item><item><title>ICD</title><link>https://www.physician.tw/ICD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ICD/</guid><description>ICD For 1Â° prevention if EF â‰¤30â€“35% or 2Â° prevention; not if NYHA IV
â†“ mort. in ischemic CMP but perhaps only SCD in modern era in niCMP (NEJM 2005;352:225 &amp;amp; 2016;375:1221)</description></item><item><title>ICU-level care-asthma-EXACERBATION</title><link>https://www.physician.tw/ICU-level-care-asthma-EXACERBATION/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ICU-level-care-asthma-EXACERBATION/</guid><description>ICU-level care-asthma-EXACERBATION Invasive ventilation: Large ET tube, Pplat &amp;lt;30 cm H2O (predicts barotrauma better than PIP), max exp time</description></item><item><title>Idiopathic interstitial pneumonias IIPs</title><link>https://www.physician.tw/Idiopathic-interstitial-pneumonias-IIPs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Idiopathic-interstitial-pneumonias-IIPs/</guid><description>Idiopathic interstitial pneumonias (IIPs) (AJRCCM 2013;188:733)
[[Definition]]: ILD of unknown cause; dx by radiographic, histologic, and clinical features [[Type of Idiopathic interstitial pneumonias (IIPs)]]</description></item><item><title>IgA nephropathy</title><link>https://www.physician.tw/IgA-nephropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgA-nephropathy/</guid><description>IgA nephropathy (CJASN 2017;12:677; AJKD 2021;78:429)
Most common cause of GN; â™‚ pred; peak incidence 20â€“30s; can also be post-infectious Wide range of clinical presentations: asx hematuria (30â€“40%), gross hematuria ~1â€“3 d after URI (10â€“15%), chronic GN (10%), nephrotic syndrome (5%), RPGN (&amp;lt;5%) Though clinical presentation can be highly suggestive, definitive dx only w/ bx Prognosis: â†‘Cr, HTN, proteinuria a/w poor prog.</description></item><item><title>IgA vasculitis</title><link>https://www.physician.tw/IgA-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IgA-vasculitis/</guid><description>IgA vasculitis (formerly Henoch-SchÃ¶nlein purpura [HSP]) (Rheumatol 2019;58:1607)
IgA-mediated [[small-vessel vasculitis]] w/ predilectionåå¥½ for skin, GI tract, and kidneys Epidemiology: * incidence 140/million/y; * å†¬å¤©çš„å¥³å­© * â™‚ &amp;gt;â™€, * children &amp;gt;adults, * winter &amp;gt;summer * May develop ~10 d after onset of upper resp infx or after drug exposure [[Clinical manifestations of IgA vasculitis]] Dx studies: skin bx w/ immunofluorescence â†’ leukocytoclastic vasculitis w/ IgA and C3 deposition in vessel wall; renal bx â†’ mesangial IgA deposition Treatment: * often self-limiting over 4 wk; * steroids Â± DMARDs for renal or severe disease [Henoch-Schonlein purpura | Circulatory System and Disease | NCLEX-RN | Khan Academy - YouTube]( https://www.</description></item><item><title>Imaging studies of acute pancreatitis</title><link>https://www.physician.tw/Imaging-studies-of-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-studies-of-acute-pancreatitis/</guid><description>Imaging studies of acute pancreatitis (Am J Gastro 2013;108:1400)
Abd U/S: bowel gas often obscures pancreas visualization; however should be ordered to r/o biliary etiology (ie, gallstones, BD dilatation)</description></item><item><title>Imaging-Diagnosis-osteomyelitis</title><link>https://www.physician.tw/Imaging-Diagnosis-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-Diagnosis-osteomyelitis/</guid><description>Imaging-Diagnosis-osteomyelitis Plain radiographs: normal early in disease; lytic lesions seen after 2â€“6 wk MRI: preferred imaging study (overall Se 90%, Sp 82%; Archives 2007;167:125) CT: can demonstrate periosteal reaction and cortical and medullary destruction CT &amp;amp; MRI very Se but â†“ Sp; false âŠ• if contig focus w/ periosteal reaction, Charcot Î”s Radionuclide imaging: very Se but non-Sp (false âŠ• if soft-tissue inflammation)</description></item><item><title>Imaging-for-stress-test</title><link>https://www.physician.tw/Imaging-for-stress-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Imaging-for-stress-test/</guid><description>Imaging-for-stress-test Use if uninterpretable ECG (V-paced, LBBB, resting ST â†“ &amp;gt;1 mm, digoxin, LVH, WPW), after indeterminate ECG test, or if pharmacologic test</description></item><item><title>IMI complications</title><link>https://www.physician.tw/IMI-complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IMI-complications/</guid><description>IMI complications Heart block: ~20%, occurs in part because RCA typically supplies AV node 40% on present., 20% w/in 24 h, rest by 72 h; high-grade AVB can develop abruptly</description></item><item><title>immune complex IC â€“associated small-vessel vasculitis</title><link>https://www.physician.tw/immune-complex-ICassociated-small-vessel-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immune-complex-ICassociated-small-vessel-vasculitis/</guid><description>immune complex (IC)â€“associated small-vessel vasculitis see [[Immune Complex (IC) Disease (granular staining) ]]
[[IgA vasculitis]] [[Cryoglobulinemic vasculitis]] [[connective tissue diseaseâ€“associated vasculitis]] [[cutaneous leukocytoclastic angiitis]]</description></item><item><title>Immune Complex (IC) Disease granular staining</title><link>https://www.physician.tw/Immune-Complex-IC-Disease-granular-staining-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immune-Complex-IC-Disease-granular-staining-/</guid><description>Immune Complex (IC) Disease (granular staining) Renal-Limited Diseases Infection-Related GN (Staph &amp;amp; Strep; â†“ C3, Â± ASLO) Membranoproliferative GN (MPGN) (â†“ C3) Fibrillary and immunotactoid GN (normal C3/C4) [[IgA nephropathy]] (normal C3, Â±â†‘ IgA) (NEJM 2013;368:2402; CJASN 2017;12:677) Systemic Diseases SLE (CJASN 2017;12:825) (âŠ• ANA, âŠ• anti-dsDNA, âŠ• anti-Sm, â†“ C3, â†“ C4) Cryoglobulinemia (âŠ• cryocrit, âŠ• RF, âŠ• HCV, SPEP, â†“ C3, â†“ C4) Endocarditis (fever, âŠ• BCx, valvular disease, â†“ C3) Henoch-SchÃ¶nlein purpura ([[IgA nephropathy]] + syst.</description></item><item><title>Immunosuppression-Kidney transplantation</title><link>https://www.physician.tw/Immunosuppression-Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunosuppression-Kidney-transplantation/</guid><description>Immunosuppression-Kidney transplantation : calcineurin inhib (tacrolimus&amp;gt;CsA) or CTLA4 inhib (belatacept) (NEJM 2016;374:333), antimetabolite (MMF&amp;gt;AZA), prednisone, mTOR inhib (sirolimus) if others contraindicated</description></item><item><title>Immunotherapies-asthma</title><link>https://www.physician.tw/Immunotherapies-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Immunotherapies-asthma/</guid><description>Immunotherapies-asthma (NEJM 2017;377:965)
Allergen ImmunoRx (â€œallergy shotsâ€) may help if sig. allerg. component (JAMA 2016;315:1715)
Anti-IgE (omalizumab) for uncontrolled mod-to-severe allergic asthma (w/ IgE &amp;gt;30) on ICS Â± LABA (JAMA 2017; 318:279); â†“ exacerbations in severe asthma (Cochrane 2014;CD003559)</description></item><item><title>immunotherapy and cellular therapy</title><link>https://www.physician.tw/immunotherapy-and-cellular-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/immunotherapy-and-cellular-therapy/</guid><description>immunotherapy and cellular therapy [[template]]
[Toxicities associated with checkpoint inhibitor immunotherapy - UpToDate]( https://www.uptodate.com/contents/toxicities-associated-with-checkpoint-inhibitor-immunotherapy?search=irae&amp;source=search result&amp;amp;selectedTitle=1~53&amp;amp;usage type=default&amp;amp;display rank=1) Science: Cancer immunotherapy using checkpoint blockade - PubMed [[irAE]]</description></item><item><title>Impaired cell-mediated immunity</title><link>https://www.physician.tw/Impaired-cell-mediated-immunity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Impaired-cell-mediated-immunity/</guid><description>Impaired cell-mediated immunity (CMI) (eg, HIV/AIDS, chronic steroids, posttransplant, DM, ESRD, autoimmune dis.) Bacteria: Salmonella spp., Campylobacter, Listeria, Yersinia, Legionella (Lancet 2016;387:376), Rhodococcus, Nocardia, TB, non-TB mycobacteria Fungi: Candida, Crypto, Histo, Coccidio, Aspergillus, Pneumocystis, Zygomycetes spp.</description></item><item><title>Implantable cardiac defibrillator ICD</title><link>https://www.physician.tw/Implantable-cardiac-defibrillator-ICD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Implantable-cardiac-defibrillator-ICD/</guid><description>Implantable cardiac defibrillator (ICD) (Circ 2019;140:e382)
RV lead: defib &amp;amp; pacing (Â± antitachycardia pacing [ATP] = burst pacing &amp;gt; VT rate to stop VT); Â± RA lead for dual-chamber PPM.</description></item><item><title>incidence of vasculitides</title><link>https://www.physician.tw/incidence-of-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/incidence-of-vasculitides/</guid><description>incidence of vasculitides reported to be 40-60 cases per 1 million persons, with giant cell arteritis (GCA) being the most common type of primary systemic vasculitis among adults, particularly those aged &amp;gt; 50 years.</description></item><item><title>Indications for Permanent Pacing</title><link>https://www.physician.tw/Indications-for-Permanent-Pacing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-Permanent-Pacing/</guid><description>Indications for Permanent Pacing (JACC 2013;61:e6 &amp;amp; 2017;70:e39, Circ 2019;140:e382)
AV block 2Â° type II, high-grade or 3Â° AVB; symptomatic 1Â°, 2Â° type I AVB or asx with Lamin A/C or neuromuscular disease; bifasc or alter.</description></item><item><title>Indications for surgery-bacterial endocarditis</title><link>https://www.physician.tw/Indications-for-surgery-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-surgery-bacterial-endocarditis/</guid><description>Indications for surgery-bacterial endocarditis (consult early; JTCS 2017;153:1241; Circ 2021;143:e72)
Emergent if refractory cardiogenic shock Urgent (during initial hospitalization): Sx HF Penetrating infection: periannular abscess, heart block, fistula, worsening conduction Persistent infection: âŠ• BCx after &amp;gt;5 d of appropriate abx, â†‘ or ?</description></item><item><title>Indications for urgent dialysis</title><link>https://www.physician.tw/Indications-for-urgent-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-for-urgent-dialysis/</guid><description>Indications for urgent dialysis Acid-base disturbance: refractory acidemia
Electrolyte disorder: hyperK; hyperCa, hyperPO4, tumor lysis syndrome</description></item><item><title>indications of thoracentesis</title><link>https://www.physician.tw/indications-of-thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/indications-of-thoracentesis/</guid><description>indications of thoracentesis all effusions &amp;gt;1 cm in decubitus view if suspect due to CHF, can diurese and see if effusions resolve (75% do so in 48 h); asymmetry, fever, chest pain or failure to resolve â†’ thoracentesis [[parapneumonic effusions]] should be tapped ASAP (cannot exclude infxn clinically)</description></item><item><title>Indications PA catheter and tailored therapy</title><link>https://www.physician.tw/Indications-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Indications-PA-catheter-and-tailored-therapy/</guid><description>Indications PA catheter and tailored therapy * Diagnosis and evaluation Ddx of shock (cardiogenic vs. distributive; espec if trial of IVF failed or is high risk) and of pulmonary edema (cardiogenic vs.</description></item><item><title>Infection as Etiologies of Classic FUO</title><link>https://www.physician.tw/Infection-as-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Infection-as-Etiologies-of-Classic-FUO/</guid><description>Infection as Etiologies of Classic FUO Tuberculosis: disseminated or extrapulm. disease can have normal CXR, PPD/IGRA, sputum AFB; bx (lung, liver, bone marrow) for granulomas has 80â€“90% yield in milliary disease</description></item><item><title>infections of the nervous system</title><link>https://www.physician.tw/infections-of-the-nervous-system/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infections-of-the-nervous-system/</guid><description>infections of the nervous system [[cerebrospinal fluid lab results]]
[[acute bacterial meningitis]] [[aseptic meningitis]] [[encephalitis]] [[Bellâ€™s palsy]] [[herpes zoster]] (SHINGLES) [[Cryptococcus neoformans]] [[herpes simplex virus infection]] å–®ç´”çš°ç–¹ç—…æ¯’ [[computed tomogram in central nervous system infection]]</description></item><item><title>infectious disease</title><link>https://www.physician.tw/infectious-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infectious-disease/</guid><description>infectious disease [[pneumonia]] [[fungal infections]] [[infxns in immunosuppressed hosts]] [[urinary tract infections]] [[sexually transmitted infections]] [[skin and soft tissue infections]] [[infections of the nervous system]] [[bacteremia and endocarditis]] [[infective endocarditis]] [[tuberculosis]] [[HIV AIDS]] [[tick-borne diseases]] [[fever syndromes]] [[antibiotics]] [[pathogen]] Resident 360 topics [[Diabetic Foot Infection]] [[opportunistic infections]] Tuberculosis Clostridium difficile Infection Epidural Abscess and [[vertebral osteomyelitis]], Meningitis/Encephalitis (Neurology) others [[An Approach to Diagnosing and Treating Infectious Diseases]] [[infectious diseases and pathophysiology]] [[infectious diseases key medications &amp;amp; interventions]] [[infectious diseases key clinical trials &amp;amp; publications]]</description></item><item><title>inflammatory bowel disease</title><link>https://www.physician.tw/inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inflammatory-bowel-disease/</guid><description>inflammatory bowel disease Definition (NEJM 2020;383:2652) Ulcerative colitis (UC): inflammation of the colonic mucosa; contiguous, starting at rectum Crohnâ€™s disease (CD): transmural inflammation anywhere along GI tract, skip lesions Epidemiology &amp;amp; pathophysiology (Lancet 2016;387:156 &amp;amp; 2017;390:2769) Age of onset 15â€“30 y; bimodal w/ 2nd peak at 50â€“70 y; 1:1 M:F in N America</description></item><item><title>Inflammatory diarrhea</title><link>https://www.physician.tw/Inflammatory-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inflammatory-diarrhea/</guid><description>Inflammatory diarrhea (âŠ• fecal WBC, calprotectin, lactoferrin; âŠ• FOB; fever, abd pain)
Infections: chronic C. diff, Entamoeba histolytica, Yersinia, CMV, TB especially in immunocompromised hosts.</description></item><item><title>INFLAMMATORY-Acute Infectious Etiologies</title><link>https://www.physician.tw/INFLAMMATORY-Acute-Infectious-Etiologies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/INFLAMMATORY-Acute-Infectious-Etiologies/</guid><description>INFLAMMATORY-Acute Infectious Etiologies Predom. colonic invasion. Small-vol diarrhea. LLQ cramps, tenesmus, fever, typically âŠ• fecal WBC or FOB.
Bacterial (SYSCC) Campylobacter Undercooked poultry, unpasteurized milk; carried by -puppies &amp;amp; kittens.</description></item><item><title>infxns in immunosuppressed hosts</title><link>https://www.physician.tw/infxns-in-immunosuppressed-hosts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/infxns-in-immunosuppressed-hosts/</guid><description>infxns in immunosuppressed hosts Overview
Many Pts have â‰¥1 risk (eg, DM, ESRD, transplant, extremes of age) Accurate dx of opportunistic infections and targeted Rx key in this population The following is not an exhaustive list, but a delineation of common or classic etiologies (NEJM 2007;357:2601; Am J Med 2007;120:764; CID 2011;53:798) [[Humoral immune dysfunction]] [[Granulocytopenia or neutropenia]] [[Impaired cell-mediated immunity]] [[Organ dysfunction]] [[Biologics]]</description></item><item><title>Ingestions-caused-metabolic-acidosis</title><link>https://www.physician.tw/Ingestions-caused-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ingestions-caused-metabolic-acidosis/</guid><description>Ingestions-caused-metabolic-acidosis (NEJM 2018;378:270) Call poison control for guidance (02-28757525-821 åŒ—æ¦®æ¯’ç‰©ç§‘)
Acetaminophen Hepatitis Salicylates Fever, tachycardia, tinnitus; met. acid. + resp. alkalosis</description></item><item><title>Inherited Disorders of Connective Tissue</title><link>https://www.physician.tw/Inherited-Disorders-of-Connective-Tissue/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inherited-Disorders-of-Connective-Tissue/</guid><description>Ehlers-Danlos syndrome (EDS) Epidermolysis bullosa (EB) Marfan syndrome Osteogenesis imperfecta</description></item><item><title>Inherited Hypercoagulable States</title><link>https://www.physician.tw/Inherited-Hypercoagulable-States/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Inherited-Hypercoagulable-States/</guid><description>Inherited Hypercoagulable States Factor V Leiden 3â€“7% 2.65 Activated protein C (APC) resistance Prothrombin mutation 2% 1.45 G20210A â†’ â†‘ prothrombin level Hyperhomocysteinemia 5â€“10% Inherited or acquired (vitamin defic.</description></item><item><title>Initial antibiotic therapy of fever and neutropenia</title><link>https://www.physician.tw/Initial-antibiotic-therapy-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-antibiotic-therapy-of-fever-and-neutropenia/</guid><description>Initial antibiotic therapy of fever and neutropenia Empiric regimens should include antipseudomonal activity; consider VRE coverage if âŠ• Low risk: PO abx or home IV abx may be considered in select Pts (JCO 2013;31:1149) PO options: cipro+amoxicillin-clavulanate; levofloxacin; moxifloxacin (avoid if FQ Ppx) High risk: hospital admission &amp;amp; IV abx; monotherapy preferred options: cefepime, imipenem, meropenem, piperacillin/tazobactam, ceftazidime Antifungal Rx added for neutropenic fever â‰¥4 d despite abx: micafungin, liposomal amphotericin B, caspofungin, anidulafungin, voriconazole, &amp;amp; posaconazole are options</description></item><item><title>Initial anticoagulation options for-venous thromboembolism</title><link>https://www.physician.tw/Initial-anticoagulation-options-for-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-anticoagulation-options-for-venous-thromboembolism/</guid><description>Initial anticoagulation options for-venous thromboembolism (EHJ 2020;41:543; Chest 2021;160:e545)
Initiate immediately if high or intermed suspicion but dx test results will take â‰¥4 h</description></item><item><title>Initial evaluation diagnostic studies-acute aortic syndromes</title><link>https://www.physician.tw/Initial-evaluation-diagnostic-studies-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-diagnostic-studies-acute-aortic-syndromes/</guid><description>Initial evaluation diagnostic studies-acute aortic syndromes (Circ 2010;121:e266; EHJ 2018;39:739)
H&amp;amp;P, incl. bilat BP &amp;amp; radial pulses for symmetry; ECG w/ STE if propagates to cor CXR: abnl in 60â€“90% [â†‘ mediast.</description></item><item><title>Initial evaluation of change in mental status</title><link>https://www.physician.tw/Initial-evaluation-of-change-in-mental-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-of-change-in-mental-status/</guid><description>Initial evaluation of change in mental status see [[Stepwise Evaluation of a Patient with Delirium]]
History (witness &amp;amp; background crucial): tempo, premorbid sx (eg, focal neuro deficits, HA, infxn, pain, falls), medical conditions (eg, dementia, epilepsy, onc, cardiac, psych, infection/immune status), accompanied by head trauma, current meds (eg, sedatives, opioids, anticoag, anticonvulsants, immunosuppressants), drug/alcohol use General exam: VS, breathing pattern (eg, Cheyne-Stokes), tongue bite (seizure), nuchal rigidity (meningitis, SAH; do not test if c/f trauma/cervical spine fx), ecchymoses, rash, signs of head trauma (eg, Battle sign, raccoon eyes, hemotympanum, CSF rhinorrhea), asterixis, liver disease stigmata, embolic phenomena/endocarditis, s/s drug use Neuro exam</description></item><item><title>Initial evaluation-management-inflammatory bowel disease</title><link>https://www.physician.tw/Initial-evaluation-management-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-management-inflammatory-bowel-disease/</guid><description>Initial evaluation-management-inflammatory bowel disease H&amp;amp;P (âœ“ for intestinal &amp;amp; extraintestinal manifestations) and dx studies as above
Lab: consider CBC/diff, LFTs, iron studies, B12, folate, vit D, ESR, CRP, fecal calprotectin</description></item><item><title>Initial evaluation-solitary pulmonary nodule</title><link>https://www.physician.tw/Initial-evaluation-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-evaluation-solitary-pulmonary-nodule/</guid><description>Initial evaluation-solitary pulmonary nodule History: h/o cancer, smoking, age (&amp;lt;30 y = 2% malignant, +15% each decade &amp;gt;30)</description></item><item><title>initial test of hypophosphatemia</title><link>https://www.physician.tw/initial-test-of-hypophosphatemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/initial-test-of-hypophosphatemia/</guid><description>initial test of hypophosphatemia serum calcium, vitamin D, and parathyroid hormone levels; arterial blood gas; urine phosphorus and creatinine levels; fractional excretion of phosphorus; fractional excretion of phosphorus &amp;lt; 5% suggests a nonrenal mechanism (intracellular uptake or gastrointestinal); x-ray, if osteomalacia is suspected.</description></item><item><title>Initial treatment details of asthma</title><link>https://www.physician.tw/Initial-treatment-details-of-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-treatment-details-of-asthma/</guid><description>Initial treatment details of asthma Oxygen to keep SaO2 â‰¥93â€“95%
Inhaled SABA (eg, albuterol) by MDI (4â€“8 puffs) or nebulizer (2.</description></item><item><title>Initial treatment-clostridioides difficile infection</title><link>https://www.physician.tw/Initial-treatment-clostridioides-difficile-infection-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-treatment-clostridioides-difficile-infection-/</guid><description>Initial treatment-clostridioides difficile infection (CID 2021;73:5; Am J Gastro 2021;116:1124)
If possible, d/c abx ASAP; stop antimotility agents &amp;amp; cholestyramine if using (binds vanco)</description></item><item><title>Initial workup-bronchiectasis</title><link>https://www.physician.tw/Initial-workup-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Initial-workup-bronchiectasis/</guid><description>Initial workup-bronchiectasis H&amp;amp;P: cough, dyspnea, copious sputum production, Â±hemoptysis, inspiratory â€œsqueaksâ€
CXR: scattered or focal; rings of bronchial cuffing; â€œtram trackâ€ of dilated, thick airways</description></item><item><title>inpatient oncology</title><link>https://www.physician.tw/inpatient-oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/inpatient-oncology/</guid><description>inpatient oncology [[assessment of hospitalized cancer patients]]</description></item><item><title>Insulin Preparations</title><link>https://www.physician.tw/Insulin-Preparations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Insulin-Preparations/</guid><description>Insulin Preparations</description></item><item><title>integrase strand transfer inhibitor-INSTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/integrase-strand-transfer-inhibitor-INSTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/integrase-strand-transfer-inhibitor-INSTI-Antiretrovirals-ARVs/</guid><description>integrase strand transfer inhibitor-INSTI-Antiretrovirals (ARVs) bictegravir (BIC; Biktarvy) dolutegravir (DTG; Tivicay) elvitegravir (EVG; Vitekta) raltegravir (RAL; Isentress) cabotegravir (CAB; Vocabria) Class: diarrhea; weight gain; â†‘ CPK DTG/BIC â†‘ metformin levels; monitor glc DTG a/w 0.</description></item><item><title>interpretation of serum calcium</title><link>https://www.physician.tw/interpretation-of-serum-calcium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interpretation-of-serum-calcium/</guid><description>interpretation of serum calcium é›¢å­éˆ£ä»ç„¶æ˜¯è©•ä¼°éˆ£ç‹€æ…‹çš„é‡‘æ¨™æº–ï¼Œç‰¹åˆ¥æ˜¯å¦‚æœç”±æ–¼ä½ç™½è›‹ç™½è¡€ç—‡ã€éå…¸å‹æˆ–ç„¡ç—‡ç‹€æˆ–è¡€æ¸…éˆ£æ¿ƒåº¦æœ€ä½é™åº¦é™ä½è€Œå°ä½éˆ£è¡€ç—‡çš„è¨ºæ–·å­˜åœ¨ç–‘å•ã€‚å¦‚æœæ²’æœ‰å·²çŸ¥çš„å¯é æ¸¬é‡é›¢å­éˆ£çš„å¯¦é©—å®¤ï¼Œå‰‡æ‡‰ä½¿ç”¨éˆ£æ ¡æ­£å…¬å¼å°è¡€æ¸…ç™½è›‹ç™½ä¸­çš„ä»»ä½•ç•°å¸¸é€²è¡Œç¸½éˆ£æ ¡æ­£ã€‚
å°æ–¼è¼•åº¦ä½éˆ£è¡€ç—‡æˆ–æ…¢æ€§ä½éˆ£è¡€ç—‡ï¼ˆç”±æ–¼ç”²ç‹€æ—è…ºåŠŸèƒ½æ¸›é€€ç—‡ï¼‰çš„æ‚£è€…ï¼Œç„¡æ³•æœç”¨æˆ–å¸æ”¶å£æœè£œå……åŠ‘ï¼ˆå¦‚åœ¨éœ€è¦é•·æ™‚é–“ä¼‘é¤Šçš„è¤‡é›œå¤–ç§‘æ‰‹è¡“å¾Œå¯èƒ½ç™¼ç”Ÿï¼‰ï¼Œå¯èƒ½éœ€è¦éœè„ˆè£œéˆ£ä»¥é é˜²æ€¥æ€§ä½éˆ£è¡€ç—‡ã€‚
æœ€åˆï¼ŒIV éˆ£ï¼ˆ1 æˆ– 2 g è‘¡è„ç³–é…¸éˆ£ï¼Œç›¸ç•¶æ–¼ 90 æˆ– 180 mg å…ƒç´ éˆ£ï¼Œåœ¨ 50 mL D5W æˆ– NS ä¸­ï¼‰å¯ä»¥åœ¨ 10 åˆ° 20 åˆ†é˜å…§è¼¸æ³¨ã€‚å¦‚æœéœ€è¦è§£æ±ºç—‡ç‹€ï¼Œå¯åœ¨ 10 è‡³ 60 åˆ†é˜å¾Œé‡è¤‡ã€‚ç­‰æ•ˆåŠ‘é‡ï¼ŒSI å–®ä½ï¼š2.</description></item><item><title>interstitial lung disease</title><link>https://www.physician.tw/interstitial-lung-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/interstitial-lung-disease/</guid><description>interstitial lung disease WORKUP OF ILD [[Broad categories-interstitial lung disease]] [[Rule out mimickers of ILD]] [[History and physical exam-interstitial lung disease]] [[Diagnostic studies-interstitial lung disease]]</description></item><item><title>Intracardiac pressures PA catheter and tailored therapy</title><link>https://www.physician.tw/Intracardiac-pressures-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intracardiac-pressures-PA-catheter-and-tailored-therapy/</guid><description>Intracardiac pressures PA catheter and tailored therapy Transmural pressure (â‰ˆ preload) = measured intracardiac pressure â€“ intrathoracic pressure</description></item><item><title>intrathecal chemotherapy</title><link>https://www.physician.tw/intrathecal-chemotherapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/intrathecal-chemotherapy/</guid><description>intrathecal chemotherapy The distinction between the two different leptomeningeal tumor spreading patterns described above has an impact on the indication for an intrathecal chemotherapy:</description></item><item><title>Intrinsic acute kidney injury etiology</title><link>https://www.physician.tw/Intrinsic-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Intrinsic-acute-kidney-injury-etiology/</guid><description>Intrinsic acute kidney injury etiology [[Acute tubular necrosis (ATN)]] Pigmented granular [[muddy brown casts]] Â± RBCs &amp;amp; protein from tubular damage FENa &amp;gt;2%, BUN/Cr &amp;lt;20 (except pigment, CIN) FEUN &amp;gt;50% [[Acute interstitial nephritis]] WBCs, WBC casts, Â± RBCs w/ neg UCx âŠ• urine eos in abx âŠ• lymphs in NSAIDs [[Small-med vessel acute kidney injury]] Â± RBCs âŠ• urine eos in chol emboli Glomerulonephritis Dysmorphic RBCs, RBC casts</description></item><item><title>IPF idiopathic pulm fibrosis</title><link>https://www.physician.tw/IPF-idiopathic-pulm-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IPF-idiopathic-pulm-fibrosis/</guid><description>IPF idiopathic pulm fibrosis UIP imaging pattern: reticular opacities, honeycombing, traction bronchiectasis; peripheral, subpleural, &amp;amp; basal
Sx &amp;gt;12 mo
5-y mort ~80%</description></item><item><title>ipratropium</title><link>https://www.physician.tw/ipratropium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ipratropium/</guid><description>ipratropium Atroventï¼Œå±¬æ–¼ä¸€ç¨®æ”¯æ°£ç®¡æ“´å¼µè—¥ã€‚
æœ¬å“é€šå¸¸ç”¨æ–¼æ²»ç™‚æ…¢æ€§é˜»å¡æ€§è‚ºç—…ä»¥åŠå“®å–˜ï¼Œé€šå¸¸ä»¥å¸å…¥åŠ‘æˆ–éœ§åŒ–åŠ‘çš„å½¢å¼éŠ·å”®ã€‚ é€šå¸¸è—¥æ•ˆæœƒæ–¼15-30åˆ†é˜å¾Œé–‹å§‹ä½œç”¨ï¼Œ ä½œç”¨æ™‚é–“ç¶­æŒ3è‡³5å°æ™‚ã€‚ å£ä¹¾ã€å’³å—½ï¼Œä»¥åŠæ”¯æ°£ç®¡ç‚ã€‚ æ½›åœ¨å‰¯ä½œç”¨åŒ…å«å°¿ç€¦ç•™ã€å‘¼å¸é“ç—™æ”£ï¼Œ</description></item><item><title>Ipratropium of COPDAE</title><link>https://www.physician.tw/Ipratropium-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ipratropium-of-COPDAE/</guid><description>Ipratropium of COPDAE MDI 4â€“8 puffs q1â€“2h or Nebulizer 0.5 mg q1â€“2h First-line therapy (NEJM 2011;364:1093)</description></item><item><title>irAE</title><link>https://www.physician.tw/irAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/irAE/</guid><description>irAE [[my report about irAE]] [[oncology]] [[immunotherapy and cellular therapy]]
reference Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series - PubMed PD-1/PD-L and autoimmunity: A growing relationship - ScienceDirect Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab - PubMed Oral mucositisâ€”case series of a rare adverse effect associated with immunotherapy | SpringerLink</description></item><item><title>Iron deficiency</title><link>https://www.physician.tw/Iron-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Iron-deficiency/</guid><description>Iron deficiency (Lancet 2021;397:233)
â†“ marrow iron &amp;amp; depleted body iron stores â†’ â†“ heme synthesis â†’ microcytosis â†’ anemia</description></item><item><title>Iron-supplementation</title><link>https://www.physician.tw/Iron-supplementation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Iron-supplementation/</guid><description>Iron-supplementation ? IV (not PO) if NYHA II/III, EF â‰¤40%, Fe-defic (ferritin &amp;lt;100 or 100â€“ 300 &amp;amp; TSAT &amp;lt;20%). ~20% â†“ HF hosp.</description></item><item><title>Irradiated blood products</title><link>https://www.physician.tw/Irradiated-blood-products/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irradiated-blood-products/</guid><description>Irradiated blood products Prevents donor T-cell engraftment and risk of transfusion-assoc. GVHD (HSCT, heme malignancy, congenital immunodeficiency).</description></item><item><title>irregular of narrow complex</title><link>https://www.physician.tw/irregular-of-narrow-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/irregular-of-narrow-complex/</guid><description>irregular of narrow complex AF, AFL, or MAT
Control rate w/ diltiazem or metoprolol or amiodarone</description></item><item><title>Irritable bowel syndrome</title><link>https://www.physician.tw/Irritable-bowel-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Irritable-bowel-syndrome/</guid><description>Irritable bowel syndrome (JAMA 2015;313:949; Gastro 2015;149:1399 &amp;amp; 2018;154:1140)
Abd discomfort for 6+ mos a/w â‰¥2: improves w/ defecation, Î” stool frequency, Î” stool form</description></item><item><title>ischemic colitis</title><link>https://www.physician.tw/ischemic-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ischemic-colitis/</guid><description>ischemic colitis Definition &amp;amp; pathophysiology Nonocclusive disease 2Â° to Î”s in systemic circulation or anatomic/fxnal Î”s in local mesenteric vasculature; often underlying etiology unknown, frequently seen in elderly â€œWatershedâ€ areas (splenic flexure &amp;amp; rectosigmoid) most susceptible; 25% involve R side; confers worse prognosis (Clin Gastroenterol Hepatol 2015;13:1969) Clinical manifestations, diagnosis, &amp;amp; treatment Usually p/w cramping LLQ pain w/ overtly bloody stool; fever and peritoneal signs should raise clinical suspicion for infarction Disease spectrum: reversible colopathy (35%), transient colitis (15%), chronic ulcerating colitis (20%), resulting stricture (10%), gangrene (15%), fulminant colitis (&amp;lt;5%) Dx: flex sig/colonoscopy or CT abd/pelvis to make diagnosis; r/o IBD, infectious colitis Treatment: bowel rest, IV fluids, broad-spectrum abx, serial abd exams; surgery for infarction, fulminant colitis, hemorrhage, failure of med Rx, recurrent sepsis, stricture Resolution w/in 48 h w/ conservative measures occurs in &amp;gt;50% of cases</description></item><item><title>Ischemic hepatitis</title><link>https://www.physician.tw/Ischemic-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ischemic-hepatitis/</guid><description>Ischemic hepatitis â€œShock liverâ€ w/ AST &amp;amp; ALT &amp;gt;1000 + â†‘â†‘ LDH (ALT:LDH ratio often &amp;lt;1:5); delayed â†‘â†‘ Tbili</description></item><item><title>Isolated proteinuria</title><link>https://www.physician.tw/Isolated-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Isolated-proteinuria/</guid><description>Isolated proteinuria By defâ€™n: asx, normal renal fxn, sed, &amp;amp; imaging, no h/o renal disease Etiologies Functional (fever, exercise, CHF) Orthostatic (only when upright) Idiopathic (transient or persistent)</description></item><item><title>Isopropanol-toxicology</title><link>https://www.physician.tw/Isopropanol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Isopropanol-toxicology/</guid><description>Isopropanol-toxicology CNS depression, gastritis
Supportive care</description></item><item><title>IV Drugs for Hypertensive Crises</title><link>https://www.physician.tw/IV-Drugs-for-Hypertensive-Crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IV-Drugs-for-Hypertensive-Crises/</guid><description>IV Drugs for Hypertensive Crises (Circ 2018;138:e426; Stroke 2018;49:46) Labetalol 20â€“80 mg IVB q10min or 0.4â€“2 mg/min AoD, ACS, Stroke, Eclampsia Esmolol 0.</description></item><item><title>IV immune globulin</title><link>https://www.physician.tw/IV-immune-globulin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/IV-immune-globulin/</guid><description>IV immune globulin Polyvalent IgG from &amp;gt;1000 donors. For postexposure prophylaxis (eg, HAV), certain autoimmune disorders (eg, ITP, Guillain-BarrÃ©, MG, CIDP), congenital or acquired hypogammaglobulinemia (CVID, CLL).</description></item><item><title>Ivabradine</title><link>https://www.physician.tw/Ivabradine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ivabradine/</guid><description>Ivabradine Reasonable if EF â‰¤35%, NYHA II or III, HR â‰¥70, NSR on max bB.
18% â†“ CV mort or HF hosp (Lancet 2010;376:875)</description></item><item><title>JAMA 2021;325:962</title><link>https://www.physician.tw/JAMA-2021325962/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/JAMA-2021325962/</guid><description>JAMA 2021;325:962 é‡è¦æ€§ è‚ºç™Œæ˜¯ç¾åœ‹ç¬¬äºŒå¸¸è¦‹çš„ç™Œç—‡ï¼Œä¹Ÿæ˜¯ç¾åœ‹ç™Œç—‡æ­»äº¡çš„ä¸»è¦åŸå› ã€‚ 2020å¹´ï¼Œä¼°è¨ˆæœ‰228820äººè¢«è¨ºæ–·å‡ºæ‚£æœ‰è‚ºç™Œï¼Œ135720äººæ­»æ–¼è©²ç–¾ç—…ã€‚è‚ºç™Œæœ€é‡è¦çš„å±éšªå› ç´ æ˜¯å¸ç…™ã€‚å¹´é½¡å¢é•·ä¹Ÿæ˜¯è‚ºç™Œçš„å±éšªå› ç´ ã€‚è‚ºç™Œçš„é å¾Œé€šå¸¸ä¸ä½³ï¼Œç¸½5å¹´ç”Ÿå­˜ç‡ç‚º20.5ï¼…ã€‚ ä½†æ˜¯ï¼Œæ—©æœŸè‚ºç™Œçš„é å¾Œè¼ƒå¥½ï¼Œä¸¦ä¸”æ›´é©åˆæ²»ç™‚ã€‚
ç›®çš„ æ˜¯æ›´æ–°å…¶2013å¹´å»ºè­°ï¼Œç¾åœ‹é é˜²æœå‹™å·¥ä½œçµ„ï¼ˆUSPSTFï¼‰å§”è¨—å°ä½¿ç”¨ä½åŠ‘é‡è¨ˆç®—æ©Ÿæ–·å±¤æƒæï¼ˆLDCTï¼‰ï¼ˆLDCTï¼‰é€²è¡Œç¯©æŸ¥çš„æº–ç¢ºæ€§ä»¥åŠè‚ºç™Œç¯©æŸ¥çš„ç›Šè™•å’Œå±å®³ï¼Œä¸¦å§”è¨—ä¸€é …å”ä½œå»ºæ¨¡ç ”ç©¶ï¼Œæ—¨åœ¨æä¾›æœ‰é—œé–‹å§‹å’ŒçµæŸç¯©æŸ¥ï¼Œæœ€ä½³ç¯©é¸é–“éš”ä»¥åŠèˆ‡å¤šå…ƒé¢¨éšªé æ¸¬æ¨¡å‹çš„ä¿®æ”¹ç‰ˆæœ¬ç›¸æ¯”ï¼Œä¸åŒç¯©é¸ç­–ç•¥çš„ç›¸å°ç›Šè™•å’Œå±å®³çš„ä¿¡æ¯ã€‚
äººå£ æ­¤å»ºè­°è²æ˜é©ç”¨æ–¼50è‡³80æ­²çš„æˆå¹´äººï¼Œä»–å€‘æœ‰20å¹´çš„å¸ç…™å²ï¼Œç›®å‰å¸ç…™æˆ–åœ¨éå»15å¹´å…§æˆ’è¸ã€‚
è­‰æ“š è©•ä¼°USPSTFä»¥é©åº¦çš„ç¢ºå®šæ€§å¾—å‡ºçµè«–ï¼šä½¿ç”¨LDCTé€²è¡Œè‚ºç™Œçš„å¹´åº¦ç¯©æŸ¥åœ¨è‚ºç™Œé«˜é¢¨éšªçš„äººä¸­å…·æœ‰é©åº¦çš„æ·¨ç›Šè™•ï¼Œå› ç‚ºå¹´é½¡ï¼Œç´¯ç©ç´¯ç©æš´éœ²æ–¼è¸è‰ç…™éœ§ä»¥åŠè‡ªå¾æˆ’è¸ä»¥ä¾†çš„å¹´ä»½ã€‚
å»ºè­° USPSTFå»ºè­°åœ¨50è‡³80æ­²çš„æˆå¹´äººä¸­å°LDCTé€²è¡Œ å¹´åº¦ç¯©æŸ¥ï¼Œä»–å€‘æ“æœ‰20å¹´çš„å¸ç…™å²ï¼Œç›®å‰å¸ç…™æˆ–åœ¨éå»15å¹´å…§æˆ’è¸ã€‚ ä¸€æ—¦ä¸€å€‹äººåœ¨15å¹´æ²’æœ‰å¸ç…™æˆ–è£½å®šå¥åº·å•é¡Œï¼Œè©²ç¯©æŸ¥æ‡‰åœæ­¢ç¯©æŸ¥ï¼Œè©²å•é¡Œå¯¦è³ªä¸Šé™åˆ¶äº†é æœŸå£½å‘½æˆ–é€²è¡Œæ²»æ„ˆæ€§è‚ºæ‰‹è¡“çš„èƒ½åŠ›æˆ–æ„é¡˜ã€‚ ï¼ˆbå»ºè­°ï¼‰è©²å»ºè­°å–ä»£äº†2013å¹´USPSTFè²æ˜ï¼Œè©²è²æ˜å»ºè­°åœ¨55è‡³80æ­²çš„æˆå¹´äººä¸­å°LDCTé€²è¡Œå¹´åº¦ç¯©æŸ¥ï¼Œä»–å€‘æ“æœ‰30å¹´çš„å¸ç…™å²ï¼Œç›®å‰åœ¨éå»15å¹´å…§å¸ç…™æˆ–é€€å‡ºã€‚
ä¾†è‡ª: [[lung cancer]]</description></item><item><title>JAMA review of hyponatremia</title><link>https://www.physician.tw/JAMA-review-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/JAMA-review-of-hyponatremia/</guid><description>Diagnosis and Management of Hyponatremia JAMA.Â 2022;328(3):280-291. ç¶“éé€™éº¼å¤šå¹´å¾Œï¼Œç†±é¨°é¨°çš„Hyponatremia review.
&amp;ldquo;Hyponatremia, which is defined as a serum sodium level of less than 135 mEq/L, affects approximately 5% of adults.</description></item><item><title>jupyter</title><link>https://www.physician.tw/jupyter/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/jupyter/</guid><description>docker run -i &amp;ndash;rm &amp;ndash;user root -p 8888:8888 -e NB UID=1026 -e NB GID=100 -e NB USER=lizard -e CHOWN HOME=yes -e CHOWN HOME OPTS=&amp;quot;-R&amp;quot; -w &amp;ldquo;/home/${NB USER}&amp;rdquo; -v /volume1/docker/jupyter:/home/${NB USER}/ jupyter/minimal-notebook:latest</description></item><item><title>K-sparing diuretics</title><link>https://www.physician.tw/K-sparing-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/K-sparing-diuretics/</guid><description>K-sparing diuretics (NEJM 2017;377:1964)
Drugs: spironolactone (Aldactone), amiloride, triamterene, eplerenone
Mech: â†“ Na reabsorption (~1%) in collecting duct (amiloride/triamterene inhibit principal cell Na channel [ENaC]; spironolactone/eplerenone inhibit mineralocorticoid receptor).</description></item><item><title>Kawasaki disease</title><link>https://www.physician.tw/Kawasaki-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kawasaki-disease/</guid><description>Kawasaki disease Usually Asian children &amp;lt; 4 years old.
CRASH Conjunctivitis, Bilateral nonexudative bulbar Rash (polymorphous desquamating), Adenopathy (cervical) Strawberry tongue (oral mucositis), Hand-foot changes (edema, erythema), Burn: fever.</description></item><item><title>ketamine</title><link>https://www.physician.tw/ketamine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ketamine/</guid><description>ketamine contraindicated in patients with underlying conditions in which increased blood pressure would pose a risk of complications such as aortic dissection, uncontrolled hypertension, myocardial infarction, or aneurysms.</description></item><item><title>KEYNOTE-181</title><link>https://www.physician.tw/KEYNOTE-181/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/KEYNOTE-181/</guid><description>KEYNOTE-181 Purpose: Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy.
Patients and methods: In this open-label, phase III study, we randomly assigned (1:1) 628 patients with advanced/metastatic squamous cell carcinoma or adenocarcinoma of the esophagus, that progressed after one prior therapy, to pembrolizumab 200 mg every 3 weeks for up to 2 years or chemotherapy (investigator&amp;rsquo;s choice of paclitaxel, docetaxel, or irinotecan).</description></item><item><title>kidney disease</title><link>https://www.physician.tw/kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/kidney-disease/</guid><description>kidney disease [[acute kidney injury (AKI)]] [[disease-specific management of kidney disease]] [[chronic kidney disease (CKD)]] [[diuresis]] [[renal replacement and dialysis]]</description></item><item><title>Kidney transplantation</title><link>https://www.physician.tw/Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kidney-transplantation/</guid><description>Kidney transplantation (Med Clin N Am 2016;100:435)
Refer when GFR &amp;lt;20. Contraindic: active malig, infxn, ischemia, noncompl, subst use 5-yr survival: living donor 91%; deceased donor 70â€“84% (AJKD 2016;23:281).</description></item><item><title>Kingâ€™s College Criteria for Liver Transplantation consideration</title><link>https://www.physician.tw/Kings-College-Criteria-for-Liver-Transplantation-consideration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Kings-College-Criteria-for-Liver-Transplantation-consideration/</guid><description>Kingâ€™s College Criteria for Liver Transplantation consideration Acetaminophen ALF: arterial pH &amp;lt;7.30 or Grade III/IV enceph + INR &amp;gt;6.5 + Cr &amp;gt;3.</description></item><item><title>Laboratory Findings in Calcium Disorders</title><link>https://www.physician.tw/Laboratory-Findings-in-Calcium-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-Findings-in-Calcium-Disorders/</guid><description>Laboratory Findings in Calcium Disorders [[interpretation of serum calcium]] [[Serum parathyroid hormone (PTH) concentrations in hypercalcemia and hypocalcemia]] Ca: bones parathyroid hormone: thief of bones 25-(OH)D: intestine to blood Ca PTH Disease PO4 25-(OH)D 1,25-(OH),D up upup Hyperparathyroidism (1Â° and 3Â°) down down to normal normal to up up up or normal Familial hypocalciuric hypercalcemia down var.</description></item><item><title>Laboratory studies-cirrhosis</title><link>https://www.physician.tw/Laboratory-studies-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Laboratory-studies-cirrhosis/</guid><description>Laboratory studies-cirrhosis LFTs: â†‘ bili, â†‘ PT/INR (poor correlation w/ bleeding; factor VIII nl b/c not synthesized by liver), â†“ alb, Â± â†‘ aminotransferases (AST &amp;gt;ALT if late) and â†‘ AÏ• (variable)</description></item><item><title>Lactic acidosis</title><link>https://www.physician.tw/Lactic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lactic-acidosis/</guid><description>Lactic acidosis Type A: hypoxic (eg, shock, mesenteric ischemia, CO poisoning, cyanide) Type B: nonhypoxic. â†“ clearance (eg, hepatic dysfxn) or â†‘ generation [eg, malig, EtOH, thiamine def.</description></item><item><title>laryngoscopy and confirmation of placement</title><link>https://www.physician.tw/laryngoscopy-and-confirmation-of-placement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/laryngoscopy-and-confirmation-of-placement/</guid><description>laryngoscopy and confirmation of placement âœ¨é‡é»: åœ¨ç¢ºä¿é©ç•¶çš„æº–å‚™ã€è¨­å‚™è¨­ç½®ã€åŠŸèƒ½ç›£æ¸¬å™¨ã€å®šä½å’Œé æ°§åˆå¾Œï¼Œé€šå¸¸æœƒç‚ºæ‚£è€…æ–½ç”¨å¼•èµ·å‘¼å¸æš«åœçš„è—¥ç‰©å’Œéº»ç—ºåŠ‘ï¼Œé€™å…©ç¨®è—¥ç‰©éƒ½æ˜¯æ ¹æ“šæ‚£è€…çš„æƒ…æ³å’Œè‡¨åºŠæƒ…æ³é¸æ“‡çš„ã€‚ é‚„æ‡‰æ³¨æ„ï¼Œåœ¨æŸäº›æƒ…æ³ä¸‹ï¼Œä¾‹å¦‚å¿ƒè‡Ÿé©Ÿåœï¼Œå¯èƒ½ä¸éœ€è¦èª˜å°åŠ‘ã€‚ ç•¶æ‚£è€…è¢«èªç‚ºå·²é©ç•¶éº»é†‰æ™‚ï¼Œå–‰é¡ç”±æä¾›è€…çš„å·¦æ‰‹æ‹¿è‘—ï¼Œè€Œå³æ‰‹ç”¨ä»–æˆ–å¥¹çš„æ‹‡æŒ‡å’Œé£ŸæŒ‡ä»¥å‰ªç‹€å‹•ä½œæ‰“é–‹æ‚£è€…çš„å˜´ã€‚ ç„¶å¾Œå°‡å–‰é¡æ’å…¥å£ä¸­ï¼Œæ³¨æ„ä¸è¦æå£æ‚£è€…çš„å˜´å”‡æˆ–ç‰™é½’ã€‚ åœ¨å½æ›²çš„ MAC åˆ€ç‰‡çš„æƒ…æ³ä¸‹ï¼ŒèˆŒé ­å‘å·¦æƒéï¼Œåˆ€ç‰‡çš„å°–ç«¯æ”¾ç½®åœ¨æœƒå­å‰é¢çš„æœƒå­è°·ä¸­ï¼Œè€Œç›´çš„ç±³å‹’åˆ€ç‰‡æ’å…¥æœƒå­ä¸‹æ–¹çš„ä¸­ç·šä½ç½®ã€‚ å–‰é¡æ‰‹æŸ„å‘ä¸Šå‘å‰æèµ·ï¼Œéœ²å‡ºè²å¸¶ã€‚ åˆ‡å‹¿å°‡æ‰‹æŸ„å‘å¾Œå‚¾æ–œï¼Œå› ç‚ºé€™æœƒå°è‡´ç‰™é½’æå‚·ã€‚ ç„¶å¾Œåœ¨ç›´æ¥å¯è¦–åŒ–ä¸‹é€šéè²å¸¶æ’å…¥ ETTã€‚ æ’å…¥ ETT å¾Œï¼Œç®¡å¿ƒé‡ï¼ˆå¦‚æœä½¿ç”¨ï¼‰å’Œå–‰é¡ä¸€æ¨£è¢«ç§»é™¤ã€‚ ç„¶å¾Œä½¿ç”¨ 10 mL æ³¨å°„å™¨å°‡å¼•å°æ°£çƒå……æ°£è‡³ä¸è¶…é 30 mmHg çš„å£“åŠ›ã€‚ ç‚ºäº†ç¢ºèªæ°£ç®¡æ”¾ç½®ï¼ŒETT é€£æ¥åˆ°æ°£å›Šé€šæ°£è¿´è·¯ä¸¦é€²è¡Œé€šæ°£ï¼Œè§€å¯Ÿé›™å´èƒ¸éƒ¨ä¸Šå‡ã€ETT ä¸­çš„å†·å‡æ°£ï¼Œæœ€é‡è¦çš„æ˜¯ï¼Œé€šéäºŒæ°§åŒ–ç¢³åœ–è§€å¯Ÿé€£çºŒçš„å‘¼æ°£æœ« CO 2 - è¢«èªç‚ºæ˜¯é»ƒé‡‘æ¨™æº–ã€‚ å¦‚æœæœªæª¢æ¸¬åˆ°æŒçºŒçš„å‘¼æ°£æœ« CO 2 ï¼Œæ‡‰æ‡·ç–‘é£Ÿç®¡æ’ç®¡ä¸¦é‡æ–°å˜—è©¦å–‰é¡æª¢æŸ¥ã€‚ ETT çš„é ç«¯æ‡‰ä½æ–¼è²å¸¶ä¹‹å¤–ä½†åœ¨carinaéš†çªä¹‹ä¸Šï¼Œé¿å…ä¸»å¹¹æ’ç®¡ã€‚ åœ¨æˆäººä¸­ï¼Œé€™é€šå¸¸èˆ‡æ‚£è€…å”‡éƒ¨çš„ 21-23 å˜ç±³ç›¸é—œã€‚ æ”¾ç½®å¾Œæ‡‰ç«‹å³ CXR ä»¥ç¢ºèªæ­£ç¢ºä½ç½®ã€‚</description></item><item><title>Late renal dysfxn</title><link>https://www.physician.tw/Late-renal-dysfxn/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Late-renal-dysfxn/</guid><description>Late renal dysfxn usual AKI causes + calcineurin tox, rejection (NEJM 2010;363:1451), BK virus, recurrence of 1Â° disease; usual w/u + immunosupp levels, donor-specific antigen (DSA), BK virus load, U/S, then bx if no other cause (CJASN 2008;3:S56; CJASN 2011;6:1774)</description></item><item><title>Left-ventricular-hypertrophy</title><link>https://www.physician.tw/Left-ventricular-hypertrophy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Left-ventricular-hypertrophy/</guid><description>Left-ventricular-hypertrophy Etiologies: HTN, AS/AI, HCM, coarctation of aorta
Criteria (all w/ Se &amp;lt;50%, Sp &amp;gt;85%; accuracy affected by age, sex, race, BMI)</description></item><item><title>Lennox Gastaut Syndrome</title><link>https://www.physician.tw/Lennox-Gastaut-Syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lennox-Gastaut-Syndrome/</guid><description>Lennox Gastaut Syndrome é€™å€‹ç—‡å€™ç¾¤æ˜¯ä¸€å€‹å¤šå…ƒæ€§ç™²ç™‡ç™¼ä½œé¡å‹çš„é ‘å›ºæ€§ç™²ç™‡æ‚£è€…æœƒå‡ºç¾å¤šç¨®ä¸åŒé¡å‹çš„ç™¼ä½œè¡¨ç¾ï¼›ä¾‹å¦‚ï¼šåœ¨ç¡çœ çš„éå¿«é€Ÿå‹•çœ¼æœŸæ™‚å‡ºç¾åƒµç›´ç™¼ä½œã€éå…¸å‹å¤±ç¥æ€§ç™¼ä½œã€å¤±å¼µåŠ›å‹ç™¼ä½œæˆ–æ˜¯è¼ƒå°‘è¦‹çš„è‚ŒæŠ½èºç™¼ä½œã€å»£æ³›æ€§å¤§ç™¼ä½œåŠå±€éƒ¨æ€§æŠ½æã€‚åœ¨ç™¼ç—…ä¹‹å¾Œï¼Œå®ƒæœƒé€ æˆæ™ºèƒ½éšœç¤™å’Œé€€åŒ–ã€‚åœ¨è…¦é›»åœ–ä¸­çœ‹è¦‹å½Œæ¼«æ€§æ…¢æ£˜è¤‡åˆæ³¢ï¼ˆdiffuse slow spike-and-waveï¼‰å’Œé™£ç™¼æ€§å¿«é€Ÿæ´»å‹•æœŸçš„è®ŠåŒ–ã€‚
å¥½ç™¼å¹´é½¡ç”±1æ­²è‡³7æ­²ï¼ˆé«˜å³°å¹´é½¡ç‚º3æ­²è‡³5æ­²ï¼‰ã€‚æ‚£è€…çš„ç”·å¥³æ¯”ç´„ç‚º5:1å·¦å³ã€‚æ—¢å¾€ç—…å²ã€å‡ºç”Ÿå²å’Œæ–°ç”Ÿå…’å²å¯èƒ½æ˜¯æ­£å¸¸çš„ï¼Œæˆ–å¯èƒ½æœƒæœ‰è…¦éƒ¨çµæ§‹ç•°å¸¸çš„ç—…å²ã€‚ç¥ç¶“å­¸æª¢æŸ¥å’Œé ­åœå¯èƒ½æ˜¯æ­£å¸¸ï¼Œæˆ–è€…æœƒå‡ºç¾èˆ‡å…¶è…¦éƒ¨çµæ§‹ç•°å¸¸ç›¸é—œçš„ç¥ç¶“ç™¼ç•°å¸¸ã€‚ç”Ÿé•·ç™¼å±•ã€æ™ºèƒ½å’ŒèªçŸ¥å¸¸æœ‰ç™¼å±•éšœç¤™ï¼Œä½†å¶ç„¶é‚„æ˜¯æœƒçœ‹åˆ°æ­£å¸¸ç™¼å±•çš„å°å­©ã€‚ä½†ç•¶ç™¼ä½œå¾Œï¼Œå°å­©å­çš„å…¶å¾Œç”Ÿé•·ç™¼å±•å°±æœƒåœæ»¯æˆ–ç”šè‡³é€€æ­¥ã€‚
å¤§ç´„æœ‰10-30%çš„æ‚£è€…åœ¨æ—©æœŸæ›¾æœ‰éå…¶ä»–ç¨®é¡çš„ç™²ç™‡ç—‡å€™ç¾¤ï¼Œä¾‹å¦‚West syndromeså’ŒOhtahara syndromesç­‰ç—…å²ï¼›ä¸éå°±ç™¼ç—…å¹´é½¡ä¾†èªªï¼Œæœ‰éå»ç™²ç™‡ç—…å²å’Œæ²’æœ‰çš„æ—ç¾¤ï¼Œå…¶ç™¼ç—…å¹´ç´€ä¸¦æ²’æœ‰å¤ªå¤§å·®ç•°ã€‚å¶ç„¶æœ‰äº›å€‹æ¡ˆéå»æœƒæœ‰ç†±ç—™æ”£ã€å±€éƒ¨ç™¼ä½œæˆ–å…¨èº«æ€§ç™¼ä½œç­‰ç—…å²ã€‚ç›®å‰èªç‚ºçš„æˆå› åŒ…å«äº†è…¦éƒ¨çµæ§‹ç•°å¸¸ï¼ˆé€™æ˜¯å¤§éƒ¨åˆ†ä¸»è¦çš„åŸå› ï¼Œç´„ä½”äº†70%çš„å€‹æ¡ˆï¼‰ã€éºå‚³æ€§ç—…å› ï¼Œä½†ä»æœ‰äº›ç—…äººæ˜¯æ‰¾ä¸åˆ°è‡´ç—…åŸå› çš„ã€‚é›–ç„¶ç›®å‰çš„ç—…ç”Ÿç†é‚„ä¸æ¸…æ¥šï¼Œä¹Ÿæ²’æœ‰å‹•ç‰©æ¨¡å¼è¢«å»ºç«‹ï¼Œä¸éæœ‰ä¸€äº›å‡èªªèªç‚ºè·Ÿå…ç–«èª˜ç™¼çš„æ©Ÿè½‰äº›é—œè¯ã€‚
é•·æœŸä¾†èªªï¼Œå…¶é å¾Œä¸¦ä¸æ¨‚è§€ï¼Œä¸éé‚„æ˜¯æœ‰å¾ˆå¤§è®Šç•°æ€§çš„ã€‚æœ‰å¾ˆå°‘æ•¸çš„æ‚£è€…é‚„æ˜¯å¯ä»¥æ“æœ‰æ­£å¸¸å·¥ä½œï¼Œä½†ç´„æœ‰äº”åˆ°å…«æˆçš„æ‚£è€…å…·æœ‰æ™ºèƒ½éšœç¤™ï¼Œä¸”éœ€è¦è¨±å¤šé¡å¤–çš„å”åŠ©ã€‚åƒµç›´ç™¼ä½œé€šå¸¸æ˜¯æ­¤ç—‡å€™ç¾¤çš„å¤šå…ƒç™¼ä½œé¡å‹ä¸­æœ€ä¸æ˜“æ§åˆ¶çš„ä¸€ç¨®ï¼Œä¹Ÿå› æ­¤ç´„æœ‰3-7%çš„æ‚£è€…æœƒå› ç‚ºé€™é¡ç™¼ä½œæ‰€é€ æˆçš„æ„å¤–èº«æ•…ã€‚</description></item><item><title>lenvatinib</title><link>https://www.physician.tw/lenvatinib/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lenvatinib/</guid><description> è—¥ç‰©ä»‹ç´¹ï¼šLenvatinib (LenvimaÂ®,æ¨‚è¡›ç‘ª)-è²¡åœ˜æ³•äººå°ç£ç™Œç—‡è‡¨åºŠç ”ç©¶ç™¼å±•åŸºé‡‘æœƒ
[[hepatocellular carcinoma]]] Lenvatinibåœ¨2017å¹´ç™¼è¡¨çš„ç¬¬äºŒæœŸè‡¨åºŠè©¦é©—æ•¸æ“šé¡¯ç¤ºï¼Œç„¡æ³•é–‹åˆ€æˆ–å±€éƒ¨æ²»ç™‚çš„è‚ç™Œæ‚£è€…(46äºº)ï¼Œä½¿ç”¨lenvatinibï¼Œæœ‰37% (17äºº)çš„è…«ç˜¤å¯ä»¥ç¸®å°ï¼Œæœ‰41%(19äºº)è…«ç˜¤å¯ä»¥ç¶­æŒä¸è®Šã€‚ æ¥è‘—ï¼Œlenvatinibåˆé€²è¡Œäº†ä¸€å€‹èˆ‡è‚ç™Œå¦ä¸€æ¨™é¶è—¥ç‰©sorafenibç™‚æ•ˆæ¯”è¼ƒçš„ç¬¬ä¸‰æœŸè‡¨åºŠè©¦é©—ï¼Œæ ¹æ“š2017ç¾åœ‹ç™Œç—‡é†«å­¸æœƒå¹´æœƒ (ASCO)æ–¼2017-06-04ç™¼è¡¨çš„æœ€æ–°æ•¸æ“šï¼Œç¸½å…±ç´„950äººåƒåŠ æ­¤è‡¨åºŠè©¦é©—ï¼Œä¸€çµ„ä½¿ç”¨lenvatinibé€™å€‹è—¥ç‰©ï¼Œå¦ä¸€çµ„ä½¿ç”¨sorafenibé€™å€‹è—¥ç‰©ï¼Œçµæœç™¼ç¾ï¼Œä½¿ç”¨lenvatinibçš„å­˜æ´»æœŸ(13.6å€‹æœˆ)ä¸¦ä¸è¼¸çµ¦sorafenib(12.3å€‹æœˆ)ï¼Œä¸”æœ‰è¼ƒå¤š(24%)çš„ç—…äººè…«ç˜¤é¡¯è‘—ç¸®å°ï¼Œå°ç…§çµ„å‰‡åªæœ‰9.2%ã€‚æƒ¡åŒ–æ™‚é–“ç‚º7.4å€‹æœˆï¼Œå°ç…§çµ„ç‚º3.7å€‹æœˆï¼Œæ¯”å°ç…§çµ„å»¶é•·3.7å€‹æœˆã€‚é›–ç„¶lenvatnibå…¶é«˜è¡€å£“çš„å‰¯ä½œç”¨ç™¼ç”Ÿç‡è¼ƒå°ç…§çµ„é«˜ï¼Œä½†æœ€ä»¤æ‚£è€…å›°æ“¾çš„çš®è†šå‰¯ä½œç”¨å‰‡è¼ƒå°‘ï¼Œlenvatinibç‚º27%ï¼Œå°ç…§çµ„å‰‡æœ‰52%ã€‚ é›–ç„¶lenvatinibç›®å‰å°šæœªå–å¾—åœ¨è‚ç™Œçš„è‡¨åºŠé©æ‡‰ç—‡ï¼Œæ­¤è—¥åœ¨è‚ç™Œçš„æ•ˆæœå·²æœ‰ç¬¬ä¸‰æœŸè‡¨åºŠè©¦é©—è³‡æ–™å¯åƒè€ƒã€‚</description></item><item><title>leptomeningeal disease</title><link>https://www.physician.tw/leptomeningeal-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/leptomeningeal-disease/</guid><description>leptomeningeal disease [[urgent symptomatic interventions of leptomeningeal disease]]</description></item><item><title>Leuko-reduced blood products</title><link>https://www.physician.tw/Leuko-reduced-blood-products/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Leuko-reduced-blood-products/</guid><description>Leuko-reduced blood products WBCs cause HLA alloimmunization &amp;amp; fever (cytokines) and carry CMV. For chronically transfused Pts, potential Tx recip., h/o febrile nonhemolytic transfusion rxn, cases in which CMV-neg products desired but unavailable.</description></item><item><title>levamisole</title><link>https://www.physician.tw/levamisole/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/levamisole/</guid><description>levamisole é©æ‡‰ç—‡ æ²»ç™‚è›”èŸ²ã€é‰¤èŸ²ã€ç³åœ“èŸ²
Levamisoleæ˜¯tetramisoleçš„å·¦æ—‹ç•°æ§‹ç‰©ï¼Œç‚ºä¸€å»£æ•ˆçš„æŠ—å¯„ç”ŸèŸ²è—¥ç‰©ï¼Œ å¯ä½¿èŸ²é«”çš„ç¥ç¶“èˆ‡å¥®ï¼Œä¸¦å°è‡´è‚Œè‚‰å¼·ç›´ã€ç™±ç˜“ï¼Œé‚„æœ‰é˜»æ–·åˆæˆèƒ½é‡æ‰€ éœ€çš„é…µç´ ï¼Œä½¿èŸ²é«”ç„¡æ³•ç²å¾—èƒ½é‡è€Œæ­»äº¡ã€‚</description></item><item><title>Lidocaine</title><link>https://www.physician.tw/Lidocaine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lidocaine/</guid><description>Lidocaine 1.0~1.5mg/kg 2% 50kg 75mg èƒ–ä¸€é»çš„100mg</description></item><item><title>Likelihood of ACS Circ 2007 116 e148 Circ 1994 90 1 613 22</title><link>https://www.physician.tw/Likelihood-of-ACS-Circ-2007-116-e148-Circ-1994-90-1-613-22-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Likelihood-of-ACS-Circ-2007-116-e148-Circ-1994-90-1-613-22-/</guid><description>Likelihood of ACS Circ 2007 116 e148 Circ 1994 90 1 613 22 | Feature | High (any of below) | Intermediate (no high features, any of below) | Low (no high/inter.</description></item><item><title>lipid disorders</title><link>https://www.physician.tw/lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lipid-disorders/</guid><description>lipid disorders [[Measurements-lipid disorders]] [[Drug Treatment-lipid disorders]] [[Treatment of LDL-C]] (Lancet 2014;384:607) [[Treatment of other lipid fractions]] (Lancet 2014;384:618 &amp;amp; 626) [[2018 ACC AHA Cholesterol Guidelines]] (Circ 2019;139:e1082)</description></item><item><title>Lithium-toxicology</title><link>https://www.physician.tw/Lithium-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lithium-toxicology/</guid><description>Lithium-toxicology N/V/D, tremor, hyperreflexia, clonus, drowsiness, seizure, â†‘ QT, AV block, bradycardia
IVF (NS), maintain UOP
Consider hemodialysis</description></item><item><title>Localization of MI</title><link>https://www.physician.tw/Localization-of-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Localization-of-MI/</guid><description>Localization of MI Anatomic Area ECG Leads w/ STE Coronary Artery Septal V1â€“V2 Â± aVR Proximal LAD Anterior V3â€“V4 LAD Apical V5â€“V6 Distal LAD, LCx, or RCA Lateral I, aVL LCx Inferior II, III, aVF Â± aVR RCA (~85%), LCx (~15%) RV V1â€“V2 &amp;amp; V4R (most Se) Proximal RCA Posterior ST depression V1â€“V3 (= STE V7â€“V9 posterior leads, âœ“ if clinical suspicion) RCA or LCx</description></item><item><title>Long-term anticoagulation options-venous thromboembolism</title><link>https://www.physician.tw/Long-term-anticoagulation-options-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-anticoagulation-options-venous-thromboembolism/</guid><description>Long-term anticoagulation options-venous thromboembolism For nonpregnant Pt without severe renal dysfunction or active cancer â†’ DOAC
For severe renal insufficiency or APLAS â†’ warfarin.</description></item><item><title>Long-term follow-up of Migraine</title><link>https://www.physician.tw/Long-term-follow-up-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-follow-up-of-Migraine/</guid><description>Long-term follow-up of Migraine Manage migraine long-term in primary care Repatriate patients from specialist care in a timely manner and with a comprehensive treatment plan Maintain stability of effective treatment in primary care and react to change</description></item><item><title>Long-term management-wide-complex tachycardias WCTS</title><link>https://www.physician.tw/Long-term-management-wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Long-term-management-wide-complex-tachycardias-WCTS/</guid><description>Long-term management-wide-complex tachycardias (WCTS) (EHJ 2015;36:2793; Circ 2018;138:e272; NEJM 2019;380:1555)
Workup: echo to âœ“ LV fxn, cath or stress test to r/o ischemia, ?</description></item><item><title>Loop diuretics</title><link>https://www.physician.tw/Loop-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Loop-diuretics/</guid><description>Loop diuretics (NEJM 2017;377:1964)
Drugs: furosemide (Lasix), torsemide, bumetanide (Bumex), ethacrynic acid [[Mechanisms-Loop diuretics]] Dosing: bioavailability PO furosemide ~50%, PO torsemide &amp;amp; bumetanide ~90% 40 mg IV = 80 mg PO Lasix = 20 mg PO/IV torsemide = 1 mg IV/PO bumetanide Dose furosemide bid-qid; qd dosing can yield initial diuresis, but then anti-natriuresis.</description></item><item><title>Low-voltage</title><link>https://www.physician.tw/Low-voltage/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Low-voltage/</guid><description>Low-voltage QRS amplitude (R + S) &amp;lt;5 mm in all limb leads &amp;amp; &amp;lt;10 mm in all precordial leads</description></item><item><title>lumbar puncture after brain imaging</title><link>https://www.physician.tw/lumbar-puncture-after-brain-imaging/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lumbar-puncture-after-brain-imaging/</guid><description>lumbar puncture after brain imaging A computed tomography (CT) scan of the head is frequently ordered by clinicians prior to performing a lumbar puncture (LP) to rule out an intracranial abnormality with elevated intracranial pressure</description></item><item><title>lung cancer</title><link>https://www.physician.tw/lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lung-cancer/</guid><description>lung cancer [[Epidemiology and risk factors-lung cancer]] Screening ([[JAMA 2021;325:962]]) Annual low-dose chest CT in â‰¥20 pack-year current or former (quit w/in 15 y) smokers, age 50â€“80 y â†’ 20% â†“ lung cancer-related mortality (NEJM 2020;382:503) High rates of screen-detected nodules.</description></item><item><title>lung transplant</title><link>https://www.physician.tw/lung-transplant/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lung-transplant/</guid><description>lung transplant Overview Indications: end stage, progressive decline despite max medical Rx, &amp;lt;2-y life expectancy; COPD, ILD (IPF), pulmonary HTN, cystic fibrosis, alpha 1-antitrypsin Contraindic: age &amp;gt;70, uncontrolled/unRxâ€™d infxn, malig in prior 5 yrs, severe non-pulm dis.</description></item><item><title>LV failure</title><link>https://www.physician.tw/LV-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/LV-failure/</guid><description>LV failure Diurese to achieve PCWP ~14 â†’ â†“ pulmonary edema, â†“ myocardial O2 demand â†“ Afterload â†’ â†‘ stroke volume &amp;amp; CO, â†“ myocardial O2 demand.</description></item><item><title>lymphadenopathy</title><link>https://www.physician.tw/lymphadenopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphadenopathy/</guid><description>lymphadenopathy Viral HIV, EBV, CMV, HSV, VZV, hepatitis, measles, rubella
Bacterial Generalized (brucellosis, leptospirosis, TB, atypical mycobacteria, syphilis)
Localized (streptococci, staphylococci, cat-scratch disease, tularemia)</description></item><item><title>Lymphocytic pleocytosis</title><link>https://www.physician.tw/Lymphocytic-pleocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Lymphocytic-pleocytosis/</guid><description>Lymphocytic pleocytosis Lymphocytic [[pleocytosis]] is an abnormal increase in the amount of lymphocytes in the cerebrospinal fluid (CSF)</description></item><item><title>lymphocytosis</title><link>https://www.physician.tw/lymphocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/lymphocytosis/</guid><description>lymphocytosis (&amp;gt;4000â€“5000/ÂµL)
Infection Usually viral; â€œatypical lymphocytesâ€ with mononucleosis syndromes Other: pertussis, toxoplasmosis
Hypersensitivity Drug-induced, serum sickness
Autoimmune Rheumatoid arthritis (large granular lymphocytes), malignant thymoma</description></item><item><title>macos config</title><link>https://www.physician.tw/macos-config/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/macos-config/</guid><description>macos config MACOS CATALINA 10.15 ç¬¬ä¸‰æ–¹è½¯ä»¶æ–‡ä»¶æç¤ºå·²æŸåè§£å†³åŠæ³• macOS 10.15 åï¼Œè‹¹æœåŠ å¼ºäº†å¯¹ç¬¬ä¸‰æ–¹æ¸ é“ä¸‹è½½è½¯ä»¶çš„è¯ä¹¦æ ¡éªŒï¼Œå¯¹äºæ— è¯ä¹¦çš„åº”ç”¨ï¼Œä¸å…è®¸æ‰“å¼€ã€‚å¯ä»¥è¯•è¯•ä½¿ç”¨ä¸‹é¢å‘½ä»¤ï¼š
1 sudo xattr -r -d com.apple.quarantine xxx.app</description></item><item><title>macrocytic anemias</title><link>https://www.physician.tw/macrocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/macrocytic-anemias/</guid><description>macrocytic anemias includes megaloblastic and nonmegaloblastic causes
[[Megaloblastic anemia]] [[Folate deficiency]] [[Vitamin B12 deficiency]] [[Nonmegaloblastic macrocytic anemias]]</description></item><item><title>Major-risk-factor-modification-stable ischemic heart disease</title><link>https://www.physician.tw/Major-risk-factor-modification-stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Major-risk-factor-modification-stable-ischemic-heart-disease/</guid><description>Major-risk-factor-modification-stable ischemic heart disease Lipids: statin (typically high-intensity) Â± ezetimibe &amp;amp; PCSK9i (see â€œDyslipidemiaâ€) BP &amp;lt;130/80 (see â€œHypertensionâ€); in SIHD may opt for ACEI and Î²B (if angina) Diabetes management (qv): HbA1c â‰¤7% and consider GLP1RA or SGLT2i Smoking cessation; influenza vaccine Diet (â†‘ vegetables, fruits, whole grains; â†“ saturated fat, trans fatty acids, sweets, red meat, Na); target BMI 18.</description></item><item><title>Malabsorption</title><link>https://www.physician.tw/Malabsorption/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malabsorption/</guid><description>Malabsorption (fatty; â†‘ fecal fat, â†‘ osmotic gap, â†“ diarrhea w/ fasting)
Defective mucosal absorption of nutrients b/c Î”s in: mucosal surface (surgical resection) or gen.</description></item><item><title>Maldigestion</title><link>https://www.physician.tw/Maldigestion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Maldigestion/</guid><description>Maldigestion (fatty; â†‘ fecal fat, â†‘ osmotic gap, â†“ diarrhea w/ fasting)
Defective intraluminal hydrolysis of nutrients, typ. 2/2 pancreatic/hepatobiliary pathology</description></item><item><title>Malignancy workup-adrenal incidentalomas</title><link>https://www.physician.tw/Malignancy-workup-adrenal-incidentalomas/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Malignancy-workup-adrenal-incidentalomas/</guid><description>Malignancy workup-adrenal incidentalomas CT and MRI characteristics may suggest adenoma vs. carcinoma Benign features: unenhanced CT &amp;lt;10 Hounsfield units or CT contrast-medium washout &amp;gt;50% at 10 min; size &amp;lt;4 cm; smooth margins, homogenous and hypodense appearance; can follow such incidentalomas w/ periodic scans Suspicious features: size â‰¥4 cm or â†‘ size on repeat scan; &amp;gt;10 Hounsfield units on CT, irregular margins, heterogeneous, dense or vascular appearance; h/o malignancy or young age.</description></item><item><title>Mallory-Weiss tear</title><link>https://www.physician.tw/Mallory-Weiss-tear/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mallory-Weiss-tear/</guid><description>Mallory-Weiss tear GE jxn lacerations due to vomiting â†’ â†‘ intraabd pressure &amp;amp; shearing Often self-resolve; Rxâ†’ antiemetics, PPI, endoscopic therapy</description></item><item><title>management of Barrettâ€™s esophagitis</title><link>https://www.physician.tw/management-of-Barretts-esophagitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-of-Barretts-esophagitis/</guid><description>management of Barrettâ€™s esophagitis PPI.
W/o dysplasia: surveillance EGD q3â€“5y.
Low-grade dysplasia: EGD q12mo; possible endoscopic eradication.
High-grade dysplasia: endoscopic eradication; consider chemoprophylaxis w/ high-dose PPI &amp;amp; ASA (Lancet 2018;392:400).</description></item><item><title>Management of hyperglycemia in inPts</title><link>https://www.physician.tw/Management-of-hyperglycemia-in-inPts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-hyperglycemia-in-inPts/</guid><description>Management of hyperglycemia in inPts (for ICU: see â€œSepsisâ€) (Clin Ther 2013;35:724)
[[Hyperglycemic Emergencies]] (Endocrinology)
Identify reversibl causes/precipitants (dextrose IVF, glucocorticoids, postop, â†‘ carb diet)</description></item><item><title>Management of ICU patient-pulmonary hypertension</title><link>https://www.physician.tw/Management-of-ICU-patient-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-of-ICU-patient-pulmonary-hypertension/</guid><description>Management of ICU patient-pulmonary hypertension Avoid tachyarrhythmias &amp;amp; overly aggressive volume resuscitation
Caution w/ vasodilators if any L-sided dysfunction</description></item><item><title>Management-acute liver failure</title><link>https://www.physician.tw/Management-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-acute-liver-failure/</guid><description>Management-acute liver failure (J Clin Exp Hepatol 2015;5:S104; Gastro 2017;152:644)
ICU care at liver transplant center for hemodynamic &amp;amp; ventilatory support; CVVH for AKI</description></item><item><title>management-inflammatory bowel disease</title><link>https://www.physician.tw/management-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/management-inflammatory-bowel-disease/</guid><description>management-inflammatory bowel disease (Lancet 2017;398:1756; Mayo 2017;92:1088)
[[Initial evaluation-management-inflammatory bowel disease]] Goals of treatment (Ther Adv Gastro 2015;8:143)
Induce remission of acute flare â†’ maintain remission; mucosal healing 1Â° goal Step-up Rx (least â†’ most toxic) vs.</description></item><item><title>Management-solitary pulmonary nodule</title><link>https://www.physician.tw/Management-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Management-solitary-pulmonary-nodule/</guid><description>Management-solitary pulmonary nodule Low risk (&amp;lt;5%): serial CT (freq depending on risk); shared decision w/ Pt re: bx</description></item><item><title>Managing complications of Migraine</title><link>https://www.physician.tw/Managing-complications-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-complications-of-Migraine/</guid><description>Managing complications of Migraine Identify comorbid conditions Select drugs and adiust their use according to comorbidities present Alleviate comborbidities if possible to improve outcome</description></item><item><title>Managing complications-acute kidney injury AKI</title><link>https://www.physician.tw/Managing-complications-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-complications-acute-kidney-injury-AKI/</guid><description>Managing complications-acute kidney injury (AKI) May take 1â€“3 wk to recover from ATN; anticipate volume overload, â†‘ K, â†‘ PO4, acidosis</description></item><item><title>Managing migraine in special populations</title><link>https://www.physician.tw/Managing-migraine-in-special-populations/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Managing-migraine-in-special-populations/</guid><description>Managing migraine in special populations Older people Secondary headache, comorbidities and adverse events are all more likely Poor evidence base for all drugs in this age group Children and adolescents Be aware that presentation can differ from migraine in adults Parents and schools have important roles in the management of young children Bed rest alone can be sufficient Use ibuprofen for acute treatment and propranolol, amitriptyline or topiramate for prevention Women who are pregnant or breastfeeding Use paracetamol for acute treatment Avoid preventive treatment if possible Women with menstrual migraine Perimenstrual preventive therapy with long-acting NSAID or triptan</description></item><item><title>Markdownify</title><link>https://www.physician.tw/Markdownify/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Markdownify/</guid><description>To import a URL as Markdown, turn on the option under &amp;ldquo;Editing&amp;rdquo; in nvALT&amp;rsquo;s Preferences. Now, when you drag a URL to the notes list, it will convert it to Markdown as much as possible.</description></item><item><title>MASCC Risk Index</title><link>https://www.physician.tw/MASCC-Risk-Index/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MASCC-Risk-Index/</guid><description>MASCC Risk Index Use in neutropenic patients (see ANC calculator) with fever at least 100.4Â°F (38ÂºC). Do not use in patients with acute leukemia undergoing induction chemotherapy or allogeneic hematopoietic stem cell transplant conditioning, per IDSA guidelines.</description></item><item><title>Massive transfusion</title><link>https://www.physician.tw/Massive-transfusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Massive-transfusion/</guid><description>Massive transfusion Large-vol. PRBC â†’ â†“ Ca, â†‘ K, â†“ plt, â†‘ coags; initial ratio of 1 PRBC: 1 plt:1 FFP accepted but controversial, follow labs (JAMA Surg 2017;152:574).</description></item><item><title>Measure plasma osmolality</title><link>https://www.physician.tw/Measure-plasma-osmolality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measure-plasma-osmolality/</guid><description>Measure plasma osmolality Hypotonic (Posm &amp;lt;280) most common scenario; true excess of free H2O relative to Na
Isotonic (Posm 280â€“295): rare lab artifact from</description></item><item><title>Measure Uosm</title><link>https://www.physician.tw/Measure-Uosm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measure-Uosm/</guid><description>Measure Uosm although useful for dx in limited circumstances, b/c almost always &amp;gt;300 Uosm &amp;lt;100 in â†‘ H2O intake (1o polydipsia) or â†“ solute intake (beer potomania, â€œtea &amp;amp; toastâ€)</description></item><item><title>Measurements-lipid disorders</title><link>https://www.physician.tw/Measurements-lipid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Measurements-lipid-disorders/</guid><description>Measurements-lipid disorders è…°åœ: é«”é‡*1/2 from ileic creast
Lipoproteins = lipid core (cholesteryl esters &amp;amp; triglycerides) + phospholipid surface + proteins.</description></item><item><title>Mechanical complications</title><link>https://www.physician.tw/Mechanical-complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-complications/</guid><description>Mechanical complications Mechanical complications (incid. &amp;lt;1% for each; typically occur a few days post-MI)
Free wall rupture: â†‘ risk w/ lysis, large MI, â†‘ age, â™€, HTN; p/w PEA or hypoTN, pericardial sx, tamponade; Rx: volume resusc.</description></item><item><title>Mechanical intervention-venous thromboembolism</title><link>https://www.physician.tw/Mechanical-intervention-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-intervention-venous-thromboembolism/</guid><description>Mechanical intervention-venous thromboembolism (JACC 2020;76:2117)
[[catheter-directed pharmacomech]]
Catheter-based clot extraction (eg, AngioVac or FlowTriever): â†“ PA pressure</description></item><item><title>mechanical ventilation</title><link>https://www.physician.tw/mechanical-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanical-ventilation/</guid><description>mechanical ventilation [[indications-mechanical ventilation]]
supportive strategies prior to intub. or after extub. [[oxygen delivery systems]] [[Noninvasive Positive Pressure Ventilation (NPPV)]] ventilator management [[Ventilator Modes and Principles]] [[Volume or Pressure Targeted]] [[Variables on the Ventilator]] [[Tailoring the ventilator settings]] [[Acute ventilatory deterioration (usually elevated PIP)]] [[Liberating from the ventilator]] [[Complications-mechanical ventilation]]</description></item><item><title>Mechanical-prosthetic-heart-valves</title><link>https://www.physician.tw/Mechanical-prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanical-prosthetic-heart-valves/</guid><description>Mechanical-prosthetic-heart-valves Bileaflet (eg, St. Jude Medical); tilting disk; caged-ball Very durable (20â€“30 y), but thrombogenic and âˆ´ require anticoagulation consider if age &amp;lt;50 y or if anticoagulation already indicated (JACC 2010;55:2413)</description></item><item><title>Mechanisms and Etiologies of Platelet Function Abnormalities</title><link>https://www.physician.tw/Mechanisms-and-Etiologies-of-Platelet-Function-Abnormalities/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-and-Etiologies-of-Platelet-Function-Abnormalities/</guid><description>Mechanisms and Etiologies of Platelet Function Abnormalities</description></item><item><title>mechanisms of hypophosphatemia</title><link>https://www.physician.tw/mechanisms-of-hypophosphatemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mechanisms-of-hypophosphatemia/</guid><description>mechanisms of hypophosphatemia Intracellular uptake of phosphate from the extracellular fluid #anki acute respiratory alkalosis: increased intracellular pH stimulates phosphofructokinase activity and glycolysis which leads to intracellular uptake of phosphate; hyperventilation (caused for example by sepsis, anxiety, diabetic ketoacidosis, or other underlying conditions) can precipitate intracellular shift of phosphate into cells; refeeding of malnourished patients; administration of insulin or glucose (which stimulates insulin secretion); hungry bone syndrome.</description></item><item><title>Mechanisms-Loop diuretics</title><link>https://www.physician.tw/Mechanisms-Loop-diuretics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mechanisms-Loop-diuretics/</guid><description>Mechanisms-Loop diuretics inhib NaK2Cl cotransporter in thick ascending limb (ThAL, site of 25% Na reabsorp) â†’ â†“ medullary osmotic gradient &amp;amp; â†“ free H2O reabsorption via ADH</description></item><item><title>Meckelâ€™s diverticulum</title><link>https://www.physician.tw/Meckels-diverticulum/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Meckels-diverticulum/</guid><description>Meckelâ€™s diverticulum Congenital intestinal pouch due to incomplete obliteration of vitelline duct. 2% of pop, w/in 2â€² of IC valve, 2â€³ long, â™‚:â™€ 2:1, can present as obscure GIB in adults.</description></item><item><title>Medical Therapy for IBD</title><link>https://www.physician.tw/Medical-Therapy-for-IBD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-for-IBD/</guid><description>Medical Therapy for IBD (NEJM 2021;385:1302)
[[Medical Therapy of Ulcerative Colitis]] [[Medical Therapy of Crohnâ€™s Disease]]</description></item><item><title>Medical Therapy of Crohnâ€™s Disease</title><link>https://www.physician.tw/Medical-Therapy-of-Crohns-Disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-of-Crohns-Disease/</guid><description>Medical Therapy of Crohnâ€™s Disease Mild Oral 5-ASA: for colonic Crohnâ€™s disease
Symptom control: loperamide/cholestyramine for diarrhea management.</description></item><item><title>Medical Therapy of Ulcerative Colitis</title><link>https://www.physician.tw/Medical-Therapy-of-Ulcerative-Colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medical-Therapy-of-Ulcerative-Colitis/</guid><description>Medical Therapy of Ulcerative Colitis Mild Rectal mesalamine or glucocorticoids as suppository or enema Mild- moderate Oral 5-ASA: many formulations (sulfasalazine, mesalamine, olsalazine, balsalazide) depending on disease location.</description></item><item><title>Medication causes of abnormal LFTs</title><link>https://www.physician.tw/Medication-causes-of-abnormal-LFTs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medication-causes-of-abnormal-LFTs/</guid><description>Medication causes of abnormal LFTs</description></item><item><title>Medullary thyroid cancer</title><link>https://www.physician.tw/Medullary-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Medullary-thyroid-cancer/</guid><description>Medullary thyroid cancer Neuroendocrine tumor of C cells, peak incidence 40 to 60 y, a/w MEN2A and MEN2B Most commonly solitary nodule; calcitonin production (presents with diarrhea, flushing) and level used to trend dz progression, dx w/ FNA (Se 50â€“80%); mortality 25â€“50% at 5 y Surgery first-line treatment</description></item><item><title>Megaloblastic anemia</title><link>https://www.physician.tw/Megaloblastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Megaloblastic-anemia/</guid><description>Megaloblastic anemia Impaired DNA synthesis â†’ cytoplasm matures faster than nucleus â†’ ineffective erythropoiesis and macrocytosis; due to folate or B12 deficiency; also in MDS</description></item><item><title>Membranoproliferative GN</title><link>https://www.physician.tw/Membranoproliferative-GN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Membranoproliferative-GN/</guid><description>Membranoproliferative GN (5%, mixed nephrotic/nephritic features; CJASN 2014;9:600)
Immune complex mediated: infection (esp. HCV Â± cryos, IE, HBV, â€œshuntâ€ nephritis, other chronic infxns), SLE, cryos, SjÃ¶grenâ€™s, lymphomas, dysproteinemia, idiopathic</description></item><item><title>Membranous nephropathy</title><link>https://www.physician.tw/Membranous-nephropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Membranous-nephropathy/</guid><description>Membranous nephropathy (30%; CJASN 2017;12:938, JASN 2021;32:268):
Primary: Ab to PLA2R [70%], THSD7A [5%], other (EXT1-2, NELL1, Sema3B)
Secondary: infxn (HBV, HCV, HIV, syphilis) autoimmune (eg, SLE) carcinomas drugs (NSAIDs, penicillamine).</description></item><item><title>mental health</title><link>https://www.physician.tw/mental-health/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mental-health/</guid><description>mental health</description></item><item><title>Mesangial proliferative GN</title><link>https://www.physician.tw/Mesangial-proliferative-GN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mesangial-proliferative-GN/</guid><description>Mesangial proliferative GN (? atypical forms of MCD/FSGS, 5%) IgM, C1q nephropathy</description></item><item><title>metabolic-acidosis</title><link>https://www.physician.tw/metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-acidosis/</guid><description>metabolic-acidosis Initial workup (NEJM 2014;371:1434) âœ“ [[anion gap]] [[Etiologies-of-AG-Metabolic-Acidosis]] [[Workup-for-AG-metabolic-acidosis]] (AJKD 2021;78:A16) [[Ingestions-caused-metabolic-acidosis]] [[Etiologies of Non-AG Metabolic Acidosis]] [[Workup for non-AG metabolic acidosis]] [[Renal tubular acidoses]] Figure 4-2 [[Approach to metabolic acidosis]]</description></item><item><title>metabolic-alkalosis</title><link>https://www.physician.tw/metabolic-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metabolic-alkalosis/</guid><description>metabolic-alkalosis [[Pathophysiology-metabolic-alkalosis]] [[Etiologies-of-Metabolic-Alkalosis]]
Workup metabolic alkalosis Check volume status and UCl UCl &amp;lt;25 mEq/L â†’ saline responsive UCl &amp;gt;40 mEq/L â†’ saline resistant (unless currently receiving diuretics) (UNa unreliable determinant of volume status in alkalemia â†’ â†‘ HCO3- excretion â†’ â†‘ Na excretion; negatively charged HCO3- w/ Na+ maintaining electrical neutrality) If UCl &amp;gt;40 and volume replete, âœ“ UK; UK &amp;lt;20 laxative abuse; UK &amp;gt;30, âœ“ blood pressure Treatment of severe metabolic alkalosis (pH &amp;gt;7.</description></item><item><title>metastatic esophageal cancer</title><link>https://www.physician.tw/metastatic-esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/metastatic-esophageal-cancer/</guid><description>metastatic esophageal cancer trial after fluropyrimidine and platinum-based chemotherapy
[[KEYNOTE-181]] [[ATTRACTION-3]] [[CPS-22C3]] [[Dako 28-8]] [[Diagnostic and staging evaluation]]</description></item><item><title>Methanol-toxicology</title><link>https://www.physician.tw/Methanol-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Methanol-toxicology/</guid><description>Methanol-toxicology CNS depression, blindness
â†‘ AG &amp;amp; OG met. acidosis
Ethanol or fomepizole, NaHCO3
Consider hemodialysis</description></item><item><title>Methotrexate</title><link>https://www.physician.tw/Methotrexate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Methotrexate/</guid><description>Methotrexate MTX is a folic acid antagonist. DNA synthesis is inhibited by inhibition of dihydrofolate reductase, which provides reduced folates for purine synthesis.</description></item><item><title>methylprednisolone</title><link>https://www.physician.tw/methylprednisolone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/methylprednisolone/</guid><description>methylprednisolone [[acute respiratory distress syndrome]] IV (succinate): Loading dose of 1 mg/kg over 30 minutes, 1 to 14: 1 mg/kg/day in divided doses or as a continuous infusion.</description></item><item><title>MI in absence of obstructive CAD</title><link>https://www.physician.tw/MI-in-absence-of-obstructive-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MI-in-absence-of-obstructive-CAD/</guid><description>MI in absence of obstructive CAD Definition: MI but w/o coronary stenosis â‰¥50% in any major epicardial vessel More common in younger Pts, women, Black/Pacific race or Hispanic Advanced coronary imaging (eg, OCT) &amp;amp; cardiac MRI to exclude missed coronary obstruction, other causes of myocyte injury (eg, myocarditis), other causes of â†‘ Tn (eg, PE) ~75% ischemic (ie, plaque disruption identified) and 25% alternative dx (eg, myocarditis)</description></item><item><title>Microangiopathic hemolytic anemia</title><link>https://www.physician.tw/Microangiopathic-hemolytic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microangiopathic-hemolytic-anemia/</guid><description>Microangiopathic hemolytic anemia (MAHA; NEJM 2014;371:654)
Intra-arteriolar fibrin damages RBCs â†’ acquired intravascular hemolysis
Etiologies: [[hemolytic-uremic syndrome]] (HUS), [[thrombotic thrombocytopenic purpura]] (TTP), [[disseminated intravascular coagulation]] (DIC), malignancy, malignant HTN, eclampsia/[[HELLP]], mech.</description></item><item><title>Microbiology and severity-diabetic foot infections</title><link>https://www.physician.tw/Microbiology-and-severity-diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-and-severity-diabetic-foot-infections/</guid><description>Microbiology and severity-diabetic foot infections (CID 2004;39:885)
Mild (superficial ulcer, no involvement of deeper structures, surrounding erythema &amp;lt;2 cm, and no systemic illness): usually S.</description></item><item><title>Microbiology in Bacterial Meningitis</title><link>https://www.physician.tw/Microbiology-in-Bacterial-Meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-in-Bacterial-Meningitis/</guid><description>Microbiology in Bacterial Meningitis å…­éš»ï¼šS.N.H.L.E.S
(NEJM 2011;364:2016)
S. pneumoniae (30â€“60%) Look for preceding infection (bacteremia, pneumonia, endocarditis) Drug-resistant S. pneumoniae: ~40% PCN-resistant (even intermediate resistance problematic) ~&amp;lt;10% 3rd-gen.</description></item><item><title>Microbiology-necrotizing soft-tissue infections</title><link>https://www.physician.tw/Microbiology-necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-necrotizing-soft-tissue-infections/</guid><description>Microbiology-necrotizing soft-tissue infections Necrotizing soft tissue infections = NSTI
Type I: polymicrobial (mixed aerobes &amp;amp; anaerobes), typically in older Pts w/ above RFs.</description></item><item><title>Microbiology-of-Pneumonia</title><link>https://www.physician.tw/Microbiology-of-Pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-of-Pneumonia/</guid><description>Microbiology-of-Pneumonia Clinical Setting: CAP Etiologies No pathogen identified in 50â€“60%, virus alone in ~25%, bacteria alone in ~10%, virus-bacteria coinfection in &amp;lt;5% Viruses: influenza, RSV, hMPV, parainfluenza, rhinovirus, coronavirus S.</description></item><item><title>Microbiology-skin and soft tissue infections</title><link>https://www.physician.tw/Microbiology-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-skin-and-soft-tissue-infections/</guid><description>Microbiology-skin and soft tissue infections çš®è†šå’Œè»Ÿçµ„ç¹”æ„ŸæŸ“ (SSTI) å¾ˆå¸¸è¦‹ï¼Œç¯„åœå¾è¼•åº¦èœ‚çª©çµ„ç¹”ç‚åˆ°å±åŠç”Ÿå‘½çš„å£æ­»æ€§è»Ÿçµ„ç¹”æ„ŸæŸ“ (NSTI)ã€‚é—œéµçš„ç®¡ç†è€ƒæ…®å› ç´ åŒ…æ‹¬åšå‡ºæº–ç¢ºçš„è¨ºæ–·ã€è©•ä¼°æ„ŸæŸ“çš„åŒ–è†¿æ€§å’Œåš´é‡ç¨‹åº¦ï¼Œä»¥åŠé¸æ“‡æŠ—ç”Ÿç´ ä»¥é‡å°æœ€å¯èƒ½çš„å¾®ç”Ÿç‰©ã€‚åœ¨æœ¬ç¯€ä¸­ï¼Œæˆ‘å€‘å°‡ä»‹ç´¹ä»¥ä¸‹ç–¾ç—…çš„è¨ºæ–·å’Œæ²»ç™‚
(CID 2014;59:e10)
Purulent: MRSA (NEJM 2006;355:666) causes up to 75% of purulent skin/soft tissue infections, followed by MSSA and strep Non-purulent: Strep, MSSA, aerobic GNRs.</description></item><item><title>Microbiology-urinary tract infections</title><link>https://www.physician.tw/Microbiology-urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microbiology-urinary-tract-infections/</guid><description>Microbiology-urinary tract infections Uncomplicated: E. coli (80%), [[S saprophyticus]] (CID 2004;39:75). Proteus Klebsiella
In healthy, nonpregnant women: lactobacilli, enterococci, Group B strep, and coag-neg staph (except S.</description></item><item><title>microcytic anemias</title><link>https://www.physician.tw/microcytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/microcytic-anemias/</guid><description>microcytic anemias [[Approach to microcytic anemias]] [[Iron deficiency]] [[Thalassemias]] [[Sideroblastic anemia]]</description></item><item><title>Microscopic polyangiitis</title><link>https://www.physician.tw/Microscopic-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Microscopic-polyangiitis/</guid><description>Microscopic polyangiitis Necrotizing vasculitis commonly involving lung, kidneys, and skin with pauci-immune glomerulonephritis and palpable purpura. Presentation similar to granulomatosis with polyangiitis Similar to GPA, but w/o ENT/upper airway involvement &amp;amp; nongranulomatous Epidemiology: incidence 4/million/y.</description></item><item><title>Migraine</title><link>https://www.physician.tw/Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine/</guid><description>Migraine å°éº»å…§å®¹ [[Definition and clinical manifestations of Migraine]] [[Treatment of Migraine]] (Lancet 2021;397:1505 &amp;amp; Continuum 2021;27:613) Step 1: [[When to suspect migraine]] Step 2: [[Diagnosis of migraine]] Step 3: [[Education and patient centricity]] Step 4: [[Acute treatment of Migraine]] Step 5: [[Preventive treatment of Migraine]] Step 6: [[Managing migraine in special populations]] Step 7: [[Follow-up, treatment response and failure of Migraine]] Step 8: [[Managing complications of Migraine]] Step 9: [[Recognizing and managing comorbidities of Migraine]] Step 10: [[Long-term follow-up of Migraine]]</description></item><item><title>Migraine with aura</title><link>https://www.physician.tw/Migraine-with-aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine-with-aura/</guid><description>Migraine with aura [[aura]]
Approximately one third of individuals with migraine experience aura, either with every attack or with some attacks.</description></item><item><title>Migraine without aura</title><link>https://www.physician.tw/Migraine-without-aura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Migraine-without-aura/</guid><description>Migraine without aura Migraine without aura is characterized by recurrent headache attacks that last 4â€“72 h. Typical features of an attack include a unilateral location, pulsating quality, moderate or severe pain intensity, and aggravation by routine physical activity,</description></item><item><title>Milk-alkali syndrome</title><link>https://www.physician.tw/Milk-alkali-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Milk-alkali-syndrome/</guid><description>Milk-alkali syndrome ä¹³é¹¼ç¶œåˆå¾µç”±é«˜éˆ£è¡€ç—‡ã€ä»£è¬æ€§é¹¼ä¸­æ¯’å’Œèˆ‡æ”å…¥å¤§é‡éˆ£å’Œå¯å¸æ”¶é¹¼ç›¸é—œçš„æ€¥æ€§è…æå‚·ä¸‰è¯å¾µçµ„æˆã€‚ è©²ç¶œåˆå¾µæœ€åˆèˆ‡ä½¿ç”¨ç‰›å¥¶å’Œç¢³é…¸æ°«éˆ‰æ²»ç™‚æ¶ˆåŒ–æ€§æ½°ç˜ç–¾ç—…æœ‰é—œ[1]ã€‚ ç‰›å¥¶-é¹¼ç¶œåˆå¾µæ›¾ç¶“æ˜¯é«˜éˆ£è¡€ç—‡çš„å…¸å‹ç—…å› ï¼Œä½†éš¨è‘—æ¶ˆåŒ–æ€§æ½°ç˜ç—…æ–°ç™‚æ³•çš„å‡ºç¾å¹¾ä¹æ¶ˆå¤±äº†ï¼Œä¸¦ä¸”è¢«èªç‚ºæ˜¯å°è‡´é«˜éˆ£è¡€ç—‡ç—…ä¾‹ä¸åˆ° 1% çš„åŸå›  ä¸‰å€‹å› ç´ æ˜¯é€ æˆé€™ç¨®ç™¼ç—…ç‡å¢åŠ çš„åŸå› ï¼š - é‡è¦–éˆ£ç™‚æ³•å°éª¨è³ªç–é¬†ç—‡çš„é˜²æ²»ã€‚ - ç¾æˆçš„éè™•æ–¹ç¢³é…¸éˆ£è£½åŠ‘ã€‚ - ä½¿ç”¨ç¢³é…¸éˆ£ä»¥æ¸›å°‘æ…¢æ€§è…ç—…æ‚£è€…ç¹¼ç™¼æ€§ç”²ç‹€æ—è…ºåŠŸèƒ½äº¢é€²ï¼ˆåƒè¦‹â€œæˆäººæ…¢æ€§è…ç—…é«˜ç£·è¡€ç—‡çš„ç®¡ç†â€ï¼‰</description></item><item><title>Minimal change disease</title><link>https://www.physician.tw/Minimal-change-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Minimal-change-disease/</guid><description>Minimal change disease (20%, more common in children; CJASN 2017;12:332) allergies, NSAIDs, ampicillin, Hodgkinâ€™s disease, SLE, DM, MG, celiac disease</description></item><item><title>mitral-regurgitation</title><link>https://www.physician.tw/mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-regurgitation/</guid><description>mitral-regurgitation [[Etiology-mitral-regurgitation]] (NEJM 2010;363:156 &amp;amp; 2020;383:1458) [[Clinical-manifestations-mitral-regurgitation]] [[Physical-exam-mitral-regurgitation]] [[Diagnostic-studies-mitral-regurgitation]] (Circ 2021;143:e72) [[Treatment-mitral-regurgitation]] (Circ 2021;143:e72)</description></item><item><title>mitral-stenosis</title><link>https://www.physician.tw/mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-stenosis/</guid><description>mitral-stenosis [[Etiology-mitral-stenosis]] (Lancet 2012;379:953) [[Clinical manifestations-mitral-stenosis]] (Lancet 2009;374:1271) [[Physical exam-mitral-stenosis]] [[Diagnostic studies-mitral-stenosis]] [[Treatment-mitral-stenosis]] (Lancet 2016;387:1324; Circ 2021;143:e72)</description></item><item><title>mitral-valve-prolapse</title><link>https://www.physician.tw/mitral-valve-prolapse/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/mitral-valve-prolapse/</guid><description>mitral-valve-prolapse Definition and Etiology
Billowing of MV leaflet â‰¥2 mm above mitral annulus in parasternal long axis echo view Primary: sporadic or familial myxomatous proliferation of spongiosa of MV apparatus Secondary: trauma, endocarditis, congenital, CTD (eg, Marfanâ€™s, OI, Ehlers-Danlos) Clinical manifestations (usually asymptomatic) MR, endocarditis, emboli, arrhythmias (rarely SCD from VT from papillary muscle) High-pitched, midsystolic click (earlier w/ â†“ preload) Â± mid-to-late systolic murmur No Rx per se [endocarditis Ppx not rec.</description></item><item><title>Mixed-disorders</title><link>https://www.physician.tw/Mixed-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mixed-disorders/</guid><description>Mixed-disorders If compensation less or greater than predicted, may be two disorders: PaCO2 too low â†’ concomitant 1Â° resp. alk.</description></item><item><title>Modalities-renal replacement and dialysis</title><link>https://www.physician.tw/Modalities-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modalities-renal-replacement-and-dialysis/</guid><description>Modalities-renal replacement and dialysis [[Hemodialysis (HD)]] Physiology: Diffusion Access: AV fistula/graft or CVC Prescription: Duration, volume goal; K, Na, Ca, HCO3 in bath, anticoag Complic.</description></item><item><title>model for clinical reasoning</title><link>https://www.physician.tw/model-for-clinical-reasoning/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/model-for-clinical-reasoning/</guid><description>model for clinical reasoning Step 1: Identify the Problem Step 2: Frame the Differential Diagnosis Step 3: Organize the Differential Diagnosis Step 4: Limit the Differential Diagnosis Step 5: Explore Possible Diagnoses Using History and Physical Exam Findings Step 6: [[Rank the Differential Diagnosis]] Step 7: Test Your Hypotheses Step 8: Re-rank the Differential Based on New Data Step 9: Test the New Hypotheses</description></item><item><title>Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia</title><link>https://www.physician.tw/Modification-to-initial-antibiotic-regimen-based-on-site-specific-evaluation-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modification-to-initial-antibiotic-regimen-based-on-site-specific-evaluation-of-fever-and-neutropenia/</guid><description>Modification to initial antibiotic regimen based on site-specific evaluation of fever and neutropenia Vancomycin only if HoTN, PNA, clinically apparent catheter-related or soft-tissue infxn, gram âŠ• BCx, mucositis + on quinolone Ppx; d/c when BCx âŠ– Ã— 48 h for GPCs Mouth/esoph (ulcer, thrush): anaerobic (if necrotizing), anti-HSV and/or antifungal Rx Sinus/nasal: add vanc if periorbital cellulitis, ampho if concern for Aspergillus/Mucor Abd pain/diarrhea: PO vanc if concern for C.</description></item><item><title>Modified Duke Criteria</title><link>https://www.physician.tw/Modified-Duke-Criteria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Modified-Duke-Criteria/</guid><description>Modified Duke Criteria å¤§çš„2.5åˆ†ã€å°çš„ä¸€åˆ†ã€ç¸½åˆ†è¦äº”åˆ†
Definitive: äº”åˆ† 2 major or 1 major + 3 minor or 0 major + 5 minor;</description></item><item><title>Molecular description of lymphoma</title><link>https://www.physician.tw/Molecular-description-of-lymphoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Molecular-description-of-lymphoma/</guid><description>Molecular description of lymphoma Marginal zone B cell lymphoma, MALT type IGH clonally rearranged t(11;18)
DLBCL IGH clonally rearranged t(8;14) c-myc-IGH t(14;18) IGH-BCL2</description></item><item><title>molecular diagnostics</title><link>https://www.physician.tw/molecular-diagnostics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/molecular-diagnostics/</guid><description>molecular diagnostics Sequencing Cytogenetics</description></item><item><title>monocytosis</title><link>https://www.physician.tw/monocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/monocytosis/</guid><description>monocytosis (&amp;gt;500/ÂµL)
Infection Usually TB, SBE, Listeria, Brucella, Rickettsia, fungi, parasites, syphilis
Inflammation IBD, sarcoidosis, collagen vascular diseases
Stress MI, splenectomy, exercise (Cytokine 2013;61:364)</description></item><item><title>Monomorphic ventricular tachycardia MMVT</title><link>https://www.physician.tw/Monomorphic-ventricular-tachycardia-MMVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Monomorphic-ventricular-tachycardia-MMVT/</guid><description>Monomorphic ventricular tachycardia (MMVT) All beats look similar; predominantly upward in V1 = RBBB-type vs. downward = LBBB-type In obviously structurally abnormal heart: prior MI (scar); CMP In apparently nl heart that is actually diseased: subtle HCM, infiltrative CMP, myocarditis, arrhythmogenic CMP (ACM): incomplete RBBB, Îµ wave (terminal notch in QRS) &amp;amp; TWI in V1â€“V3 on resting ECG LBBB-type VT, dx w/ MRI (Lancet 2009;373:1289) In structurally normal heart w/ normal resting ECG &amp;amp; cardiac MRI: RVOT VT: LBBB-type VT or PVCs w/ inferior axis; typically ablate LVOT VT: RBBB-type VT or PVCs w/ superior axis; responds to verapamil</description></item><item><title>Mount-Sinai-Expert-Guides</title><link>https://www.physician.tw/Mount-Sinai-Expert-Guides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mount-Sinai-Expert-Guides/</guid><description>Mount-Sinai-Expert-Guides PART 1: BASIC TECHNIQUES AND PROCEDURES, 1 1 [[Airway-Management]], 3 2 Sedation and Analgesia, 10 3 Vascular Access, 17 4 Bedside Ultrasound, 26 5 Bronchoscopy, 37 6 Bedside Percutaneous Dilational Tracheostomy, 42 7 Nutritional Support and Total Parenteral Nutrition, 49 8 Glycemic Control, 55 9 Prevention of Complications, 62 10 Palliative Care, 68</description></item><item><title>muddy brown casts</title><link>https://www.physician.tw/muddy-brown-casts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/muddy-brown-casts/</guid><description>muddy brown casts Urine Sediment of the Month: Granular &amp;amp; &amp;ldquo;Muddy Brown&amp;rdquo; Casts - Renal Fellow Network
å°¿æ¶²æ²‰ç©ç‰©é¡¯ç¤ºå¤šç¨®æ³¥æ¿˜çš„æ£•è‰²é¡†ç²’é‘„ä»¶ã€‚ é€™äº›ç™¼ç¾å¼·çƒˆæš—ç¤ºè‘—æ€¥æ€§è…æå‚·æ‚£è€…ï¼ˆæ€¥æ€§è…è¡°ç«­ï¼‰çš„æ€¥æ€§ç®¡ç‹€å£æ­»ã€‚</description></item><item><title>Multiple Endocrine Neoplasia</title><link>https://www.physician.tw/Multiple-Endocrine-Neoplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Multiple-Endocrine-Neoplasia/</guid><description>Multiple Endocrine Neoplasia Type Main Features
1 (MENIN inactiv.) Parathyroid hyperplasia/adenomas â†’ hypercalcemia (~100% penetrance) Pancreatic islet cell neoplasia (gastrin, VIP, insulin, glucagon) Pituitary adenomas (fxn or non-fxn)</description></item><item><title>Mx of ACLS Tachycardia Algorithm</title><link>https://www.physician.tw/Mx-of-ACLS-Tachycardia-Algorithm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Mx-of-ACLS-Tachycardia-Algorithm/</guid><description>Mx of ACLS Tachycardia Algorithm adenosine 6 mg rapid IVP then 20-cc NS bolus, 12 mg IVP q2min 2 if needed</description></item><item><title>my report about irAE</title><link>https://www.physician.tw/my-report-about-irAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/my-report-about-irAE/</guid><description>https://docs.google.com/presentation/d/1JZhMp-Iv gJbsajKC7M-fHTpygJ3Or npNY85xAuhTg/edit?usp=sharing</description></item><item><title>myelodysplastic syndromes</title><link>https://www.physician.tw/myelodysplastic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myelodysplastic-syndromes/</guid><description>myelodysplastic syndromes see: [[pancytopenia]]
[[Myeloid neoplasm overview]]
[[WHO 2016 Classification of Myeloid Neoplasms and Acute Leukemia]]
[[myelodysplastic syndromes (MDS) overview]]</description></item><item><title>Myelophthisic anemia</title><link>https://www.physician.tw/Myelophthisic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myelophthisic-anemia/</guid><description>Myelophthisic anemia (see also â€œPrimary Myelofibrosisâ€)
Infiltration of bone marrow by cancer (commonly metastatic solid tumors), leukemia, infection, fibrosis (primary myelofibrosis), granulomas, lysosomal storage disorders</description></item><item><title>myeloproliferative neoplasms</title><link>https://www.physician.tw/myeloproliferative-neoplasms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myeloproliferative-neoplasms/</guid><description>[[index]]
[[overview of myeloproliferative neoplasms]]
[[polycythemia vera (PV)]]
[[essential thrombocythemia (ET)]]
[[primary myelofibrosis (PMF)]]</description></item><item><title>myocarditis</title><link>https://www.physician.tw/MYOCARDITIS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/MYOCARDITIS/</guid><description>myocarditis Etiologies [[infectious myocarditis]]
[[autoimmune myocarditis]]
Clinical manifestations Highly variable, ranging from incidental dx based on labs/imaging to fulminant HF w/ shock Can present as ACS-like syndrome (chest pain, ECG Î”s, â†‘ Tn), acute HF, arrhythmias Diagnostic studies and workup Echo: systolic dysfxn (typically global but can be regional); Â± â†‘ LV wall thickness due to edema; LV size may be small in fulminant and dilated in chronic; Â± pericardial effusion Cardiac MRI: can show hyperemia, edema, and scar (JACC 2009;53:1475) Endomyocardial biopsy: useful in GCM &amp;amp; eosinophilic; âˆ´ consider if rapidly progressive HF, high-grade AVB or sustained VT, suspected allergic rxn or eosinophilia Treatment Standard HF Rx if LV dysfxn (but do not start if e/o shock); temporary MCS as needed Immunosuppression: for GCM (high-dose steroids + CsA or tacrolimus Â± AZA), collagen vascular disease, peripartum (?</description></item><item><title>myofascial pain syndrome</title><link>https://www.physician.tw/myofascial-pain-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myofascial-pain-syndrome/</guid><description>myofascial pain syndrome âœ¨é‡é»: myofascial pain syndromeè‚Œç­‹è†œç–¼ç—›ç¶œåˆå¾µè¢«å®šç¾©ç‚ºä¸€ç¨®å€åŸŸæ€§ç–¼ç—›ç¶œåˆå¾µï¼Œå…¶ç‰¹å¾µæ˜¯åœ¨ç¹ƒç·Šçš„è‚Œè‚‰å¸¶ä¸­å­˜åœ¨è§¸ç™¼é»å’Œå±€éƒ¨æ·±éƒ¨è‚Œè‚‰å£“ç—›å€åŸŸã€‚ è§¸ç™¼é»ä¸Šçš„å£“åŠ›æœƒé‡ç¾ç–¼ç—›ã€‚ ç›¸æ¯”ä¹‹ä¸‹ï¼Œçº–ç¶­è‚Œç—›æ˜¯ä¸€ç¨®å…¨èº«æ€§ç–¼ç—›ç–¾ç—…ï¼Œèˆ‡èº«é«”æ‰€æœ‰å››å€‹åƒé™çš„å£“ç—›é»ç›¸é—œï¼Œ æŒçºŒè‡³å°‘ 3 å€‹æœˆï¼Œé€šå¸¸ä¼´æœ‰ç¡çœ éšœç¤™ã€è…¸æ˜“æ¿€ç¶œåˆå¾µå’ŒæŠ‘é¬±ç—‡ã€‚ åœ¨è‚Œç­‹è†œç–¼ç—›ç¶œåˆå¾µä¸­ï¼Œé€™äº›ç›¸é—œç‰¹å¾µæ˜é¡¯ä¸é‚£éº¼é »ç¹ã€‚</description></item><item><title>Myxedema coma</title><link>https://www.physician.tw/Myxedema-coma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Myxedema-coma/</guid><description>Myxedema coma Presentation: hypothermia, hypotension, hypoventilation, Î” MS (coma rare), hyponatremia, hypoglycemia; often precipitated by infxn or major cardiopulmonary or neurologic illness Treatment: supportive care most important.</description></item><item><title>myxoma</title><link>https://www.physician.tw/myxoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/myxoma/</guid><description>myxoma é»æ¶²ç˜¤ã€ï¼ˆmyxomaï¼‰ï¼Œè„‚è‚ªç˜¤è£¡æ˜¯è„‚è‚ªï¼Œ è€Œé»æ¶²ç˜¤å‰‡æ˜¯ä»¥é»æ¶²ç´ æˆ–ç¨±é»è›‹ç™½ï¼ˆmucinï¼‰ç‚ºä¸»è¦æˆä»½ï¼Œ æœ€å¸¸è¦‹çš„æ˜¯é•·åœ¨å¿ƒè‡Ÿè£¡ï¼Œä½†ä¹Ÿæœƒé•·åœ¨éª¨éª¼ã€æ³Œå°¿ç”Ÿæ®–é“ï¼Œåœ¨çš®ä¸‹æˆ–æ˜¯çš®è†šä¸­æ¯”è¼ƒå°‘è¦‹ã€‚</description></item><item><title>Names for vasculitides</title><link>https://www.physician.tw/Names-for-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Names-for-vasculitides/</guid><description>Names for vasculitides [[other names for vasculitides]]
Immune complex SVV Anti-glomerular basement membrane (anti-GBM) disease Cryoglobulinemic vasculitis (CV) IgA vasculitis (Henoch-SchÃ¶nlein) (IgAV) Hypocomplementemic urticarial vasculitis (HUV) (anti-C1g vasculitis)</description></item><item><title>narrow complex</title><link>https://www.physician.tw/narrow-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/narrow-complex/</guid><description>narrow complex regular [[vagal maneuvers]] adenosine 6 12 12 â˜ ï¸ å¯èƒ½æœƒæƒ¡åŒ–æˆVt converts: Likely AVNRT Or AVRT Rx recurrence w/ adenosine or long-acting AV nodal agent such as diltiazem or metoprolol does not convert: Possibly AFL, ATAC, NPUT Control rate w/ [[diltiazem]] or metoprolol or [[amiodarone]] 150 bolus drip 30min [[irregular of narrow complex]]</description></item><item><title>NCCN guideline</title><link>https://www.physician.tw/NCCN-guideline/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NCCN-guideline/</guid><description>NCCN guideline [[acute lymphoblastic leukemia]] acute myeloid leukemia ampullary adenocarcinoma [[anal carcinoma]] [[basal cell skin cancer]] B-cell lymphomas [[bladder cancer]] bone cancer breast cancer central nervous system cancers cervical cancer chronic lymphocytic leukemia small lymphocytic lymphoma chronic myeloid leukemia colon cancer dermatofibrosarcoma protuberans esophageal and esophagogastric junction cancers gastric cancer gastrointestinal stromal tumors (GIST) gestational trophoblastic neoplasia hairy cell leukemia head and neck cancers hepatobiliary cancers histiocytic neoplasms hodgkin lymphoma kaposi sarcoma kidney cancer malignant peritoneal mesothelioma malignant pleural mesothelioma melanoma cutaneous melanoma uveal merkel cell carcinoma multiple myeloma myelodysplastic syndromes myeloidlymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes myeloproliferative neoplasms neuroendocrine and adrenal tumors non-small cell lung cancer occult primary ovarian cancerfallopian tube cancerprimary peritoneal cancer pancreatic adenocarcinoma pediatric acute lymphoblastic leukemia pediatric aggressive mature B-cell lymphomas pediatric central nervous system cancers pediatric hodgkin lymphoma penile cancer primary cutaneous lymphomas prostate cancer rectal cancer small bowel adenocarcinoma small cell lung cancer soft tissue sarcoma squamous cell skin cancer systemic light chain amyloidosis systemic mastocytosis T-cell lymphomas testicular cancer thymomas and thymic carcinomas thyroid carcinoma uterine neoplasms vulvar cancer WaldenstrÃ¶m macroglobulinemia lymphoplasmacytic lymphoma Wilms tumor (Nephroblastoma)</description></item><item><title>necrotizing soft-tissue infections</title><link>https://www.physician.tw/necrotizing-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/necrotizing-soft-tissue-infections/</guid><description>necrotizing soft-tissue infections (NEJM 2017;377:2253)
[[Definition-necrotizing soft-tissue infections]] [[Evolution of Necrotizing Fasciitis or Myonecrosis]] [[Microbiology-necrotizing soft-tissue infections]] [[Clinical manifestations-necrotizing soft-tissue infections]] [[Diagnosis-necrotizing soft-tissue infections]]</description></item><item><title>Neoplasm Etiologies of Classic FUO</title><link>https://www.physician.tw/Neoplasm-Etiologies-of-Classic-FUO/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neoplasm-Etiologies-of-Classic-FUO/</guid><description>Neoplasm Etiologies of Classic FUO Lymphoma: LAN, HSM, â†“ Hct or plt, â†‘ LDH; leukemia; myelodysplasia
Renal cell carcinoma: microscopic hematuria, â†‘ Hct</description></item><item><title>nephrolithiasis</title><link>https://www.physician.tw/nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrolithiasis/</guid><description>nephrolithiasis [[Types of stones and risk factors]] [[Clinical manifestations-nephrolithiasis]] [[Workup-nephrolithiasis]] [[Acute treatment-nephrolithiasis]] [[Chronic treatment-nephrolithiasis]]</description></item><item><title>nephrology</title><link>https://www.physician.tw/nephrology-copy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology-copy/</guid><description>nephrology [[acid-base disturbances]] [[sodium and water homeostasis]] [[potassium homeostasis]] [[kidney disease]] [[glomerular disease]] [[urinalysis]] [[nephrolithiasis]] Acute Kidney Injury (AKI) Chronic Kidney Disease (CKD) and End-Stage Kidney Disease (ESKD) Glomerular Diseases Disorders of Sodium Homeostasis Kidney Transplant Immunosuppression Kidney Stones Additional topics are covered in the following rotation guides:</description></item><item><title>nephrology</title><link>https://www.physician.tw/nephrology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrology/</guid><description>å°¿æ¯’ç—‡ï¼Œè…è¡°ç«­ï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚ æ°´æ¶²ä¸å¹³ï¼Œé«”å…§æ¯’ç´ ï¼Œ è…è‡Ÿå…§ç—…ï¼Œè‹¦é›£å¤šã€‚
nephrology [[acid-base disturbances]]
[[sodium and water homeostasis]]
[[potassium homeostasis]]</description></item><item><title>nephrotic syndrome</title><link>https://www.physician.tw/nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nephrotic-syndrome/</guid><description>nephrotic syndrome [[proteinuria]] [[Definition-nephrotic syndrome]] [[Primary glomerular diseases (grouped by pathology)]] [[Systemic diseases with secondary glomerular involvement]] [[Workup-nephrotic syndrome]] [[Treatment-nephrotic syndrome]] [[glomerular disease]]</description></item><item><title>Nervous System Dysfunction</title><link>https://www.physician.tw/Nervous-System-Dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nervous-System-Dysfunction/</guid><description>Nervous System Dysfunction Chapter 21: [[syncope]] Chapter 22: [[dizziness and vertigo]] Chapter 23: [[fatigue]] Chapter 24: [[neurologic causes of weakness and paralysis]] Chapter 25: [[numbness, tingling, and sensory loss]] Chapter 26: [[gait disorders, imbalance, and falls]] Chapter 27: [[Confusion and Delirium]] Chapter 28: [[coma]] Chapter 29: [[dementia]] Chapter 30: [[aphasia, memory loss, and other cognitive disorders]] Chapter 31: [[sleep disorders]]</description></item><item><title>neurologic critical care</title><link>https://www.physician.tw/neurologic-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurologic-critical-care/</guid><description>neurologic critical care 26 Delirium 30 Intracranial Pressure and Neuromonitoring 31 Coma and Brain Death 32 Toxicology and Drug Reactions</description></item><item><title>Neurologic Psychologic-complications of HIV AIDS</title><link>https://www.physician.tw/Neurologic-Psychologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neurologic-Psychologic-complications-of-HIV-AIDS/</guid><description>Neurologic Psychologic-complications of HIV AIDS Meningitis: Crypto (dx w/ CSF; serum CrAg 90% Se), bacterial (inc. Listeria), viral (HSV, CMV, 1Â° HIV), TB, histo, Coccidio, lymphoma; neurosyphilis (cranial nerve palsies) Space-occupying lesions: may present as HA, focal deficits or Î” MS.</description></item><item><title>neurology</title><link>https://www.physician.tw/neurology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neurology/</guid><description>neurology [[change in mental status]] [[seizures]] [[alcohol withdrawal]] [[dizziness]] [[stroke]] [[weakness and neuromuscular dysfunction]] [[headache]] [[back pain]] [[spinal cord compression]] [[nerve root compression]] [[head injury]] part 4: [[neurologic critical care]] [[neurology anatomy and physiology]]</description></item><item><title>Neuromuscular dysphagia</title><link>https://www.physician.tw/Neuromuscular-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Neuromuscular-dysphagia/</guid><description>Neuromuscular dysphagia (solids &amp;amp; liquids; Neurogastero Motil 2021;33:e14058)
Caused by aberrant motility or innervation of oropharynx/esophagus Oropharyngeal: consider CNS disorders (eg, stroke, ALS, myopathies, CNS tumors) Esophageal: motility disorder w/ dysphagia, chest pain, GERD; dx: conventional or high-res manometry w/ esophageal pressure topography.</description></item><item><title>neutropenia</title><link>https://www.physician.tw/neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neutropenia/</guid><description>neutropenia (&amp;lt;1000/ÂµL)
Congenital Myelokathexis, Shwachman-Diamond-Oski, ChÃ©diak-Higashi, retic dysgen., WHIM syndrome, cyclic neutropenia, monoMAC syndrome (â†“ monos, NKs)
Infection Viral (CMV, EBV, HIV); bacterial (Brucella, Rickettsia, TB); malaria</description></item><item><title>neutrophilia</title><link>https://www.physician.tw/neutrophilia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/neutrophilia/</guid><description>neutrophilia (&amp;gt;7500â€“10,000/ÂµL)
Infection Usually bacterial; Â± toxic granulations, DÃ¶hle bodies
Inflammation Burn, tissue necrosis, MI, PE, collagen vascular disease
Drugs and toxins Corticosteroids, Î²-agonists, lithium, G-CSF; cigarette smoking</description></item><item><title>new note</title><link>https://www.physician.tw/new-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/new-note/</guid><description>AM/AMP Ampicillin Aminopenicillin 10 AMC/&amp;lsquo;A/C&amp;rsquo;/AUG/XL/AML* Amoxicillin + clavulanic acid Aminopenicillin 25/10 AMX/AMOX/AC/AML* Amoxicillin</description></item><item><title>new report</title><link>https://www.physician.tw/new-report/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/new-report/</guid><description>https://docs.google.com/presentation/d/1JZhMp-Iv gJbsajKC7M-fHTpygJ3Or npNY85xAuhTg/edit?usp=sharing</description></item><item><title>New York Heart Association class</title><link>https://www.physician.tw/New-York-Heart-Association-class/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/New-York-Heart-Association-class/</guid><description>New York Heart Association class Class I: no sx w/ ordinary activity class II: sx w/ ordinary activity class III: sx w/ minimal activity class IV: sx at rest</description></item><item><title>nitrofurantoin</title><link>https://www.physician.tw/nitrofurantoin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nitrofurantoin/</guid><description>nitrofurantoin Tradename Macrodantin, Furadantin, Macrobid
Usage and Dosing Nitrofurantoin is used to treat uncomplicated lower urinary tract infections (UTI), e.</description></item><item><title>nnnnnnnnew note</title><link>https://www.physician.tw/nnnnnnnnew-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nnnnnnnnew-note/</guid><description>A new note</description></item><item><title>non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/non-nucleoside-reverse-transcriptase-inhibitor-NNRTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/non-nucleoside-reverse-transcriptase-inhibitor-NNRTI-Antiretrovirals-ARVs/</guid><description>non- nucleoside reverse transcriptase inhibitor-NNRTI-Antiretrovirals (ARVs) efavirenz (EFV; Sustiva) etravirine (ETR; Intelence) nevirapine (NVP; Viramune) rilpivirine (RPV; Edurant) Class: rash, hepatitis, mixed CYP450 inducer/inhib EFV: CNS effects (incl depression) NVP: rash and hypersensitivity [risk factors are female, CD4 &amp;gt;250, pregnancy (âˆ´ avoid)]</description></item><item><title>Non-tuberculous mycobacterium-bronchiectasis</title><link>https://www.physician.tw/Non-tuberculous-mycobacterium-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Non-tuberculous-mycobacterium-bronchiectasis/</guid><description>Non-tuberculous mycobacterium-bronchiectasis (NTM; eg, MAC, Mycobacterium kansaii)
Chronic cough, â†“ wt; Lady Windermere syndrome: R middle lobe and lingula bronchiectasis in elderly â™€ who suppress expectoration</description></item><item><title>Nonalcoholic fatty liver disease NAFLD</title><link>https://www.physician.tw/Nonalcoholic-fatty-liver-disease-NAFLD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonalcoholic-fatty-liver-disease-NAFLD/</guid><description>Nonalcoholic fatty liver disease (NAFLD) (JAMA 2020;323:1175; Lancet 2021;397:2212)
Definition: fatty infiltration of liver + absence of EtOH or other cause of steatosis (HCV, etc.</description></item><item><title>NONINFLAMMATORY-Acute Infectious Etiologies</title><link>https://www.physician.tw/NONINFLAMMATORY-Acute-Infectious-Etiologies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NONINFLAMMATORY-Acute-Infectious-Etiologies/</guid><description>NONINFLAMMATORY-Acute Infectious Etiologies Predom. disruption small intestine absorp. &amp;amp; secretion. Voluminous diarrhea, N/V. âŠ– Fecal WBC &amp;amp; FOB.
Preformed toxin â€œFood poisoning,â€ &amp;lt;24 h dur.</description></item><item><title>Noninvasive positive-pressure ventilation of COPDAE</title><link>https://www.physician.tw/Noninvasive-positive-pressure-ventilation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Noninvasive-positive-pressure-ventilation-of-COPDAE/</guid><description>Noninvasive positive-pressure ventilation of COPDAE Initiate early if moderate/severe dyspnea, â†“ pH / â†‘ PaCO2, RR &amp;gt;25
Results in 58% â†“ intubation, â†“ LOS by 3.</description></item><item><title>Nonmegaloblastic macrocytic anemias</title><link>https://www.physician.tw/Nonmegaloblastic-macrocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonmegaloblastic-macrocytic-anemias/</guid><description>Nonmegaloblastic macrocytic anemias Liver disease: often macrocytic, may see target cells, or spur cell anemia w/ hemolysis
Alcoholism: BM suppression &amp;amp; macrocytosis independent of folate/B12 defic.</description></item><item><title>Nonneutrocytic bacterascites NNBA</title><link>https://www.physician.tw/Nonneutrocytic-bacterascites-NNBA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonneutrocytic-bacterascites-NNBA/</guid><description>Nonneutrocytic bacterascites (NNBA) âŠ• cx w/o â†‘ PMNs. Natural course may resolve w/o Rx. Start abx if symptomatic; if asymptomatic repeat para in 48 hrs.</description></item><item><title>Nonpharmacologic stroke prevent</title><link>https://www.physician.tw/Nonpharmacologic-stroke-prevent-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonpharmacologic-stroke-prevent-/</guid><description>Nonpharmacologic stroke prevent</description></item><item><title>Nonspecific Low Back Pain</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-metadata/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-metadata/</guid><description>Nonspecific Low Back Pain Metadata Item Type: [[Article]] Authors: [[Alessandro Chiarotto]], [[Bart W. Koes]] Date: [[2022-05-05]] Date Added: [[2022-08-07]] URL: https://doi.</description></item><item><title>Nonspecific Low Back Pain</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain/</guid><description>Nonspecific Low Back Pain ![[Nonspecific Low Back Pain-metadata#Metadata]]
Other files:
Mdnotes File Name: [[Nonspecific Low Back Pain]] Metadata File Name: [[Nonspecific Low Back Pain-metadata]] Zotero links [Local library](zotero://select/items/1 YKXMT6WM) Cloud library Notes</description></item><item><title>Nonspecific Low Back Pain - New Note</title><link>https://www.physician.tw/Nonspecific-Low-Back-Pain-New-Note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nonspecific-Low-Back-Pain-New-Note/</guid><description>Related to: [[Nonspecific Low Back Pain-zotero]]
Notes [[Annotations]]</description></item><item><title>nonthyroidal illness sick euthyroid syndrome</title><link>https://www.physician.tw/nonthyroidal-illness-sick-euthyroid-syndrome-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nonthyroidal-illness-sick-euthyroid-syndrome-/</guid><description>nonthyroidal illness (sick euthyroid syndrome) (J Endocrinol 2010;205:1)
TFT abnormalities in Pts w/ severe nonthyroidal illness (âˆ´ in acute illness, âœ“ TFTs only if â†‘ concern for thyroid disease); may have acquired transient central hypothyroidism If thyroid dysfxn suspected in critically ill Pt, TSH alone not reliable; must measure total T4, free T4, &amp;amp; T3 Mild illness: â†“ T4 â†’ T3 conversion, â†‘ rT3 â†’ â†“ T3; in severe illness: â†“ TBG &amp;amp; albumin, â†‘â†‘ rT3 â†’ â†“â†“ T3, â†‘ degradation of T4, central â†“ TSH â†’ â†“â†“ T3, â†“â†“ T4, â†“ free T4, â†“ TSH Recovery phase: â†‘ TSH followed by recovery of T4 and then T3 Replacement thyroxine not helpful or recommended for critically ill Pts w/ â†“ T3 and T4 unless other s/s of hypothyroidism</description></item><item><title>Normal GFR but with â†“ renal K excretion-hyperkalemia</title><link>https://www.physician.tw/Normal-GFR-but-with-renal-K-excretion-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Normal-GFR-but-with-renal-K-excretion-hyperkalemia/</guid><description>Normal GFR but with â†“ renal K excretion-hyperkalemia Normal aldosterone function â†“ EAV (K excretion limited by â†“ distal Na delivery &amp;amp; urine flow): CHF, cirrhosis</description></item><item><title>Normal hepatic vasculature</title><link>https://www.physician.tw/Normal-hepatic-vasculature/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Normal-hepatic-vasculature/</guid><description>Normal hepatic vasculature (Modified from The Nature of Disease Pathology for the Health Professions, 2007. Hepatology 2009;49:1729.)</description></item><item><title>normocytic anemias</title><link>https://www.physician.tw/normocytic-anemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/normocytic-anemias/</guid><description>normocytic anemias [[Anemia of chronic inflammation ]] [[Anemias of other chronic disorders]] [[Pure red cell aplasia]]</description></item><item><title>NSCLC Treatment</title><link>https://www.physician.tw/NSCLC-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSCLC-Treatment/</guid><description>NSCLC Treatment Localized disease: surgery if possible; RT (eg, stereotactic ablative radiotherapy [SABR]) vs. chemo/RT if not (see Figure 5-7)</description></item><item><title>NSIP nonspecific IP</title><link>https://www.physician.tw/NSIP-nonspecific-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSIP-nonspecific-IP/</guid><description>NSIP nonspecific IP Homogenous ground-glass opacities or consolid., reticular irreg lines; subpleural sparing; symmetric, peripheral, basal. Cellular &amp;amp; fibrotic subtypes.</description></item><item><title>NSTE-ACS</title><link>https://www.physician.tw/NSTE-ACS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NSTE-ACS/</guid><description>NSTE-ACS Key issues are antithrombotic regimen and decision regarding angiography
[[Antiplatelet Therapy]] [[Anticoagulant Therapy]] (choose one) [[Coronary angiography]] (Circ 2014;130:e344) [[TIMI Risk Score]] (TRS) for UA/NSTEMI (JAMA 2000;284:835)</description></item><item><title>nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals ARVs</title><link>https://www.physician.tw/nucleoside-reverse-transcriptase-inhibitor-NRTI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/nucleoside-reverse-transcriptase-inhibitor-NRTI-Antiretrovirals-ARVs/</guid><description>nucleoside reverse transcriptase inhibitor NRTI-Antiretrovirals (ARVs) Class: GI intol, lipoatrophy, lactic acidosis
abacavir (ABC; Ziagen) ABC: hypersensitivity (3%), âœ“ HLA-B*5701</description></item><item><title>Nutritional Support and Total Parenteral Nutrition</title><link>https://www.physician.tw/Nutritional-Support-and-Total-Parenteral-Nutrition/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Nutritional-Support-and-Total-Parenteral-Nutrition/</guid><description>Nutritional Support and Total Parenteral Nutrition Enteral &amp;amp; parenteral with similar clinical outcomes (Lancet 2018;391:133) Enteral (EN): starting w/in 48 h of ICU admit may â†“ infection &amp;amp; mortality.</description></item><item><title>NV would have selected</title><link>https://www.physician.tw/NV-would-have-selected/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/NV-would-have-selected/</guid><description>Wow</description></item><item><title>Obscure GIB</title><link>https://www.physician.tw/Obscure-GIB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obscure-GIB/</guid><description>Obscure GIB (Am J Gastro 2015;110:1265; Gastro 2017;152:497)
Definition: continued bleeding (melena, hematochezia) despite âŠ– EGD &amp;amp; colo; 5% of GIB Etiologies: Dieulafoyâ€™s lesion, GAVE, small bowel angiodysplasia, ulcer or cancer, Crohnâ€™s disease, aortoenteric fistula, Meckelâ€™s diverticulum, hemobilia Diagnosis: repeat EGD w/ push enteroscopy/colonoscopy when bleeding is active If âŠ–, video capsule to evaluate small intestine (contraindic.</description></item><item><title>Obstructive diseases-disease-specific management of kidney disease</title><link>https://www.physician.tw/Obstructive-diseases-disease-specific-management-of-kidney-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-diseases-disease-specific-management-of-kidney-disease-/</guid><description>Obstructive diseases-disease-specific management of kidney disease Dx: renal U/S if undifferentiated or CT abd/pelvic (Iâ€“) if suspect nephrolithiasis
Rx: Foley if urethra vs.</description></item><item><title>Obstructive shock</title><link>https://www.physician.tw/Obstructive-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Obstructive-shock/</guid><description>Obstructive shock Tension pneumothorax
Cardiac tamponade
Constrictive pericarditis
Pulmonary embolism
Aortic dissection</description></item><item><title>OI Prophylaxis-HIV AIDS</title><link>https://www.physician.tw/OI-Prophylaxis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OI-Prophylaxis-HIV-AIDS/</guid><description>OI Prophylaxis-HIV AIDS ( https://aidsinfo.nih.gov/guidelines &amp;amp; JAMA 2018;320:379, HIV.gov:2020) OI Indication 1Â° Prophylaxis
Tuberculosis âŠ• PPD (â‰¥5 mm), IGRA, or high-risk exposure See treatment for latent TB</description></item><item><title>old headache</title><link>https://www.physician.tw/old-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/old-headache/</guid><description>old headache Are there indication for brain imaging? YES: Obtain appropriate imaging
Does the headache fufill the highly specific [[POUNDing Mnemonic]] for migraines</description></item><item><title>Ommaya</title><link>https://www.physician.tw/Ommaya/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ommaya/</guid><description>Ommaya ï¼ˆ1ï¼‰æ“ä½œæ›´åŠ å®‰å…¨ã€ä¾¿æ·ï¼Œæ‚£è€…ç–¼ç—›å°‘ã€‚ ï¼ˆ2ï¼‰å¯ä¾æ“šé¡±å…§å£“è¡Œè…¦è„Šæ¶²å¼•æµï¼ŒåŠæ™‚æ”¹å–„é¡±é«˜å£“ç—‡ç‹€ï¼›ä¾¿æ–¼é‡è¤‡é€æª¢è…¦è„Šæ¶²ï¼Œç­è§£è—¥ç‰©æ¿ƒåº¦åŠè…«ç˜¤æŒ‡æ¨™çš„å‹•æ…‹è®ŠåŒ–ï¼Œæœ‰åŠ©æ–¼èª¿æ•´ç”¨è—¥ã€ç™‚æ•ˆè©•åƒ¹åŠè©•ä¼°é å¾Œã€‚ ï¼ˆ3ï¼‰è—¥ç‰©éš¨è…¦è„Šæ¶²çš„å¾ªç’°ï¼Œå¯å‡å‹»åˆ†ä½ˆæ–¼ä¸­æ¨ç¥ç¶“ç³»çµ±ï¼ˆcentral nervous system, CNSï¼‰çš„å„å€‹éƒ¨ä½ï¼Œè—¥ç‰©æ¿ƒåº¦å¯é”åˆ°åŒç­‰åŠ‘é‡ç¶“è…°æ¤ç©¿åˆºçµ¦è—¥çš„10å€[6]ï¼Œå› è€Œæœ‰æ›´å¥½çš„ç”Ÿå­˜ç²ç›Š[14]ã€‚
åŸºæ–¼æ­¤ï¼Œå„ªå…ˆæ¨è–¦é¸æ“‡ç¶“Ommayaå›Šè…¦å®¤å…§çµ¦è—¥ä¾†é€²è¡Œé˜å…§åŒ–ç™‚ [7, 15-17] ç¶“Ommayaå›Šé˜å…§åŒ–ç™‚å·²æˆåŠŸç”¨æ–¼æ²»ç™‚å¤šç¨®æƒ¡æ€§è…«ç˜¤ç›¸é—œçš„LMï¼ˆè¡¨ 1ï¼‰ã€‚
Ommayaå›Šç½®å…¥è¡“å¾Œä½µç™¼ç—‡ç™¼ç”Ÿç‡è¼ƒä½[18]ï¼Œå¸¸è¦‹çš„ä½µç™¼ç—‡åŒ…æ‹¬ï¼šé¡±å…§å‡ºè¡€ã€å°ç®¡æ˜“ä½å’Œå µå¡ã€ç¹¼ç™¼æ„ŸæŸ“ä»¥åŠåŒ–ç™‚è—¥ç‰©æ¯’å‰¯åæ‡‰ç­‰ã€‚è©²æ‚£è€…Ommayaå›Šç½®å…¥è¡“å¾Œï¼ŒçŸ­æœŸå…§å‡ºç¾å™å¿ƒã€å˜”åä»¥åŠç¡çœ éšœç¤™ï¼Œè€ƒæ…®å’Œè—¥ç‰©åˆºæ¿€ã€è…¦è„Šæ¶²æ³¢å‹•ç›¸é—œã€‚</description></item><item><title>oncologic emergencies</title><link>https://www.physician.tw/oncologic-emergencies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oncologic-emergencies/</guid><description>oncologic emergencies [[fever and neutropenia]] (FN) (NCCN Guidelines v.1.2021)</description></item><item><title>oncology</title><link>https://www.physician.tw/oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oncology/</guid><description>oncology è…«ç˜¤è”“å»¶ï¼Œç™Œç—‡ç–«æƒ…ï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚ é«”å…§ç•°ç‰©ï¼Œç—…è‹—æ»‹é•·ï¼Œ è…«ç˜¤å…§ç—…ï¼Œè‹¦é›£å¤šã€‚
[[hematology]] [[NCCN guideline]]
Pocket Oncology [[general oncology]] [[inpatient oncology]] [[clinical research methods]] [[radiation oncology]] [[cancer biology]] [[molecular diagnostics]] [[cancer immunology]] [[cancer genetics]] [[cancer pharmacology]] [[chemo side effects]] [[cancer complications]] [[pain and palliative care]] [[cancer survivorship]] [[infectious disease]] [[immunotherapy and cellular therapy]] [[oncologic emergencies.</description></item><item><title>Oncology-related glomerulopathy</title><link>https://www.physician.tw/Oncology-related-glomerulopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oncology-related-glomerulopathy/</guid><description>Oncology-related glomerulopathy (CJASN 2016;11:1681)
Associations between malig (solid tumors &amp;amp; heme) and/or their Rx (HSCT &amp;amp; chemo- therapeutics) and GN, nephrotic syndrome, and thrombotic microangiopathies (TMA)</description></item><item><title>open pressure</title><link>https://www.physician.tw/open-pressure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/open-pressure/</guid><description>open pressure æ­£å¸¸ 9â€“18 cmH2O Open pressure ä¸Šå‡å¯èƒ½åŸå› åŒ…æ‹¬ï¼šinfectionã€bleedingã€tumor ã€æŸäº› encephalitis ç­‰ã€‚</description></item><item><title>OpenAIDemo</title><link>https://www.physician.tw/OpenAIDemo/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/OpenAIDemo/</guid><description>What are the treatment of lung cancer
Lung cancer is the leading cause of cancer death in both men and women in the United States.</description></item><item><title>Ophthalmologic-complications of HIV AIDS</title><link>https://www.physician.tw/Ophthalmologic-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ophthalmologic-complications-of-HIV-AIDS/</guid><description>Ophthalmologic-complications of HIV AIDS CMV retinitis (CD4 usu &amp;lt;50); Rx: ganciclovir or valganciclovir, foscarnet, or cidofovir HZV, VZV, syphilis (any CD4 count, treat as neurosyphilis) or Toxo (CD4 usually &amp;lt;100)</description></item><item><title>Opioids-toxicology</title><link>https://www.physician.tw/Opioids-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Opioids-toxicology/</guid><description>Opioids-toxicology â†“ mentation, â†“ RR, miosis
IV naloxone</description></item><item><title>Optimal-medical-therapy-stable ischemic heart disease</title><link>https://www.physician.tw/Optimal-medical-therapy-stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Optimal-medical-therapy-stable-ischemic-heart-disease/</guid><description>Optimal-medical-therapy-stable ischemic heart disease ASA 75â€“162 mg/d; can substitute clopi if ASA-intolerant. ~12 mos after PCI, clopi monoRx â†“ risk of ischemic and bleeding events by ~30% c/w ASA monoRx (Lancet 2021;397:2487).</description></item><item><title>Oral anticoagulation-atrial fibrillation</title><link>https://www.physician.tw/Oral-anticoagulation-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oral-anticoagulation-atrial-fibrillation/</guid><description>Oral anticoagulation-atrial fibrillation (Circ 2014;130:e199 &amp;amp; 2019;140:125; EHJ 2021;42:373)
All valvular AF because stroke risk very high Nonvalvular AF (NVAF): stroke risk ~4.</description></item><item><title>Oral-complications of HIV AIDS</title><link>https://www.physician.tw/Oral-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oral-complications-of-HIV-AIDS/</guid><description>Oral-complications of HIV AIDS Aphthous ulcers; KS; thrush/oral candidiasis (curd-like patches, often painless)
Oral hairy leukoplakia: painless proliferation of papillae w/ adherent white coating usually on lateral tongue, caused by EBV but not precancerous</description></item><item><title>Organ dysfunction</title><link>https://www.physician.tw/Organ-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Organ-dysfunction/</guid><description>Organ dysfunction Liver (esp. cirrhosis): Vibrio spp., encapsulated bacteria ESRD: impaired granulocyte fxn and CMI as above Iron overload (or deferoxamine Rx): Yersinia, Zygomycetes</description></item><item><title>Organopho- sphate-toxicology</title><link>https://www.physician.tw/Organopho-sphate-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Organopho-sphate-toxicology/</guid><description>Organopho- sphate-toxicology Salivation, lacrimation, diaphoresis, miosis, emesis, bronchospasm, Î”MS
Endotracheal intubation for respiratory failure, atropine, pralidoxime, benzodiazepines</description></item><item><title>orthopaedic</title><link>https://www.physician.tw/orthopaedic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/orthopaedic/</guid><description>orthopaedic [[Joint Hypermobility Syndrome]]</description></item><item><title>Orthostatic proteinuria</title><link>https://www.physician.tw/Orthostatic-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Orthostatic-proteinuria/</guid><description>Orthostatic proteinuria typically in adolescents; ~90% of young â™‚ with isolated proteinuria have orthostatic proteinuria; typically resolves spontaneously</description></item><item><title>Osmotic diarrhea</title><link>https://www.physician.tw/Osmotic-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Osmotic-diarrhea/</guid><description>Osmotic diarrhea (watery; âŠ– fecal fat, â†‘ osmotic gap, â†“ diarrhea w/ fasting)
Caused by ingestion of poorly absorbed cations/anions (Mg, sulfate, phos; found in laxatives) or poorly absorbed carbs (eg, mannitol, sorbitol [found in chewing gum]) or lactose if lactose intolerant.</description></item><item><title>osteomyelitis</title><link>https://www.physician.tw/osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/osteomyelitis/</guid><description>osteomyelitis [!note]
Infection of bone due to hematogenous seeding or direct spread from contiguous focus
[[Etiology-osteomyelitis]] [[Clinical manifestations-osteomyelitis]] [[Diagnosis-osteomyelitis]] [[Treatment-osteomyelitis]] Backlinkï¼š [[Complications-diabetes mellitus]] [[diabetic foot infections]] [[Diagnosis-osteomyelitis]] [[differential diagnosis of back pain]] [[Etiology-osteomyelitis]] [[Imaging-Diagnosis-osteomyelitis]] [[Infection as Etiologies of Classic FUO]] [[infectious disease]] [[Risk factors for bloodstream infections]] [[Sickle cell anemia ]] [[skin and soft tissue infections]] [[Treatment-bacterial endocarditis]] [[Treatment-osteomyelitis]] [[vertebral osteomyelitis]]</description></item><item><title>Other Uosm >700â€“800</title><link>https://www.physician.tw/Other-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Uosm-700800/</guid><description>Other (Uosm &amp;gt;700â€“800) Na overload: hypertonic saline (eg, resuscitation w/ NaHCO3), mineralocorticoid excess
Seizures, â†‘ exercise: â†‘ intracellular osmoles â†’ H2O shifts â†’ transient â†‘ [Na]serum</description></item><item><title>Other antimicrobial agents of Drug fever</title><link>https://www.physician.tw/Other-antimicrobial-agents-of-Drug-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-antimicrobial-agents-of-Drug-fever/</guid><description>Other antimicrobial agents of Drug fever antimicrobial agents are also the most common cause of drug fever, accounting for approximately one-third of episodes</description></item><item><title>Other Complication-cirrhosis</title><link>https://www.physician.tw/Other-Complication-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Complication-cirrhosis/</guid><description>Other Complication-cirrhosis [[Portopulmonary hypertension (POPH)]] Cirrhotic cardiomyopathy: â†“ inotropic &amp;amp; chronotropic response, â†“ systolic &amp;amp; diastolic fxn, â†‘ QT, hyperkinetic circulation, high output; â†‘ troponin &amp;amp; BNP Infxns: unless immune, vaccinate for HAV, HBV, PCV13, PPSV23, COVID-19; flu yearly.</description></item><item><title>Other diagnostic studies-syncope</title><link>https://www.physician.tw/Other-diagnostic-studies-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-diagnostic-studies-syncope/</guid><description>Other diagnostic studies-syncope (consider based on results of H&amp;amp;P and ECG)
Ambulatory ECG monitoring: if suspect arrhythmogenic syncope Holter monitoring (continuous ECG 24â€“72 h): useful if frequent events Event recorder (activated by Pt to record rhythm): limited role if LOC w/o prodrome External loop recorder (continuously saves rhythm, âˆ´ can be activated after an event): useful for episodes (including w/o prodrome) likely to occur w/in 2â€“6 wks; can be coupled w/ mobile cardiac telemetry than can be auto-triggered for specific rhythms External patch recorder (1-lead recording; saves for 1â€“4 wks): Pt-activated or auto-triggered; more comfortable for Pts Implantable loop recorders (SC; can record 2â€“3 y; can be triggered): useful if episodes &amp;lt;1/mo; dx in 55% of cases; recommended for recurrent syncope w/o prodrome Echo: consider to r/o structural heart disease (eg, CMP [incl HCMP &amp;amp; ARVC], valvular disease [incl AS, MS, MVP], myxoma, amyloid, PHT, Â± anomalous coronaries) ETT/CCTA/Cath: esp.</description></item><item><title>Other measures of COPDAE</title><link>https://www.physician.tw/Other-measures-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-measures-of-COPDAE/</guid><description>Other measures of COPDAE Mucolytics overall not supported by data (Chest 2001;119:1190) Monitor for cardiac arrhythmias</description></item><item><title>other names for vasculitides</title><link>https://www.physician.tw/other-names-for-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-names-for-vasculitides/</guid><description>other names for vasculitides Variable vessel vasculitis (VVV) Behcet&amp;rsquo;s disease (BD) Cogan&amp;rsquo;s syndrome (CS)
Single-organ vasculitis (SOV) Cutaneous leukocytoclastic angiitis Cutaneous arteritis Primary central nervous system vasculitis Isolated aortitis Others</description></item><item><title>Other Post MI Complications</title><link>https://www.physician.tw/Other-Post-MI-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Other-Post-MI-Complications/</guid><description>Other Post MI Complications Complication Clinical Features Treatment LV thrombus ~30% incid. (espec lg antero-apical MI) ACÃ—3-6 mo (?</description></item><item><title>other solid tumors</title><link>https://www.physician.tw/other-solid-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-solid-tumors/</guid><description>[[index]]
[[hepatocellular carcinoma]] (HCC) [[urothelial carcinoma]] [[ddMVAC]]] [[esophageal cancer]] [[renal-cell-carcinoma]]</description></item><item><title>other-Secondary Causes of Hypertension</title><link>https://www.physician.tw/other-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/other-Secondary-Causes-of-Hypertension/</guid><description>other-Secondary Causes of Hypertension Obstructive sleep apnea (qv); alcohol Medications: OCP, steroids, [[licorice]]; NSAIDs (espec COX-2); Epo; CsA; TKI Aortic coarctation: â†“ LE pulses, systolic murmur, radial-femoral delay; abnl TTE, CXR Polycythemia vera: â†‘ Hct</description></item><item><title>Outpatient screening and treatment goals-diabetes mellitus</title><link>https://www.physician.tw/Outpatient-screening-and-treatment-goals-diabetes-mellitus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Outpatient-screening-and-treatment-goals-diabetes-mellitus/</guid><description>Outpatient screening and treatment goals-diabetes mellitus (Diabetes Care 2022;45;S83 &amp;amp; S144)
âœ“ HbA1C q3â€“6mo, goal &amp;lt;7% for most Pts. Goal &amp;lt;6.</description></item><item><title>Overflow proteinuria</title><link>https://www.physician.tw/Overflow-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overflow-proteinuria/</guid><description>Overflow proteinuria â†‘ production of freely filtered proteins Etiologies Multiple myeloma Myoglobinuria</description></item><item><title>Overview-immunotherapy and cellular therapy</title><link>https://www.physician.tw/Overview-immunotherapy-and-cellular-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-immunotherapy-and-cellular-therapy/</guid><description>Overview-immunotherapy and cellular therapy immunotherapy and cellular therapy
Immune checkpoints: co-inhibitory signaling molecules that limit immune responses Cytotoxic T-lymphocyte-assoc. protein 4 (CTLA-4): â†“ T cell activation via negative signals and ligand competition w/ CD28 (activating co-stim.</description></item><item><title>Overview-potassium homeostasis</title><link>https://www.physician.tw/Overview-potassium-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Overview-potassium-homeostasis/</guid><description>Overview-potassium homeostasis Renal: K excretion regulated at distal nephron (CCD) by principal &amp;amp; Î±-intercalated cells Distal Na delivery &amp;amp; urine flow: Na absorption â†’ lumen electronegative â†’ K secretion Metabolic alkalemia and aldosterone: increase Na absorption and K secretion nb, diurnal urinary K excretion (day &amp;gt;night), âˆ´ 24-h sample preferred over spot Transcellular shifts: most common cause of acute âˆ† in serum K (98% intracellular)</description></item><item><title>overview-sodium and water homeostasis</title><link>https://www.physician.tw/overview-sodium-and-water-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/overview-sodium-and-water-homeostasis/</guid><description>overview-sodium and water homeostasis General (NEJM 2015;372:55 &amp;amp; 373:1350)
Disorders of serum sodium are generally due to Î”s in total body water, not sodium Hyper- or hypo-osmolality â†’ rapid water shifts â†’ Î”s in brain cell volume â†’ Î” MS, seizures Key hormones [[Antidiuretic hormone]] (ADH) [[Aldosterone]]</description></item><item><title>Oxygen for chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Oxygen-for-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oxygen-for-chronic-obstructive-pulmonary-disease/</guid><description>Oxygen for chronic obstructive pulmonary disease if PaO2 â‰¤55 mmHg or SaO2 â‰¤89% (during rest, exercise, or sleep) to prevent cor pulmonale; only Rx proven to â†“ mortality (Annals 1980;93:391; Lancet 1981;i:681); no benefit in Pts with moderate hypoxemia (SaO2 89â€“93%) (NEJM 2016;375:1617) or nocturnal O2 alone (NEJM 2020;383:1129); unknown benefit of isolated exertional O2 (AJRCCM 2020;202:121).</description></item><item><title>oxygenation</title><link>https://www.physician.tw/oxygenation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/oxygenation/</guid><description>oxygenation æ­£å¸¸æ°§åˆï¼ˆæµ·å¹³é¢ï¼‰é æ¸¬ï¼š æ°§åˆ†å£“ (Pa o 2 ) ç‚º 75â€“100 mm Hgï¼Œ21% FiO2ï¼ˆå®¤å…§ç©ºæ°£ï¼‰ï¼ŒPaO2 ç‚º ~ 660 mm Hgï¼Œ100% FiO2 å¾è¼•åº¦ï¼ˆç•°å¸¸ A-a æ¢¯åº¦ï¼‰åˆ°é‡åº¦ï¼ˆåˆ†æµï¼‰ï¼Œæ°§åˆå—æï¼š Pao2 &amp;lt; 200 mm Hg on Fio2 of 100% = â€œåˆ†æµç”Ÿç†å­¸â€ å¦‚æœæ²’æœ‰â€œåˆ†æµç”Ÿç†å­¸â€ï¼ŒFio2 &amp;gt; 40%ï¼ˆ~ &amp;gt; 6 L/min é€šéé¼»æ’ç®¡ (NC)ï¼‰æ‡‰è©²çµ¦å‡º Pao2 &amp;gt; 60 mm Hgï¼Œå„˜ç®¡ç—…ç†æœƒå°è‡´ A-a æ¢¯åº¦ç•°å¸¸å¢åŠ  6Lçš„ncå¤§æ¦‚å°±è¦æ›ä¾†PaO2 60+ è¡¨ç¾å‡ºåˆ†æµç”Ÿç†å­¸çš„æ‚£è€…ç™¼ç”Ÿä½æ°§æ€§å‘¼å¸è¡°ç«­çš„é¢¨éšªå¾ˆé«˜ï¼Œéœ€è¦å°‹æ‰¾æ ¹æœ¬åŸå› ï¼Œä»¥åŠå¯†åˆ‡è§€å¯Ÿå’Œç©æ¥µæ”¯æŒï¼ˆä¾‹å¦‚èƒ¸éƒ¨æˆåƒï¼Œ100% Fi0 2 ï¼‰ Hypoxemic respiratory failure is practically defined as a Pa o 2 &amp;lt; 60 mm Hg é‡è¦å®šç¾©(æ•¸å­—è¦è¨˜ä¸€ä¸‹60) An acute drop in Pa o 2 &amp;lt; 60 mm Hg (but &amp;gt; 54 mm Hg), ie, â€œmild hypoxemia,â€ may cause a range of symptoms: Increased left ventricular end-diastolic pressure (LVEDP) (a.</description></item><item><title>Oxygenation of COPDAE</title><link>https://www.physician.tw/Oxygenation-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Oxygenation-of-COPDAE/</guid><description>Oxygenation of COPDAE â†‘ FiO2 to achieve PaO2 â‰¥55â€“60 or SaO2 88â€“92%
Watch for CO2 retention (due to â†‘ V/Q mismatch, loss of hypoxemic resp drive, [[Haldane effect]]), but must maintain acceptable SaO2!</description></item><item><title>PA catheter and tailored therapy</title><link>https://www.physician.tw/PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PA-catheter-and-tailored-therapy/</guid><description>[[index]]
Rationale [[Rationale PA catheter and tailored therapy]]
Indication [[Indications PA catheter and tailored therapy]] (NEJM 2013;369:e35; Circ 2017;136:e268)
Efficacy [[Efficacy concerns PA catheter and tailored therapy]] (NEJM 2006;354:2213; JAMA 2005;294:1664)</description></item><item><title>Pacemaker Code</title><link>https://www.physician.tw/Pacemaker-Code/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pacemaker-Code/</guid><description>Pacemaker Code</description></item><item><title>Pacemaker Complications</title><link>https://www.physician.tw/Pacemaker-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pacemaker-Complications/</guid><description>Pacemaker Complications Perforation Effusion/tamp/pain Typically acute, consider if HoTN
Failure to pace Bradycardia â†“ Battery, lead fx/dislodgment, â†‘ pacing threshold due to tissue rxn/injury; oversense â†’ inapprop.</description></item><item><title>Packed red blood cells</title><link>https://www.physician.tw/Packed-red-blood-cells/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Packed-red-blood-cells/</guid><description>Packed red blood cells For acute blood loss or to â†‘ O2-carrying capacity if end organ ischemia. 1 U PRBC â†’ â†‘ Hb by ~1 g/dL.</description></item><item><title>Pain</title><link>https://www.physician.tw/Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pain/</guid><description>Pain [[Pain: Pathophysiology and Management]] [[Chest Discomfort]] [[Abdominal Pain]] [[headache]] [[Back and Neck Pain]]</description></item><item><title>pain and palliative care</title><link>https://www.physician.tw/pain-and-palliative-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pain-and-palliative-care/</guid><description>pain and palliative care âœ¨é‡é»: ç–¼ç—›å¯æ ¹æ“šæ¨æ–·çš„ç—…ç†ç”Ÿç†å­¸ã€æ™‚é–“é€²ç¨‹ã€éƒ¨ä½æˆ–ç—…å› é€²è¡Œåˆ†é¡ã€‚ æ­£ç¢ºçš„ç–¼ç—›åˆ†é¡å¯èƒ½æœ‰åŠ©æ–¼æ­£ç¢ºæ²»ç™‚ç–¼ç—›å•é¡Œã€‚ æ…¢æ€§éç™Œç—‡ç›¸é—œç–¼ç—›èˆ‡æ€¥æ€§ç–¼ç—›é¡¯è‘—ä¸åŒï¼Œå› ç‚ºæ…¢æ€§éç™Œç—‡ç›¸é—œç–¼ç—›æ²’æœ‰æœ‰ç”¨çš„ç”Ÿç‰©å­¸ç›®çš„ã€‚ Topics: [[Classification of Pain]] [[paresthesia and dysesthesia]] [[deafferentation pain]] [[myofascial pain syndrome]]</description></item><item><title>palliative care</title><link>https://www.physician.tw/palliative-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/palliative-care/</guid><description>[[index]]</description></item><item><title>Pancoastâ€™s syndrome</title><link>https://www.physician.tw/Pancoasts-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pancoasts-syndrome/</guid><description>Pancoastâ€™s syndrome apical tumor â†’ brachial plexus involvement (C8, T1, T2) â†’ [[Hornerâ€™s syndrome]], shoulder pain, rib destruction, atrophy of hand muscles</description></item><item><title>pancreatic tumors</title><link>https://www.physician.tw/pancreatic-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatic-tumors/</guid><description>pancreatic tumors</description></item><item><title>pancreatitis</title><link>https://www.physician.tw/pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancreatitis/</guid><description>pancreatitis [[acute pancreatitis]] [[chronic pancreatitis]] [[autoimmune pancreatitis]]</description></item><item><title>pancytopenia</title><link>https://www.physician.tw/pancytopenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pancytopenia/</guid><description>pancytopenia [[Etiologies-pancytopenia]] Clinical manifestations Anemia â†’ fatigue; neutropenia â†’ recurrent infections; thrombocytopenia â†’ mucosal bleeding &amp;amp; easy bruisability</description></item><item><title>Papillary thyroid cancer</title><link>https://www.physician.tw/Papillary-thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Papillary-thyroid-cancer/</guid><description>Papillary thyroid cancer Most common form (85% of differentiated thyroid cancers); peak incidence 30 to 50 y Risk factors: childhood radiation exposure, FHx in 1Â° relative, familial syndrome Low-risk, mort.</description></item><item><title>Paralytic ileus of the colon &amp; small bowel</title><link>https://www.physician.tw/Paralytic-ileus-of-the-colon-small-bowel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paralytic-ileus-of-the-colon-small-bowel/</guid><description>Paralytic ileus of the colon &amp;amp; small bowel (Dis Colon Rectum 2021;64:1046)
Definition: loss of intestinal peristalsis in absence of mechanical obstruction</description></item><item><title>Paraneoplastic syndromes</title><link>https://www.physician.tw/Paraneoplastic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paraneoplastic-syndromes/</guid><description>Paraneoplastic syndromes å…§åˆ†æ³Œã€è‚Œè‚‰ã€ç¥ç¶“ã€è¡€æ¶²
Endo SIADH (SCLC); ACTH (SCLC) â†’ Cushingâ€™s; PTH-rP (SCC) â†’ hyperCa
Skeletal digital clubbing (NSCLC), [[hypertrophic pulm osteoarthropathy]] (adenocarcinoma) = symmetric polyarthritis and proliferative periostitis of long bones Neuro (SCLC) [[Eaton-Lambert]] peripheral neuropathy (anti-Hu, anti-PCA-2, anti-CRMP5), cerebellar degeneration (anti-Hu, anti-Yo, anti-Ri, anti-Tr), encephalomyelitis (anti-Hu, anti-Ma1/2, anti-CRMP5) Hematologic hypercoagulable state (adenocarcinoma) DIC</description></item><item><title>parapneumonic effusions</title><link>https://www.physician.tw/parapneumonic-effusions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/parapneumonic-effusions/</guid><description>parapneumonic effusions parapneumonicç©æ¶²æ˜¯åœ¨èˆ‡è‚ºç‚ç›¸é„°çš„èƒ¸è†œç©ºé–“ä¸­å½¢æˆçš„èƒ¸è…”ç©æ¶²ã€‚ ç•¶å¾®ç”Ÿç‰©æ„ŸæŸ“èƒ¸è†œç©ºé–“æ™‚ï¼Œå¯èƒ½æœƒå°è‡´è¤‡é›œçš„parapneumonicç©æ¶²æˆ–è†¿èƒ¸ã€‚ åœ¨æ²’æœ‰ç›¸é„°çš„è‚ºç‚çš„æƒ…æ³ä¸‹ï¼Œè†¿èƒ¸ä¹Ÿå¯ä»¥ç™¼å±•ã€‚</description></item><item><title>Parathyroid MIBI Scan</title><link>https://www.physician.tw/Parathyroid-MIBI-Scan/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Parathyroid-MIBI-Scan/</guid><description>Parathyroid MIBI Scan https://www.insideradiology.com.au/parathyroid-mibi-scan-hp/
ç”²ç‹€æ—è…º MIBI æƒæç”¨æ–¼æ ¸é†«å­¸
ç”²ç‹€æ—è…ºæƒæä½¿ç”¨æ”¾å°„æ€§åŒä½ç´ é 99m sestamibiï¼ˆæˆ– MIBIï¼‰ï¼Œå°‡å…¶è¨»å…¥é«”å…§ä¸¦è¢«éåº¦æ´»èºçš„ç”²ç‹€æ—è…ºç·šç²’é«”å¸æ”¶ã€‚ å°ä¼½é¦¬ç›¸æ©Ÿæ‹æ”çš„åœ–åƒé€²è¡Œæƒæï¼Œç™¼ç¾ä¸€å€‹éåº¦æ´»èºçš„è…ºé«”ã€‚ åœ¨æŸäº›æƒ…æ³ä¸‹ï¼Œåœ¨ MIBI ä¹‹å‰çµ¦äºˆå¦ä¸€ç¨®æ”¾å°„æ€§ç‰©è³ªï¼ˆé«˜é”é…¸éˆ‰ï¼‰ï¼Œä»¥ä¾¿åƒ…è­˜åˆ¥ç”²ç‹€è…ºã€‚ é€™å…è¨±è©•ä¼°ç”²ç‹€æ—è…ºç›¸å°æ–¼ç”²ç‹€è…ºçš„ä½ç½®ã€‚ é€²è¡Œç”²ç‹€æ—è…º MIBI æƒæçš„å…ˆæ±ºæ¢ä»¶æ˜¯ä»€éº¼ï¼Ÿ</description></item><item><title>paresthesia and dysesthesia</title><link>https://www.physician.tw/paresthesia-and-dysesthesia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/paresthesia-and-dysesthesia/</guid><description>paresthesia and dysesthesia âœ¨é‡é»: paresthesia æ„Ÿè¦ºéº»æœ¨è¢«ç°¡å–®åœ°æè¿°ç‚ºä¸€ç¨®ç„¡ç—›çš„æ„Ÿè¦ºæ”¹è®Šï¼ˆä¾‹å¦‚ï¼Œéº»æœ¨ï¼‰ã€‚ dysesthesia æ„Ÿè¦ºé²éˆæ˜¯ä¸€ç¨®ç–¼ç—›çš„æ„Ÿè¦ºæ”¹è®Šï¼ˆä¾‹å¦‚ï¼Œç–¼ç—›çš„éº»æœ¨ï¼‰ã€‚</description></item><item><title>Paroxysmal nocturnal hemoglobinuria</title><link>https://www.physician.tw/Paroxysmal-nocturnal-hemoglobinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Paroxysmal-nocturnal-hemoglobinuria/</guid><description>Paroxysmal nocturnal hemoglobinuria (PNH) (Blood 2009;113:6522)
Acquired clonal stem cell disorder = inactivating somatic mutation of PIG-A gene â†’ deficiency of GPI-anchor for CD55 &amp;amp; CD59 (inhib of complement) â†’ complement-mediated RBC lysis, plt aggregation, &amp;amp; hypercoagulability</description></item><item><title>pathogen</title><link>https://www.physician.tw/pathogen/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogen/</guid><description>pathogen [[Acinetobacter sp]] [[CAPT-resistant GNB]] [[HACEK]]</description></item><item><title>Pathogenesis epidemiology-clostridioides difficile infection</title><link>https://www.physician.tw/Pathogenesis-epidemiology-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-epidemiology-clostridioides-difficile-infection/</guid><description>Pathogenesis epidemiology-clostridioides difficile infection Ingestion of C. diff spores â†’ colonization when colonic flora Î”â€™d by abx or chemo â†’ release of toxin A/B â†’ colonic mucosal necrosis &amp;amp; inflammation â†’ pseudomembranes</description></item><item><title>Pathogenesis etiology-chronic pancreatitis</title><link>https://www.physician.tw/Pathogenesis-etiology-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-etiology-chronic-pancreatitis/</guid><description>Pathogenesis etiology-chronic pancreatitis (Gastro 2013;144:1292; JAMA 2019;322:2422)
Often recurrent acute attacks â†’ inflam infiltrate â†’ fibrosis â†’ loss of exocrine &amp;amp; endocrine tissue.</description></item><item><title>pathogenesis of disseminated intravascular coagulation DIC</title><link>https://www.physician.tw/pathogenesis-of-disseminated-intravascular-coagulation-DIC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogenesis-of-disseminated-intravascular-coagulation-DIC/</guid><description>pathogenesis of disseminated intravascular coagulation (DIC) massive activation of coagulation that overwhelms control mechanisms
Thrombosis in microvasculature â†’ ischemia + microangiopathic hemolytic anemia</description></item><item><title>pathogenesis of vasculitides</title><link>https://www.physician.tw/pathogenesis-of-vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathogenesis-of-vasculitides/</guid><description>pathogenesis of vasculitides is not well understood, but potential pathophysiologic processes leading to vascular damage include immune complex deposition, antineutrophil cytoplasmic antibodies (ANCAs) (humoral mechanism), and T-lymphocyte response with granuloma formation (cell-mediated mechanism).</description></item><item><title>Pathogenesis-acute pancreatitis</title><link>https://www.physician.tw/Pathogenesis-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-acute-pancreatitis/</guid><description>Pathogenesis-acute pancreatitis Pancreatic duct and acinar injury via direct or indirect toxicity â†’ impaired secretion and premature activation of digestive enzymes â†’ autodigestion and acute inflammation</description></item><item><title>Pathogenesis-cholecystitis</title><link>https://www.physician.tw/Pathogenesis-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-cholecystitis/</guid><description>Pathogenesis-cholecystitis Acute cholecystitis: stone impaction in cystic duct â†’ inflammation behind obstruction â†’ GB swelling Â± secondary infection (50%) of biliary fluid</description></item><item><title>Pathogenesis-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Pathogenesis-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathogenesis-chronic-obstructive-pulmonary-disease/</guid><description>Pathogenesis-chronic obstructive pulmonary disease Lancet 2017;389:1931
Cigarette smoke (centrilobular emphysema, affects 15â€“20% of smokers) Recurrent airway infections [[Î±1-antitrypsin deficiency]] Low FEV1 in early adulthood associated with COPD (NEJM 2015;373:111)</description></item><item><title>Pathologic-Q-waves</title><link>https://www.physician.tw/Pathologic-Q-waves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathologic-Q-waves/</guid><description>Pathologic-Q-waves Q wave, Q
Definition: â‰¥30 msec (â‰¥20 msec V2â€“V3) or &amp;gt;25% height of R wave in that QRS complex</description></item><item><title>Pathology pathogenesis esophageal cancer</title><link>https://www.physician.tw/Pathology-pathogenesis-esophageal-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathology-pathogenesis-esophageal-cancer/</guid><description>Pathology pathogenesis esophageal cancer Squamous cell carcinoma Squamous cell carcinomas (SCCs) are usually located in the proximal or mid third of the esophagus.</description></item><item><title>Pathophysiology risk factors -aortic aneurysms</title><link>https://www.physician.tw/Pathophysiology-risk-factors-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-risk-factors-aortic-aneurysms/</guid><description>Pathophysiology risk factors -aortic aneurysms (JACC 2020:76:201 &amp;amp; 2021;78:201)
Medial degen and/or â†‘ wall stress; wall stress âˆ [(âˆ†P Ã— r) / (wall thickness)] (Laplaceâ€™s law) TAA: medial degeneration (muscle apoptosis, elastin fiber weakening); a/w CTD, aortitis AAA: long-standing HTN + athero/inflammation â†’ medial weakening Clinical risk factors: HTN, athero, smoking, age, â™‚, presence of other aortic dilation CTD (Marfan, Ehlers-Danlos type IV, Loeys-Dietz); congenital (bicuspid AoV, Turnerâ€™s) aortitis (Takayasuâ€™s GCA, spondyloarthritis, IgG4); infection (eg, syphilis); FQ; trauma</description></item><item><title>Pathophysiology and microbiology of fever and neutropenia</title><link>https://www.physician.tw/Pathophysiology-and-microbiology-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-and-microbiology-of-fever-and-neutropenia/</guid><description>Pathophysiology and microbiology of fever and neutropenia Predisposing factors: catheters, skin breakdown, GI mucositis, obstruction (lymphatics, biliary tract, GI, urinary tract), immune defect associated with malignancy Often thought due to seeding of bloodstream by GI flora, eg, GNRs (esp.</description></item><item><title>pathophysiology gastroesophageal reflux disease</title><link>https://www.physician.tw/pathophysiology-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pathophysiology-gastroesophageal-reflux-disease/</guid><description>pathophysiology gastroesophageal reflux disease (JAMA 2020;324:2536)
â†‘ acid exposure in esophagus, caused by â†‘ transient LES relaxations. Worsened by â†‘ intraabd pressure (eg, obesity, pregnancy), â†“ esophagogastric motility, hiatal hernia.</description></item><item><title>Pathophysiology of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Pathophysiology-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-Cryoglobulinemic-vasculitis/</guid><description>Pathophysiology of Cryoglobulinemic vasculitis Type I: cryo precipitation in microcirculation â†’ hyperviscosity &amp;amp; vascular occlusion Types II/III: defective/insufficient immune complex (IC) clearance â†’ IC-mediated inflammation of blood vessels w/ complement activation â†’ vasculitis</description></item><item><title>Pathophysiology of diverticulitis</title><link>https://www.physician.tw/Pathophysiology-of-diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-diverticulitis/</guid><description>Pathophysiology of diverticulitis (NEJM 2007;357:2057; Gastro 2015;149:1944)
Retention of undigested food and bacteria in diverticulum â†’ fecalith formation â†’ obstruction â†’ compromise of diverticulumâ€™s blood supply, infection, microperforation Uncomplicated (75%): microperforation â†’ localized infection, LLQ pain, fever, â†‘ WBC Complicated (25%): macroperf â†’ abscess, peritonitis, fistula (65% w/ bladder), obstrxn Clinical manifestations LLQ abdominal pain, fever, nausea, vomiting, constipation or diarrhea PEx ranges from LLQ tenderness Â± palpable mass to peritoneal signs &amp;amp; septic shock Ddx includes IBD, infectious colitis, PID, tubal pregnancy, cystitis, colorectal cancer</description></item><item><title>Pathophysiology of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Pathophysiology-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-of-hypertrophic-cardiomyopathy/</guid><description>Pathophysiology of hypertrophic cardiomyopathy LV outflow tract obstruction (LVOTO) in â‰¥70%: narrowed tract 2Â° hypertrophied septum + systolic anterior motion (SAM) of ant.</description></item><item><title>Pathophysiology-Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Pathophysiology-Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-Acetaminophen-hepatotoxicity/</guid><description>Pathophysiology-Acetaminophen hepatotoxicity 90% of acetaminophen (N-acetyl-p-aminophenol, APAP) metab into nontoxic metab, but ~5% metab by CYP2E1 into NAPQI, a hepatotoxic metab detoxified by glutathione conjugation; APAP overdose (&amp;gt;10 g) depletes glutathione stores â†’ injury</description></item><item><title>Pathophysiology-ascites</title><link>https://www.physician.tw/Pathophysiology-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-ascites/</guid><description>Pathophysiology-ascites ( Hepatology 2021;74:1014) [[Pathogenesis of ascites and related complications of cirrhosis]]
Portal HTN â†’ â†‘ NO &amp;amp; prostaglandins â†’ splanchnic vasodilatationâ†’ â†“ effective arterial volume â†’ â†‘ RAAS &amp;amp; ADH â†’ renal Na &amp;amp; H2O retention â†’ volume overload and ascites Portal hypertension leads to increased nitric oxide and prostaglandins, resulting in splanchnic vasodilation and decreased effective arterial volume.</description></item><item><title>Pathophysiology-constrictive pericarditis</title><link>https://www.physician.tw/Pathophysiology-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-constrictive-pericarditis/</guid><description>Pathophysiology-constrictive pericarditis Adhesion of visceral and parietal pericardial layers â†’ rigid pericardium that limits diastolic filling of ventricles â†’ â†‘ systemic venous pressures Venous return is limited only after early rapid filling phase; âˆ´ rapid â†“ in RA pressure with atrial relaxation and opening of tricuspid valve and prominent x and y descents Kussmaul sign: JVP does not decrease with inspiration (â†‘ venous return with inspiration, but negative intrathoracic pressure not transmitted to heart because of rigid pericardium)</description></item><item><title>Pathophysiology-diabetic ketoacidosis</title><link>https://www.physician.tw/Pathophysiology-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-diabetic-ketoacidosis/</guid><description>Pathophysiology-diabetic ketoacidosis (NEJM 2015;372:546)
Occurs in T1D (and in ketosis-prone T2D); â†‘ glucagon and â†“ insulin Hyperglycemia due to: â†‘ gluconeogenesis, â†‘ glycogenolysis, â†“ glucose uptake into cells Ketosis due to: insulin deficiency â†’ mobilization and oxidation of fatty acids, â†‘ substrate for ketogenesis, â†‘ ketogenic state of the liver, â†“ ketone clearance</description></item><item><title>Pathophysiology-gastroesophageal reflux disease</title><link>https://www.physician.tw/Pathophysiology-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-gastroesophageal-reflux-disease/</guid><description>Pathophysiology-gastroesophageal reflux disease Gastroesophageal reflux disease (GERD) is the second most common gastrointestinal diagnosis in the ambulatory setting and affects 18%â€“28% of people living in the North America.</description></item><item><title>Pathophysiology-Heparin-Induced Thrombocytopenias</title><link>https://www.physician.tw/Pathophysiology-Heparin-Induced-Thrombocytopenias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-Heparin-Induced-Thrombocytopenias/</guid><description>Pathophysiology-Heparin-Induced Thrombocytopenias Ab binds heparin-PF4 â†’ immune complex binds to plt â†’ plt activation, further PF4 release â†’ plt aggregates removed from circulation â†’ thrombocytopenia; procoagulants released by plts and tissue factor released by endothelial cells damaged by HIT Abs â†’ prothrombotic state</description></item><item><title>Pathophysiology-hypernatremia</title><link>https://www.physician.tw/Pathophysiology-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-hypernatremia/</guid><description>Pathophysiology-hypernatremia (Crit Care 2013;17:206; NEJM 2015;372:55)
Deficit of water relative to sodium; by definition, all hypernatremic Pts are hypertonic</description></item><item><title>Pathophysiology-hyponatremia</title><link>https://www.physician.tw/Pathophysiology-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-hyponatremia/</guid><description>Pathophysiology-hyponatremia (JASN 2008;19:1076; NEJM 2015;372:1349)
Pathophysiology (JASN 2008;19:1076; NEJM 2015;372:1349)
Excess H2O relative to Na, usually due to â†‘ ADH â†‘ ADH may be appropriate (eg, hypovolemia or hypervolemia with â†“ EAV) â†‘ ADH may be inappropriate (SIADH) Rarely, â†“ ADH (appropriately suppressed), but kidneys unable to maintain nl [Na]serum at steady state, solute intake = solute excretion; urine output = solute excretion/Uosm nl dietary solute load ~750 mOsm/d, min Uosm = 50 mOsm/L, âˆ´ UOP can be up to ~15 L â†‘ H2O intake (1Â° polydipsia): ingestion of massive quantities (usually &amp;gt;15 L/d) of free H2O overwhelms diluting ability of kidney â†’ H2O retention â†“ solute intake (â€œtea &amp;amp; toastâ€ &amp;amp; beer potomania): â†“â†“ daily solute load â†’ insufficient solute to excrete H2O intake (eg, if only 250 mOsm/d, minimum Uosm = 50 mOsm/L â†’ excrete in ~5 L; if H2O ingestion exceeds this amount â†’ H2O retention)</description></item><item><title>Pathophysiology-metabolic-alkalosis</title><link>https://www.physician.tw/Pathophysiology-metabolic-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-metabolic-alkalosis/</guid><description>Pathophysiology-metabolic-alkalosis (CJASN 2020;15:1848)
Saline-responsive etiologies require
initiating event and maintenance phase Initiating event: net HCO3âˆ’ reabsorption (due to loss of volume, Cl-, and/or K+) or loss of H+ Loss of H+ (Â± Cl-) from GI tract, kidneys, or transcellular shift in hypokalemia Contraction alkalosis: loss of HCO3&amp;ndash;poor fluid â†’ extracellular fluid â€œcontractsâ€ around fixed amount of HCO3- â†’ â†‘ HCO3- concentration æµå¤±æ‰é…¸æ¶² Exogenous alkali: iatrogenic HCO3- (with renal impairment), [[milk-alkali syndrome]] Posthypercapnia: resp.</description></item><item><title>Pathophysiology-pericardial tamponade</title><link>https://www.physician.tw/Pathophysiology-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-pericardial-tamponade/</guid><description>Pathophysiology-pericardial tamponade â†‘ intrapericardial pressure, compression of heart chambers, â†“ venous return â†’ â†“ CO Diastolic pressures â†‘ &amp;amp; equalize in all cardiac chambers â†’ minimal flow of blood from RA to RV when TV opens â†’ blunted y descent â†‘ ventricular interdependence â†’ pulsus paradoxus (pathologic exaggeration of nl physio) Inspiration â†’ â†“ intrapericardial &amp;amp; RA pressures â†’ â†‘ venous return â†’ â†‘ RV size â†’ septal shift to left.</description></item><item><title>Pathophysiology-pleural effusion</title><link>https://www.physician.tw/Pathophysiology-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pathophysiology-pleural-effusion/</guid><description>Pathophysiology-pleural effusion Systemic factors (eg, â†‘ PCWP, â†“ oncotic pressure) â†’ transudative effusion pcwp è‚ºæ¯›ç´°è¡€ç®¡å¥‘å£“ Local factors (ie, Î” pleural surface permeability) â†’ exudative effusion</description></item><item><title>Patient isolation-tuberculosis</title><link>https://www.physician.tw/Patient-isolation-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patient-isolation-tuberculosis/</guid><description>Patient isolation-tuberculosis Decision based on likelihood of active disease. Consider when cough, dyspnea, hemoptysis, â‰¥1 risk factor (HIV âŠ•, foreign born, substance use disorder, homeless, recent incarceration, prior TB or exposure).</description></item><item><title>Patterns of LFTs</title><link>https://www.physician.tw/Patterns-of-LFTs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Patterns-of-LFTs/</guid><description>Patterns of LFTs LFTsç•°å¸¸çš„å››å¤§é¡DDx hepatocellular ä¸Šå‡çš„ALT, aspartate aminotransferaseï¼Œå…¶ä»–çš„ä¸ä¸€å®š Cholestatic Infiltrative Nonhepatic hepatocellular æƒ³å››å€‹DDx Viral hepatitis, non-alcoholic fatty liver disease ä¸€èˆ¬ä¾†èªªæœƒæ˜¯ALT&amp;gt;AST Alchololic hepatitis AST&amp;gt;2*ALT Ischemic injury å››é …éƒ½é«˜ï¼Œå› æ­¤shock liverçš„è¨ºæ–·é‚„æ˜¯æŠŠå››é …éƒ½æŠ½ä¸€æŠ½ Wilson Disease AÏ† : Tbili &amp;lt; 4 (if fulminat) Cholestatic Infiltrative åè€Œæ˜¯AÏ†, Bilirubiné«˜ Nonhepatic Skeletal muscle injury Bone Disease Hemolysis</description></item><item><title>PD peritonitis</title><link>https://www.physician.tw/PD-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-peritonitis/</guid><description>PD peritonitis : abd pain &amp;amp; cloudy drainage (WBC &amp;gt;100 &amp;amp; &amp;gt;50% PMNs). 60â€“70% GPC, 15â€“20% GNR. Rx: abx IV or in PD, catheter removal for certain org (yeast, Pseudomonas).</description></item><item><title>PD-1 PD-L1 pathway</title><link>https://www.physician.tw/PD-1-PD-L1-pathway/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-1-PD-L1-pathway/</guid><description>PD-1 PD-L1 pathway Programmed Cell Death Protein 1 (PD-1) original: PD-1/PD-L1 pathway: current researches in cancer
PD-1/PD-L1 pathway controls the induction and maintenance of immune tolerance within the tumor microenvironment.</description></item><item><title>PD-L1</title><link>https://www.physician.tw/PD-L1/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PD-L1/</guid><description>å…ç–«æ²»ç™‚|ä¸€æ–‡è®€æ‡‚PD-L1æª¢æ¸¬ä¹‹æŠ—é«”é¸æ“‡ [[PD-1 PD-L1 pathway]]: current researches in cancer [[atezolizumab]]
TPSï¼šè…«ç˜¤ç´°èƒé™½æ€§æ¯”ä¾‹åˆ†æ•¸ï¼ˆTumor Proportion Score)ï¼Œè¨ˆç®—å…¬å¼å¦‚ä¸‹ï¼š
PD-L1åˆ¤è®€æ¨™æº–ï¼ˆTPSï¼‰ï¼š
PD-L1å¼·è¡¨é”ï¼ˆTPSâ‰¥50%ï¼‰ï¼›PD-L1è¡¨é”ï¼ˆ1%â‰¤TPSâ‰¤49%ï¼‰ï¼›PD-L1æœªè¡¨é”ï¼ˆTPSï¼œ1%ï¼‰
CPSï¼šé™½æ€§è¯åˆåˆ†æ•¸ï¼ˆCombined Positive Scoreï¼‰ã€‚é™¤äº†è…«ç˜¤ç´°èƒè¡¨é”PD-L1ä¹‹å¤–ï¼Œæ·‹å·´ç´°èƒã€å·¨å™¬ç´°èƒç­‰å…ç–«ç´° èƒä¹Ÿæœƒæœ‰PD-L1è¡¨é”ã€‚è¨ˆç®—å…¬å¼å¦‚ä¸‹ï¼š
PD-L1åˆ¤è®€æ¨™æº–ï¼ˆCPSï¼‰ï¼š</description></item><item><title>Pel-Ebstein fever</title><link>https://www.physician.tw/Pel-Ebstein-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pel-Ebstein-fever/</guid><description>Pel-Ebstein fever âœ¨é‡é»: é€™æ˜¯ 16% çš„éœå¥‡é‡‘ç—…ç—…ä¾‹çš„ç™¼ç‡’ã€‚ å®ƒçš„ç‰¹é»æ˜¯ç™¼ä½œæŒçºŒæ•¸å°æ™‚æˆ–æ•¸å¤©ï¼Œç„¶å¾Œæ˜¯æ•¸å¤©ç”šè‡³æ•¸é€±çš„ç„¡ç™¼ç†±æœŸã€‚ å› æ­¤ï¼Œé€™æ˜¯å…¸å‹çš„å›æ­¸ç†±ã€‚ å®ƒæ–¼ 19 ä¸–ç´€ç”±è·è˜­äºº Pieter Pel å’Œå¾·åœ‹äºº Wilhelm Ebstein é¦–æ¬¡æè¿°ã€‚ å¾Œè€…å¯èƒ½å› ç‚ºä»–çš„èª²å¤–èˆˆè¶£è€Œè¢«æ›´å¥½åœ°è¨˜ä½ï¼Œå¾è—è¡“å’Œæ–‡å­¸åˆ°æ­·å²ã€‚</description></item><item><title>Pembrolizumab plus Chemotherapy in Metastatic Nonâ€“Small-Cell Lung Cancer</title><link>https://www.physician.tw/Pembrolizumab-plus-Chemotherapy-in-Metastatic-NonSmall-Cell-Lung-Cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pembrolizumab-plus-Chemotherapy-in-Metastatic-NonSmall-Cell-Lung-Cancer/</guid><description>Pembrolizumab plus Chemotherapy in Metastatic Nonâ€“Small-Cell Lung Cancer After a median follow-up of 10.5 months, the estimated rate of overall survival at 12 months was 69.</description></item><item><title>Penetrating injury</title><link>https://www.physician.tw/Penetrating-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Penetrating-injury/</guid><description>Penetrating injury Pseudomonas Can be a/w deep tissue abscess Directed based on suscept.</description></item><item><title>peptic ulcer disease</title><link>https://www.physician.tw/peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/peptic-ulcer-disease/</guid><description>peptic ulcer disease [[definition and etiologies of peptic ulcer disease]]
(20â€“60%; duodenal&amp;gt;gastric)
(Am J Gastro 2021;116:899)
See â€œ[[PUD]]â€
Treatment: PPI: 40 mg PO or IV BID</description></item><item><title>pericardial disease</title><link>https://www.physician.tw/pericardial-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardial-disease/</guid><description>pericardial disease Anatomy
2-layered (parietal &amp;amp; visceral) tissue sac surrounding heart &amp;amp; proximal great vessels Disease states
Inflammation (w/ or w/o fluid accumulation) â†’ pericarditis</description></item><item><title>pericardial tamponade</title><link>https://www.physician.tw/pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericardial-tamponade/</guid><description>pericardial tamponade [[Etiology-pericardial tamponade]] [[Pathophysiology-pericardial tamponade]] [[Clinical manifestations-pericardial tamponade]] [[Physical exam-pericardial tamponade]] [[Diagnostic studies-pericardial tamponade]] [[Treatment-pericardial tamponade]]</description></item><item><title>pericarditis and pericardial effusion</title><link>https://www.physician.tw/pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pericarditis-and-pericardial-effusion/</guid><description>pericarditis and pericardial effusion [[Etiologies of Acute Pericarditis]] [[Clinical manifestations-pericarditis and pericardial effusion]] [[Physical exam-pericarditis and pericardial effusion]] [[Diagnostic studies-pericarditis and pericardial effusion]] [[Workup for effusion]] [[Treatment of pericarditis]]</description></item><item><title>peripheral artery disease</title><link>https://www.physician.tw/peripheral-artery-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/peripheral-artery-disease/</guid><description>peripheral artery disease [[Clinical features-peripheral artery disease]] [[Diagnosis-peripheral artery disease]] [[Treatment-peripheral artery disease]] [[Acute limb ischemia (ALI)-peripheral artery disease]]</description></item><item><title>Periprocedural â€œBridgingâ€ of Anticoagulation in Pts with Mechanical Valve s</title><link>https://www.physician.tw/Periprocedural-Bridging-of-Anticoagulation-in-Pts-with-Mechanical-Valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Periprocedural-Bridging-of-Anticoagulation-in-Pts-with-Mechanical-Valves/</guid><description>Periprocedural â€œBridgingâ€ of Anticoagulation in Pts with Mechanical Valve(s) AVR w/o risk factors d/c warfarin 2â€“4 d before surg; restart 12â€“24 h after surg</description></item><item><title>Peritoneal dialysis PD</title><link>https://www.physician.tw/Peritoneal-dialysis-PD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peritoneal-dialysis-PD/</guid><description>Peritoneal dialysis (PD) (JAMA 2017;317:1864)
Fluid removed via convection using oncotic pressure (eg, dextrose). â†‘ concentrations and dwell times removes more fluid (less as glc equilibrates).</description></item><item><title>Peritoneal dialysis-associated-Bacterial peritonitis</title><link>https://www.physician.tw/Peritoneal-dialysis-associated-Bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Peritoneal-dialysis-associated-Bacterial-peritonitis/</guid><description>Peritoneal dialysis-associated-Bacterial peritonitis cloudy fluid, abd pain, fever, nausea. Dx can be made with &amp;gt;50 PMNs. Culture most often GPC (50%) or GNR (15%).</description></item><item><title>Pharmacologic options-Treatment-hypertension</title><link>https://www.physician.tw/Pharmacologic-options-Treatment-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pharmacologic-options-Treatment-hypertension/</guid><description>Pharmacologic options-Treatment-hypertension Pre-HTN: ARB prevents onset of HTN, no â†“ in clinical events (NEJM 2006;354:1685) HTN: choice of therapy controversial, concomitant disease and stage may help guide Rx; ?</description></item><item><title>Pharmacologic-stress-test</title><link>https://www.physician.tw/Pharmacologic-stress-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pharmacologic-stress-test/</guid><description>Pharmacologic-stress-test Use if unable to exercise, low exercise tolerance, or recent MI. Se &amp;amp; Sp â‰ˆ exercise.
Preferred if LBBB, WPW or V-paced, because higher prob of false âŠ• imaging with exercise</description></item><item><title>Phases of Chronic HBV Infection</title><link>https://www.physician.tw/Phases-of-Chronic-HBV-Infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Phases-of-Chronic-HBV-Infection/</guid><description>Phases of Chronic HBV Infection</description></item><item><title>pheochromocytoma and paraganglioma</title><link>https://www.physician.tw/pheochromocytoma-and-paraganglioma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pheochromocytoma-and-paraganglioma/</guid><description>pheochromocytoma and paraganglioma [[Clinical manifestations-pheochromocytoma and paraganglioma]] [[Diagnostic studies-pheochromocytoma and paraganglioma]] Treatment
Î±-blockade first (usually phenoxybenzamine) Â± Î²-blockade (often propranolol) â†’ surgery Preoperative volume expansion is critical due to possible hypotension after tumor excision</description></item><item><title>phosphate disorders</title><link>https://www.physician.tw/phosphate-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/phosphate-disorders/</guid><description>phosphate disorders [[Hypophosphatemia - Approach to the Patient]]</description></item><item><title>phosphate replacement therapies</title><link>https://www.physician.tw/phosphate-replacement-therapies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/phosphate-replacement-therapies/</guid><description>phosphate replacement therapies In adults with symptomatic mild hypophosphatemia (2-2.5 mg/dL [0.65-0.81 mmol/L]) treat with increased dietary phosphate or oral phosphate supplements 1,000-2,000 mg/day.</description></item><item><title>Physical exam heart failure</title><link>https://www.physician.tw/Physical-exam-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-heart-failure/</guid><description>Physical exam heart failure (â€œ2-minuteâ€ hemodynamic profile; JAMA 1996;275:630 &amp;amp; 2002;287:628)
Physical exam (â€œ2-minuteâ€ hemodynamic profile; JAMA 1996;275:630 &amp;amp; 2002;287:628)</description></item><item><title>Physical exam of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Physical-exam-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-of-hypertrophic-cardiomyopathy/</guid><description>Physical exam of hypertrophic cardiomyopathy Sustained PMI, S2 paradoxically split if severe outflow obstruction, âŠ• S4 (occ. palpable)</description></item><item><title>Physical Exam Secret</title><link>https://www.physician.tw/Physical-Exam-Secret/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-Exam-Secret/</guid><description>Physical Exam Secret Postural dizziness (severe enough to stop the test) or an increase in heart rate of at least 30 beats/minute has sensitivity of 97% and specificity of 96% for blood loss &amp;gt;630 mL.</description></item><item><title>Physical exam-acute bacterial meningitis</title><link>https://www.physician.tw/Physical-exam-acute-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-acute-bacterial-meningitis/</guid><description>Physical exam-acute bacterial meningitis Brudzinski and Kernig signs of meningeal irritation appear unreliable for diagnosis or ruling out of meningitis.</description></item><item><title>Physical exam-bacterial endocarditis</title><link>https://www.physician.tw/Physical-exam-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-bacterial-endocarditis/</guid><description>Physical exam-bacterial endocarditis Cardiac murmur (85%), s/s of new HF (pulmonary edema, JVP elevation, edema) Skin/ocular changes (uncommon but highly specific) Janeway lesions (painless hemorrhagic macules on palms/ soles due to septic emboli) Oslerâ€™s nodes (painful nodules on pads of digits due to immune complex deposition) Splinter hemorrhages in fingernails or toenails Roth spots (retinal hemorrhages) MSK: point tenderness along spine, red/hot joints Neurologic deficits c/f embolic stroke; vertebral tenderness c/f osteo or epidural abscess Devices: evaluate CVCs, PM/ICD pocket, and sites of other hardware/ prosthetics</description></item><item><title>Physical exam-cirrhosis</title><link>https://www.physician.tw/Physical-exam-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-cirrhosis/</guid><description>Physical exam-cirrhosis Liver: initially enlarged, palpable (L lobe predom), firm; eventually shrunken, nodular
Signs of liver failure: jaundice (bili &amp;gt;2.</description></item><item><title>Physical exam-constrictive pericarditis</title><link>https://www.physician.tw/Physical-exam-constrictive-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-constrictive-pericarditis/</guid><description>Physical exam-constrictive pericarditis â†‘ JVP with prominent y descent, âŠ• Kussmaul sign [Ddx: tricuspid stenosis, acute cor pulmonale, RV dysfxn (CMP, RV MI), SVC syndrome] Hepatosplenomegaly, ascites, peripheral edema.</description></item><item><title>Physical exam-mitral-stenosis</title><link>https://www.physician.tw/Physical-exam-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-mitral-stenosis/</guid><description>Physical exam-mitral-stenosis Low-pitched mid-diastolic rumble at apex w/ presystolic accentuation (if not in AF); best heard in L lat decubitus position during expiration, â†‘ w/ exercise; severity proportional to duration (not intensity) of murmur; loud S 1 Opening snap (high-pitched early diastolic sound at apex) from fused leaflet tips; MVA proportional to S2â€“OS interval (tighter valve â†’ â†‘ LA pressure â†’ shorter interval) Loud S1 (unless MV calcified and immobile)</description></item><item><title>Physical exam-pericardial tamponade</title><link>https://www.physician.tw/Physical-exam-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-pericardial-tamponade/</guid><description>Physical exam-pericardial tamponade Beckâ€™s triad (present in minority of cases): distant heart sounds (28%), â†‘ JVP (76%) w/ blunted y descent, hypotension (26%); Â± pericardial friction rub (30%) Reflex tachycardia (77%), cool extremities Pulsus paradoxus (Se 82%, Sp 70%) = â†“ SBP â‰¥10 mmHg during inspiration âŠ• LR 3.</description></item><item><title>Physical exam-pericarditis and pericardial effusion</title><link>https://www.physician.tw/Physical-exam-pericarditis-and-pericardial-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-pericarditis-and-pericardial-effusion/</guid><description>Physical exam-pericarditis and pericardial effusion Pericarditis: multiphasic friction rub best heard at LLSB w/ diaphragm of stethoscope. Notoriously variable and evanescent leathery sound w/ up to 3 components: atrial contraction, ventricular contraction, ventricular relaxation (NEJM 2012;367:e20).</description></item><item><title>Physical Examination</title><link>https://www.physician.tw/Physical-examination/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-examination/</guid><description>Physical Examination Wheezing and prolonged expiratory phase
Presence of nasal polyps, rhinitis, rash â†’ allergic component</description></item><item><title>physical findings may help identify the cause of a fever</title><link>https://www.physician.tw/physical-findings-may-help-identify-the-cause-of-a-fever/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/physical-findings-may-help-identify-the-cause-of-a-fever/</guid><description>physical findings may help identify the cause of a fever âœ¨é‡é»: ç„¡æ±—ç—‡æ”¯æŒä¸­æš‘æˆ–ä¹¾æ“¾å‡ºæ±—çš„è—¥ç‰©ã€‚
è‚Œè‚‰å¼·ç›´æç¤ºç¥ç¶“é˜»æ»¯åŠ‘æƒ¡æ€§ç¶œåˆå¾µæˆ–æƒ¡æ€§é«˜ç†±ã€‚
é»ƒç–¸å¯è¦‹æ–¼ç´°èŒæ„ŸæŸ“ï¼Œèˆ‡è‚è†½ç³»çµ±ç›´æ¥å—ç´¯ç„¡é—œï¼ˆå¦‚è†½ç®¡ç‚æˆ–è‚ç‚ï¼Œè¦‹å•é¡Œ 14ï¼‰ã€‚</description></item><item><title>Physical-exam-aortic-regurgitation</title><link>https://www.physician.tw/Physical-exam-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-aortic-regurgitation/</guid><description>Physical-exam-aortic-regurgitation Early diastolic decrescendo murmur at LSB (RSB if dilated Ao root); â†‘ w/ sitting forward, expir, handgrip; severity of AR âˆ duration of murmur (except in acute and severe late); Austin Flint murmur: mid-to-late diastolic rumble at apex (AR jet interfering w/ mitral inflow) Wide pulse pressure due to â†‘ stroke volume, hyper-dynamic pulse; pulse pressure narrows in late AR with â†“ LV fxn; bisferiens (twice-beating) arterial pulse PMI diffuse and laterally displaced; soft S1 (early closure of MV); Â± S3 (â‰  â†“ EF but rather just volume overload in AR)</description></item><item><title>Physical-exam-aortic-stenosis</title><link>https://www.physician.tw/Physical-exam-aortic-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-aortic-stenosis/</guid><description>Physical-exam-aortic-stenosis Midsystolic crescendo-decrescendo murmur at RUSB, harsh, high-pitched, radiates to carotids, apex (holosystolic = Gallavardin effect), â†‘ w/ passive leg raise, â†“ w/ standing &amp;amp; Valsalva.</description></item><item><title>Physical-exam-mitral-regurgitation</title><link>https://www.physician.tw/Physical-exam-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Physical-exam-mitral-regurgitation/</guid><description>Physical-exam-mitral-regurgitation Early diastolic decrescendo murmur at LSB (RSB if dilated Ao root); â†‘ w/ sitting forward, expir, handgrip; severity of AR âˆ duration of murmur (except in acute and severe late); Austin Flint murmur: mid-to-late diastolic rumble at apex (AR jet interfering w/ mitral inflow) Wide pulse pressure due to â†‘ stroke volume, hyper-dynamic pulse; pulse pressure narrows in late AR with â†“ LV fxn; bisferiens (twice-beating) arterial pulse PMI diffuse and laterally displaced; soft S1 (early closure of MV); Â± S3 (â‰  â†“ EF but rather just volume overload in AR) Classic Eponymous Signs in Chronic AR Corriganâ€™s pulse â€œwater hammerâ€ pulse (ie, rapid rise/fall or distention/collapse) Hillâ€™s sign (popliteal SBP â€“ brachial SBP) &amp;gt;60 mmHg Duroziezâ€™s sign to-and-fro murmur heard over femoral artery w/ light compression Pistol shot sounds pistol shot sound heard over femoral artery Traubeâ€™s sound double sound heard over femoral artery when compressed distally de Mussetâ€™s sign head-bobbing with each heartbeat (low Se) MÃ¼llerâ€™s sign systolic pulsations of the uvula Quinckeâ€™s pulses subungual capillary pulsations (low Sp)</description></item><item><title>physiology of pulmary</title><link>https://www.physician.tw/physiology-of-pulmary/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/physiology-of-pulmary/</guid><description>physiology of pulmary æ½®æ°£2.5L~3L æœ€å¤§(Total lung capacity)å…©å€=5L~6L æœ€å°(Residual Vol)ä¸€åŠ=1.25~1.5L Vital capacity = æœ€å¤§-æœ€å° reserve æ½®æ°£ - æœ€å° æœ€å¤§ - æ½®æ°£</description></item><item><title>PIK3CA</title><link>https://www.physician.tw/PIK3CA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/PIK3CA/</guid><description>PIK3CA PI3K inhib Alpelisib + fulvestrant â†‘ PFS in met HRâŠ• (NEJM 2019;380:1929)</description></item><item><title>Pituitary apoplexy</title><link>https://www.physician.tw/Pituitary-apoplexy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pituitary-apoplexy/</guid><description>Pituitary apoplexy Rapid expansion of pituitary tumor (typically adenoma) due to hemorrhage or infarction Sx include excruciating headache, diplopia, hypopituitarism Rx: immediate high-dose glucocorticoids; prompt surgical decompression if severe neurologic impairment or Î” MS; conservative management if mild</description></item><item><title>pituitary disorders</title><link>https://www.physician.tw/pituitary-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pituitary-disorders/</guid><description>pituitary disorders [[hypopituitary syndromes]] [[hyperpituitary syndromes]] FIGURE 5.2: Hormones secreted by the pituitary gland and their functions. The pituitary is a small gland that is positioned in the base of the brain.</description></item><item><title>Pituitary tumors</title><link>https://www.physician.tw/Pituitary-tumors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pituitary-tumors/</guid><description>Pituitary tumors Pathophysiology: adenoma â†’ excess of trophic hormone (if tumor fxnal, but 30â€“40% not) and potentially deficiencies in other trophic hormones due to compression; cosecretion of PRL and growth hormone in 10% of prolactinomas Clinical manifestations: specific syndromes due to oversecretion of hormones (see below) Â± non-specific mass effect: headache, visual Î”s, diplopia, cranial neuropathies Workup: MRI brain pituitary protocol, hormone levels, Â± visual field testing if &amp;lt;10 mm, no mass effect, no hormone overproduction, can f/up in 12 mos</description></item><item><title>Placement PA catheter and tailored therapy</title><link>https://www.physician.tw/Placement-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Placement-PA-catheter-and-tailored-therapy/</guid><description>Placement PA catheter and tailored therapy Insertion site: R IJ or L subclavian veins preferred for â€œanatomicâ€ flotation into PA</description></item><item><title>platelet disorders</title><link>https://www.physician.tw/platelet-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/platelet-disorders/</guid><description>platelet disorders thrombocytopenia [[Thrombocytopenia and Risk of Bleeding]] [[Etiologies-of thrombocytopenia]] [[Diagnostic evaluation of thrombocytopenia]] [[Approach to thrombocytopenia]] [[Primary immune thrombocytopenic purpura (ITP) ]] [[Secondary immune thrombocytopenic purpura (2Â° ITP)]] [[Heparin-Induced Thrombocytopenias]] [[Thrombotic microangiopathies]] [[Disseminated intravascular coagulation (DIC)]] disorders of platelet function [[Mechanisms and Etiologies of Platelet Function Abnormalities]] Platelet aggregation tests: measure aggregation in response to agonists (eg, ADP) [[von Willebrandâ€™s disease (vWD)]] [[Uremic bleeding]] Backlinkï¼š [[Diagnostic evaluation of thrombocytopenia]] [[hematology]] [[Microangiopathic hemolytic anemia]]</description></item><item><title>Platelets-transfusion</title><link>https://www.physician.tw/Platelets-transfusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Platelets-transfusion/</guid><description>Platelets-transfusion For plts &amp;lt;10k (NEJM 2010;362:600) due to chemo/abx. If &amp;lt;20k or if &amp;lt;50k w/ active bleeding. Variable pre-procedure.100k for neurosurgery.</description></item><item><title>pleocytosis</title><link>https://www.physician.tw/pleocytosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pleocytosis/</guid><description>pleocytosis åœ¨è¡€ä¸­å«leukocytosis åœ¨CSF ä¸­å«åšpleocytosis å…©è€…éƒ½åœ¨æ˜¯åœ¨ç´°èƒå¢å¤šçš„æ„æ€
In medicine, pleocytosis (or pleiocytosis) is an increased cell count (from Greek pleion, &amp;ldquo;more&amp;rdquo;) particularly an increase in white blood cell count, in a bodily fluid, such as cerebrospinal fluid.</description></item><item><title>pleural effusion</title><link>https://www.physician.tw/pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pleural-effusion/</guid><description>pleural effusion [[Pathophysiology-pleural effusion]]
[[Transudates]]
[[Exudates]]
[[Diagnostic studies-pleural effusion]]
[[Characteristics of Pleural Fluid]]</description></item><item><title>Pneumocystis jiroveci PCP pneumonia</title><link>https://www.physician.tw/Pneumocystis-jiroveci-PCP-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pneumocystis-jiroveci-PCP-pneumonia/</guid><description>Pneumocystis jiroveci (PCP) pneumonia fever, night sweats, dyspnea on exertion, dry (â€œdoorstopâ€) cough CXR w/ interstitial pattern, â†“ PaO2, â†‘ A-a âˆ‡, â†‘ LDH, âŠ• PCP sputum stain, âŠ• Î²-glucan Rx if PaO2 &amp;gt;70: TMP-SMX 15â€“20 mg of TMP/kg divided tid, avg dose = DS 2 tabs PO tid Rx if PaO2 &amp;lt;70 or A-a gradient &amp;gt;35: prednisone before abx (40 mg PO bid; â†“ after 5 d) HIV âŠ• smokers much more likely to die from lung cancer than OI (JAMA 2017;177:1613)</description></item><item><title>pneumonia</title><link>https://www.physician.tw/pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pneumonia/</guid><description>pneumonia [[Definitions-and-clinical-manifestations]] [[Microbiology-of-Pneumonia]] [[Diagnostic studies-pneumonia]] (AJRCC 2019;200:e45) [[Triage-pneumonia]] [[Treatment-pneumonia]] (NEJM 2019;380:651; AJRCC 2019;200:e45) [[Prevention-pneumonia]] [[viral respiratory infections]] [[coronavirus (covid-19)]] / sars-cov-2 infection</description></item><item><title>POCUS</title><link>https://www.physician.tw/POCUS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/POCUS/</guid><description>[[index]] [[icu]]</description></item><item><title>Polyarteritis nodosa</title><link>https://www.physician.tw/Polyarteritis-nodosa/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polyarteritis-nodosa/</guid><description>Polyarteritis nodosa Usually middle-aged males. Hepatitis B seropositivity in 30% of patients. Fever, weight loss, malaise, headache. GI: abdominal pain, melena.</description></item><item><title>Polycystic kidney disease</title><link>https://www.physician.tw/Polycystic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polycystic-kidney-disease/</guid><description>Polycystic kidney disease (NEJM 2008;359:1477; 2017;377:1988)
Mostly AD PKD1/PKD2 mutations â†’ renal cysts. PKD1 (85%) younger-onset ESRD.
Rx: hydration, low-salt diet; tolvaptan reduces GFR decline.</description></item><item><title>Polymorphic ventricular tachycardia PMVT</title><link>https://www.physician.tw/Polymorphic-ventricular-tachycardia-PMVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polymorphic-ventricular-tachycardia-PMVT/</guid><description>Polymorphic ventricular tachycardia (PMVT) QRS morphology changes from beat to beat Etiologies: ischemia; CMP; catecholaminergic torsades de pointes (TdP = â€œtwisting of the points,â€ PMVT + â†‘ QT): â†‘ QT acquired (meds, lytes, stroke, see â€œECGâ€) w/ risk â†‘ w/ â†“ HR, freq PVCs (pause dependent) or congenital (K/Na channelopathies) w/ resting Tw abnl &amp;amp; TdP triggered by sympathetic stimulation (eg, exercise, emotion, sudden loud noises) (Lancet 2008;372:750) Brugada syndrome (Na channelopathy; JACC 2018;72:1046): â™‚ &amp;gt; â™€; pseudo-RBBB w/ STE in V1â€“V3 (provoked w/ class IA or IC) on resting ECG</description></item><item><title>Polymyalgia rheumatica</title><link>https://www.physician.tw/Polymyalgia-rheumatica/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polymyalgia-rheumatica/</guid><description>Polymyalgia rheumatica (JAMA 2016;315:2442; Lancet 2017;390:1700)
Prev 7/1000 of age â‰¥50. In 50% of GCA Pts; 15% of PMR Pts develop GCA.</description></item><item><title>Polyp or Tumor</title><link>https://www.physician.tw/Polyp-or-Tumor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Polyp-or-Tumor/</guid><description>Polyp or Tumor Typically slow ooze, p/w fatigue, weight loss, iron deficiency, anemia</description></item><item><title>polyps</title><link>https://www.physician.tw/polyps/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polyps/</guid><description>polyps Pathophysiology &amp;amp; epidemiology (NEJM 2016;374:1065) Accumulation of mutations in colonic epithelial cell DNA affecting oncogenes &amp;amp; tumor suppressor genes â†’ tumor initiation (formation of adenoma; APC loss of fxn) â†’ tumor progression (adenoma â†’ carcinoma; K-ras gain of fxn, DCC, p53 loss of fxn) Risk factors: â†‘ age, FHx (sporadic in 1Â° relatives, Lynch, FAP), IBD, â†‘ dietary fat, central adiposity, â†‘ EtOH, â†“ fiber, â†‘ red meat, smoking, DM Protective factors: â†‘ physical activity, ASA/NSAIDs, Ca2+ intake, HRT, â†“ BMI; possibly â†‘ fiber, vitamin D, fish oil, statins, selenium Neoplastic polyps: adenomas (tubular, villous, tubulovillous dysplasia), sessile serrated adenomas/polyps (concern for interval CRC), carcinomas Non-neoplastic polyps: hyperplastic, juvenile, Peutz-Jeghers (can undergo malignant transformation), inflammatory [[CRC screening]]</description></item><item><title>polyuria</title><link>https://www.physician.tw/polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/polyuria/</guid><description>polyuria Definition and pathophysiology Polyuria defined as &amp;gt;3 L UOP per day Due to an osmotic or a water diuresis; almost always due to osmotic diuresis in inpatients Workup Perform a timed urine collection (6 h sufficient) and measure Uosm 24-h osmole excretion rate = 24-h UOP (actual or estimate) Ã— Uosm 1000 mOsm/d â†’ osmotic diuresis; &amp;lt;800 mOsm/d â†’ water diuresis</description></item><item><title>Poor-R-wave-progression</title><link>https://www.physician.tw/Poor-R-wave-progression/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Poor-R-wave-progression/</guid><description>Poor-R-wave-progression Definition: loss of anterior forces w/o frank Q waves (V1â€“V3); R wave in V3 â‰¤3 mm
Etiologies: old anteroseptal MI (w/ R wave V3 â‰¤1.</description></item><item><title>Portal HTN gastropathy</title><link>https://www.physician.tw/Portal-HTN-gastropathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portal-HTN-gastropathy/</guid><description>Portal HTN gastropathy â†‘ portal venous pressure â†’ ectatic vessels, hyperemia in gastric antrum. Rx: reduce portal HTN (octreotide), Î²B, TIPS.</description></item><item><title>Portal vein thrombosis PVT</title><link>https://www.physician.tw/Portal-vein-thrombosis-PVT-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portal-vein-thrombosis-PVT-/</guid><description>Portal vein thrombosis (PVT) (Clin Liver Dis 2017;10:152; Gastro 2019;156:1582)
Definition: thrombosis of portal vein often w/ extension into mesenteric vein/splenic vein Etiologies: commonly due to cirrhosis or hypercoaguable state (cancer, infection, OCP, collagen vascular diseases, BehÃ§etâ€™s, IBD, surgery, trauma, OCPs, preg) [[Clinical manifestations-Portal vein thrombosis (PVT)]] [[Dx-Portal vein thrombosis (PVT)]] [[Treatment-Portal vein thrombosis (PVT)]]</description></item><item><title>Portopulmonary hypertension POPH</title><link>https://www.physician.tw/Portopulmonary-hypertension-POPH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Portopulmonary-hypertension-POPH/</guid><description>Portopulmonary hypertension (POPH) (Expert Rev Gastro Hepatol 2015;9:983)
Pulm HTN in Pt w/ portal HTN w/o other cause. ESLDâ†’ â†‘ endothelinâ†’ pulm vasoconst.</description></item><item><title>positioning-airway-management</title><link>https://www.physician.tw/positioning-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/positioning-airway-management/</guid><description>positioning-airway-management âœ¨é‡é»: æä¾›è€…ç«™åœ¨åºŠé ­ï¼Œæ‚£è€…çš„é ­éƒ¨æ‡‰ç›¡å¯èƒ½é è¿‘åºŠé ­ã€‚ æ­£ç¢ºçš„å®šä½å¯ä»¥å‰µå»ºå¾æ‚£è€…å£è…”åˆ°å–‰éƒ¨çš„ç›´æ¥è¦–ç·šã€‚ é€™æ˜¯é€šéä½¿ç”¨æ•é ­/æ¯¯å­ä½¿é ¸æ¤å½æ›²å¤§ç´„ 30Â° ä»¥åŠä¼¸å±•å¯°æ•é—œç¯€ï¼ˆç¶“å…¸çš„â€œå—…æ¢å§¿å‹¢â€ï¼‰ä¾†å¯¦ç¾çš„ã€‚ å®šä½è‚¥èƒ–æ‚£è€…å¯èƒ½ç‰¹åˆ¥å…·æœ‰æŒ‘æˆ°æ€§ã€‚ é€™å¯ä»¥é€šéå½¢æˆä¸€å€‹å¡é“ä¾†å¯¦ç¾ï¼ŒæŠ¬é«˜ä¸ŠèƒŒéƒ¨å’Œè‚©éƒ¨ä»¥é©æ‡‰è¶³å¤ çš„é ¸æ¤å±ˆæ›²ã€‚ Confirming horizontal alignment of the external auditory meatus with the sternal notch can be a useful guide.</description></item><item><title>positive and negative predictive values of tests</title><link>https://www.physician.tw/positive-and-negative-predictive-values-of-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/positive-and-negative-predictive-values-of-tests/</guid><description>positive and negative predictive values of tests âœ¨é‡é»: æ•æ„Ÿæ€§ï¼šæ‚£æœ‰æ­£åœ¨æ¥å—æª¢æ¸¬çš„ç–¾ç—…ä¸¦ä¸”æª¢æ¸¬çµæœå‘ˆé™½æ€§çš„æ‚£è€…çš„ç™¾åˆ†æ¯” ç‰¹ç•°æ€§ï¼šæœªæ‚£ç—…ä¸”æª¢æ¸¬çµæœç‚ºé™°æ€§çš„æ‚£è€…ç™¾åˆ†æ¯” é™½æ€§é æ¸¬å€¼ï¼šæª¢æ¸¬çµæœå‘ˆé™½æ€§ä¸¦æ‚£æœ‰æ­£åœ¨æª¢æ¸¬çš„ç–¾ç—…çš„æ‚£è€…ç™¾åˆ†æ¯” é™°æ€§é æ¸¬å€¼ï¼šæª¢æ¸¬çµæœç‚ºé™°æ€§ä½†æœªæ‚£ç—…çš„æ‚£è€…ç™¾åˆ†æ¯”</description></item><item><title>Post-exacerb care of COPDAE</title><link>https://www.physician.tw/Post-exacerb-care-of-COPDAE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-exacerb-care-of-COPDAE/</guid><description>Post-exacerb care of COPDAE Follow up within 1 mo; smoking cessation if current smoker; vaccinations (influenza, pneumococcal), referral to pulm rehab (AJRCCM 2007;176:532)</description></item><item><title>Post-renal acute kidney injury etiology</title><link>https://www.physician.tw/Post-renal-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-renal-acute-kidney-injury-etiology/</guid><description>Post-renal acute kidney injury etiology Bladder neck: BPH, prostate cancer, neurogenic bladder, anticholinergic meds Ureteral (bilateral or unilateral in single kidney): malig, LAN, retroperitoneal fibrosis, nephrolithiasis UA, Sediment, Indices Bland Â± non-dysmorphic RBCs, WBC, crystals</description></item><item><title>Post-sphincter-otomy bleeding</title><link>https://www.physician.tw/Post-sphincter-otomy-bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Post-sphincter-otomy-bleeding/</guid><description>Post-sphincter-otomy bleeding Occurs in ~2% of ERCP w/ sphincterotomy; â†‘ risk w/ more complic. procedure. Bleeding into duodenum. Rx w/ endo hemostasis.</description></item><item><title>potassium homeostasis</title><link>https://www.physician.tw/potassium-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/potassium-homeostasis/</guid><description>potassium homeostasis [[Overview-potassium homeostasis]] [[hypokalemia]] [[hyperkalemia]]</description></item><item><title>POUNDing Mnemonic</title><link>https://www.physician.tw/POUNDing-Mnemonic/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/POUNDing-Mnemonic/</guid><description>POUNDing Mnemonic Pulsatile hOurs (duration of 4-72 hours) Unilateral Nauseating Disabling</description></item><item><title>Prasugrel</title><link>https://www.physician.tw/Prasugrel/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prasugrel/</guid><description>Prasugrel 60 mg Ã— 1 at PCI â†’ 10 mg qd (consider 5 mg/d if &amp;lt;60 kg) Wait 7 d prior to surgery Contraindicated if h/o TIA/CVA; caution if &amp;gt;75 y More rapid and potent plt inhib c/w clopi 19% â†“ CVD/MI/stroke in ACS w/ planned PCI vs.</description></item><item><title>Precipitants of acute heart failure</title><link>https://www.physician.tw/Precipitants-of-acute-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-of-acute-heart-failure/</guid><description>Precipitants of acute heart failure Dietary indiscretion or medical nonadherence (~40% of cases) Myocardial ischemia or infarction (~10â€“15% of cases); myocarditis Renal failure (acute, progression of CKD, or insufficient dialysis) â†’ â†‘ preload Hypertensive crisis (incl.</description></item><item><title>Precipitants of Migraine</title><link>https://www.physician.tw/Precipitants-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-of-Migraine/</guid><description>Precipitants of Migraine stress foods (cheese, chocolate, MSG) fatigue EtOH menses exercise</description></item><item><title>Precipitants-diabetic ketoacidosis</title><link>https://www.physician.tw/Precipitants-diabetic-ketoacidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-diabetic-ketoacidosis/</guid><description>Precipitants-diabetic ketoacidosis (the Iâ€™s)
Insulin defic. (ie, failure to take enough insulin); ç‚ Infection (pneumonia, UTI) or Inflammation (pancreatitis, cholecystitis) ç¼ºè¡€ Ischemia or Infarction (myocardial, cerebral, gut); å¤–ç‰© Iatrogenesis (glucocorticoids; SGLT2 inhibitorsâ€”can be w/o marked hyperglycemia; Diabetes Care 2016;39:532) Intoxication (alcohol, drugs)</description></item><item><title>Precipitants-hypertensive crises</title><link>https://www.physician.tw/Precipitants-hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Precipitants-hypertensive-crises/</guid><description>Precipitants-hypertensive crises Progression of essential HTN Â± medical noncompliance (espec clonidine) or âˆ† in diet Progression of renovascular disease; acute glomerulonephritis; scleroderma; preeclampsia Endocrine: pheochromocytoma, Cushingâ€™s Sympathomimetics: cocaine, amphetamines, MAO inhibitors + foods rich in tyramine</description></item><item><title>predictors of difficult mask ventilation</title><link>https://www.physician.tw/predictors-of-difficult-mask-ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/predictors-of-difficult-mask-ventilation/</guid><description>predictors of difficult mask ventilation ç„¡ç‰™é œå¹´é½¡ 55 æ­²æˆ–ä»¥ä¸Š ç”·æ€§æ‚£è€… é¢éƒ¨æ¯›é«® è‚¥èƒ– é˜»å¡æ€§ç¡çœ å‘¼å¸æš«åœ</description></item><item><title>premedication of airway-management</title><link>https://www.physician.tw/premedication-of-airway-management/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/premedication-of-airway-management/</guid><description>premedication of airway-management A: Atopine 1mg C: Cardiac monitor L: [[Lidocaine]] 1.0~1.5mg/kg 2% 50kg 75mg èƒ–ä¸€é»çš„100mg S: Sedation: * dormicum 0.</description></item><item><title>Preoperative evaluation</title><link>https://www.physician.tw/Preoperative-evaluation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preoperative-evaluation/</guid><description>Preoperative evaluation (Circ 2014;130:e278, NEJM 2015;373:2258, JAMA 2020;324:279)
(Modified with permission Circulation. 2014;130:2215-2245 Â© 2014 American Heart Association, Inc.)</description></item><item><title>preoxygenation</title><link>https://www.physician.tw/preoxygenation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/preoxygenation/</guid><description>preoxygenation é™¤æœ€ç·Šæ€¥çš„æƒ…æ³å¤–ï¼Œæ‡‰åœ¨æ‰€æœ‰æƒ…æ³ä¸‹æä¾›å……åˆ†çš„é æ°§åˆã€‚
ç›®çš„æ˜¯ç”¨æ°§æ°£ä»£æ›¿è‚ºéƒ¨çš„æ°®æ°£ã€‚
ç•¶æ‚£è€…å‡ºç¾å‘¼å¸æš«åœæ™‚ï¼Œé€™æœƒå¢åŠ å»é£½å’Œå‰çš„æ™‚é–“é•·åº¦ï¼ˆâ€œå‘¼å¸æš«åœæ™‚é–“â€ï¼‰ï¼Œå¾è€Œåœ¨é€šæ°£å’Œæ’ç®¡è®Šå¾—å›°é›£çš„æƒ…æ³ä¸‹æä¾›å®‰å…¨é‚Šéš›ã€‚
å¯ä»¥ä½¿ç”¨é¢ç½©ã€é€£çºŒæˆ–é›™æ°´å¹³æ°£é“æ­£å£“æˆ–é«˜æµé‡é¼»å°ç®¡ (HFNC) é€²è¡Œé æ°§åˆï¼Œä»¥è‡³å°‘ 10 L/min çš„æµé‡æä¾› 100% æ°§æ°£ã€‚</description></item><item><title>Prerenal acute kidney injury etiology</title><link>https://www.physician.tw/Prerenal-acute-kidney-injury-etiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prerenal-acute-kidney-injury-etiology/</guid><description>Prerenal acute kidney injury etiology â†“ Effective arterial volume (NEJM 2007;357:797) Hypovolemia, â†“ CO (CHF), â†“ oncotic pressure (cirrhosis, nephrotic), vasodilation (sepsis) Î” local renal perfusion: NSAIDs, ACEI/ARB, contrast, calcineurin inhib, HRS, hyperCa Large vessel: RAS (bilateral + ACEI), VTE, dissection, abd compart.</description></item><item><title>Presentation of Thyroid storm</title><link>https://www.physician.tw/Presentation-of-Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Presentation-of-Thyroid-storm/</guid><description>Presentation of Thyroid storm delirium, fever, tachycardia, systolic HTN w/ wide pulse pressure and â†“ MAP, GI symptoms; 20â€“30% mortality</description></item><item><title>Pressors inotropes-sepsis and shock</title><link>https://www.physician.tw/Pressors-inotropes-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pressors-inotropes-sepsis-and-shock/</guid><description>Pressors inotropes-sepsis and shock MAP target 65 mmHg as good as 80â€“85 and â†“ AF (NEJM 2014;370:1583; JAMA 2020;323:938)</description></item><item><title>Prevention of chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Prevention-of-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-of-chronic-obstructive-pulmonary-disease/</guid><description>Prevention of chronic obstructive pulmonary disease Flu/Pneumovax; smoking cessation â†’ 50% â†“ in lung function decline (AJRCCM 2002;166:675) and â†“ long-term mortality (Annals 2005;142:223)</description></item><item><title>Prevention-Contrast-induced acute kidney injury</title><link>https://www.physician.tw/Prevention-Contrast-induced-acute-kidney-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-Contrast-induced-acute-kidney-injury/</guid><description>Prevention-Contrast-induced acute kidney injury consider if eGFR &amp;lt;60 (espec. w/ proteinuria) DM MI HoTN (CJASN 2013;8:1618) Prevention Isotonic IV fluids: may be helpful if high risk (Lancet 2017;389:1312) Outpatients: 3 mL/kg/h Ã— 1 h prior, 1â€“1.</description></item><item><title>Prevention-pneumonia</title><link>https://www.physician.tw/Prevention-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prevention-pneumonia/</guid><description>Prevention-pneumonia All persons &amp;gt;65 or age 19â€“64 w/ CHF, lung disease, cirrhosis, DM, EtOH, smoker, immunosupp. (eg, ESRD, organ transplant, HIV, leukemia, lymphoma, asplenia) PCV20 vaccine or PCV15 + PPSV23 1 yr later</description></item><item><title>Preventive treatment of Migraine</title><link>https://www.physician.tw/Preventive-treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Preventive-treatment-of-Migraine/</guid><description>Preventive treatment of Migraine Recommended for patients adversely affected on â‰¥2 days per month despite optimized acute therapy First-line medication Beta blockers (propranolol, metoprolol, atenolol, bisoprolol) [[Topiramate]] Candesartan Second-line medication Flunarizine Amitriptyline Sodium valproate Third-line medication CGRP monoclonal antibodies</description></item><item><title>Primary biliary cholangitis PBC</title><link>https://www.physician.tw/Primary-biliary-cholangitis-PBC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-biliary-cholangitis-PBC/</guid><description>Primary biliary cholangitis (PBC) (Hep 2019;69:394; Nat Rev 2020;17:93; Lancet 2020;396:1915)
Autoimmune destruction of intrahepatic bile ducts
Epi: â™€ 40â€“60 y; a/w SjÃ¶grenâ€™s (50%), Raynaudâ€™s, scleroderma, celiac &amp;amp; thyroid disease; may be triggered by infxns or toxins; a/w X monosomy, variants in IL12Î± &amp;amp; IL12R genes</description></item><item><title>Primary central nervous system vasculitis</title><link>https://www.physician.tw/Primary-central-nervous-system-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-central-nervous-system-vasculitis/</guid><description>Primary central nervous system vasculitis åŸç™¼æ€§ä¸­æ¨ç¥ç¶“ç³»çµ±è¡€ç®¡ç‚æ˜¯ä¸€ç¨®ç½•è¦‹çš„ä¸”çŸ¥è­˜æ·µåšçš„è¡€ç®¡ç‚ï¼Œåƒ…é™æ–¼å¤§è…¦å’Œè„Šé«“ã€‚ èªè­˜åˆ°é€™ç¨®ç–¾ç—…æ˜¯ä¸€ç¨®ç¨ç‰¹çš„ç—…æ…‹å¯¦é«”ï¼Œå…¶æ­·å²å¯ä»¥è¿½æº¯åˆ°1950å¹´ä»£ä¸­æœŸï¼Œ ç•¶æ™‚Craviotoå’ŒFeigin1æè¿°äº†èˆ‡ç¥ç¶“ç³»çµ±ç›¸é—œçš„å¹¾ä¾‹éæ„ŸæŸ“æ€§è‚‰èŠ½è…«æ€§è¡€ç®¡ç‚ã€‚
CNSï¼Œ3ã€4æˆ–æ›´å…·é«”åœ°ï¼ŒCNSçš„éæ„ŸæŸ“æˆ–ç‰¹ç™¼æ€§é¡†ç²’ç‹€è¡€ç®¡ç‚å’Œä¸­æ¨ç¥ç¶“ç³»çµ±çš„é‰…ç´°èƒå‹•è„ˆç‚ï¼Œ7å€‹CNSçš„7å€‹å­¤ç«‹è¡€ç®¡ç‚ï¼Œ8å€‹CNSçš„åŸç™¼æ€§è¡€ç®¡ç‚ï¼Œ9å’ŒCNSçš„åŸç™¼æ€§è¡€ç®¡ç‚ï¼Œ9å’ŒCNSç‚ã€‚CNS.</description></item><item><title>Primary glomerular diseases grouped by pathology</title><link>https://www.physician.tw/Primary-glomerular-diseases-grouped-by-pathology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-glomerular-diseases-grouped-by-pathology/</guid><description>Primary glomerular diseases (grouped by pathology) [[Focal segmental glomerulosclerosis]] [[Membranous nephropathy]] [[Minimal change disease]] [[Membranoproliferative GN]] [[Fibrillary-immunotactoid glomerulopathy]] (1%) Fibrillary Glomerulonephritis and Immunotactoid Glomerulopat&amp;hellip; : Journal of the American Society of Nephrology [[Mesangial proliferative GN]]</description></item><item><title>Primary headache syndromes</title><link>https://www.physician.tw/Primary-headache-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-headache-syndromes/</guid><description>Primary headache syndromes [[Tension-type headache]] [[Cluster headache]] [[Migraine]]</description></item><item><title>Primary Hyperaldosteronism</title><link>https://www.physician.tw/Primary-Hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-Hyperaldosteronism/</guid><description>Primary Hyperaldosteronism (adrenal disorders, renin-independent increase in aldosterone; JCEM 2015;100:1)
[[adrenal hyperplasia]] (60â€“70%), adenoma ([[Connâ€™s syndrome]], 30â€“40%), [[adrenocortical cancer]], [[glucocorticoid-remediable aldosteronism]] (GRA; ACTH-dep.</description></item><item><title>Primary hyperparathyroidism</title><link>https://www.physician.tw/Primary-hyperparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-hyperparathyroidism/</guid><description>Primary hyperparathyroidism The serum level of parathyroid hormone, calcium, phosphorus, and 25-hydroxyvitamin D should be measured. Patients with secondary hyperparathyroidism usually have low-normal calcium and elevated parathyroid hormone.</description></item><item><title>Primary immune thrombocytopenic purpura ITP</title><link>https://www.physician.tw/Primary-immune-thrombocytopenic-purpura-ITP-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-immune-thrombocytopenic-purpura-ITP-/</guid><description>Primary immune thrombocytopenic purpura (ITP) (Blood 2010;115:168)
Isolated thrombocytopenia due to immune plt destruction (auto-Ab to plts) &amp;amp; â†“ production (auto-Ab to megakaryocytes) without precipitant</description></item><item><title>Primary sclerosing cholangitis PSC</title><link>https://www.physician.tw/Primary-sclerosing-cholangitis-PSC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Primary-sclerosing-cholangitis-PSC/</guid><description>Primary sclerosing cholangitis (PSC) (NEJM 2016;375:1161; Clin Liver Dis 2020;15:125)
Diffuse inflammation of intrahepatic and extrahepatic bile ducts leading to fibrosis &amp;amp; stricturing of biliary system.</description></item><item><title>Principles of Imaging in Vasculitides</title><link>https://www.physician.tw/Principles-of-Imaging-in-Vasculitides/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-Imaging-in-Vasculitides/</guid><description>Principles of Imaging in Vasculitides for large- and certain medium-vessel vasculitides, various imaging techniques can be useful magnetic resonance angiography (MRA) or computed tomography angiography (CTA) allow for the assessment of extensive vascular territories vessels not readily accessible for tissue biopsy ultrasound, particularly color-coded duplex sonography, is often used as first-line imaging in patients with suspected giant cell arteritis (GCA) small-vessel vasculitides difficult to directly visualize with imaging indirect signs can be detected; this may play a role in evaluating disease activity and extent of involvement Reference - Curr Rheumatol Rep 2020 Jun 19;22(8):34</description></item><item><title>Principles of treatment-asthma</title><link>https://www.physician.tw/Principles-of-treatment-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-of-treatment-asthma/</guid><description>Principles of treatment-asthma Education and avoidance of environmental triggers (Lancet 2015;386:1075); yearly flu shot
Use quick-relief rescue medication as needed for all Pts</description></item><item><title>Principles-solitary pulmonary nodule</title><link>https://www.physician.tw/Principles-solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Principles-solitary-pulmonary-nodule/</guid><description>Principles-solitary pulmonary nodule Definition: single, well-defined, &amp;lt;3 cm, surrounded by nl lung, no LAN or pleural effusion
Often â€œincidentalomas,â€ esp with â†‘ CT use, but may still be early, curable malignancy</description></item><item><title>Prinzmetal's variant angina</title><link>https://www.physician.tw/Prinzmetal-s-variant-angina/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prinzmetal-s-variant-angina/</guid><description>Prinzmetal&amp;rsquo;s variant angina Coronary spasm â†’ transient STE usually w/o MI (but MI, AVB, VT can occur) Pts usually young, smokers Â± other vasospastic disorders (eg, migraines, Raynaudâ€™s) Angiography: nonobstructive CAD (spasm can be provoked during cath but rarely done) [[Treatment of Prinzmetals variant angina]] Cocaine-induced vasospasm: CCB, nitrates, ASA; ?</description></item><item><title>Procainamide</title><link>https://www.physician.tw/Procainamide/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Procainamide/</guid><description>Procainamide 10-15 mg/kg IV n/a decrease BP: 1 QT:Â± AVN blocker %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Procedures-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Procedures-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Procedures-Endocarditis-Prophylaxis/</guid><description>Procedures-Endocarditis Prophylaxis Dental: manipulation of gingival tissue or periapical region of teeth or perf oral mucosa (eg, extraction, periodontal, implant, root canal, cleaning)</description></item><item><title>Prognosis-acute liver failure</title><link>https://www.physician.tw/Prognosis-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-acute-liver-failure/</guid><description>Prognosis-acute liver failure (Ann Intern Med 2016;164:724; World J Gastro 2016;22:1523)
Non-acetaminophen ALF mortality ~70%, acetaminophen-induced ALF mortality ~25â€“30%</description></item><item><title>Prognosis-acute pancreatitis</title><link>https://www.physician.tw/Prognosis-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-acute-pancreatitis/</guid><description>Prognosis-acute pancreatitis (NEJM 2016;375:1972)
Ransonâ€™s, APACHE II: predict severity at 48 h using multiple physiolog. criteria; poor PPV</description></item><item><title>Prognosis-Alcohol-associated hepatitis</title><link>https://www.physician.tw/Prognosis-Alcohol-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-Alcohol-associated-hepatitis/</guid><description>Prognosis-Alcohol-associated hepatitis scoring systems include Maddreyâ€™s discriminant fxn (MDF), Lille model, MELD
MDF (4.6 Ã— [PT â€“ control] + Tb) â‰¥32 w/ 30â€“50% 1-mo mortality if unRxâ€™d (Gastro 1996;110:1847)</description></item><item><title>Prognosis-cirrhosis</title><link>https://www.physician.tw/Prognosis-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-cirrhosis/</guid><description>Prognosis-cirrhosis ( www.mdcalc.com/child-pugh-score-cirrhosis-mortality)
Modified Child-Turcotte-Pugh (CPS) score based on ascites, enceph., &amp;amp; labs (bili, alb &amp;amp; INR; see Appendix).</description></item><item><title>Prognosis-pulmonary hypertension</title><link>https://www.physician.tw/Prognosis-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-pulmonary-hypertension/</guid><description>Prognosis-pulmonary hypertension Median survival after dx ~2.8 y; PAH (all etiologies): 2-y 66%, 5-y 48% (Chest 2004;126:78â€“S)
Poor prognostic factors: clinical evidence of RV failure, rapidly progressive sx, WHO (modified NYHA) class IV, 6MWT &amp;lt;300 m, peak VO2 &amp;lt;10.</description></item><item><title>Prognosis-syncope</title><link>https://www.physician.tw/Prognosis-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-syncope/</guid><description>Prognosis-syncope (Ann Emerg Med 1997;29:459; NEJM 2002;347:878)
22% overall recurrence rate if idiopathic, else 3% recurrence Cardiac syncope has poor prognosis (20â€“40% 1-y SCD rate); vasovagal good prognosis Unexplained syncope w/ 1.</description></item><item><title>Prognosis-ulcerative colitis</title><link>https://www.physician.tw/Prognosis-ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prognosis-ulcerative-colitis/</guid><description>Prognosis-ulcerative colitis 50% in remission at any given time. Intermittent exacerbations in 90%; continual active disease in ~18%. Prox progression in 25% at 10 y.</description></item><item><title>Prolonged-QT-interval</title><link>https://www.physician.tw/Prolonged-QT-interval/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prolonged-QT-interval/</guid><description>Prolonged-QT-interval Prolonged QT interval (NEJM 2008;358:169; www.torsades.org) Measure QT using threshold method (start of QRS to end of Tw at isoelectric line) or tangent (QRS to where tangent of Tw downslope intersects baseline) when long tail.</description></item><item><title>Propafenone</title><link>https://www.physician.tw/Propafenone/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Propafenone/</guid><description>Propafenone 600 mg PO x 150-300mg tid n/a [[Flecainide]] %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Properties and Antidotes for Anticoagulants Fibrinolytics</title><link>https://www.physician.tw/Properties-and-Antidotes-for-Anticoagulants-Fibrinolytics/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Properties-and-Antidotes-for-Anticoagulants-Fibrinolytics/</guid><description>Properties and Antidotes for Anticoagulants Fibrinolytics [[Direct Oral Anticoagulants (DOACs) for NVAF]]
UFH 60â€“90â€², RES â†‘ PTT Protamine IV 1 mg/100 U UFH (max 50 mg).</description></item><item><title>Prophylaxis-HIV AIDS</title><link>https://www.physician.tw/Prophylaxis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Prophylaxis-HIV-AIDS/</guid><description>Prophylaxis-HIV AIDS (NEJM 2015;373:2237; Lancet 2016;387:53; J Infect Dis 2018;218:16; CDC 2021)
Pre-exposure (PrEP): TDF/FTC daily, â†“ transmission &amp;gt;90% if adherent.</description></item><item><title>prostate cancer</title><link>https://www.physician.tw/prostate-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prostate-cancer/</guid><description>prostate cancer Epidemiology and risk factors (NEJM 2003;349:366) Most common cancer in U.S. men; 2nd most common cause of cancer death in men Lifetime risk of prostate cancer dx ~16%; lifetime risk of dying of prostate cancer ~3% â†‘ risk with â†‘ age (rare if &amp;lt;45 y), in African Americans, âŠ• FHx, BRCA mutations Clinical manifestations Most prostate cancers (78%) are asymptomatic and localized at diagnosis Metastatic dis.</description></item><item><title>prosthetic-heart-valves</title><link>https://www.physician.tw/prosthetic-heart-valves/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/prosthetic-heart-valves/</guid><description>prosthetic-heart-valves [[Mechanical-prosthetic-heart-valves]] [[Bioprosthetic]]
Physical exam Crisp sounds Â± soft murmur during forward flow (normal to have small âˆ‡) [[Anticoagulation antiplatelet therapy-prosthetic-heart-valves]] [[Correction of overanticoagulation]] (Circ 2021;143:e72) Endocarditis prophylaxis: for all prosthetic valves [[bacterial endocarditis]] [[Complications-prosthetic-heart-valves]]</description></item><item><title>protease inhibitors - PI-Antiretrovirals ARVs</title><link>https://www.physician.tw/protease-inhibitors-PI-Antiretrovirals-ARVs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/protease-inhibitors-PI-Antiretrovirals-ARVs/</guid><description>protease inhibitors - PI-Antiretrovirals (ARVs) atazanavir (ATV; Reyataz) darunavir (DRV; Prezista) lopinavir (LPV; Kaletra) PIs given w/boosters ritonavir or cobicistat for â†‘ PK Class: GI intol; hepatotoxicity; inhibit CYP450 (many DDIs, eg statins, steroids, DOACs); â†‘ glc; hyperlipid (less w/ ATV); MI (NEJM 2007;356:1723) ATV: crystalluria â†’ nephrolithiasis DRV: rash (10%); possible sulfa cross-reactivity</description></item><item><title>Protein of cerebrospinal fluid</title><link>https://www.physician.tw/Protein-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Protein-of-cerebrospinal-fluid/</guid><description>Protein of cerebrospinal fluid æ˜¯å¤§åˆ†å­ï¼Œæœƒè¢«BBBæ“‹ä½ï¼Œæ­£å¸¸ç´„ 15â€“40 mg/dL ä¸Šå‡åŸå› åŒ…æ‹¬æ„ŸæŸ“ã€è…«ç˜¤ã€è…¦ç‚ç­‰ â†‘â†‘ (å¯èƒ½&amp;gt;200)ï¼šbacteria â†‘ï¼šviralã€fungusã€TBã€parasiteã€malignancyã€viral/autoimmune encephalitis ç­‰ å¦å¤– SAHã€traumatic tapping ä¹Ÿå¯èƒ½ä½¿ protein ç¨å¾®ä¸Šå‡</description></item><item><title>Protein of Urine Dipstick</title><link>https://www.physician.tw/Protein-of-Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Protein-of-Urine-Dipstick/</guid><description>Protein of Urine Dipstick Detects albuminuria (&amp;gt;300 mg/d); False âŠ–: dilute urine
1+ â‰ˆ30 mg/dL, 2+ â‰ˆ100 mg/dL, 3+ â‰ˆ300 mg/dL, 4+ &amp;gt;2 g/dL;</description></item><item><title>proteinuria</title><link>https://www.physician.tw/proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/proteinuria/</guid><description>proteinuria [[Etiologies of Proteinuria]]
[[Urine dipstick]] 1+ â‰ˆ30 mg/dL, 2+ â‰ˆ100 mg/dL, 3+ â‰ˆ300 mg/dL, 4+ &amp;gt;2 g/dL; interpretation depends on SG; eg, 3+ in very concentrated urine might not indicate heavy proteinuria</description></item><item><title>Pseudo-hypoparathyroidism</title><link>https://www.physician.tw/Pseudo-hypoparathyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pseudo-hypoparathyroidism/</guid><description>Pseudo-hypoparathyroidism (Endo Metab Clin North Am 2018;47:865)
1a, 1b, &amp;amp; 1c: PTH end-organ resistance (âˆ´ â†‘ serum PTH) 1a &amp;amp; 1c: + skeletal abnormalities, short stature &amp;amp; developmental delay 1b: w/o extra features Pseudopseudohypoparathyroidism = 1a mutation inherited from father, no hormonal abnormalities</description></item><item><title>Pseudoinfarct</title><link>https://www.physician.tw/Pseudoinfarct/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pseudoinfarct/</guid><description>Pseudoinfarct In left ventricular hypertrophy, there is often a QS deflection or poor R wave progression in the right precordial leads that suggests anterior myocardial infarction.</description></item><item><title>pulmonary critical care</title><link>https://www.physician.tw/pulmonary-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-critical-care/</guid><description>pulmonary critical care 20 Respiratory Monitoring 21 Mechanical Ventilatory Support 22 Nonâ€Invasive Positive Pressure Ventilation 23 Acute Respiratory Distress Syndrome 24 Bronchospasm and Chronic Obstructive Pulmonary Disease 25 [[Weaning from Mechanical Ventilation]]</description></item><item><title>pulmonary function tests</title><link>https://www.physician.tw/pulmonary-function-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-function-tests/</guid><description>pulmonary function tests [[physiology of pulmary]]
Spirometry: evaluate for obstructive disease è‚ºæ´»é‡æ¸¬å®šï¼šè©•ä¼°é˜»å¡æ€§ç–¾ç—… Flow-volume loops: diagnose and/or localize obstructionï¼šè¨ºæ–·å’Œ/æˆ–å®šä½é˜»å¡</description></item><item><title>pulmonary hypertension</title><link>https://www.physician.tw/pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonary-hypertension/</guid><description>pulmonary hypertension PHT defined as PA mean pressure â‰¥20 mmHg at rest (ERJ 2019;53:1801913) PA mean = CO Ã— PVR + PA wedge pressure.</description></item><item><title>Pulmonary infiltrates with eosinophilia PIE</title><link>https://www.physician.tw/Pulmonary-infiltrates-with-eosinophilia-PIE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-infiltrates-with-eosinophilia-PIE/</guid><description>Pulmonary infiltrates with eosinophilia (PIE) eos on BAL Ã© peripheral blood
Allergic bronchopulmonary aspergillosis (ABPA)
EGPA</description></item><item><title>Pulmonary-complications of HIV AIDS</title><link>https://www.physician.tw/Pulmonary-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-complications-of-HIV-AIDS/</guid><description>Pulmonary-complications of HIV AIDS Radiographic Pattern Common Causes
Normal Early PCP
Diffuse interstitial infiltrates PCP, TB, viral, or disseminated fungal</description></item><item><title>Pulmonary-Renal Syndromes</title><link>https://www.physician.tw/Pulmonary-Renal-Syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulmonary-Renal-Syndromes/</guid><description>Pulmonary-Renal Syndromes differential diagnosis: hemorrhagic pulmonary edema associated with renal failure from superimposed CHF or pulmonary emboli.
Most Pulmonary-Renal Syndromes are associated with: antineutrophilic cytoplasmic Ab (anca) è¬›å‡ºä¾†å¯ä»¥å¸¥ä¸€æ³¢çš„è¨ºæ–·: Micorsopic polyangiitis Granulomatosis with polyangiitis Churg-Strauss systemic lupus erythematosus Goodpastur&amp;rsquo;s syndrome Behcet&amp;rsquo;s disease Rheumatoid vasculitis</description></item><item><title>pulmonology</title><link>https://www.physician.tw/pulmonology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulmonology/</guid><description>è‚ºè‡Ÿç–¾ç—…ï¼Œæ°£ç®¡ç—…è®Šï¼Œ ç—…ç—‡å¤šç«¯ï¼Œéœ€é«˜æ˜ã€‚ å‘¼å¸ä¸é †ï¼Œæ°£å–˜å›°æ“¾ï¼Œ èƒ¸è…”å…§ç—…ï¼Œè‹¦é›£å¤šã€‚
pulmonary [[dyspnea]]
[[pulmonary function tests]]
[[asthma]]
[[anaphylaxis]]</description></item><item><title>Pulseless Arrest</title><link>https://www.physician.tw/Pulseless-Arrest/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pulseless-Arrest/</guid><description>Pulseless Arrest é ¸60 è‚¡70 æ‰‹80 è¶³90
CPR Compressions
Push hard (2-2.4 inches) &amp;amp; fast (100-120/min) Minimize interruptions; rotate compressor q2min Airway: open airway (eg, head tilt-chin lift) Breathing: 10 breaths/min; 2 breaths q 30 compressions Bag-mask acceptable; supplemental O2</description></item><item><title>pulsus paradoxus</title><link>https://www.physician.tw/pulsus-paradoxus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pulsus-paradoxus/</guid><description>pulsus paradoxus æ­£å¸¸æƒ…æ³ä¸‹ï¼Œå¸æ°£æ™‚è¡€å£“æœƒç¨å¾®é™ä½ï¼Œ è€Œå‘¼æ°£æ™‚è¡€å£“æœƒç¨å¾®ä¸Šå‡ï¼Œä¸‹é™çš„æ­£å¸¸ç¯„åœæ˜¯&amp;lt;10 mmHg å¦‚æœä¸‹é™çš„å¹…åº¦&amp;gt;10mmHgå‰‡ç¨±ç‚ºpulsus paradoxus ç†å­¸æª¢æŸ¥ä¸Šçš„ç™¼ç¾ï¼šè½è¨ºå™¨å¯è½åˆ°å¿ƒè·³ä½†åœ¨radial arteryæ‘¸ä¸åˆ°pulseã€‚</description></item><item><title>Pure red cell aplasia</title><link>https://www.physician.tw/Pure-red-cell-aplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Pure-red-cell-aplasia/</guid><description>Pure red cell aplasia Destructive antibodies or lymphocytes â†’ ineffective erythropoiesis
Associated with thymoma, CLL, parvovirus infection, autoimmunity, drugs</description></item><item><title>purpura</title><link>https://www.physician.tw/purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/purpura/</guid><description>purpura (nonblanching purple/red lesions due to extravasation of RBCs into dermis)
Nonpalpable (macular; â‰¤3 mm in diameter = petechiae; &amp;gt;3 mm = ecchymoses) platelet disorder: thrombocytopenia, defect in platelet fxn</description></item><item><title>pyenv</title><link>https://www.physician.tw/pyenv/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/pyenv/</guid><description>/Users/htlin/.pyenv/versions/neovim2/bin/python
/Users/htlin/.pyenv/versions/neovim3/bin/python</description></item><item><title>radiation oncology</title><link>https://www.physician.tw/radiation-oncology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/radiation-oncology/</guid><description>radiation oncology Basic Radiation Biology and Physics [[external beam radiation therapy]] Stereotactic Radiotherapy Brachytherapy Total Body Irradiation and TSEB Radiation Oncology Emergencies</description></item><item><title>radiology</title><link>https://www.physician.tw/radiology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/radiology/</guid><description>radiology [[chest radiograph]]</description></item><item><title>Rank the Differential Diagnosis</title><link>https://www.physician.tw/Rank-the-Differential-Diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rank-the-Differential-Diagnosis/</guid><description>Rank the Differential Diagnosis</description></item><item><title>Rapid correction of Treatment-of-hyponatremia</title><link>https://www.physician.tw/Rapid-correction-of-Treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rapid-correction-of-Treatment-of-hyponatremia/</guid><description>Rapid correction of Treatment-of-hyponatremia can lead to CPM/ODS (esp if chronic or Na &amp;lt;120 mEq/L). Should be emergently reversed w/ dDAVP Â± D5W; partial neuro recovery possible (CJASN 2014;9:229).</description></item><item><title>rapid progressive glomerulonephritis RPGN</title><link>https://www.physician.tw/rapid-progressive-glomerulonephritis-RPGN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rapid-progressive-glomerulonephritis-RPGN/</guid><description>rapid progressive glomerulonephritis (RPGN) åˆ‡ç‰‡ä¸‹å…¸å‹æœƒå‡ºç¾å»£æ³›çš„æ–°æœˆå½¢æˆ(crescent formation)ã€‚
æ–°æœˆå½¢æˆ(Crescent formation)
ç‚ºæ‡‰å°è…çµ²çƒå¾®è¡€ç®¡å£åš´é‡å‚·å®³çš„éç‰¹ç•°æ€§åæ‡‰ï¼Œåœ¨å¤šç¨®åš´é‡çš„è…çµ²çƒç™¼ç‚ç–¾ç—…éƒ½å¯èƒ½å‡ºç¾ è…çµ²çƒå¾®è¡€ç®¡å£å—æå¾Œï¼Œè¡€æ¼¿ä¸­çš„ç‰©è³ªæœƒé€²å…¥Bowmanâ€™s spaceï¼Œé€²è€Œå°è‡´fibrinå½¢æˆã€‚æ­¤å¤–ï¼Œç™¼ç‚ç´°èƒå’Œç´°èƒæ¿€ç´ çš„é€²å…¥ï¼Œä¹ŸæŠ‘åˆ¶äº†fibrinåˆ†è§£çš„éç¨‹ RPGNçš„ç¨®é¡ (1) Anti-GBMæŠ—é«”
å¦‚Goodpastureâ€™s diseaseï¼Œå…¸å‹æœ‰è…è‡Ÿå’Œè‚ºéƒ¨çš„ä¾µçŠ¯ (2) å…ç–«è¤‡åˆé«”ä»‹å°
åœ¨è…çµ²çƒä¸­èƒ½çœ‹åˆ°å…ç–«è¤‡åˆé«”çš„æ²‰ç©ï¼Œä¸åŒç–¾ç—…çš„æ²‰ç©åˆ†å­æœ‰å·®ç•°ï¼Œå¦‚IgA nephropathyã€PSGNã€lupus nephritisã€å†·å‡çƒè›‹ç™½è¡€ç—‡ç­‰ (3) Pauci-immune</description></item><item><title>RASi ACEI ARB</title><link>https://www.physician.tw/RASi-ACEI-ARB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RASi-ACEI-ARB/</guid><description>RASi ACEI ARB Choose one of ARNI (ARB + neprilysin inhib), ACEI or ARB
36-hr washout when transitioning ACEI to ARNI</description></item><item><title>Rate Control-atrial fibrillation</title><link>https://www.physician.tw/Rate-Control-atrial-fibrillation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rate-Control-atrial-fibrillation/</guid><description>Rate Control-atrial fibrillation (if sxï¼Œ goal HR â‰¤80; if asx &amp;amp; EF &amp;gt;40%. goal HR â‰¤110ï¼› Circ 2014:130e199)
Agent Acute (IV) Maint.</description></item><item><title>Rate of correction of hypernatremia</title><link>https://www.physician.tw/Rate-of-correction-of-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rate-of-correction-of-hypernatremia/</guid><description>Rate of correction of hypernatremia depends on acuity of onset and risk:
chronic (&amp;gt;48 hr): ~12 mEq/d appears safe w/o risk of cerebral edema (CJASN 2019;14:656)</description></item><item><title>Rationale PA catheter and tailored therapy</title><link>https://www.physician.tw/Rationale-PA-catheter-and-tailored-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rationale-PA-catheter-and-tailored-therapy/</guid><description>Rationale PA catheter and tailored therapy Cardiac output (CO) = SV Ã— HR; optimize SV (and thereby CO) by manipulating preload/ LVEDV (w/ IVF, diuretics), contractility (w/ inotropes), &amp;amp; afterload (w/ vasodilators)</description></item><item><title>Raynaud phenomenon</title><link>https://www.physician.tw/Raynaud-phenomenon/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Raynaud-phenomenon/</guid><description>Raynaud phenomenon a problem that causes decreased blood flow to the fingers. In some cases, it also causes less blood flow to the ears, toes, nipples, knees, or nose.</description></item><item><title>RB-ILD resp bronchiolitis-assoc ILD</title><link>https://www.physician.tw/RB-ILD-resp-bronchiolitis-assoc-ILD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RB-ILD-resp-bronchiolitis-assoc-ILD/</guid><description>RB-ILD resp bronchiolitis-assoc ILD Bronchial thickening, centrilobular nodules, patchy ground-glass opacities; upper lobe predom. MÏ† in alveoli.</description></item><item><title>Recognizing and managing comorbidities of Migraine</title><link>https://www.physician.tw/Recognizing-and-managing-comorbidities-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recognizing-and-managing-comorbidities-of-Migraine/</guid><description>Recognizing and managing comorbidities of Migraine Identify comorbid conditions Select drugs and adjust their use according to comorbidities present Alleviate comborbidities if possible to improve outcome</description></item><item><title>Recommended Chronic Therapy by HF Stage</title><link>https://www.physician.tw/Recommended-Chronic-Therapy-by-HF-Stage/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recommended-Chronic-Therapy-by-HF-Stage/</guid><description>Recommended Chronic Therapy by HF Stage (JACC 2021;77:772)
Utility of BNP-guided Rx (inPt and outPt) remains debated (Eur Heart J 2014;35:16) Implantable PA pressure sensor in sx Pts: ~19â€“37% â†“ risk of hosp (Lancet 2016;387:453 &amp;amp; 2021;398:991) Stage (not NYHA Class) Therapy A At risk for HF (eg, HTN); but asx &amp;amp; w/o struct.</description></item><item><title>Recommended First-Line Oral Direct-Acting Antiviral DAA Regimens</title><link>https://www.physician.tw/Recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recommended-First-Line-Oral-Direct-Acting-Antiviral-DAA-Regimens/</guid><description>Recommended First-Line Oral Direct-Acting Antiviral (DAA) Regimens Sofosbuvir &amp;amp; velpatasvir Genotypes 1â€“6, 12 weeks Rx Glecaprevir &amp;amp; pibrentasvir Gentotypes 1â€“6; 8 weeks Rx Simplified treatment: adults w/ HCV w/o cirrhosis or w/ compensated cirrhosis &amp;amp; no prior HCV treatment; cannot have HIV, HBsAg âŠ•, pregnancy, HCC, ESRD, or liver transplant; if decompensated or previously treated, refer to GI for assistance.</description></item><item><title>Recurrent infection-clostridioides difficile infection</title><link>https://www.physician.tw/Recurrent-infection-clostridioides-difficile-infection/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Recurrent-infection-clostridioides-difficile-infection/</guid><description>Recurrent infection-clostridioides difficile infection (15â€“30% risk after d/c of abx, most w/in 2 wk of stopping abx)
1st recurrence: fidaxomicin 200 mg PO bid Ã— 10 d or vanco 125 mg PO q6h Ã— 10â€“14 d.</description></item><item><title>Refractory ascites</title><link>https://www.physician.tw/Refractory-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Refractory-ascites/</guid><description>Refractory ascites seen in 5â€“10% of Pts; 2-y survival 25%
Defined as [[diuretic-resistant]] if on 2-g Na diet w/ minimal weight loss on max diuretics, or diuretic-induced complications (AKI, Na &amp;lt;125, â†‘ K, encephalopathy) Conflicting evid.</description></item><item><title>Regimens-Endocarditis Prophylaxis</title><link>https://www.physician.tw/Regimens-Endocarditis-Prophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Regimens-Endocarditis-Prophylaxis/</guid><description>Regimens-Endocarditis Prophylaxis Oral: amoxicillin 2 g 30â€“60 min before Unable to take PO: amp 2 g IM/IV or cefazolin or CTX 1 g IM/IV PCN-allergic: cephalexin or azithro or claritho or doxy</description></item><item><title>Region or Exposure Common Etiologies -fever in a returned traveler</title><link>https://www.physician.tw/Region-or-Exposure-Common-Etiologies-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Region-or-Exposure-Common-Etiologies-fever-in-a-returned-traveler/</guid><description>Region or Exposure Common Etiologies -fever in a returned traveler Sub-Saharan Africa Malaria &amp;raquo; dengue and other arboviruses, rickettsial disease, enteric fever</description></item><item><title>Rejection-Kidney transplantation</title><link>https://www.physician.tw/Rejection-Kidney-transplantation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rejection-Kidney-transplantation/</guid><description>Rejection-Kidney transplantation : Ab (ABMR) or T-cell mediated (TCMR), a/w poor graft survival; BANFF criteria (Am J Transplant 2018;18:293). Rx options: â†‘ immunosupp.</description></item><item><title>Reliever medications-asthma</title><link>https://www.physician.tw/Reliever-medications-asthma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Reliever-medications-asthma/</guid><description>Reliever medications-asthma (used prn to quickly relieve sx)
Low-dose inhaled corticosteroids (ICS) + long-acting inh Î²2-agonists (LABA): budesonide-formoterol (NEJM 2019;380:2020)</description></item><item><title>Renal H2O loss Uosm &lt;700â€“800</title><link>https://www.physician.tw/Renal-H2O-loss-Uosm-700800/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-H2O-loss-Uosm-700800/</guid><description>Renal H2O loss (Uosm &amp;lt;700â€“800) Diuresis: osmotic (glucose, mannitol, urea), loop diuretics
Diabetes insipidus (Nature Reviews Nephrology 2015;11:576)</description></item><item><title>Renal losses of Hypovolemic-hypotonic-hyponatremia</title><link>https://www.physician.tw/Renal-losses-of-Hypovolemic-hypotonic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-losses-of-Hypovolemic-hypotonic-hyponatremia/</guid><description>Renal losses of Hypovolemic-hypotonic-hyponatremia (UNa &amp;gt;20 mEq/L, FENa &amp;gt;1%): diuretics (esp. thiazides, because loop diuretics â†“ tonicity of medullary interstitium, Î” for H2O absorption, &amp;amp; âˆ´ urine concentrating ability), salt-wasting nephropathy, cerebral salt wasting, mineralocorticoid deficiency</description></item><item><title>Renal potassium losses</title><link>https://www.physician.tw/Renal-potassium-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-potassium-losses/</guid><description>Renal potassium losses Hypotensive or normotensive acidosis: DKA, RTA [distal RTAs (type I) &amp;gt;proximal RTAs (type II)]
alkalosis: diuretics (thiazide &amp;gt;loop), vomiting/NGT drainage (via 2Â° hyperaldosteronism)</description></item><item><title>renal replacement and dialysis</title><link>https://www.physician.tw/renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-replacement-and-dialysis/</guid><description>renal replacement and dialysis [[General-renal replacement and dialysis]] [[Modalities-renal replacement and dialysis]] [[Hemodialysis (HD)]] [[Vascular Access-renal replacement and dialysis]] [[Continuous veno-venous hemofiltration (CVVH)]] [[Peritoneal dialysis (PD)]] [[Kidney transplantation]]</description></item><item><title>Renal tubular acidoses</title><link>https://www.physician.tw/Renal-tubular-acidoses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-tubular-acidoses/</guid><description>Renal tubular acidoses (RTAs) (Adv Ther 2021;38:949)
(Adv Ther 2021;38:949)
Proximal (Type II): â†“ proximal reabsorption of HCO3 1Â° (Fanconiâ€™s syndrome) = â†“ proximal reabsorption of HCO3, PO4, glc, amino acids Acquired: paraprotein (MM, amyloidosis), metals (Pb, Cd, Hg, Cu), â†“ vit D, PNH, renal Tx Meds: acetazolamide, aminoglycosides, ifosfamide, cisplatin, topiramate, tenofovir Distal (Type I): defective distal H+ secretion 1Â°, autoimmune (SjÃ¶grenâ€™s, RA, SLE), hypercalciuria, meds (ampho, Li, ifosfamide); normally a/w â†“ K; if with â†‘ K â†’ sickle cell, obstruction, renal transplant Hypoaldo (Type IV): hypoaldo â†’ â†‘ K â†’ â†“ NH3 synthesis â†’ â†“ urine acid-carrying capacity â†“ renin: diabetic nephropathy, NSAIDs, chronic interstitial nephritis, calcineurin inh, HIV â†“ aldo production: 1Â° AI, ACEI/ARBs, heparin, severe illness, inherited (â†“ 21-hydroxylase) â†“ response to aldosterone Meds: K-sparing diuretics, TMP-SMX, pentamidine, calcineurin inhibitors Tubulointerstitial disease: sickle cell, SLE, amyloid, DM</description></item><item><title>renal-cell-carcinoma</title><link>https://www.physician.tw/renal-cell-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-cell-carcinoma/</guid><description>renal-cell-carcinoma [[systematic-Treatment]]</description></item><item><title>Renal-complications of HIV AIDS</title><link>https://www.physician.tw/Renal-complications-of-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-complications-of-HIV-AIDS/</guid><description>Renal-complications of HIV AIDS HIV-assoc. nephropathy (collapsing FSGS); nephrotoxic drugs (eg, TDF â†’ prox tub dysfxn)</description></item><item><title>Renal-limited vasculitis</title><link>https://www.physician.tw/Renal-limited-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Renal-limited-vasculitis/</guid><description>Renal-limited vasculitis Small vessel pauci-immune vasculitis causing RPGN w/o other organ involvement Dx studies: 80% âŠ• ANCA (MPO &amp;gt;PR3); biopsy with pauci-immune GN Â± granulomas Treatment identical to that for GPA/MPA</description></item><item><title>renal-Secondary Causes of Hypertension</title><link>https://www.physician.tw/renal-Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/renal-Secondary-Causes-of-Hypertension/</guid><description>renal-Secondary Causes of Hypertension Renal parenchymal (2â€“3%) h/o DM, polycystic kidney disease, glomerulonephritis CrCl, albuminuria See â€œKidney Diseaseâ€
Renovascular (1â€“2%) Athero (90%) FMD (10%, young women) PAN, scleroderma ARF induced by ACEI/ARB Recurrent flash pulm edema Renal bruit; hypokalemia (NEJM 2009;361:1972) MRA (&amp;gt;90% Se &amp;amp; Sp, less for FMD), CTA, duplex U/S, angio, plasma renin (low Sp)</description></item><item><title>Replace free H2O deficit</title><link>https://www.physician.tw/Replace-free-H2O-deficit/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Replace-free-H2O-deficit/</guid><description>Replace free H2O deficit (also replace concurrent volume deficit if appropriate):
eg, 1 L D5W given to 70-kg man w/ [Na] = 160 mEq/L will â†“ [Na]serum by 3.</description></item><item><title>Replacement fluid of continuous veno-venous hemofiltration</title><link>https://www.physician.tw/Replacement-fluid-of-continuous-veno-venous-hemofiltration/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Replacement-fluid-of-continuous-veno-venous-hemofiltration/</guid><description>Replacement fluid of continuous veno-venous hemofiltration Choice of replacement fluid buffer:
HCO3 (+ heparin to prevent clotting, although can be run heparin-free)</description></item><item><title>Residual syndrome</title><link>https://www.physician.tw/Residual-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Residual-syndrome/</guid><description>Residual syndrome Inadequate removal of uremic toxins through conventional dialysis may result in a phenomenon known as residual syndrome. Patients with this syndrome may experience subtle signs of malnutrition, mild lethargy, infection, and serositis</description></item><item><title>Resistant HTN</title><link>https://www.physician.tw/Resistant-HTN/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Resistant-HTN/</guid><description>Resistant HTN (BP &amp;gt;goal on â‰¥3 drugs incl diuretic; HTN 2018;72:e53)
Exclude: 2Â° causes (see table) and pseudoresistance: inaccurate measure (cuff size), diet noncomp (â†‘ Na), poor Rx compliance/dosing, white coat HTN (âœ“ ABPM) Ensure effective diuresis (chlorthalidone or indapamide &amp;gt;HCTZ; loop &amp;gt;thiazide if eGFR &amp;lt;30) Can add aldosterone antagonist (Lancet 2015;386:2059), Î²-blocker (particularly vasodilators such as carvedilol, labetalol, or nebivolol), Î±-blocker, or direct vasodilator Consider renal denervation therapy (Lancet 2018;391:2346; 2021;397:2476)</description></item><item><title>respiratory failure</title><link>https://www.physician.tw/respiratory-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-failure/</guid><description>respiratory failure A-a gradient = PAO2 â€“ PaO2: normal (on room air) = â€œ4 + age/4â€ or â€œ2.5 + (0.</description></item><item><title>respiratory-acidosis</title><link>https://www.physician.tw/respiratory-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-acidosis/</guid><description>respiratory-acidosis (NEJM 1989;321:1223; Crit Care 2010;14:220)
[[Etiologies of High elevated PaCO2]]
Etiologies (also see â€œHypercapniaâ€; PaCO2 = VCO2/VE(1-VD/VT); VE = RR x VT)</description></item><item><title>respiratory-alkalosis</title><link>https://www.physician.tw/respiratory-alkalosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/respiratory-alkalosis/</guid><description>respiratory-alkalosis Etiologies (NEJM 2002;347:43; Crit Care 2010;14:220)
Hypoxia â†’ hyperventilation: pneumonia, CHF, PE, restrictive lung disease, anemia Primary hyperventilation CNS stimulation, pain, anxiety, trauma, stroke, CNS infection, pontine tumors drugs: salicylates toxicity (early), Î²-agonists, progesterone, methylxanthines, nicotine pregnancy, sepsis, hepatic failure, hyperthyroidism, fever Pseudorespiratory alkalosis: â†“ perfusion w/ preserved ventilation (eg, CPR, severe HoTN) â†’ â†“ delivery of CO2 to lungs for excretion; low PaCO2 but â†‘ tissue CO2</description></item><item><title>RESTRICTIVE---INFILTRATIVE</title><link>https://www.physician.tw/RESTRICTIVE---INFILTRATIVE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/RESTRICTIVE---INFILTRATIVE/</guid><description>RESTRICTIVE&amp;mdash;INFILTRATIVE</description></item><item><title>Revascularization</title><link>https://www.physician.tw/Revascularization/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Revascularization/</guid><description>Revascularization OMT should be initial focus if stable &amp;amp; w/o evidence of critical anatomy &amp;amp; w/ normal EF Goal of revasc should be to â†“ risk of CV morbidity &amp;amp; mortality or to relieve refractory sx Older studies: survival benefit w/ revascularization (CABG) vs.</description></item><item><title>Rhabdomyolysis</title><link>https://www.physician.tw/Rhabdomyolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhabdomyolysis/</guid><description>Rhabdomyolysis (NEJM 2009;361:62)
Pathophys: myoglobin-induced oxidant injury, vasoconstriction, myoglobin precipitation &amp;amp; pre-renal (extravasation). Can lead to â†“ Ca, â†‘ K, and â†‘ PO4.</description></item><item><title>rheumatology</title><link>https://www.physician.tw/rheumatology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/rheumatology/</guid><description>rheumatology [[allergy immunology]] [[approach to rheumatic disease]] [[rheumatoid arthritis]] [[adult-onset Stillâ€™s disease ]]&amp;amp; relapsing polychondritis [[crystal deposition arthritides]] [[seronegative spondyloarthritis]] [[infectious arthritis and bursitis]] [[connective tissue diseases]] [[systemic lupus erythematosus]] [[IgG4-related disease]] [[vasculitis]] [[autoinflammatory syndromes]] [[amyloidosis]] [[osteoarthritis]] (OA) [[Undifferentiated Inflammatory Arthritis]]</description></item><item><title>Rhythm control</title><link>https://www.physician.tw/Rhythm-control/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rhythm-control/</guid><description>Rhythm control (Lancet 2016;388:829)
Consider if sx w/ rate control (eg, HF), difficult to control rate, or tachycardia-mediated CMP If minimally sx or asx, previously no clear benefit vs.</description></item><item><title>Right-ventricular-hypertrophy</title><link>https://www.physician.tw/Right-ventricular-hypertrophy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Right-ventricular-hypertrophy/</guid><description>Right-ventricular-hypertrophy Etiologies: cor pulmonale, congenital (tetralogy of Fallot, TGA, PS, ASD, VSD), MS, TR
Criteria [all insensitive, but specific (except in COPD); all w/ poor PPV in general population]</description></item><item><title>risk factor of delirium</title><link>https://www.physician.tw/risk-factor-of-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/risk-factor-of-delirium/</guid><description>risk factor of delirium older aged &amp;gt;65 baseline cognitive dysfunction preexisting hearing and visual impairment, as well as indices for poor overall health, including baseline immobility, malnutrition, and underlying medical or neurologic illness.</description></item><item><title>Risk Factors and Screening</title><link>https://www.physician.tw/Risk-Factors-and-Screening/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Factors-and-Screening/</guid><description>Risk Factors and Screening High risk: &amp;gt;10 lifetime sexual partners, prior STI, MSM, sex workers Screening recommendations: differ based on sexual practices and risk.</description></item><item><title>Risk factors for bloodstream infections</title><link>https://www.physician.tw/Risk-factors-for-bloodstream-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-for-bloodstream-infections/</guid><description>Risk factors for bloodstream infections (JAMA 2012;308:502; CID;2020;71)
Syndromes with high likelihood of bacteremia: Sepsis Endovascular infxns: endocarditis, infection of pacemaker, vascular graft or IV catheter [[vertebral osteomyelitis]], epidural abscess, septic arthritis Risk factors: indwelling lines, IVDU, immunosupp.</description></item><item><title>Risk factors-acute aortic syndromes</title><link>https://www.physician.tw/Risk-factors-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-acute-aortic-syndromes/</guid><description>Risk factors-acute aortic syndromes (Lancet 2015;385:800)
Classic (in older Pts): HTN (h/o HTN in &amp;gt;70% of dissections); age (60sâ€“70s), sex (~65% â™‚); smoking; â†‘ lipids.</description></item><item><title>Risk Factors-bacterial endocarditis</title><link>https://www.physician.tw/Risk-Factors-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Factors-bacterial-endocarditis/</guid><description>Risk Factors-bacterial endocarditis Abnormal valve (JAMA 1997;277:1794; JACC 2018;72:2443) High risk: prior endocarditis, prosthetic valve or ring, some congenital heart disease (unrepaired cyanotic; shunt/conduit; prosthesis in past 6 mos), transplant heart, valvulopathy, VAD Medium risk previous rheumatic fever non-rheumatic valve disease (including MVP w/ MR or thickened leaflet), HCM bicuspid AoV Risk of bacteremia: IVDU indwelling venous catheters, hemodialysis, prosthetic material in heart (eg, pacemaker, ICD, graft), poor dentition</description></item><item><title>Risk factors-venous thromboembolism</title><link>https://www.physician.tw/Risk-factors-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-factors-venous-thromboembolism/</guid><description>Risk factors-venous thromboembolism [[Virchowâ€™s triad]] for thrombogenesis.
Malignancy (12% of â€œidiopathicâ€ DVT/PE; Circ 2013;128:2614)
[[Venous Thromboembolism and Cancer]] History of thrombosis</description></item><item><title>Risk stratification for Pts with PE</title><link>https://www.physician.tw/Risk-stratification-for-Pts-with-PE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-stratification-for-Pts-with-PE/</guid><description>Risk stratification for Pts with PE clinical: [[simplified PE severity index]]
[[Hestia Criteria for Outpatient Pulmonary Embolism Treatment]] [[Pulmonary Embolism Severity Index PESI]] imaging:</description></item><item><title>Risk stratification of fever and neutropenia</title><link>https://www.physician.tw/Risk-stratification-of-fever-and-neutropenia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-stratification-of-fever-and-neutropenia/</guid><description>Risk stratification of fever and neutropenia History: outPt, ECOG 0â€“1, age &amp;lt;60 y, solid tumor, no sx, no major comorbidities, no h/o fungal infection, MASCC Risk Index â‰¥21 (Support Care Cancer 2013;21:1487) Exam: temp &amp;lt;39 Â°C, no tachypnea, no HoTN, no Î” MS, no dehydration Labs: ANC &amp;gt;100 cells/ÂµL, anticipated duration of neutropenia â‰¤100 cells/ÂµL &amp;lt;7 d</description></item><item><title>Risk-Stratification-andreatment-of-Localized-Prostate</title><link>https://www.physician.tw/Risk-Stratification-andreatment-of-Localized-Prostate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Risk-Stratification-andreatment-of-Localized-Prostate/</guid><description>Risk-Stratification-andreatment-of-Localized-Prostate IMAGE: Risk Stratification and Treatment of Localized Prostate Cancer</description></item><item><title>Roflumilast</title><link>https://www.physician.tw/Roflumilast/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Roflumilast/</guid><description>Roflumilast (PDE-4 inhib) + bronchodil: â†‘ FEV1, â†“ exacerb in Pts with severe COPD, chronic bronchitis, and a hx of exacerbations (Lancet 2015;385:857)</description></item><item><title>Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer</title><link>https://www.physician.tw/Role-of-Circulating-Tumor-DNA-in-Guiding-Adjuvant-Therapy-in-Colon-Cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Role-of-Circulating-Tumor-DNA-in-Guiding-Adjuvant-Therapy-in-Colon-Cancer/</guid><description>Role of Circulating Tumor DNA in Guiding Adjuvant Therapy in Colon Cancer Adjuvant chemotherapy after resection of stage III colon cancer appears to improve outcomes, but many patients are treated to benefit a few.</description></item><item><title>Role of hematopoietic growth factors</title><link>https://www.physician.tw/Role-of-hematopoietic-growth-factors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Role-of-hematopoietic-growth-factors/</guid><description>Role of hematopoietic growth factors Granulocyte (G-CSF) and granulocyte-macrophage (GM-CSF) colony-stimulating factors can be used (but not in AML) as 1Â° Ppx when expected FN incidence &amp;gt;20% or as 2Â° Ppx after FN has occurred in a prior cycle (to maintain dose-intensity for curable tumors) CSFs â†“ rate of FN but have not been shown to affect mortality (Cochrane 2014 CD003039)</description></item><item><title>Rule out mimickers of ILD</title><link>https://www.physician.tw/Rule-out-mimickers-of-ILD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rule-out-mimickers-of-ILD/</guid><description>Rule out mimickers of ILD Congestive heart failure (âœ“ BNP, trial of diuresis); infection: viral, atypical bacterial; malignancy: lymphangitic carcinomatosis, bronchoalveolar, leukemia, lymphoma</description></item><item><title>Rx-Primary biliary cholangitis PBC</title><link>https://www.physician.tw/Rx-Primary-biliary-cholangitis-PBC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Rx-Primary-biliary-cholangitis-PBC/</guid><description>Rx-Primary biliary cholangitis (PBC) Obeticholic acid (FXR agonist): monoRx if cannot tolerate UDCA (but not in decompen cirrhosis) or if no Î” w/ UDCA after 1 y; found to â†“ AÏ†, â†‘ pruritus (NEJM 2016;375:631) ursodeoxycholic acid (UDCA) (13â€“15 mg/kg bid), monitor for 3â€“6 mos â†’ ~25% complete response, â†‘ survival &amp;amp; â†“ histologic change &amp;amp; â†“ complications (varices).</description></item><item><title>Salicylates-toxicology</title><link>https://www.physician.tw/Salicylates-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Salicylates-toxicology/</guid><description>Salicylates-toxicology Tinnitus, hyperventilation, abd. pain, vomiting, Î”MS, mixed â†‘ AG &amp;amp; nl OG metabolic acidosis + respiratory alkalosis
IVF resuscitation</description></item><item><title>Salt H2O or raw oysters fish</title><link>https://www.physician.tw/Salt-H2O-or-raw-oysters-fish/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Salt-H2O-or-raw-oysters-fish/</guid><description>Salt H2O or raw oysters fish V. vulnificus Hemorrhagic bullae &amp;amp; sepsis (esp. in cirrhotics) Doxy + Ceftaz/CTX Mycobacterium marinum Indolent, nodules on extremities/ superficial lymphadenitis Macrolide + rifampin/ ethambutol</description></item><item><title>Sarcoidosis</title><link>https://www.physician.tw/Sarcoidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sarcoidosis/</guid><description>Sarcoidosis (AJRCCM 2020;201:e26; JAMA 2022;327:856)
Prevalence: African Americans, northern Europeans, and females; onset in 3rd-5th decade
Pathophysiology: depression of cellular immune system peripherally, activation centrally</description></item><item><title>Schistosoma haematobium</title><link>https://www.physician.tw/Schistosoma-haematobium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Schistosoma-haematobium/</guid><description>Schistosoma haematobium åŸƒåŠè¡€å¸èŸ²ï¼Œä¸€ç¨®æ‰å½¢å‹•ç‰©ï¼Œå¯„ç”ŸèŸ²ï¼Œæ˜¯å¯„ç”Ÿæ–¼äººé¡å¼•èµ·è¡€å¸èŸ²ç—…çš„ä¸€ç¨®è¡€å¸èŸ²</description></item><item><title>SCLC staging and treatment</title><link>https://www.physician.tw/SCLC-staging-and-treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SCLC-staging-and-treatment/</guid><description>SCLC staging and treatment SCLC usually disseminated at presentation; poor overall survival Can be very responsive to chemotherapy, but rapidly develop resistance Diagnosis: all have Rb &amp;amp; p53 mutations (Nature 2015;524:47); 90% w/ neuroendo markers Treatment: primarily chemo (platinum + etoposide); adding anti-[[PD-L1]] Ab [[atezolizumab]] â†‘ survival (NEJM 2018;379:2220), as does concurrent thoracic RT in limited-stage disease Prophylactic cranial irradiation (PCI) controversial.</description></item><item><title>Scleroderma renal crisis</title><link>https://www.physician.tw/Scleroderma-renal-crisis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Scleroderma-renal-crisis/</guid><description>Scleroderma renal crisis (Nature Neph 2016;12:678)
5â€“20% diffuse cutaneous SSc w/ narrowing glomerular vessels. Sx: renal failure, severe HTN, encephalopathy.</description></item><item><title>Screening and Diagnosis-HIV AIDS</title><link>https://www.physician.tw/Screening-and-Diagnosis-HIV-AIDS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-and-Diagnosis-HIV-AIDS/</guid><description>Screening and Diagnosis-HIV AIDS (JAMA 2018;320:379)
Screen all 13â€“64 yo at least once, every preg, if new STI dx; screen high risk annually HIV Ab/p24Ag (ELISA assay): âŠ• 1â€“12 wk after acute infxn; &amp;gt;99% Se; 1Â° screening test If âŠ•, Ab differentiation assay confirms and differentiates HIV-1 vs.</description></item><item><title>Screening for latent TB</title><link>https://www.physician.tw/Screening-for-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-for-latent-TB/</guid><description>Screening for latent TB Whom to screen: high likelihood of exposure and/or high risk of progression to active disease including HIV âŠ• and prior to immunosuppression (pre-transplant or anti-TNF) Relies on host immune system, so limited Se in immunosuppressed individuals Nb, testing for host exposure &amp;amp; immune response to TB, not whether TB active (vide infra) Screening tests IFN-Î³ release assays (IGRA): preferred test; Ag-stimulated IFN-Î³ release from Ptâ€™s T-cells.</description></item><item><title>Screening of breast cancer</title><link>https://www.physician.tw/Screening-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-of-breast-cancer/</guid><description>Screening of breast cancer (JAMA 2015;314:1599; Annals 2019;170:547)
Mammography: ~20â€“30% â†“ in breast cancer mortality, smaller abs. benefit in women &amp;lt;50 y (JAMA 2018;319:1814); digital breast tomosynthesis (3-D) â†‘ specificity (JAMA Oncol 2019;5:635); suspicious findings: clustered microcalcifications, spiculated, enlarging ACS: annual mammo starting at 45 (consider biennial after 54), cont.</description></item><item><title>Screening Test Abnormalities in Inherited and Acquired Coagulopathies</title><link>https://www.physician.tw/Screening-Test-Abnormalities-in-Inherited-and-Acquired-Coagulopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-Test-Abnormalities-in-Inherited-and-Acquired-Coagulopathies/</guid><description>Screening Test Abnormalities in Inherited and Acquired Coagulopathies</description></item><item><title>Screening-aortic aneurysms</title><link>https://www.physician.tw/Screening-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Screening-aortic-aneurysms/</guid><description>Screening-aortic aneurysms (JAMA 2015;313:1156)
TAA: if bicuspid AoV or 1Â° relative w/: (a) TAA or bicuspid AoV, (b) CTD as above AAA: âœ“ for pulsatile abd mass; U/S â™‚ &amp;gt;60 y w/ FHx of AAA &amp;amp; â™‚ 65â€“75 y w/ prior tobacco</description></item><item><title>Second-line or maintainence therapy for idiopathic thrombocytopenic purpura</title><link>https://www.physician.tw/Second-line-or-maintainence-therapy-for-idiopathic-thrombocytopenic-purpura/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Second-line-or-maintainence-therapy-for-idiopathic-thrombocytopenic-purpura/</guid><description>Second-line or maintainence therapy for idiopathic thrombocytopenic purpura Romiplostim, el/avatrombopag TPO-R agonists â†’ â†‘ plt prod
Rituximab (anti-CD20) Â± dex antiâ€“B-cell Ab</description></item><item><title>secondary bacterial peritonitis</title><link>https://www.physician.tw/secondary-bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/secondary-bacterial-peritonitis/</guid><description>secondary bacterial peritonitis 2/2 intra-abd abscess, perf. Runyonâ€™s criteria: AFTP &amp;gt;1 g/dL, glc &amp;lt;50 mg/dL, LDH &amp;gt;ULN for serum. Cx polymicrobial.</description></item><item><title>Secondary causes of headaches</title><link>https://www.physician.tw/Secondary-causes-of-headaches/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-causes-of-headaches/</guid><description>Secondary causes of headaches Traumatic: post-concussion, SAH, SDH, postcraniotomy â†‘ ICP: mass (tumor, abscess, vascular malformations, ICH), hydrocephalus, idiopathic intracranial hypertension (pseudotumor cerebri), altitude-associated cerebral edema â†“ ICP: post-LP headache, CSF leak/dural tear, overshunting Vascular: stroke (esp.</description></item><item><title>Secondary Causes of Hypertension</title><link>https://www.physician.tw/Secondary-Causes-of-Hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Causes-of-Hypertension/</guid><description>Secondary Causes of Hypertension [[renal-Secondary Causes of Hypertension]] [[endocrine-Secondary Causes of Hypertension]] [[other-Secondary Causes of Hypertension]]</description></item><item><title>Secondary causes of iron overload</title><link>https://www.physician.tw/Secondary-causes-of-iron-overload/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-causes-of-iron-overload/</guid><description>Secondary causes of iron overload iron-loading anemias (eg, thalassemia major, sideroblastic anemia, aplastic anemia), parenteral iron overload (RBC transfusions, long-term HD), chronic liver disease (due to EtOH, HBV, HCV, NASH, etc.</description></item><item><title>Secondary Hyperaldosteronism</title><link>https://www.physician.tw/Secondary-Hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-Hyperaldosteronism/</guid><description>Secondary Hyperaldosteronism (extra-adrenal disorders, â†‘ aldosterone is renin-dependent) 2Â° hyperaldosteronism (eg, renovascular dis., [[renin-secreting tumor]])
Primary reninism: renin-secreting tumor (very rare) Secondary reninism: renovascular disease: RAS, malignant hypertension; edematous states w/ â†“ effective arterial volume: CHF, cirrhosis, nephrotic syndrome; hypovolemia, diuretics, T2D, Bartterâ€™s (defective Na/K/2Cl transporter â‰ˆ receiving loop diuretic), Gitelmanâ€™s (defective renal Na/Cl transporter â‰ˆ receiving thiazide diuretic)</description></item><item><title>Secondary hyperPTH</title><link>https://www.physician.tw/Secondary-hyperPTH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-hyperPTH/</guid><description>Secondary hyperPTH â†‘ PO4, â†‘ FGF-23, â†“ calcitriol, &amp;amp; â†“ Ca â†’ â†‘ PTH â†’ renal osteodystrophy
Stage 3 4 5 Target parathyroid hormone (pg/mL) 35-70 70-110 150-600 [[chronic kidney disease (CKD)]]</description></item><item><title>Secondary immune thrombocytopenic purpura 2Â° ITP</title><link>https://www.physician.tw/Secondary-immune-thrombocytopenic-purpura-2-ITP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secondary-immune-thrombocytopenic-purpura-2-ITP/</guid><description>Secondary immune thrombocytopenic purpura (2Â° ITP) Diagnosis: viral serologies (HIV, HCV, HBV, EBV), H. pylori Ab, ANA, pregnancy test, APLA, TSH, parvovirus, &amp;amp; CMV PCR.</description></item><item><title>Secretory diarrhea</title><link>https://www.physician.tw/Secretory-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Secretory-diarrhea/</guid><description>Secretory diarrhea (watery; nl osmotic gap, no Î” diarrhea w/ fasting, nocturnal, cramps)
Caused by secretion of anions or K+ into lumen or inhib of Na absorption â†’ â†‘ H2O in stool.</description></item><item><title>Sedation-and-Analgesia</title><link>https://www.physician.tw/Sedation-and-Analgesia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sedation-and-Analgesia/</guid><description>Sedation-and-Analgesia [[Context sensitive half time]] [[propofol infusion syndrome]]</description></item><item><title>seizures</title><link>https://www.physician.tw/seizures/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/seizures/</guid><description/></item><item><title>Select clinical manifestations-fever in a returned traveler</title><link>https://www.physician.tw/Select-clinical-manifestations-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Select-clinical-manifestations-fever-in-a-returned-traveler/</guid><description>Select clinical manifestations-fever in a returned traveler Ebola: fever in traveler from area with active transmission of Ebola w/in 21 d Malaria: nonspecific sx including diarrhea, headache, myalgias, cough, Î” MS Dengue: nonspecific sx including headache, severe myalgias, rash/petechiae Chikungunya: nonspecific sx including joint pain, moderate myalgias Typhoid (Lancet 2015;385:1136): diarrhea/constipation, abd pain, Â± rash, relative bradycardia Rickettsial disease: headache, myalgias, lymphadenopathy, Â± rash/eschar Zika: rash, arthralgia, headache, conjunctivitis; often less severe than dengue, Chikungunya</description></item><item><title>selexipag</title><link>https://www.physician.tw/selexipag/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/selexipag/</guid><description>selexipag k</description></item><item><title>sensible and insensible fluid losses</title><link>https://www.physician.tw/sensible-and-insensible-fluid-losses/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sensible-and-insensible-fluid-losses/</guid><description>sensible and insensible fluid losses Insensible losses (nonmeasurable) Lungs: 200 mL Skin: 600 mL Sweat: Variable Sensible losses (measurable) Fecal: 200 mL Urine: 800 to 1500 mL These losses account for 2000 to 2500 mL/day, giving a 24-hour fluid requirement of 30 to 35 mL/kg to maintain normal fluid balance.</description></item><item><title>sepsis and shock</title><link>https://www.physician.tw/sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sepsis-and-shock/</guid><description>sepsis and shock [[Definitions-sepsis and shock]] [[Shock]] MANAGEMENT [[Fluids-sepsis and shock]] [[Pressors inotropes-sepsis and shock]] [[Targets-sepsis and shock]] [[Antibiotics-sepsis and shock]] [[Steroids-sepsis and shock]] [[Early Goal-Directed Therapy (EGDT)]] Backlinkï¼š [[Adrenal insufficiency and critical illness]] [[Antibiotics-sepsis and shock]] [[Definitions-sepsis and shock]] [[Fluids-sepsis and shock]] [[ICU]] [[Pressors inotropes-sepsis and shock]] [[pulmonology]] [[Steroids-sepsis and shock]] [[Targets-sepsis and shock]]</description></item><item><title>Sequential management of bacterial meningitis</title><link>https://www.physician.tw/Sequential-management-of-bacterial-meningitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sequential-management-of-bacterial-meningitis/</guid><description>Sequential management of bacterial meningitis Blood cx, initiate empiric antibiotics, consider corticosteroids (vide infra) CT head if indicated (see below) LP ASAP (if not contraindicated); yield of CSF cx unlikely to be changed if obtained w/in ~4 h of initiation of abx Diagnostic studies (NEJM 2017;388:3036) Blood cultures Ã—2 before abx WBC count: &amp;gt;10,000 in &amp;gt;90% of bacterial meningitis in healthy hosts Head CT to r/o mass effect before LP if â‰¥1 high-risk feature: immunosupp.</description></item><item><title>Serologic and virologic tests</title><link>https://www.physician.tw/Serologic-and-virologic-tests/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serologic-and-virologic-tests/</guid><description>Serologic and virologic tests Precore mutant: HBeAg not made, but anti-HBe can develop due to x-reactivity w/ HBcAg; a/w â†‘ HBV DNA HBsAg: appears before sx; used to screen blood donors; persists &amp;gt;6 mo = chronic HBV</description></item><item><title>Serum parathyroid hormone PTH concentrations in hypercalcemia and hypocalcemia</title><link>https://www.physician.tw/Serum-parathyroid-hormone-PTH-concentrations-in-hypercalcemia-and-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-parathyroid-hormone-PTH-concentrations-in-hypercalcemia-and-hypocalcemia/</guid><description>Serum parathyroid hormone (PTH) concentrations in hypercalcemia and hypocalcemia â­Serum parathyroid hormone (PTH) concentrations in hypercalcemia and hypocalcemia â­ iPTH æ¿ƒåº¦æ ¹æ“šä¸åŒç–¾ç—…ç‹€æ…‹ä¸‹çš„è¡€æ¸…ç¸½éˆ£æ¿ƒåº¦ã€‚ æ­£å¸¸ç¯„åœé¡¯ç¤ºåœ¨ç™½æ¡†ä¸­ã€‚ S å½¢æ›²ç·šï¼ˆç¶ è‰²æ˜Ÿå½¢ï¼‰æºè‡ªå° 38 åæ­£å¸¸å—è©¦è€…é€²è¡Œçš„æª¸æª¬é…¸éˆ£è¼¸æ³¨æ–¹æ¡ˆã€‚ è¡€æ¸… PTH å’Œéˆ£å€¼åœ¨ç”²ç‹€æ—è…ºåŠŸèƒ½æ¸›é€€ç—‡ï¼ˆè—è‰²ç©ºå¿ƒæ¡†ï¼‰ä¸­è¼ƒä½ï¼Œåœ¨åŸç™¼æ€§ç”²ç‹€æ—è…ºåŠŸèƒ½äº¢é€²ç—‡ï¼ˆè—è‰²æ–¹å¡Šï¼‰ä¸­è¼ƒé«˜ã€‚ éPTHå¼•èµ·çš„æƒ¡æ€§è…«ç˜¤é«˜éˆ£è¡€ç—‡æ‚£è€…è¡€æ¸…éˆ£æ¿ƒåº¦é«˜ï¼Œè¡€æ¸…PTHé©ç•¶ä½ï¼ˆç´…è‰²åœ“åœˆï¼‰ã€‚</description></item><item><title>Serum-ascites albumin gradient SAAG</title><link>https://www.physician.tw/Serum-ascites-albumin-gradient-SAAG/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Serum-ascites-albumin-gradient-SAAG/</guid><description>Serum-ascites albumin gradient (SAAG) serum alb (g/dL) â€“ ascites alb (g/dL)
SAAG â‰¥1.1 diagnoses portal HTN with ~97% accuracy Ann Intern Med 1992;117:215</description></item><item><title>Severity of Asthma Exacerbation</title><link>https://www.physician.tw/Severity-of-Asthma-Exacerbation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severity-of-Asthma-Exacerbation/</guid><description>Severity of Asthma Exacerbation Mild-Moderate Talks in phrases RR &amp;gt;20, HR 100-120, Room air Sa02 90-95%
50% predicted or best 02, SABA 4-10 puffs q20min, prednisone</description></item><item><title>Severity-acute pancreatitis</title><link>https://www.physician.tw/Severity-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Severity-acute-pancreatitis/</guid><description>Severity-acute pancreatitis (Gut 2013;62:102; Gastro 2018;154:1096)
Severity defined by presence of organ failure (AKI, resp failure, GIB, shock) &amp;amp; local or systemic complic.</description></item><item><title>sexually transmitted infections</title><link>https://www.physician.tw/sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sexually-transmitted-infections/</guid><description>sexually transmitted infections [[Risk Factors and Screening]] (MMWR 2021;70:1) [[Genital Lesions]] (MMWR 2021; 70:1) [[Genital Discharge]] [[Diagnosis-sexually transmitted infections]] [[Treatment-sexually transmitted infections]]</description></item><item><title>SGLT2i</title><link>https://www.physician.tw/SGLT2i/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2i/</guid><description>SGLT2i ~25% â†“ death or HF hospitalization in NYHA IIâ€“IV (DAPA-HF, NEJM 2019; 381:1995, EMPEROR-Reduced; NEJM 2020;383:1413).</description></item><item><title>SGLT2i in chronic kidney disease</title><link>https://www.physician.tw/SGLT2i-in-chronic-kidney-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SGLT2i-in-chronic-kidney-disease/</guid><description>SGLT2i in chronic kidney disease in proteinuric CKD (min eGFR 25-30) w/ or w/o DM, transient â†“ in eGFR (&amp;lt;5) but then 30-40% â†“ risk of CKD progression &amp;amp; â†“ mortality (NEJM 2019;380:2295 &amp;amp; 2020;383:1436)</description></item><item><title>Shock</title><link>https://www.physician.tw/Shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Shock/</guid><description>Shock è¢«å®šç¾©ç‚ºç”±æ–¼æ°§æ°£éé€æˆ–èƒå–å¤±èª¿è€Œå°è‡´æœ«ç«¯æå‚·å°è‡´çµ„ç¹”ç¼ºæ°§çš„ç‹€æ…‹ã€‚è‡¨åºŠè¡¨ç¾åŒ…æ‹¬ï¼š æ³¨æ„ï¼Œä¸æ˜¯è¡€å£“ä½å°±æ˜¯shockä¸æ˜¯è¡€å£“ä½å°±æ˜¯shock
SHOCKçš„å…¬å¼ï¼š #anki SHOCK å°±æ˜¯æŒ‡DO2ä¸å¤ªè¡Œç”¢ç”Ÿend organ damamges
DO2 = (HR Ã— SV) Ã— CaO2 æ‰€ä»¥shockçš„éƒ¨åˆ†ï¼ŒåŒ…å«å…©å€‹å±¤é¢ï¼šè¡€å£“è·Ÿè¡€æ°§ CaO2 = (Hb Ã— 1.</description></item><item><title>Short-Term Central Venous Catheter-Related Bloodstream Infxns</title><link>https://www.physician.tw/Short-Term-Central-Venous-Catheter-Related-Bloodstream-Infxns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Short-Term-Central-Venous-Catheter-Related-Bloodstream-Infxns/</guid><description>Short-Term Central Venous Catheter-Related Bloodstream Infxns S. aureus Risk of endocarditis in bacteremia: ~25% (JACC 1997;30:1072). ID consult a/w â†“ mortality (ClD 2015;60:1451).</description></item><item><title>SIADH</title><link>https://www.physician.tw/SIADH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SIADH/</guid><description>SIADH (euvolemia or mild hypervolemia, typically inapprop Uosm &amp;gt;100, UNa &amp;gt;20 mEq/L ) Malignancy: lung (SCLC), brain, GI, GU, lymphoma, leukemia, thymoma, mesothelioma Pulmonary: pneumonia, TB, aspergillosis, asthma, COPD, PTX, mechanical ventilation Intracranial: trauma, stroke, SAH, seizure, infxn, hydrocephalus, Guillain-BarrÃ© Drugs: antipsychotics, antidepress.</description></item><item><title>Sickle cell anemia</title><link>https://www.physician.tw/Sickle-cell-anemia-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sickle-cell-anemia-/</guid><description>Sickle cell anemia (NEJM 2017;376:1561 &amp;amp; Lancet 2017;390:311)
Recessive Î²-globin mutation â†’ structurally abnl hemoglobin (HbS). ~8% African Americans heterozygotes (â€œsickle traitâ€; usually w/o sx); ~1/400 homozygotes (sickle cell disease).</description></item><item><title>Sideroblastic anemia</title><link>https://www.physician.tw/Sideroblastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sideroblastic-anemia/</guid><description>Sideroblastic anemia Defective heme biosynthesis within RBC precursors
Etiologies: hereditary/X-linked (ALAS2 mutations), idiopathic, MDS-RARS, reversible (alcohol, lead, isoniazid, chloramphenicol, copper deficiency, hypothermia)</description></item><item><title>Signs and Symptoms of Uremia -chronic kidney disease CKD</title><link>https://www.physician.tw/Signs-and-Symptoms-of-Uremia-chronic-kidney-disease-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Signs-and-Symptoms-of-Uremia-chronic-kidney-disease-CKD/</guid><description>Signs and Symptoms of Uremia -chronic kidney disease (CKD) (NEJM 2018;379:669)
General Nausea, anorexia, malaise, uremic fetor, metallic taste, hypothermia</description></item><item><title>Sinus bradycardia</title><link>https://www.physician.tw/Sinus-bradycardia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinus-bradycardia/</guid><description>Sinus bradycardia (SB, &amp;lt;50â€“60 bpm) (NEJM 2000;342:703, Circ 2019;140:e382)
Etiologies: meds (incl Î²B, CCB, amio, Li, dig), â†‘ vagal tone (incl.</description></item><item><title>Sinusoidal obstruction syndrome SOS</title><link>https://www.physician.tw/Sinusoidal-obstruction-syndrome-SOS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sinusoidal-obstruction-syndrome-SOS/</guid><description>Sinusoidal obstruction syndrome (SOS) (Bone Marrow Transplant 2020:55:485)
Occlusion of hepatic venules &amp;amp; sinusoids (formerly veno-occlusive disease) 2/2 toxic insult</description></item><item><title>skin and soft tissue infections</title><link>https://www.physician.tw/skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/skin-and-soft-tissue-infections/</guid><description>skin and soft tissue infections [[Definitions-skin and soft tissue infections]] Risk Factors
Trauma, edema, preceding skin inflammation or infection, obesity, DM, other immunosupp.</description></item><item><title>sodium and water homeostasis</title><link>https://www.physician.tw/sodium-and-water-homeostasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sodium-and-water-homeostasis/</guid><description>sodium and water homeostasis [[overview-sodium and water homeostasis]] [[hyponatremia]] [[hypernatremia]] [[polyuria]]</description></item><item><title>solitary pulmonary nodule</title><link>https://www.physician.tw/solitary-pulmonary-nodule/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/solitary-pulmonary-nodule/</guid><description>solitary pulmonary nodule [[Principles-solitary pulmonary nodule]] [[Etiologies-solitary pulmonary nodule]] [[Initial evaluation-solitary pulmonary nodule]] [[Diagnostic studies of solitary pulmonary nodule]] [[Management-solitary pulmonary nodule]]</description></item><item><title>sorafenib</title><link>https://www.physician.tw/sorafenib/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/sorafenib/</guid><description>sorafenib inhib RAS and B-Raf
è…«ç˜¤ç”Ÿé•·éˆ RAS-&amp;gt;B-RAF-MEK-MAPK-Nuclear Transcription-Tumor cell prolifertaion</description></item><item><title>Sotalol</title><link>https://www.physician.tw/Sotalol/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sotalol/</guid><description>Sotalol n/a 80-160 mg bid check for HR, 1 QT; renal adj %
Backlink: [[Antiarrhythmic Drugs (AAD) for AF]]</description></item><item><title>Specialized Diagnostic Tests in Thyroid Disorders</title><link>https://www.physician.tw/Specialized-Diagnostic-Tests-in-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Specialized-Diagnostic-Tests-in-Thyroid-Disorders/</guid><description>Specialized Diagnostic Tests in Thyroid Disorders Total T4 Total serum concentrations (âˆ´ influenced by TBG). Checked if concern that TSH and free T4 are not accurate.</description></item><item><title>Specific gravity of Urine Dipstick</title><link>https://www.physician.tw/Specific-gravity-of-Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Specific-gravity-of-Urine-Dipstick/</guid><description>Specific gravity of Urine Dipstick æ­£å¸¸å€¼ï¼š300-1000 mOsm/kg H2O
Estimate Uosm: each 0.001 above 1 â‰ˆ 30 osm (SG 1.</description></item><item><title>Splenic vein thrombosis</title><link>https://www.physician.tw/Splenic-vein-thrombosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Splenic-vein-thrombosis/</guid><description>Splenic vein thrombosis Can occur 2/2 local inflam. (eg, panc.). Can p/w isol. gastric varices. Splenectomy curative.</description></item><item><title>Spontaneous bacterial peritonitis</title><link>https://www.physician.tw/Spontaneous-bacterial-peritonitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spontaneous-bacterial-peritonitis/</guid><description>Spontaneous bacterial peritonitis (SBP; see â€œAscitesâ€; Hepatology 2021;74:1014)
High mortality rate; risk factors include ascitic TP &amp;lt;1 g/dL, hx of SBP, current GIB</description></item><item><title>Spontaneous bacterial peritonitis SBP</title><link>https://www.physician.tw/Spontaneous-bacterial-peritonitis-SBP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spontaneous-bacterial-peritonitis-SBP/</guid><description>[[Spontaneous bacterial peritonitis]] (SBP) gut bacterial translocation to ascites. In cirrhosis, â†“ ascites opsonins (esp. if â†“AFTP) â†‘ risk of infxn.</description></item><item><title>Spot urine</title><link>https://www.physician.tw/Spot-urine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Spot-urine/</guid><description>Spot urine protein (mg/dL)/creatinine (mg/dL) â‰ˆ g/d of proteinuria (NEJM 1983;309:1543) unlike urine dipstick, will accurately measure myeloma light chains</description></item><item><title>ST-depression</title><link>https://www.physician.tw/ST-depression/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ST-depression/</guid><description>ST-depression Myocardial ischemia (Â± Tw abnl)
Acute true posterior MI: posterior STE appearing as anterior STD (Â± â†‘ R wave) in V1â€“V3 âœ“ posterior ECG leads; manage as a STEMI with rapid reperfusion (see â€œACSâ€)</description></item><item><title>ST-elevation</title><link>https://www.physician.tw/ST-elevation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ST-elevation/</guid><description>ST-elevation Acute MI: upward convexity STE (ie, a â€œfrownâ€) Â± TWI (or prior MI w/ persistent STE)
Coronary spasm: Prinzmetalâ€™s angina; transient STE in a coronary distribution</description></item><item><title>stable ischemic heart disease</title><link>https://www.physician.tw/stable-ischemic-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stable-ischemic-heart-disease/</guid><description>stable ischemic heart disease Definition SIHD refers to asx and stably sx Pts as well as low-risk new-onset chest pain felt to be due to IHD, and excludes Pts w/ rapidly progressive sx or rest sx (ie, ACS)</description></item><item><title>Stages of CKD</title><link>https://www.physician.tw/Stages-of-CKD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stages-of-CKD/</guid><description>Stages of CKD (Kid Int 2013;3[Suppl]:5)
GFR Stage GFR mL/min/1.73 m2 : Goals
1 (nl or â†‘ GFR) &amp;gt;90 Dx/Rx of underlying condition &amp;amp; comorbidities, slow progression; cardiovascular risk reduction</description></item><item><title>Staging and prognosis-chronic obstructive pulmonary disease</title><link>https://www.physician.tw/Staging-and-prognosis-chronic-obstructive-pulmonary-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-and-prognosis-chronic-obstructive-pulmonary-disease/</guid><description>Staging and prognosis-chronic obstructive pulmonary disease Assess breathlessness, cough, sputum, exercise capacity &amp;amp; energy (tools such as CAT and mMRC may be used as part of assessment) Ratio of diam PA/aorta &amp;gt;1 associated with ~3Ã— â†‘ risk of exacerbations (NEJM 2012;367:913) FEV1 stages: I = â‰¥80%; II = 50â€“79% (~11% 3-y mort.</description></item><item><title>Staging of breast cancer</title><link>https://www.physician.tw/Staging-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-of-breast-cancer/</guid><description>Staging of breast cancer Anatomic: tumor size, chest wall invasion, axillary LN mets (strongest prognostic factor) Histopathologic: type (little prognostic relevance) &amp;amp; grade; lymphatic/vascular invasion In situ carcinoma: no invasion of surrounding stroma Ductal (DCIS): â†‘ risk of invasive cancer in ipsilateral breast (~30%/10 y) Lobular (LCIS): benign entity; marker of â†‘ risk of inv.</description></item><item><title>Staging of lung cancer</title><link>https://www.physician.tw/Staging-of-lung-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Staging-of-lung-cancer/</guid><description>Staging of lung cancer based on tumor size and extent of invasion (T), regional LN involvement [N: N0 (none), N1 (ipsilat.</description></item><item><title>Standard workup-hypertension</title><link>https://www.physician.tw/Standard-workup-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Standard-workup-hypertension/</guid><description>Standard workup-hypertension Goals: (1) identify CV risk factors; (2) consider 2Â° causes; (3) assess for target-organ damage History: CAD, HF, TIA/CVA, PAD, DM, renal insufficiency, sleep apnea, preeclampsia; âŠ• FHx for HTN; diet, Na intake, smoking, alcohol, prescription and OTC meds, OCP Physical exam: âœ“ BP in both arms; funduscopic exam, BMI, cardiac (LVH, murmurs), vascular (bruits, radial-femoral delay), abdominal (masses or bruits), neuro exam Testing: K, BUN, Cr, Ca, glc, Hct, U/A, lipids, TSH, urinary albumin:creatinine (if â†‘ Cr, DM, peripheral edema), ?</description></item><item><title>STEMI</title><link>https://www.physician.tw/STEMI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/STEMI/</guid><description>STEMI Requisite STE (at J point) â‰¥2 contiguous leads w/ â‰¥1 mm (except for V2â€“V3: â‰¥2 mm in â™‚ and â‰¥1.</description></item><item><title>Stepwise Evaluation of a Patient with Delirium</title><link>https://www.physician.tw/Stepwise-Evaluation-of-a-Patient-with-Delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stepwise-Evaluation-of-a-Patient-with-Delirium/</guid><description>Stepwise Evaluation of a Patient with Delirium from Harrison&amp;rsquo;s Principles of Internal Medicine, 21e
Initial Evaluation History with special attention to medications (including over-the-counter and herbals) General physical examination and neurologic examination Complete blood count Electrolyte panel including calcium, magnesium, phosphorus Liver function tests, including albumin Renal function tests First-Tier Further Evaluation Guided by Initial Evaluation Systemic infection screen - Urinalysis and culture - Chest radiograph - Blood cultures Electrocardiogram Arterial blood gas Serum and/or urine toxicology screen (perform earlier in young persons) Brain imaging with MRI with diffusion and gadolinium (preferred) or CT Suspected CNS infection or other inflammatory disorder: [[lumbar puncture after brain imaging]] Suspected seizure-related etiology: electroencephalogram (EEG) (if high suspicion, should be performed immediately)</description></item><item><title>Steroids-sepsis and shock</title><link>https://www.physician.tw/Steroids-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Steroids-sepsis-and-shock/</guid><description>Steroids-sepsis and shock Steroids (Crit Care Med 2018;46:1411)
Hydrocortisone 50 mg IV q6 + fludrocortisone 50 Âµg via NGT daily in septic shock â†“ duration of shock and may â†“ mortality (NEJM 2018; 378:797 &amp;amp; 809)</description></item><item><title>Stress testing</title><link>https://www.physician.tw/Stress-testing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Stress-testing/</guid><description>Stress testing Indications: evaluate possible CAD sx or âˆ† in clinical status in Pt w/ known CAD, risk stratify after chest pain, evaluate exercise tolerance, localize ischemia (imaging required)</description></item><item><title>stroke</title><link>https://www.physician.tw/stroke/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/stroke/</guid><description>stroke æ€¥æ€§ä¸­é¢¨åˆ†ç‚ºå…©ç¨®ï¼š ç¼ºè¡€æ€§ï¼ˆç´„ 85% çš„ç—…ä¾‹ï¼‰ å‡ºè¡€æ€§ï¼ˆç´„ 15% çš„ç—…ä¾‹ï¼‰</description></item><item><title>Structural dysphagia</title><link>https://www.physician.tw/Structural-dysphagia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Structural-dysphagia/</guid><description>Structural dysphagia (solids &amp;gt;liquids; JAMA 2015;313:18; Gastro 2018;155:1022)
Oropharyngeal [[Zenkerâ€™s divertic]]. (pharyngeal pouch): in elderly, a/w aspir., dx w/ video fluoro, Rx endo/surg Malignancy; proximal strictures/rings/webs; infection; radiation injury; goiter; osteophytes Esophageal Rings (intermittent dysphagia, concentric obstructing tissue, Schatzki ring): near GE jxn, a/w food impaction, linked to GERD; Rx w/ PPI, dilation Webs: thin, partially occlusive structure, proximal, a/w Fe defic.</description></item><item><title>Subclinical hypothyroidism</title><link>https://www.physician.tw/Subclinical-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Subclinical-hypothyroidism/</guid><description>Subclinical hypothyroidism Mild â†‘ TSH and normal free T4 with only subtle or no sx If TSH &amp;lt;7 or âŠ– anti-TPO Ab, ~Â½ resolve after 2 y (JCEM 2012;97:1962) if â†‘ titers of antithyroid Abs, progression to overt hypothyroidism is ~4%/y No clear benefit to Rx (NEJM 2017;376:2534).</description></item><item><title>supraventricular tachycardias SVTS</title><link>https://www.physician.tw/supraventricular-tachycardias-SVTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/supraventricular-tachycardias-SVTS/</guid><description>supraventricular tachycardias (SVTS) Arise above the ventricles, âˆ´ narrow QRS unless aberrant conduction or pre-excitation. [[Common Etiologies of SVT]] [[Diagnosis of SVT Type]] [[Treatment of SVT]]</description></item><item><title>surgery and radiation for local control of breast cancer</title><link>https://www.physician.tw/surgery-and-radiation-for-local-control-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgery-and-radiation-for-local-control-of-breast-cancer/</guid><description>surgery and radiation for local control of breast cancer Intervention Indication Breast conserving Stage Iâ€“II, lumpectomy + sentinel lymph node biopsy* + RT Modified radical mastectomy Large tumor relative to breast, multicentric dis.</description></item><item><title>Surgery of inflammatory bowel disease</title><link>https://www.physician.tw/Surgery-of-inflammatory-bowel-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Surgery-of-inflammatory-bowel-disease/</guid><description>Surgery of inflammatory bowel disease UC: colectomy if sx refractory to or intolerable side effects from meds, CRC, perforation, toxic megacolon, uncontrolled hemorrhage.</description></item><item><title>surgical critical care</title><link>https://www.physician.tw/surgical-critical-care/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-critical-care/</guid><description>surgical critical care 33 gastrointestinal bleeding 34 Acute Abdomen and Abdominal Sepsis 35 Abdominal Compartment Syndrome 36 Acute Mesenteric Ischemia 37 Surgical Trauma 38 Burns 39 Acute Hepatic Failure 40 Abdominal Organ Transplantation 41 Obstetric Emergencies</description></item><item><title>surgical issues</title><link>https://www.physician.tw/surgical-issues/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/surgical-issues/</guid><description>surgical issues [[orthopaedic]]</description></item><item><title>SVC syndrome</title><link>https://www.physician.tw/SVC-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/SVC-syndrome/</guid><description>SVC syndrome (NEJM 2007;356:1862): central tumor â†’ SVC compression â†’ face/arm swelling (&amp;gt;80%), neck/chest vein distention (~60%), SOB/cough (~50%), HA (~10%); Rx = steroids, diuretics, RT Â± chemo, SVC stent if severe sx, anticoag if clot</description></item><item><title>Sx of Hemochromatosis</title><link>https://www.physician.tw/Sx-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Sx-of-Hemochromatosis/</guid><description>Sx of Hemochromatosis fatigue &amp;amp; arthralgias, loss of libido in â™‚. In advanced disease (rare): bronze skin (melanin + iron), hypogonadism (esp.</description></item><item><title>symptom to diagnosis of dyspnea</title><link>https://www.physician.tw/symptom-to-diagnosis-of-dyspnea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptom-to-diagnosis-of-dyspnea/</guid><description>symptom to diagnosis of dyspnea Four most common Heart failure Pneumonia Obstructive lung disease (chronic obstructive pulmonary disease/asthma) Pulmonary embolism Immediate threat to life (ACT ASAP) (å¤§æ¦‚å°±æ˜¯5T) Arrhythmia Coronary syndrome, Acute Tamponade Airway obstruction Stenosis, Aortic Anaphylaxis Pneumothorax [[Differential Diagnosis of Dyspnea]]</description></item><item><title>Symptoms-ascites</title><link>https://www.physician.tw/Symptoms-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Symptoms-ascites/</guid><description>Symptoms-ascites â†‘ abd girth, wt gain, new abd hernia, abd pain, dyspnea, nausea, early satiety</description></item><item><title>syncope</title><link>https://www.physician.tw/syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/syncope/</guid><description>syncope [[Definition-syncope]] [[Etiologies-syncope]] [[Workup-syncope]] [[Other diagnostic studies-syncope]] [[Approach to syncope-syncope]] [[High-risk features-syncope]] [[Treatment-syncope]] [[Prognosis-syncope]]</description></item><item><title>Synthesis and Metabolism of Vitamin D</title><link>https://www.physician.tw/Synthesis-and-Metabolism-of-Vitamin-D/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Synthesis-and-Metabolism-of-Vitamin-D/</guid><description>Synthesis and Metabolism of Vitamin D ç¶­ç”Ÿç´  D æœ€åˆæ˜¯åœ¨çš®è†šä¸­é€šéç¶­ç”Ÿç´  D3 åˆ°ç¶­ç”Ÿç´  D3 çš„éé…¶è½‰åŒ–ç”¢ç”Ÿçš„ã€‚ ç¶­ç”Ÿç´  D çš„è†³é£Ÿæ”å…¥é‡é€šå¸¸ç›¸å°æœ‰é™ï¼Œå› ç‚ºé™¤æŸäº›é­šé¡å¤–ï¼Œå¾ˆå°‘æœ‰é£Ÿç‰©å«æœ‰å¤§é‡ï¼›è£œå……åŠ‘æ˜¯å¸¸ç”¨çš„ã€‚ ç¶­ç”Ÿç´  D è¦ä¹ˆå„²å­˜åœ¨è„‚è‚ªçµ„ç¹”ä¸­ï¼Œè¦ä¹ˆé€šé 25-ç¾¥åŒ–é…¶åœ¨è‚è‡Ÿä¸­è½‰åŒ–ç‚º 25-ç¾¥åŸºç¶­ç”Ÿç´  D3 (25[OH]D3)ï¼Œé€™ç¨®å½¢å¼ä»¥æœ€é«˜æ¿ƒåº¦å¾ªç’°ä¸¦åæ˜ é™½å…‰å’Œé£²é£Ÿæš´éœ²ã€‚ å®ƒåœ¨è…è‡Ÿä¸­è½‰åŒ–ç‚ºæ´»æ€§ä»£è¬ç‰© 25-äºŒç¾¥åŸºç¶­ç”Ÿç´  D (25[OH]2D) æˆ–éª¨åŒ–ä¸‰é†‡ï¼Œå„˜ç®¡å…¶ä»–çµ„ç¹”å…·æœ‰ 1Î±-ç¾¥åŒ–é…¶é…¶æ´»æ€§ã€‚ éª¨åŒ–ä¸‰é†‡çš„åˆæˆé€šéå¢åŠ ç”²ç‹€æ—è…ºæ¿€ç´  (PTH) çš„æ°´å¹³ä¾†å¢å¼· (+)ï¼Œç”²ç‹€æ—è…ºç´  (PTH) æœƒéš¨è‘—è¡€æ¸…éˆ£æ°´å¹³çš„é™ä½è€Œå‡é«˜ã€‚ è¡€æ¸…ç£·é…¸é¹½æ°´å¹³é™ä½ä¹Ÿå¯ä»¥å¢åŠ ï¼ˆ+ï¼‰éª¨åŒ–ä¸‰é†‡çš„ç”¢ç”Ÿã€‚ å®ƒçš„åˆæˆè¢«æˆçº–ç¶­ç´°èƒç”Ÿé•·å› å­ 23 (FGF-23) çš„ç”¢ç”ŸæŠ‘åˆ¶ (-)ï¼Œè©²å› å­ç”±éª¨åŸºè³ªä¸­çš„éª¨ç´°èƒåˆ†æ³Œã€‚ éª¨åŒ–ä¸‰é†‡æŠ‘åˆ¶ 1Î±-ç¾¥åŒ–é…¶ (CYP27B1) çš„æ´»æ€§ä¸¦åˆºæ¿€ 24-ç¾¥åŒ–é…¶ (CYP24R1) çš„æ´»æ€§ï¼Œè©²é…¶å¯ä¿ƒé€² 25(OH)2D çš„ç”¢ç”Ÿï¼Œé€™æ˜¯ä¸€ç¨®éç”Ÿç‰©æ´»æ€§çš„ç¶­ç”Ÿç´  D ç”¢å“ã€‚ åœ¨ CYP2R CYP27B å’Œ CYP24R ä¸­ï¼ŒCYP è¡¨ç¤ºç´°èƒè‰²ç´  Pã€‚ KEY: é™½å…‰åœ¨çš®è†šç”ŸæˆD3 è‚åŠ 25ã€è…åŠ 1</description></item><item><title>systematic-Treatment</title><link>https://www.physician.tw/systematic-Treatment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systematic-Treatment/</guid><description>systematic-Treatment The poor risk model used in the global ARCC trial to direct treatment with temsirolimus included at least 3 of the following 6 predictors of short survival:</description></item><item><title>Systemic diseases with secondary glomerular involvement</title><link>https://www.physician.tw/Systemic-diseases-with-secondary-glomerular-involvement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-diseases-with-secondary-glomerular-involvement/</guid><description>Systemic diseases with secondary glomerular involvement [[diabetes mellitus]] (CJASN 2017;12:2032): nodular glomerulosclerosis ([[Kimmelstiel-Wilson]] lesion); glomerular hyperfiltration â†’ microalbuminuria â†’ dipstick âŠ• â†’ nephrotic range (10â€“15 y).</description></item><item><title>systemic therapy of breast cancer</title><link>https://www.physician.tw/systemic-therapy-of-breast-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/systemic-therapy-of-breast-cancer/</guid><description>systemic therapy of breast cancer [[ER PR]] [[PIK3CA]] [[HER2]] treatment Stage Iâ€“III (above) Chemo
Neoadjuvant: to conserve breast &amp;amp; evaluate Rx efficacy, equivalent OS as adjuvant (JCO 2008;26:778) Adjuvant: use anthracycline Â± taxane.</description></item><item><title>Systemic thrombolysis</title><link>https://www.physician.tw/Systemic-thrombolysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Systemic-thrombolysis/</guid><description>Systemic thrombolysis (EHJ 2020;41:543; Chest 2021;160:e545)
Typically TPA 100 mg over 2h or wt-adjusted TNK bolus; risk of ICH ~2-5%, â†‘ w/ age</description></item><item><title>T-wave-inversion</title><link>https://www.physician.tw/T-wave-inversion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/T-wave-inversion/</guid><description>T-wave-inversion Ischemia or infarct; Wellensâ€™ sign (deep, symm precordial TWI) â†’ critical prox LAD lesion
Myopericarditis; CMP ([[Takotsubo]], ARVC, apical HCM); MVP; PE (espec if TWI V1â€“V4)</description></item><item><title>Tachycardia-bradycardia â€œtachy-bradyâ€ syndrome</title><link>https://www.physician.tw/Tachycardia-bradycardia-tachy-brady-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tachycardia-bradycardia-tachy-brady-syndrome/</guid><description>Tachycardia-bradycardia (â€œtachy-bradyâ€) syndrome (â€œtachy-bradyâ€) syndrome
Features may include: periods of unprovoked SB, SA arrest, paroxysms of SB and atrial tachyarrhythmias, chronotropic incompetence w/ ETT Treatment: meds alone usually fail (adeq.</description></item><item><title>Tailored therapy in cardiogenic shock</title><link>https://www.physician.tw/Tailored-therapy-in-cardiogenic-shock-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tailored-therapy-in-cardiogenic-shock-/</guid><description>Tailored therapy in cardiogenic shock Goals: optimize both MAP and CO while â†“ risk of pulmonary edema MAP = CO Ã— SVR; CO = HR Ã— SV (which depends on preload, afterload, and contractility)</description></item><item><title>TaitaNo5</title><link>https://www.physician.tw/TaitaNo5/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TaitaNo5/</guid><description>TaitaNo5 éˆ‰é›¢å­ 36mEq/L æ°¯é›¢å­ 17 mEq/L é‰€é›¢å­ 18 mEq/L é‚é›¢å­ 3 mEq/L phosphate 12 mM/L acetate 28 mEq/L 10% [[glucose water osmolarity]] æ»²é€å£“ç‚º 669 mOsm/L -&amp;gt; éƒ½æ˜¯ç³–æ°´è²¢ç»çš„ Acetate 28mEq/L é©ç”¨æ–¼ä½ç£·è¡€ç—‡ç—…äººä¹‹ phosphorus è£œå……(éç³–å°¿ç—…äººï¼‰ æŒçºŒæ€§ä¸‹ ç—¢ã€è‚ç‚ã€é…’ç²¾ä¸­æ¯’ ç‡Ÿé¤Šä¸è‰¯æ‚£è€…ä¹‹é«˜ç†±èƒ½åŠé›»è§£è³ªè£œå…… å¤–ç§‘ã€å©¦ç”¢ç§‘æ‰‹è¡“ å‰å¾Œç‡Ÿé¤ŠåŠé›»è§£è³ªä¹‹è£œå……(å°¤å…¶æ˜¯éª¨æŠ˜ç—…äºº)ã€‚ ä¸­å¿ƒéœè„ˆç‡Ÿé¤Šæ³¨å°„ä¹‹åŸºç¤æ¶²ã€‚</description></item><item><title>Takayasuâ€™s arteritis</title><link>https://www.physician.tw/Takayasus-arteritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Takayasus-arteritis/</guid><description>Takayasuâ€™s arteritis TL;DR
Usually Asian females &amp;lt; 40 years old.
&amp;ldquo;Pulseless disease&amp;rdquo; (weak upper extremity pulses), fever, night sweats, arthritis, myalgias, skin nodules, ocular disturbances.</description></item><item><title>Targets-sepsis and shock</title><link>https://www.physician.tw/Targets-sepsis-and-shock/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Targets-sepsis-and-shock/</guid><description>Targets-sepsis and shock Lactate clearance (â‰¥20%/2 h) as effective as ScvO2 to guide resusc. (JAMA 2010;303:739)
Targeting capillary refill time â‰¤3 sec (check q30min) as good if not better than lactate clearance (JAMA 2019;321:654)</description></item><item><title>TAVI</title><link>https://www.physician.tw/TAVI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TAVI/</guid><description>TAVI TAVI (transcatheter AoV implantation) (JAMA 2021;325:2480; Circ 2021;143:e72)
Valves: balloon-expandable or self-expanding. Most commonly deployed retrograde via perc. transfemoral access (best outcomes) Peri- &amp;amp; postprocedural complic.</description></item><item><title>Temporary pacing wires</title><link>https://www.physician.tw/Temporary-pacing-wires/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Temporary-pacing-wires/</guid><description>Temporary pacing wires Consider w/ bradycardia with hemodyn instability or unstable escape rhythm when perm pacer not readily available. Risks: infxn, RV perf, VT, PTX, CHB if existing LBBB.</description></item><item><title>tension pneumocephalus</title><link>https://www.physician.tw/tension-pneumocephalus/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tension-pneumocephalus/</guid><description>tension pneumocephalus Tension pneumocephalus is a neurosurgical emergency that occurs when subdural air causes a mass-effect over the underlying brain parenchyma, often from a ball-valve mechanism causing one-way entry of air into the subdural space 1.</description></item><item><title>Tension-type headache</title><link>https://www.physician.tw/Tension-type-headache/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tension-type-headache/</guid><description>Tension-type headache bilateral, pressure-like pain of mildâ€“mod intensity, not throbbing or aggravated by physical activity. A/w photophobia or phonophobia, not N/V.</description></item><item><title>terms used to describe patients with delirium</title><link>https://www.physician.tw/terms-used-to-describe-patients-with-delirium/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/terms-used-to-describe-patients-with-delirium/</guid><description>terms used to describe patients with delirium encephalopathy acute brain failure acute confusional state postoperative intensive care unit (ICU) psychosis</description></item><item><title>test pandoc</title><link>https://www.physician.tw/demo/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/demo/</guid><description>test pandoc [@alavi2021american] Output [@2022evolution]</description></item><item><title>Test results noninvasive evaluation of CAD</title><link>https://www.physician.tw/noninvasive-evaluation-of-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/noninvasive-evaluation-of-CAD/</guid><description>[[Stress testing]] (J Nucl Cardiol 2016;23:606; EHJ 2020;41:407) [[Exercise-tolerance-test]] (w/ ECG alone) [[Pharmacologic-stress-test]] (nb, requires imaging because ECG not interpretable) [[Imaging-for-stress-test]] [[Test-results-noninvasive evaluation of CAD]] High-risk test results (PPV ~50% for LM or 3VD, âˆ´ consider coronary angio) ECG: ST â†“ â‰¥2 mm or â‰¥1 mm in stage 1 or in â‰¥5 leads or â‰¥5 min in recovery; ST â†‘; VT Physiologic: â†“ or fail to â†‘ BP, &amp;lt;4 METS, angina during exercise, Duke score â‰¤â€“11; â†“ EF Radionuclide: â‰¥1 lg or â‰¥2 mod.</description></item><item><title>Test-results-noninvasive evaluation of CAD</title><link>https://www.physician.tw/Test-results-noninvasive-evaluation-of-CAD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Test-results-noninvasive-evaluation-of-CAD/</guid><description>Test-results-noninvasive evaluation of CAD HR (must achieve â‰¥85% of max pred HR [220-age] for exer. test to be dx), BP response, peak double product (HR Ã— BP; nl &amp;gt;20k), HR recovery (HRpeak â€“ HR1 min later; nl &amp;gt;12)</description></item><item><title>test202207</title><link>https://www.physician.tw/test202207/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/test202207/</guid><description>Test</description></item><item><title>Tests of hepatic function</title><link>https://www.physician.tw/Tests-of-hepatic-function/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tests-of-hepatic-function/</guid><description>Tests of hepatic function Albumin: marker for liver protein synthesis, can help differentiate acute vs. chronic liver failure, may be normal in acute hepatocellular injury (t1/2 ~15â€“18 d)</description></item><item><title>Tests of hepatocellular injury or cholestasis</title><link>https://www.physician.tw/Tests-of-hepatocellular-injury-or-cholestasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tests-of-hepatocellular-injury-or-cholestasis/</guid><description>Tests of hepatocellular injury or cholestasis (J Clin Transl Hepatol 2017;5:394)
Aminotransferases (AST, ALT): intracellular enzymes released 2Â° necrosis/inflammation ALT more specific for liver than is AST (heart, skeletal muscle, kidney, brain, RBC/WBC)</description></item><item><title>Thalassemias</title><link>https://www.physician.tw/Thalassemias/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thalassemias/</guid><description>Thalassemias (Lancet 2018;391:155)
â†“ synthesis of Î±- or Î²-globin chains of Hb â†’ â‰  subunits â†’ destruction of RBCs and erythroid precursors; âˆ´ anemia from hemolysis and ineffective erythropoiesis</description></item><item><title>The Confusion Assessment Method</title><link>https://www.physician.tw/The-Confusion-Assessment-Method/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Confusion-Assessment-Method/</guid><description>The Confusion Assessment Method (CAM) Diagnostic Algorithm
The diagnosis of delirium requires the presence of
features 1 and 2 and either feature 3 or 4.</description></item><item><title>The Effect of Advances in Lung-Cancer Treatment on Population Mortality</title><link>https://www.physician.tw/The-Effect-of-Advances-in-Lung-Cancer-Treatment-on-Population-Mortality/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/The-Effect-of-Advances-in-Lung-Cancer-Treatment-on-Population-Mortality/</guid><description>The Effect of Advances in Lung-Cancer Treatment on Population Mortality NSCLCçš„æ­£å¸¸æ€§æ¯”è©²äºå‹çš„ç™¼ç”Ÿç‡æ›´å¿«ï¼Œä¸¦ä¸”é€™ç¨®é™ä½èˆ‡éš¨è‘—æ™‚é–“çš„æµé€çš„ç”Ÿå­˜ç‡é¡¯è‘—æé«˜ï¼Œé€™èˆ‡é¶å‘æ²»ç™‚çš„æ‰¹å‡†æ™‚é–“ç›¸å°æ‡‰ã€‚ åœ¨ç”·æ€§ä¸­ï¼Œå¾2013å¹´åˆ°2016å¹´ï¼ŒNSCLCçš„ç™¼ç—…ç‡æ­»äº¡ç‡æ¯å¹´ä¸‹é™6.3ï¼…ï¼Œè€Œå¾2008å¹´åˆ°2016å¹´ï¼Œç™¼ç—…ç‡æ¯å¹´é™ä½3.1ï¼…ã€‚ ç›¸æ‡‰çš„è‚ºç™Œç‰¹ç•°æ€§ç”Ÿå­˜ç‡å¾2001å¹´è¨ºæ–·ç‚ºNSCLCçš„ç”·æ€§çš„26ï¼…æé«˜åˆ°2001å¹´çš„26ï¼…ã€‚ åœ¨2014å¹´è¢«è¨ºæ–·å‡ºçš„äººä¸­ï¼Œæœ‰35ï¼…çš„äººåœ¨æ‰€æœ‰ç¨®æ—å’Œç¨®æ—ä¸­éƒ½ç™¼ç¾äº†é€™ç¨®ç”Ÿå­˜çš„æ”¹å–„ã€‚ åœ¨NSCLCå¥³æ€§ä¸­ç™¼ç¾äº†é¡ä¼¼çš„æ¨¡å¼ã€‚ ç›¸æ¯”ä¹‹ä¸‹ï¼ŒSCLCçš„æ­»äº¡ç‡å¹¾ä¹ç”±æ–¼ç™¼ç—…ç‡ä¸‹é™è€Œä¸‹é™ï¼Œç”Ÿå­˜ç‡æ²’æœ‰æé«˜ã€‚ è©²çµæœèˆ‡æˆ‘å€‘æª¢æŸ¥çš„æ™‚é–“ç¯„åœä¸­SCLCçš„æ²»ç™‚é€²å±•æœ‰é™ç›¸é—œã€‚</description></item><item><title>Therapeutic apheresis</title><link>https://www.physician.tw/Therapeutic-apheresis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Therapeutic-apheresis/</guid><description>Therapeutic apheresis Removes plasma large molec wt subst. (eg, cryoglobulinemia, Goodpastureâ€™s, Guillain-BarrÃ©, hyperviscosity syndrome), or cells (eg, leukemia w/ hyperleukocytosis, sx thrombocytosis) from plasma.</description></item><item><title>thereis</title><link>https://www.physician.tw/thereis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thereis/</guid><description>thereis ä¾†è‡ª: [[emergency medicine]]</description></item><item><title>Thiazide diuretics</title><link>https://www.physician.tw/Thiazide-diuretics-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thiazide-diuretics-/</guid><description>Thiazide diuretics (JASN 2017;28:3414)
Drugs: hydrochlorothiazide (HCTZ), chlorothiazide (Diuril), metolazone (Zaroxolyn)
Mech: inhib Na-Cl cotransporter in the distal convoluted tubule (DCT); 5% Na reabsorp</description></item><item><title>this is a book</title><link>https://www.physician.tw/this-is-a-book/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/this-is-a-book/</guid><description/></item><item><title>Thoracentesis</title><link>https://www.physician.tw/Thoracentesis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thoracentesis/</guid><description>Thoracentesis (ideally U/S guided) (NEJM 2006;355:e16) [[indications of thoracentesis]]
[[Diagnostic studies of thoracentesis]]
Complications: PTX (5â€“10%), hemothorax (~1%), re-expansion pulm edema (if &amp;gt;1.</description></item><item><title>three-component friction rub</title><link>https://www.physician.tw/three-component-friction-rub/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/three-component-friction-rub/</guid><description>three-component friction rub âœ¨ å­¸ç¿’é‡é» ğŸ¦ (1) ä¸€ç¨®ç™¼ç”Ÿåœ¨æ”¶ç¸®æœŸçš„ä»»ä½•åœ°æ–¹ï¼Œå„˜ç®¡æœ€å¸¸è¦‹æ–¼æ”¶ç¸®ä¸­æœŸï¼ˆå› æ­¤å°æ‡‰æ–¼å¿ƒå®¤æ”¶ç¸®ï¼‰ï¼› (2) å…©å€‹ç™¼ç”Ÿåœ¨èˆ’å¼µæ—©æœŸå’Œæ™šæœŸï¼ˆå› æ­¤åˆ†åˆ¥å°æ‡‰æ–¼æ—©æœŸå¿ƒå®¤å……ç›ˆå’Œå¿ƒæˆ¿æ”¶ç¸®ï¼‰ã€‚</description></item><item><title>thromboangiitis obliterans</title><link>https://www.physician.tw/thromboangiitis-obliterans/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thromboangiitis-obliterans/</guid><description>thromboangiitis obliterans Buerger disease Heavy tobacco smoking history, males &amp;lt; 40 years old. Intermittent claudication. May lead to gangrene, autoamputation of digits, superficial nodular phlebitis.</description></item><item><title>Thrombocytopenia and Risk of Bleeding</title><link>https://www.physician.tw/Thrombocytopenia-and-Risk-of-Bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombocytopenia-and-Risk-of-Bleeding/</guid><description>Thrombocytopenia and Risk of Bleeding 50,000â€“100,000 Risk with major trauma; can proceed with general surgery
&amp;lt;50,000 Risk with minor trauma or surgery</description></item><item><title>Thromboprophylaxis</title><link>https://www.physician.tw/Thromboprophylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thromboprophylaxis/</guid><description>Thromboprophylaxis Blood Adv 2018;2:3198
Low-risk med; same-day surg &amp;amp; &amp;lt;40 y Early, aggressive ambulation Â± mechanical
Moderate-risk (hosp., â‰¥1 risk factor) or high-risk medical (hosp.</description></item><item><title>Thrombotic microangiopathies</title><link>https://www.physician.tw/Thrombotic-microangiopathies/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thrombotic-microangiopathies/</guid><description>Thrombotic microangiopathies (TMA; NEJM 2014;371:654; Lancet 2017;390:681)
Endothelial injury â†’ plt aggreg. &amp;amp; microvasc. thrombosis â†’ â†“ plt &amp;amp; RBC hemolysis (MAHA)</description></item><item><title>thyroid cancer</title><link>https://www.physician.tw/thyroid-cancer/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thyroid-cancer/</guid><description>thyroid cancer [[Thyroid nodules]] (JAMA 2018;319:914) [[Papillary thyroid cancer]] [[Follicular thyroid cancer]] [[Anaplastic thyroid cancer]] (Endo Metab Clin NA 2019;48:269) [[Medullary thyroid cancer]] (Endo Metab Clin NA 2019;48:285)</description></item><item><title>thyroid disorders</title><link>https://www.physician.tw/thyroid-disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/thyroid-disorders/</guid><description>thyroid disorders [[Common Diagnostic Tests in Thyroid Disorders]] [[Specialized Diagnostic Tests in Thyroid Disorders]] [[hypothyroidism]] [[hyperthyroidism]] [[nonthyroidal illness (sick euthyroid syndrome) ]] [[amiodarone and thyroid disease]] [[thyroid cancer]] [[Washington Manual Thyroid Disorders]] FIGURE 5.</description></item><item><title>Thyroid nodules</title><link>https://www.physician.tw/Thyroid-nodules/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-nodules/</guid><description>Thyroid nodules Prevalence 5â€“10% (50â€“60% if screen with U/S), â™€ &amp;gt; â™‚, ~7â€“15% malignant Screening U/S recommended if FHx of MEN2 or medullary thyroid cancer, personal h/o neck XRT, palpable nodules or multinodular goiter Features a/w â†‘ risk of malig: age &amp;lt;30 y, h/o neck XRT, family history of thyroid cancer U/S features a/w benign dx: cystic nodules, â€œspongiformâ€ sonographic pattern Worrisome findings: hypoechoic, solid, irregular borders, microCa2+, height&amp;gt;width, &amp;gt;20 mm Indications for FNA: &amp;gt;10-mm nodule w/ suspicious features</description></item><item><title>Thyroid storm</title><link>https://www.physician.tw/Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroid-storm/</guid><description>Thyroid storm [[Presentation of Thyroid storm]]: Diagnosis: no universally accepted criteria. Biochemical hyperthyroidism + severe sx, consider additional dx that may explain/contribute to sx.</description></item><item><title>Thyroiditis</title><link>https://www.physician.tw/Thyroiditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Thyroiditis/</guid><description>Thyroiditis Acute: bacterial infection (very rare in U.S. except postsurgical), typically Staph/Strep spp. Subacute: transient thyrotoxicosis â†’ transient hypothyroidism â†’ normal thyroid fxn</description></item><item><title>Ticagrelor</title><link>https://www.physician.tw/Ticagrelor/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ticagrelor/</guid><description>Ticagrelor 180 mg Ã— 1 â†’ 90 mg bid Reversible, but wait 3â€“5 d prior to surg. Antidote being developed (NEJM 2019;380:1825).</description></item><item><title>tick-borne diseases</title><link>https://www.physician.tw/tick-borne-diseases/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tick-borne-diseases/</guid><description>tick-borne diseases</description></item><item><title>timeV</title><link>https://www.physician.tw/timeV/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/timeV/</guid><description>#![[Title 2 test]] #![[title 2 test test]]</description></item><item><title>TIMI Risk Score</title><link>https://www.physician.tw/TIMI-Risk-Score/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/TIMI-Risk-Score/</guid><description>TIMI Risk Score TIMI Score
Calculation of Risk Score Historical Age â‰¥65 y â‰¥3 Risk factors for CAD Known CAD (stenosis â‰¥50%) ASA use in past 7 d Presentation Severe angina (â‰¥2 episodes w/in 24 h) ST deviation â‰¥0.</description></item><item><title>Title 2 test</title><link>https://www.physician.tw/Title-2-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Title-2-test/</guid><description>Title 2 test some content</description></item><item><title>Topiramate</title><link>https://www.physician.tw/Topiramate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Topiramate/</guid><description>Topiramate ä½œç”¨ ç”¨æ–¼æˆäººåŠå…©æ­²ä»¥ä¸Šå…’ç«¥å±€éƒ¨ç™²ç™‡æˆ–ä½µæœ‰ [[Lennox Gastaut Syndrome]] ç—‡å€™ç¾¤ä¹‹ç™²ç™‡åŠåŸç™¼æ€§å…¨èº«æ€§å¼·ç›´é™£æ”£ç™²ç™‡çš„è¼”åŠ©æ²»ç™‚ï¼Œç”¨æ–¼Partial Onset Seizureç—…æ‚£ä¹‹å–®ä¸€è—¥ç‰©æ²»ç™‚ã€é é˜²åé ­ç—›ã€‚
æ³¨æ„äº‹é … ä¸å¯æ“…è‡ªåœè—¥ï¼Œçªç„¶åœè—¥å¯èƒ½æœƒå°è‡´åå½ˆæ€§ç™²ç™‡ä¹‹ç™¼ä½œã€‚ ä¸­ã€é‡åº¦è…åŠŸèƒ½ä¸å…¨çš„ç—…äººéœ€è¦é™ä½åŠ‘é‡ã€‚è‚åŠŸèƒ½ä¸å…¨çš„ç—…äººæ‡‰å°å¿ƒä½¿ç”¨ã€‚ æ˜“ç½¹æ‚£è…çµçŸ³çš„ç—…äººæœç”¨æ­¤è—¥å¯èƒ½æœƒå¢åŠ è…çµçŸ³å½¢æˆçš„å±éšªæ€§ï¼Œå»ºè­°çµ¦èˆ‡è¶³é‡çš„æ°´ä»½ä»¥é™ä½æ­¤å±éšªæ€§ã€‚</description></item><item><title>toxicology</title><link>https://www.physician.tw/toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/toxicology/</guid><description>toxicology [[Acetaminophen-toxicology]] [[Salicylates-toxicology]] [[Opioids-toxicology]] [[Benzodiazepines-toxicology]] [[Calcium channel blockers-toxicology]] [[Beta blockers-toxicology]] [[Digoxin-toxicology]] [[Tricyclic antidepressants-toxicology]] [[Lithium-toxicology]] [[Ethylene glycol-toxicology]] [[Methanol-toxicology]] [[Isopropanol-toxicology]] [[Carbon monoxide-toxicology]] [[Organopho- sphate-toxicology]] [[Cyanide-toxicology]]</description></item><item><title>Transcellular shifts</title><link>https://www.physician.tw/Transcellular-shifts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transcellular-shifts/</guid><description>Transcellular shifts Alkalemia, insulin, catecholamines [[Î²2-agonists]] hypothermia hypokalemic/thyrotoxic periodic paralysis, acute â†‘ [[hematopoiesis]] (megaloblastic anemia Rx w/ B12, AML crisis), [[chloroquine]] overdose: Ba/Cs, antipsychotics (risperidone, quetiapine) theophylline</description></item><item><title>Transcellular shifts-hyperkalemia</title><link>https://www.physician.tw/Transcellular-shifts-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transcellular-shifts-hyperkalemia/</guid><description>Transcellular shifts-hyperkalemia (BMJ 2009;339:1019)
Acidemia, â†“ insulin (DM), cell lysis (tumor, rhabdo, ischemic bowel, hemolysis, transfusions, resorbing hematomas, hyperthermia, rewarming), hyperkalemic periodic paralysis, â†‘ osmolality.</description></item><item><title>Transfusion Complications</title><link>https://www.physician.tw/Transfusion-Complications/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-Complications/</guid><description>Transfusion Complications Noninfectious Risk (per unit) Infectious Risk (per unit) Febrile 1:100 CMV Common Allergic 1:100 Hepatitis B 1:220,000 Delayed hemolytic 1:50â€“75,000 Hepatitis C 1:1,600,000 Acute hemolytic 1:200,000 HIV 1:1,800,000 Febr.</description></item><item><title>Transfusion reactions</title><link>https://www.physician.tw/Transfusion-reactions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-reactions/</guid><description>Transfusion reactions Reason why blood products (unless massive txfusion) run 1 at a time. For all rxns (except minor allergic): stop txfusion; send remaining blood product + fresh blood draw to blood bank.</description></item><item><title>transfusion therapy</title><link>https://www.physician.tw/transfusion-therapy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transfusion-therapy/</guid><description>transfusion therapy [[Blood Products and Indications]] [[Transfusion Complications]] [[Transfusion reactions]]</description></item><item><title>Transfusion-associated circulatory overload</title><link>https://www.physician.tw/Transfusion-associated-circulatory-overload/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transfusion-associated-circulatory-overload/</guid><description>Transfusion-associated circulatory overload : â†‘ volume â†’ pulm. edema, â†‘ BP. Rx: slow transfusion rate, diuretics, O2, Â± nitrates, Â± positive pressure ventilation.</description></item><item><title>transfusion-related acute lung injury</title><link>https://www.physician.tw/transfusion-related-acute-lung-injury/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transfusion-related-acute-lung-injury/</guid><description>transfusion-related acute lung injury : non-cardiogenic pulm. edema due to donor allo-Abs (from multiparous â™€ plasma) binding recipient WBCs, which then aggregate in pulmonary vasculature and release mediators causing â†‘ capillary permeability.</description></item><item><title>Transjugular intrahepatic portosystemic shunt TIPS</title><link>https://www.physician.tw/Transjugular-intrahepatic-portosystemic-shunt-TIPS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transjugular-intrahepatic-portosystemic-shunt-TIPS/</guid><description>Transjugular intrahepatic portosystemic shunt (TIPS) (Gastro 2017;152:157) â†“ ascites in 75%; â†‘ CrCl, â†‘ enceph, survival benefit over LVP remains controversial Contraindic: grade II enceph, CHF or pulm HTN, active infxn or biliary obstruction Complications: bleeding, fistula; stent thrombosis (1-y patency w/ coated stents ~80%); infxn (â€œendotipsitisâ€); new or â†‘ enceph in 20â€“30% (Am J Gastro 2016;111:523), hemolysis Consider for liver transplant if above fail</description></item><item><title>transthoracic echo vs transesophageal echo in-Diagnosis-bacterial endocarditis</title><link>https://www.physician.tw/transthoracic-echo-vs-transesophageal-echo-in-Diagnosis-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/transthoracic-echo-vs-transesophageal-echo-in-Diagnosis-bacterial-endocarditis/</guid><description>transthoracic echo vs transesophageal echo in-Diagnosis-bacterial endocarditis NVE PVE Abscess Transthoracic (TTE) 39â€“58% 33% 18â€“63% Transesophageal (TEE) &amp;gt;90% 86% 76â€“100% (Mayo Clin Proc 2014;89:799; Circ 2015;132:1435; Eur Radiol 2015; 25:2125; J Am Soc Echo 2016;29:315)</description></item><item><title>Transudate vs exudate</title><link>https://www.physician.tw/Transudate-vs-exudate/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transudate-vs-exudate/</guid><description>Transudate vs exudate (JAMA 2014;311:2422)
Lightâ€™s criteria åŸºæœ¬ä¸Šéƒ½æ˜¯è·Ÿåˆ†å­éƒ½æ˜¯pleuralï¼Œåˆ†æ¯éƒ½æ˜¯è¡€ è›‹å¤§æ–¼äº”æˆã€LDHå¤§æ–¼å…­æˆæˆ–2/3
protein/serum protein ratio greater than 0.5 lactate dehydrogenase (LDH)/serum LDH ratio greater than 0.</description></item><item><title>Transudates</title><link>https://www.physician.tw/Transudates/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Transudates/</guid><description>Transudates Congestive heart failure (40%): 80% bilateral, Â± cardiomegaly on CXR occasionally exudative (especially after aggressive diuresis or if chronic) Constrictive pericarditis (knock on exam, calcification or thickening on imaging) Cirrhosis (â€œhepatic hydrothoraxâ€): diaphragmatic pores allow passage of ascitic fluid often right-sided (Â²âˆ•Â³) &amp;amp; massive (even witho marked ascites) Nephrotic syndrome: usually small, bilateral, asymptomatic (r/o PE b/c hypercoag) Other: PE (usually exudate), malignancy (lymphatic obstruction), myxedema, CAPD</description></item><item><title>Treatment acute diarrhea</title><link>https://www.physician.tw/Treatment-acute-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-diarrhea/</guid><description>Treatment acute diarrhea (Am J Gastro 2016;111:602; Clin Infect Dis 2017;65:e45)
If no WS, nl PO intake â†’ supportive: hydrate, loperamide, bismuth subsalicylate (Ã˜ antichol)</description></item><item><title>Treatment and prognosis-Aplastic anemia</title><link>https://www.physician.tw/Treatment-and-prognosis-Aplastic-anemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-and-prognosis-Aplastic-anemia/</guid><description>Treatment and prognosis-Aplastic anemia Immunosuppression (CsA/tacrolimus, ATG): 70â€“80% respond, with 80â€“90% 5-y survival in responders (96% vs. 76% w/ horse vs.</description></item><item><title>Treatment for acute HBV</title><link>https://www.physician.tw/Treatment-for-acute-HBV/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-for-acute-HBV/</guid><description>Treatment for acute HBV [[When to treat chronic HBV with anti-virals]]
[[Entecavir or tenofovir]]
[[hepatitis B virus Rx duration]]</description></item><item><title>Treatment gastroesophageal reflux disease</title><link>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease-/</guid><description>Treatment [[gastroesophageal reflux disease]] (World J Gastrointest Endosc 2018;10:175; Am J Gastro 2022;117:27)
Lifestyle: avoid precipitants, lose weight, no eating 2 hrs before bed, exercise, Ã˜ tobacco</description></item><item><title>treatment gastroesophageal reflux disease</title><link>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-gastroesophageal-reflux-disease/</guid><description>treatment gastroesophageal reflux disease (World J Gastrointest Endosc 2018;10:175; Am J Gastro 2022;117:27)
Lifestyle: avoid precipitants, lose weight, no eating 2 hrs before bed, exercise, Ã˜ tobacco Medical: start low-dose PPI, uptitrate up to 40 mg bid; H2 blockers for intermittent sx Refractory (max dose â‰¥8 wks): confirm w/ pH testing on or off PPI, consider hernia repair If acidic or sx correlate w/ reflux episodes: surgical fundoplication (emerging Rx: LES sphincter augmentation w/ radiofrequency, implantable magnetic or electrical devices) If nl pH or no sx correlation = â€œfxnal dyspepsiaâ€ (Gastro 2020;158:2286); Rx w/ TCA, SSRI</description></item><item><title>Treatment of active tuberculosis</title><link>https://www.physician.tw/Treatment-of-active-tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-active-tuberculosis/</guid><description>Treatment of active tuberculosis (NEJM 2015;373:2149; Lancet 2016;387:1211)
Prior to treatment, consult ID, check LFTs, Cr, HIV &amp;amp; hepatitis A/B/C screen, DM screen, pregnancy screen, vision testing for acuity and color, EtOH use history Treatment requires several drugs to prevent resistance (see below) Suspect MDR TB if prior TB Rx (esp.</description></item><item><title>Treatment of acute advanced heart failure</title><link>https://www.physician.tw/Treatment-of-acute-advanced-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-acute-advanced-heart-failure/</guid><description>Treatment of acute advanced heart failure (Circ 2013;128:e240)
Consider PAC if not resp to Rx, unsure re: vol status, HoTN, hypoperfusion, need inotropes</description></item><item><title>treatment of acute decompensating heart failure</title><link>https://www.physician.tw/treatment-of-acute-decompensating-heart-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-acute-decompensating-heart-failure/</guid><description>treatment of acute decompensating heart failure (NEJM 2017;377:1964)
Assess congestion &amp;amp; adequacy of perfusion
For congestion: â€œLMNOPâ€ Lasix IV; 1â€“2.</description></item><item><title>Treatment of Alchololic-associated hepatitis</title><link>https://www.physician.tw/Treatment-of-Alchololic-associated-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Alchololic-associated-hepatitis/</guid><description>Treatment of Alchololic-associated hepatitis consider if MDF â‰¥32, MELD &amp;gt;18, or presence of encephalopathy
Glucocorticoids (eg, methylprednisolone 32 mg/d or prednisolone 40 mg/d Ã— 4 wk â†’ 4â€“6 wk taper) may â†“ 1-mo but not 6-mo mortality, a/w â†‘ infection (NEJM 2015;372:1619, CD001511)</description></item><item><title>Treatment of Antiphospholipid syndrome</title><link>https://www.physician.tw/Treatment-of-Antiphospholipid-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Antiphospholipid-syndrome/</guid><description>Treatment of Antiphospholipid syndrome UFH/LMWH â†’ warfarin (lifelong for most Pts)
Rivaroxaban inferior to warfarin in triple positive (âŠ• ACL, LA, &amp;amp; Î²2-GP) (Blood 2018;132:1365)</description></item><item><title>Treatment of asymptomatic 1Â° HPT</title><link>https://www.physician.tw/Treatment-of-asymptomatic-1-HPT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-asymptomatic-1-HPT/</guid><description>Treatment of asymptomatic 1Â° HPT Surgery if: age &amp;lt;50 y; serum Ca &amp;gt;1 mg/dL &amp;gt;ULN; CrCl &amp;lt;60 mL/min, DEXA T score &amp;lt;â€“2.</description></item><item><title>Treatment of BehÃ§etâ€™s syndrome</title><link>https://www.physician.tw/Treatment-of-Beh%C3%A7ets-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Beh%C3%A7ets-syndrome/</guid><description>Treatment of BehÃ§etâ€™s syndrome Mucocutaneous: Mild: topical steroids, colchicine (esp. for erythema nodosum), dapsone, apremilast (PDE-4 inhib) for oral ulcers and ?</description></item><item><title>Treatment of Chronic HF with Reduced EF</title><link>https://www.physician.tw/Treatment-of-Chronic-HF-with-Reduced-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Chronic-HF-with-Reduced-EF/</guid><description>Treatment of Chronic HF with Reduced EF (Circ 2017;136:e137; JACC 2021;77:772)
Diuretics | Loop Â± thiazides diuretics (sx relief; no mortality benefit) [[RASi ACEI ARB]] [[Î²-blocker]] [[Aldosterone-antagonists]] [[SGLT2i]] [[Hydralazine&amp;mdash;nitrates]] [[Ivabradine]] (If blocker w/o âŠ– ino) [[Digoxin]] [[Vericiguat]] [[Cardiac-resynch-therapy]] (CRT, qv) [[ICD]] (see â€œCardiac Rhythm Mgmt Devicesâ€) [[Iron-supplementation]] [[Anticoagulation-Treatment of Chronic HF with Reduced EF]] Heart rhythm If AF &amp;amp; NYHA IIâ€“IV w/ EF &amp;lt;35%, catheter ablation â†“ D/HF hosp vs.</description></item><item><title>Treatment of Constipation</title><link>https://www.physician.tw/Treatment-of-Constipation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Constipation/</guid><description>Treatment of Constipation 1st line â†‘ fluid, fiber, exercise; emollient laxative (docusate) to soften stool.
2nd line: Bulk laxatives (psyllium, methylcellulose) to â†‘ colonic residue, â†‘ peristalsis.</description></item><item><title>Treatment of Cryoglobulinemic vasculitis</title><link>https://www.physician.tw/Treatment-of-Cryoglobulinemic-vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Cryoglobulinemic-vasculitis/</guid><description>Treatment of Cryoglobulinemic vasculitis (Blood 2017;129:289; J Inflamm Res 2017;10:49): Rx underlying disorder. Heme malig â†’ chemoradiation; HCV â†’ antivirals; CTD â†’ DMARD/steroids Â± RTX.</description></item><item><title>Treatment of Cushingâ€™s syndrome</title><link>https://www.physician.tw/Treatment-of-Cushings-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Cushings-syndrome/</guid><description>Treatment of Cushingâ€™s syndrome (JCEM 2015;100:2807. J Intern Med 2019;286:526)
Surgical: * resection of pituitary adenoma, adrenal tumor or ectopic ACTH-secreting tumor, or bilateral surgical adrenalectomy if unable to control source of ACTH Medical: [[ketoconazole]] [[metyrapone]] [[osilodrostat]] [[cabergoline]] [[pasireotide]] mitotane to â†“ cortisol, and/or mifepristone to block cortisol action at glucocorticoid receptor frequently used as bridge to surgery or when surgery contraindicated Radiation: can do pituitary XRT, but not effective immediately (takes 6 mo to 2 y) Glucocorticoid replacement therapy Ã— 6â€“36 mo after TSS (lifelong glucocorticoid + mineralocorticoid replacement if medical or surgical adrenalectomy)</description></item><item><title>Treatment of DKA</title><link>https://www.physician.tw/Treatment-of-DKA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-DKA/</guid><description>Treatment of DKA (BMJ 2019;365:1114)
R/o possible precipitants Infection, intra-abdominal process, MI, etc. (see above) Aggressive hydration 1L NS then ~250 cc/hr, tailor to dehydration &amp;amp; CV status Insulin 0.</description></item><item><title>Treatment of Granulomatosis with polyangiitis</title><link>https://www.physician.tw/Treatment-of-Granulomatosis-with-polyangiitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Granulomatosis-with-polyangiitis/</guid><description>Treatment of Granulomatosis with polyangiitis assess severity w/ BVAS/GPA score (Arth Rheum Dis 2009;68:1827) same as [[Microscopic polyangiitis.md]]
Mild disease (no end-organ dysfxn; BVAS 0â€“3): MTX + steroids (Arth Rheum 2012;64:3472)</description></item><item><title>Treatment of Heart failure with preserved EF</title><link>https://www.physician.tw/Treatment-of-Heart-failure-with-preserved-EF/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Heart-failure-with-preserved-EF/</guid><description>Treatment of Heart failure with preserved EF diuresis, Rx HTN, tachycardia, and ischemia
SGLT2i â†“ CV death or HF hosp (NEJM 2021;385:1451; DELIVER)</description></item><item><title>Treatment of Hemochromatosis</title><link>https://www.physician.tw/Treatment-of-Hemochromatosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hemochromatosis/</guid><description>Treatment of Hemochromatosis phlebotomy (250 mL = 1 unit, ~250 mg of Fe) qwk until Fe sat &amp;lt;50% &amp;amp; ferritin 50â€“100 Âµg/L, then q3â€“4mo; PPI â†“ intestinal Fe absorption &amp;amp; may â†“ need for phlebotomy; avoid vit C &amp;amp; uncooked seafood; deferoxamine if phleb.</description></item><item><title>Treatment of HIT</title><link>https://www.physician.tw/Treatment-of-HIT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-HIT/</guid><description>Treatment of HIT (NEJM 2015;373:252; Blood Adv 2018;2:3360)
Discontinue heparin (incl. flushes, LMWH Ppx, heparin lines). Avoid plts (anecdotal link w/ thrombosis); if given warfarin, give vit K to reverse, prevent warfarin skin necrosis.</description></item><item><title>Treatment of Hyperkalemia-hyperkalemia</title><link>https://www.physician.tw/Treatment-of-Hyperkalemia-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hyperkalemia-hyperkalemia/</guid><description>Treatment of Hyperkalemia-hyperkalemia [[Ca gluconate Ca chloride]] 1â€“2 amps IV onset &amp;lt;3 min with Transient effect (30â€“60 min) Stabilizes cell membrane CaCl contains more calcium and is typically reserved for codes (â†‘ risk of tissue necrosis) or via central line</description></item><item><title>Treatment of hypertrophic cardiomyopathy</title><link>https://www.physician.tw/Treatment-of-hypertrophic-cardiomyopathy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-hypertrophic-cardiomyopathy/</guid><description>Treatment of hypertrophic cardiomyopathy (Circ 2020;142:e558; Lancet 2021;398:2102; JACC 2022;79:390)
Heart failure âŠ– inotropes/chronotropes: Î²-blockers (JACC 2021;78:2505), CCB (verapamil), disopyramide</description></item><item><title>Treatment of Hypervolemic hyponatremia</title><link>https://www.physician.tw/Treatment-of-Hypervolemic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hypervolemic-hyponatremia/</guid><description>Treatment of Hypervolemic hyponatremia free water restrict (1st line), diurese w/ loop diuretics (avoid thiazides) &amp;amp; â†‘ EAV (vasodilators to â†‘ CO in CHF, colloid infusion in cirrhosis)</description></item><item><title>Treatment of Hypovolemic hyponatremia</title><link>https://www.physician.tw/Treatment-of-Hypovolemic-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Hypovolemic-hyponatremia/</guid><description>Treatment of Hypovolemic hyponatremia volume repletion with isotonic 0.9% saline at a slow rate. Once volume replete â†’ stimulus for ADH removed (w/ very short ADH tÂ½) â†’ kidneys excrete free H2O â†’ serum Na will correct rapidly (D5W Â± dDAVP if overcorrection)</description></item><item><title>Treatment of latent TB</title><link>https://www.physician.tw/Treatment-of-latent-TB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-latent-TB/</guid><description>Treatment of latent TB If screening test âŠ• and no risk factors, confirm prior to treatment; if âŠ• w/ risk factors, proceed to treatment (CID 2017;64:11).</description></item><item><title>Treatment of LDL-C</title><link>https://www.physician.tw/Treatment-of-LDL-C/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-LDL-C/</guid><description>Treatment of LDL-C Statins: every 1 mmol (39 mg/dL) â†“ LDL-C â†’ 22% â†“ major vascular events (CV death, MI, stroke, revasc) in individuals w/ &amp;amp; w/o CAD (Lancet 2010;376:1670) Ezetimibe: â†“ major vascular events incl MI &amp;amp; stroke when added to statin post-ACS, w/ magnitude of benefit consistent w/ LDL-statin relationship (IMPROVE-IT, NEJM 2015;372:2387) PCSK9 inhibitors: ~60% â†“ LDL-C on top of statin, as monoRx, and in FH (EHJ 2014;35:2249); â†“ CV outcomes (NEJM 2017;376:1713 &amp;amp; 2018;379:2097) In homozygous FH: apheresis; evinacumab (ANGPTL3 inhib) â†“ LDL-C by ~50% (NEJM 2020;383:711)</description></item><item><title>Treatment of Migraine</title><link>https://www.physician.tw/Treatment-of-Migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Migraine/</guid><description>Treatment of Migraine Abortive Rx: 5-HT1 agonists (triptans) effective if given early in migraine attack; Abortive: The goal of abortive treatment is to stop a migraine once it starts.</description></item><item><title>Treatment of other lipid fractions</title><link>https://www.physician.tw/Treatment-of-other-lipid-fractions/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-other-lipid-fractions/</guid><description>Treatment of other lipid fractions HDL-C: low levels a/w â†‘ risk of MI, but no clinical benefit shown by raising Triglycerides: reasonable to treat levels &amp;gt;500 mg/dL w/ fibrates or Î©-3 FA to â†“ risk of pancreatitis.</description></item><item><title>Treatment of overt hypothyroidism</title><link>https://www.physician.tw/Treatment-of-overt-hypothyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-overt-hypothyroidism/</guid><description>Treatment of overt hypothyroidism Levothyroxine (1.5â€“1.7 Âµg/kg/d), re âœ“ TSH q5â€“6wk, titrate q8-12 wks if TSH not in range Lower starting dose (0.</description></item><item><title>treatment of peptic ulcer disease</title><link>https://www.physician.tw/treatment-of-peptic-ulcer-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/treatment-of-peptic-ulcer-disease/</guid><description>treatment of peptic ulcer disease (Lancet 2016;388:2355; Gastro 2016;151:51; Gut 2017;66:6; AJG 2017;112:212)
If H. pylori âŠ• â†’ eradicate (â€œtest and treatâ€); if âŠ– â†’ gastric acid suppression w/ PPI 1st line: Quad.</description></item><item><title>Treatment of pericarditis</title><link>https://www.physician.tw/Treatment-of-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-pericarditis/</guid><description>Treatment of pericarditis High-dose NSAID (eg, ibuprofen 600â€“800 mg tid) or ASA (eg, 650â€“1000 mg tid) Ã— 7â€“14 d then taper over wks; ASA preferred over NSAID in acute MI; consider PPI to â†“ risk of GIB Add colchicine 0.</description></item><item><title>Treatment of Primary ITP in Adults</title><link>https://www.physician.tw/Treatment-of-Primary-ITP-in-Adults/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Primary-ITP-in-Adults/</guid><description>Treatment of Primary ITP in Adults [[First-line or upfront therapy for idiopathic thrombocytopenic purpura]] [[Second-line or maintainence therapy for idiopathic thrombocytopenic purpura]] [[Chronic or refractory for idiopathic thrombocytopenic purpura]] [[Bleeding Treatment for idiopathic thrombocytopenic purpura]]</description></item><item><title>Treatment of Prinzmetals variant angina</title><link>https://www.physician.tw/Treatment-of-Prinzmetals-variant-angina/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Prinzmetals-variant-angina/</guid><description>Treatment of Prinzmetals variant angina high-dose CCB &amp;amp; standing nitrates (+SL prn), ? Î±-blockers/statins; d/c smoking; avoid high-dose ASA (can inhibit prostacyclin and worsen spasm), nonselect Î²B, triptans</description></item><item><title>Treatment of SIADH</title><link>https://www.physician.tw/Treatment-of-SIADH/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-SIADH/</guid><description>Treatment of SIADH (NEJM 2007;356:2064; AJKD 2020;76:203): fluid restrict + treat underlying cause
hypertonic saline (Â± loop diuretic; AJKD 2020;76:203) if sx or Na fails to â†‘ w/ fluid restriction Intermittent bolus of 3% saline (~2 mL/kg q6h) vs.</description></item><item><title>Treatment of SVT</title><link>https://www.physician.tw/Treatment-of-SVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-SVT/</guid><description>Treatment of SVT Rhythm Acute Treatment Long-term Treatment
Unstable Acute: Cardioversion per ACLS n/a
ST Acute: Treat underlying stressor(s) Long-term: n/a</description></item><item><title>Treatment of Thyroid storm</title><link>https://www.physician.tw/Treatment-of-Thyroid-storm/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-Thyroid-storm/</guid><description>Treatment of Thyroid storm Î²-blocker, PTU or methimazole, iopanoic acid or iodide (for [[Wolff-Chaikoff effect]]) &amp;gt;1 h after PTU, Â± steroids (â†“ T4 â†’ T3)</description></item><item><title>Treatment of UTIs</title><link>https://www.physician.tw/Treatment-of-UTIs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-UTIs/</guid><description>Treatment of UTIs Scenario Empiric Treatment Guidelines (narrow based on UCx)
Asymptomatic bacteruria Do not treat. Exceptions: pregnant women, renal transplant, prophylaxis prior to invasive urologic procedures (CID 2019;68:1611).</description></item><item><title>Treatment peptic ulcer disease</title><link>https://www.physician.tw/Treatment-peptic-ulcer-disease-/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-peptic-ulcer-disease-/</guid><description>Treatment peptic ulcer disease (Lancet 2016;388:2355; Gastro 2016;151:51; Gut 2017;66:6; AJG 2017;112:212)
If H. pylori âŠ• â†’ eradicate (â€œtest and treatâ€); if âŠ– â†’ gastric acid suppression w/ PPI 1st line: Quad.</description></item><item><title>Treatment prevention-herpes zoster</title><link>https://www.physician.tw/Treatment-prevention-herpes-zoster/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-prevention-herpes-zoster/</guid><description>Treatment prevention-herpes zoster Uncomplicated: acyclovir, valacyclovir, or famciclovir x 7 d; initiate w/in 72 h of onset for greatest benefit; consider after 72 h if new lesions present; minimal benefit after crusting Superimposed bacterial cellulitis is common; if suspected, treat with appropriate antibiotics Disseminated/immunosupp.</description></item><item><title>Treatment-accessory pathways wolff-parkinson-white</title><link>https://www.physician.tw/Treatment-accessory-pathways-wolff-parkinson-white/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-accessory-pathways-wolff-parkinson-white/</guid><description>Treatment-accessory pathways (wolff-parkinson-white) (Heart Rhythm 2012;9:1006, Circ 2014;130:e199 &amp;amp; 2016;133:e506)
AVRT (orthodromic): vagal, Î²B, CCB; care w/ adenosine (can precip AF); have defib ready AF/AFL w/ conduction down accessory pathway: need to Rx arrhythmia and â†‘ pathway refractoriness.</description></item><item><title>Treatment-Acetaminophen hepatotoxicity</title><link>https://www.physician.tw/Treatment-Acetaminophen-hepatotoxicity/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Acetaminophen-hepatotoxicity/</guid><description>Treatment-Acetaminophen hepatotoxicity NG lavage, activated charcoal if w/in 4 h. Consider early transfer to transplant ctr
N-acetylcysteine: administer up to 72 h after ingestion, if time of ingestion unknown or chronic ingestion &amp;gt;4g/d; low threshold to start NAC w/ low or undetectable APAP levels</description></item><item><title>Treatment-acute aortic syndromes</title><link>https://www.physician.tw/Treatment-acute-aortic-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-aortic-syndromes/</guid><description>Treatment-acute aortic syndromes (Circ 2010;121:1544; EHJ 2018;39:739; JACC 2019;74:1494 &amp;amp; 2020;76:1703)
â†“ dP/dt targeting HR &amp;lt;60 &amp;amp; central BP &amp;lt;120 (or lowest that preserves perfusion; r/o pseudohypotension, eg, arm BP â†“ due to subclavian dissection; use highest BP reading) First IV Î²B (eg, esmolol, labetalol) to blunt reflex â†‘ HR &amp;amp; inotropy in response to vasodilators; verapamil/diltiazem if Î²B contraindic; then â†“ SBP w/ IV vasodilators (eg, nitroprusside) If HoTN: urgent surgical consult, IVF to achieve euvolemia, pressors to keep MAP 60-65 mmHg; r/o complication (eg, tamponade, contained rupture, severe AI) Proximal: surgery considered in all acute and in chronic if c/b progression, AI or aneurysm Distal: med Rx unless complication (see below) or favorable TEVAR anatomy w/ high-risk imaging features (JACC 2019;74:1494); pre-emptive TEVAR may â†“ late complic.</description></item><item><title>Treatment-acute mesenteric ischemia</title><link>https://www.physician.tw/Treatment-acute-mesenteric-ischemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-mesenteric-ischemia/</guid><description>Treatment-acute mesenteric ischemia IVF, NPO, optimize hemodynamics (minimize pressors), broad-spectrum abx, anticoagulation w/ heparin Â± tPA (for occlusive disease), IV papaverine (vasodilator; for non-occlusive mesenteric ischemia)</description></item><item><title>Treatment-acute pancreatitis</title><link>https://www.physician.tw/Treatment-acute-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-pancreatitis/</guid><description>Treatment-acute pancreatitis Fluid resusc.: aggressive in 1st 24 hrs, even if mild. 20 mL/kg IVB â†’ 3 mL/kg/hr. Goal â†“ BUN &amp;amp; Hct over 12â€“24 h.</description></item><item><title>Treatment-acute respiratory distress syndrome</title><link>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-acute-respiratory-distress-syndrome/</guid><description>Treatment-acute respiratory distress syndrome [[methylprednisolone]]</description></item><item><title>Treatment-adrenal insufficiency</title><link>https://www.physician.tw/Treatment-adrenal-insufficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-adrenal-insufficiency/</guid><description>Treatment-adrenal insufficiency Acute insufficiency: volume resusc. w/ normal saline + hydrocortisone IV (see below) Chronic insufficiency: (1) prednisone ~4â€“5 mg PO qam or hydrocortisone 15â€“25 mg PO qd (2/3 a.</description></item><item><title>Treatment-anaphylaxis</title><link>https://www.physician.tw/Treatment-anaphylaxis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-anaphylaxis/</guid><description>Treatment-anaphylaxis Epi: 0.5 mg IM (0.5 mL of 1 mg/mL solution) q5â€“15min as needed. For those who do not respond, IV infusion starting at 0.</description></item><item><title>Treatment-Anemia of chronic inflammation</title><link>https://www.physician.tw/Treatment-Anemia-of-chronic-inflammation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Anemia-of-chronic-inflammation/</guid><description>Treatment-Anemia of chronic inflammation treat underlying disease Â± iron and/or erythropoiesis-stimulating agent (ESA; eg, Epo). Iron if ferritin &amp;lt;100 or Fe/TIBC &amp;lt;20%.</description></item><item><title>Treatment-aortic aneurysms</title><link>https://www.physician.tw/Treatment-aortic-aneurysms/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-aortic-aneurysms/</guid><description>Treatment-aortic aneurysms (Circ 2010;121:e266 &amp;amp; 2016;133:680; JACC 2020;76:201; NEJM 2021;385:1690)
Goal is to prevent rupture (50% mortality prior to hospital) by modifying risk factors Risk factor modification: smoking cessation; statins to achieve LDL-C &amp;lt;70 mg/dL BP control (goal SBP 100â€“120): Î²B (â†“ dP/dt) â†“ aneurysm growth; ACEI a/w â†“ rupture risk (Lancet 2006;368:659); ARB may â†“ rate of aortic root growth in Marfan (NEJM 2008;358:2787) Mod CV exercise OK, no burst activity requiring Valsalva maneuvers (eg, heavy lifting) Indications for intervention (individualized based on FHx, body size, sex, anatomy) TAA: sxs; ascending Ao â‰¥5.</description></item><item><title>Treatment-aortic-regurgitation</title><link>https://www.physician.tw/Treatment-aortic-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-aortic-regurgitation/</guid><description>Treatment-aortic-regurgitation Acute decompensation (consider endocarditis as possible acute precipitant): surgery usually urgently needed for acute severe AR, which is poorly tolerated by LV IV afterload reduction (nitroprusside) and inotropic support (dobutamine) Â± chronotropic support (â†‘ HR â†’ â†“ diastole â†’ â†“ time for regurgitation) pure vasoconstrictors and IABP contraindicated In chronic AR, management decisions based on LV size and fxn (and before sx occur); low diastolic BP and high resting HR associated with mortality (JACC 2020;75:29) Surgery (AVR, replacement or repair if possible): Severe and sx (if equivocal, consider stress test) Asx and either EF â‰¤55%, LV dilation [LVESD &amp;gt;50 mm or LVESDi (indexed to BSA) â‰¥ 25 mm/m2 (JACC 2019;73:1741)], or undergoing cardiac surg Transcatheter AoV implantation (TAVI) being explored (JACC 2013;61:1577 &amp;amp; 2017;70:2752) Medical therapy: vasodilators (nifedipine, ACEI/ARB, hydralazine) if severe AR w/ sx or LV dysfxn &amp;amp; not operative candidate or to improve hemodynamics before AVR.</description></item><item><title>Treatment-ascites</title><link>https://www.physician.tw/Treatment-ascites/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-ascites/</guid><description>Treatment-ascites â†“ Na intake (1â€“2 g/d); restrict intake of free water if Na &amp;lt;125
Diuretics: goal diurese ~1 L/d.</description></item><item><title>Treatment-bacterial endocarditis</title><link>https://www.physician.tw/Treatment-bacterial-endocarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-bacterial-endocarditis/</guid><description>Treatment-bacterial endocarditis Empiric NVE or PVE &amp;gt;12 mos post-op: vanc + CTX PVE &amp;lt;12 mos post op: vanc + CTX Â± gentamicin (if OK renal fxn)</description></item><item><title>Treatment-bronchiectasis</title><link>https://www.physician.tw/Treatment-bronchiectasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-bronchiectasis/</guid><description>Treatment-bronchiectasis Acute exacerbations: antibiotics directed against prior pathogens; if no prior Cx data â†’ FQ
Chronic mgmt: treat underlying condition, chest PT, inhaled hypertonic saline, bronchodil.</description></item><item><title>Treatment-Candida species</title><link>https://www.physician.tw/Treatment-Candida-species/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Candida-species/</guid><description>Treatment-Candida species Mucocutaneous Clotrimazole, nystatin, fluconazole, itraconazole Candiduria (if pyuria or sx of infxn) Fluconazole or intravesical ampho if severe infxn, immunosupp.</description></item><item><title>Treatment-cholangitis</title><link>https://www.physician.tw/Treatment-cholangitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholangitis/</guid><description>Treatment-cholangitis Antibiotics (broad spectrum) to cover common bile pathogens (see above) ampicillin + gentamicin (or levofloxacin) Â± MNZ (if severe); carbapenems; pip/tazo ~80% respond to conservative Rx and abx â†’ biliary drainage on elective basis ~20% require urgent biliary decompression via ERCP (papillotomy, stone extraction, and/or stent insertion).</description></item><item><title>Treatment-cholecystitis</title><link>https://www.physician.tw/Treatment-cholecystitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholecystitis/</guid><description>Treatment-cholecystitis (Ann Surg 2013;258:385; NEJM 2015;373:357)
NPO, IV fluids, nasogastric tube if intractable vomiting, analgesia
Antibiotics (E.</description></item><item><title>Treatment-cholelithiasis</title><link>https://www.physician.tw/Treatment-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cholelithiasis/</guid><description>Treatment-cholelithiasis (Am Fam Physician 2014;89:795; J Hepatol 2016;65:146)
Cholecystectomy (CCY), usually laparoscopic, if symptomatic (earlier is better)
CCY in asx Pts if: GB calcification (â†‘ risk of cancer), GB polyps &amp;gt;10 mm, stones &amp;gt;3 cm; Pts undergoing bariatric surgery, cardiac Tx candidates, hemolytic anemia (sickle cell)</description></item><item><title>Treatment-chronic pancreatitis</title><link>https://www.physician.tw/Treatment-chronic-pancreatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-chronic-pancreatitis/</guid><description>Treatment-chronic pancreatitis (JAMA 2019;322:2422; Lancet 2020;396:499)
Pancreatic enzyme replacement (may â†“ pain by reducing CCK). Rx routine vitamin D &amp;amp; Ca.</description></item><item><title>Treatment-cystic fibrosis</title><link>https://www.physician.tw/Treatment-cystic-fibrosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-cystic-fibrosis/</guid><description>Treatment-cystic fibrosis Lancet 2021;397:2195)
Acute exacerbations: may be assoc w/ persistent drop in FEV1 (AJRCCM 2010;182:627); continue aggressive airway clearance, target abx based on sputum cx (incl double coverage for PsA); common pathogens include PsA, S.</description></item><item><title>Treatment-diabetic foot infections</title><link>https://www.physician.tw/Treatment-diabetic-foot-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-diabetic-foot-infections/</guid><description>Treatment-diabetic foot infections (CID 2012;54:e132)
Mild infxn: oral abx. Target GPCs (diclox, cephalexin, or amox/clav); use TMP-SMX or doxy for MRSA.</description></item><item><title>Treatment-diverticulitis</title><link>https://www.physician.tw/Treatment-diverticulitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-diverticulitis/</guid><description>Treatment-diverticulitis (JAMA 2017;318:291; NEJM 2018;379:1635; Gastro 2021;160:906)
Mild: outPt Rx indicated if Pt has few comorbidities and can tolerate POs PO abx: (MNZ + FQ) or amox/clav for 7 d; liquid diet until clinical improvement No abx is noninferior to abx in uncomplicated diverti (Clin Gastroenterol Hepatol 2021;19:503)</description></item><item><title>Treatment-epidural abscess</title><link>https://www.physician.tw/Treatment-epidural-abscess/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-epidural-abscess/</guid><description>Treatment-epidural abscess Antibiotics (typically MRSA and gram-negative coverage initially then narrowed based on culture data) Â± surgery (decompressive laminectomy and debridement) for failure to improve on medical Rx.</description></item><item><title>Treatment-fever of unknown origin</title><link>https://www.physician.tw/Treatment-fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-fever-of-unknown-origin/</guid><description>Treatment-fever of unknown origin Empiric abx not indicated (unless Pt neutropenic or critically ill) Empiric glucocorticoids not indicated unless strong suspicion for specific rheumatologic dx Stop unnecessary meds (only 20% with a med cause have eos or rash) Up to 30% of cases remain undiagnosed, most spontaneously defervesce (wks to mos)</description></item><item><title>Treatment-glomerulonephritis</title><link>https://www.physician.tw/Treatment-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-glomerulonephritis/</guid><description>Treatment-glomerulonephritis (AJKD 2020;75:124 &amp;amp; 2020;76:265)
If acute GN/RPGN suspected, give 500â€“1000 mg methylpred. IV qd Ã— 3d ASAP while awaiting bx results.</description></item><item><title>Treatment-hemoptysis</title><link>https://www.physician.tw/Treatment-hemoptysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hemoptysis/</guid><description>Treatment-hemoptysis Death is from [[asphyxiation]]çª’æ¯ not exsanguination; maintain gas exchange, reverse coagulopathy and Rx underlying condition; cough suppressant may â†‘ risk of asphyxiation Inhaled tranexamic acid promising (Chest 2018;154:1379) nebulized TA (500 mg tid) Massive hemoptysis: put bleeding side dependent; selectively intubate nl lung if needed Angiography: Dx &amp;amp; Rx (vascular occlusion balloons or selective embol of bronchial art) Rigid bronch: allows more options (electrocautery, laser) than flexible bronch Surgical resection</description></item><item><title>Treatment-Hepatorenal syndrome HRS</title><link>https://www.physician.tw/Treatment-Hepatorenal-syndrome-HRS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Hepatorenal-syndrome-HRS/</guid><description>Treatment-Hepatorenal syndrome (HRS) if critically ill â†’ vasopressor (eg, norepinephrine or vasopressin) + albumin (1 g/kg, max 100 g, bolus daily) to â†‘ MAP 10 mmHg.</description></item><item><title>Treatment-hyperaldosteronism</title><link>https://www.physician.tw/Treatment-hyperaldosteronism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperaldosteronism/</guid><description>Treatment-hyperaldosteronism (SCNA 2014;94:643)
Adenoma â†’ adrenalectomy vs. medical Rx w/ spironolactone or eplerenone Hyperplasia â†’ spironolactone or eplerenone; GRA â†’ glucocorticoids Â± spironolactone Carcinoma â†’ adrenalectomy</description></item><item><title>Treatment-hypernatremia</title><link>https://www.physician.tw/Treatment-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypernatremia/</guid><description>Treatment-hypernatremia Restore access to H2O or supply daily requirement of H2O (â‰¥1 L/d)
[[Replace free H2O deficit]]</description></item><item><title>Treatment-hyperosmolar hyperglycemic state</title><link>https://www.physician.tw/Treatment-hyperosmolar-hyperglycemic-state/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperosmolar-hyperglycemic-state/</guid><description>Treatment-hyperosmolar hyperglycemic state Rule-out possible precipitants; ~15% mortality due to precipitating factors Aggressive hydration: initially NS, then Â½ NS, average fluid loss up to 8â€“10 L Insulin (eg, 10 U IV followed by 0.</description></item><item><title>Treatment-hypertension</title><link>https://www.physician.tw/Treatment-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypertension/</guid><description>Treatment-hypertension Every â†“ 5 mmHg â†’ ~10% â†“ ischemic heart disease, stroke, and HF (Lancet 2021;397:1625) Lifestyle modifications (each may â†“ SBP ~5 mmHg) weight loss: goal BMI 18.</description></item><item><title>Treatment-hypertensive crises</title><link>https://www.physician.tw/Treatment-hypertensive-crises/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypertensive-crises/</guid><description>Treatment-hypertensive crises (Circ 2018;138:e426)
AoD, eclampsia/severe preeclampsia, pheo: target SBP &amp;lt;140 (&amp;lt;120 for AoD) in 1 hour Emerg w/o above: â†“ BP by ~25% in 1 h; to 160/100â€“110 over next 2â€“6 h, then nl over 1â€“2 d Acute ischemic stroke (w/in 72 hr from sx onset): &amp;lt;185/110 before lysis initiated, o/w target &amp;lt;220/120 (same SBP goal for ICH) Watch UOP, Cr, mental status: may indicate a lower BP is not tolerated [[IV Drugs for Hypertensive Crises]] HTN urgency: goal to return to normal BP over hrs to days.</description></item><item><title>Treatment-hyperthyroidism</title><link>https://www.physician.tw/Treatment-hyperthyroidism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hyperthyroidism/</guid><description>Treatment-hyperthyroidism Î²-blockers: control tachycardia (propranolol also â†“ T4 â†’ T3 conversion) Gravesâ€™ disease: either antithyroid drugs or radioactive iodine (NEJM 2016;375:1552) methimazole: 60% chance of recurrence after 1 y; side effects include pruritus, rash, arthralgia, fever, N/V and agranulocytosis in 0.</description></item><item><title>Treatment-hypocalcemia</title><link>https://www.physician.tw/Treatment-hypocalcemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypocalcemia/</guid><description>Treatment-hypocalcemia also treat concomitant vitamin D deficiency; Endocrine 2020;69:485
ä¹Ÿè¦æ²»ç™‚ç¶­ç”Ÿç´  D ç¼ºä¹ç—‡
Severely symptomatic: Ca gluconate (1â€“2 g IV over 20 min) + oral Ca + calcitriol (but takes hrs to work) Â± Mg (50â€“100 mEq/d); 10% CaCl2 in codes or via CVL</description></item><item><title>Treatment-hypokalemia</title><link>https://www.physician.tw/Treatment-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypokalemia/</guid><description>Treatment-hypokalemia (JAMA 2000;160:2429)
If true potassium deficit: potassium repletion (â†“ 1 mEq/L â‰ˆ 200 mEq total body loss) Dosage: 40 mEq PO q4h, 10 mEq/h (IV), 20 mEq/h (central line), 40 mEq in 1 L IVF</description></item><item><title>Treatment-hypopituitary syndromes</title><link>https://www.physician.tw/Treatment-hypopituitary-syndromes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-hypopituitary-syndromes/</guid><description>Treatment-hypopituitary syndromes Replace deficient target gland hormones Most important deficiencies to recognize and treat in inpatients are adrenal insufficiency and hypothyroidism; if both present, treat with glucocorticoids first, then replace thyroid hormone so as not to precipitate adrenal crisis</description></item><item><title>Treatment-mitral-regurgitation</title><link>https://www.physician.tw/Treatment-mitral-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-mitral-regurgitation/</guid><description>Treatment-mitral-regurgitation Treatment (Lancet 2016;387:1312; Circ 2021;143:e72)
Acute decompensation (consider endocarditis as possible acute precipitant): surgery usually urgently needed for acute severe AR, which is poorly tolerated by LV IV afterload reduction (nitroprusside) and inotropic support (dobutamine) Â± chronotropic support (â†‘ HR â†’ â†“ diastole â†’ â†“ time for regurgitation) pure vasoconstrictors and IABP contraindicated In chronic AR, management decisions based on LV size and fxn (and before sx occur); low diastolic BP and high resting HR associated with mortality (JACC 2020;75:29) Surgery (AVR, replacement or repair if possible): Severe and sx (if equivocal, consider stress test) Asx and either EF â‰¤55%, LV dilation [LVESD &amp;gt;50 mm or LVESDi (indexed to BSA) â‰¥ 25 mm/m2 (JACC 2019;73:1741)], or undergoing cardiac surg Transcatheter AoV implantation (TAVI) being explored (JACC 2013;61:1577 &amp;amp; 2017;70:2752) Medical therapy: vasodilators (nifedipine, ACEI/ARB, hydralazine) if severe AR w/ sx or LV dysfxn &amp;amp; not operative candidate or to improve hemodynamics before AVR.</description></item><item><title>Treatment-mitral-stenosis</title><link>https://www.physician.tw/Treatment-mitral-stenosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-mitral-stenosis/</guid><description>Treatment-mitral-stenosis Medical: Na restriction, cautious diuresis, Î²B, AF control, sx-limited physical stress Antibiotic Ppx recommended if h/o RHD w/ valvular disease for 10 y or until age 40 Anticoag w/ warfarin (not DOAC) if: AF; prior embolism; LA clot Mechanical intervention indicated if sx severe MS; reasonable if asx severe MS but PASP &amp;gt;50 mmHg and morphology favorable for PMBC; consider PMBC if non-severe MS but exertional sx and hemodyn signif w/ exercise, or if asx severe MS and new-onset AF Percutaneous mitral balloon commissurotomy (PMBC): preferred Rx if RHD; â‰ˆ MVR if valvuloplasty score &amp;lt;8, Ã˜ if mod-severe MR or LA clot Surgical (MV repair if possible, o/w replacement) if PMBC contraindicated Calcific MS: surgical MVR if severe &amp;amp; highly sx; use of transcatheter aortic prosthesis experimental and w/ high rate of complications (Circ CVI 2020;13:e008425) Pregnancy: if NYHA class III/IV â†’ PMBC, o/w medical Rx w/ low-dose diuretic &amp;amp; Î²B</description></item><item><title>Treatment-nephrotic syndrome</title><link>https://www.physician.tw/Treatment-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-nephrotic-syndrome/</guid><description>Treatment-nephrotic syndrome (NEJM 2013;368:10)
General: protein suppl.; diuretics for edema; treat hyperlipidemia, Na restriction (&amp;lt;2 g/d)
ACEI or ARB: â†“ proteinuria â†’ slow nonimmunologic progression of renal disease</description></item><item><title>Treatment-Nonalcoholic fatty liver disease NAFLD</title><link>https://www.physician.tw/Treatment-Nonalcoholic-fatty-liver-disease-NAFLD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Nonalcoholic-fatty-liver-disease-NAFLD/</guid><description>Treatment-Nonalcoholic fatty liver disease (NAFLD) wt loss (â‰¥10%), exercise, DM control, liraglutide (Lancet 2016;387:679), statins (Metabolism 2017;71:17), vit E in Pts w/o DM (Hepatol 2018;67:328), bariatric surgery (World J Hepatol 2019;11:138).</description></item><item><title>Treatment-of-hyponatremia</title><link>https://www.physician.tw/Treatment-of-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-of-hyponatremia/</guid><description>Treatment-of-hyponatremia NEJM 2015;372:55; JASN 2017;28:1340; CJASN 2018;13:641 &amp;amp; 984)
[[Approach to treatment-of-hyponatremia]]: Frequent lab draws and IVF rate adjustments are cornerstones of treatment [[Rapid correction of Treatment-of-hyponatremia]]: [[Effect of IV fluids-treatment-of-hyponatremia]] [[Effect of 1 L infusion in 70-kg male]] åˆ†é¡ï¼š [[Treatment of Hypovolemic hyponatremia]] [[Treatment of SIADH]] [[Treatment of Hypervolemic hyponatremia]]</description></item><item><title>Treatment-osteomyelitis</title><link>https://www.physician.tw/Treatment-osteomyelitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-osteomyelitis/</guid><description>Treatment-osteomyelitis Antibiotics: based on cx data. If clinically stable, consider holding antibiotics until bone bx obtained. Duration depends on Rx strategy/goals of Rx management (eg, 6 wks for vertebral osteo; Lancet 2015;385:875).</description></item><item><title>Treatment-Paroxysmal nocturnal hemoglobinuria</title><link>https://www.physician.tw/Treatment-Paroxysmal-nocturnal-hemoglobinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Paroxysmal-nocturnal-hemoglobinuria/</guid><description>Treatment-Paroxysmal nocturnal hemoglobinuria supportive care (iron, folate, transfusions); consider anticoagulation.
Allogeneic HSCT for hypoplasia or severe thrombosis.
Pegcetacoplan (binds C3, prevents complement cascade activation) superior to eculizumab (Ab inactivates terminal complement C5s) in â†“ hemolysis &amp;amp; stabilizing Hb levels (NEJM 2021;384:1028).</description></item><item><title>Treatment-pericardial tamponade</title><link>https://www.physician.tw/Treatment-pericardial-tamponade/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pericardial-tamponade/</guid><description>Treatment-pericardial tamponade Volume (but be careful b/c overfilling can worsen tamponade) and âŠ• inotropes (avoid Î²B) Avoid vasoconstrictors b/c will â†“ stroke volume &amp;amp; potentially â†“ HR Avoid positive pressure ventilation b/c it can further impair cardiac filling (Circ 2006;113:1622) Pericardiocentesis (except if due to aortic/myocardial rupture, for which emergent surgery is treatment of choice; if too unstable, consider small pericardiocentesis to prevent PEA) Surgical drainage considered if fluid rapidly reaccumulates, loculated, or hemorrhagic</description></item><item><title>Treatment-pleural effusion</title><link>https://www.physician.tw/Treatment-pleural-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pleural-effusion/</guid><description>Treatment-pleural effusion Symptomatic effusion: therapeutic thoracentesis, treat underlying disease process
Parapneumonic effusion (Chest 2000;118:1158)
uncomplicated â†’ antibiotics for pneumonia</description></item><item><title>Treatment-pneumonia</title><link>https://www.physician.tw/Treatment-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pneumonia/</guid><description>Treatment-pneumonia CAP (outPt) Amoxicillin, azithro, or doxy (avoid latter two if &amp;gt;25% resistance locally)
CAP (ward) [3rd-gen ceph + azithro] or levoflox; omadacycline â‰ˆ FQ (NEJM 2019;380:517)</description></item><item><title>Treatment-polyuria</title><link>https://www.physician.tw/Treatment-polyuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-polyuria/</guid><description>Treatment-polyuria 1Â° polydipsia: treat psychiatric illness, check meds, restrict access to free H2O Osmotic diuresis: address underlying cause, replace free H 2O deficit (see â€œHypernatremiaâ€ for formula to calculate) and ongoing losses Treatment of Diabetes insipidus Central DI: desmopressin (dDAVP, 1st line), low Na/protein diet + HCTZ, chlorpropamide Nephrogenic DI: treat underlying cause if possible; Na restriction + HCTZ (mild volume depletion â†’ â†“ delivery of filtrate for free H2O absorption), consider amiloride for Li- induced DI (Kid Int 2009;76:44), indomethacin (NEJM 1991;324:850) or trial desmopression Pregnancy-induced DI: due to vasopressinase from placenta, âˆ´ Rx w/ dDAVP</description></item><item><title>Treatment-Portal vein thrombosis PVT</title><link>https://www.physician.tw/Treatment-Portal-vein-thrombosis-PVT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Portal-vein-thrombosis-PVT/</guid><description>Treatment-Portal vein thrombosis (PVT) Treatment: Acute: If noncirrhotic, LMWH â†’ warfarin or DOAC Ã— 6 mo, or indefinitely if irreversible cause.</description></item><item><title>Treatment-Primary sclerosing cholangitis PSC</title><link>https://www.physician.tw/Treatment-Primary-sclerosing-cholangitis-PSC/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Primary-sclerosing-cholangitis-PSC/</guid><description>Treatment-Primary sclerosing cholangitis (PSC) supportive care, fat-soluble vitamins; no meds have improved survival
UDCA may â†“ AÏ• &amp;amp; improve Sx, but unclear if beneficial</description></item><item><title>Treatment-pulmonary hypertension</title><link>https://www.physician.tw/Treatment-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-pulmonary-hypertension/</guid><description>Treatment-pulmonary hypertension Principles: 1) prevent &amp;amp; reverse vasoactive substance imbalance and vascular remodeling 2) prevent RV failure: â†“ wall stress (â†“ PVR, PAP, RV diam); ensure adeq systemic DBP Supportive Oxygen: maintain SaO2 &amp;gt;90â€“92% (reduces vasoconstriction) Diuretics: â†“ RV wall stress and relieve RHF sx; gentle b/c RV is preload dependent Anticoag: not routinely used; â†“ VTE risk of RHF; ?</description></item><item><title>Treatment-Pure red cell aplasia</title><link>https://www.physician.tw/Treatment-Pure-red-cell-aplasia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Pure-red-cell-aplasia/</guid><description>Treatment-Pure red cell aplasia : thymectomy if thymus enlarged; IVIg if parvovirus and immunosuppressed (Clin Infect Dis 2013;56:968); immunosuppression/chemoRx if CLL or idiopathic; supportive care w/ PRBC transfusions; ?</description></item><item><title>Treatment-sexually transmitted infections</title><link>https://www.physician.tw/Treatment-sexually-transmitted-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-sexually-transmitted-infections/</guid><description>Treatment-sexually transmitted infections (MMWR 2021;70:1; JAMA 2022;327:161)
Syphilis 1Â°/2Â°/early latent: PCN G benzathine 2.4 mil U IM Ã— 1 3Â°/late latent: PCN G 2.</description></item><item><title>Treatment-skin and soft tissue infections</title><link>https://www.physician.tw/Treatment-skin-and-soft-tissue-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-skin-and-soft-tissue-infections/</guid><description>Treatment-skin and soft tissue infections (CID 2014;60:169)
Urgent surgical exploration with debridement of necrotic tissue and ID consultation Empiric antibiotics: [pip/tazo or ceftriaxone + metronidazole or carbapenem] + [vanco or linezolid].</description></item><item><title>Treatment-syncope</title><link>https://www.physician.tw/Treatment-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-syncope/</guid><description>Treatment-syncope (JACC 2017;70:620 &amp;amp; 2019;74:2410; EHJ 2018;39:1883)
Arrhythmia, cardiac mechanical or neurologic syncope: treat underlying disorder, ? ICD if Brugada pattern, sarcoid, ARVC, early repol + syncope Vasovagal: avoidance of triggers; physical counterpressure; consider â†‘ Na &amp;amp; fluid intake, fludrocortisone or midodrine (JACC 2016;68:1; Ann Intern Med 2021;174:1349); SSRI; ?</description></item><item><title>Treatment-Vitamin B12 deficiency</title><link>https://www.physician.tw/Treatment-Vitamin-B12-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Vitamin-B12-deficiency/</guid><description>Treatment-Vitamin B12 deficiency 1 mg B12 IM qd Ã— 7 d â†’ q wk Ã— 4â€“8 wk â†’ q month for life</description></item><item><title>Treatment-Wilson disease</title><link>https://www.physician.tw/Treatment-Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Treatment-Wilson-disease/</guid><description>Treatment-Wilson disease chelation w/ D-penicillamine (supplement B6 as D-pen inactivates); alternative is trientine (â†“ toxicity w/ â‰ˆ efficacy, but $$), ammonium or bis-choline tetrathiomolybdate (investigational) may â†“ neurologic deterioration compared to trientine.</description></item><item><title>Triage-pneumonia</title><link>https://www.physician.tw/Triage-pneumonia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Triage-pneumonia/</guid><description>Triage-pneumonia qSOFA predicts poor outcomes, prolonged ICU stay, and in-hospital mortality if &amp;gt;2 of 3: RR&amp;gt;22, AMS, SBP&amp;lt;100 (JAMA 2016; 315:801)</description></item><item><title>tricuspid-regurgitation</title><link>https://www.physician.tw/tricuspid-regurgitation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tricuspid-regurgitation/</guid><description>tricuspid-regurgitation TRICUSPID REGURGITATION (Circ 2014;129:2440; Lancet 2016;388:2431)
Fxnl etiol (90%): RV dilation, PHT (may be 2Â° to L-sided dis.), large L â†’ R shunts 1Â° etiol: myxomatous, IE, pacemaker leads, RHD, CTD, XRT, Ebsteinâ€™s, carcinoid, tumors Holosystolic murmur, 3rd/4th ICS, â†‘ w/ insp (Carvalloâ€™s sign); S3; prominent cv wave in JVP Consider repair/replacement in severe TR (eg, ERO â‰¥0.</description></item><item><title>Tricyclic antidepressants-toxicology</title><link>https://www.physician.tw/Tricyclic-antidepressants-toxicology/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tricyclic-antidepressants-toxicology/</guid><description>Tricyclic antidepressants-toxicology Hypotension, seizures, arrhythmia, â†‘ QRS, â†‘ QT
IVF resuscitation, IV sodium bicarbonate, vasopressors</description></item><item><title>Troponin</title><link>https://www.physician.tw/Troponin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Troponin/</guid><description>Troponin 99th %ile w/ rise and/or fall in approp. setting is dx of AMI (Circ 2018;138:e618)
[[Fourth Universal Definition of Myocardial Infarction (2018)]]</description></item><item><title>Tuberculin skin test</title><link>https://www.physician.tw/Tuberculin-skin-test/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tuberculin-skin-test/</guid><description>Tuberculin skin test (TST/ PPD): inject purified protein intradermally, examine for wheal 48â€“72 hrs later. Interpret based on max diameter of induration, not erythema.</description></item><item><title>tuberculosis</title><link>https://www.physician.tw/tuberculosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tuberculosis/</guid><description>tuberculosis [[Definitions-tuberculosis]] [[Epidemiology-tuberculosis]] [[Screening for latent TB]] [[Clinical manifestations-Screening for latent TB]] [[Diagnostics for active TB]] [[Extrapulmonary TB]] [[Treatment of latent TB]] [[Patient isolation-tuberculosis]] [[Treatment of active tuberculosis]] [[Antituberculous Medications]] [[Antituberculous Treatment Regimens]]</description></item><item><title>Tubulointerstitial proteinuria</title><link>https://www.physician.tw/Tubulointerstitial-proteinuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Tubulointerstitial-proteinuria/</guid><description>Tubulointerstitial proteinuria (usually &amp;lt;1â€“2 g/d) â†“ reabsorption of freely filtered proteins â†’ lose globulins
Etiologies ATN; AIN [[Fanconiâ€™s syndrome]]</description></item><item><title>tutorial</title><link>https://www.physician.tw/tutorial/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/tutorial/</guid><description> CS 61Aï¼šç¼–ç¨‹å…¥é—¨ï¼ˆç”¨çš„ Pythonï¼Œä¹‹å‰ç”¨çš„æ˜¯ Schemeï¼‰ CS 61Bï¼šç®—æ³•ä¸æ•°æ®ç»“æ„ï¼ˆç”¨çš„ Javaï¼‰ CS 61Cï¼šè®¡ç®—æœºä½“ç³»ç»“æ„ï¼ˆç”¨çš„ Cï¼‰</description></item><item><title>type</title><link>https://www.physician.tw/type/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type/</guid><description>type</description></item><item><title>type 1 MI</title><link>https://www.physician.tw/type-1-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-1-MI/</guid><description>type 1 MI includes detection of a rise and/or fall of cTn with at least one value above the 99th percentile and with at least one of the following: Symptoms of acute myocardial ischemia; New ischemic electrocardiographic (ECG) changes; Development of pathological Q waves; Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischemic etiology; Identification of a coronary thrombus by angiography including intracoronary imaging or by autopsy.</description></item><item><title>type 2 MI</title><link>https://www.physician.tw/type-2-MI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-2-MI/</guid><description>type 2 MI includes detection of a rise and/or fall of cTn with at least one value above the 99th percentile and evidence of an imbalance between myocardial oxygen supply and demand unrelated to coronary thrombosis, requiring at least one of the following: Symptoms of acute myocardial ischemia; New ischemic ECG changes; Development of pathological Q waves; Imaging evidence of new loss of viable myocardium, or new regional wall motion abnormality in a pattern consistent with an ischemic etiology.</description></item><item><title>type 3 myocardial infarction</title><link>https://www.physician.tw/type-3-myocardial-infarction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-3-myocardial-infarction/</guid><description>type 3 myocardial infarction Cardiac death in patients with symptoms suggestive myocardialischaemia and presumed new ischaemic EcG changes before cTn values become available or abnormal meets criteria for type 3 MI</description></item><item><title>type my note</title><link>https://www.physician.tw/type-my-note/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/type-my-note/</guid><description>content</description></item><item><title>Type of Idiopathic interstitial pneumonias IIPs</title><link>https://www.physician.tw/Type-of-Idiopathic-interstitial-pneumonias-IIPs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Type-of-Idiopathic-interstitial-pneumonias-IIPs/</guid><description>Type of Idiopathic interstitial pneumonias (IIPs) [[IPF idiopathic pulm fibrosis]] [[NSIP nonspecific IP]] [[COP cryptogenic organizing PNA]] [[AIP acute IP (Hamman-Rich syndrome)]] [[DIP desquamative IP]] [[RB-ILD resp bronchiolitis-assoc ILD]]</description></item><item><title>Types of Cryoglobulinemia</title><link>https://www.physician.tw/Types-of-Cryoglobulinemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-Cryoglobulinemia/</guid><description>Types of Cryoglobulinemia</description></item><item><title>Types of gallstones-cholelithiasis</title><link>https://www.physician.tw/Types-of-gallstones-cholelithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-gallstones-cholelithiasis/</guid><description>Types of gallstones-cholelithiasis (J Hepatol 2016;65:146)
Cholesterol (90%): 2 subtypes mixed: contain &amp;gt;50% cholesterol; typically smaller, multiple stones</description></item><item><title>Types of stones and risk factors</title><link>https://www.physician.tw/Types-of-stones-and-risk-factors/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Types-of-stones-and-risk-factors/</guid><description>Types of stones and risk factors (Nat Rev Dis Prim 2016;2:16008)
Calcium (Ca oxalate &amp;gt;Ca phosphate): 70â€“90% of kidney stones (NEJM 2010;363:954)</description></item><item><title>Typical Characteristics and Diagnostic Studies of Chest Pain</title><link>https://www.physician.tw/Typical-Characteristics-and-Diagnostic-Studies-of-Chest-Pain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Typical-Characteristics-and-Diagnostic-Studies-of-Chest-Pain/</guid><description>Typical Characteristics and Diagnostic Studies of Chest Pain Cardiovascular Causes Pulmonary Causes GI Causes Musculoskeletal and Miscellaneous Causes [@hematology]</description></item><item><title>typical electrocardiogram in a patient with acute pericarditis</title><link>https://www.physician.tw/typical-electrocardiogram-in-a-patient-with-acute-pericarditis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/typical-electrocardiogram-in-a-patient-with-acute-pericarditis/</guid><description>typical electrocardiogram in a patient with acute pericarditis åœ¨æ‰€æç¹ªçš„å¿ƒé›»åœ–ä¸­ï¼Œæœ‰ä¸€å€‹ ST æ®µçŸ¢é‡æŒ‡å‘å‰æ–¹ã€ä¸‹æ–¹å’Œå·¦å´ï¼Œé€™å°è‡´é™¤ AVR å’Œ V1 ä¹‹å¤–çš„æ‰€æœ‰å°è¯ ST æ®µæŠ¬é«˜ã€‚ é‚„æœ‰ PR æ®µå£“ä½ï¼Œé€™åœ¨å°è¯ II ä¸­æœ€ç‚ºæ˜é¡¯ã€‚</description></item><item><title>UIP usual interstitial PNA IP</title><link>https://www.physician.tw/UIP-usual-interstitial-PNA-IP/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/UIP-usual-interstitial-PNA-IP/</guid><description>UIP usual interstitial PNA (IP) UIP imaging pattern: reticular opacities, honeycombing, traction bronchiectasis; peripheral, subpleural, &amp;amp; basal
Sx &amp;gt;12 mo</description></item><item><title>ulcerative colitis</title><link>https://www.physician.tw/ulcerative-colitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/ulcerative-colitis/</guid><description>ulcerative colitis (Lancet 2018;389:1756; Am J Gastro 2019:114:384)
[[Clinical manifestations-ulcerative colitis]] [[Diagnosis-ulcerative colitis]] [[Complications-ulcerative colitis]] [[Prognosis-ulcerative colitis]]</description></item><item><title>Uremia</title><link>https://www.physician.tw/Uremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Uremia/</guid><description>Uremia hemodialysis indication: pericarditis, encephalopathy, bleeding
[[Residual syndrome]]
Classical signs of uremia are: progressive weakness and easy fatigue, loss of appetite due to nausea and vomiting, muscle atrophy, tremors, abnormal mental function, frequent shallow respiration, and metabolic acidosis.</description></item><item><title>Uremic bleeding</title><link>https://www.physician.tw/Uremic-bleeding/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Uremic-bleeding/</guid><description>Uremic bleeding Uremia â†’ platelet dysfunction including â†“ aggregation, impaired adhesiveness
Treatment: dDAVP, cryoprecipitate, correct anemia (improves plt aggregation and adhesion by increasing plt interactions with endothelium), consider holding anti-plt agents</description></item><item><title>urgent symptomatic interventions of leptomeningeal disease</title><link>https://www.physician.tw/urgent-symptomatic-interventions-of-leptomeningeal-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urgent-symptomatic-interventions-of-leptomeningeal-disease/</guid><description>urgent symptomatic interventions of leptomeningeal disease Radiation to symptomatic sites
Hydrocephalus and increased intracranial pressure Glucocorticoids 8 to 16 mg Lumbar puncture</description></item><item><title>urinalysis</title><link>https://www.physician.tw/urinalysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urinalysis/</guid><description>urinalysis [[Urine Dipstick]] [[Urine Sediment]] (microscopic examination)
[[proteinuria]] [[hematuria]] [[Etiologies of Hematuria]] [[Workup-of-hematuria]]
Backlinkï¼š [[Clinical manifestations-nephrolithiasis]] [[Diagnostic studies-urinary tract infections]] [[Diagnostic workup-hemoptysis]] [[Evaluation of vasculitis]] [[nephrology]] [[# The Profession of Medicine PA RT 1 ]] [[Stepwise Evaluation of a Patient with Delirium]] [[Workup-acute kidney injury (AKI)]]</description></item><item><title>urinary tract infections</title><link>https://www.physician.tw/urinary-tract-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urinary-tract-infections/</guid><description>urinary tract infections [[Definitions-urinary tract infections]] [[Microbiology-urinary tract infections]] [[Clinical manifestations-urinary tract infections]] [[Diagnostic studies-urinary tract infections]] [[Treatment of UTIs]]</description></item><item><title>Urine Dipstick</title><link>https://www.physician.tw/Urine-Dipstick/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urine-Dipstick/</guid><description>Urine Dipstick [[Specific gravity of Urine Dipstick]] [[pH of Urine Dipstick]] Range: 4.5â€“8.5; useful in evaluation of stones, RTAs, infection (urease UTI) [[Protein of Urine Dipstick]] Blood [[Workup-of-hematuria]] âŠ• from RBCs, free Hgb, or free myoglobin (eg, rhabdo) False âŠ•: semen, dilute urine (â†’ osmotic cell lysis), â†‘ pH, vaginal blood False âŠ–: vit C WBC Suggests inflammation (UTI, interstitial nephritis, GN) Ketones Detects acetoacetate (ie, ketoacidosis) but not Î²-hydroxybutyrate Leuk est Lysed PMNs.</description></item><item><title>Urine Sediment</title><link>https://www.physician.tw/Urine-Sediment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Urine-Sediment/</guid><description>Urine Sediment (Am J Kidney Dis 2008;51:1052)
Method Centrifuge fresh sample (prox. port if Foley) Ã— 3â€“5 min at 1500â€“3000 rpm pour off supernatant in one motion resuspend pellet by agitating base of tube pour suspension onto slide w/ coverslip view under â€œhigh dryâ€ power phase contrast for RBC morphology Urine Sediment Cells RBCs: assess amount &amp;amp; morphology (many dysmorphic â†’ glomerular) WBCs: PMNs (UTI) vs.</description></item><item><title>urothelial carcinoma</title><link>https://www.physician.tw/urothelial-carcinoma/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/urothelial-carcinoma/</guid><description>topic: [[ddMVAC]]]</description></item><item><title>Use of 1,3-Î²-D-glucan in invasive fungal diseases in hematology patients</title><link>https://www.physician.tw/Use-of-13-%CE%B2-D-glucan-in-invasive-fungal-diseases-in-hematology-patients/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Use-of-13-%CE%B2-D-glucan-in-invasive-fungal-diseases-in-hematology-patients/</guid><description>Use of 1,3-Î²-D-glucan in invasive fungal diseases in hematology patients âœ¨é‡é»: å…¥ä¾µæ€§çœŸèŒç–¾ç—…ï¼ˆIFDï¼‰ä»ç„¶æ˜¯è¡€æ¶²å­¸æ‚£è€…ç™¼ç—…å’Œæ­»äº¡ç‡çš„ä¸»è¦åŸå› ã€‚ åœ¨è¨ºæ–·é©…å‹•çš„æ–¹æ³•ä¸­ï¼Œä½¿ç”¨è¡€æ¸…ï¼ˆ1ï¼‰-Î²-D-Glucanï¼ˆBDGï¼‰æ¸¬è©¦ä»£è¡¨äº†IFDæ—©æœŸè¨ºæ–·å’Œæ²»ç™‚çš„æœ‰æ•ˆå·¥å…·ã€‚ æ¶µè“‹çš„å€åŸŸï¼šç³»çµ±åœ°æª¢ç´¢äº†æœ‰é—œBDGåœ¨è¡€æ¶²å­¸æ‚£è€…ä¸­ä½¿ç”¨çš„å¯ç”¨æ–‡ç»ã€‚ ç„¶å¾Œï¼Œé€²è¡Œäº†å¯©æŸ¥å’Œè¨è«–ï¼Œä»¥ç¢ºå®šèˆ‡è©²ä¸»é¡Œçš„è‡¨åºŠæ•˜äº‹ä»‹ç´¹æœ‰é—œçš„é—œéµå•é¡Œã€‚ å°ˆå®¶è©•è«–ï¼š ä½¿ç”¨BDGåœ¨æœ‰ä¾µå…¥æ€§æ›²éœ‰ç—…é¢¨éšªçš„è¡€æ¶²å­¸æ‚£è€…ä¸­ä½¿ç”¨æ˜¯ä½¿ç”¨åŠä¹³ç³–é‡ä½¿ç”¨çš„ã€‚ ä½†æ˜¯ï¼Œç”±æ–¼BDGä¸¦éé‡å°IAç‰¹å®šï¼Œå› æ­¤å®ƒæä¾›äº†è¨ºæ–·å…¶ä»–IFDçš„å„ªå‹¢ï¼Œ ä¾‹å¦‚å¿µç èŒç—…å’Œè‚ºç‚ç´°èƒç—‡ã€‚ èˆ‡å…¶ä»–éšŠåˆ—ç›¸æ¯”ï¼ŒBDGçš„å±€é™æ€§åŒ…æ‹¬è¡€æ¶²å­¸æ‚£è€…çš„é«˜æˆæœ¬å’Œè¼ƒä½çš„æ•æ„Ÿæ€§ã€‚ åœ¨ç¾å¯¦ç”Ÿæ´»ä¸­ï¼Œå‡é™½æ€§çµæœçš„é¢¨éšªå¯èƒ½ä½æ–¼ç†è«–ä¸Šï¼Œ å› ç‚ºç„¡è‘¡èšé†£è¨­å‚™å¯ç”¨ï¼Œç¾ä»£é€æè†œå’Œè¡€æ¶²ç”¢å“é€šå¸¸ä¸æœƒé‡‹æ”¾BDGã€‚ å› æ­¤ï¼Œåœ¨ç¶“é©—è±å¯Œçš„æ‰‹å’Œé¸å®šçš„è‡¨åºŠæƒ…æ³ä¸‹ï¼ŒBDGæ˜¯ä¸€ç¨®æœ‰ç”¨çš„è¨ºæ–·å·¥å…·ï¼Œ å°¤å…¶æ˜¯ç”±æ–¼å¤±èª¤æ™‚é–“çŸ­ï¼Œçµæœå’Œå¤šåŠŸèƒ½æ€§åœ¨è¨ºæ–·ä¸åŒçš„IFDæ–¹é¢ã€‚</description></item><item><title>vagal maneuvers</title><link>https://www.physician.tw/vagal-maneuvers/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vagal-maneuvers/</guid><description>vagal maneuvers 10s
é ¸å‹•è„ˆç«‡æŒ‰æ‘©: å°‡æ‚£è€…ç½®æ–¼ä»°è‡¥ä½ï¼Œé ¸éƒ¨ä¼¸å±•ä¸¦æ—‹è½‰åˆ°æä¾›è€…æ‰“ç®—æŒ‰æ‘©çš„é ¸å‹•è„ˆç«‡çš„å¦ä¸€å´ã€‚é ¸å‹•è„ˆç«‡ä½æ–¼ä¸‹é œè§’ä¸‹æ–¹ã€èƒ¸é–ä¹³çªè‚Œå‰æ–¹å’Œç”²ç‹€è»Ÿéª¨ä¸Šå±¤çš„å‹•è„ˆè¡å‹•è™•ã€‚æä¾›è€…ä½¿ç”¨é£ŸæŒ‡å’Œä¸­æŒ‡çš„æŒ‡å°–åœ¨å¾Œå…§å´æ–¹å‘æ–½åŠ å£“åŠ› 5 åˆ° 10 ç§’ã€‚å¦‚æœä¸æˆåŠŸï¼Œè©²éç¨‹å¯åœ¨ 1 åˆ†é˜å¾Œé‡è¤‡ã€‚å¦‚æœä»ç„¶ä¸æˆåŠŸï¼Œè‡¨åºŠé†«ç”Ÿå¯èƒ½æœƒå˜—è©¦åœ¨å¦ä¸€å´é€²è¡Œæ“ä½œã€‚ CSM çš„è¼”åŠ©åŒ…æ‹¬å°‡æ‚£è€…ç½®æ–¼ç‰¹å€«å¾·å€«ä¼¯è‡¥ä½ã€æŠ¬è…¿ã€ä¼´éš¨ VM æˆ–åŒæ™‚å°æ‚£è€…çš„ä¸Šè…¹éƒ¨æ–½åŠ å£“åŠ›ã€‚å° CSM çš„å¯èƒ½åæ‡‰åŒ…æ‹¬æ‚£è€…å¿ƒç‡æ¸›æ…¢ã€å¿ƒå¾‹å¤±å¸¸çµ‚æ­¢æˆ–ç„¡åæ‡‰ã€‚</description></item><item><title>valve-replacement</title><link>https://www.physician.tw/valve-replacement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/valve-replacement/</guid><description>valve-replacement (Circ 2021;143:e72)
Based on symptoms: once they develop â†’ AVR needed Indicated in: sx severe (stage D1; D2; D3 if AS felt to be cause of sx); asx severe + EF &amp;lt;50% (stage C2); or severe (stage C1) and undergoing other cardiac surgery Reasonable if: asx severe (C1) but either sx or â†“ BP w/ exercise (can carefully exercise asx AS to uncover sx; do not exercise sx AS), very severe, â†‘ BNP, rapid progression Growing data to support AVR in asx severe AS (NEJM 2020;382:111; Circ 2021;143:e72) Type of valve: mechanical reasonable if Pt &amp;lt;50 yrs, bioprosthetic if &amp;gt;65 yrs or cannot tolerate long-term anticoagulation; individualize if 50â€“65 yrs Transcatheter AoV implantation (TAVI, see below) attractive alternative to surgery Medical (if not AVR candidate or to temporize): careful diuresis prn, control HTN, maintain SR; digoxin if â†“ EF &amp;amp; HF or if AF; avoid venodilators (nitrates) &amp;amp; âŠ– inotropes (Î²B/CCB) if severe AS; avoid vigorous physical exertion once AS modâ€“severe ?</description></item><item><title>valvular heart disease</title><link>https://www.physician.tw/valvular-heart-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/valvular-heart-disease/</guid><description>valvular heart disease [[aortic-stenosis]] (AS) [[aortic-regurgitation]] (AR) [[mitral-regurgitation]] (MR) [[mitral-valve-prolapse]] (MVP) [[mitral-stenosis]] (MS) [[tricuspid-regurgitation]] (Circ 2014;129:2440; Lancet 2016;388:2431) [[prosthetic-heart-valves]]</description></item><item><title>Variable and Possible Etiology-fever and rash</title><link>https://www.physician.tw/Variable-and-Possible-Etiology-fever-and-rash/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Variable-and-Possible-Etiology-fever-and-rash/</guid><description>Variable and Possible Etiology-fever and rash Summer/fall &amp;gt; other seasons Enterovirus Winter Parvovirus, Meningococcemia Spring/summer Lyme, RMSF, Ehrlichiosis, Anaplasmosis Year-round Adenovirus, Mycoplasma Cat and dog exposure Bartonella, Pasteurella, Toxoplasma, Capnocytophaga Tick exposure Lyme, RMSF, Ehrlichiosis, Anaplasmosis Adult &amp;lt;30 y Mononucleosis (EBV or CMV) Inadequate immunization Measles, Rubella, VZV, influenza Sexually active HIV, syphilis, disseminated gonococcal infection, HSV</description></item><item><title>Vascular Access-renal replacement and dialysis</title><link>https://www.physician.tw/Vascular-Access-renal-replacement-and-dialysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Access-renal-replacement-and-dialysis/</guid><description>Vascular Access-renal replacement and dialysis AV fistula Pros
Highest patency Lowest risk of bacteremia Lowest mortality (JASN 2013;24:465) Cons Long maturation time (2â€“6 mo) Primary nonfunction (20%) AVgraft Easier to create than AVF Maturation time (2â€“3 wk) Cons: Poor 1Â° patency, often requiring thrombectomy or angioplasty Catheter Immediate use Use as bridge to AVF/AVG Cons: Highest risk of bacteremia â†“ blood flow â†’ â†“ HD efficiency</description></item><item><title>Vascular Beds Affected by Inherited and Acquired Hypercoagulable States</title><link>https://www.physician.tw/Vascular-Beds-Affected-by-Inherited-and-Acquired-Hypercoagulable-States/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vascular-Beds-Affected-by-Inherited-and-Acquired-Hypercoagulable-States/</guid><description>Vascular Beds Affected by Inherited and Acquired Hypercoagulable States Inher. Venous Factor V Leiden Prothrombin mutation â†“ protein C, S or AT III Venous and Arterial Hyperhomocysteinemia (inherited or acquired) Dysfibrinogenemia Acquired Venous Stasis: immobilization, surgery, CHF Malignancy Hormonal: OCPs, HRT, tamoxifen, pregnancy Nephrotic syndrome## Venous Venous and Arterial Platelet defects: myeloproliferative disorders, HIT, PNH (although venous &amp;gt;arterial) Hyperviscosity: polycythemia vera, WaldenstrÃ¶mâ€™s -macroglobulinemia, sickle cell, acute leukemia Vessel wall defects: vasculitis, trauma, foreign bodies Others: antiphospholipid syndrome, IBD</description></item><item><title>vasculitis</title><link>https://www.physician.tw/vasculitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vasculitis/</guid><description>vasculitis [[Background of vasculitis]] [[Evaluation of vasculitis]] [[Distinguihing Characteristics of Vascuiti Subtypes]] LARGE-VESSEL VASCULITIS [[Takayasuâ€™s arteritis]] [[Giant cell arteritis]] (GCA) MEDIUM-VESSEL VASCULITIS [[Kawasaki disease]] (KD) [[Polyarteritis nodosa]] (PAN) [[thromboangiitis obliterans]] Buerger disease SMALL VESSEL VASCULITIS [[ANCA positive Vasculitis]] (AAV) [[immune complex (IC)â€“associated small-vessel vasculitis]] VARIABLE-VESSEL VASCULITIS [[BehÃ§etâ€™s syndrome]] [[Cogan&amp;rsquo;s syndrome]] Single-organ vasculitis [[Cutaneous leukocytoclastic angiitis]] [[Cutaneous arteritis]] [[Primary central nervous system vasculitis]] Isolated aortitis Others Vasculitis associated with systemic disease Lupus vasculitis Rheumatoid vasculitis Sarcoid vasculitis Others Vasculitis associated with probable etiology Hepatitis C virus-associated cryoglobulinemic vasculitis Hepatitis B virus-associated vasculitis Syphilis-associated aortitis Drug-associated immune complex vasculitis Drug-associated ANCA-associated vasculitis Cancer-associated vasculitis Others</description></item><item><title>Vasoactive Agents as Treatment-pulmonary hypertension</title><link>https://www.physician.tw/Vasoactive-Agents-as-Treatment-pulmonary-hypertension/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vasoactive-Agents-as-Treatment-pulmonary-hypertension/</guid><description>Vasoactive Agents as Treatment-pulmonary hypertension PDE-5 inhibitor sildenafil, tadalafil, [[vardenafil]] â†‘ cGMP â†’ vasodilatation, â†“ smooth muscle proliferation, â†“ sx, â†‘ 6MWT, no data on clinical outcomes.</description></item><item><title>venous thromboembolism</title><link>https://www.physician.tw/venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/venous-thromboembolism/</guid><description>venous thromboembolism [[Definitions-venous thromboembolism]] [[Risk factors-venous thromboembolism]] [[Thromboprophylaxis]] clinical manifestations [[deep vein thrombosis]] [[pulmonary embolism]] treatment [[Whom to treat-venous thromboembolism]] [[Initial anticoagulation options for-venous thromboembolism]] [[Systemic thrombolysis]] [[Mechanical intervention-venous thromboembolism]] [[Duration of full-intensity anticoagulation-venous thromboembolism]] [[Long-term anticoagulation options-venous thromboembolism]] [[Extended DOAC strategies-venous thromboembolism]] [[Complications &amp;amp; prognosis-venous thromboembolism]] Ref: Acute Pulmonary Embolism: A Review | Emergency Medicine | JAMA | JAMA Network</description></item><item><title>Ventilator Modes and Principles</title><link>https://www.physician.tw/Ventilator-Modes-and-Principles/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Ventilator-Modes-and-Principles/</guid><description>Ventilator Modes and Principles REF: Volume Control Ventilation â€“ Basic Principles of Mechanical Ventilation
[[how the human body breathes]]
Backlinkï¼š [[mechanical ventilation]]</description></item><item><title>Vericiguat</title><link>https://www.physician.tw/Vericiguat/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vericiguat/</guid><description>Vericiguat 10% â†“ CV mort or HF hosp in NYHA IIâ€“IV (NEJM 2020;382:1883)</description></item><item><title>viral respiratory infections</title><link>https://www.physician.tw/viral-respiratory-infections/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/viral-respiratory-infections/</guid><description>viral respiratory infections Microbiology epidemiology-viral respiratory infections ( http://www.cdc.gov/flu/weekly)
Typical pathogens: Short, mild = rhinovirus, other non-SARS-CoV-2 coronavirus. Longer, more severe or complicated = influenza, parainfluenza, RSV, adenovirus, metapneumovirus, COVID-19 (vide infra).</description></item><item><title>Vitamin B12 deficiency</title><link>https://www.physician.tw/Vitamin-B12-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vitamin-B12-deficiency/</guid><description>Vitamin B12 deficiency (NEJM 2013;368:149)
B12 present only in foods of animal origin; total body stores sufficient for 2â€“3 y</description></item><item><title>vitamin D replacement</title><link>https://www.physician.tw/vitamin-D-replacement/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/vitamin-D-replacement/</guid><description>vitamin D replacement uptodate: - ç¶­ç”Ÿç´  D åŠå…¶ä»£è¬ç‰©å› å…¶èˆ‡éˆ£ç©©æ…‹å’Œéª¨ä»£è¬çš„ç›¸äº’é—œä¿‚è€Œå…·æœ‰é‡è¦çš„è‡¨åºŠä½œç”¨ã€‚ - é›–ç„¶ç”±æ–¼åš´é‡çš„ç¶­ç”Ÿç´  D ç¼ºä¹ç—‡ï¼ˆå…’ç«¥ï¼‰å’Œéª¨è»ŸåŒ–ç—‡ï¼ˆå…’ç«¥å’Œæˆäººï¼‰ç¾åœ¨ä¸¦ä¸å¸¸è¦‹ï¼ˆé™¤äº†åœ¨é™½å…‰ç…§å°„ç•°å¸¸ä½ã€å¼·åŒ–é£Ÿå“ä¸­ç¼ºä¹ç¶­ç”Ÿç´  D å’Œå¸æ”¶ä¸è‰¯ç¶œåˆå¾µçš„äººç¾¤ï¼‰ã€äºè‡¨åºŠç¶­ç”Ÿç´  D ç¼ºä¹ç—‡ã€ç”±ä½è¡€æ¸… 25-ç¾¥åŸºç¶­ç”Ÿç´  D (25[OH]D) æ¸¬é‡ï¼Œæ˜¯å¾ˆå¸¸è¦‹çš„ã€‚ - è¨±å¤šäºè‡¨åºŠç¶­ç”Ÿç´  D ç¼ºä¹ç—‡æ‚£è€…å­˜åœ¨ç›¸å°ä½éˆ£è¡€ç—‡å’Œé«˜è¡€æ¸…ç”²ç‹€æ—è…ºæ¿€ç´  (PTH) æ¿ƒåº¦ï¼Œé€™å¯èƒ½å°è‡´éª¨è³ªç–é¬†ç—‡çš„ç™¼å±•ï¼Œä¸¦å¢åŠ è€å¹´äººéª¨æŠ˜å’Œè·Œå€’çš„é¢¨éšªã€‚ - é€™ç¨®ç¹¼ç™¼æ€§ç”²ç‹€æ—è…ºåŠŸèƒ½äº¢é€²å¯ä»¥é€šéæœç”¨ç¶­ç”Ÿç´  D è£œå……åŠ‘ä¾†æ¸›è¼• [58-60]ã€‚ â­ å­¸ç¿’é‡é» â­ ç¶­ç”Ÿç´  D åŠå…¶ä»£è¬ç‰©çš„å¤šç¨®è£½åŠ‘å¯ç”¨æ–¼æ²»ç™‚ç¶­ç”Ÿç´  D ç¼ºä¹ç—‡ã€‚ ç›¡å¯èƒ½ä½¿ç”¨ç¶­ç”Ÿç´  Dï¼Œè€Œä¸æ˜¯å…¶ä»£è¬ç‰©ï¼Œå› ç‚ºæˆæœ¬è¼ƒä½ã€‚ å…©ç¨®å¸¸ç”¨å½¢å¼çš„ç¶­ç”Ÿç´  D è£œå……åŠ‘æ˜¯è†½éˆ£åŒ–é†‡ï¼ˆç¶­ç”Ÿç´  D3ï¼‰å’Œéº¥è§’éˆ£åŒ–é†‡ï¼ˆç¶­ç”Ÿç´  D2ï¼‰ã€‚ åœ¨ä¸€é …ä¸ƒé …éš¨æ©Ÿè©¦é©—çš„è–ˆèƒåˆ†æä¸­ï¼Œè©•ä¼°è£œå……è†½éˆ£åŒ–é†‡èˆ‡éº¥è§’éˆ£åŒ–é†‡å¾Œè¡€æ¸… 25(OH)D æ¿ƒåº¦ï¼Œè†½éˆ£åŒ–é†‡æ¯”éº¥è§’éˆ£åŒ–é†‡æ›´æœ‰æ•ˆåœ°å¢åŠ è¡€æ¸… 25(OH)Dï¼ˆè¡€æ¸… 25[OH]D çš„å¹³å‡å·®ç•°ç‚º 6 ng/æ¯«å‡ [15.</description></item><item><title>Vitamin K deficiency</title><link>https://www.physician.tw/Vitamin-K-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Vitamin-K-deficiency/</guid><description>Vitamin K deficiency Etiologies: malnutrition, â†“ absorption (antibiotic suppression of vitamin K-producing intestinal flora or malabsorption), liver disease (â†“ stores), warfarin</description></item><item><title>volume status</title><link>https://www.physician.tw/volume-status/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/volume-status/</guid><description>volume status (JVP, skin turgor, dry axilla, mucous membranes, edema, ascites), effusions, vital signs, orthostatics, BUN/Cr, FEUricAcid, UNa</description></item><item><title>von Willebrandâ€™s disease vWD</title><link>https://www.physician.tw/von-Willebrands-disease-vWD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/von-Willebrands-disease-vWD/</guid><description>von Willebrandâ€™s disease (vWD) (NEJM 2016;375:2067)
von Willebrandâ€™s factor (vWF) function = platelet glue &amp;amp; plasma carrier of factor VIII</description></item><item><title>Washington Manual Thyroid Disorders</title><link>https://www.physician.tw/Washington-Manual-Thyroid-Disorders/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Washington-Manual-Thyroid-Disorders/</guid><description>Washington Manual Thyroid Disorders Hyperthyroidism4,5 GENERAL PRINCIPLES
Gravesâ€™ disease causes most cases of hyperthyroidism, especially in young patients. This autoimmune disorder may also cause proptosis (exophthalmos) and pretibial myxedema, neither of which is found in other causes of hyperthyroidism.</description></item><item><title>WBC of cerebrospinal fluid</title><link>https://www.physician.tw/WBC-of-cerebrospinal-fluid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/WBC-of-cerebrospinal-fluid/</guid><description>WBC of cerebrospinal fluid æ­£å¸¸ CSF WBC &amp;lt; 5 è‹¥ traumatic tappingï¼Œæ¯ 500â€“1500 å€‹ RBC è¦æ¸›å» 1 WBC è‹¥ neutrophil ç‚ºä¸»ä¸Šå‡ï¼Œå¯èƒ½åŸå› åŒ…æ‹¬ï¼šbacteria è‹¥ lymphocyte ç‚ºä¸»ä¸Šå‡ï¼Œå¯èƒ½åŸå› åŒ…æ‹¬ï¼š virusã€fungusã€TBã€malignancyã€viral/autoimmune encephalitis [[Lymphocytic pleocytosis]] è‹¥ eosinophils ç‚ºä¸»ä¸Šå‡ã€å¯èƒ½åŸå› åŒ…æ‹¬ï¼šparasiteã€æŸäº›ç‰¹æ®Šæ„ŸæŸ“æˆ–è¡€æ¶²ç–¾ç—…ç­‰</description></item><item><title>weakness and neuromuscular dysfunction</title><link>https://www.physician.tw/weakness-and-neuromuscular-dysfunction/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/weakness-and-neuromuscular-dysfunction/</guid><description/></item><item><title>Weaning from Mechanical Ventilation</title><link>https://www.physician.tw/Weaning-from-Mechanical-Ventilation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Weaning-from-Mechanical-Ventilation/</guid><description>Weaning from Mechanical Ventilation è‚ºæå‚·ç©©å®šæˆ–æ¶ˆé€€ å……åˆ†çš„æ°£é«”äº¤æ›ï¼Œå‘¼æ°£æœ«æ­£å£“ (PEEP) å’Œå¸å…¥æ°§åˆ†æ•¸ (FiO 2 ) è¦æ±‚ä½ï¼ˆä¾‹å¦‚ï¼ŒPEEP &amp;lt; 5â€“8 cm H2Oï¼ŒFiO 2 &amp;lt; 0.4â€“0.5ï¼‰ è¡€æµå‹•åŠ›å­¸ç©©å®šæ€§ï¼ˆä¾‹å¦‚ï¼Œä¸éœ€è¦å‡å£“æˆ–æ–·å¥¶ï¼Œä¸¦ä¸”æ²’æœ‰åš´é‡çš„å¿ƒå¾‹å¤±å¸¸ï¼‰ èƒ½å¤ å•Ÿå‹•å¸æ°£åŠªåŠ›çš„æ‚£è€… âœ¨ å­¸ç¿’é‡é» ğŸ¦ ä¸Šè¿°æ¨™æº–æ‡‰ä½œç‚ºæ–·å¥¶ç¯©æŸ¥æ¯å¤©é€²è¡Œè©•ä¼°ã€‚å°æ–¼é€šéæ¯æ—¥æ–·å¥¶ç¯©æŸ¥çš„æ‚£è€…ï¼Œé¦–å…ˆé€²è¡Œåˆæ­¥çš„ç°¡çŸ­è©¦é©—æˆ–æº–å‚™æƒ…æ³è©•ä¼°ï¼Œåœ¨æ­¤æœŸé–“å°æ‚£è€…é€²è¡Œ 1 è‡³ 5 åˆ†é˜çš„å¯†åˆ‡è§€å¯Ÿï¼ŒåŒæ™‚æ¥å—æœ€å°‘æˆ–ä¸æ¥å—æ”¯æŒï¼ˆæŒçºŒæ°£é“æ­£å£“é€šæ°£ [CPAP] â‰¤ 5 cm H 2 O)ï¼Œè©•ä¼°ä»–å€‘é€²è¡Œæ­£å¼è‡ªä¸»å‘¼å¸è©¦é©— (SBT) çš„èƒ½åŠ›ã€‚ å¦‚æœæ‚£è€…åœ¨æº–å‚™æƒ…æ³è©•ä¼°æœŸé–“è¡¨ç¾è‰¯å¥½ï¼Œå‰‡é€²è¡Œå¤§ç´„ 30 åˆ†é˜çš„ SBTã€‚ åœ¨æ­¤æœŸé–“ï¼Œå¯†åˆ‡ç›£æ¸¬æ‚£è€…å‘¼å¸åŠŸèƒ½ä¸å…¨ã€è¡€æµå‹•åŠ›å­¸æƒ¡åŒ–ã€æ°£é«”äº¤æ›å•é¡Œæˆ–æ‚£è€…ä¸é©çš„è·¡è±¡ã€‚ å¦‚æœå‡ºç¾å•é¡Œï¼Œå°‡ç«‹å³é‡æ–°å•Ÿå‹•å…¨é¢çš„å‘¼å¸æ©Ÿæ”¯æŒã€‚ æˆåŠŸå®Œæˆ SBT å¯é«˜åº¦é æ¸¬æˆåŠŸåœç”¨å‘¼å¸æ©Ÿã€‚</description></item><item><title>What are the most commonly encountered fever patterns</title><link>https://www.physician.tw/What-are-the-most-commonly-encountered-fever-patterns/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/What-are-the-most-commonly-encountered-fever-patterns/</guid><description>What are the most commonly encountered fever patterns Sustained or continued (little variability from day to day): this used to be the pattern of lobar pneumonia , steady until abruptly resolving by either crisis or death.</description></item><item><title>When to suspect migraine</title><link>https://www.physician.tw/When-to-suspect-migraine/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/When-to-suspect-migraine/</guid><description>When to suspect migraine Recurrent headache of moderate to severe intensity Visual aura Family history of migraine Onset of symptoms at or around puberty In the third edition of the International Classification of Headache Disorders (ICHD-3), migraine is classified into three main types:</description></item><item><title>When to treat chronic HBV with anti-virals</title><link>https://www.physician.tw/When-to-treat-chronic-HBV-with-anti-virals/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/When-to-treat-chronic-HBV-with-anti-virals/</guid><description>When to treat chronic HBV with anti-virals (1) immune active phase; (2) HBeAg âŠ– chronic hepatitis B; (3) cirrhosis w/ HBV DNA â‰¥2K; (4) decomp.</description></item><item><title>Whippleâ€™s disease</title><link>https://www.physician.tw/Whipples-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Whipples-disease/</guid><description>Whippleâ€™s disease infxn w/ T. whipplei (Lancet 2016;16:13)
Other s/s: fever, LAN, edema, arthritis, CNS Î”s, gray-brown skin pigmentation, AI &amp;amp; MS, oculomasticatory myorhythmia (eye oscillations + mastication muscle contract).</description></item><item><title>Whom to treat-venous thromboembolism</title><link>https://www.physician.tw/Whom-to-treat-venous-thromboembolism/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Whom-to-treat-venous-thromboembolism/</guid><description>Whom to treat-venous thromboembolism (JAMA 2020;324:1765; Chest 2021;160:e545)
Superficial venous thrombosis:
elevate extremity, warm compresses, compression stockings, NSAIDs for sx.</description></item><item><title>wide complex</title><link>https://www.physician.tw/wide-complex/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wide-complex/</guid><description>wide complex regular VT or unknown WCT try adenosine
if no response then: [[amiodarone]] or procainamide or sotalol or lidocaine (if VT) &amp;amp; prepare for synch cardioversion</description></item><item><title>wide-complex tachycardias WCTS</title><link>https://www.physician.tw/wide-complex-tachycardias-WCTS/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wide-complex-tachycardias-WCTS/</guid><description>wide-complex tachycardias (WCTS) [[Etiologies-wide-complex tachycardias (WCTS)]] [[Monomorphic ventricular tachycardia (MMVT)]] [[Polymorphic ventricular tachycardia (PMVT)]] [[Diagnostic clues that favor VT]] [[Long-term management-wide-complex tachycardias (WCTS)]]</description></item><item><title>Wilson disease</title><link>https://www.physician.tw/Wilson-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wilson-disease/</guid><description>Wilson disease (World J Hepatol 2015;7:2859)
Recessive disorder of copper transport (mutation in ATP7B) â†’ copper overload
Epidemiology: 1 in ~30,000 w/ age of presentation generally ranging from 3 to 55 y</description></item><item><title>Wolff-Chaikoff effect</title><link>https://www.physician.tw/Wolff-Chaikoff-effect/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wolff-Chaikoff-effect/</guid><description>Wolff-Chaikoff effect Excess iodide transiently inhibits thyroid iodide organification (step 2) In individuals with a normal thyroid, the gland escapes from this inhibitory effect In individuals with underlying autoimmune thyroid disease (Hashimoto&amp;rsquo;s thyroiditis or Graves&amp;rsquo; disease), the suppressive effect may persist</description></item><item><title>woman health</title><link>https://www.physician.tw/woman-health/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/woman-health/</guid><description>woman health Contraception Vaginitis/Sexually Transmitted Infections (STIs)/Pelvic Inflammatory Disease (PID) Polycystic Ovary Syndrome (PCOS) Menstrual and Bleeding Disorders Menopause Preconception Care and Pregnancy Infertility Miscarriage and Abortion</description></item><item><title>Wonâ€™t Breathe as Etiologies of High elevated PaCO2</title><link>https://www.physician.tw/Wont-Breathe-as-Etiologies-of-High-elevated-PaCO2/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Wont-Breathe-as-Etiologies-of-High-elevated-PaCO2/</guid><description>Wonâ€™t Breathe as Etiologies of High elevated PaCO2 decreae RR Respiratory Drive Voluntary hypervent. NI Pimax &amp;amp; A-a grad Metabolic alkalosis 1Â° neurologic: brain- stem stroke, tumor, 1Â° alveolar hypovent 2Â° neurologic: sedatives, CNS infxn, [[hypothyroidism]]</description></item><item><title>Workup for effusion</title><link>https://www.physician.tw/Workup-for-effusion/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-effusion/</guid><description>Workup for effusion r/o infxn: usually apparent from Hx &amp;amp; CXR; ? value of âœ“ acute and convalescent serologies</description></item><item><title>Workup for idiopathic VTE</title><link>https://www.physician.tw/Workup-for-idiopathic-VTE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-idiopathic-VTE/</guid><description>Workup for idiopathic VTE (NEJM 2015;373:697)
Thrombophilia workup âœ“ if âŠ• FH; may be helpful but consider timing as thrombus, heparin and warfarin Î” results Useful for relatives, if dx APLAS (given requires warfarin), or if not planning lifelong anticoagulation for Pt.</description></item><item><title>Workup for non-AG metabolic acidosis</title><link>https://www.physician.tw/Workup-for-non-AG-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-non-AG-metabolic-acidosis/</guid><description>Workup for non-AG metabolic acidosis Evaluate history for causes (see above)
âœ“ urine anion gap (UAG) = (UNa + UK) â€“ UCl UAG = unmeasured anions â€“ unmeasured cations; NH4+ is primary unmeasured cation (represented by UCl).</description></item><item><title>Workup of acute hypoxemia</title><link>https://www.physician.tw/Workup-of-acute-hypoxemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-acute-hypoxemia/</guid><description>Workup of acute hypoxemia Cyanosis: when &amp;gt;5 g/dL of deoxygenated Hb in vessels of skin/mucous membranes.
Central: â†“ SaO2 (pulm disease, shunt); abnl Hb [metHb, sulfHb, COHb (not true cyanosis)]</description></item><item><title>Workup of chronic diarrhea</title><link>https://www.physician.tw/Workup-of-chronic-diarrhea/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-chronic-diarrhea/</guid><description>Workup of chronic diarrhea positive: FOB WBC calprotectin lactoferrin Inflammatory: stool culture, colonoscopy
positive: fecal fat Malabsorption: * Based on hx: âœ” tissue transglut.</description></item><item><title>Workup-acid-base disturbances</title><link>https://www.physician.tw/Workup-acid-base-disturbances/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acid-base-disturbances/</guid><description>Workup-acid-base disturbances Traditional or physiologic approach (BrÃ¸nsted-Lowry definition of acids &amp;amp; bases) Determine primary disorder: âœ“ pH, PaCO2, HCO3 Determine if degree of compensation is appropriate [[Compensation-for-Acid-Base-Disorders]] Alternative approaches Base excess/deficit (NEJM 2018;378:1419) Strong ion difference or â€œStewart Methodâ€ (NEJM 2014;371:1821)</description></item><item><title>Workup-acute kidney injury AKI</title><link>https://www.physician.tw/Workup-acute-kidney-injury-AKI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acute-kidney-injury-AKI/</guid><description>Workup-acute kidney injury (AKI) H&amp;amp;P: meds, contrast, or other nephrotoxins; â†“ PO intake, HoTN, infxn/sepsis; trauma, myalgias; BPH/retention. Search for insult 24â€“48 hr prior â†‘ Cr.</description></item><item><title>Workup-acute liver failure</title><link>https://www.physician.tw/Workup-acute-liver-failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-acute-liver-failure/</guid><description>Workup-acute liver failure (Clin Liver Dis 2017;21:769)
CBC, PT/PTT, LFTs, lytes, BUN/Cr, NH3, pH, arterial lactate, acetaminophen level, HIV, amylase/lipase, viral serologies (qv) in all Pts, with additional labs as below if suspected</description></item><item><title>Workup-cirrhosis</title><link>https://www.physician.tw/Workup-cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-cirrhosis/</guid><description>Workup-cirrhosis (Am J Gastro 2017;112:18; Lancet 2021;398:1359)
Abd U/S w/ Doppler: liver size &amp;amp; echotexture, r/o HCC, ascites, âœ“ patency of vasculature</description></item><item><title>Workup-fever in a returned traveler</title><link>https://www.physician.tw/Workup-fever-in-a-returned-traveler/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-fever-in-a-returned-traveler/</guid><description>Workup-fever in a returned traveler Routine testing: CBC w/ diff, BMP, LFTs, BCx, UA, rapid malaria test Fever in a traveler from a malaria zone is malaria until proven otherwise; consider a medical emergency â†’ hospitalization &amp;amp; empiric Rx.</description></item><item><title>Workup-fever of unknown origin</title><link>https://www.physician.tw/Workup-fever-of-unknown-origin/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-fever-of-unknown-origin/</guid><description>Workup-fever of unknown origin Initial: CBC w/ diff, CMP, ESR, CRP, 3 sets BCx (off abx), U/A, UCx, CXR Additional workup based on sx: ANA, RF, cryoglobulin, LDH, CK/aldolase, SPEP, TFTs, PPD or IGRA, HIV Ag/Ab Â± PCR, RPR, EBV serologies, CMV PCR, HBV/HCV serologies Consider imaging: chest &amp;amp; abd CT, tagged WBC scan, FDG-PET, TTE, LE duplex US Tissue dx: consider bx of LN (excisional preferred), liver (especially if â†‘ AÏ•), TA (for GCA), BM, kidney (RPGN)</description></item><item><title>Workup-for-AG-metabolic-acidosis</title><link>https://www.physician.tw/Workup-for-AG-metabolic-acidosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-for-AG-metabolic-acidosis/</guid><description>Workup-for-AG-metabolic-acidosis (AJKD 2021;78:A16)
âœ“ for ketonuria (dipstick acetoacetate) or plasma Î²-hydroxybutyrate (Î²OHB) nb, urine acetoacetate often not present in early ketoacidosis due to shunting to Î²OHB; âˆ´ acetoacetate may later turn âŠ• but does not signify worsening disease If âŠ– ketones, âœ“ renal function, lactate, toxin screen, and osmolal gap If obtunded or â†‘â†‘ AG, check osmolal gap (OG) = measured osmoles â€“ calculated osmoles Calculated osmoles = (2 Ã— Na) + (glucose/18) + (BUN/2.</description></item><item><title>Workup-glomerulonephritis</title><link>https://www.physician.tw/Workup-glomerulonephritis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-glomerulonephritis/</guid><description>Workup-glomerulonephritis (JAMA 2017;318:1276)
Acute GN/RPGN Â± lung hemorrhage is an emergency â†’ requires early Dx and Rx
UA + sediment (dysmorphic RBCs) âœ“ ANCA, anti-GBM, C3/C4, SPEP, serum FLC</description></item><item><title>Workup-hyperkalemia</title><link>https://www.physician.tw/Workup-hyperkalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hyperkalemia/</guid><description>Workup-hyperkalemia (Crit Care Med 2008;36:3246)
Rule out pseudohyperkalemia (IVF w/ K, tourniquet, hemolysis, â†‘ plt or WBC), rule out transcellular shift</description></item><item><title>Workup-hypernatremia</title><link>https://www.physician.tw/Workup-hypernatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hypernatremia/</guid><description>Workup-hypernatremia âœ“ Uosm, UNa, volume status (vital signs, orthostatics, JVP, skin turgor, BUN, Cr)</description></item><item><title>Workup-hypokalemia</title><link>https://www.physician.tw/Workup-hypokalemia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-hypokalemia/</guid><description>Workup-hypokalemia (JAMA 2021;12:1216)
Identify transcellular shifts &amp;amp; treat. TTKG validity questioned (Curr Op Nephro 2011;20:547).
âœ“ UK:Cr: &amp;gt;13 mEq/g â†’ renal loss; &amp;lt;13 mEq/g â†’ extrarenal loss (AJKD 2019;74:682)</description></item><item><title>workup-hyponatremia</title><link>https://www.physician.tw/workup-hyponatremia/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/workup-hyponatremia/</guid><description>workup-hyponatremia (JASN 2012;23:1140 &amp;amp; 2017;28:1340; Crit Care 2013;17:206; NEJM 2015;372:55)
Workup History: acute vs. chronic (&amp;gt;48 h); sx severity; risk for neuro complications (alcoholism, malnourished, cirrhosis, older women on thiazides, hypoxia, hypoK) [[Measure plasma osmolality]] For hypotonic hyponatremia, âœ“ [[volume status]] [[Measure Uosm]] If euvolemic and â†‘ Uosm, evaluate for glucocorticoid insufficiency and hypothyroidism If available, consider FEUricAcid as &amp;gt;12% suggests SIADH (J Clinc Endo 2008;93:2991) Backlinkï¼š [[sodium and water homeostasis]]</description></item><item><title>Workup-nephrolithiasis</title><link>https://www.physician.tw/Workup-nephrolithiasis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-nephrolithiasis/</guid><description>Workup-nephrolithiasis Non-contrast CT 97% Se, 96% Sp (ureteral dilation w/o stone suggests recent passage); U/S (Se 57%, Sp 98%) may serve as initial test in stable patient (NEJM 2014;371:1100)</description></item><item><title>Workup-nephrotic syndrome</title><link>https://www.physician.tw/Workup-nephrotic-syndrome/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-nephrotic-syndrome/</guid><description>Workup-nephrotic syndrome (BMJ 2008;336:1185)
U/A + sediment: usually benign; Â± oval fat bodies (â€œMaltese crossesâ€; NEJM 2007;357:806)
Measure proteinuria: 24-h urine or spot urine protein/Cr ratio (not accurate in AKI), renal bx</description></item><item><title>Workup-of-hematuria</title><link>https://www.physician.tw/Workup-of-hematuria/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-of-hematuria/</guid><description>Workup-of-hematuria (NEJM 2021;385:153)
Urine dipstick: âŠ• if â‰¥3 RBCs; âŠ• dipstick and âŠ– sediment â†’ myo- or hemoglobinuria</description></item><item><title>Workup-syncope</title><link>https://www.physician.tw/Workup-syncope/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Workup-syncope/</guid><description>Workup-syncope (etiology cannot be determined in ~40% of cases) (JAMA 2019;321:2448)
H&amp;amp;P incl. orthostatic VS have highest yield and most cost effective R/o life-threatening dx including: cardiac syncope, severe blood loss, PE, SAH History (from Pt and witnesses if available) activity and posture before the incident precipitating factors: exertion (AS, HCMP, PHT), positional âˆ† (orthostatic HoTN), stressors such as sight of blood, pain, emotional distress, fatigue, prolonged standing, warm environment, N/V, cough/deglutition/micturition/defecation (neurocardiogenic), head turning or shaving (carotid sinus hypersens.</description></item><item><title>wowoowow</title><link>https://www.physician.tw/wowoowow/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/wowoowow/</guid><description>wowoowow Thromboembolism is a book of writing is therefore is a book of Backlinkï¼š [[é€™è£¡ä¸»è¦å°±æ˜¯ä¸€äº›å¯¦é©—çš„å…§å®¹]]</description></item><item><title>YPM0hbw1azf qwq2fpw</title><link>https://www.physician.tw/YPM0hbw1azf-qwq2fpw/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/YPM0hbw1azf-qwq2fpw/</guid><description/></item><item><title>zettle</title><link>https://www.physician.tw/zettle/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/zettle/</guid><description>zettle</description></item><item><title>Zygomycetes</title><link>https://www.physician.tw/Zygomycetes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/Zygomycetes/</guid><description>Zygomycetes Epidemiology: diabetes (espec. those w/ prior DKA), heme malignancy, neutropenia, transplant, chronic steroids, iron overload, trauma, h/o voriconazole Rx or Ppx Clinical: rhinocerebral = severe periorbital/facial pain, swelling, vision changes, sinusitis, opthalmoplegia, nasal ulcerations/ necrosis, HA.</description></item><item><title>Î±1-antitrypsin deficiency</title><link>https://www.physician.tw/%CE%B11-antitrypsin-deficiency/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B11-antitrypsin-deficiency/</guid><description>Î±1-antitrypsin deficiency early-onset panacinar emphysema or signif basilar disease,
1â€“3% of COPD cases. Suspect if age &amp;lt;45,
lower lungs affected,</description></item><item><title>Î±1-antitrypsin deficiency Î±1-AT</title><link>https://www.physician.tw/%CE%B11-antitrypsin-deficiency-%CE%B11-AT/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B11-antitrypsin-deficiency-%CE%B11-AT/</guid><description>Î±1-antitrypsin deficiency (Î±1-AT) (J Hepatol 2016;65:413; NEJM 2020;382:1443)
Abnl Î±1-AT â†’ polymerization in liver (cirrhosis) &amp;amp; uninhibited protease activity in lung (emphysema).</description></item><item><title>Î²-blocker</title><link>https://www.physician.tw/%CE%B2-blocker/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%CE%B2-blocker/</guid><description>Î²-blocker (data for carvedilol, metoprolol, bisoprolol)
Add in concert w/ RASi
35% â†“ mort. &amp;amp; 40% â†“ rehosp. in NYHA IIâ€“IV (JAMA 2002;287:883)</description></item><item><title>å…¶ä»–ç§‘</title><link>https://www.physician.tw/%E5%85%B6%E4%BB%96%E7%A7%91/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%85%B6%E4%BB%96%E7%A7%91/</guid><description>å…¶ä»–ç§‘</description></item><item><title>å¯¶ç›Šå…’å¤šç¨®ç¶­ä»–å‘½</title><link>https://www.physician.tw/%E5%AF%B6%E7%9B%8A%E5%85%92%E5%A4%9A%E7%A8%AE%E7%B6%AD%E4%BB%96%E5%91%BD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E5%AF%B6%E7%9B%8A%E5%85%92%E5%A4%9A%E7%A8%AE%E7%B6%AD%E4%BB%96%E5%91%BD/</guid><description>å¯¶ç›Šå…’å¤šç¨®ç¶­ä»–å‘½ å¯¶ç›Šå…’å°å…’æ»´åŠ‘ï¼Œæ¯æ—¥1ccç‚ºå¯¶å¯¶çš„å¥åº·åŠ åˆ†ï¼ å…¨æ–°çš„ç¶œåˆé…æ–¹ï¼ˆå«ç¶­ä»–å‘½D3 400IU)ä¸€æ¬¡åˆ°ä½æä¾›å¯¶å¯¶éœ€è¦çš„å„ç¨®ç‡Ÿé¤Šç´ ã€‚
é£Ÿç”¨æ–¹å¼(ç”¨æ³•ç”¨é‡) : 3 æ­²ä»¥ä¸‹æ¯æ—¥1ccï¼Œ4-12 æ­²æ¯æ—¥1.5ccï¼Œ 13 æ­²ä»¥ä¸Šæ¯æ—¥2ccï¼Œè€å¹´äººæ¯æ—¥2-3ccã€‚ è«‹ç”¨å¸ç®¡æŒ‰å£“å¸å–è‡³åˆ»åº¦1ç‚º1ccã€‚å¯ç›´æ¥é¤µé£Ÿæ–¼å£å…§æˆ–æ·»åŠ æ–¼é–‹æ°´ã€ç‰›å¥¶ã€æœæ±ä¸­é£²ç”¨ã€‚</description></item><item><title>å¸¸è¦‹ä¸»è¨´çš„apporach</title><link>https://www.physician.tw/symptom-to-diagnosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/symptom-to-diagnosis/</guid><description>å¸¸è¦‹ä¸»è¨´çš„apporach é€™æ˜¯ä¸€å€‹å¾ˆå¥½çš„æ€è€ƒç·´å€ [[sxtodx]]
[[diagnostic process]] [[screening and health maintenance]] [[abdominal pain]] [[acid-base abnormalities]] [[AIDS HIV infection]] [[anemia]] [[back pain]] [[bleeding disorders]] [[chest pain]] [[cough, fever, and respiratory infections]] [[delirium and dementia]] [[Diabetes key clinical trials]] [[diarrhea, acute]] [[dizziness]] [[dyspnea]] [[dysuria]] [[edema]] [[fatigue]] [[gi bleeding]] [[headache]] [[hematuria]] [[hypercalcemia]] [[hypertension]] [[hyponatremia and hypernatremia]] [[hypotension]] [[jaundice and abnormal liver enzymes]] [[joint pain]] [[acute kidney injury]] [[rash]] [[sore throat]] [[syncope]] [[unintentional weight loss]] [[wheezing and stridor]]</description></item><item><title>è²¼ç‰‡</title><link>https://www.physician.tw/%E8%B2%BC%E7%89%87/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.physician.tw/%E8%B2%BC%E7%89%87/</guid><description>è²¼ç‰‡ é–‹æ©Ÿå°±è½‰åˆ°é›»æ“Šæ¨¡å¼ ç´…å¿ƒ(å…¶å¯¦æ˜¯è…³)</description></item></channel></rss>